data_2k4v_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k4v _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 t80 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.912 0.387 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.01 152.54 55.26 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 125.309 1.444 . . . . 0.0 107.929 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.3 97.15 0.29 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.769 1.646 . . . . 0.0 111.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.4 -15.3 6.08 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.636 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -160.83 153.75 21.22 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 117.378 0.589 . . . . 0.0 112.202 -172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt -135.6 125.74 26.2 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -98.1 139.83 33.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.315 1.046 . . . . 0.0 110.148 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -132.26 117.89 18.78 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.728 0.811 . . . . 0.0 110.809 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 162.489 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.244 0.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.78 82.7 4.98 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.477 HG23 HG21 ' A' ' 49' ' ' ILE . 1.3 pp -109.83 128.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 p30 -150.86 123.59 8.58 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 46.1 mt -140.47 140.52 34.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.517 ' O ' ' HA ' ' A' ' 45' ' ' MET . 6.6 m170 -114.24 134.29 55.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 171.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.401 HG12 ' HG2' ' A' ' 45' ' ' MET . 58.2 mt -123.5 105.76 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -102.87 132.69 48.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -129.25 123.73 32.68 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.2 116.45 20.64 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 41' ' ' VAL . 79.2 t -79.11 117.14 24.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -118.76 159.51 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -107.93 119.35 39.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.7 0.4 . . . . 0.0 109.928 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.434 HD21 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -99.53 148.8 23.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.252 1.021 . . . . 0.0 109.152 168.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.61 60.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.981 0.513 . . . . 0.0 111.972 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.99 -55.29 5.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.841 0.856 . . . . 0.0 111.823 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.413 ' HB3' HD22 ' A' ' 34' ' ' ASN . 35.7 t -114.63 -6.97 12.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.236 0.614 . . . . 0.0 111.668 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.41 -108.23 3.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -172.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.19 141.73 45.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.117 0.459 . . . . 0.0 111.289 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 7.7 p90 -156.64 166.87 32.15 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.929 0.891 . . . . 0.0 108.796 168.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 31' ' ' VAL . 3.9 t -115.8 126.51 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 122.066 -0.396 . . . . 0.0 110.219 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.422 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 63.9 t60 -90.69 120.54 31.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.228 1.011 . . . . 0.0 108.7 170.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -107.75 145.05 34.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.1 0.56 . . . . 0.0 110.336 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -128.64 128.6 44.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.603 1.161 . . . . 0.0 108.672 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 82.7 mtp -123.82 129.41 50.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.1 0.409 . . . . 0.0 110.352 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -154.16 147.44 24.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.854 0.462 . . . . 0.0 111.425 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.44 -151.18 16.75 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.83 108.73 3.7 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.895 1.348 . . . . 0.0 111.022 171.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.477 HG21 HG23 ' A' ' 23' ' ' ILE . 68.4 mt -100.76 127.97 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.485 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 63.22 22.16 13.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.004 1.321 . . . . 0.0 109.167 -170.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.48 -3.41 87.07 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.558 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.51 109.98 28.14 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 112.003 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.68 141.95 31.62 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.868 2.378 . . . . 0.0 111.96 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.09 147.92 39.32 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.141 0.577 . . . . 0.0 110.072 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.4 p -138.68 116.51 11.54 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.87 147.13 51.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.591 1.157 . . . . 0.0 108.964 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.9 m -142.63 129.59 20.67 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -138.81 143.43 38.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.737 0.815 . . . . 0.0 109.019 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 62.4 mt-10 -126.38 133.6 51.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.365 0.666 . . . . 0.0 110.202 -174.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt -124.2 128.86 24.92 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 124.159 0.983 . . . . 0.0 109.231 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 44.7 Cg_endo -63.99 161.76 31.91 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.75 2.3 . . . . 0.0 111.466 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -44.91 -32.27 1.55 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.934 0.894 . . . . 0.0 113.161 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -70.53 -29.6 66.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.742 1.217 . . . . 0.0 112.443 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.6 p -130.49 16.29 5.43 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.854 0.861 . . . . 0.0 110.319 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.18 98.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.353 0.661 . . . . 0.0 111.053 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -73.46 -2.51 22.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.482 1.113 . . . . 0.0 112.566 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.48 2.08 53.54 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.686 0.794 . . . . 0.0 110.41 173.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.545 ' HE2' ' SD ' ' A' ' 98' ' ' MET . 12.3 p90 -54.39 -49.97 68.64 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.225 1.01 . . . . 0.0 112.528 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.14 -28.44 39.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -71.79 -51.88 20.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.768 0.427 . . . . 0.0 110.146 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -52.24 13.95 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.4 13.8 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.865 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 m -75.8 -44.59 40.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -56.02 -45.19 79.18 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.789 1.236 . . . . 0.0 112.002 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.05 -31.65 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.765 0.826 . . . . 0.0 110.937 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.77 -43.15 80.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.127 0.571 . . . . 0.0 110.618 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.591 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 18.3 pt20 -78.71 -25.82 44.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.258 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -65.76 -25.13 67.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.184 0.594 . . . . 0.0 110.422 169.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -86.67 0.73 54.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.302 0.641 . . . . 0.0 112.595 176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.39 43.47 0.64 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 4.4 mm? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 165.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.1 t80 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.36 -32.9 72.81 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.747 0.654 . . . . 0.0 111.811 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.73 -44.59 66.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.381 0.673 . . . . 0.0 111.17 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.545 ' SD ' ' HE2' ' A' ' 68' ' ' PHE . 28.6 ttm -63.76 -39.83 95.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.397 0.679 . . . . 0.0 111.844 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.52 -50.29 74.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.416 1.486 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.487 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 11.9 pt-20 -70.55 -30.91 67.76 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.67 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.47 -54.4 47.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.67 -38.03 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.62 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.582 HH11 ' HB1' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -69.74 -31.15 68.98 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.202 0.91 . . . . 0.0 111.46 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.582 ' HB1' HH11 ' A' ' 103' ' ' ARG . . . -75.09 -44.7 45.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.561 0.345 . . . . 0.0 110.469 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -59.26 -42.78 91.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.924 1.29 . . . . 0.0 113.117 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.94 -32.14 72.53 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.712 0.805 . . . . 0.0 111.412 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -80.7 -19.91 44.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 110.676 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 C-N-CA 126.689 1.996 . . . . 0.0 110.884 179.019 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.374 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.54 118.64 64.04 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.087 0.955 . . . . 0.0 109.945 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.47 114.91 2.19 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.288 2.659 . . . . 0.0 112.982 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.0 p -71.75 139.91 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.641 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.57 1.63 13.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -63.07 -33.83 76.29 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.876 0.762 . . . . 0.0 111.801 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.63 -39.35 73.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.219 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -60.34 -21.32 61.92 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.429 1.092 . . . . 0.0 111.535 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.97 -33.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.366 0.603 . . . . 0.0 109.472 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.49 -27.11 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.893 0.877 . . . . 0.0 110.123 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 . . . . . 0 N--CA 1.482 1.153 0 C-N-CA 123.262 0.625 . . . . 0.0 111.745 -177.014 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.48 151.61 25.81 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.96 0.904 . . . . 0.0 109.03 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -56.42 92.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.654 2.236 . . . . 0.0 112.127 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.54 -40.61 1.03 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.896 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -154.69 144.16 21.36 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.209 0.603 . . . . 0.0 111.832 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.8 tp -126.91 134.58 50.42 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.863 1.265 . . . . 0.0 108.869 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -98.72 115.54 28.96 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.655 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 1.3 tm? -97.51 110.14 22.76 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.069 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -127.07 103.78 7.63 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.601 HG22 ' HG ' ' A' ' 81' ' ' LEU . 1.7 pp -120.31 149.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -153.52 120.77 5.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.32 0.648 . . . . 0.0 109.862 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 55.8 mt -139.14 141.37 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.659 0.784 . . . . 0.0 109.601 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.1 m170 -104.26 112.42 25.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.2 mt -112.23 109.78 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.62 123.99 51.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.874 1.27 . . . . 0.0 107.679 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -121.04 128.28 52.5 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -119.52 113.3 20.53 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 92.1 t -77.54 115.84 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -145.51 167.58 22.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 108.734 -170.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -111.4 121.62 45.7 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.744 0.417 . . . . 0.0 110.495 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.78 153.53 19.05 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.521 1.129 . . . . 0.0 110.317 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.86 -24.48 61.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.204 0.601 . . . . 0.0 111.991 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -73.57 -49.34 26.8 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.222 1.009 . . . . 0.0 112.273 -172.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -133.89 17.13 3.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.352 0.661 . . . . 0.0 111.187 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.09 -111.97 3.4 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.007 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB2' ' HD3' ' A' ' 62' ' ' ARG . . . -78.43 147.48 34.0 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 117.298 0.549 . . . . 0.0 110.451 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -159.6 179.54 8.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 t -132.64 130.59 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.462 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 4.6 t60 -88.42 109.0 19.66 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.174 0.99 . . . . 0.0 108.59 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.406 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 56.4 m-85 -94.91 127.49 40.98 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.16 127.83 28.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.413 0.685 . . . . 0.0 109.296 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 84.1 mtp -133.79 145.05 49.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.92 0.888 . . . . 0.0 110.861 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.18 165.53 17.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.436 0.694 . . . . 0.0 109.846 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.79 -134.4 5.25 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.9 172.19 17.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.186 0.594 . . . . 0.0 110.157 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 79' ' ' HIS . 58.4 mt -155.27 101.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 -166.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 54.39 41.13 32.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.483 0.713 . . . . 0.0 111.189 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.26 16.26 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.543 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.77 109.9 12.4 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.167 0.987 . . . . 0.0 111.369 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -81.35 152.44 18.02 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.028 2.486 . . . . 0.0 113.73 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.07 160.52 41.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 p -141.03 118.11 11.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.972 0.909 . . . . 0.0 109.358 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -139.62 150.0 44.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.884 0.874 . . . . 0.0 109.799 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 p -150.68 137.53 19.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.956 0.502 . . . . 0.0 109.904 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.91 145.04 45.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 0.0 108.738 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 39.6 mt-10 -124.55 123.91 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -175.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.1 mt -120.63 133.49 24.07 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.188 0.595 . . . . 0.0 109.398 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.01 163.97 6.94 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.317 2.678 . . . . 0.0 113.286 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.509 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 31.4 ptt85 -45.46 -37.12 4.91 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.821 1.248 . . . . 0.0 112.537 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.07 -28.09 68.58 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.817 1.247 . . . . 0.0 112.886 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.4 p -130.55 15.28 5.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.674 0.79 . . . . 0.0 111.16 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.7 73.54 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.072 0.549 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.03 -23.97 64.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.501 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -77.29 -2.45 34.86 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.587 0.755 . . . . 0.0 111.64 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -66.0 -21.14 66.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.43 62.35 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 -161.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 p -67.62 -33.63 75.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.228 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' HG22 ' A' ' 75' ' ' VAL . 5.1 m-20 -72.27 -56.8 4.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.433 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.02 67.04 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.673 1.189 . . . . 0.0 112.41 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 90.8 m -67.06 -50.24 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.249 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -56.93 -35.51 69.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.104 0.962 . . . . 0.0 112.795 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 71' ' ' ASP . 53.4 t -57.93 -44.86 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.74 0.816 . . . . 0.0 109.676 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.75 74.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.903 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 11.0 mm100 -60.14 -38.32 82.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.295 0.638 . . . . 0.0 111.364 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.91 -30.32 70.11 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.079 0.951 . . . . 0.0 111.982 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.455 ' HB3' HD12 ' A' ' 49' ' ' ILE . 63.4 t60 -91.69 24.84 2.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.872 0.469 . . . . 0.0 111.515 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.2 49.48 2.83 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 111.846 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.601 ' HG ' HG22 ' A' ' 23' ' ' ILE . 1.7 tt . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 . . . . . 0 C--O 1.213 -0.855 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.72 -45.5 74.07 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.599 0.76 . . . . 0.0 112.35 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.64 -48.34 60.23 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.995 0.518 . . . . 0.0 110.45 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.16 -38.02 81.91 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.963 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -53.91 -45.63 71.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.545 1.138 . . . . 0.0 110.142 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -71.15 -28.77 64.51 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.382 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 28.2 t70 -68.19 -54.18 19.69 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.358 0.411 . . . . 0.0 110.044 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.33 -47.59 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.947 0.899 . . . . 0.0 111.481 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -63.59 -28.27 69.81 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.565 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.59 -54.47 6.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.807 0.843 . . . . 0.0 112.439 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 14.1 mmmm -67.85 -37.36 81.77 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.66 -24.56 63.63 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.516 0.326 . . . . 0.0 111.181 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -76.99 -17.91 58.56 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.914 0.886 . . . . 0.0 109.699 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 C-N-CA 126.293 1.837 . . . . 0.0 112.572 175.656 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.076 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -147.94 154.28 43.21 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.94 0.896 . . . . 0.0 109.323 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.42 148.94 92.33 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.49 2.126 . . . . 0.0 111.132 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.92 142.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.92 20.81 15.46 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.099 0.559 . . . . 0.0 111.98 -173.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 117' ' ' GLU . 4.4 pp -57.15 -37.62 72.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.529 0.732 . . . . 0.0 112.289 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.466 ' N ' HD12 ' A' ' 116' ' ' LEU . 26.4 tt0 -87.27 -14.79 39.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.472 0.709 . . . . 0.0 110.947 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -80.68 -11.92 59.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.083 0.553 . . . . 0.0 110.543 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.56 -35.99 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.1 mt -86.05 14.54 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 124.215 1.006 . . . . 0.0 110.57 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 . . . . . 0 CA--C 1.555 1.14 0 O-C-N 121.187 -0.945 . . . . 0.0 109.911 175.204 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.2 t80 . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 120.839 0.352 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -143.47 154.6 60.34 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.275 1.03 . . . . 0.0 108.681 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.76 101.4 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.698 2.266 . . . . 0.0 112.644 174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.62 -14.24 11.75 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.936 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -158.01 122.46 4.23 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.509 0.655 . . . . 0.0 112.182 -175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.6 tp -102.98 120.98 41.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.58 1.152 . . . . 0.0 108.848 168.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -99.49 121.97 41.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.5 mt -98.92 137.26 37.74 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 165.82 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.64 69.34 0.97 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.643 0.735 . . . . 0.0 110.834 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.02 134.63 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -156.11 111.07 2.89 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.746 0.784 . . . . 0.0 109.443 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 60.1 mt -124.47 143.87 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.591 1.156 . . . . 0.0 110.041 -168.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.6 m170 -104.68 111.47 24.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 44' ' ' ASP . 61.8 mt -109.98 109.19 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -115.17 119.66 37.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 47.8 p90 -121.11 131.73 54.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.013 0.525 . . . . 0.0 110.307 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.78 122.45 28.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.419 0.688 . . . . 0.0 110.018 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 HG21 ' A' ' 41' ' ' VAL . 59.2 t -70.86 124.74 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.465 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 43.9 ttt180 -146.12 165.08 30.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.064 0.946 . . . . 0.0 109.278 -175.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.465 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 24.1 mm-40 -114.74 115.57 27.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.803 0.841 . . . . 0.0 108.872 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.421 HD22 ' HB2' ' A' ' 37' ' ' SER . 0.1 OUTLIER -101.93 147.77 26.15 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.173 0.589 . . . . 0.0 110.002 170.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.18 65.2 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.989 0.516 . . . . 0.0 111.29 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.84 -54.63 20.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.91 0.884 . . . . 0.0 112.293 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.421 ' HB2' HD22 ' A' ' 34' ' ' ASN . 23.1 m -120.26 4.16 10.81 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.245 0.618 . . . . 0.0 112.09 -168.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -134.83 12.87 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.495 ' HB1' ' HD3' ' A' ' 62' ' ' ARG . . . -73.6 141.59 46.59 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -161.4 178.69 8.92 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.023 0.44 . . . . 0.0 110.788 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.437 HG21 HG23 ' A' ' 31' ' ' VAL . 23.8 t -125.97 132.8 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 48.0 t60 -92.88 129.56 38.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.479 1.112 . . . . 0.0 108.593 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.419 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 50.8 m-85 -119.18 143.28 47.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.264 0.626 . . . . 0.0 110.447 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 41.5 m-20 -130.23 141.53 50.62 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.054 0.942 . . . . 0.0 109.183 174.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 87.5 mtp -132.97 128.51 36.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.882 0.873 . . . . 0.0 108.784 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.86 161.19 31.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.502 0.321 . . . . 0.0 110.488 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.64 -122.89 2.47 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.93 164.11 38.9 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.749 0.82 . . . . 0.0 110.001 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -155.58 113.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -169.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.48 40.14 29.69 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.221 1.01 . . . . 0.0 110.383 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.99 -39.0 3.04 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.608 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -79.69 129.4 71.31 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 123.851 0.86 . . . . 0.0 111.754 -169.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.64 164.22 23.5 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.26 2.64 . . . . 0.0 113.879 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.94 159.92 37.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.616 0.766 . . . . 0.0 110.688 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.5 p -144.22 112.95 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.529 0.732 . . . . 0.0 110.459 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 154.38 51.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.85 1.26 . . . . 0.0 109.643 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.8 p -152.97 139.71 18.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.979 0.512 . . . . 0.0 109.799 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.1 150.25 44.07 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.596 0.758 . . . . 0.0 110.126 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.45 125.68 38.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.779 0.831 . . . . 0.0 109.36 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.9 mt -119.38 134.43 23.77 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.459 0.704 . . . . 0.0 109.812 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.67 158.8 48.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.04 2.493 . . . . 0.0 112.225 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.495 ' HD3' ' HB1' ' A' ' 39' ' ' ALA . 26.1 ptt180 -41.64 -38.24 1.34 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.172 1.389 . . . . 0.0 114.2 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.85 -25.59 62.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.788 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 p -131.83 8.44 4.48 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.558 0.743 . . . . 0.0 111.494 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.23 88.09 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -68.03 -14.26 62.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.04 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -79.55 2.01 23.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.412 0.685 . . . . 0.0 111.697 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -65.0 -14.41 60.29 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 124.127 0.971 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.623 ' HB2' ' HE3' ' A' ' 98' ' ' MET . . . -73.17 -36.78 66.67 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -73.2 -40.99 64.32 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.01 -52.21 60.59 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.255 0.622 . . . . 0.0 110.662 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -55.08 -49.32 71.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.51 1.124 . . . . 0.0 112.01 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -64.84 -29.1 70.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.851 0.461 . . . . 0.0 111.454 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.6 tpp180 -72.3 -41.56 66.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.038 0.535 . . . . 0.0 110.238 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.81 -31.78 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.397 1.079 . . . . 0.0 109.9 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.418 ' HB3' HD23 ' A' ' 81' ' ' LEU . . . -71.41 -49.89 37.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.54 0.736 . . . . 0.0 109.799 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.57 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 46.4 mt-30 -70.09 -28.87 65.76 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.753 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.71 -29.9 68.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.475 0.71 . . . . 0.0 110.453 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -105.97 21.36 17.44 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 111.214 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.16 40.08 5.57 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 121.969 -0.457 . . . . 0.0 113.951 166.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.57 ' HB3' ' HG2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER . . . . . 0 CA--C 1.552 1.032 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.767 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.2 t80 . . . . . 0 C--O 1.217 -0.657 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.23 -39.98 93.46 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.545 0.738 . . . . 0.0 111.735 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.01 70.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.266 0.627 . . . . 0.0 111.114 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.623 ' HE3' ' HB2' ' A' ' 69' ' ' ALA . 53.2 ttp -64.4 -43.0 95.79 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.401 1.08 . . . . 0.0 112.323 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.07 -50.09 49.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.703 1.201 . . . . 0.0 111.492 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.85 -28.37 50.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.646 0.591 . . . . 0.0 110.687 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.68 -59.98 3.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.707 0.803 . . . . 0.0 111.299 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 56.2 mt -63.79 -36.42 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.38 0.672 . . . . 0.0 111.372 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -29.16 70.0 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.13 -38.14 63.87 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.327 0.651 . . . . 0.0 110.689 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.424 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -65.61 -35.84 81.99 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 112.179 173.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 mp -65.3 -32.71 74.5 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.59 0.756 . . . . 0.0 110.728 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.62 -16.4 59.58 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.349 1.059 . . . . 0.0 111.216 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 C-N-CA 127.599 2.359 . . . . 0.0 112.248 175.289 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 143.29 94.51 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.207 0.603 . . . . 0.0 111.906 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -93.31 105.95 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.029 2.486 . . . . 0.0 112.22 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.79 107.49 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 CA-C-O 122.36 1.076 . . . . 0.0 109.491 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.91 21.35 1.61 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.475 1.11 . . . . 0.0 111.983 -163.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.78 -27.5 68.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.268 0.627 . . . . 0.0 110.792 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -68.05 -11.59 59.26 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.973 1.309 . . . . 0.0 111.39 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -87.77 -19.86 26.95 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.052 0.941 . . . . 0.0 112.4 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.16 74.0 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.8 mt 72.15 -5.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 C-N-CA 125.323 1.449 . . . . 0.0 112.364 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 . . . . . 0 N--CA 1.483 1.216 0 O-C-N 121.822 -0.549 . . . . 0.0 109.709 -174.764 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.5 t80 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.48 157.13 63.16 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 125.126 1.37 . . . . 0.0 108.858 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.61 102.34 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.279 1.986 . . . . 0.0 111.33 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.01 -25.15 5.85 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.569 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -152.81 142.04 21.48 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.56 0.68 . . . . 0.0 112.118 -171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.7 tp -131.51 133.33 44.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.643 1.577 . . . . 0.0 108.55 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -107.56 117.99 35.55 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 80.7 mt -88.74 128.77 35.63 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.246 0.912 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 159.102 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 C--O 1.224 -0.287 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -114.73 101.39 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.274 1.03 . . . . 0.0 108.935 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.504 HG22 HG23 ' A' ' 49' ' ' ILE . 2.1 pp -113.95 143.86 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 171.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -144.36 108.65 4.81 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.8 mt -131.68 139.19 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.57 0.748 . . . . 0.0 110.411 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.4 m170 -104.65 111.04 23.59 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.524 HG12 ' HG2' ' A' ' 45' ' ' MET . 37.4 mt -112.08 119.84 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.59 123.64 50.35 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -112.01 115.79 29.5 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.83 111.92 16.06 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.817 0.447 . . . . 0.0 109.991 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 105' ' ' LYS . 89.0 t -81.5 119.69 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.805 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -131.93 145.77 51.7 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -103.1 113.17 26.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.428 HD21 ' HD1' ' A' ' 40' ' ' TYR . 3.5 p30 -99.95 142.32 31.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.63 -16.8 63.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.265 0.626 . . . . 0.0 112.162 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 14.2 tp10 -75.22 -46.66 32.51 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.759 0.823 . . . . 0.0 111.675 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.6 t -126.77 -11.71 6.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.356 0.663 . . . . 0.0 112.06 -168.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.96 -139.41 14.38 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.3 143.58 57.1 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.434 0.617 . . . . 0.0 111.257 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.428 ' HD1' HD21 ' A' ' 34' ' ' ASN . 8.8 p90 -148.15 165.37 31.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.451 HG23 HG23 ' A' ' 31' ' ' VAL . 10.1 t -130.38 134.71 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.552 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 57.5 t60 -94.36 113.46 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.857 1.263 . . . . 0.0 108.863 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 71.4 m-85 -104.12 115.45 30.44 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.814 . . . . 0.0 108.945 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -120.93 119.32 32.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.524 ' HG2' HG12 ' A' ' 27' ' ' ILE . 81.2 mtp -126.09 134.84 51.25 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.159 0.583 . . . . 0.0 111.086 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -165.37 177.31 7.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.085 0.554 . . . . 0.0 110.181 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.43 -123.7 2.98 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 10.1 pt-20 -152.96 167.35 29.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.387 1.075 . . . . 0.0 109.868 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.504 HG23 HG22 ' A' ' 23' ' ' ILE . 36.8 mt -157.15 105.31 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -172.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.515 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 3.2 m-20 64.03 40.76 6.91 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.193 0.997 . . . . 0.0 109.838 -174.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.23 -23.56 3.89 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.638 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.515 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 44.4 mtmt -82.88 116.57 64.8 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.159 0.984 . . . . 0.0 110.413 -171.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 88.8 Cg_endo -74.92 162.26 37.58 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.049 2.5 . . . . 0.0 113.841 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -158.3 165.68 34.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.715 0.806 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.9 p -153.13 121.66 6.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.283 1.033 . . . . 0.0 109.819 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -155.4 145.04 21.25 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.96 0.904 . . . . 0.0 110.047 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 t -146.58 146.73 30.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.095 0.558 . . . . 0.0 110.653 -170.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -142.19 149.78 40.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.34 1.056 . . . . 0.0 110.297 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.3 mp0 -118.6 135.48 54.41 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 89.7 mt -124.45 124.97 25.68 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.68 168.91 12.33 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.108 2.539 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HG3' HD22 ' A' ' 106' ' ' LEU . 76.4 ttt180 -47.06 -35.96 7.5 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.222 1.009 . . . . 0.0 112.504 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -58.6 -35.34 72.27 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.554 1.142 . . . . 0.0 112.632 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -129.11 8.03 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 0.0 112.104 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.08 90.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.506 0.722 . . . . 0.0 112.094 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.47 -12.57 61.39 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.832 -1.077 . . . . 0.0 113.216 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -80.69 5.63 15.12 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.55 0.74 . . . . 0.0 111.66 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.513 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 5.9 p90 -73.52 -27.13 61.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.2 1.0 . . . . 0.0 113.334 -172.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.89 -45.32 36.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.364 0.602 . . . . 0.0 109.511 -164.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -74.33 -33.35 63.12 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.159 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' HG22 ' A' ' 75' ' ' VAL . 22.6 t70 -72.97 -51.61 17.67 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.913 0.485 . . . . 0.0 111.501 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.73 -41.23 66.83 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.155 0.982 . . . . 0.0 112.091 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.4 m -61.81 -48.45 80.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.972 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.9 ttm180 -53.73 -45.06 70.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.689 1.196 . . . . 0.0 111.61 174.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 71' ' ' ASP . 43.5 t -61.46 -41.04 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.756 1.222 . . . . 0.0 110.204 -177.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.85 -42.25 70.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -67.71 -26.49 66.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.035 0.934 . . . . 0.0 111.811 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HB3' ' HZ3' ' A' ' 78' ' ' LYS . 9.4 mtpm? -65.54 -22.4 66.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.307 0.643 . . . . 0.0 111.177 171.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.497 ' HD1' HD11 ' A' ' 49' ' ' ILE . 45.6 t-80 -106.74 20.98 18.22 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.441 0.696 . . . . 0.0 110.39 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.59 39.32 8.97 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 121.724 -0.61 . . . . 0.0 113.441 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.462 HD23 HG23 ' A' ' 23' ' ' ILE . 2.1 tm? . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 123.829 0.852 . . . . 0.0 110.322 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.6 t80 . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.76 -34.81 78.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 110.856 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.24 -49.5 49.3 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.226 0.61 . . . . 0.0 110.442 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.513 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 84.4 mmm -60.95 -42.94 99.21 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.644 0.778 . . . . 0.0 112.983 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -49.79 -46.56 50.94 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.789 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HA ' ' CG ' ' A' ' 103' ' ' ARG . 3.7 mt-10 -80.06 -25.82 39.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.618 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.0 -58.76 4.31 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.943 0.897 . . . . 0.0 110.107 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.9 mt -60.53 -41.13 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.528 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.446 ' CG ' ' HA ' ' A' ' 100' ' ' GLU . 4.8 ppt_? -64.63 -30.22 71.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.444 0.566 . . . . 0.0 110.34 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 107' ' ' HIS . . . -71.25 -47.25 58.24 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.492 ' HB3' HG21 ' A' ' 31' ' ' VAL . 6.2 tmtp? -69.78 -30.56 68.15 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.998 0.519 . . . . 0.0 111.847 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.523 HD22 ' HG3' ' A' ' 62' ' ' ARG . 2.2 mp -63.9 -23.82 67.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.839 0.855 . . . . 0.0 111.717 172.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' A' ' 104' ' ' ALA . 85.2 t60 -72.57 -15.15 61.76 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.571 1.148 . . . . 0.0 110.907 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.761 0 C-N-CA 126.528 1.931 . . . . 0.0 112.509 178.966 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.436 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.73 143.44 27.05 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.26 1.024 . . . . 0.0 109.514 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.81 132.29 22.95 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.012 2.474 . . . . 0.0 112.19 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.512 HG23 ' HG ' ' A' ' 116' ' ' LEU . 7.8 p -77.02 121.81 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.05 -21.56 58.95 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 122.078 -0.389 . . . . 0.0 111.982 -168.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 114' ' ' VAL . 4.3 pp -59.47 -26.6 65.38 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.311 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.14 -35.65 81.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.219 1.008 . . . . 0.0 110.815 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.9 -27.06 66.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.318 1.047 . . . . 0.0 111.085 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.514 HG23 HG13 ' A' ' 120' ' ' ILE . 2.3 mp -74.67 -57.8 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.319 0.648 . . . . 0.0 109.676 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.514 HG13 HG23 ' A' ' 119' ' ' ILE . 78.2 mt -116.7 101.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 123.658 0.783 . . . . 0.0 109.411 175.045 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 C--O 1.241 0.634 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.0 153.74 60.88 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.055 0.942 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.34 106.28 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.319 2.013 . . . . 0.0 112.112 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.88 -22.02 9.34 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.014 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -153.89 124.58 7.16 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.304 0.574 . . . . 0.0 112.474 -170.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.803 HD22 ' HE1' ' A' ' 98' ' ' MET . 56.8 tp -103.5 148.13 26.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.898 0.879 . . . . 0.0 108.78 165.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -122.78 116.6 23.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.601 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 71.6 mt -89.29 109.59 20.47 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 19.9 m . . . . . 0 C--N 1.318 -0.787 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.406 ' H ' ' HA ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER -101.45 70.71 1.31 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 2.5 pp -88.15 119.6 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.303 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -142.52 109.78 5.63 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 49.1 mt -133.53 129.8 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.732 0.813 . . . . 0.0 109.194 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 45' ' ' MET . 14.7 m170 -100.11 108.69 20.89 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.557 HD13 HD21 ' A' ' 10' ' ' LEU . 41.5 mt -103.22 108.5 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -109.5 112.61 24.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -111.07 118.11 35.13 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -124.31 115.03 20.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.036 0.934 . . . . 0.0 109.09 -172.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.99 120.69 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.594 0.711 . . . . 0.0 109.567 170.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -138.4 154.79 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.78 120.6 41.3 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.625 0.25 . . . . 0.0 111.224 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.446 HD21 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.609 1.164 . . . . 0.0 110.419 169.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.07 61.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.094 0.558 . . . . 0.0 111.449 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -67.23 -54.61 19.46 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.258 1.023 . . . . 0.0 111.755 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.404 ' HB3' HD22 ' A' ' 34' ' ' ASN . 35.5 t -120.94 5.91 10.4 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.226 0.611 . . . . 0.0 111.812 -171.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.68 -101.09 1.5 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB1' ' HD3' ' A' ' 62' ' ' ARG . . . -83.78 145.36 28.74 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.961 0.505 . . . . 0.0 110.706 171.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -151.48 174.32 13.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -125.73 132.57 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -96.94 134.16 40.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.195 0.998 . . . . 0.0 108.613 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -120.66 125.75 48.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 109.829 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 30.4 m-20 -108.13 148.74 29.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.646 0.779 . . . . 0.0 109.505 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 21.4 mtm -141.4 132.53 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.587 1.155 . . . . 0.0 108.469 171.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -167.53 159.55 12.3 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.266 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.78 -121.1 1.36 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 11.8 pt-20 -142.08 171.01 14.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 15.7 mt -154.95 103.79 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.406 ' HA ' ' H ' ' A' ' 22' ' ' ASP . 36.6 t70 58.37 46.13 15.81 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 122.345 1.069 . . . . 0.0 109.467 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.16 -36.22 3.53 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.177 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.01 111.95 23.93 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.568 1.147 . . . . 0.0 112.312 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 Cg_exo -61.3 146.83 96.91 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.795 2.997 . . . . 0.0 113.099 175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -151.22 163.92 37.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.442 0.297 . . . . 0.0 110.683 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -153.58 117.43 4.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.288 0.635 . . . . 0.0 111.206 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -130.32 159.27 37.47 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.687 1.195 . . . . 0.0 109.751 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -157.19 133.46 9.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.731 0.413 . . . . 0.0 110.61 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.3 145.95 50.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.826 0.85 . . . . 0.0 109.635 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -114.08 143.57 44.56 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.74 138.95 27.65 Favored Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.6 149.27 91.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.523 2.149 . . . . 0.0 110.797 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.522 ' HD3' ' HB1' ' A' ' 39' ' ' ALA . 30.8 ptt85 -42.14 -39.29 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.15 -19.77 61.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.557 0.743 . . . . 0.0 112.744 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.1 p -130.48 9.66 5.13 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.55 0.74 . . . . 0.0 109.91 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.76 71.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.948 0.899 . . . . 0.0 111.048 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -69.11 -11.33 60.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.393 1.077 . . . . 0.0 113.046 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -80.62 3.87 20.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.294 0.637 . . . . 0.0 111.195 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -67.88 -21.18 65.16 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 124.324 1.05 . . . . 0.0 112.571 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.12 19.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -69.61 -35.23 75.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.841 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 -54.55 10.31 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.498 0.719 . . . . 0.0 111.602 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.15 -44.72 64.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.24 1.016 . . . . 0.0 111.947 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -63.02 -49.24 75.42 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.418 0.449 . . . . 0.0 110.312 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.491 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 18.3 ttp85 -51.15 -52.78 40.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.322 1.049 . . . . 0.0 111.999 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.92 -32.39 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.862 0.465 . . . . 0.0 110.551 -175.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.0 -41.56 74.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 96.4 mt-30 -54.27 -30.77 51.84 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.604 1.162 . . . . 0.0 112.969 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 13.8 mptt -75.2 -7.64 54.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.53 0.732 . . . . 0.0 111.175 -176.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -93.11 7.57 43.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.587 0.755 . . . . 0.0 110.684 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.26 64.51 1.02 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.265 0.466 . . . . 0.0 114.265 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 11.0 mp . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 168.028 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.1 t80 . . . . . 0 C--O 1.204 -1.326 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.32 -33.9 63.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.028 0.531 . . . . 0.0 111.458 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.66 -50.34 63.22 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.445 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.803 ' HE1' HD22 ' A' ' 10' ' ' LEU . 28.3 ttm -71.87 -37.21 70.23 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.757 0.823 . . . . 0.0 112.541 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -51.12 -48.22 61.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.465 1.506 . . . . 0.0 110.301 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.544 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 23.2 mt-10 -77.84 -28.75 50.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.287 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.53 -50.53 69.2 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.2 0.6 . . . . 0.0 110.423 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.404 ' O ' HD13 ' A' ' 106' ' ' LEU . 56.0 mt -61.02 -49.15 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.998 0.919 . . . . 0.0 111.597 175.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 1.2 ppt_? -61.85 -30.63 70.97 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.146 0.43 . . . . 0.0 111.31 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.26 -44.76 58.78 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.033 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -65.6 -33.68 76.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.25 1.02 . . . . 0.0 111.787 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 102' ' ' ILE . 6.8 mp -70.52 -22.16 62.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.506 1.122 . . . . 0.0 111.338 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -89.25 -18.7 26.5 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.15 0.58 . . . . 0.0 109.854 170.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 C-N-CA 126.001 1.72 . . . . 0.0 111.526 176.322 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.96 0 N-CA-C 112.698 -0.161 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -127.45 145.26 53.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.293 1.037 . . . . 0.0 109.634 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.66 105.23 1.59 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.667 2.245 . . . . 0.0 110.126 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 100' ' ' GLU . 7.3 p -67.97 125.35 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.39 0.614 . . . . 0.0 110.491 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.24 7.93 8.42 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.893 0.877 . . . . 0.0 112.52 -166.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 117' ' ' GLU . 3.1 pp -55.88 -26.83 49.03 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.416 ' N ' HD13 ' A' ' 116' ' ' LEU . 44.2 tt0 -72.76 -33.2 66.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.504 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -81.61 -7.45 59.59 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.691 -167.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.1 -19.82 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.703 0.801 . . . . 0.0 110.519 170.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.8 mt 81.26 112.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.802 2.041 . . . . 0.0 109.081 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 117' ' ' GLU . 8.9 ptp180 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 124.803 1.241 . . . . 0.0 110.195 -174.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.2 t80 . . . . . 0 C--O 1.239 0.522 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.33 154.22 78.5 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.27 1.428 . . . . 0.0 107.834 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.1 110.19 0.42 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.276 1.984 . . . . 0.0 111.658 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.2 -21.56 10.06 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 123.057 0.36 . . . . 0.0 112.736 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -150.93 119.83 6.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.255 0.622 . . . . 0.0 111.434 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.438 HD21 HD13 ' A' ' 27' ' ' ILE . 59.9 tp -102.35 143.21 32.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.346 1.058 . . . . 0.0 108.912 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 24' ' ' ASN . 13.8 t-160 -120.71 124.67 45.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.234 0.613 . . . . 0.0 110.298 174.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.8 mt -102.0 128.31 48.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.882 0.473 . . . . 0.0 109.921 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 159.043 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 . . . . . 0 C--O 1.24 0.579 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -87.41 70.65 9.94 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.462 0.648 . . . . 0.0 109.799 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.86 142.15 20.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.363 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.628 ' ND2' ' HG2' ' A' ' 48' ' ' GLU . 8.1 p30 -151.78 128.71 11.0 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 67.3 mt -127.99 129.23 69.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -171.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 45' ' ' MET . 1.5 m170 -102.05 109.02 20.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.438 HD13 HD21 ' A' ' 10' ' ' LEU . 53.8 mt -101.75 105.52 18.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.539 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 27.0 mtp-105 -101.59 108.8 20.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.335 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -111.83 116.97 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.21 111.21 17.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.459 HG21 HG23 ' A' ' 41' ' ' VAL . 44.3 t -83.94 116.52 27.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -127.61 155.15 44.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.116 0.966 . . . . 0.0 108.51 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -105.87 111.84 24.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.402 ' H ' HD21 ' A' ' 34' ' ' ASN . 0.1 OUTLIER -97.64 146.94 24.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.828 0.851 . . . . 0.0 110.087 173.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.45 -18.05 62.33 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.922 0.489 . . . . 0.0 111.694 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -69.04 -53.32 21.1 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.01 0.924 . . . . 0.0 111.555 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.3 t -124.96 5.71 7.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.05 0.54 . . . . 0.0 112.294 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.92 -114.77 3.98 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 137.98 36.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.021 0.529 . . . . 0.0 110.129 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -152.84 166.96 30.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG23 HG21 ' A' ' 31' ' ' VAL . 10.8 t -124.02 122.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -81.09 116.6 21.1 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -100.26 135.53 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 25.5 t70 -137.9 141.52 40.65 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.757 0.823 . . . . 0.0 108.831 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 86.6 mtp -138.46 131.91 30.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 0.0 110.0 -174.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -150.48 176.42 10.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.017 0.527 . . . . 0.0 109.92 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.08 -135.34 7.43 Favored Glycine 0 N--CA 1.465 0.599 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.628 ' HG2' ' ND2' ' A' ' 24' ' ' ASN . 8.0 pt-20 -151.63 168.06 26.17 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 mt -157.66 109.29 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -166.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t70 61.65 32.98 18.36 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.798 0.808 . . . . 0.0 109.431 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.35 -25.41 9.25 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -82.15 118.94 73.83 Favored Pre-proline 0 N--CA 1.484 1.252 0 CA-C-N 117.831 0.816 . . . . 0.0 111.708 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -69.89 148.21 63.73 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.639 2.226 . . . . 0.0 112.887 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -142.8 150.52 40.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.313 0.645 . . . . 0.0 109.959 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 m -146.75 122.49 10.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.442 0.697 . . . . 0.0 110.348 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.89 152.62 36.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.127 0.971 . . . . 0.0 109.175 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.0 p -147.98 137.2 22.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.217 0.607 . . . . 0.0 110.699 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.47 140.18 41.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 0.0 109.71 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -112.86 129.58 56.4 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.19 129.01 25.1 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.581 0.753 . . . . 0.0 109.332 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.73 164.75 20.33 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.042 2.495 . . . . 0.0 112.126 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.13 -32.61 7.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.223 1.009 . . . . 0.0 113.467 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.74 -31.51 66.76 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.344 1.058 . . . . 0.0 112.191 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -125.73 12.48 7.94 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.338 0.655 . . . . 0.0 110.517 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.18 89.97 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.826 0.85 . . . . 0.0 112.116 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.23 -8.05 46.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.476 1.11 . . . . 0.0 113.096 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -80.55 1.2 30.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.785 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -66.1 -18.97 65.69 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.722 1.209 . . . . 0.0 113.058 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -50.78 14.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.437 0.637 . . . . 0.0 109.734 -162.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.9 p -73.28 -31.41 64.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.309 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' HG21 ' A' ' 75' ' ' VAL . 14.2 t70 -70.78 -58.22 3.85 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.282 0.633 . . . . 0.0 111.35 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.27 -47.58 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.251 1.02 . . . . 0.0 112.547 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.3 m -57.59 -47.08 83.11 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.866 0.467 . . . . 0.0 110.758 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HA ' ' HG2' ' A' ' 77' ' ' GLN . 39.4 ttp180 -57.96 -38.77 76.61 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.949 0.781 . . . . 0.0 112.508 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -59.63 -47.78 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.116 0.566 . . . . 0.0 109.758 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.462 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -72.22 -40.09 68.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.896 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 20.8 pt20 -73.56 -22.69 60.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -66.13 -21.25 66.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 121.951 0.101 . . . . 0.0 110.732 166.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -99.56 6.16 45.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.857 0.863 . . . . 0.0 110.537 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.44 -95.85 0.43 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 77' ' ' GLN . 32.5 tp . . . . . 0 CA--C 1.549 0.904 0 C-N-CA 126.466 1.906 . . . . 0.0 112.952 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.9 t80 . . . . . 0 C--O 1.222 -0.36 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.85 -32.62 65.97 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.071 0.857 . . . . 0.0 112.182 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.24 -47.95 63.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 tpp -65.51 -40.79 93.41 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -55.04 -51.82 65.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.982 1.313 . . . . 0.0 111.311 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.7 -30.37 68.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.67 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.11 -45.62 59.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.311 0.244 . . . . 0.0 110.889 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.87 -45.35 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.396 0.678 . . . . 0.0 110.683 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -29.84 70.86 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 120.614 0.245 . . . . 0.0 110.568 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.59 -45.72 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.439 0.696 . . . . 0.0 110.619 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.513 ' HA ' ' HE2' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -69.88 -29.88 67.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.941 0.496 . . . . 0.0 112.243 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.2 -31.37 68.78 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.065 0.946 . . . . 0.0 110.486 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -72.76 -18.0 61.54 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.905 0.882 . . . . 0.0 110.493 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 C-N-CA 126.268 1.827 . . . . 0.0 112.619 176.642 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.295 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.424 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 11.6 pt-20 -77.68 172.02 10.91 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.915 0.886 . . . . 0.0 109.742 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 112' ' ' GLU . 95.8 Cg_endo -76.95 48.75 2.58 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.654 2.236 . . . . 0.0 112.882 172.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.19 130.0 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.08 29.7 5.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.2 0.6 . . . . 0.0 111.009 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -55.3 -30.62 60.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 112.317 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.481 ' HG2' ' HG2' ' A' ' 121' ' ' ARG . 34.1 tt0 -80.45 -32.91 37.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.458 0.703 . . . . 0.0 110.789 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.03 -18.55 65.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.299 1.04 . . . . 0.0 112.27 -168.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.523 HG21 HG12 ' A' ' 120' ' ' ILE . 3.9 mp -67.28 -52.83 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.523 HG12 HG21 ' A' ' 119' ' ' ILE . 33.3 mm -133.99 96.99 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.555 0.742 . . . . 0.0 109.567 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.481 ' HG2' ' HG2' ' A' ' 117' ' ' GLU . 52.2 mtp180 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.043 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.5 t80 . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.95 156.02 55.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.192 1.397 . . . . 0.0 108.363 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.72 105.76 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.109 1.872 . . . . 0.0 111.397 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.11 -20.61 11.36 Favored Glycine 0 N--CA 1.473 1.126 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.243 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -153.04 143.88 22.87 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.413 0.607 . . . . 0.0 111.584 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.2 tp -129.33 141.26 51.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.237 1.415 . . . . 0.0 108.276 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -127.57 121.18 29.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.563 0.745 . . . . 0.0 109.211 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 79.3 mt -100.53 128.9 46.45 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.419 0.687 . . . . 0.0 109.865 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 166.742 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.92 53.65 2.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.839 0.828 . . . . 0.0 111.102 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.528 HG23 HD22 ' A' ' 81' ' ' LEU . 2.2 pp -90.54 116.03 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -139.14 107.85 5.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 59.1 mt -133.18 133.43 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.643 0.777 . . . . 0.0 109.966 -163.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.7 m170 -104.8 113.87 27.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.8 mt -112.5 107.74 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 ttp-105 -102.54 110.12 21.96 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -111.57 123.62 50.6 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -118.73 114.46 22.73 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.541 0.737 . . . . 0.0 109.15 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.473 HG13 ' HG3' ' A' ' 105' ' ' LYS . 98.0 t -77.71 117.38 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -140.43 159.86 41.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.899 0.879 . . . . 0.0 109.103 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -110.68 113.48 26.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.405 ' H ' HD21 ' A' ' 34' ' ' ASN . 0.1 OUTLIER -95.57 148.77 22.16 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.722 0.809 . . . . 0.0 109.598 170.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.22 -19.36 63.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.872 0.469 . . . . 0.0 111.432 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.05 -44.93 64.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.284 1.034 . . . . 0.0 112.323 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -133.73 1.93 3.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.83 -115.5 4.12 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.01 143.52 43.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.26 0.53 . . . . 0.0 110.359 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -160.3 172.79 16.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.439 0.696 . . . . 0.0 109.148 169.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.01 130.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -88.68 116.45 26.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.866 0.866 . . . . 0.0 108.884 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.59 110.39 22.43 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -105.11 139.69 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.799 0.84 . . . . 0.0 109.165 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 40.5 mtm -141.71 140.19 33.1 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.906 0.482 . . . . 0.0 110.833 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -164.1 158.61 19.51 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.424 0.69 . . . . 0.0 109.724 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.18 -127.56 2.16 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.052 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -156.82 160.35 39.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.414 1.085 . . . . 0.0 109.27 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.434 ' HB ' ' CD2' ' A' ' 79' ' ' HIS . 47.7 mt -158.04 107.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 60.24 42.12 15.63 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.531 1.158 . . . . 0.0 109.348 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.99 -28.76 3.19 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.382 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -82.57 121.41 78.03 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.147 0.979 . . . . 0.0 111.19 -169.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.26 152.21 76.01 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.833 2.356 . . . . 0.0 113.231 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -146.98 146.39 30.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.313 0.645 . . . . 0.0 109.369 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.7 m -142.63 118.9 10.82 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.003 0.521 . . . . 0.0 110.153 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.24 154.92 37.76 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.073 0.949 . . . . 0.0 109.917 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.4 p -145.74 144.91 30.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.853 0.461 . . . . 0.0 110.41 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.64 136.95 39.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.09 0.956 . . . . 0.0 109.555 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -112.92 124.53 52.83 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.25 128.98 25.65 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.38 159.26 27.86 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.075 2.517 . . . . 0.0 112.069 171.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -42.63 -40.02 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.944 1.298 . . . . 0.0 114.262 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.79 -15.12 60.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.777 0.831 . . . . 0.0 112.552 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -132.03 4.55 4.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.698 0.799 . . . . 0.0 111.778 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.15 71.64 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.947 0.899 . . . . 0.0 111.789 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -65.34 -24.39 67.24 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.261 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -73.96 -2.06 22.45 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.599 0.76 . . . . 0.0 112.294 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -70.9 -18.01 62.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.88 -43.78 57.46 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -167.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 p -76.11 -35.77 59.17 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.206 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 75' ' ' VAL . 19.8 t70 -71.17 -57.12 4.8 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.345 0.658 . . . . 0.0 112.071 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.36 -43.29 43.89 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.212 1.005 . . . . 0.0 112.454 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -64.44 -46.66 82.19 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.256 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 68.6 ttt180 -53.76 -44.21 69.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.75 0.82 . . . . 0.0 111.729 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.432 ' HB ' ' HE2' ' A' ' 45' ' ' MET . 57.4 t -60.75 -38.82 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.083 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.16 -41.69 73.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.783 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -60.61 -34.04 73.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.214 1.006 . . . . 0.0 111.363 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.3 mtpp -61.51 -36.76 81.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.743 . . . . 0.0 111.809 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.434 ' CD2' ' HB ' ' A' ' 49' ' ' ILE . 14.5 t60 -87.53 -33.19 19.04 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.81 41.32 0.02 OUTLIER Glycine 0 C--N 1.358 1.788 0 C-N-CA 121.591 -0.338 . . . . 0.0 113.395 156.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 23' ' ' ILE . 1.6 tm? . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.9 t80 . . . . . 0 C--O 1.214 -0.769 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.18 -37.96 78.65 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.163 0.985 . . . . 0.0 112.663 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.85 -48.81 23.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.509 0.323 . . . . 0.0 111.317 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.2 ttm -65.55 -32.62 74.31 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.174 0.59 . . . . 0.0 111.523 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -50.31 -45.76 54.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.275 1.03 . . . . 0.0 109.683 169.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 27.0 mm-40 -74.9 -28.22 60.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.061 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.51 -55.31 12.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 120.793 0.33 . . . . 0.0 110.357 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.32 -42.0 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.531 1.133 . . . . 0.0 112.211 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.461 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.39 -31.27 72.39 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.863 0.363 . . . . 0.0 110.444 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.47 -52.39 10.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.566 0.746 . . . . 0.0 110.526 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.473 ' HG3' HG13 ' A' ' 31' ' ' VAL . 17.7 tppt? -55.46 -52.97 61.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.769 1.228 . . . . 0.0 113.134 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.07 -26.95 69.08 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.276 0.63 . . . . 0.0 111.872 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -68.6 -31.92 71.43 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.652 0.595 . . . . 0.0 109.457 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 125.608 1.563 . . . . 0.0 113.298 169.04 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.424 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.14 152.32 90.46 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.6 91.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.536 2.158 . . . . 0.0 111.52 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.7 p -79.81 142.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.613 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 118' ' ' ARG . 29.0 m-20 -99.21 43.24 1.07 Allowed 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.975 0.91 . . . . 0.0 110.579 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.63 -33.64 73.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.466 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -117.2 85.72 2.38 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.341 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.542 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 1.8 tmm_? -133.2 14.8 4.19 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 165.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.66 -63.6 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.772 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.8 mt -88.5 70.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.991 0.9 . . . . 0.0 108.979 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 . . . . . 0 N--CA 1.469 0.488 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.322 -179.544 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.3 t80 . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 121.002 0.429 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.44 153.45 58.97 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.038 1.335 . . . . 0.0 108.28 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.75 96.98 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.139 1.893 . . . . 0.0 111.824 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.09 -25.59 4.09 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.384 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -151.91 147.24 26.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.177 0.591 . . . . 0.0 111.219 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.56 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 41.9 tp -126.84 134.59 50.5 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.126 1.37 . . . . 0.0 107.863 173.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -97.47 138.48 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.58 110.58 14.61 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.262 0.625 . . . . 0.0 109.504 175.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.249 1.057 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 160.582 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 . . . . . 0 C--O 1.245 0.822 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -77.33 82.71 3.79 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.804 0.69 . . . . 0.0 109.237 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.579 HG23 HG22 ' A' ' 49' ' ' ILE . 1.6 pp -110.36 126.57 67.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -147.09 117.61 7.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 43.1 mt -144.85 145.94 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.308 1.043 . . . . 0.0 108.381 -168.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 9.2 m-70 -108.73 145.66 34.74 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 55.9 mt -131.75 109.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 99.5 mtt180 -98.59 140.1 33.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 168.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -121.65 116.85 25.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 165.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -123.96 111.89 16.56 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.512 HG21 HG22 ' A' ' 41' ' ' VAL . 90.2 t -90.15 118.75 36.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.29 0.636 . . . . 0.0 110.337 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -114.58 153.24 30.45 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -111.42 111.41 22.43 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.551 HD21 ' HB3' ' A' ' 36' ' ' GLU . 9.4 p-10 -105.24 136.81 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.37 -20.17 66.01 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.04 0.536 . . . . 0.0 112.308 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.551 ' HB3' HD21 ' A' ' 34' ' ' ASN . 5.7 tm-20 -68.97 -45.59 70.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.589 1.156 . . . . 0.0 111.508 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -115.54 -40.71 3.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.865 0.466 . . . . 0.0 111.205 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.76 -148.17 17.22 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.09 129.19 37.92 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.401 0.68 . . . . 0.0 110.867 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 3.4 p90 -144.45 166.29 25.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.512 HG22 HG21 ' A' ' 31' ' ' VAL . 2.3 t -122.11 128.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.943 0.497 . . . . 0.0 110.329 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.544 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 78.1 t60 -88.92 112.32 23.16 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 164.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.407 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 91.8 m-85 -95.12 121.3 36.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 19.7 t70 -120.43 114.67 22.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.859 0.864 . . . . 0.0 109.517 -170.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 85.8 mtp -119.31 144.3 46.9 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.546 0.739 . . . . 0.0 110.881 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -156.05 164.48 38.38 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.459 0.704 . . . . 0.0 109.461 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.62 -158.6 31.54 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 118.843 -0.976 . . . . 0.0 111.458 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -145.79 109.97 4.95 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.301 1.051 . . . . 0.0 110.589 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.579 HG22 HG23 ' A' ' 23' ' ' ILE . 49.0 mt -99.78 128.0 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.901 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 62.04 17.62 9.23 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.821 1.248 . . . . 0.0 111.846 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 -20.25 40.86 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.629 -0.54 . . . . 0.0 113.495 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.542 ' HB3' ' HZ3' ' A' ' 52' ' ' LYS . 8.1 mtpm? -82.8 111.17 27.44 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.96 0.904 . . . . 0.0 112.513 -174.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.65 143.39 33.91 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.535 2.157 . . . . 0.0 111.979 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -148.85 161.77 41.16 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -146.65 121.32 9.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -138.52 145.67 41.02 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 p -144.26 144.66 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.749 0.42 . . . . 0.0 111.154 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -137.53 137.15 38.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.069 0.947 . . . . 0.0 108.701 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 6.4 mp0 -113.84 126.5 55.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.386 -177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 94.2 mt -129.32 125.85 22.73 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 40' ' ' TYR . 57.2 Cg_endo -67.19 163.91 32.38 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.635 2.223 . . . . 0.0 111.555 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -45.78 -37.43 6.02 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.678 1.191 . . . . 0.0 113.384 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.87 -29.85 71.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.194 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.0 p -129.76 12.27 5.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.882 0.873 . . . . 0.0 111.02 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -27.95 68.71 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.655 0.782 . . . . 0.0 111.73 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.469 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 27.1 m-85 -70.46 -2.49 14.07 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.361 1.064 . . . . 0.0 113.79 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -95.3 4.94 52.93 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.604 0.761 . . . . 0.0 110.581 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -55.59 -49.16 73.5 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 124.27 1.028 . . . . 0.0 112.899 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.05 -35.2 61.89 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 123.162 0.585 . . . . 0.0 111.777 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -71.51 -40.12 70.36 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.728 0.643 . . . . 0.0 109.359 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.59 -56.64 9.84 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.307 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.49 -40.61 12.76 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.878 1.271 . . . . 0.0 113.429 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -71.03 -46.36 62.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.182 0.593 . . . . 0.0 110.327 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -61.71 -51.01 70.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.849 0.859 . . . . 0.0 111.343 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.98 -34.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.789 0.836 . . . . 0.0 110.689 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.04 84.35 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.18 0.514 . . . . 0.0 110.142 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.7 -36.73 59.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.45 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -64.05 -34.74 78.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.431 0.692 . . . . 0.0 111.094 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -80.17 3.02 21.95 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.04 -31.92 2.32 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 118.927 0.785 . . . . 0.0 113.605 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.447 HD13 HG21 ' A' ' 23' ' ' ILE . 17.8 tp . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 124.019 0.928 . . . . 0.0 110.766 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.5 t80 . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.656 ' HB2' HH12 ' A' ' 118' ' ' ARG . 4.7 m-20 -55.77 -42.83 76.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 111.985 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.79 89.22 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.081 0.863 . . . . 0.0 110.746 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.0 ttm -61.15 -51.63 68.25 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.237 1.015 . . . . 0.0 111.397 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -51.19 -52.13 47.26 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.828 1.651 . . . . 0.0 112.21 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.486 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 pt-20 -82.26 -27.44 32.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.295 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.91 -36.55 83.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.3 mt -58.96 -55.65 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.549 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.11 -28.1 64.33 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.343 0.52 . . . . 0.0 111.448 -178.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . 0.411 ' HB1' HH11 ' A' ' 103' ' ' ARG . . . -71.99 -48.03 47.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.753 0.821 . . . . 0.0 110.677 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -58.52 -35.01 71.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.928 0.891 . . . . 0.0 112.246 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.448 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.3 mm? -64.29 -22.55 66.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.436 0.694 . . . . 0.0 112.851 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.83 -17.88 61.51 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 173.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.456 0 C-N-CA 126.476 1.91 . . . . 0.0 111.886 177.199 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.21 146.03 97.84 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.354 1.062 . . . . 0.0 111.574 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.38 -179.26 5.11 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.29 1.993 . . . . 0.0 112.567 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.57 117.25 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.26 45.34 2.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.919 0.888 . . . . 0.0 109.122 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.48 -36.34 82.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.056 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.14 -19.92 60.41 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.534 0.734 . . . . 0.0 111.229 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.656 HH12 ' HB2' ' A' ' 96' ' ' ASP . 7.6 ttt180 -71.52 -28.13 63.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.034 0.534 . . . . 0.0 111.144 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.58 -31.38 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.414 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.29 -18.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.194 0.998 . . . . 0.0 111.82 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.413 ' HG2' ' HA ' ' A' ' 118' ' ' ARG . 19.3 mmm180 . . . . . 0 N--CA 1.491 1.605 0 C-N-CA 123.697 0.799 . . . . 0.0 111.73 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' A' ' 98' ' ' MET . 67.8 t80 . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 121.43 0.633 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.55 154.42 69.28 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.968 1.307 . . . . 0.0 109.94 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.43 100.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.81 2.34 . . . . 0.0 113.202 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.55 -24.38 6.5 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.68 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -147.65 150.75 34.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.625 . . . . 0.0 110.411 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 42.6 tp -124.18 129.61 51.11 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.978 1.311 . . . . 0.0 107.627 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.67 134.87 40.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.642 0.377 . . . . 0.0 110.137 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 69.2 mt -125.46 113.09 17.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.474 0.709 . . . . 0.0 110.446 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 159.893 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -73.29 78.05 1.33 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.557 HG22 HG23 ' A' ' 49' ' ' ILE . 1.5 pp -123.97 138.47 53.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.052 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -152.68 126.63 9.02 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 49' ' ' ILE . 36.2 mt -142.92 142.04 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.293 1.037 . . . . 0.0 108.271 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.7 m170 -103.56 141.99 35.06 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 33.1 mt -126.62 108.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 119.27 0.941 . . . . 0.0 109.089 169.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 18.5 mtp180 -95.39 138.56 32.91 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.236 1.014 . . . . 0.0 108.397 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -124.43 117.29 24.1 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.66 111.23 16.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 41' ' ' VAL . 74.7 t -85.43 117.06 29.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -131.32 158.84 39.59 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.079 0.951 . . . . 0.0 110.012 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -115.89 110.53 19.14 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.96 152.09 20.18 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.982 0.513 . . . . 0.0 110.85 172.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.38 -25.96 63.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.693 0.797 . . . . 0.0 110.965 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -66.51 -53.45 34.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.317 1.047 . . . . 0.0 112.275 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 m -126.68 -0.44 6.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -168.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.22 -133.94 12.11 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 117.741 0.246 . . . . 0.0 112.632 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.574 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -82.27 131.13 35.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.906 0.482 . . . . 0.0 110.256 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -156.99 173.66 16.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.784 0.433 . . . . 0.0 110.773 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 31' ' ' VAL . 20.9 t -132.45 125.65 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.393 0.677 . . . . 0.0 109.526 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.425 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 73.2 t60 -87.91 119.35 28.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 109.581 172.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 74.0 m-85 -102.79 127.94 49.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.0 t70 -130.26 123.87 31.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.084 0.554 . . . . 0.0 110.589 -170.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 79.1 mtp -122.59 132.38 54.27 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.018 0.927 . . . . 0.0 111.097 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -154.38 154.23 32.93 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 0.0 110.965 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.24 -151.94 22.09 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 118.588 -1.118 . . . . 0.0 110.403 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -145.65 110.5 5.16 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.096 1.448 . . . . 0.0 111.72 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.557 HG23 HG22 ' A' ' 23' ' ' ILE . 68.8 mt -98.64 124.3 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.603 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.508 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 7.7 m-20 63.98 24.45 13.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.909 1.283 . . . . 0.0 109.822 -170.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.47 10.38 86.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.39 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 51.3 mtmt -94.78 108.37 37.12 Favored Pre-proline 0 C--N 1.354 0.771 0 C-N-CA 123.494 0.717 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.86 133.54 39.4 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.796 2.331 . . . . 0.0 111.732 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -137.76 147.39 44.65 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.2 p -132.71 113.1 12.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.77 136.59 34.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.2 p -148.95 145.7 27.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.736 0.303 . . . . 0.0 110.593 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -137.87 142.46 40.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.307 1.043 . . . . 0.0 109.325 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 7.4 mp0 -116.13 140.44 49.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.3 mt -132.87 135.93 26.81 Favored Pre-proline 0 C--O 1.237 0.435 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 165.26 19.95 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.495 2.13 . . . . 0.0 111.713 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 24.6 ptt180 -38.76 -36.91 0.3 Allowed 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 125.404 1.482 . . . . 0.0 114.15 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -78.78 -19.14 52.91 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 p -130.53 3.05 4.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.339 0.656 . . . . 0.0 111.307 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.51 70.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.29 1.036 . . . . 0.0 112.178 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -71.15 -17.74 62.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.059 0.944 . . . . 0.0 112.366 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.95 -3.84 57.54 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.869 0.467 . . . . 0.0 111.103 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -51.65 -44.11 62.89 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.026 0.93 . . . . 0.0 112.963 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.22 30.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -172.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -67.69 -47.55 69.12 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.975 0.51 . . . . 0.0 109.855 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.44 -47.5 33.23 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.778 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.51 -39.18 10.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.008 1.323 . . . . 0.0 112.477 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.1 m -73.77 -44.03 57.27 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.982 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -61.67 -46.99 87.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.041 0.936 . . . . 0.0 112.464 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.53 -31.92 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.415 0.686 . . . . 0.0 110.805 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.21 85.79 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.984 0.514 . . . . 0.0 110.594 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -76.84 -25.76 53.56 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.217 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -68.03 -27.87 66.91 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.032 0.933 . . . . 0.0 110.669 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.79 6.65 20.52 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.636 0.774 . . . . 0.0 111.448 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.4 54.13 2.02 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 114.701 0.64 . . . . 0.0 114.701 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.6 mt . . . . . 0 N--CA 1.485 1.297 0 CA-C-N 118.089 0.945 . . . . 0.0 109.575 165.312 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.5 t80 . . . . . 0 C--O 1.21 -0.979 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -53.27 -41.71 65.79 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.28 29.19 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.135 0.574 . . . . 0.0 110.268 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.4 ' SD ' ' CE1' ' A' ' 5' ' ' PHE . 8.6 tpt -51.69 -42.12 61.95 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.824 1.249 . . . . 0.0 111.686 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -58.99 -53.26 60.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.335 1.454 . . . . 0.0 110.839 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.72 -27.6 66.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.827 0.704 . . . . 0.0 112.101 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.08 -55.69 8.83 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 123.335 0.397 . . . . 0.0 110.243 176.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.8 -37.03 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.914 0.325 . . . . 0.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.4 62.39 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.072 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -61.94 -38.82 89.91 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.321 1.048 . . . . 0.0 112.898 174.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.31 -38.66 92.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.241 0.616 . . . . 0.0 110.802 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -66.81 -29.32 69.22 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.737 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.439 0 C-N-CA 125.839 1.656 . . . . 0.0 112.081 177.562 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.619 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.15 129.14 68.23 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.337 1.055 . . . . 0.0 109.561 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.87 105.13 1.09 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.735 2.29 . . . . 0.0 110.687 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.84 143.99 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 0.0 111.944 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.79 -30.63 69.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.302 1.041 . . . . 0.0 111.891 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.22 -6.15 22.04 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.169 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.78 -43.66 2.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.663 0.785 . . . . 0.0 110.89 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -75.49 -31.56 60.25 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.667 0.787 . . . . 0.0 111.578 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.39 -28.75 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.0 mp -88.28 83.82 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.74 0.816 . . . . 0.0 109.092 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.488 1.428 0 C-N-CA 123.516 0.726 . . . . 0.0 111.324 176.112 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.13 157.2 37.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.455 1.502 . . . . 0.0 107.865 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.57 105.14 0.34 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 121.876 1.717 . . . . 0.0 111.122 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.1 -16.2 12.0 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.866 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -158.36 151.61 22.96 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.74 0.77 . . . . 0.0 112.307 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -140.22 143.15 35.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.045 1.738 . . . . 0.0 107.972 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -124.41 137.55 54.44 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.417 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -136.47 118.55 15.41 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.577 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.246 0.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.973 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.569 ' HG3' HG23 ' A' ' 23' ' ' ILE . 19.0 pt20 . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.2 57.82 4.7 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.152 0.581 . . . . 0.0 111.648 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.569 HG23 ' HG3' ' A' ' 21' ' ' GLN . 2.0 pp -90.54 119.91 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.25 118.62 12.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.417 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 19.2 mt -140.53 139.42 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.36 0.664 . . . . 0.0 109.715 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -107.3 131.93 53.67 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.471 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.6 mt -128.11 110.19 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -99.88 139.66 35.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -122.58 116.17 23.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 164.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -123.86 113.17 18.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.471 HG21 HG23 ' A' ' 41' ' ' VAL . 87.2 t -80.22 131.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 30.3 ttt180 -146.83 161.24 41.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.438 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.1 mm-40 -109.74 119.41 39.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.037 0.535 . . . . 0.0 110.419 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.432 HD21 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -96.61 146.76 24.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.776 0.831 . . . . 0.0 110.311 170.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.83 62.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.403 0.681 . . . . 0.0 111.82 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -71.96 -55.34 7.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.893 0.877 . . . . 0.0 112.171 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -121.13 0.69 10.21 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.167 0.587 . . . . 0.0 111.859 -168.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.74 -113.78 4.15 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB1' ' HD3' ' A' ' 62' ' ' ARG . . . -78.87 144.07 35.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.866 0.466 . . . . 0.0 111.279 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.417 ' OH ' ' HD3' ' A' ' 32' ' ' ARG . 9.3 p90 -154.85 177.42 11.29 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 108.666 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.471 HG23 HG21 ' A' ' 31' ' ' VAL . 16.3 t -128.3 124.13 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -84.02 122.52 28.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.641 1.176 . . . . 0.0 108.983 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -106.95 126.72 52.68 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -125.89 115.03 19.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.809 0.843 . . . . 0.0 110.02 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.471 ' SD ' HG12 ' A' ' 27' ' ' ILE . 38.9 mtm -120.95 148.09 44.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.566 0.746 . . . . 0.0 111.004 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -167.79 166.36 13.68 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.213 1.005 . . . . 0.0 109.94 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.11 -144.78 10.03 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-O 118.708 -1.051 . . . . 0.0 110.7 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.99 110.06 3.27 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.582 1.182 . . . . 0.0 111.549 171.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 23' ' ' ILE . 70.3 mt -100.22 127.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.015 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 65.09 23.53 12.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.088 1.355 . . . . 0.0 109.206 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.48 -0.63 84.67 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.401 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -86.37 109.13 21.0 Favored Pre-proline 0 C--N 1.353 0.745 0 C-N-CA 124.092 0.957 . . . . 0.0 111.48 -175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.24 129.84 18.89 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.849 2.366 . . . . 0.0 111.902 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -138.49 160.25 40.02 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -147.77 129.06 14.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 169.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -130.87 142.02 50.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.374 1.069 . . . . 0.0 109.102 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -143.25 133.62 24.7 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.538 0.335 . . . . 0.0 110.425 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.86 144.71 33.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.72 0.808 . . . . 0.0 109.231 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -126.1 127.25 45.49 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 65' ' ' ALA . 80.8 mt -124.7 129.87 24.46 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -175.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -59.32 156.31 36.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.951 2.434 . . . . 0.0 111.215 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HD3' ' HB1' ' A' ' 39' ' ' ALA . 30.1 ptt180 -45.53 -26.88 0.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.38 -21.79 45.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.373 0.669 . . . . 0.0 111.809 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -128.65 2.87 5.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.833 0.853 . . . . 0.0 110.977 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . . . -55.32 -37.37 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.448 1.099 . . . . 0.0 112.545 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.52 0.7 7.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.202 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.16 3.82 47.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.482 0.713 . . . . 0.0 110.241 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -57.76 -52.03 67.14 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.998 0.919 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.57 -31.1 63.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.5 m -73.44 -50.83 19.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.977 0.511 . . . . 0.0 110.333 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.21 -55.6 15.45 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.745 0.818 . . . . 0.0 111.383 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.36 -46.75 13.28 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.986 1.314 . . . . 0.0 113.059 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.1 m -70.6 -33.15 70.74 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.913 0.485 . . . . 0.0 111.028 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -67.33 -40.77 85.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.396 0.679 . . . . 0.0 111.003 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.93 -33.21 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 110.727 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.96 -47.92 73.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.323 0.582 . . . . 0.0 109.548 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 3.6 pt20 -69.63 -31.89 70.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.825 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -53.69 -41.66 67.16 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 110.876 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -90.79 8.66 33.57 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.075 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.47 -10.02 4.66 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.451 HD12 ' HB ' ' A' ' 23' ' ' ILE . 8.7 mp . . . . . 0 N--CA 1.49 1.544 0 CA-C-N 118.898 1.349 . . . . 0.0 111.215 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.7 t80 . . . . . 0 C--O 1.221 -0.442 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.0 -34.73 72.19 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.962 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.34 64.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.564 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mmt -72.27 -30.74 65.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.623 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -51.92 -52.4 50.28 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.087 0.955 . . . . 0.0 110.625 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.78 -28.76 61.82 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.798 0.686 . . . . 0.0 112.241 -173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.24 -44.81 58.82 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.382 0.273 . . . . 0.0 110.811 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.433 ' O ' HD13 ' A' ' 106' ' ' LEU . 97.6 mt -63.47 -46.52 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.688 0.795 . . . . 0.0 111.648 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -59.69 -31.5 69.64 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.349 0.595 . . . . 0.0 110.496 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.93 56.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.573 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.437 ' HG2' HG22 ' A' ' 31' ' ' VAL . 1.9 tpmt? -64.63 -32.67 74.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.475 0.71 . . . . 0.0 111.873 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -67.83 -20.96 65.22 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.679 1.192 . . . . 0.0 111.149 171.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -88.24 -17.18 31.35 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.126 0.97 . . . . 0.0 110.202 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 C-N-CA 126.916 2.086 . . . . 0.0 112.638 173.812 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.806 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 139.4 73.39 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.033 0.933 . . . . 0.0 112.436 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.22 66.02 8.85 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.382 2.722 . . . . 0.0 112.531 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.54 72.44 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 122.845 1.307 . . . . 0.0 109.532 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.68 41.24 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.779 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 117' ' ' GLU . 3.9 pp -63.23 -29.69 70.98 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.325 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.4 ' N ' HD12 ' A' ' 116' ' ' LEU . 31.7 tt0 -73.65 -19.17 60.92 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.496 0.718 . . . . 0.0 111.43 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -68.53 -16.46 63.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.958 0.503 . . . . 0.0 111.407 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.3 mm -71.64 -35.3 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.112 0.565 . . . . 0.0 109.805 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.428 ' N ' HD11 ' A' ' 120' ' ' ILE . 3.4 mp -84.36 78.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 122.261 1.029 . . . . 0.0 108.246 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.792 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.861 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.82 156.91 62.35 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.824 1.25 . . . . 0.0 108.504 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.61 105.03 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.538 2.159 . . . . 0.0 112.242 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.63 -19.89 13.95 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.691 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -150.97 135.33 16.96 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.524 0.678 . . . . 0.0 112.363 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.464 HD21 ' HE2' ' A' ' 98' ' ' MET . 46.2 tp -114.8 141.02 48.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.583 1.553 . . . . 0.0 108.957 170.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.532 0.733 . . . . 0.0 109.349 168.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.572 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -123.29 110.21 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.644 0.735 . . . . 0.0 110.529 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.248 1.015 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 164.47 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -85.95 53.17 2.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.625 0.726 . . . . 0.0 110.255 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.52 HG22 HG22 ' A' ' 49' ' ' ILE . 2.0 pp -89.67 115.57 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -138.2 106.39 5.75 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.572 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 48.6 mt -127.6 132.98 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -166.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -107.35 119.17 38.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.492 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -120.55 114.1 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 18.4 mtp180 -104.11 135.34 45.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 108.234 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -121.88 116.06 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 167.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.6 111.8 17.67 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 41' ' ' VAL . 52.1 t -82.37 118.33 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.03 159.0 30.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -109.27 119.39 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.722 0.409 . . . . 0.0 110.35 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.04 154.9 16.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.877 0.871 . . . . 0.0 109.232 167.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.75 -27.65 64.1 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.714 0.406 . . . . 0.0 111.454 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.21 -54.38 7.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.862 0.865 . . . . 0.0 112.348 -173.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 t -108.57 -1.92 19.25 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.11 0.564 . . . . 0.0 111.532 -173.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.84 -110.31 3.06 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 138.34 37.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.9 0.48 . . . . 0.0 110.567 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.5 166.79 26.2 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 31' ' ' VAL . 7.6 t -127.81 127.12 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.563 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 55.4 t60 -86.18 114.41 23.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.462 1.105 . . . . 0.0 108.859 171.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 76.0 m-85 -99.73 111.38 23.72 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 27.1 t70 -107.13 124.58 49.9 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 109.408 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.492 ' HG2' HG12 ' A' ' 27' ' ' ILE . 79.4 mtp -124.58 140.34 53.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.259 0.624 . . . . 0.0 110.286 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.04 170.0 21.38 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.739 0.815 . . . . 0.0 109.663 173.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.16 -137.78 6.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 119.429 -0.651 . . . . 0.0 112.002 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 9.7 pt-20 -152.55 157.73 41.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.756 1.222 . . . . 0.0 108.546 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.52 HG22 HG22 ' A' ' 23' ' ' ILE . 51.2 mt -156.46 105.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -168.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.9 t70 59.14 47.96 11.14 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.216 1.007 . . . . 0.0 108.994 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.97 -35.05 3.13 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 114.836 -1.075 . . . . 0.0 114.384 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -86.94 128.88 54.31 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.218 1.007 . . . . 0.0 112.053 -168.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 89.6 Cg_endo -74.17 161.07 41.47 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.064 2.509 . . . . 0.0 113.821 -177.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.406 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 8.9 p90 -152.86 148.9 27.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.903 0.881 . . . . 0.0 109.021 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -142.54 113.83 7.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.154 0.582 . . . . 0.0 110.278 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -127.21 143.09 51.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.295 1.038 . . . . 0.0 109.186 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 t -143.53 134.43 25.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.013 0.435 . . . . 0.0 110.093 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -146.97 148.81 32.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.853 0.861 . . . . 0.0 109.703 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.563 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 4.7 mp0 -118.94 138.72 52.59 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 73.4 mt -128.89 134.36 26.23 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.71 160.85 34.66 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.641 2.227 . . . . 0.0 111.373 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -36.2 9.96 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.57 -23.73 61.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.056 0.942 . . . . 0.0 112.258 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -125.3 7.2 7.77 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.952 0.901 . . . . 0.0 110.779 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.04 80.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.029 0.931 . . . . 0.0 112.282 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.83 -6.51 38.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.086 0.954 . . . . 0.0 113.186 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -78.57 -6.3 55.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.414 0.685 . . . . 0.0 111.131 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -64.14 -24.13 67.57 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 124.542 1.137 . . . . 0.0 113.06 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.7 -49.06 16.98 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.252 0.549 . . . . 0.0 109.693 -162.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 m -72.41 -31.01 65.17 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.283 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.07 -54.24 13.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.182 0.993 . . . . 0.0 110.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.02 74.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.631 1.172 . . . . 0.0 111.92 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.5 m -63.86 -50.24 69.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.657 0.383 . . . . 0.0 110.34 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -54.92 -45.37 74.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.216 1.006 . . . . 0.0 112.058 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.34 -32.06 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.543 0.337 . . . . 0.0 110.671 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.99 -47.48 58.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.023 0.529 . . . . 0.0 110.096 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.585 ' HA ' HD21 ' A' ' 81' ' ' LEU . 13.2 pt20 -65.4 -22.16 66.75 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.757 0.823 . . . . 0.0 112.641 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -64.65 -19.24 65.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.741 0.816 . . . . 0.0 111.918 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -90.2 25.23 2.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.373 0.669 . . . . 0.0 112.33 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.22 49.85 1.67 Allowed Glycine 0 C--N 1.35 1.312 0 CA-C-O 120.218 -0.212 . . . . 0.0 113.493 170.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.585 HD21 ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 C-N-CA 122.953 0.501 . . . . 0.0 109.701 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 t80 . . . . . 0 C--O 1.223 -0.298 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.27 -34.08 74.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.473 1.109 . . . . 0.0 111.815 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.37 68.38 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.711 0.632 . . . . 0.0 110.696 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.464 ' HE2' HD21 ' A' ' 10' ' ' LEU . 30.4 ttm -65.45 -41.53 93.35 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.012 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.24 -48.29 68.33 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.388 1.075 . . . . 0.0 110.91 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.0 -26.85 57.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.7 t70 -65.72 -57.35 8.26 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.487 0.492 . . . . 0.0 110.212 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.9 -42.41 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.431 0.693 . . . . 0.0 111.551 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -28.38 69.13 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.22 47.74 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 110.326 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 30.7 mmmt -58.34 -40.46 82.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 mp -66.62 -34.47 77.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.537 1.135 . . . . 0.0 111.046 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -81.28 -17.86 47.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.444 0.697 . . . . 0.0 110.562 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 C-N-CA 125.569 1.547 . . . . 0.0 111.667 -179.362 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.729 0 CA-C-O 119.445 -0.641 . . . . 0.0 113.371 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.99 114.91 16.75 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -88.64 123.18 1.48 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.845 2.363 . . . . 0.0 112.83 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . 0.403 HG23 HD22 ' A' ' 116' ' ' LEU . 11.6 p -79.05 152.91 4.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -113.42 17.48 18.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.038 0.535 . . . . 0.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.403 HD22 HG23 ' A' ' 114' ' ' VAL . 4.4 pp -65.65 -24.26 66.98 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -114.59 -3.14 12.96 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.11 0.964 . . . . 0.0 110.865 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -72.29 -5.27 34.92 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.558 0.743 . . . . 0.0 112.707 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.3 -7.42 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 C-N-CA 123.998 0.919 . . . . 0.0 109.648 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.2 mm 60.77 54.91 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.286 0 C-N-CA 125.12 1.368 . . . . 0.0 107.501 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 . . . . . 0 C--O 1.24 0.553 0 CA-C-N 113.423 -1.717 . . . . 0.0 110.666 -164.499 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.47 155.6 32.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.575 1.15 . . . . 0.0 108.304 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.72 90.83 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.285 1.99 . . . . 0.0 111.995 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.91 -26.3 3.01 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.721 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 26' ' ' HIS . 55.5 t-80 -150.53 151.63 32.94 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.196 0.498 . . . . 0.0 111.692 -170.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 53.8 tp -135.02 111.63 9.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 108.557 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -98.42 127.9 44.56 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.424 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -121.05 132.38 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.215 0.606 . . . . 0.0 109.931 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.248 1.009 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 166.329 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.05 65.83 8.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.852 0.834 . . . . 0.0 110.509 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.601 HD13 HD21 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -92.69 126.85 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.442 HD22 ' HG3' ' A' ' 48' ' ' GLU . 6.0 p30 -151.81 110.02 3.73 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.424 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 27.8 mt -132.32 137.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -168.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.532 ' O ' ' HA ' ' A' ' 45' ' ' MET . 4.7 m170 -99.53 128.52 45.65 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.551 HG12 ' HG2' ' A' ' 45' ' ' MET . 56.2 mt -121.9 109.62 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -96.18 124.84 40.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . 0.463 ' HB2' HG13 ' A' ' 41' ' ' VAL . 45.7 p90 -111.69 116.98 31.65 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -124.63 112.32 16.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.676 0.79 . . . . 0.0 109.29 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.501 HG23 HG21 ' A' ' 41' ' ' VAL . 56.3 t -75.9 126.64 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.771 0.428 . . . . 0.0 110.663 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -143.97 154.79 43.66 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.05 125.56 41.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.713 0.405 . . . . 0.0 111.132 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 1.5 p30 -100.1 147.08 26.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.635 1.174 . . . . 0.0 109.155 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.81 -10.94 60.51 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 122.954 0.501 . . . . 0.0 112.233 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.532 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 16.4 tt0 -75.81 -55.27 5.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.196 0.999 . . . . 0.0 112.012 -177.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.1 p -130.32 1.98 4.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.338 0.655 . . . . 0.0 112.263 -167.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.88 -106.27 3.4 Favored Glycine 0 C--O 1.213 -1.171 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 146.76 41.22 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.794 0.797 . . . . 0.0 111.887 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.442 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.5 p90 -152.85 173.53 15.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.501 HG21 HG23 ' A' ' 31' ' ' VAL . 23.5 t -128.7 130.85 68.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -89.03 110.95 21.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 63.3 m-85 -96.56 139.32 32.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.467 0.707 . . . . 0.0 109.181 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 34.1 t70 -135.04 127.95 31.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.358 0.663 . . . . 0.0 109.722 -177.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.551 ' HG2' HG12 ' A' ' 27' ' ' ILE . 83.4 mtp -123.91 131.17 53.53 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.919 0.888 . . . . 0.0 110.114 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -161.03 162.18 31.65 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.71 -128.03 2.6 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HG3' HD22 ' A' ' 24' ' ' ASN . 10.3 pt-20 -156.59 165.43 36.31 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.198 0.599 . . . . 0.0 109.864 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 90.6 mt -155.98 103.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 -161.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.16 37.43 20.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.687 0.795 . . . . 0.0 110.1 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.12 -21.03 7.32 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.312 -0.858 . . . . 0.0 115.239 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -79.65 120.23 79.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 117.621 0.711 . . . . 0.0 110.825 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.61 157.05 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.017 2.478 . . . . 0.0 113.266 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -154.7 161.51 41.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.679 0.392 . . . . 0.0 111.279 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.5 p -141.89 116.26 9.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.431 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.35 144.31 31.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.244 1.018 . . . . 0.0 108.861 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.3 p -148.12 149.59 32.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.452 0.569 . . . . 0.0 110.753 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -141.46 151.32 43.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.558 0.743 . . . . 0.0 110.571 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.76 132.56 54.29 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.55 0.74 . . . . 0.0 109.863 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 95.7 mt -127.53 139.05 34.15 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.374 0.67 . . . . 0.0 109.791 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.44 158.54 40.36 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.053 2.502 . . . . 0.0 112.02 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -41.36 -34.83 0.56 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.126 1.37 . . . . 0.0 114.65 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.86 -19.88 62.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.625 0.77 . . . . 0.0 112.416 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.3 p -131.7 10.1 4.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.829 0.852 . . . . 0.0 110.231 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.57 96.79 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.493 0.717 . . . . 0.0 111.36 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -70.05 -22.19 63.1 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.549 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -80.6 -8.76 59.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.809 0.844 . . . . 0.0 109.545 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -53.04 -30.61 36.76 Favored 'General case' 0 C--O 1.205 -1.276 0 C-N-CA 123.949 0.899 . . . . 0.0 112.918 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 -34.16 20.77 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -69.52 -48.3 60.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.37 -57.04 10.45 Favored 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -43.55 -45.27 6.53 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.778 1.631 . . . . 0.0 113.461 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.4 m -68.75 -40.55 79.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.668 0.387 . . . . 0.0 110.892 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.59 -39.09 81.09 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.534 0.734 . . . . 0.0 111.828 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.98 -50.21 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.397 1.079 . . . . 0.0 109.451 173.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB1' HD23 ' A' ' 81' ' ' LEU . . . -60.74 -43.06 98.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.667 0.787 . . . . 0.0 111.622 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -71.11 -35.52 71.82 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.638 0.375 . . . . 0.0 111.284 -176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -65.1 -31.65 72.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.619 0.368 . . . . 0.0 110.697 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -89.38 5.38 45.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.234 0.613 . . . . 0.0 112.143 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.02 -27.09 2.45 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.601 HD21 HD13 ' A' ' 23' ' ' ILE . 9.8 mp . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 121.767 0.794 . . . . 0.0 111.955 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.47 -31.29 69.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.59 -48.88 53.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.991 0.516 . . . . 0.0 110.976 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.6 ptm -65.97 -31.44 72.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.505 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -56.48 -45.97 80.67 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.175 0.59 . . . . 0.0 110.828 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.554 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 12.3 pt-20 -76.75 -27.67 55.44 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.705 0.402 . . . . 0.0 111.934 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.51 -58.97 3.78 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.864 0.364 . . . . 0.0 110.028 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.413 ' O ' HD12 ' A' ' 106' ' ' LEU . 74.7 mt -57.16 -38.05 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.879 1.271 . . . . 0.0 112.361 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.554 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.69 -29.61 70.82 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.234 0.47 . . . . 0.0 111.611 177.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.82 -41.19 60.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.741 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -57.35 -45.09 84.71 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.789 0.836 . . . . 0.0 112.514 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 102' ' ' ILE . 9.7 mp -64.21 -24.95 67.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.871 0.869 . . . . 0.0 111.766 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -85.68 -16.91 37.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.319 0.648 . . . . 0.0 110.657 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 125.134 1.374 . . . . 0.0 111.608 175.72 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.711 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -72.49 144.11 86.06 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.98 0.912 . . . . 0.0 110.167 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.21 148.81 69.45 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.994 2.462 . . . . 0.0 112.128 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.97 149.98 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -140.83 32.68 1.79 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.668 0.787 . . . . 0.0 110.105 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 117' ' ' GLU . 4.5 pp -61.97 -43.03 99.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.813 0.445 . . . . 0.0 110.821 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -76.18 -22.48 55.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.757 1.223 . . . . 0.0 111.853 -178.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 tpp85 -50.36 -49.14 55.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.997 1.319 . . . . 0.0 112.246 -170.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.91 -29.19 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.754 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.3 -24.36 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.752 0.821 . . . . 0.0 111.628 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 31.0 mmm180 . . . . . 0 N--CA 1.49 1.536 0 C-N-CA 123.396 0.679 . . . . 0.0 111.364 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.1 t80 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.13 161.3 54.13 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.923 1.289 . . . . 0.0 108.451 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.495 ' HG3' ' HB3' ' A' ' 112' ' ' GLU . 29.8 Cg_exo -62.44 109.66 0.91 Allowed 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 121.859 1.706 . . . . 0.0 111.491 172.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.29 -13.83 33.45 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.896 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -155.12 146.79 23.23 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.542 0.671 . . . . 0.0 112.062 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.9 tp -136.35 128.93 30.55 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.641 1.176 . . . . 0.0 109.039 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -100.3 125.63 46.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 85.8 mt -107.17 134.82 49.71 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.269 0.628 . . . . 0.0 109.928 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 23' ' ' ILE . 13.8 p . . . . . 0 C--O 1.249 1.038 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.494 HE21 ' HB2' ' A' ' 50' ' ' ASP . 31.2 tt0 . . . . . 0 C--O 1.238 0.46 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . 0.573 ' HB3' ' HA ' ' A' ' 50' ' ' ASP . 27.8 t70 -85.74 42.48 0.97 Allowed 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.488 1.137 . . . . 0.0 110.727 -173.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.625 HG22 HG21 ' A' ' 49' ' ' ILE . 44.3 pt -89.7 139.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.445 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.586 HD22 ' HG2' ' A' ' 48' ' ' GLU . 5.5 p30 -152.85 125.01 8.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 172.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 31.4 mt -132.43 132.79 60.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.174 -172.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.517 ' O ' ' HA ' ' A' ' 45' ' ' MET . 5.5 m170 -108.09 109.82 21.35 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -105.27 108.37 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -102.91 109.93 21.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -115.93 117.96 31.6 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.69 114.52 18.12 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 105' ' ' LYS . 7.1 p -82.25 126.63 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.051 0.54 . . . . 0.0 109.726 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -141.16 166.49 24.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -109.49 117.13 33.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -91.65 156.96 17.23 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.681 0.793 . . . . 0.0 109.665 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.42 -20.76 62.08 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -84.72 -53.62 5.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.28 0.632 . . . . 0.0 111.438 -171.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -117.86 3.92 12.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.958 0.903 . . . . 0.0 111.537 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.44 -122.41 5.72 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.55 51.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.618 0.709 . . . . 0.0 111.994 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -157.75 170.65 21.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.002 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.07 130.35 69.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.49 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.0 t60 -88.27 129.8 35.27 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -115.07 135.12 54.55 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -137.99 141.36 40.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 91.3 mtp -135.19 131.59 36.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.564 0.746 . . . . 0.0 109.281 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -150.54 162.79 39.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.72 -144.08 12.8 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.586 ' HG2' HD22 ' A' ' 24' ' ' ASN . 1.9 pm0 -147.23 163.16 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.295 1.038 . . . . 0.0 108.547 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.625 HG21 HG22 ' A' ' 23' ' ' ILE . 38.0 mt -157.81 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 -160.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.573 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 37.3 t70 55.38 26.64 8.97 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 121.614 0.721 . . . . 0.0 111.394 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.22 50.97 4.33 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.212 -173.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 52.4 mtpt -146.11 108.41 4.26 Favored Pre-proline 0 N--CA 1.497 1.92 0 C-N-CA 123.564 0.746 . . . . 0.0 110.798 -176.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.91 121.44 4.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.863 2.375 . . . . 0.0 111.794 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -125.54 143.68 50.9 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.861 0.465 . . . . 0.0 110.687 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 p -139.92 110.55 6.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.312 0.645 . . . . 0.0 109.477 171.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.22 151.85 39.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.697 1.199 . . . . 0.0 109.299 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.8 p -151.43 123.16 8.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.909 0.483 . . . . 0.0 109.85 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.16 146.44 42.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.317 1.047 . . . . 0.0 108.98 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 49.6 mt-10 -123.89 141.29 52.17 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.077 0.551 . . . . 0.0 109.672 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -124.79 130.28 24.3 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -65.65 169.65 12.55 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.936 2.424 . . . . 0.0 112.193 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -41.5 -39.67 1.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.473 1.109 . . . . 0.0 113.617 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.04 -29.5 66.55 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.243 1.017 . . . . 0.0 112.526 -174.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -130.99 8.39 4.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.966 0.507 . . . . 0.0 111.376 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.83 70.95 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.531 0.732 . . . . 0.0 111.917 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.16 -21.55 66.79 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.898 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -72.76 3.26 5.33 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.406 0.683 . . . . 0.0 112.593 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.56 -20.61 61.29 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.402 1.081 . . . . 0.0 112.209 -173.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.16 -42.9 45.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.938 0.875 . . . . 0.0 108.844 -169.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -74.46 -39.62 62.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.155 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 75' ' ' VAL . 19.9 t70 -73.71 -59.1 2.87 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.016 0.526 . . . . 0.0 112.14 -171.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.45 66.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.559 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.533 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 95.4 m -65.81 -48.23 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 173.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -57.74 -34.33 69.4 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.545 0.738 . . . . 0.0 111.951 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 71' ' ' ASP . 94.0 t -68.8 -36.81 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' HD13 ' A' ' 81' ' ' LEU . . . -68.44 -49.72 57.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.54 0.736 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 73' ' ' THR . 65.7 mm-40 -66.21 -25.08 66.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -60.13 -28.73 68.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.439 1.096 . . . . 0.0 111.363 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -91.66 12.13 22.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.648 0.779 . . . . 0.0 112.232 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.1 74.32 1.11 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 122.948 0.155 . . . . 0.0 113.292 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.51 ' HG ' HG23 ' A' ' 23' ' ' ILE . 11.2 mp . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 124.163 0.985 . . . . 0.0 109.681 170.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.3 t80 . . . . . 0 C--O 1.221 -0.414 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.67 -30.45 70.7 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.199 0.937 . . . . 0.0 111.847 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.12 17.82 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.942 0.497 . . . . 0.0 110.893 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -70.96 -25.9 62.93 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.565 0.346 . . . . 0.0 111.869 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -50.97 -42.73 60.3 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.127 0.971 . . . . 0.0 110.303 164.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 35.0 mt-10 -79.33 -27.57 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.488 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.83 -50.31 30.68 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.8 -38.81 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.567 0.347 . . . . 0.0 111.648 173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.42 -28.55 69.33 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.21 -40.6 62.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.053 0.541 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.542 ' HB3' HG12 ' A' ' 31' ' ' VAL . 9.5 mmpt? -58.44 -40.18 81.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.61 0.764 . . . . 0.0 112.059 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.25 -25.58 67.73 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.179 0.992 . . . . 0.0 111.162 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -80.68 -17.91 49.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 110.891 172.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 125.899 1.679 . . . . 0.0 111.628 174.856 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.38 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . 0.495 ' HB3' ' HG3' ' A' ' 7' ' ' PRO . 1.1 mm-40 -96.9 114.2 64.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.35 94.28 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.437 2.091 . . . . 0.0 112.822 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.47 93.06 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.21 1.005 . . . . 0.0 109.009 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.99 43.45 1.12 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.3 -173.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.03 -27.82 69.67 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.814 0.445 . . . . 0.0 111.959 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 42.5 tt0 -78.28 -22.07 48.82 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.964 0.506 . . . . 0.0 110.799 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -79.96 -17.09 53.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.985 0.514 . . . . 0.0 110.561 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.3 mm -78.97 91.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 124.063 0.945 . . . . 0.0 108.696 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.1 mt 82.41 -21.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.846 163.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 117' ' ' GLU . 15.8 mtp180 . . . . . 0 N--CA 1.478 0.97 0 C-N-CA 122.744 0.418 . . . . 0.0 111.14 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.79 157.02 32.61 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.82 1.248 . . . . 0.0 108.02 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.19 89.84 0.39 Allowed 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.943 1.762 . . . . 0.0 110.554 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -14.43 3.78 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.928 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -164.59 153.08 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.955 0.877 . . . . 0.0 111.978 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.412 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 4.8 tt -143.26 132.83 23.63 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 175.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -114.55 134.09 55.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.279 0.632 . . . . 0.0 109.667 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 95.1 mt -111.1 128.83 56.01 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 121.317 0.58 . . . . 0.0 110.364 176.979 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 . . . . . 0 C--O 1.242 0.671 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.92 112.38 23.24 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.95 138.65 38.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.95 127.7 10.21 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 165.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -137.81 128.87 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.717 0.807 . . . . 0.0 109.355 -163.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -93.82 131.65 39.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.428 HG12 ' HE2' ' A' ' 45' ' ' MET . 56.7 mt -120.36 103.99 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 171.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -91.96 140.17 29.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.31 137.8 19.74 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 111.197 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.25 130.77 37.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.848 0.859 . . . . 0.0 109.271 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.2 t -80.74 117.27 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 42.7 ttt180 -132.95 166.56 22.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.689 1.196 . . . . 0.0 108.144 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 25.7 mm-40 -106.34 127.67 53.43 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 118.349 0.522 . . . . 0.0 111.19 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 40' ' ' TYR . 3.2 p30 -102.95 146.54 28.17 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.825 1.25 . . . . 0.0 108.63 170.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.13 61.79 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 9.5 tp10 -77.37 -54.32 6.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.354 0.662 . . . . 0.0 112.008 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -113.55 -23.09 9.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.956 0.902 . . . . 0.0 111.218 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.16 -116.33 4.75 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 149.65 47.23 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.501 0.651 . . . . 0.0 111.724 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.428 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.1 p90 -159.05 173.74 16.0 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.992 0.917 . . . . 0.0 109.278 167.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.45 124.47 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -87.63 122.75 31.72 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -108.14 138.62 44.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.504 0.722 . . . . 0.0 110.18 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -130.48 120.46 24.18 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.329 1.052 . . . . 0.0 108.221 172.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.428 ' HE2' HG12 ' A' ' 27' ' ' ILE . 80.8 mtp -116.04 130.58 56.87 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.444 0.565 . . . . 0.0 109.702 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.8 161.73 40.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 159.48 -151.09 21.84 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 109.4 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.171 0.986 . . . . 0.0 110.426 175.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 80' ' ' GLY . 72.7 mt -99.47 123.9 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.135 174.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.6 t70 63.52 22.93 13.42 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.82 1.248 . . . . 0.0 110.079 -174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.05 3.88 84.83 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.228 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -93.03 108.4 32.18 Favored Pre-proline 0 C--N 1.355 0.823 0 C-N-CA 123.453 0.701 . . . . 0.0 110.722 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 66.8 Cg_endo -72.26 128.36 13.69 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.476 2.117 . . . . 0.0 111.389 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -131.45 150.17 52.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.235 0.614 . . . . 0.0 109.88 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -139.39 125.83 20.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.033 0.533 . . . . 0.0 110.292 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -141.71 147.59 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.4 p -148.51 140.08 23.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.03 151.08 37.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.659 0.783 . . . . 0.0 109.931 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.54 131.6 51.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.861 0.865 . . . . 0.0 109.281 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.63 125.75 23.84 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.69 157.15 33.79 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.912 2.408 . . . . 0.0 111.382 172.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -44.8 -26.73 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.0 -28.64 62.49 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.779 . . . . 0.0 111.442 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.8 p -131.54 7.19 4.48 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.316 1.046 . . . . 0.0 111.11 -173.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.47 71.64 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.992 0.917 . . . . 0.0 111.401 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -70.91 -8.12 50.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.084 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -90.45 0.5 57.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.662 0.785 . . . . 0.0 110.05 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.471 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 6.4 p90 -52.94 -43.62 66.45 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -30.28 65.87 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.651 0.78 . . . . 0.0 112.604 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 t -73.03 -50.45 22.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 109.864 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.15 -45.5 63.41 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.87 0.468 . . . . 0.0 112.025 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.87 -38.93 11.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.717 0.807 . . . . 0.0 112.835 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -71.9 -38.28 69.97 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.62 0.368 . . . . 0.0 110.816 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -57.62 -48.53 79.18 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.912 0.885 . . . . 0.0 110.947 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.87 0.868 . . . . 0.0 110.358 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.72 -41.81 87.36 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.104 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.445 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 13.8 pt20 -72.39 -36.11 68.61 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.243 0.617 . . . . 0.0 110.973 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -27.93 69.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.23 0.612 . . . . 0.0 111.336 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -98.09 7.36 46.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.824 0.45 . . . . 0.0 111.672 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 49' ' ' ILE . . . 102.12 93.0 2.21 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.062 0.226 . . . . 0.0 112.648 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 77' ' ' GLN . 57.5 tp . . . . . 0 N--CA 1.475 0.784 0 CA-C-N 117.371 0.585 . . . . 0.0 110.691 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.8 t80 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.37 -33.54 74.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.592 1.183 . . . . 0.0 112.959 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.09 -52.33 20.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.004 0.431 . . . . 0.0 110.839 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.471 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 1.1 mpt? -61.93 -34.18 75.62 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.787 173.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.4 -54.73 39.86 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.049 0.843 . . . . 0.0 110.203 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.95 -27.45 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.191 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.29 -58.55 6.22 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.394 0.616 . . . . 0.0 110.168 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.97 -38.22 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 114.526 -1.216 . . . . 0.0 113.179 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -34.57 78.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.291 0.95 . . . . 0.0 111.157 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.22 -46.8 48.19 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.212 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -57.68 -41.68 82.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.085 0.954 . . . . 0.0 111.926 174.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.71 -38.24 90.32 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.823 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -72.64 -31.21 64.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.439 0.296 . . . . 0.0 111.067 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 125.273 1.429 . . . . 0.0 114.036 172.273 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.606 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.32 146.77 55.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.163 0.985 . . . . 0.0 110.812 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -88.36 -167.67 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.352 2.701 . . . . 0.0 111.87 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.37 144.77 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.322 0.649 . . . . 0.0 109.694 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.55 -4.95 59.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 113.345 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.24 -32.89 74.79 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.529 0.604 . . . . 0.0 111.35 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -85.43 -2.28 57.94 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.493 0.717 . . . . 0.0 110.982 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -86.16 -20.54 28.45 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.253 0.621 . . . . 0.0 110.709 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -81.19 -59.95 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.25 94.73 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.99 161.61 28.62 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.404 1.082 . . . . 0.0 109.236 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.77 100.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.747 2.298 . . . . 0.0 112.599 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.36 -6.87 32.13 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.775 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -158.86 151.92 22.37 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.207 1.004 . . . . 0.0 111.957 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.1 tt -146.75 149.27 33.07 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.607 1.563 . . . . 0.0 107.33 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -127.26 139.73 52.71 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.183 0.593 . . . . 0.0 110.452 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 96.9 mt -125.56 135.24 52.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.383 1.473 . . . . 0.0 108.14 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.479 1.009 0 C-N-CA 123.931 0.892 . . . . 0.0 110.691 178.198 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -94.87 87.8 5.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.615 0.366 . . . . 0.0 110.529 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -106.76 128.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -137.12 131.4 32.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 71.1 mt -144.93 135.82 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -173.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -112.4 139.97 47.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -127.21 106.19 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -97.99 141.9 30.38 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -126.33 118.55 25.31 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.65 113.56 17.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 41' ' ' VAL . 58.0 t -79.35 118.11 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.45 158.2 30.26 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -107.06 121.55 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.61 -0.681 . . . . 0.0 110.344 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 5.1 p30 -102.04 145.41 29.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.765 0.826 . . . . 0.0 108.858 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.29 -18.05 65.03 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.335 0.654 . . . . 0.0 112.57 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.442 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 28.5 tt0 -73.63 -47.09 42.7 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.743 0.817 . . . . 0.0 112.685 -173.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -134.91 -7.87 2.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.508 0.723 . . . . 0.0 111.594 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -123.39 7.76 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.25 128.81 37.38 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 117.062 0.431 . . . . 0.0 111.747 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -140.62 162.26 35.79 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.519 HG22 HG23 ' A' ' 31' ' ' VAL . 15.8 t -119.15 127.29 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 5.4 t-160 -84.76 108.34 17.4 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 166.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 89.6 m-85 -94.9 116.45 28.72 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -110.44 134.45 52.32 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' A' ' 72' ' ' ALA . 87.1 mtp -129.55 129.11 44.04 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 118.908 0.776 . . . . 0.0 110.531 175.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -149.99 153.53 36.71 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 0.0 109.763 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 171.37 -145.88 9.14 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.952 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.61 109.75 3.52 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.736 1.268 . . . . 0.0 112.088 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.528 HD11 ' HB3' ' A' ' 79' ' ' HIS . 50.3 mt -102.15 128.42 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.589 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . 0.579 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 38.7 t70 66.56 23.76 10.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.39 1.476 . . . . 0.0 108.618 -169.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 3.36 88.52 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.101 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.579 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 51.4 mtmt -97.77 110.18 54.22 Favored Pre-proline 0 C--O 1.245 0.826 0 C-N-CA 124.302 1.041 . . . . 0.0 110.843 -173.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 41.6 Cg_endo -63.67 143.56 87.26 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.889 2.393 . . . . 0.0 112.52 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.73 155.27 43.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.441 0.696 . . . . 0.0 109.724 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -148.83 131.21 15.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.324 0.65 . . . . 0.0 109.866 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.41 160.63 39.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.587 1.555 . . . . 0.0 109.168 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 m -148.91 138.51 21.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 109.811 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -136.77 132.86 35.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.6 mp0 -113.96 125.2 53.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 75.3 mt -127.08 125.64 24.17 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.28 166.66 16.43 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.884 2.389 . . . . 0.0 112.164 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.49 ' HG3' HD11 ' A' ' 106' ' ' LEU . 74.2 ttt180 -47.62 -25.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.868 0.867 . . . . 0.0 112.923 174.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.83 -37.24 81.67 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.171 0.988 . . . . 0.0 112.678 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.2 p -129.39 4.97 5.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.422 0.689 . . . . 0.0 112.142 -170.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.76 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.186 0.994 . . . . 0.0 112.189 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -71.37 0.44 8.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.892 1.277 . . . . 0.0 113.975 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -93.3 -0.46 56.68 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.646 0.779 . . . . 0.0 110.999 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -54.35 -34.02 60.26 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.56 68.99 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.562 0.619 . . . . 0.0 112.582 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.8 m -73.54 -39.25 64.89 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.571 0.544 . . . . 0.0 109.99 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.15 -52.97 14.17 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.452 0.701 . . . . 0.0 111.271 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.505 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -48.98 -30.24 5.79 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.056 1.342 . . . . 0.0 113.106 172.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -81.66 -41.43 21.41 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.327 0.251 . . . . 0.0 110.665 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -63.73 -42.09 97.95 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.336 0.655 . . . . 0.0 111.612 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.21 -39.26 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.51 1.124 . . . . 0.0 110.401 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.92 83.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.003 0.921 . . . . 0.0 110.982 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 12.9 pt20 -78.85 -32.7 46.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.627 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -51.92 -48.11 64.34 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.77 1.228 . . . . 0.0 112.505 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.528 ' HB3' HD11 ' A' ' 49' ' ' ILE . 22.5 t60 -80.72 14.06 2.3 Favored 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.87 50.8 0.62 Allowed Glycine 0 C--N 1.349 1.265 0 O-C-N 122.051 -0.406 . . . . 0.0 112.865 170.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.41 HD12 HG12 ' A' ' 23' ' ' ILE . 65.5 tp . . . . . 0 CA--C 1.543 0.684 0 C-N-CA 123.436 0.694 . . . . 0.0 109.716 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.9 t80 . . . . . 0 C--O 1.219 -0.526 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.04 -30.33 71.29 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.766 0.827 . . . . 0.0 110.82 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.52 61.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.905 0.482 . . . . 0.0 110.532 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.2 ttt -62.17 -39.25 92.04 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.467 0.707 . . . . 0.0 111.353 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.51 -50.83 64.57 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.334 1.454 . . . . 0.0 110.106 174.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -65.61 -34.02 77.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.99 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.32 -50.2 64.41 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.11 0.564 . . . . 0.0 109.948 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.47 -39.94 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.727 0.811 . . . . 0.0 112.054 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -68.63 -30.7 69.48 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.96 0.41 . . . . 0.0 110.613 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.33 62.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.822 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.03 0.932 . . . . 0.0 112.43 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.49 HD11 ' HG3' ' A' ' 62' ' ' ARG . 26.6 mt -65.7 -27.17 68.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.977 0.911 . . . . 0.0 112.56 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -71.5 -16.85 62.36 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.445 0 C-N-CA 124.843 1.257 . . . . 0.0 110.656 -179.19 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.713 0 CA-C-O 121.184 0.325 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.76 124.74 61.42 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.903 0.881 . . . . 0.0 110.342 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.97 168.33 23.61 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.952 2.435 . . . . 0.0 111.322 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.34 151.86 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.369 0.668 . . . . 0.0 109.578 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -117.54 69.19 0.77 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.72 -28.58 13.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.337 0.655 . . . . 0.0 110.825 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.69 -37.07 65.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -71.26 -14.18 62.15 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.077 0.551 . . . . 0.0 111.782 -171.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp -75.25 -53.28 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.591 0.756 . . . . 0.0 109.219 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.97 92.57 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.937 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.9 t80 . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.87 155.0 51.97 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.553 1.141 . . . . 0.0 108.601 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.69 108.97 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.643 2.229 . . . . 0.0 112.532 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.23 11.57 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.496 0.569 . . . . 0.0 113.354 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -148.28 141.95 25.55 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.632 0.73 . . . . 0.0 112.191 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.89 139.86 53.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.179 . . . . 0.0 108.347 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -128.56 117.5 21.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.558 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -120.6 110.05 15.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.837 0.855 . . . . 0.0 110.039 -179.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 168.31 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 . . . . . 0 C--O 1.241 0.634 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.97 59.08 4.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.503 0.721 . . . . 0.0 110.424 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.5 HG23 HG21 ' A' ' 49' ' ' ILE . 2.3 pp -89.9 121.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 173.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -150.65 116.58 5.57 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.558 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 25.8 mt -138.61 145.08 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.323 1.049 . . . . 0.0 108.181 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -132.44 127.14 34.68 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.537 HG12 ' HG2' ' A' ' 45' ' ' MET . 52.3 mt -109.74 123.44 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 108.675 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 14.0 mmm180 -109.54 117.89 35.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.863 0.865 . . . . 0.0 109.088 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -111.43 119.61 39.39 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -122.06 113.92 20.21 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.945 0.898 . . . . 0.0 109.346 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.69 121.72 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 122.701 0.4 . . . . 0.0 110.434 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -140.53 162.86 34.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.559 1.144 . . . . 0.0 108.102 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -111.19 117.56 33.56 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.832 0.453 . . . . 0.0 109.825 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.438 HD22 ' HB2' ' A' ' 37' ' ' SER . 0.1 OUTLIER -102.46 147.32 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.983 0.913 . . . . 0.0 109.93 172.046 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.24 -20.55 63.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.326 0.65 . . . . 0.0 111.692 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -70.15 -53.62 16.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.883 0.873 . . . . 0.0 111.626 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.438 ' HB2' HD22 ' A' ' 34' ' ' ASN . 13.9 m -119.21 0.88 11.28 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -170.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.3 -119.27 4.84 Favored Glycine 0 C--N 1.345 1.037 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.44 144.72 44.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.224 0.512 . . . . 0.0 110.473 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.443 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 p90 -158.36 169.88 23.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.5 0.5 . . . . 0.0 110.501 171.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.18 133.24 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -96.91 133.18 41.88 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -119.01 135.08 54.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.758 0.423 . . . . 0.0 110.036 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 22.9 m-20 -115.85 139.47 50.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.45 1.1 . . . . 0.0 108.948 173.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.537 ' HG2' HG12 ' A' ' 27' ' ' ILE . 84.4 mtp -135.18 128.47 32.09 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 158.09 32.87 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.742 0.817 . . . . 0.0 109.046 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.92 -126.28 2.02 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -159.31 163.29 35.82 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.5 HG21 HG23 ' A' ' 23' ' ' ILE . 44.1 mt -157.32 107.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 -166.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.34 39.01 5.49 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.325 1.059 . . . . 0.0 108.493 -166.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.76 -17.96 2.54 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.27 123.03 69.3 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.011 0.905 . . . . 0.0 110.273 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.27 152.8 56.09 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.815 2.343 . . . . 0.0 113.437 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -144.67 146.68 32.36 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.75 0.82 . . . . 0.0 108.875 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -145.45 114.52 6.99 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.262 0.625 . . . . 0.0 109.421 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.53 160.23 38.08 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.079 1.352 . . . . 0.0 108.957 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 p -152.21 136.39 16.58 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.08 0.552 . . . . 0.0 110.01 172.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -136.56 141.48 43.34 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.162 0.985 . . . . 0.0 109.607 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -115.31 125.04 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.9 mt -115.06 125.56 28.81 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 123.389 0.676 . . . . 0.0 109.184 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 33.4 Cg_endo -60.79 156.52 42.8 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.888 2.392 . . . . 0.0 111.703 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -41.53 -44.85 3.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.919 1.288 . . . . 0.0 112.818 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.69 -25.4 66.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.749 1.22 . . . . 0.0 112.503 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.7 p -132.04 17.91 4.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.873 0.869 . . . . 0.0 110.728 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.34 -44.06 76.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.884 0.474 . . . . 0.0 111.453 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.26 -4.79 23.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.135 0.974 . . . . 0.0 112.674 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.51 4.6 15.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.88 0.872 . . . . 0.0 111.407 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -63.37 -19.47 64.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.432 1.093 . . . . 0.0 113.115 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.17 56.5 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.231 0.539 . . . . 0.0 109.926 -167.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -71.53 -39.07 70.97 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.366 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' HG21 ' A' ' 75' ' ' VAL . 21.6 t70 -74.6 -49.22 22.5 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.478 0.486 . . . . 0.0 111.375 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.94 83.05 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.513 0.725 . . . . 0.0 112.412 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 m -66.67 -43.39 84.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.649 0.38 . . . . 0.0 110.264 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.0 ttm180 -52.8 -38.63 61.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.133 0.973 . . . . 0.0 111.751 171.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -71.11 -38.88 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.346 0.658 . . . . 0.0 109.552 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.73 -49.64 51.21 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 -173.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -70.1 -24.36 63.2 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.863 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.8 -30.0 69.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.353 0.661 . . . . 0.0 110.929 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.471 ' HB2' HD11 ' A' ' 49' ' ' ILE . 54.7 m80 -99.78 10.59 41.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.214 0.606 . . . . 0.0 110.85 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.59 43.9 5.37 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.935 174.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.7 tp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.292 0.568 . . . . 0.0 109.634 171.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.4 t80 . . . . . 0 C--O 1.21 -1.017 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -57.91 -40.04 79.42 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.37 -45.58 54.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.419 0.288 . . . . 0.0 111.18 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.41 -34.05 76.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.537 0.735 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.49 -51.09 71.35 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.525 1.13 . . . . 0.0 109.824 172.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.485 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 34.1 mt-10 -69.52 -26.79 64.69 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.943 0.777 . . . . 0.0 111.429 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 14.3 t70 -70.98 -55.37 8.47 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.45 0.469 . . . . 0.0 109.803 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.19 -40.73 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.724 0.809 . . . . 0.0 112.056 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -63.01 -30.34 71.53 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.121 0.486 . . . . 0.0 110.521 177.106 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.045 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.3 mmmt -59.24 -40.07 84.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.857 0.863 . . . . 0.0 112.009 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.71 -28.22 69.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.586 0.755 . . . . 0.0 111.917 174.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -77.64 -16.79 58.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.133 0.573 . . . . 0.0 111.146 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 126.094 1.758 . . . . 0.0 110.413 179.664 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.338 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 128.11 90.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.562 0.745 . . . . 0.0 111.283 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.45 106.43 1.05 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.246 1.964 . . . . 0.0 112.206 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.26 148.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -124.67 18.09 8.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -171.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.47 -36.02 79.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.563 0.345 . . . . 0.0 111.565 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.61 -30.23 29.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.231 0.612 . . . . 0.0 110.666 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -66.16 -28.29 68.67 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.423 0.689 . . . . 0.0 111.336 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.76 -30.35 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.241 0.616 . . . . 0.0 109.998 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.7 mt -76.67 80.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.608 0.718 . . . . 0.0 109.609 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 . . . . . 0 C--O 1.243 0.738 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.094 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.78 153.48 70.44 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.309 1.044 . . . . 0.0 108.935 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.15 109.92 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.41 -8.4 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-O 120.25 -0.195 . . . . 0.0 112.666 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.568 ' HE2' ' HB3' ' A' ' 26' ' ' HIS . 11.3 t-160 -160.02 126.01 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.321 0.581 . . . . 0.0 110.437 -173.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 tp -100.95 145.63 28.41 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.49 1.116 . . . . 0.0 109.03 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . 0.459 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 2.6 t-160 -124.85 117.34 23.91 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 170.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 89.5 mt -89.91 110.04 21.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.513 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.82 55.12 3.24 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.014 0.912 . . . . 0.0 110.529 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 49' ' ' ILE . 2.2 pp -87.95 115.32 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.437 HD22 ' HG3' ' A' ' 48' ' ' GLU . 5.9 p30 -146.01 110.21 4.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.0 mt -130.01 141.21 46.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.613 -166.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.587 ' O ' ' HA ' ' A' ' 45' ' ' MET . 19.1 m170 -107.4 122.21 46.15 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -123.07 109.6 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 17.7 ttt180 -91.41 133.29 35.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -123.9 118.62 27.5 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.19 113.12 13.47 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.532 HG22 HG21 ' A' ' 41' ' ' VAL . 91.1 t -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 15.6 ttt180 -127.9 161.07 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.404 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.6 mm-40 -111.27 114.34 27.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -96.04 154.76 17.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.915 0.886 . . . . 0.0 110.503 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.32 -16.19 61.89 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.02 0.528 . . . . 0.0 111.952 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.08 -53.1 11.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.702 0.801 . . . . 0.0 111.981 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.8 t -126.55 -1.11 6.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.4 0.68 . . . . 0.0 112.461 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.57 -114.47 4.16 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 145.19 42.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.176 0.488 . . . . 0.0 110.817 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -153.27 171.91 17.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.532 HG21 HG22 ' A' ' 31' ' ' VAL . 7.1 t -124.32 128.02 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.477 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 8.5 t60 -84.48 123.4 30.22 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 94.0 m-85 -115.88 140.11 49.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.279 0.632 . . . . 0.0 109.47 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -143.41 137.9 28.98 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.346 172.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.587 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 83.7 mtp -123.17 136.91 54.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 111.114 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -163.47 162.77 24.85 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.125 0.57 . . . . 0.0 110.958 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.11 -130.47 3.73 Favored Glycine 0 N--CA 1.469 0.864 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HG3' HD22 ' A' ' 24' ' ' ASN . 10.4 pt-20 -157.89 166.32 32.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.686 0.794 . . . . 0.0 110.08 173.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 23' ' ' ILE . 97.3 mt -155.77 105.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -161.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 60.67 35.34 19.83 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.098 0.951 . . . . 0.0 108.739 -170.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.17 -22.26 8.73 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 114.563 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -77.84 113.75 35.43 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.891 0.877 . . . . 0.0 111.148 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.41 154.13 40.38 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.143 2.562 . . . . 0.0 113.122 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . 0.409 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 11.8 p90 -152.69 156.42 39.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.712 0.405 . . . . 0.0 111.282 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 p -153.11 124.52 7.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.858 0.863 . . . . 0.0 110.264 168.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -144.72 165.25 28.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.397 1.479 . . . . 0.0 108.524 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 p -153.2 142.06 21.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.723 0.409 . . . . 0.0 110.7 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -144.03 141.06 29.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.834 0.853 . . . . 0.0 110.154 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 44.6 mt-10 -125.55 125.38 43.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.23 132.54 24.19 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -171.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.78 160.86 34.86 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.646 2.231 . . . . 0.0 111.175 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -51.75 -28.4 15.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.03 -37.96 89.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.927 0.891 . . . . 0.0 112.161 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.7 p -126.72 12.84 7.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.098 0.559 . . . . 0.0 112.061 -171.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.46 76.48 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.201 0.6 . . . . 0.0 111.831 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -69.89 -11.49 60.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.384 1.074 . . . . 0.0 113.667 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -83.61 1.59 41.5 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.145 0.578 . . . . 0.0 111.73 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -54.89 -25.61 30.17 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.227 1.411 . . . . 0.0 113.937 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.22 -33.27 61.35 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -167.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 m -69.69 -38.24 76.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.473 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -72.09 -46.62 56.07 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.507 0.505 . . . . 0.0 110.027 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . 0.501 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -58.06 -50.81 72.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.56 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 m -69.15 -23.24 63.93 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 0.0 111.533 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.5 ttp-105 -74.46 -34.03 63.06 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.107 0.479 . . . . 0.0 110.465 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.77 -32.56 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 109.908 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.66 -54.35 7.11 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.043 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.428 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 21.2 mm-40 -62.49 -22.86 66.58 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.253 -1.339 . . . . 0.0 112.935 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -48.6 -36.45 15.7 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.209 0.604 . . . . 0.0 112.08 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -108.11 -31.27 8.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.738 0.245 . . . . 0.0 110.527 170.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.59 94.35 0.53 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 160.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.428 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 52.7 tp . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 110.109 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.6 t80 . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.39 -33.7 76.11 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.008 0.817 . . . . 0.0 110.728 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.55 61.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.937 0.495 . . . . 0.0 110.961 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.6 ttm -68.04 -34.39 76.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.372 0.669 . . . . 0.0 111.459 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -55.26 -47.27 75.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.311 1.045 . . . . 0.0 110.044 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.3 -25.57 60.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.0 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.4 -60.85 2.67 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.423 HG21 HD23 ' A' ' 106' ' ' LEU . 72.6 mt -54.75 -40.99 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.084 0.954 . . . . 0.0 111.729 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -31.39 72.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 123.207 0.317 . . . . 0.0 111.61 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.08 -51.65 56.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.394 0.677 . . . . 0.0 111.535 -176.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -28.19 62.41 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.973 0.509 . . . . 0.0 110.542 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.423 HD23 HG21 ' A' ' 102' ' ' ILE . 6.0 mp -71.77 -28.76 63.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.572 0.349 . . . . 0.0 110.447 175.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -81.51 -17.06 49.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.252 1.021 . . . . 0.0 109.643 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -177.681 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.446 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.58 159.99 69.37 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.257 1.023 . . . . 0.0 110.319 -172.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.62 124.99 15.15 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.674 2.249 . . . . 0.0 111.414 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.89 131.16 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 122.961 0.504 . . . . 0.0 109.902 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -94.88 3.05 55.42 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 118.439 -0.791 . . . . 0.0 113.009 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -53.11 -34.88 58.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.762 0.664 . . . . 0.0 111.416 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.54 87.34 2.34 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 166.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -133.39 29.62 3.94 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.9 mm -106.74 -53.39 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.296 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.9 mm -87.97 74.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.342 1.057 . . . . 0.0 109.699 177.214 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.7 t80 . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.85 157.14 34.5 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.486 1.114 . . . . 0.0 108.356 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.71 102.78 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.919 1.746 . . . . 0.0 111.651 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.34 -8.62 24.61 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.338 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -157.8 151.66 24.09 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.529 0.664 . . . . 0.0 111.898 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.713 HD22 ' HE1' ' A' ' 98' ' ' MET . 59.7 tp -140.51 142.27 35.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.596 1.558 . . . . 0.0 108.382 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -111.7 138.25 48.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.587 0.755 . . . . 0.0 109.265 173.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 75.3 mt -118.53 126.65 52.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.076 0.95 . . . . 0.0 109.145 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 C--O 1.248 1.012 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 164.933 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.735 0.303 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.73 84.68 6.76 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 -171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.46 HG23 HG21 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -106.97 145.71 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.432 -175.379 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -151.74 138.13 18.53 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.17 166.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 53.5 mt -142.64 136.49 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.4 m170 -107.34 136.19 47.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.7 mt -130.44 108.47 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.408 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 26.2 mtp180 -92.97 134.63 34.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -129.38 117.11 20.06 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -132.74 117.14 17.45 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.55 0.74 . . . . 0.0 109.438 -171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 41' ' ' VAL . 48.0 t -80.03 115.67 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 24.5 ttt180 -120.98 162.4 19.97 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.3 mm-40 -106.55 124.85 50.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.054 -0.404 . . . . 0.0 110.277 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -94.98 144.25 25.83 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -12.84 61.87 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.467 0.707 . . . . 0.0 112.089 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -79.62 -49.91 11.45 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.006 0.922 . . . . 0.0 112.488 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t -128.8 -4.8 5.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.759 0.823 . . . . 0.0 111.543 -169.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.57 -118.34 5.55 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.96 138.01 47.72 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.049 0.54 . . . . 0.0 112.335 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.92 171.13 18.79 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.176 0.99 . . . . 0.0 109.083 170.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 31' ' ' VAL . 30.5 t -120.77 127.68 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 122.892 0.477 . . . . 0.0 110.169 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.6 t60 -88.93 108.67 19.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.53 135.39 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 24.7 t70 -125.82 136.05 52.68 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.384 1.073 . . . . 0.0 108.545 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 87.0 mtp -136.32 131.19 34.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.463 0.574 . . . . 0.0 110.496 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -155.62 162.2 40.67 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 122.772 0.429 . . . . 0.0 111.523 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.09 -151.07 21.94 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.66 111.07 4.7 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.122 0.961 . . . . 0.0 111.172 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.46 HG21 HG23 ' A' ' 23' ' ' ILE . 74.2 mt -97.61 125.47 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.605 177.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 63.24 25.57 14.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.11 1.364 . . . . 0.0 109.687 -170.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.2 4.35 90.5 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.294 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -94.59 110.44 49.11 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.899 0.88 . . . . 0.0 111.724 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.37 140.82 45.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.829 2.353 . . . . 0.0 112.209 -175.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.4 145.63 35.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.143 0.577 . . . . 0.0 109.958 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 p -140.56 115.15 9.47 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.93 152.45 39.44 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -174.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -147.57 155.9 42.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.136 0.575 . . . . 0.0 111.189 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.92 147.35 31.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.914 0.886 . . . . 0.0 109.88 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 41.2 mt-10 -124.89 128.09 48.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.924 0.889 . . . . 0.0 109.273 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.58 123.87 21.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 123.913 0.885 . . . . 0.0 109.326 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.52 164.57 20.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.782 2.321 . . . . 0.0 112.199 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.679 ' HG3' ' HB3' ' A' ' 106' ' ' LEU . 37.6 ttt180 -44.66 -33.72 1.94 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.776 1.23 . . . . 0.0 113.773 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.31 -36.68 71.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.418 0.687 . . . . 0.0 111.569 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -118.53 9.65 12.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.465 0.706 . . . . 0.0 110.853 -170.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.48 -29.06 65.93 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.675 0.79 . . . . 0.0 111.235 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.11 -8.69 55.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.283 1.433 . . . . 0.0 113.294 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -90.69 8.03 36.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.113 0.965 . . . . 0.0 110.764 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -51.34 -45.4 62.29 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.34 71.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 m -65.98 -50.32 64.72 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.377 0.535 . . . . 0.0 110.336 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -70.94 -48.93 50.75 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.425 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.9 -51.01 56.1 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.171 0.988 . . . . 0.0 112.066 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.0 m -59.86 -43.56 94.62 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.456 0.703 . . . . 0.0 111.34 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 33.6 ttm180 -58.87 -48.48 81.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.892 0.877 . . . . 0.0 110.49 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.6 t -62.66 -35.0 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.664 0.786 . . . . 0.0 110.429 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.01 -53.41 14.89 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 110.704 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 14.0 pt20 -71.2 -34.29 70.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.778 -171.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 50.6 mtmt -60.86 -32.58 72.0 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.553 0.533 . . . . 0.0 110.759 173.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -92.58 15.47 14.2 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.15 0.58 . . . . 0.0 111.676 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.15 62.95 0.84 Allowed Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 3.5 mm? . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 162.656 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 119.645 -0.216 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.934 0.771 . . . . 0.0 111.932 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.86 -49.77 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.713 ' HE1' HD22 ' A' ' 10' ' ' LEU . 48.3 ttm -64.2 -35.15 79.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 111.243 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -61.32 -51.41 68.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.498 1.119 . . . . 0.0 110.422 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.94 -28.67 67.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 37.6 t70 -71.67 -47.7 52.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . 0.474 ' O ' HD21 ' A' ' 106' ' ' LEU . 42.0 mt -58.74 -44.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.809 0.843 . . . . 0.0 111.563 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -62.89 -28.78 70.27 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.36 14.92 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.814 0.846 . . . . 0.0 111.911 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.0 mmmt -58.86 -42.59 89.76 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.21 1.004 . . . . 0.0 112.43 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.679 ' HB3' ' HG3' ' A' ' 62' ' ' ARG . 4.4 mm? -71.52 -22.22 61.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.604 0.761 . . . . 0.0 112.067 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -75.23 -24.61 57.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.689 0.396 . . . . 0.0 110.474 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.832 0 C-N-CA 125.701 1.6 . . . . 0.0 110.624 -174.944 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.725 0 N-CA-C 113.494 0.157 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.57 148.93 70.72 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -171.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -56.35 164.41 5.39 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.843 3.029 . . . . 0.0 114.123 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.53 122.48 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-O 121.459 0.647 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.53 27.83 1.06 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.832 0.853 . . . . 0.0 112.406 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.03 -30.22 71.18 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.471 0.308 . . . . 0.0 110.657 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.63 9.23 40.99 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.897 0.879 . . . . 0.0 111.929 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -76.43 -9.3 58.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.313 0.578 . . . . 0.0 111.412 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.76 -39.71 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.26 1.024 . . . . 0.0 109.681 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.1 mt -112.12 89.08 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.702 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 t80 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.082 0.468 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.38 154.69 73.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 125.335 1.454 . . . . 0.0 107.894 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.82 99.45 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.284 1.99 . . . . 0.0 111.917 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.43 -18.49 6.84 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.542 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.539 ' NE2' ' HB3' ' A' ' 26' ' ' HIS . 20.8 t-80 -158.27 151.25 22.67 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.246 0.523 . . . . 0.0 111.793 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.522 HD23 HD13 ' A' ' 27' ' ' ILE . 54.4 tp -134.61 150.04 50.65 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.001 1.32 . . . . 0.0 108.509 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -124.15 139.67 53.71 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.534 0.734 . . . . 0.0 109.24 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.48 128.01 48.33 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.554 1.131 0 CA-C-O 122.728 1.251 . . . . 0.0 112.526 -175.0 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.439 HE21 HG21 ' A' ' 23' ' ' ILE . 55.9 tp60 . . . . . 0 CA--C 1.543 0.701 0 CA-C-O 122.748 1.261 . . . . 0.0 112.833 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.49 113.33 26.02 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.886 173.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.439 HG21 HE21 ' A' ' 21' ' ' GLN . 0.6 OUTLIER -120.38 132.3 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -139.82 119.63 13.38 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.2 mt -143.66 151.52 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -170.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.539 ' HB3' ' NE2' ' A' ' 9' ' ' HIS . 15.1 m170 -126.61 146.53 50.13 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.522 HD13 HD23 ' A' ' 10' ' ' LEU . 60.2 mt -125.77 106.44 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -97.33 132.61 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.02 125.24 26.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -127.32 115.55 19.17 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.437 HG21 HG23 ' A' ' 41' ' ' VAL . 47.0 t -86.93 115.21 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 51.1 ttt85 -125.17 163.64 22.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.412 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.7 mm-40 -112.87 112.55 24.1 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.436 HD22 ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -95.42 144.34 26.02 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.343 0.657 . . . . 0.0 109.511 171.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -19.09 65.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.121 0.569 . . . . 0.0 111.432 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.81 -52.15 40.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.749 1.22 . . . . 0.0 112.091 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . 0.436 ' HB3' HD22 ' A' ' 34' ' ' ASN . 32.6 t -123.4 -14.52 7.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -172.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -125.97 8.69 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.67 134.53 50.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.817 0.447 . . . . 0.0 110.773 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.1 170.82 19.0 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.553 0.741 . . . . 0.0 109.21 170.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.437 HG23 HG21 ' A' ' 31' ' ' VAL . 4.8 t -127.69 121.9 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -89.52 121.34 31.64 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -107.39 137.93 44.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.402 0.681 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -126.9 123.3 36.92 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtp -118.88 130.03 55.52 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.279 0.491 . . . . 0.0 110.391 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.92 159.84 43.0 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 0.0 110.713 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.4 -147.11 12.49 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 0.8 OUTLIER -148.45 108.29 4.03 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.303 1.051 . . . . 0.0 111.653 172.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.59 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.22 16.67 9.37 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 124.545 1.153 . . . . 0.0 110.5 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.36 -15.22 59.08 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.088 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 95.6 mttt -83.28 109.93 20.76 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.816 0.847 . . . . 0.0 112.748 -173.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.2 138.67 33.77 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.324 2.016 . . . . 0.0 110.601 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -145.47 155.7 43.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.524 0.33 . . . . 0.0 110.824 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 p -150.56 130.06 13.01 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.978 0.911 . . . . 0.0 108.969 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -144.91 157.29 44.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -176.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 m -143.62 142.14 30.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.917 0.487 . . . . 0.0 110.969 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -141.11 146.58 37.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.882 0.873 . . . . 0.0 109.077 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.22 129.81 49.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.87 122.0 24.41 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.48 163.95 25.17 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.767 2.312 . . . . 0.0 111.089 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.474 ' HG3' HD13 ' A' ' 106' ' ' LEU . 61.7 ttt180 -48.6 -30.62 5.56 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.761 0.825 . . . . 0.0 111.568 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.77 -40.52 80.0 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.766 1.226 . . . . 0.0 112.726 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 p -128.36 14.23 6.62 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.594 0.758 . . . . 0.0 111.87 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 68' ' ' PHE . . . -63.74 -29.38 70.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.541 0.737 . . . . 0.0 111.66 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . 0.633 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 71.6 m-85 -70.77 -1.13 10.53 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -96.53 5.42 50.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.958 0.903 . . . . 0.0 110.269 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 25.7 p90 -53.72 -49.66 67.64 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.632 1.173 . . . . 0.0 112.474 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.04 -29.8 60.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.591 0.756 . . . . 0.0 111.087 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -71.35 -45.34 63.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.003 0.814 . . . . 0.0 109.209 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.26 -41.01 64.16 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.878 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.55 56.33 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.504 0.722 . . . . 0.0 112.42 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 95.2 m -71.18 -43.24 67.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.708 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 44.7 ttt180 -55.66 -53.21 59.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.515 1.126 . . . . 0.0 111.734 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.78 -32.17 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.489 0.716 . . . . 0.0 111.381 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.04 82.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.415 0.626 . . . . 0.0 110.429 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . 0.776 ' HA ' HD23 ' A' ' 81' ' ' LEU . 96.3 mt-30 -76.32 -40.09 52.33 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.387 -1.278 . . . . 0.0 112.361 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.7 mtpp -53.18 -35.63 60.04 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.024 0.93 . . . . 0.0 112.45 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -79.6 25.07 0.35 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.48 59.45 10.82 Favored Glycine 0 C--N 1.363 2.079 0 C-N-CA 123.275 0.464 . . . . 0.0 114.141 174.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 77' ' ' GLN . 1.2 pt? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.658 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--O 1.218 -0.565 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.97 -39.1 73.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.21 1.004 . . . . 0.0 112.085 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.29 -50.53 67.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.737 0.415 . . . . 0.0 110.813 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.477 ' HE3' HD21 ' A' ' 10' ' ' LEU . 37.1 ttm -70.76 -31.28 68.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.617 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.73 -56.11 18.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HB3' ' HD3' ' A' ' 113' ' ' PRO . 6.0 mm-40 -69.82 -28.28 65.58 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.658 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.23 -49.35 61.3 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.93 -42.77 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.441 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . 0.633 ' HB3' ' HE1' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -65.94 -31.18 71.95 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.464 0.575 . . . . 0.0 111.563 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.91 84.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.66 -28.77 62.93 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.845 0.858 . . . . 0.0 112.805 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . 0.474 HD13 ' HG3' ' A' ' 62' ' ' ARG . 89.3 mt -63.98 -34.11 77.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.392 0.677 . . . . 0.0 110.572 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -68.69 -17.95 64.17 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.607 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 126.379 1.871 . . . . 0.0 109.583 -175.712 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.468 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.72 159.38 83.32 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.241 1.016 . . . . 0.0 112.604 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 26.5 Cg_endo -59.13 96.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.237 2.625 . . . . 0.0 113.706 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -167.74 136.58 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.708 0.803 . . . . 0.0 109.75 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -127.5 41.83 3.44 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.075 0.95 . . . . 0.0 110.157 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.38 -35.61 77.96 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.726 0.81 . . . . 0.0 112.042 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.45 -6.43 52.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.862 0.865 . . . . 0.0 111.504 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -77.4 5.01 9.56 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 122.156 -0.34 . . . . 0.0 111.817 -174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.6 mm -77.19 -64.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.396 0.679 . . . . 0.0 110.062 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.3 mt -108.74 105.82 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.906 0.882 . . . . 0.0 108.83 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 123.66 0.784 . . . . 0.0 109.6 177.819 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.2 t80 . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.04 152.33 23.41 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.342 1.057 . . . . 0.0 109.376 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.07 96.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.862 2.375 . . . . 0.0 112.749 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.57 -22.11 5.28 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.961 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' HIS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 26' ' ' HIS . 54.5 t-80 -155.26 151.6 28.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -172.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.466 HD21 ' SD ' ' A' ' 98' ' ' MET . 55.4 tp -135.88 131.47 35.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.747 1.619 . . . . 0.0 107.411 176.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -113.82 139.96 48.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.554 0.741 . . . . 0.0 110.452 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 30.3 mt -134.15 124.72 26.54 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.487 1.389 0 CA-C-N 120.192 1.36 . . . . 0.0 114.325 -174.345 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 23' ' ' ILE . 20.1 pt20 . . . . . 0 C--O 1.244 0.793 0 CA-C-O 120.932 0.396 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.52 100.94 7.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ILE . . . . . 0.431 HG23 ' HG3' ' A' ' 21' ' ' GLN . 19.2 pt -117.0 145.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.22 0.534 . . . . 0.0 109.954 169.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . 0.478 HD22 ' HG2' ' A' ' 48' ' ' GLU . 4.4 p30 -152.92 125.94 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 163.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.7 mt -139.32 116.3 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.5 m170 -104.25 122.69 45.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ILE . . . . . 0.499 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 57.3 mt -114.88 105.34 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 44' ' ' ASP . 67.2 ttt180 -97.89 140.4 32.3 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.729 1.212 . . . . 0.0 108.478 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.41 136.38 36.21 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -131.52 116.04 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.375 1.07 . . . . 0.0 108.419 -172.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 105' ' ' LYS . 72.8 t -87.01 123.66 40.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 19.2 ttt180 -153.14 169.25 23.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.476 1.111 . . . . 0.0 108.759 -170.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLN . . . . . 0.47 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 23.2 mm-40 -106.68 127.0 53.0 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.32 0.648 . . . . 0.0 110.225 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 3.1 p30 -102.96 147.69 26.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.35 1.06 . . . . 0.0 108.896 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.16 -20.23 62.32 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 10.6 tp10 -71.09 -48.18 53.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.9 0.88 . . . . 0.0 111.677 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.5 m -131.47 -6.91 3.73 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.492 0.717 . . . . 0.0 112.905 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.94 -124.17 8.08 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -68.5 137.14 54.16 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.403 0.602 . . . . 0.0 111.286 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -155.91 178.37 10.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.492 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . 0.407 HG23 HG22 ' A' ' 31' ' ' VAL . 20.2 t -133.44 127.85 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.778 0.831 . . . . 0.0 109.397 173.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -89.31 121.43 31.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.831 0.852 . . . . 0.0 108.912 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -102.8 133.22 48.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 108.913 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 27.1 t70 -133.48 114.15 13.3 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.023 0.929 . . . . 0.0 109.883 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 27' ' ' ILE . 43.4 mtm -119.86 145.43 46.68 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.736 -0.603 . . . . 0.0 111.451 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -156.93 157.9 35.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.146 0.578 . . . . 0.0 111.24 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.85 -156.05 27.48 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HG2' HD22 ' A' ' 24' ' ' ASN . 12.5 pt-20 -148.28 115.19 6.08 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.845 1.322 . . . . 0.0 111.411 173.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 79' ' ' HIS . 50.5 mt -97.74 130.69 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.212 176.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.33 -69.88 0.1 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.159 1.783 . . . . 0.0 110.617 -168.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.27 47.21 0.11 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.597 -2.201 . . . . 0.0 107.597 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -137.07 104.29 8.82 Favored Pre-proline 0 C--N 1.35 0.592 0 CA-C-N 114.261 -0.97 . . . . 0.0 108.91 -172.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 136.75 33.83 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.381 2.054 . . . . 0.0 110.834 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -135.35 138.02 42.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.2 p -134.14 118.22 17.44 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -132.74 139.73 47.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.276 1.03 . . . . 0.0 109.385 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.7 p -140.54 124.0 16.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -136.55 142.1 43.4 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.814 0.846 . . . . 0.0 108.782 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -121.33 130.58 53.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.423 0.689 . . . . 0.0 109.772 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.29 130.32 23.57 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.79 155.64 36.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.716 2.277 . . . . 0.0 111.187 171.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 32.3 ptt180 -41.85 -26.08 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -85.53 -13.61 48.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.753 0.821 . . . . 0.0 111.621 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.0 p -132.49 -2.4 3.43 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.404 1.082 . . . . 0.0 111.222 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.94 -36.71 72.92 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.552 1.141 . . . . 0.0 111.988 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.88 -9.43 54.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.374 1.07 . . . . 0.0 112.761 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -91.73 -7.57 49.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.315 0.646 . . . . 0.0 110.514 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PHE . . . . . 0.515 ' HZ ' ' SD ' ' A' ' 98' ' ' MET . 4.0 p90 -54.12 -35.78 62.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.602 0.761 . . . . 0.0 112.769 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.43 -26.56 20.49 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -72.49 -52.66 14.81 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 75' ' ' VAL . 38.9 t0 -73.14 -54.28 8.88 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.472 0.709 . . . . 0.0 112.799 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.03 -38.43 4.83 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.3 1.04 . . . . 0.0 113.041 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.9 m -77.27 -37.69 52.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.462 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.7 -47.98 81.27 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.946 0.898 . . . . 0.0 111.402 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' VAL . . . . . 0.426 ' HB ' ' HE1' ' A' ' 45' ' ' MET . 41.5 t -61.25 -39.5 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.079 0.952 . . . . 0.0 110.264 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 25' ' ' ILE . . . -66.67 -44.7 81.14 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.857 0.863 . . . . 0.0 110.953 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -76.59 -26.85 55.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -59.77 -45.9 90.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.342 0.657 . . . . 0.0 111.968 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HB2' HD13 ' A' ' 49' ' ' ILE . 56.3 m80 -74.34 -30.35 61.98 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.42 80.34 0.04 OUTLIER Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 158.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.9 tp . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 178.398 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 C--O 1.214 -0.804 0 CA-C-O 119.288 -0.386 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.0 -35.9 67.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.042 0.537 . . . . 0.0 111.942 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 -44.69 69.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.541 0.686 . . . . 0.0 110.854 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' MET . . . . . 0.515 ' SD ' ' HZ ' ' A' ' 68' ' ' PHE . 39.7 ttp -60.46 -34.45 74.04 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.759 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -69.53 -53.87 16.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.153 0.981 . . . . 0.0 109.859 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.7 -28.68 69.58 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.941 0.776 . . . . 0.0 112.785 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.58 -54.78 16.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.936 0.495 . . . . 0.0 109.982 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.4 mt -62.43 -42.02 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.545 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.14 -31.38 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.7 0.682 . . . . 0.0 110.907 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.61 64.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.593 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' LYS . . . . . 0.487 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.69 -47.94 80.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.646 0.779 . . . . 0.0 112.133 174.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.44 -39.04 88.67 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.683 0.615 . . . . 0.0 110.468 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -59.1 -31.9 69.33 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.244 1.017 . . . . 0.0 111.196 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 C-N-CA 125.397 1.479 . . . . 0.0 110.679 -176.236 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.17 154.73 94.35 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.627 1.171 . . . . 0.0 111.969 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.66 148.08 58.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.582 2.188 . . . . 0.0 111.945 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.73 152.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.728 0.811 . . . . 0.0 109.4 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.51 26.8 10.28 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.741 0.816 . . . . 0.0 111.651 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.5 -29.55 67.21 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.84 -2.23 53.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.302 0.641 . . . . 0.0 111.846 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.98 -9.48 58.65 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.588 0.755 . . . . 0.0 112.425 -170.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.3 mp -88.51 67.42 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 121.524 0.678 . . . . 0.0 109.628 -174.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 mt 52.95 35.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 125.396 1.478 . . . . 0.0 112.528 166.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 . . . . . 0 N--CA 1.483 1.202 0 O-C-N 121.397 -0.814 . . . . 0.0 110.439 -178.437 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.422 ' HA2' ' HB ' ' A' ' 13' ' ' VAL . . . 71.61 -85.11 0.44 Allowed Glycine 0 C--N 1.355 1.598 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -84.41 141.76 30.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.287 0.635 . . . . 0.0 109.329 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.454 ' HB3' ' HB3' ' A' ' 11' ' ' HIS . 56.8 ttp -153.04 144.26 23.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.219 1.008 . . . . 0.0 108.682 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -125.34 144.47 50.48 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.912 0.387 . . . . 0.0 110.491 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.01 152.54 55.26 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 125.309 1.444 . . . . 0.0 107.929 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.3 97.15 0.29 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.769 1.646 . . . . 0.0 111.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.4 -15.3 6.08 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.636 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -160.83 153.75 21.22 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 117.378 0.589 . . . . 0.0 112.202 -172.462 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt -135.6 125.74 26.2 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 11.4 t-160 -98.1 139.83 33.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.315 1.046 . . . . 0.0 110.148 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.553 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -132.26 117.89 18.78 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.728 0.811 . . . . 0.0 110.809 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.422 ' HB ' ' HA2' ' A' ' 2' ' ' GLY . 84.3 t -135.98 160.82 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 162.489 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.8 t -92.2 125.45 36.88 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 120.068 1.304 . . . . 0.0 107.49 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.06 138.64 87.41 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.88 133.4 47.47 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.751 2.301 . . . . 0.0 111.962 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.87 -31.79 7.87 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.913 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -77.75 -64.62 1.11 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.28 0.632 . . . . 0.0 110.263 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -156.79 109.6 2.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.389 0.676 . . . . 0.0 109.416 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.74 82.65 6.68 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.627 0.727 . . . . 0.0 109.798 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -146.05 148.72 32.97 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.78 82.7 4.98 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.477 HG23 HG21 ' A' ' 49' ' ' ILE . 1.3 pp -109.83 128.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 p30 -150.86 123.59 8.58 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.553 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 46.1 mt -140.47 140.52 34.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.517 ' O ' ' HA ' ' A' ' 45' ' ' MET . 6.6 m170 -114.24 134.29 55.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 171.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.401 HG12 ' HG2' ' A' ' 45' ' ' MET . 58.2 mt -123.5 105.76 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -102.87 132.69 48.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -129.25 123.73 32.68 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.2 116.45 20.64 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 41' ' ' VAL . 79.2 t -79.11 117.14 24.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -118.76 159.51 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -107.93 119.35 39.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.7 0.4 . . . . 0.0 109.928 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.434 HD21 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -99.53 148.8 23.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.252 1.021 . . . . 0.0 109.152 168.655 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.61 60.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.981 0.513 . . . . 0.0 111.972 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.99 -55.29 5.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.841 0.856 . . . . 0.0 111.823 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.413 ' HB3' HD22 ' A' ' 34' ' ' ASN . 35.7 t -114.63 -6.97 12.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.236 0.614 . . . . 0.0 111.668 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.41 -108.23 3.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -172.168 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.19 141.73 45.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.117 0.459 . . . . 0.0 111.289 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.41 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 7.7 p90 -156.64 166.87 32.15 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.929 0.891 . . . . 0.0 108.796 168.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.539 HG22 HG22 ' A' ' 31' ' ' VAL . 3.9 t -115.8 126.51 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 122.066 -0.396 . . . . 0.0 110.219 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.422 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 63.9 t60 -90.69 120.54 31.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.228 1.011 . . . . 0.0 108.7 170.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -107.75 145.05 34.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.1 0.56 . . . . 0.0 110.336 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -128.64 128.6 44.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.603 1.161 . . . . 0.0 108.672 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 82.7 mtp -123.82 129.41 50.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.1 0.409 . . . . 0.0 110.352 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -154.16 147.44 24.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.854 0.462 . . . . 0.0 111.425 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.44 -151.18 16.75 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.83 108.73 3.7 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.895 1.348 . . . . 0.0 111.022 171.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.477 HG21 HG23 ' A' ' 23' ' ' ILE . 68.4 mt -100.76 127.97 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.485 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 63.22 22.16 13.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.004 1.321 . . . . 0.0 109.167 -170.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.48 -3.41 87.07 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.558 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.51 109.98 28.14 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 112.003 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.68 141.95 31.62 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.868 2.378 . . . . 0.0 111.96 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.09 147.92 39.32 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.141 0.577 . . . . 0.0 110.072 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.4 p -138.68 116.51 11.54 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.87 147.13 51.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.591 1.157 . . . . 0.0 108.964 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.9 m -142.63 129.59 20.67 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -138.81 143.43 38.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.737 0.815 . . . . 0.0 109.019 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.422 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 62.4 mt-10 -126.38 133.6 51.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.365 0.666 . . . . 0.0 110.202 -174.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt -124.2 128.86 24.92 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 124.159 0.983 . . . . 0.0 109.231 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.41 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 44.7 Cg_endo -63.99 161.76 31.91 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.75 2.3 . . . . 0.0 111.466 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -44.91 -32.27 1.55 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.934 0.894 . . . . 0.0 113.161 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -70.53 -29.6 66.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.742 1.217 . . . . 0.0 112.443 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.6 p -130.49 16.29 5.43 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.854 0.861 . . . . 0.0 110.319 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.18 98.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.353 0.661 . . . . 0.0 111.053 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -73.46 -2.51 22.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.482 1.113 . . . . 0.0 112.566 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.48 2.08 53.54 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.686 0.794 . . . . 0.0 110.41 173.609 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.545 ' HE2' ' SD ' ' A' ' 98' ' ' MET . 12.3 p90 -54.39 -49.97 68.64 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.225 1.01 . . . . 0.0 112.528 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.14 -28.44 39.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -71.79 -51.88 20.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.768 0.427 . . . . 0.0 110.146 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -52.24 13.95 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.4 13.8 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.865 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 m -75.8 -44.59 40.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -56.02 -45.19 79.18 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.789 1.236 . . . . 0.0 112.002 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.05 -31.65 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.765 0.826 . . . . 0.0 110.937 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.77 -43.15 80.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.127 0.571 . . . . 0.0 110.618 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.591 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 18.3 pt20 -78.71 -25.82 44.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.258 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -65.76 -25.13 67.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.184 0.594 . . . . 0.0 110.422 169.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 26.2 m80 -86.67 0.73 54.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.302 0.641 . . . . 0.0 112.595 176.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.39 43.47 0.64 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.591 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 4.4 mm? -115.96 138.54 51.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 165.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -95.61 153.39 39.45 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.272 0.629 . . . . 0.0 109.545 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.03 -15.14 26.29 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.239 2.626 . . . . 0.0 114.006 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.16 -28.98 69.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.813 0.845 . . . . 0.0 111.019 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -61.05 -32.16 71.79 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.607 1.163 . . . . 0.0 111.222 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.82 46.44 4.53 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 -172.579 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.68 -74.27 0.16 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.988 0.515 . . . . 0.0 110.53 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 tt -101.11 -18.3 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.414 0.686 . . . . 0.0 110.368 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.9 p -84.8 -2.15 57.32 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.314 1.046 . . . . 0.0 112.646 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -103.16 118.77 37.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.6 m -69.8 97.12 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -66.13 107.02 1.79 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.531 ' HB2' ' HZ3' ' A' ' 93' ' ' LYS . 10.3 mtmp? -73.5 -28.89 62.15 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.234 0.614 . . . . 0.0 110.795 -175.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -86.12 5.92 31.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.926 0.89 . . . . 0.0 111.701 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -59.18 -38.72 80.51 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 122.899 0.479 . . . . 0.0 110.048 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.36 -32.9 72.81 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.747 0.654 . . . . 0.0 111.811 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.73 -44.59 66.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.381 0.673 . . . . 0.0 111.17 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.545 ' SD ' ' HE2' ' A' ' 68' ' ' PHE . 28.6 ttm -63.76 -39.83 95.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.397 0.679 . . . . 0.0 111.844 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.52 -50.29 74.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.416 1.486 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.487 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 11.9 pt-20 -70.55 -30.91 67.76 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.67 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.47 -54.4 47.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.67 -38.03 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.62 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.582 HH11 ' HB1' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -69.74 -31.15 68.98 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.202 0.91 . . . . 0.0 111.46 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.582 ' HB1' HH11 ' A' ' 103' ' ' ARG . . . -75.09 -44.7 45.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.561 0.345 . . . . 0.0 110.469 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -59.26 -42.78 91.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.924 1.29 . . . . 0.0 113.117 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.94 -32.14 72.53 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.712 0.805 . . . . 0.0 111.412 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -80.7 -19.91 44.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 110.676 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 83.74 -46.74 0.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.689 1.996 . . . . 0.0 110.884 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -92.15 143.24 27.24 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.85 160.14 49.69 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.66 2.24 . . . . 0.0 112.34 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.73 64.66 0.16 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -97.54 118.64 64.04 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.087 0.955 . . . . 0.0 109.945 -175.544 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.47 114.91 2.19 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.288 2.659 . . . . 0.0 112.982 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.0 p -71.75 139.91 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.641 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.57 1.63 13.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -63.07 -33.83 76.29 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.876 0.762 . . . . 0.0 111.801 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.63 -39.35 73.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.219 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -60.34 -21.32 61.92 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.429 1.092 . . . . 0.0 111.535 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.97 -33.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.366 0.603 . . . . 0.0 109.472 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.49 -27.11 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.893 0.877 . . . . 0.0 110.123 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -62.9 90.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.262 0.625 . . . . 0.0 111.745 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -167.69 174.67 7.5 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.73 1.612 . . . . 0.0 108.888 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -153.85 117.31 4.62 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.974 0.509 . . . . 0.0 109.904 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.87 -67.88 0.06 OUTLIER Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.885 0.374 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.18 149.78 21.47 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -127.81 -77.83 0.57 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.377 0.589 . . . . 0.0 110.115 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.6 ttp -75.09 105.97 6.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.963 0.505 . . . . 0.0 109.792 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -127.99 140.01 52.23 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.917 0.887 . . . . 0.0 109.389 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.48 151.61 25.81 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.96 0.904 . . . . 0.0 109.03 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -56.42 92.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.654 2.236 . . . . 0.0 112.127 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.54 -40.61 1.03 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.896 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -154.69 144.16 21.36 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.209 0.603 . . . . 0.0 111.832 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.8 tp -126.91 134.58 50.42 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.863 1.265 . . . . 0.0 108.869 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -98.72 115.54 28.96 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.655 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 1.3 tm? -97.51 110.14 22.76 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.35 139.44 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.7 t -85.02 154.35 22.16 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.403 ' HB2' HD13 ' A' ' 88' ' ' ILE . 58.8 mt -73.16 109.51 6.5 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.456 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 63.4 Cg_endo -71.19 -30.95 15.27 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.525 2.15 . . . . 0.0 112.8 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.43 -95.2 0.25 Allowed Glycine 0 C--N 1.35 1.33 0 O-C-N 123.761 0.663 . . . . 0.0 112.058 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.05 19.7 15.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.729 0.812 . . . . 0.0 109.774 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . 0.456 ' HA ' ' HB2' ' A' ' 16' ' ' PRO . 5.6 m-20 61.59 87.83 0.09 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.318 1.447 . . . . 0.0 111.738 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -114.05 -42.2 3.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.375 0.67 . . . . 0.0 110.498 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -129.78 150.5 51.06 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -127.07 103.78 7.63 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.601 HG22 ' HG ' ' A' ' 81' ' ' LEU . 1.7 pp -120.31 149.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -153.52 120.77 5.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.32 0.648 . . . . 0.0 109.862 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.655 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 55.8 mt -139.14 141.37 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.659 0.784 . . . . 0.0 109.601 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.1 m170 -104.26 112.42 25.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.2 mt -112.23 109.78 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.62 123.99 51.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.874 1.27 . . . . 0.0 107.679 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -121.04 128.28 52.5 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -119.52 113.3 20.53 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 92.1 t -77.54 115.84 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -145.51 167.58 22.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 108.734 -170.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -111.4 121.62 45.7 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.744 0.417 . . . . 0.0 110.495 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -99.78 153.53 19.05 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.521 1.129 . . . . 0.0 110.317 173.125 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.86 -24.48 61.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.204 0.601 . . . . 0.0 111.991 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -73.57 -49.34 26.8 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.222 1.009 . . . . 0.0 112.273 -172.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -133.89 17.13 3.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.352 0.661 . . . . 0.0 111.187 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.09 -111.97 3.4 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.007 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.509 ' HB2' ' HD3' ' A' ' 62' ' ' ARG . . . -78.43 147.48 34.0 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 117.298 0.549 . . . . 0.0 110.451 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -159.6 179.54 8.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 t -132.64 130.59 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.462 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 4.6 t60 -88.42 109.0 19.66 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.174 0.99 . . . . 0.0 108.59 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.406 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 56.4 m-85 -94.91 127.49 40.98 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.16 127.83 28.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.413 0.685 . . . . 0.0 109.296 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 84.1 mtp -133.79 145.05 49.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.92 0.888 . . . . 0.0 110.861 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.18 165.53 17.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.436 0.694 . . . . 0.0 109.846 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.79 -134.4 5.25 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.9 172.19 17.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.186 0.594 . . . . 0.0 110.157 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.455 HD12 ' HB3' ' A' ' 79' ' ' HIS . 58.4 mt -155.27 101.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 -166.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 54.39 41.13 32.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.483 0.713 . . . . 0.0 111.189 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.26 16.26 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.543 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.77 109.9 12.4 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.167 0.987 . . . . 0.0 111.369 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -81.35 152.44 18.02 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.028 2.486 . . . . 0.0 113.73 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.07 160.52 41.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 p -141.03 118.11 11.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.972 0.909 . . . . 0.0 109.358 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -139.62 150.0 44.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.884 0.874 . . . . 0.0 109.799 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 p -150.68 137.53 19.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.956 0.502 . . . . 0.0 109.904 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.91 145.04 45.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 0.0 108.738 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.462 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 39.6 mt-10 -124.55 123.91 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -175.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.406 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.1 mt -120.63 133.49 24.07 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.188 0.595 . . . . 0.0 109.398 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.01 163.97 6.94 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.317 2.678 . . . . 0.0 113.286 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.509 ' HD3' ' HB2' ' A' ' 39' ' ' ALA . 31.4 ptt85 -45.46 -37.12 4.91 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.821 1.248 . . . . 0.0 112.537 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.07 -28.09 68.58 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.817 1.247 . . . . 0.0 112.886 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.4 p -130.55 15.28 5.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.674 0.79 . . . . 0.0 111.16 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.7 73.54 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.072 0.549 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.03 -23.97 64.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.501 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -77.29 -2.45 34.86 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.587 0.755 . . . . 0.0 111.64 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -66.0 -21.14 66.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.43 62.35 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 -161.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 p -67.62 -33.63 75.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.228 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' HG22 ' A' ' 75' ' ' VAL . 5.1 m-20 -72.27 -56.8 4.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.433 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.02 67.04 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.673 1.189 . . . . 0.0 112.41 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.4 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 90.8 m -67.06 -50.24 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.249 176.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -56.93 -35.51 69.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.104 0.962 . . . . 0.0 112.795 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG22 ' O ' ' A' ' 71' ' ' ASP . 53.4 t -57.93 -44.86 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.74 0.816 . . . . 0.0 109.676 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.75 74.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.903 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.519 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 11.0 mm100 -60.14 -38.32 82.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.295 0.638 . . . . 0.0 111.364 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.91 -30.32 70.11 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.079 0.951 . . . . 0.0 111.982 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.455 ' HB3' HD12 ' A' ' 49' ' ' ILE . 63.4 t60 -91.69 24.84 2.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.872 0.469 . . . . 0.0 111.515 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.2 49.48 2.83 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 111.846 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.601 ' HG ' HG22 ' A' ' 23' ' ' ILE . 1.7 tt -134.39 128.42 33.56 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -175.36 94.57 0.27 Allowed Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.26 91.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.851 2.367 . . . . 0.0 112.133 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.21 -30.59 54.75 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.861 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -74.75 -21.28 59.43 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.295 168.317 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.17 81.18 0.14 Allowed Glycine 0 C--N 1.351 1.363 0 O-C-N 124.074 0.859 . . . . 0.0 113.675 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.42 -12.72 59.99 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.218 1.007 . . . . 0.0 110.355 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.403 HD13 ' HB2' ' A' ' 15' ' ' LEU . 19.4 pt -55.1 100.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 125.128 1.371 . . . . 0.0 111.63 170.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.8 t -104.75 -25.24 12.75 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.151 0.58 . . . . 0.0 110.619 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -89.08 20.8 3.46 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.636 0.774 . . . . 0.0 111.935 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.3 m -93.9 67.69 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 124.116 0.967 . . . . 0.0 110.205 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.64 133.02 55.12 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.291 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -77.91 2.65 16.72 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.873 0.869 . . . . 0.0 110.917 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 61.96 39.33 13.57 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 124.959 1.304 . . . . 0.0 110.652 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -58.54 -35.34 72.17 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.345 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.72 -45.5 74.07 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.599 0.76 . . . . 0.0 112.35 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.64 -48.34 60.23 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.995 0.518 . . . . 0.0 110.45 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.16 -38.02 81.91 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.963 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -53.91 -45.63 71.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.545 1.138 . . . . 0.0 110.142 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -71.15 -28.77 64.51 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.382 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.442 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 28.2 t70 -68.19 -54.18 19.69 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.358 0.411 . . . . 0.0 110.044 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.33 -47.59 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.947 0.899 . . . . 0.0 111.481 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -63.59 -28.27 69.81 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.565 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.59 -54.47 6.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.807 0.843 . . . . 0.0 112.439 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.442 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 14.1 mmmm -67.85 -37.36 81.77 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.66 -24.56 63.63 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.516 0.326 . . . . 0.0 111.181 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -76.99 -17.91 58.56 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.914 0.886 . . . . 0.0 109.699 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.86 10.86 3.82 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.293 1.837 . . . . 0.0 112.572 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -148.42 143.62 17.62 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -52.87 139.85 59.15 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 122.862 2.375 . . . . 0.0 112.834 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.59 -20.93 59.81 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.823 0.702 . . . . 0.0 114.573 -170.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -147.94 154.28 43.21 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.94 0.896 . . . . 0.0 109.323 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.42 148.94 92.33 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.49 2.126 . . . . 0.0 111.132 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.92 142.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.92 20.81 15.46 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.099 0.559 . . . . 0.0 111.98 -173.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.466 HD12 ' N ' ' A' ' 117' ' ' GLU . 4.4 pp -57.15 -37.62 72.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.529 0.732 . . . . 0.0 112.289 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.466 ' N ' HD12 ' A' ' 116' ' ' LEU . 26.4 tt0 -87.27 -14.79 39.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.472 0.709 . . . . 0.0 110.947 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -80.68 -11.92 59.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.083 0.553 . . . . 0.0 110.543 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.56 -35.99 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.1 mt -86.05 14.54 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 124.215 1.006 . . . . 0.0 110.57 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -77.68 94.76 4.47 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 121.187 -0.945 . . . . 0.0 109.911 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -156.57 134.1 10.8 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.765 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -113.24 -55.1 2.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.831 0.852 . . . . 0.0 108.917 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.8 26.51 0.02 OUTLIER Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.107 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 CA--C 1.552 1.052 0 C-N-CA 123.923 0.889 . . . . 0.0 108.944 -179.284 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.21 -40.02 95.28 Favored Glycine 0 C--N 1.352 1.445 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 -169.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -138.29 105.03 5.35 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 117.047 0.424 . . . . 0.0 110.82 -171.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.417 ' HB3' ' HB3' ' A' ' 11' ' ' HIS . 8.7 tmm? -114.55 128.25 56.23 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 170.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -133.64 137.77 45.57 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.112 0.415 . . . . 0.0 110.672 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -143.47 154.6 60.34 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.275 1.03 . . . . 0.0 108.681 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.76 101.4 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.698 2.266 . . . . 0.0 112.644 174.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.62 -14.24 11.75 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.936 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -158.01 122.46 4.23 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.509 0.655 . . . . 0.0 112.182 -175.384 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.6 tp -102.98 120.98 41.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.58 1.152 . . . . 0.0 108.848 168.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.417 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 21.7 t-160 -99.49 121.97 41.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.032 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.5 mt -98.92 137.26 37.74 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.733 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.83 170.02 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 165.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.559 ' HG ' HG13 ' A' ' 23' ' ' ILE . 16.5 m -93.0 160.09 15.02 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.143 -1.598 . . . . 0.0 109.688 168.39 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -115.03 101.67 54.6 Favored Pre-proline 0 N--CA 1.48 1.072 0 O-C-N 122.049 -0.407 . . . . 0.0 110.855 173.733 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.422 ' HD2' ' HA ' ' A' ' 15' ' ' LEU . 24.3 Cg_endo -54.94 119.06 5.87 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.448 2.765 . . . . 0.0 112.727 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.85 -60.69 0.6 Allowed Glycine 0 C--N 1.344 1.018 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.97 13.54 34.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.916 0.887 . . . . 0.0 109.302 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.53 134.79 9.26 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -127.73 43.17 3.18 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.482 0.713 . . . . 0.0 110.141 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -151.35 155.57 38.96 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.219 0.608 . . . . 0.0 109.456 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.64 69.34 0.97 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.643 0.735 . . . . 0.0 110.834 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.559 HG13 ' HG ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -89.02 134.63 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.922 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -156.11 111.07 2.89 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.746 0.784 . . . . 0.0 109.443 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 60.1 mt -124.47 143.87 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.591 1.156 . . . . 0.0 110.041 -168.245 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.471 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.6 m170 -104.68 111.47 24.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.47 ' HA ' ' O ' ' A' ' 44' ' ' ASP . 61.8 mt -109.98 109.19 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -115.17 119.66 37.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.434 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 47.8 p90 -121.11 131.73 54.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.013 0.525 . . . . 0.0 110.307 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.78 122.45 28.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.419 0.688 . . . . 0.0 110.018 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.437 HG23 HG21 ' A' ' 41' ' ' VAL . 59.2 t -70.86 124.74 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.465 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 43.9 ttt180 -146.12 165.08 30.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.064 0.946 . . . . 0.0 109.278 -175.232 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.465 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 24.1 mm-40 -114.74 115.57 27.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.803 0.841 . . . . 0.0 108.872 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.421 HD22 ' HB2' ' A' ' 37' ' ' SER . 0.1 OUTLIER -101.93 147.77 26.15 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.173 0.589 . . . . 0.0 110.002 170.362 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.18 65.2 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.989 0.516 . . . . 0.0 111.29 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.84 -54.63 20.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.91 0.884 . . . . 0.0 112.293 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.421 ' HB2' HD22 ' A' ' 34' ' ' ASN . 23.1 m -120.26 4.16 10.81 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.245 0.618 . . . . 0.0 112.09 -168.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -134.83 12.87 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.495 ' HB1' ' HD3' ' A' ' 62' ' ' ARG . . . -73.6 141.59 46.59 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.789 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -161.4 178.69 8.92 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.023 0.44 . . . . 0.0 110.788 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.437 HG21 HG23 ' A' ' 31' ' ' VAL . 23.8 t -125.97 132.8 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.434 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 48.0 t60 -92.88 129.56 38.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.479 1.112 . . . . 0.0 108.593 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.419 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 50.8 m-85 -119.18 143.28 47.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.264 0.626 . . . . 0.0 110.447 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.47 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 41.5 m-20 -130.23 141.53 50.62 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.054 0.942 . . . . 0.0 109.183 174.738 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.471 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 87.5 mtp -132.97 128.51 36.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.882 0.873 . . . . 0.0 108.784 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.86 161.19 31.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.502 0.321 . . . . 0.0 110.488 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.64 -122.89 2.47 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.93 164.11 38.9 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.749 0.82 . . . . 0.0 110.001 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -155.58 113.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -169.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.48 40.14 29.69 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.221 1.01 . . . . 0.0 110.383 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.99 -39.0 3.04 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.608 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -79.69 129.4 71.31 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 123.851 0.86 . . . . 0.0 111.754 -169.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.64 164.22 23.5 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.26 2.64 . . . . 0.0 113.879 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.94 159.92 37.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.616 0.766 . . . . 0.0 110.688 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.5 p -144.22 112.95 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.529 0.732 . . . . 0.0 110.459 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 154.38 51.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.85 1.26 . . . . 0.0 109.643 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.8 p -152.97 139.71 18.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.979 0.512 . . . . 0.0 109.799 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.1 150.25 44.07 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.596 0.758 . . . . 0.0 110.126 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.45 125.68 38.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.779 0.831 . . . . 0.0 109.36 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.9 mt -119.38 134.43 23.77 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.459 0.704 . . . . 0.0 109.812 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.67 158.8 48.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.04 2.493 . . . . 0.0 112.225 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.495 ' HD3' ' HB1' ' A' ' 39' ' ' ALA . 26.1 ptt180 -41.64 -38.24 1.34 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.172 1.389 . . . . 0.0 114.2 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.85 -25.59 62.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.788 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 p -131.83 8.44 4.48 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.558 0.743 . . . . 0.0 111.494 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.23 88.09 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -68.03 -14.26 62.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.04 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -79.55 2.01 23.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.412 0.685 . . . . 0.0 111.697 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -65.0 -14.41 60.29 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 124.127 0.971 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.623 ' HB2' ' HE3' ' A' ' 98' ' ' MET . . . -73.17 -36.78 66.67 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -73.2 -40.99 64.32 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.01 -52.21 60.59 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.255 0.622 . . . . 0.0 110.662 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.419 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -55.08 -49.32 71.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.51 1.124 . . . . 0.0 112.01 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -64.84 -29.1 70.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.851 0.461 . . . . 0.0 111.454 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.6 tpp180 -72.3 -41.56 66.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.038 0.535 . . . . 0.0 110.238 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.81 -31.78 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.397 1.079 . . . . 0.0 109.9 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.418 ' HB3' HD23 ' A' ' 81' ' ' LEU . . . -71.41 -49.89 37.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.54 0.736 . . . . 0.0 109.799 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.57 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 46.4 mt-30 -70.09 -28.87 65.76 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.753 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.71 -29.9 68.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.475 0.71 . . . . 0.0 110.453 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -105.97 21.36 17.44 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 111.214 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.16 40.08 5.57 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 121.969 -0.457 . . . . 0.0 113.951 166.293 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.57 ' HB3' ' HG2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -69.82 -38.99 76.75 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.767 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.8 m80 77.34 165.79 0.13 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 125.95 1.7 . . . . 0.0 112.258 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.71 53.44 2.3 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.252 2.634 . . . . 0.0 110.165 160.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -68.71 -46.54 68.7 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.126 -1.397 . . . . 0.0 113.044 -159.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -60.92 -33.53 73.29 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.424 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.01 22.38 60.27 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.38 -173.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.8 26.12 0.12 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.642 0.777 . . . . 0.0 111.149 -169.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.2 pt -75.57 -6.19 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 122.328 0.251 . . . . 0.0 110.549 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.6 p -56.11 -46.42 79.12 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.563 1.145 . . . . 0.0 111.164 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -114.38 121.99 45.29 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.693 0.797 . . . . 0.0 109.683 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.02 146.19 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.236 1.014 . . . . 0.0 109.201 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -73.47 131.63 42.01 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -104.02 115.29 30.18 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.151 0.58 . . . . 0.0 109.805 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -104.87 19.83 19.84 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.029 0.932 . . . . 0.0 110.382 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -64.13 -40.82 97.01 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 123.871 0.868 . . . . 0.0 111.0 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.23 -39.98 93.46 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.545 0.738 . . . . 0.0 111.735 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.01 70.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.266 0.627 . . . . 0.0 111.114 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.623 ' HE3' ' HB2' ' A' ' 69' ' ' ALA . 53.2 ttp -64.4 -43.0 95.79 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.401 1.08 . . . . 0.0 112.323 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.07 -50.09 49.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.703 1.201 . . . . 0.0 111.492 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.85 -28.37 50.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.646 0.591 . . . . 0.0 110.687 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.68 -59.98 3.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.707 0.803 . . . . 0.0 111.299 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 56.2 mt -63.79 -36.42 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.38 0.672 . . . . 0.0 111.372 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -29.16 70.0 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.622 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . . . -74.13 -38.14 63.87 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.327 0.651 . . . . 0.0 110.689 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.424 ' HA ' ' HE3' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -65.61 -35.84 81.99 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 112.179 173.588 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 9.8 mp -65.3 -32.71 74.5 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.59 0.756 . . . . 0.0 110.728 170.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.62 -16.4 59.58 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.349 1.059 . . . . 0.0 111.216 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 98.04 -27.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 127.599 2.359 . . . . 0.0 112.248 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -138.7 148.82 59.99 Favored Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 123.098 0.559 . . . . 0.0 110.562 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.622 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 56.7 Cg_endo -68.02 94.94 0.41 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.737 2.292 . . . . 0.0 112.135 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.09 96.66 0.8 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 143.29 94.51 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.207 0.603 . . . . 0.0 111.906 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -93.31 105.95 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.029 2.486 . . . . 0.0 112.22 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.79 107.49 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 CA-C-O 122.36 1.076 . . . . 0.0 109.491 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.91 21.35 1.61 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.475 1.11 . . . . 0.0 111.983 -163.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.78 -27.5 68.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.268 0.627 . . . . 0.0 110.792 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -68.05 -11.59 59.26 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.973 1.309 . . . . 0.0 111.39 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -87.77 -19.86 26.95 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.052 0.941 . . . . 0.0 112.4 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.16 74.0 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.8 mt 72.15 -5.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 C-N-CA 125.323 1.449 . . . . 0.0 112.364 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -70.41 -54.78 11.02 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.822 -0.549 . . . . 0.0 109.709 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -112.67 137.93 50.23 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 166.762 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.2 -36.8 0.1 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.201 1.0 . . . . 0.0 109.899 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.93 -119.28 10.85 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.862 0.726 . . . . 0.0 114.143 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.252 1.231 0 C-N-CA 124.619 1.168 . . . . 0.0 108.602 177.531 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.74 -132.57 10.17 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.543 -0.587 . . . . 0.0 111.981 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.2 m80 59.6 21.25 9.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.002 1.321 . . . . 0.0 111.882 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.447 ' HB2' ' HB3' ' A' ' 11' ' ' HIS . 86.9 mtp -74.26 97.94 3.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.492 0.717 . . . . 0.0 110.155 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -131.49 128.85 40.23 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.31 0.644 . . . . 0.0 109.456 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.48 157.13 63.16 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 125.126 1.37 . . . . 0.0 108.858 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.61 102.34 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.279 1.986 . . . . 0.0 111.33 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.01 -25.15 5.85 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.569 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -152.81 142.04 21.48 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.56 0.68 . . . . 0.0 112.118 -171.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.7 tp -131.51 133.33 44.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.643 1.577 . . . . 0.0 108.55 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.447 ' HB3' ' HB2' ' A' ' 4' ' ' MET . 21.3 t-160 -107.56 117.99 35.55 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 80.7 mt -88.74 128.77 35.63 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.634 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m -127.52 160.29 36.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 159.102 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.517 ' HB3' HG13 ' A' ' 23' ' ' ILE . 65.7 p -75.48 164.91 25.87 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.79 -0.569 . . . . 0.0 111.406 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.47 143.75 13.26 Favored Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 124.057 0.943 . . . . 0.0 113.011 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.35 -153.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.173 2.582 . . . . 0.0 112.687 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.32 -111.38 3.46 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.897 -0.391 . . . . 0.0 112.794 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.2 mt -73.15 -31.26 64.15 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.376 0.671 . . . . 0.0 110.709 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 56.92 79.45 0.19 Allowed 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.598 1.186 . . . . 0.0 109.604 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -56.86 -35.19 68.59 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.814 0.846 . . . . 0.0 111.424 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -150.28 159.33 44.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.896 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -114.73 101.39 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.274 1.03 . . . . 0.0 108.935 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.517 HG13 ' HB3' ' A' ' 14' ' ' SER . 2.1 pp -113.95 143.86 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 171.548 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -144.36 108.65 4.81 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.8 mt -131.68 139.19 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.57 0.748 . . . . 0.0 110.411 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.45 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.4 m170 -104.65 111.04 23.59 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.524 HG12 ' HG2' ' A' ' 45' ' ' MET . 37.4 mt -112.08 119.84 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.59 123.64 50.35 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -112.01 115.79 29.5 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.83 111.92 16.06 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.817 0.447 . . . . 0.0 109.991 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.492 HG21 ' HB3' ' A' ' 105' ' ' LYS . 89.0 t -81.5 119.69 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.805 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -131.93 145.77 51.7 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -103.1 113.17 26.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.428 HD21 ' HD1' ' A' ' 40' ' ' TYR . 3.5 p30 -99.95 142.32 31.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.63 -16.8 63.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.265 0.626 . . . . 0.0 112.162 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.401 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 14.2 tp10 -75.22 -46.66 32.51 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.759 0.823 . . . . 0.0 111.675 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.6 t -126.77 -11.71 6.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.356 0.663 . . . . 0.0 112.06 -168.55 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.96 -139.41 14.38 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.3 143.58 57.1 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.434 0.617 . . . . 0.0 111.257 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.428 ' HD1' HD21 ' A' ' 34' ' ' ASN . 8.8 p90 -148.15 165.37 31.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.451 HG23 HG23 ' A' ' 31' ' ' VAL . 10.1 t -130.38 134.71 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.552 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 57.5 t60 -94.36 113.46 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.857 1.263 . . . . 0.0 108.863 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 71.4 m-85 -104.12 115.45 30.44 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.814 . . . . 0.0 108.945 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -120.93 119.32 32.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.524 ' HG2' HG12 ' A' ' 27' ' ' ILE . 81.2 mtp -126.09 134.84 51.25 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.159 0.583 . . . . 0.0 111.086 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -165.37 177.31 7.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.085 0.554 . . . . 0.0 110.181 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.43 -123.7 2.98 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 10.1 pt-20 -152.96 167.35 29.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.387 1.075 . . . . 0.0 109.868 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.504 HG23 HG22 ' A' ' 23' ' ' ILE . 36.8 mt -157.15 105.31 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -172.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.515 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 3.2 m-20 64.03 40.76 6.91 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.193 0.997 . . . . 0.0 109.838 -174.447 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.23 -23.56 3.89 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.638 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.515 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 44.4 mtmt -82.88 116.57 64.8 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.159 0.984 . . . . 0.0 110.413 -171.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.433 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 88.8 Cg_endo -74.92 162.26 37.58 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.049 2.5 . . . . 0.0 113.841 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -158.3 165.68 34.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.715 0.806 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.9 p -153.13 121.66 6.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.283 1.033 . . . . 0.0 109.819 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -155.4 145.04 21.25 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.96 0.904 . . . . 0.0 110.047 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 t -146.58 146.73 30.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.095 0.558 . . . . 0.0 110.653 -170.16 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -142.19 149.78 40.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.34 1.056 . . . . 0.0 110.297 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.3 mp0 -118.6 135.48 54.41 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 89.7 mt -124.45 124.97 25.68 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.68 168.91 12.33 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.108 2.539 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.523 ' HG3' HD22 ' A' ' 106' ' ' LEU . 76.4 ttt180 -47.06 -35.96 7.5 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.222 1.009 . . . . 0.0 112.504 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -58.6 -35.34 72.27 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.554 1.142 . . . . 0.0 112.632 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -129.11 8.03 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 0.0 112.104 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.08 90.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.506 0.722 . . . . 0.0 112.094 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.47 -12.57 61.39 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.832 -1.077 . . . . 0.0 113.216 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -80.69 5.63 15.12 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.55 0.74 . . . . 0.0 111.66 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.513 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 5.9 p90 -73.52 -27.13 61.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.2 1.0 . . . . 0.0 113.334 -172.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.89 -45.32 36.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.364 0.602 . . . . 0.0 109.511 -164.379 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -74.33 -33.35 63.12 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.159 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' HG22 ' A' ' 75' ' ' VAL . 22.6 t70 -72.97 -51.61 17.67 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.913 0.485 . . . . 0.0 111.501 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.73 -41.23 66.83 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.155 0.982 . . . . 0.0 112.091 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.4 m -61.81 -48.45 80.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.972 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.409 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.9 ttm180 -53.73 -45.06 70.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.689 1.196 . . . . 0.0 111.61 174.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 71' ' ' ASP . 43.5 t -61.46 -41.04 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.756 1.222 . . . . 0.0 110.204 -177.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.85 -42.25 70.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -67.71 -26.49 66.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.035 0.934 . . . . 0.0 111.811 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.489 ' HB3' ' HZ3' ' A' ' 78' ' ' LYS . 9.4 mtpm? -65.54 -22.4 66.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.307 0.643 . . . . 0.0 111.177 171.68 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.497 ' HD1' HD11 ' A' ' 49' ' ' ILE . 45.6 t-80 -106.74 20.98 18.22 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.441 0.696 . . . . 0.0 110.39 175.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.59 39.32 8.97 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 121.724 -0.61 . . . . 0.0 113.441 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.462 HD23 HG23 ' A' ' 23' ' ' ILE . 2.1 tm? -64.52 -46.73 81.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.829 0.852 . . . . 0.0 110.322 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 63.71 109.67 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.244 1.418 . . . . 0.0 109.655 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.555 ' HB3' ' HA2' ' A' ' 86' ' ' GLY . 21.9 Cg_exo -33.28 101.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.389 2.702 0 C-N-CA 124.769 3.646 . . . . 0.0 114.423 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -52.34 -64.26 0.87 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.52 1.128 . . . . 0.0 111.2 -173.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.484 ' HE2' ' HB2' ' A' ' 90' ' ' ARG . 52.5 t80 -90.61 -38.21 13.29 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . 0.555 ' HA2' ' HB3' ' A' ' 83' ' ' PRO . . . 98.49 -88.34 0.87 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.507 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.21 88.37 6.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.839 0.455 . . . . 0.0 109.885 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -61.93 -22.44 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 123.516 0.726 . . . . 0.0 110.744 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' THR . . . . . 0.757 ' HA ' ' HD3' ' A' ' 93' ' ' LYS . 24.7 p -65.19 -22.51 66.91 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.711 1.204 . . . . 0.0 112.816 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.484 ' HB2' ' HE2' ' A' ' 85' ' ' PHE . 23.6 mmm180 -76.84 -78.5 0.12 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.972 0.509 . . . . 0.0 109.671 174.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.9 t -118.26 149.88 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.8 m80 68.82 33.65 3.57 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.569 1.148 . . . . 0.0 110.391 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.757 ' HD3' ' HA ' ' A' ' 89' ' ' THR . 27.2 tptp -83.37 38.48 0.61 Allowed 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 125.11 1.364 . . . . 0.0 109.344 175.353 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.95 29.42 2.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.5 1.52 . . . . 0.0 109.074 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -60.33 -34.27 73.59 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.523 1.129 . . . . 0.0 109.879 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.76 -34.81 78.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 110.856 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.24 -49.5 49.3 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.226 0.61 . . . . 0.0 110.442 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.513 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 84.4 mmm -60.95 -42.94 99.21 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.644 0.778 . . . . 0.0 112.983 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -49.79 -46.56 50.94 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.789 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.446 ' HA ' ' CG ' ' A' ' 103' ' ' ARG . 3.7 mt-10 -80.06 -25.82 39.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.618 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.0 -58.76 4.31 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.943 0.897 . . . . 0.0 110.107 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.9 mt -60.53 -41.13 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.528 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.446 ' CG ' ' HA ' ' A' ' 100' ' ' GLU . 4.8 ppt_? -64.63 -30.22 71.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.444 0.566 . . . . 0.0 110.34 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.445 ' O ' ' HB3' ' A' ' 107' ' ' HIS . . . -71.25 -47.25 58.24 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.492 ' HB3' HG21 ' A' ' 31' ' ' VAL . 6.2 tmtp? -69.78 -30.56 68.15 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.998 0.519 . . . . 0.0 111.847 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.523 HD22 ' HG3' ' A' ' 62' ' ' ARG . 2.2 mp -63.9 -23.82 67.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.839 0.855 . . . . 0.0 111.717 172.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.445 ' HB3' ' O ' ' A' ' 104' ' ' ALA . 85.2 t60 -72.57 -15.15 61.76 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.571 1.148 . . . . 0.0 110.907 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 79.42 5.75 2.08 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.528 1.931 . . . . 0.0 112.509 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -151.17 134.17 8.77 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.0 84.52 0.53 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.581 2.187 . . . . 0.0 112.503 -169.128 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.29 54.68 4.22 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.73 143.44 27.05 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.26 1.024 . . . . 0.0 109.514 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.81 132.29 22.95 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.012 2.474 . . . . 0.0 112.19 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.512 HG23 ' HG ' ' A' ' 116' ' ' LEU . 7.8 p -77.02 121.81 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.05 -21.56 58.95 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 122.078 -0.389 . . . . 0.0 111.982 -168.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.512 ' HG ' HG23 ' A' ' 114' ' ' VAL . 4.3 pp -59.47 -26.6 65.38 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.311 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.14 -35.65 81.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.219 1.008 . . . . 0.0 110.815 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.9 -27.06 66.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.318 1.047 . . . . 0.0 111.085 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.514 HG23 HG13 ' A' ' 120' ' ' ILE . 2.3 mp -74.67 -57.8 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.319 0.648 . . . . 0.0 109.676 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.514 HG13 HG23 ' A' ' 119' ' ' ILE . 78.2 mt -116.7 101.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -103.14 -61.11 1.45 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.658 0.783 . . . . 0.0 109.411 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -167.16 149.77 6.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.925 0.89 . . . . 0.0 109.576 -174.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -67.76 104.07 1.57 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.55 -26.41 66.52 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.67 0.607 . . . . 0.0 113.544 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 123.973 0.909 . . . . 0.0 109.261 174.839 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.564 ' NE2' ' H2 ' ' A' ' 1' ' ' GLN . 2.1 mp0 . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.08 105.27 2.21 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -64.15 -43.25 95.79 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.353 0.661 . . . . 0.0 110.549 -171.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.1 mtp -125.06 97.46 5.26 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 173.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -119.35 125.76 49.81 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 170.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.0 153.74 60.88 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.055 0.942 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.34 106.28 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.319 2.013 . . . . 0.0 112.112 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.88 -22.02 9.34 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.014 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -153.89 124.58 7.16 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.304 0.574 . . . . 0.0 112.474 -170.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.803 HD22 ' HE1' ' A' ' 98' ' ' MET . 56.8 tp -103.5 148.13 26.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.898 0.879 . . . . 0.0 108.78 165.082 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -122.78 116.6 23.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.601 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 71.6 mt -89.29 109.59 20.47 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.17 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 23' ' ' ILE . 19.9 m -125.55 169.28 17.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.099 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.8 t -136.08 160.29 39.09 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 162.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.531 HD12 HE21 ' A' ' 20' ' ' GLN . 2.5 pp -52.32 122.6 25.43 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-N 118.108 0.413 . . . . 0.0 111.572 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.66 155.82 58.33 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.744 2.962 . . . . 0.0 113.359 -163.103 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.16 -7.36 0.18 Allowed Glycine 0 C--N 1.342 0.875 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.663 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.6 mt 73.9 -47.99 0.66 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.257 1.423 . . . . 0.0 112.302 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.63 -28.19 69.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.151 1.38 . . . . 0.0 112.698 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.531 HE21 HD12 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -83.54 -19.22 36.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.167 0.587 . . . . 0.0 111.529 177.911 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.405 ' HB2' ' O ' ' A' ' 20' ' ' GLN . 20.4 mt-30 101.14 121.25 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.318 2.647 . . . . 0.0 108.103 -171.464 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.406 ' H ' ' HA ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER -101.45 70.71 1.31 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 13' ' ' VAL . 2.5 pp -88.15 119.6 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.303 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -142.52 109.78 5.63 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.601 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 49.1 mt -133.53 129.8 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.732 0.813 . . . . 0.0 109.194 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.472 ' O ' ' HA ' ' A' ' 45' ' ' MET . 14.7 m170 -100.11 108.69 20.89 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.557 HD13 HD21 ' A' ' 10' ' ' LEU . 41.5 mt -103.22 108.5 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -109.5 112.61 24.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -111.07 118.11 35.13 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -124.31 115.03 20.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.036 0.934 . . . . 0.0 109.09 -172.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.99 120.69 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.594 0.711 . . . . 0.0 109.567 170.352 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -138.4 154.79 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.78 120.6 41.3 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.625 0.25 . . . . 0.0 111.224 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.446 ' H ' HD21 ' A' ' 34' ' ' ASN . 0.1 OUTLIER -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.609 1.164 . . . . 0.0 110.419 169.703 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.07 61.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.094 0.558 . . . . 0.0 111.449 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -67.23 -54.61 19.46 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.258 1.023 . . . . 0.0 111.755 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.404 ' HB3' HD22 ' A' ' 34' ' ' ASN . 35.5 t -120.94 5.91 10.4 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.226 0.611 . . . . 0.0 111.812 -171.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.68 -101.09 1.5 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.522 ' HB1' ' HD3' ' A' ' 62' ' ' ARG . . . -83.78 145.36 28.74 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.961 0.505 . . . . 0.0 110.706 171.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -151.48 174.32 13.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -125.73 132.57 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -96.94 134.16 40.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.195 0.998 . . . . 0.0 108.613 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -120.66 125.75 48.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 109.829 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.492 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 30.4 m-20 -108.13 148.74 29.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.646 0.779 . . . . 0.0 109.505 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.472 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 21.4 mtm -141.4 132.53 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.587 1.155 . . . . 0.0 108.469 171.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -167.53 159.55 12.3 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.266 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.78 -121.1 1.36 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.44 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 11.8 pt-20 -142.08 171.01 14.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 23' ' ' ILE . 15.7 mt -154.95 103.79 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 -176.733 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.406 ' HA ' ' H ' ' A' ' 22' ' ' ASP . 36.6 t70 58.37 46.13 15.81 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 122.345 1.069 . . . . 0.0 109.467 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.16 -36.22 3.53 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.177 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.01 111.95 23.93 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.568 1.147 . . . . 0.0 112.312 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.44 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 Cg_exo -61.3 146.83 96.91 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.795 2.997 . . . . 0.0 113.099 175.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -151.22 163.92 37.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.442 0.297 . . . . 0.0 110.683 -178.835 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -153.58 117.43 4.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.288 0.635 . . . . 0.0 111.206 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -130.32 159.27 37.47 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.687 1.195 . . . . 0.0 109.751 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -157.19 133.46 9.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.731 0.413 . . . . 0.0 110.61 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.3 145.95 50.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.826 0.85 . . . . 0.0 109.635 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -114.08 143.57 44.56 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.74 138.95 27.65 Favored Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.6 149.27 91.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.523 2.149 . . . . 0.0 110.797 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.522 ' HD3' ' HB1' ' A' ' 39' ' ' ALA . 30.8 ptt85 -42.14 -39.29 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.15 -19.77 61.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.557 0.743 . . . . 0.0 112.744 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.1 p -130.48 9.66 5.13 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.55 0.74 . . . . 0.0 109.91 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.76 71.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.948 0.899 . . . . 0.0 111.048 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -69.11 -11.33 60.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.393 1.077 . . . . 0.0 113.046 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -80.62 3.87 20.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.294 0.637 . . . . 0.0 111.195 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -67.88 -21.18 65.16 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 124.324 1.05 . . . . 0.0 112.571 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.12 19.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -69.61 -35.23 75.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.841 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 -54.55 10.31 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.498 0.719 . . . . 0.0 111.602 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.15 -44.72 64.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.24 1.016 . . . . 0.0 111.947 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -63.02 -49.24 75.42 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.418 0.449 . . . . 0.0 110.312 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.491 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 18.3 ttp85 -51.15 -52.78 40.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.322 1.049 . . . . 0.0 111.999 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.92 -32.39 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.862 0.465 . . . . 0.0 110.551 -175.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.0 -41.56 74.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.565 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 96.4 mt-30 -54.27 -30.77 51.84 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.604 1.162 . . . . 0.0 112.969 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.491 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 13.8 mptt -75.2 -7.64 54.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.53 0.732 . . . . 0.0 111.175 -176.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -93.11 7.57 43.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.587 0.755 . . . . 0.0 110.684 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.26 64.51 1.02 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.265 0.466 . . . . 0.0 114.265 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 11.0 mp -103.56 142.5 34.17 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 168.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -111.49 98.89 42.28 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 168.143 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.18 -5.92 4.54 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.675 2.917 . . . . 0.0 114.005 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -59.14 -38.32 79.38 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.501 1.121 . . . . 0.0 110.275 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -89.72 -21.09 22.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.136 0.174 . . . . 0.0 111.134 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.72 -129.51 0.16 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.195 0.426 . . . . 0.0 113.726 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.34 94.48 2.46 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 117.383 0.591 . . . . 0.0 110.041 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.9 tt -98.91 -41.72 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.521 0.729 . . . . 0.0 110.689 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -89.97 -33.69 16.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.815 0.846 . . . . 0.0 110.229 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -75.93 86.1 2.87 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.366 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.54 92.4 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -73.77 116.55 14.49 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.684 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -77.48 12.78 1.44 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.962 0.905 . . . . 0.0 111.818 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.39 -24.14 67.53 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.834 0.853 . . . . 0.0 110.364 167.134 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -62.64 -48.98 77.0 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.406 168.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.32 -33.9 63.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.028 0.531 . . . . 0.0 111.458 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.66 -50.34 63.22 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.445 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.803 ' HE1' HD22 ' A' ' 10' ' ' LEU . 28.3 ttm -71.87 -37.21 70.23 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.757 0.823 . . . . 0.0 112.541 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -51.12 -48.22 61.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.465 1.506 . . . . 0.0 110.301 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 23.2 mt-10 -77.84 -28.75 50.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.287 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.53 -50.53 69.2 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.2 0.6 . . . . 0.0 110.423 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.404 ' O ' HD13 ' A' ' 106' ' ' LEU . 56.0 mt -61.02 -49.15 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.998 0.919 . . . . 0.0 111.597 175.598 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.544 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 1.2 ppt_? -61.85 -30.63 70.97 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.146 0.43 . . . . 0.0 111.31 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.26 -44.76 58.78 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.033 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -65.6 -33.68 76.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.25 1.02 . . . . 0.0 111.787 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.404 HD13 ' O ' ' A' ' 102' ' ' ILE . 6.8 mp -70.52 -22.16 62.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.506 1.122 . . . . 0.0 111.338 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -89.25 -18.7 26.5 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.15 0.58 . . . . 0.0 109.854 170.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 72.87 -70.36 0.16 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.001 1.72 . . . . 0.0 111.526 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -72.0 133.35 83.97 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.953 0.901 . . . . 0.0 109.436 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.01 79.33 1.69 Allowed 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.95 2.433 . . . . 0.0 111.297 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.61 -20.72 55.77 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.698 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -127.45 145.26 53.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.293 1.037 . . . . 0.0 109.634 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.66 105.23 1.59 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.667 2.245 . . . . 0.0 110.126 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.522 HG22 ' HB3' ' A' ' 100' ' ' GLU . 7.3 p -67.97 125.35 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.39 0.614 . . . . 0.0 110.491 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.24 7.93 8.42 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.893 0.877 . . . . 0.0 112.52 -166.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.416 HD13 ' N ' ' A' ' 117' ' ' GLU . 3.1 pp -55.88 -26.83 49.03 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.416 ' N ' HD13 ' A' ' 116' ' ' LEU . 44.2 tt0 -72.76 -33.2 66.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.504 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -81.61 -7.45 59.59 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.691 -167.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.1 -19.82 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.703 0.801 . . . . 0.0 110.519 170.104 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.8 mt 81.26 112.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.802 2.041 . . . . 0.0 109.081 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.405 ' HD2' ' HA ' ' A' ' 117' ' ' GLU . 8.9 ptp180 -140.81 15.1 2.31 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.803 1.241 . . . . 0.0 110.195 -174.266 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -68.53 131.93 46.09 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 123.057 0.543 . . . . 0.0 110.386 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -113.27 -40.47 3.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.828 0.851 . . . . 0.0 110.241 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.8 -166.22 36.69 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.686 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 C--O 1.249 1.068 0 C-N-CA 124.043 0.937 . . . . 0.0 109.073 178.161 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.24 171.82 36.81 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 123.562 0.539 . . . . 0.0 111.903 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -86.15 168.66 13.81 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.975 0.51 . . . . 0.0 110.786 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.1 tpt -137.31 172.14 13.43 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.387 1.075 . . . . 0.0 109.095 -171.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -80.26 127.31 32.2 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.33 154.22 78.5 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.27 1.428 . . . . 0.0 107.834 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.1 110.19 0.42 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.276 1.984 . . . . 0.0 111.658 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.2 -21.56 10.06 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 123.057 0.36 . . . . 0.0 112.736 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -150.93 119.83 6.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.255 0.622 . . . . 0.0 111.434 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.438 HD21 HD13 ' A' ' 27' ' ' ILE . 59.9 tp -102.35 143.21 32.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.346 1.058 . . . . 0.0 108.912 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.431 ' HE2' ' HB2' ' A' ' 24' ' ' ASN . 13.8 t-160 -120.71 124.67 45.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.234 0.613 . . . . 0.0 110.298 174.568 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.512 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.8 mt -102.0 128.31 48.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.882 0.473 . . . . 0.0 109.921 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.78 159.71 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 159.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.9 t -67.45 129.02 38.59 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.838 0.455 . . . . 0.0 110.585 -170.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.2 108.74 2.26 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.999 0.92 . . . . 0.0 110.088 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.5 141.68 81.51 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.614 2.876 . . . . 0.0 113.705 -163.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.89 -24.9 5.94 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.85 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.1 mt -92.14 -71.99 0.61 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.286 0.634 . . . . 0.0 110.774 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -153.51 126.06 8.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.17 0.988 . . . . 0.0 108.711 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.57 69.69 10.38 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -80.92 144.55 31.83 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.456 168.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -87.41 70.65 9.94 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.462 0.648 . . . . 0.0 109.799 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.86 142.15 20.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.363 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.628 ' ND2' ' HG2' ' A' ' 48' ' ' GLU . 8.1 p30 -151.78 128.71 11.0 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.512 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 67.3 mt -127.99 129.23 69.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -171.708 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.424 ' O ' ' HA ' ' A' ' 45' ' ' MET . 1.5 m170 -102.05 109.02 20.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.438 HD13 HD21 ' A' ' 10' ' ' LEU . 53.8 mt -101.75 105.52 18.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 176.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.539 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 27.0 mtp-105 -101.59 108.8 20.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.335 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -111.83 116.97 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.21 111.21 17.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG21 HG23 ' A' ' 41' ' ' VAL . 44.3 t -83.94 116.52 27.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -127.61 155.15 44.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.116 0.966 . . . . 0.0 108.51 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -105.87 111.84 24.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.402 ' H ' HD21 ' A' ' 34' ' ' ASN . 0.1 OUTLIER -97.64 146.94 24.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.828 0.851 . . . . 0.0 110.087 173.238 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.45 -18.05 62.33 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.922 0.489 . . . . 0.0 111.694 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -69.04 -53.32 21.1 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.01 0.924 . . . . 0.0 111.555 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.3 t -124.96 5.71 7.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.05 0.54 . . . . 0.0 112.294 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.92 -114.77 3.98 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 137.98 36.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.021 0.529 . . . . 0.0 110.129 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.3 p90 -152.84 166.96 30.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG23 HG21 ' A' ' 31' ' ' VAL . 10.8 t -124.02 122.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -81.09 116.6 21.1 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -100.26 135.53 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.539 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 25.5 t70 -137.9 141.52 40.65 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.757 0.823 . . . . 0.0 108.831 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.424 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 86.6 mtp -138.46 131.91 30.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 0.0 110.0 -174.613 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -150.48 176.42 10.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.017 0.527 . . . . 0.0 109.92 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.08 -135.34 7.43 Favored Glycine 0 N--CA 1.465 0.599 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.628 ' HG2' ' ND2' ' A' ' 24' ' ' ASN . 8.0 pt-20 -151.63 168.06 26.17 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 mt -157.66 109.29 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -166.562 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t70 61.65 32.98 18.36 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.798 0.808 . . . . 0.0 109.431 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.35 -25.41 9.25 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -82.15 118.94 73.83 Favored Pre-proline 0 N--CA 1.484 1.252 0 CA-C-N 117.831 0.816 . . . . 0.0 111.708 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.459 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -69.89 148.21 63.73 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.639 2.226 . . . . 0.0 112.887 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -142.8 150.52 40.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.313 0.645 . . . . 0.0 109.959 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 m -146.75 122.49 10.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.442 0.697 . . . . 0.0 110.348 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.89 152.62 36.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.127 0.971 . . . . 0.0 109.175 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.0 p -147.98 137.2 22.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.217 0.607 . . . . 0.0 110.699 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.47 140.18 41.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 0.0 109.71 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -112.86 129.58 56.4 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.19 129.01 25.1 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.581 0.753 . . . . 0.0 109.332 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -63.73 164.75 20.33 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.042 2.495 . . . . 0.0 112.126 173.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.13 -32.61 7.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.223 1.009 . . . . 0.0 113.467 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.74 -31.51 66.76 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.344 1.058 . . . . 0.0 112.191 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -125.73 12.48 7.94 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.338 0.655 . . . . 0.0 110.517 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.18 89.97 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.826 0.85 . . . . 0.0 112.116 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.23 -8.05 46.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.476 1.11 . . . . 0.0 113.096 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -80.55 1.2 30.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.785 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -66.1 -18.97 65.69 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.722 1.209 . . . . 0.0 113.058 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -50.78 14.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.437 0.637 . . . . 0.0 109.734 -162.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.9 p -73.28 -31.41 64.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.309 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' HG21 ' A' ' 75' ' ' VAL . 14.2 t70 -70.78 -58.22 3.85 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.282 0.633 . . . . 0.0 111.35 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.27 -47.58 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.251 1.02 . . . . 0.0 112.547 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.3 m -57.59 -47.08 83.11 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.866 0.467 . . . . 0.0 110.758 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.433 ' HA ' ' HG2' ' A' ' 77' ' ' GLN . 39.4 ttp180 -57.96 -38.77 76.61 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.949 0.781 . . . . 0.0 112.508 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -59.63 -47.78 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.116 0.566 . . . . 0.0 109.758 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.462 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -72.22 -40.09 68.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.896 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.49 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 20.8 pt20 -73.56 -22.69 60.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -66.13 -21.25 66.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 121.951 0.101 . . . . 0.0 110.732 166.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -99.56 6.16 45.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.857 0.863 . . . . 0.0 110.537 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.44 -95.85 0.43 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.49 ' HB3' ' HA ' ' A' ' 77' ' ' GLN . 32.5 tp 52.32 -80.22 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.466 1.906 . . . . 0.0 112.952 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -148.82 157.87 40.17 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.256 1.022 . . . . 0.0 109.983 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.8 -167.67 0.53 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.481 2.12 . . . . 0.0 111.986 171.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -63.1 -36.08 82.42 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.636 0.774 . . . . 0.0 110.485 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -59.48 -29.41 67.81 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.515 0.726 . . . . 0.0 111.67 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.14 66.44 3.79 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 123.345 0.403 . . . . 0.0 112.437 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.23 85.75 7.34 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.043 0.537 . . . . 0.0 109.794 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.1 tt -76.24 -28.0 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.092 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.5 p -78.42 -13.19 59.95 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.993 0.917 . . . . 0.0 111.789 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -63.28 -42.86 99.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.437 0.695 . . . . 0.0 109.445 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.39 150.82 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.117 0.967 . . . . 0.0 108.913 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -84.46 86.63 7.26 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 172.08 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -79.26 71.68 5.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.8 0.81 . . . . 0.0 109.144 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 56.69 26.26 11.07 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.144 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -63.24 -41.97 99.15 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.962 0.905 . . . . 0.0 110.279 175.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.85 -32.62 65.97 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.071 0.857 . . . . 0.0 112.182 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.24 -47.95 63.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 tpp -65.51 -40.79 93.41 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -55.04 -51.82 65.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.982 1.313 . . . . 0.0 111.311 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -69.7 -30.37 68.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.67 -177.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.11 -45.62 59.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.311 0.244 . . . . 0.0 110.889 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.87 -45.35 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.396 0.678 . . . . 0.0 110.683 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.56 -29.84 70.86 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 120.614 0.245 . . . . 0.0 110.568 179.285 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.59 -45.72 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.439 0.696 . . . . 0.0 110.619 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.513 ' HA ' ' HE2' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -69.88 -29.88 67.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.941 0.496 . . . . 0.0 112.243 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.2 -31.37 68.78 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.065 0.946 . . . . 0.0 110.486 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -72.76 -18.0 61.54 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.905 0.882 . . . . 0.0 110.493 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 80.56 -6.32 1.68 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.268 1.827 . . . . 0.0 112.619 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -138.98 142.75 34.5 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.368 1.067 . . . . 0.0 108.465 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.18 128.31 22.21 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.57 2.847 . . . . 0.0 112.866 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.08 83.9 0.2 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -174.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.424 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 11.6 pt-20 -77.68 172.02 10.91 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.915 0.886 . . . . 0.0 109.742 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 112' ' ' GLU . 95.8 Cg_endo -76.95 48.75 2.58 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.654 2.236 . . . . 0.0 112.882 172.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.19 130.0 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.08 29.7 5.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.2 0.6 . . . . 0.0 111.009 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -55.3 -30.62 60.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 112.317 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.481 ' HG2' ' HG2' ' A' ' 121' ' ' ARG . 34.1 tt0 -80.45 -32.91 37.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.458 0.703 . . . . 0.0 110.789 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.03 -18.55 65.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.299 1.04 . . . . 0.0 112.27 -168.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.523 HG21 HG12 ' A' ' 120' ' ' ILE . 3.9 mp -67.28 -52.83 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.523 HG12 HG21 ' A' ' 119' ' ' ILE . 33.3 mm -133.99 96.99 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.555 0.742 . . . . 0.0 109.567 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.481 ' HG2' ' HG2' ' A' ' 117' ' ' GLU . 52.2 mtp180 -102.33 -45.75 5.01 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -160.97 145.63 13.88 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.686 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 71.46 148.19 0.08 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.926 1.29 . . . . 0.0 110.72 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.53 -56.2 1.2 Allowed Glycine 0 C--N 1.343 0.952 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.9 p . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 123.157 0.583 . . . . 0.0 109.563 177.946 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.433 ' HA3' HD22 ' A' ' 15' ' ' LEU . . . 98.88 -60.87 0.83 Allowed Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -171.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.49 ' HB2' HD13 ' A' ' 10' ' ' LEU . 47.3 p-80 -171.32 101.59 0.2 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.126 0.971 . . . . 0.0 109.428 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -86.48 97.24 10.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -101.25 141.46 34.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.735 0.814 . . . . 0.0 110.887 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.95 156.02 55.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.192 1.397 . . . . 0.0 108.363 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.72 105.76 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.109 1.872 . . . . 0.0 111.397 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.11 -20.61 11.36 Favored Glycine 0 N--CA 1.473 1.126 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.243 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -153.04 143.88 22.87 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.413 0.607 . . . . 0.0 111.584 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.49 HD13 ' HB2' ' A' ' 3' ' ' HIS . 40.2 tp -129.33 141.26 51.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.237 1.415 . . . . 0.0 108.276 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -127.57 121.18 29.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.563 0.745 . . . . 0.0 109.211 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 79.3 mt -100.53 128.9 46.45 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.419 0.687 . . . . 0.0 109.865 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t -137.06 151.13 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 166.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.7 t -86.2 115.28 23.66 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.766 1.621 . . . . 0.0 108.216 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.433 HD22 ' HA3' ' A' ' 2' ' ' GLY . 4.5 pp -71.43 144.07 88.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 119.107 -0.473 . . . . 0.0 109.943 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.94 122.93 10.09 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.026 1.817 . . . . 0.0 111.396 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 140.35 -69.24 0.47 Allowed Glycine 0 C--N 1.346 1.128 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.73 -46.67 62.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.381 0.61 . . . . 0.0 109.91 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -140.13 -177.68 5.11 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.218 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -166.22 104.79 0.65 Allowed 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.567 0.747 . . . . 0.0 109.004 168.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -158.29 165.23 35.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.697 1.199 . . . . 0.0 108.643 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.92 53.65 2.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.839 0.828 . . . . 0.0 111.102 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.528 HG23 HD22 ' A' ' 81' ' ' LEU . 2.2 pp -90.54 116.03 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -139.14 107.85 5.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 59.1 mt -133.18 133.43 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.643 0.777 . . . . 0.0 109.966 -163.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.479 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.7 m170 -104.8 113.87 27.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.8 mt -112.5 107.74 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 ttp-105 -102.54 110.12 21.96 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -111.57 123.62 50.6 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -118.73 114.46 22.73 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.541 0.737 . . . . 0.0 109.15 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.473 HG13 ' HG3' ' A' ' 105' ' ' LYS . 98.0 t -77.71 117.38 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -140.43 159.86 41.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.899 0.879 . . . . 0.0 109.103 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -110.68 113.48 26.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.483 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.405 ' H ' HD21 ' A' ' 34' ' ' ASN . 0.1 OUTLIER -95.57 148.77 22.16 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.722 0.809 . . . . 0.0 109.598 170.987 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.22 -19.36 63.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.872 0.469 . . . . 0.0 111.432 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.05 -44.93 64.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.284 1.034 . . . . 0.0 112.323 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -133.73 1.93 3.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.83 -115.5 4.12 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.01 143.52 43.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.26 0.53 . . . . 0.0 110.359 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.9 p90 -160.3 172.79 16.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.439 0.696 . . . . 0.0 109.148 169.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.01 130.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -88.68 116.45 26.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.866 0.866 . . . . 0.0 108.884 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.59 110.39 22.43 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -105.11 139.69 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.799 0.84 . . . . 0.0 109.165 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.479 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 40.5 mtm -141.71 140.19 33.1 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.906 0.482 . . . . 0.0 110.833 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -164.1 158.61 19.51 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.424 0.69 . . . . 0.0 109.724 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.18 -127.56 2.16 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.052 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -156.82 160.35 39.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.414 1.085 . . . . 0.0 109.27 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.434 ' HB ' ' CD2' ' A' ' 79' ' ' HIS . 47.7 mt -158.04 107.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.185 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 60.24 42.12 15.63 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.531 1.158 . . . . 0.0 109.348 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.99 -28.76 3.19 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.382 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -82.57 121.41 78.03 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.147 0.979 . . . . 0.0 111.19 -169.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.26 152.21 76.01 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.833 2.356 . . . . 0.0 113.231 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -146.98 146.39 30.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.313 0.645 . . . . 0.0 109.369 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.7 m -142.63 118.9 10.82 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.003 0.521 . . . . 0.0 110.153 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.24 154.92 37.76 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.073 0.949 . . . . 0.0 109.917 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.4 p -145.74 144.91 30.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.853 0.461 . . . . 0.0 110.41 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.64 136.95 39.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.09 0.956 . . . . 0.0 109.555 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -112.92 124.53 52.83 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.25 128.98 25.65 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -60.38 159.26 27.86 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.075 2.517 . . . . 0.0 112.069 171.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -42.63 -40.02 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.944 1.298 . . . . 0.0 114.262 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.79 -15.12 60.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.777 0.831 . . . . 0.0 112.552 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -132.03 4.55 4.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.698 0.799 . . . . 0.0 111.778 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.15 71.64 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.947 0.899 . . . . 0.0 111.789 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -65.34 -24.39 67.24 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.261 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -73.96 -2.06 22.45 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.599 0.76 . . . . 0.0 112.294 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -70.9 -18.01 62.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.88 -43.78 57.46 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -167.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 p -76.11 -35.77 59.17 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.206 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 75' ' ' VAL . 19.8 t70 -71.17 -57.12 4.8 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.345 0.658 . . . . 0.0 112.071 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.36 -43.29 43.89 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.212 1.005 . . . . 0.0 112.454 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -64.44 -46.66 82.19 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.256 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.456 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 68.6 ttt180 -53.76 -44.21 69.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.75 0.82 . . . . 0.0 111.729 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.432 ' HB ' ' HE2' ' A' ' 45' ' ' MET . 57.4 t -60.75 -38.82 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.083 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.16 -41.69 73.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.783 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -60.61 -34.04 73.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.214 1.006 . . . . 0.0 111.363 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.456 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.3 mtpp -61.51 -36.76 81.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.743 . . . . 0.0 111.809 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.434 ' CD2' ' HB ' ' A' ' 49' ' ' ILE . 14.5 t60 -87.53 -33.19 19.04 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.81 41.32 0.02 OUTLIER Glycine 0 C--N 1.358 1.788 0 C-N-CA 121.591 -0.338 . . . . 0.0 113.395 156.057 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.528 HD22 HG23 ' A' ' 23' ' ' ILE . 1.6 tm? -83.03 132.48 35.13 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -61.26 129.25 90.64 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.291 1.036 . . . . 0.0 111.034 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.09 90.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.569 2.179 . . . . 0.0 110.683 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -58.07 -27.73 63.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.992 1.317 . . . . 0.0 112.082 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -54.77 -52.02 63.89 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.997 0.919 . . . . 0.0 111.444 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.75 -92.22 0.08 OUTLIER Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.224 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.88 96.34 1.23 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.906 0.882 . . . . 0.0 108.977 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.1 tt -152.45 126.01 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 122.949 0.5 . . . . 0.0 110.563 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.6 p -90.77 -34.31 15.38 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.849 0.86 . . . . 0.0 110.993 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -82.99 71.08 10.1 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.518 0.727 . . . . 0.0 110.751 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.66 141.81 14.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.71 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -86.97 147.06 25.91 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.719 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 36.0 mtmm -76.41 84.87 3.15 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.163 0.506 . . . . 0.0 112.128 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -81.08 -52.08 7.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.051 0.94 . . . . 0.0 109.379 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -57.93 -48.52 79.66 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.514 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.719 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . 23.9 t70 -59.18 -37.96 78.65 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.163 0.985 . . . . 0.0 112.663 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.85 -48.81 23.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.509 0.323 . . . . 0.0 111.317 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.2 ttm -65.55 -32.62 74.31 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.174 0.59 . . . . 0.0 111.523 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -50.31 -45.76 54.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.275 1.03 . . . . 0.0 109.683 169.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.461 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 27.0 mm-40 -74.9 -28.22 60.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.061 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.51 -55.31 12.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 120.793 0.33 . . . . 0.0 110.357 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.32 -42.0 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.531 1.133 . . . . 0.0 112.211 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.461 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.39 -31.27 72.39 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.863 0.363 . . . . 0.0 110.444 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.47 -52.39 10.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.566 0.746 . . . . 0.0 110.526 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.473 ' HG3' HG13 ' A' ' 31' ' ' VAL . 17.7 tppt? -55.46 -52.97 61.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.769 1.228 . . . . 0.0 113.134 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.07 -26.95 69.08 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.276 0.63 . . . . 0.0 111.872 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -68.6 -31.92 71.43 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.652 0.595 . . . . 0.0 109.457 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.0 -1.63 3.01 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.608 1.563 . . . . 0.0 113.298 169.04 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -135.25 129.08 18.67 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.23 81.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.83 2.353 . . . . 0.0 111.709 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -124.38 53.0 0.77 Allowed Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.237 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.14 152.32 90.46 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.6 91.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.536 2.158 . . . . 0.0 111.52 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.7 p -79.81 142.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.613 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . 0.542 ' HB3' ' HB2' ' A' ' 118' ' ' ARG . 29.0 m-20 -99.21 43.24 1.07 Allowed 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.975 0.91 . . . . 0.0 110.579 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.63 -33.64 73.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.466 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -117.2 85.72 2.38 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.341 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.542 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 1.8 tmm_? -133.2 14.8 4.19 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 165.491 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.66 -63.6 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.772 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.8 mt -88.5 70.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.991 0.9 . . . . 0.0 108.979 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 12.9 mmt180 -107.38 84.43 1.97 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.322 -179.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -150.32 176.21 11.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.291 1.036 . . . . 0.0 110.532 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -140.07 151.59 45.5 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.09 0.956 . . . . 0.0 110.197 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.92 -90.14 1.08 Allowed Glycine 0 C--N 1.346 1.111 0 CA-C-N 116.33 -0.396 . . . . 0.0 113.112 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.247 0.959 0 C-N-CA 123.979 0.912 . . . . 0.0 109.19 -179.43 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.944 0.402 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.62 -133.99 27.9 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.107 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -100.99 59.87 0.92 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 122.201 1.001 . . . . 0.0 108.939 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.2 ttp -73.91 143.73 45.64 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.168 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -106.32 146.56 30.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.279 0.631 . . . . 0.0 110.048 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.44 153.45 58.97 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.038 1.335 . . . . 0.0 108.28 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.75 96.98 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.139 1.893 . . . . 0.0 111.824 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.09 -25.59 4.09 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.384 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -151.91 147.24 26.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.177 0.591 . . . . 0.0 111.219 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.56 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 41.9 tp -126.84 134.59 50.5 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.126 1.37 . . . . 0.0 107.863 173.238 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -97.47 138.48 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.479 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.58 110.58 14.61 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.262 0.625 . . . . 0.0 109.504 175.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.98 169.25 22.21 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 160.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.5 t -104.03 138.14 41.0 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -69.13 126.35 92.67 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.08 147.56 79.75 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.467 2.111 . . . . 0.0 112.032 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.42 -76.71 0.19 Allowed Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.9 tp -140.55 16.53 2.36 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.701 0.762 . . . . 0.0 109.359 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.52 31.52 5.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.962 0.905 . . . . 0.0 109.055 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -86.95 45.38 1.26 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.469 0.707 . . . . 0.0 112.278 -164.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -83.28 138.27 33.64 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 163.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -77.33 82.71 3.79 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.804 0.69 . . . . 0.0 109.237 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.579 HG23 HG22 ' A' ' 49' ' ' ILE . 1.6 pp -110.36 126.57 67.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -147.09 117.61 7.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.479 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 43.1 mt -144.85 145.94 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.308 1.043 . . . . 0.0 108.381 -168.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.405 ' O ' ' HA ' ' A' ' 45' ' ' MET . 9.2 m-70 -108.73 145.66 34.74 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.56 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 55.9 mt -131.75 109.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.465 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 99.5 mtt180 -98.59 140.1 33.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 168.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -121.65 116.85 25.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 165.551 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -123.96 111.89 16.56 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.512 HG21 HG22 ' A' ' 41' ' ' VAL . 90.2 t -90.15 118.75 36.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.29 0.636 . . . . 0.0 110.337 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -114.58 153.24 30.45 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -111.42 111.41 22.43 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.551 HD21 ' HB3' ' A' ' 36' ' ' GLU . 9.4 p-10 -105.24 136.81 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.37 -20.17 66.01 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.04 0.536 . . . . 0.0 112.308 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.551 ' HB3' HD21 ' A' ' 34' ' ' ASN . 5.7 tm-20 -68.97 -45.59 70.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.589 1.156 . . . . 0.0 111.508 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -115.54 -40.71 3.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.865 0.466 . . . . 0.0 111.205 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.76 -148.17 17.22 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.09 129.19 37.92 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.401 0.68 . . . . 0.0 110.867 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.486 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 3.4 p90 -144.45 166.29 25.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.512 HG22 HG21 ' A' ' 31' ' ' VAL . 2.3 t -122.11 128.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.943 0.497 . . . . 0.0 110.329 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.544 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 78.1 t60 -88.92 112.32 23.16 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 164.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.407 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 91.8 m-85 -95.12 121.3 36.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.465 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 19.7 t70 -120.43 114.67 22.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.859 0.864 . . . . 0.0 109.517 -170.012 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.405 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 85.8 mtp -119.31 144.3 46.9 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.546 0.739 . . . . 0.0 110.881 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -156.05 164.48 38.38 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.459 0.704 . . . . 0.0 109.461 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.62 -158.6 31.54 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 118.843 -0.976 . . . . 0.0 111.458 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -145.79 109.97 4.95 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.301 1.051 . . . . 0.0 110.589 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.579 HG22 HG23 ' A' ' 23' ' ' ILE . 49.0 mt -99.78 128.0 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.901 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 62.04 17.62 9.23 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.821 1.248 . . . . 0.0 111.846 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 -20.25 40.86 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.629 -0.54 . . . . 0.0 113.495 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.542 ' HB3' ' HZ3' ' A' ' 52' ' ' LYS . 8.1 mtpm? -82.8 111.17 27.44 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.96 0.904 . . . . 0.0 112.513 -174.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.65 143.39 33.91 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.535 2.157 . . . . 0.0 111.979 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -148.85 161.77 41.16 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -146.65 121.32 9.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -138.52 145.67 41.02 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -174.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 p -144.26 144.66 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.749 0.42 . . . . 0.0 111.154 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -137.53 137.15 38.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.069 0.947 . . . . 0.0 108.701 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 6.4 mp0 -113.84 126.5 55.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.386 -177.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.407 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 94.2 mt -129.32 125.85 22.73 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.486 ' HA ' ' HA ' ' A' ' 40' ' ' TYR . 57.2 Cg_endo -67.19 163.91 32.38 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.635 2.223 . . . . 0.0 111.555 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -45.78 -37.43 6.02 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.678 1.191 . . . . 0.0 113.384 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.87 -29.85 71.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.194 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.0 p -129.76 12.27 5.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.882 0.873 . . . . 0.0 111.02 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -27.95 68.71 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.655 0.782 . . . . 0.0 111.73 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.469 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 27.1 m-85 -70.46 -2.49 14.07 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.361 1.064 . . . . 0.0 113.79 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -95.3 4.94 52.93 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.604 0.761 . . . . 0.0 110.581 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -55.59 -49.16 73.5 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 124.27 1.028 . . . . 0.0 112.899 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.05 -35.2 61.89 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 123.162 0.585 . . . . 0.0 111.777 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -71.51 -40.12 70.36 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.728 0.643 . . . . 0.0 109.359 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.59 -56.64 9.84 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.307 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.49 -40.61 12.76 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.878 1.271 . . . . 0.0 113.429 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -71.03 -46.36 62.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.182 0.593 . . . . 0.0 110.327 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -61.71 -51.01 70.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.849 0.859 . . . . 0.0 111.343 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.98 -34.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.789 0.836 . . . . 0.0 110.689 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.04 84.35 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.18 0.514 . . . . 0.0 110.142 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.7 -36.73 59.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.45 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -64.05 -34.74 78.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.431 0.692 . . . . 0.0 111.094 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -80.17 3.02 21.95 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.04 -31.92 2.32 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 118.927 0.785 . . . . 0.0 113.605 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.448 ' HG ' ' HD3' ' A' ' 83' ' ' PRO . 17.8 tp -56.71 122.67 12.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.019 0.928 . . . . 0.0 110.766 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -130.55 85.57 55.71 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.448 ' HD3' ' HG ' ' A' ' 81' ' ' LEU . 81.4 Cg_endo -82.3 143.58 12.58 Favored 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 122.272 1.982 . . . . 0.0 112.537 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -71.59 -12.14 61.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.307 0.643 . . . . 0.0 109.666 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -57.22 -49.82 74.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.898 0.879 . . . . 0.0 109.271 165.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.36 -72.4 1.44 Allowed Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.968 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.41 4.46 0.91 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.019 0.928 . . . . 0.0 111.172 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.4 pt -92.57 146.62 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -76.72 -39.36 52.13 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.066 0.546 . . . . 0.0 111.215 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 71.12 -57.09 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.72 1.608 . . . . 0.0 111.168 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.97 157.41 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.526 1.131 . . . . 0.0 109.519 167.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -57.87 135.66 56.9 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.565 0.346 . . . . 0.0 110.338 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -64.07 119.48 10.22 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.309 0.381 . . . . 0.0 110.034 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 11.53 16.79 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.727 0.811 . . . . 0.0 109.577 167.264 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.22 -41.74 80.04 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 124.909 1.284 . . . . 0.0 112.426 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.656 ' HB2' HH12 ' A' ' 118' ' ' ARG . 4.7 m-20 -55.77 -42.83 76.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 111.985 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.79 89.22 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.081 0.863 . . . . 0.0 110.746 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.0 ttm -61.15 -51.63 68.25 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.237 1.015 . . . . 0.0 111.397 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -51.19 -52.13 47.26 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.828 1.651 . . . . 0.0 112.21 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.486 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 pt-20 -82.26 -27.44 32.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.295 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.91 -36.55 83.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.3 mt -58.96 -55.65 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.549 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.486 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.11 -28.1 64.33 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.343 0.52 . . . . 0.0 111.448 -178.551 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.411 ' HB1' HH11 ' A' ' 103' ' ' ARG . . . -71.99 -48.03 47.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.753 0.821 . . . . 0.0 110.677 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -58.52 -35.01 71.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.928 0.891 . . . . 0.0 112.246 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.448 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.3 mm? -64.29 -22.55 66.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.436 0.694 . . . . 0.0 112.851 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.83 -17.88 61.51 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 173.064 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 84.05 11.17 0.4 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 126.476 1.91 . . . . 0.0 111.886 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -143.83 137.72 14.53 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.639 1.176 . . . . 0.0 108.28 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.15 94.63 0.57 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.718 2.278 . . . . 0.0 113.524 -170.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.37 54.97 3.17 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 170.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.21 146.03 97.84 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.354 1.062 . . . . 0.0 111.574 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.38 -179.26 5.11 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.29 1.993 . . . . 0.0 112.567 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.57 117.25 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.26 45.34 2.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.919 0.888 . . . . 0.0 109.122 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.48 -36.34 82.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.056 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.14 -19.92 60.41 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.534 0.734 . . . . 0.0 111.229 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.656 HH12 ' HB2' ' A' ' 96' ' ' ASP . 7.6 ttt180 -71.52 -28.13 63.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.034 0.534 . . . . 0.0 111.144 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.58 -31.38 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.414 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.29 -18.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.194 0.998 . . . . 0.0 111.82 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.413 ' HG2' ' HA ' ' A' ' 118' ' ' ARG . 19.3 mmm180 -51.6 104.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.697 0.799 . . . . 0.0 111.73 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -87.02 127.01 35.11 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -149.18 118.38 6.81 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.07 62.3 0.35 Allowed Glycine 0 C--N 1.338 0.681 0 O-C-N 123.726 0.641 . . . . 0.0 111.561 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.248 0.98 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.289 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.36 -112.84 0.56 Allowed Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -152.62 9.77 0.47 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 117.312 0.556 . . . . 0.0 111.722 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.596 ' HE3' ' HA ' ' A' ' 4' ' ' MET . 5.9 mmt -118.78 175.54 5.7 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.838 0.855 . . . . 0.0 111.593 -176.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' A' ' 98' ' ' MET . 67.8 t80 -80.39 147.9 30.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.426 1.09 . . . . 0.0 111.447 -168.785 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.55 154.42 69.28 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.968 1.307 . . . . 0.0 109.94 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.43 100.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.81 2.34 . . . . 0.0 113.202 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.55 -24.38 6.5 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.68 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -147.65 150.75 34.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.625 . . . . 0.0 110.411 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.507 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 42.6 tp -124.18 129.61 51.11 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.978 1.311 . . . . 0.0 107.627 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.67 134.87 40.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.642 0.377 . . . . 0.0 110.137 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.473 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 69.2 mt -125.46 113.09 17.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.474 0.709 . . . . 0.0 110.446 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.93 168.74 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 159.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 t -81.69 132.5 35.29 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.22 121.17 80.13 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.82 95.18 0.34 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.348 2.032 . . . . 0.0 112.081 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.98 -56.93 0.19 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.91 -65.63 0.99 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.344 0.658 . . . . 0.0 109.699 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.03 144.47 46.53 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.361 1.065 . . . . 0.0 108.702 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -138.08 103.99 5.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -151.13 159.95 44.16 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.055 0.542 . . . . 0.0 109.59 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -73.29 78.05 1.33 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.557 HG22 HG23 ' A' ' 49' ' ' ILE . 1.5 pp -123.97 138.47 53.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.052 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -152.68 126.63 9.02 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.492 HD13 HD11 ' A' ' 49' ' ' ILE . 36.2 mt -142.92 142.04 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.293 1.037 . . . . 0.0 108.271 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.7 m170 -103.56 141.99 35.06 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.221 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.507 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 33.1 mt -126.62 108.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 119.27 0.941 . . . . 0.0 109.089 169.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.448 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 18.5 mtp180 -95.39 138.56 32.91 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.236 1.014 . . . . 0.0 108.397 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -124.43 117.29 24.1 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.275 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.66 111.23 16.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.493 HG23 HG21 ' A' ' 41' ' ' VAL . 74.7 t -85.43 117.06 29.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -131.32 158.84 39.59 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.079 0.951 . . . . 0.0 110.012 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -115.89 110.53 19.14 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -98.96 152.09 20.18 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.982 0.513 . . . . 0.0 110.85 172.525 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.38 -25.96 63.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.693 0.797 . . . . 0.0 110.965 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -66.51 -53.45 34.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.317 1.047 . . . . 0.0 112.275 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 m -126.68 -0.44 6.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -168.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.22 -133.94 12.11 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 117.741 0.246 . . . . 0.0 112.632 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.574 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -82.27 131.13 35.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.906 0.482 . . . . 0.0 110.256 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -156.99 173.66 16.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.784 0.433 . . . . 0.0 110.773 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.493 HG21 HG23 ' A' ' 31' ' ' VAL . 20.9 t -132.45 125.65 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.393 0.677 . . . . 0.0 109.526 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.425 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 73.2 t60 -87.91 119.35 28.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 109.581 172.722 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 74.0 m-85 -102.79 127.94 49.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.448 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.0 t70 -130.26 123.87 31.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.084 0.554 . . . . 0.0 110.589 -170.22 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 79.1 mtp -122.59 132.38 54.27 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.018 0.927 . . . . 0.0 111.097 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -154.38 154.23 32.93 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 0.0 110.965 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.24 -151.94 22.09 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 118.588 -1.118 . . . . 0.0 110.403 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -145.65 110.5 5.16 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.096 1.448 . . . . 0.0 111.72 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.557 HG23 HG22 ' A' ' 23' ' ' ILE . 68.8 mt -98.64 124.3 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.603 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.508 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 7.7 m-20 63.98 24.45 13.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.909 1.283 . . . . 0.0 109.822 -170.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.47 10.38 86.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.39 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.508 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 51.3 mtmt -94.78 108.37 37.12 Favored Pre-proline 0 C--N 1.354 0.771 0 C-N-CA 123.494 0.717 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -63.86 133.54 39.4 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.796 2.331 . . . . 0.0 111.732 176.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -137.76 147.39 44.65 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.2 p -132.71 113.1 12.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.77 136.59 34.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.2 p -148.95 145.7 27.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.736 0.303 . . . . 0.0 110.593 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -137.87 142.46 40.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.307 1.043 . . . . 0.0 109.325 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.425 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 7.4 mp0 -116.13 140.44 49.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.3 mt -132.87 135.93 26.81 Favored Pre-proline 0 C--O 1.237 0.435 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 165.26 19.95 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.495 2.13 . . . . 0.0 111.713 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.574 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 24.6 ptt180 -38.76 -36.91 0.3 Allowed 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 125.404 1.482 . . . . 0.0 114.15 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -78.78 -19.14 52.91 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 p -130.53 3.05 4.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.339 0.656 . . . . 0.0 111.307 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.51 70.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.29 1.036 . . . . 0.0 112.178 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -71.15 -17.74 62.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.059 0.944 . . . . 0.0 112.366 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.95 -3.84 57.54 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.869 0.467 . . . . 0.0 111.103 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -51.65 -44.11 62.89 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.026 0.93 . . . . 0.0 112.963 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.22 30.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -172.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -67.69 -47.55 69.12 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.975 0.51 . . . . 0.0 109.855 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.44 -47.5 33.23 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.778 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.51 -39.18 10.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.008 1.323 . . . . 0.0 112.477 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.1 m -73.77 -44.03 57.27 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.982 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -61.67 -46.99 87.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.041 0.936 . . . . 0.0 112.464 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.53 -31.92 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.415 0.686 . . . . 0.0 110.805 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.21 85.79 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.984 0.514 . . . . 0.0 110.594 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 9.6 pt20 -76.84 -25.76 53.56 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.217 179.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -68.03 -27.87 66.91 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.032 0.933 . . . . 0.0 110.669 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.79 6.65 20.52 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.636 0.774 . . . . 0.0 111.448 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.4 54.13 2.02 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 114.701 0.64 . . . . 0.0 114.701 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 30.6 mt -85.06 148.57 26.09 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 118.089 0.945 . . . . 0.0 109.575 165.312 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.2 m170 73.63 135.52 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 125.49 1.516 . . . . 0.0 111.666 168.269 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.01 177.51 0.69 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.358 2.705 . . . . 0.0 113.859 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -67.75 -17.0 64.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.144 0.577 . . . . 0.0 111.904 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -64.16 -43.5 95.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 168.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.12 -174.19 27.26 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.272 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.44 108.08 0.92 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.53 0.732 . . . . 0.0 109.129 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.23 118.63 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.8 t -70.51 -48.75 54.09 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.999 -0.524 . . . . 0.0 110.029 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 46.12 -78.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.026 1.73 . . . . 0.0 113.401 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.8 m -55.6 150.88 2.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 C-N-CA 124.307 1.043 . . . . 0.0 111.667 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -66.23 124.97 24.1 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -83.15 59.54 5.02 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.522 0.514 . . . . 0.0 109.967 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 52.02 28.46 5.3 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 125.451 1.5 . . . . 0.0 112.727 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -68.15 -43.28 78.61 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.953 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -53.27 -41.71 65.79 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.28 29.19 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.135 0.574 . . . . 0.0 110.268 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.4 ' SD ' ' CE1' ' A' ' 5' ' ' PHE . 8.6 tpt -51.69 -42.12 61.95 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.824 1.249 . . . . 0.0 111.686 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -58.99 -53.26 60.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.335 1.454 . . . . 0.0 110.839 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.72 -27.6 66.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.827 0.704 . . . . 0.0 112.101 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.08 -55.69 8.83 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 123.335 0.397 . . . . 0.0 110.243 176.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.8 -37.03 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.914 0.325 . . . . 0.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.4 62.39 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.072 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.505 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -61.94 -38.82 89.91 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.321 1.048 . . . . 0.0 112.898 174.014 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.31 -38.66 92.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.241 0.616 . . . . 0.0 110.802 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -66.81 -29.32 69.22 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.737 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.39 0.4 3.58 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.839 1.656 . . . . 0.0 112.081 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -161.33 143.79 9.16 Favored Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 125.887 1.675 . . . . 0.0 108.072 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -59.01 -26.73 82.74 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.449 2.099 . . . . 0.0 112.597 167.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.01 -36.57 3.89 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.241 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.15 129.14 68.23 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.337 1.055 . . . . 0.0 109.561 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.87 105.13 1.09 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.735 2.29 . . . . 0.0 110.687 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.84 143.99 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 0.0 111.944 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.79 -30.63 69.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.302 1.041 . . . . 0.0 111.891 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.22 -6.15 22.04 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.169 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.78 -43.66 2.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.663 0.785 . . . . 0.0 110.89 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -75.49 -31.56 60.25 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.667 0.787 . . . . 0.0 111.578 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.39 -28.75 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.0 mp -88.28 83.82 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.74 0.816 . . . . 0.0 109.092 -175.079 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.68 -40.12 0.71 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.516 0.726 . . . . 0.0 111.324 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -154.49 129.18 9.3 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.942 0.897 . . . . 0.0 110.667 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.4 150.28 25.0 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.022 0.929 . . . . 0.0 110.338 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.02 -77.42 0.17 Allowed Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 123.429 0.692 . . . . 0.0 109.552 176.573 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.6 -105.84 0.01 OUTLIER Glycine 0 C--N 1.356 1.678 0 N-CA-C 115.646 1.018 . . . . 0.0 115.646 -166.637 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . 0.433 ' HA ' ' O ' ' A' ' 11' ' ' HIS . 14.7 t-80 -78.72 87.6 4.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.715 0.757 . . . . 0.0 109.419 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.5 ttp -124.63 131.05 53.49 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.162 0.985 . . . . 0.0 109.396 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -116.21 148.58 40.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.911 0.885 . . . . 0.0 109.923 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.13 157.2 37.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.455 1.502 . . . . 0.0 107.865 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.57 105.14 0.34 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 121.876 1.717 . . . . 0.0 111.122 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.1 -16.2 12.0 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.866 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -158.36 151.61 22.96 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.74 0.77 . . . . 0.0 112.307 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -140.22 143.15 35.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.045 1.738 . . . . 0.0 107.972 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.433 ' O ' ' HA ' ' A' ' 3' ' ' HIS . 11.4 t-160 -124.41 137.55 54.44 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.417 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -136.47 118.55 15.41 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.577 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 m -104.33 173.7 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.561 ' HB2' HG13 ' A' ' 23' ' ' ILE . 42.4 t -81.69 102.91 11.02 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.23 144.34 98.13 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.826 0.85 . . . . 0.0 111.031 -173.118 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.44 88.85 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.734 2.289 . . . . 0.0 111.004 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.1 -37.23 0.37 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.725 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.94 86.77 2.61 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.705 0.802 . . . . 0.0 109.464 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 65.94 161.35 0.14 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.268 1.427 . . . . 0.0 113.838 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -122.4 97.56 5.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.999 0.92 . . . . 0.0 109.033 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.569 ' HG3' HG23 ' A' ' 23' ' ' ILE . 19.0 pt20 -157.1 159.11 37.55 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.802 0.841 . . . . 0.0 109.177 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.2 57.82 4.7 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.152 0.581 . . . . 0.0 111.648 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.569 HG23 ' HG3' ' A' ' 21' ' ' GLN . 2.0 pp -90.54 119.91 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.78 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.25 118.62 12.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.417 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 19.2 mt -140.53 139.42 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.36 0.664 . . . . 0.0 109.715 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -107.3 131.93 53.67 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.471 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.6 mt -128.11 110.19 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -99.88 139.66 35.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -122.58 116.17 23.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 164.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -123.86 113.17 18.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -169.77 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.471 HG21 HG23 ' A' ' 41' ' ' VAL . 87.2 t -80.22 131.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.438 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 30.3 ttt180 -146.83 161.24 41.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.438 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.1 mm-40 -109.74 119.41 39.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.037 0.535 . . . . 0.0 110.419 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.432 ' H ' HD21 ' A' ' 34' ' ' ASN . 0.1 OUTLIER -96.61 146.76 24.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.776 0.831 . . . . 0.0 110.311 170.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.83 62.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.403 0.681 . . . . 0.0 111.82 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -71.96 -55.34 7.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.893 0.877 . . . . 0.0 112.171 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -121.13 0.69 10.21 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.167 0.587 . . . . 0.0 111.859 -168.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.74 -113.78 4.15 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.482 ' HB1' ' HD3' ' A' ' 62' ' ' ARG . . . -78.87 144.07 35.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.866 0.466 . . . . 0.0 111.279 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.417 ' OH ' ' HD3' ' A' ' 32' ' ' ARG . 9.3 p90 -154.85 177.42 11.29 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 108.666 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.471 HG23 HG21 ' A' ' 31' ' ' VAL . 16.3 t -128.3 124.13 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -84.02 122.52 28.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.641 1.176 . . . . 0.0 108.983 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -106.95 126.72 52.68 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -125.89 115.03 19.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.809 0.843 . . . . 0.0 110.02 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.471 ' SD ' HG12 ' A' ' 27' ' ' ILE . 38.9 mtm -120.95 148.09 44.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.566 0.746 . . . . 0.0 111.004 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -167.79 166.36 13.68 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.213 1.005 . . . . 0.0 109.94 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.11 -144.78 10.03 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-O 118.708 -1.051 . . . . 0.0 110.7 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.99 110.06 3.27 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.582 1.182 . . . . 0.0 111.549 171.375 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.53 HG21 HG21 ' A' ' 23' ' ' ILE . 70.3 mt -100.22 127.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.015 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 65.09 23.53 12.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.088 1.355 . . . . 0.0 109.206 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.48 -0.63 84.67 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.401 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -86.37 109.13 21.0 Favored Pre-proline 0 C--N 1.353 0.745 0 C-N-CA 124.092 0.957 . . . . 0.0 111.48 -175.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.24 129.84 18.89 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.849 2.366 . . . . 0.0 111.902 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -138.49 160.25 40.02 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -147.77 129.06 14.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 169.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -130.87 142.02 50.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.374 1.069 . . . . 0.0 109.102 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -143.25 133.62 24.7 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.538 0.335 . . . . 0.0 110.425 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.86 144.71 33.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.72 0.808 . . . . 0.0 109.231 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -126.1 127.25 45.49 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.424 ' HB2' ' HA ' ' A' ' 65' ' ' ALA . 80.8 mt -124.7 129.87 24.46 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -175.73 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -59.32 156.31 36.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.951 2.434 . . . . 0.0 111.215 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.482 ' HD3' ' HB1' ' A' ' 39' ' ' ALA . 30.1 ptt180 -45.53 -26.88 0.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.38 -21.79 45.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.373 0.669 . . . . 0.0 111.809 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -128.65 2.87 5.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.833 0.853 . . . . 0.0 110.977 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.424 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . . . -55.32 -37.37 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.448 1.099 . . . . 0.0 112.545 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.52 0.7 7.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.202 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.16 3.82 47.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.482 0.713 . . . . 0.0 110.241 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -57.76 -52.03 67.14 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.998 0.919 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.57 -31.1 63.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.5 m -73.44 -50.83 19.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.977 0.511 . . . . 0.0 110.333 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.21 -55.6 15.45 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.745 0.818 . . . . 0.0 111.383 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.36 -46.75 13.28 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.986 1.314 . . . . 0.0 113.059 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.1 m -70.6 -33.15 70.74 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.913 0.485 . . . . 0.0 111.028 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -67.33 -40.77 85.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.396 0.679 . . . . 0.0 111.003 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.93 -33.21 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 110.727 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.96 -47.92 73.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.323 0.582 . . . . 0.0 109.548 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.431 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 3.6 pt20 -69.63 -31.89 70.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.825 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -53.69 -41.66 67.16 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 110.876 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -90.79 8.66 33.57 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.075 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.47 -10.02 4.66 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.451 HD12 ' HB ' ' A' ' 23' ' ' ILE . 8.7 mp -83.03 65.66 8.25 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 118.898 1.349 . . . . 0.0 111.215 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -84.71 108.26 14.34 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.27 104.12 0.12 Allowed 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.848 2.365 . . . . 0.0 111.492 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -69.03 -33.56 73.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.539 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.408 ' H ' ' HD1' ' A' ' 85' ' ' PHE . 1.3 p90 -78.3 -6.17 54.27 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.386 0.674 . . . . 0.0 111.643 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.65 -51.96 4.4 Favored Glycine 0 C--N 1.353 1.479 0 C-N-CA 123.073 0.368 . . . . 0.0 113.08 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.44 -173.84 3.52 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.94 0.896 . . . . 0.0 111.42 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.456 HG13 ' HB2' ' A' ' 90' ' ' ARG . 33.4 pt -135.75 -172.31 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.463 1.105 . . . . 0.0 108.807 173.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.4 p -66.01 -57.99 6.53 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.715 0.806 . . . . 0.0 110.749 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . 0.456 ' HB2' HG13 ' A' ' 88' ' ' ILE . 28.1 ttm-85 60.63 -77.21 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 126.04 1.736 . . . . 0.0 114.246 171.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 m -60.04 79.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 124.964 1.306 . . . . 0.0 113.272 -169.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . 0.59 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 23.1 m-70 -157.77 153.63 26.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.395 1.478 . . . . 0.0 108.63 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.33 18.26 20.05 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.551 0.74 . . . . 0.0 110.067 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.59 ' HG2' ' HB3' ' A' ' 92' ' ' HIS . 6.0 mm-40 -71.24 -30.4 66.28 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.169 0.588 . . . . 0.0 110.677 -174.312 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -65.8 -46.63 77.95 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.94 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.0 -34.73 72.19 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.962 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.34 64.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.564 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mmt -72.27 -30.74 65.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.623 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -51.92 -52.4 50.28 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.087 0.955 . . . . 0.0 110.625 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.78 -28.76 61.82 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.798 0.686 . . . . 0.0 112.241 -173.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.24 -44.81 58.82 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.382 0.273 . . . . 0.0 110.811 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.433 ' O ' HD13 ' A' ' 106' ' ' LEU . 97.6 mt -63.47 -46.52 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.688 0.795 . . . . 0.0 111.648 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -59.69 -31.5 69.64 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.349 0.595 . . . . 0.0 110.496 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.93 56.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.573 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.437 ' HG2' HG22 ' A' ' 31' ' ' VAL . 1.9 tpmt? -64.63 -32.67 74.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.475 0.71 . . . . 0.0 111.873 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -67.83 -20.96 65.22 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.679 1.192 . . . . 0.0 111.149 171.377 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -88.24 -17.18 31.35 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.126 0.97 . . . . 0.0 110.202 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 89.96 14.64 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.916 2.086 . . . . 0.0 112.638 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -138.66 127.74 14.32 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.063 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.34 153.51 65.14 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.113 2.542 . . . . 0.0 113.74 -172.772 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.24 62.15 0.54 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 139.4 73.39 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.033 0.933 . . . . 0.0 112.436 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.22 66.02 8.85 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.382 2.722 . . . . 0.0 112.531 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.54 72.44 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 122.845 1.307 . . . . 0.0 109.532 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.68 41.24 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.779 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.4 HD12 ' N ' ' A' ' 117' ' ' GLU . 3.9 pp -63.23 -29.69 70.98 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.325 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.4 ' N ' HD12 ' A' ' 116' ' ' LEU . 31.7 tt0 -73.65 -19.17 60.92 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.496 0.718 . . . . 0.0 111.43 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -68.53 -16.46 63.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.958 0.503 . . . . 0.0 111.407 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.3 mm -71.64 -35.3 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.112 0.565 . . . . 0.0 109.805 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.428 HD11 ' N ' ' A' ' 120' ' ' ILE . 3.4 mp -84.36 78.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 122.261 1.029 . . . . 0.0 108.246 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.02 -13.73 0.63 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.861 175.058 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -68.89 126.75 30.77 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.66 0.784 . . . . 0.0 109.308 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.57 159.18 16.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.326 0.65 . . . . 0.0 109.678 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.67 66.74 2.99 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.192 0.307 . . . . 0.0 112.476 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.047 0.939 . . . . 0.0 109.306 -178.473 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.68 -165.76 36.46 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 123.618 0.574 . . . . 0.0 114.164 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -74.14 118.75 17.46 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.2 ttt -120.84 130.9 54.14 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.559 0.744 . . . . 0.0 109.691 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -141.7 136.23 30.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.235 0.614 . . . . 0.0 109.801 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.82 156.91 62.35 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.824 1.25 . . . . 0.0 108.504 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.61 105.03 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.538 2.159 . . . . 0.0 112.242 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.63 -19.89 13.95 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.691 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -150.97 135.33 16.96 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.524 0.678 . . . . 0.0 112.363 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.464 HD21 ' HE2' ' A' ' 98' ' ' MET . 46.2 tp -114.8 141.02 48.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.583 1.553 . . . . 0.0 108.957 170.557 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.532 0.733 . . . . 0.0 109.349 168.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.572 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -123.29 110.21 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.644 0.735 . . . . 0.0 110.529 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.6 158.29 5.53 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 164.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.536 ' HB3' HG13 ' A' ' 23' ' ' ILE . 94.8 p -71.6 136.96 47.62 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.877 0.762 . . . . 0.0 110.555 -171.324 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.93 113.98 44.89 Favored Pre-proline 0 CA--C 1.553 1.08 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.89 126.74 13.57 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.177 2.584 . . . . 0.0 113.059 -172.293 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.2 -66.88 0.2 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -91.93 -34.45 14.48 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.367 0.667 . . . . 0.0 109.749 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -144.46 131.98 20.98 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.589 0.756 . . . . 0.0 110.583 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.52 41.54 3.45 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.179 0.991 . . . . 0.0 109.515 173.659 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -69.34 158.3 35.32 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -85.95 53.17 2.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.625 0.726 . . . . 0.0 110.255 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.536 HG13 ' HB3' ' A' ' 14' ' ' SER . 2.0 pp -89.67 115.57 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -138.2 106.39 5.75 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.572 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 48.6 mt -127.6 132.98 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -166.069 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -107.35 119.17 38.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.492 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -120.55 114.1 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.442 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 18.4 mtp180 -104.11 135.34 45.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 108.234 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -121.88 116.06 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 167.357 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.6 111.8 17.67 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 41' ' ' VAL . 52.1 t -82.37 118.33 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.03 159.0 30.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -109.27 119.39 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.722 0.409 . . . . 0.0 110.35 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.04 154.9 16.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.877 0.871 . . . . 0.0 109.232 167.455 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.75 -27.65 64.1 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.714 0.406 . . . . 0.0 111.454 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.21 -54.38 7.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.862 0.865 . . . . 0.0 112.348 -173.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 t -108.57 -1.92 19.25 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.11 0.564 . . . . 0.0 111.532 -173.609 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.84 -110.31 3.06 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 138.34 37.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.9 0.48 . . . . 0.0 110.567 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.5 166.79 26.2 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG23 HG23 ' A' ' 31' ' ' VAL . 7.6 t -127.81 127.12 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.563 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 55.4 t60 -86.18 114.41 23.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.462 1.105 . . . . 0.0 108.859 171.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.438 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 76.0 m-85 -99.73 111.38 23.72 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.442 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 27.1 t70 -107.13 124.58 49.9 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 109.408 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.492 ' HG2' HG12 ' A' ' 27' ' ' ILE . 79.4 mtp -124.58 140.34 53.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.259 0.624 . . . . 0.0 110.286 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.04 170.0 21.38 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.739 0.815 . . . . 0.0 109.663 173.913 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.16 -137.78 6.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 119.429 -0.651 . . . . 0.0 112.002 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.443 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 9.7 pt-20 -152.55 157.73 41.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.756 1.222 . . . . 0.0 108.546 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.52 HG22 HG22 ' A' ' 23' ' ' ILE . 51.2 mt -156.46 105.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -168.034 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.9 t70 59.14 47.96 11.14 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.216 1.007 . . . . 0.0 108.994 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.97 -35.05 3.13 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 114.836 -1.075 . . . . 0.0 114.384 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -86.94 128.88 54.31 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.218 1.007 . . . . 0.0 112.053 -168.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.443 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 89.6 Cg_endo -74.17 161.07 41.47 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.064 2.509 . . . . 0.0 113.821 -177.357 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.406 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 8.9 p90 -152.86 148.9 27.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.903 0.881 . . . . 0.0 109.021 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -142.54 113.83 7.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.154 0.582 . . . . 0.0 110.278 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -127.21 143.09 51.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.295 1.038 . . . . 0.0 109.186 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 t -143.53 134.43 25.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.013 0.435 . . . . 0.0 110.093 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -146.97 148.81 32.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.853 0.861 . . . . 0.0 109.703 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.563 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 4.7 mp0 -118.94 138.72 52.59 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.438 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 73.4 mt -128.89 134.36 26.23 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.71 160.85 34.66 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.641 2.227 . . . . 0.0 111.373 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -36.2 9.96 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.57 -23.73 61.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.056 0.942 . . . . 0.0 112.258 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -125.3 7.2 7.77 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.952 0.901 . . . . 0.0 110.779 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.04 80.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.029 0.931 . . . . 0.0 112.282 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.83 -6.51 38.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.086 0.954 . . . . 0.0 113.186 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -78.57 -6.3 55.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.414 0.685 . . . . 0.0 111.131 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -64.14 -24.13 67.57 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 124.542 1.137 . . . . 0.0 113.06 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.7 -49.06 16.98 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.252 0.549 . . . . 0.0 109.693 -162.48 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 m -72.41 -31.01 65.17 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.283 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.07 -54.24 13.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.182 0.993 . . . . 0.0 110.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.02 74.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.631 1.172 . . . . 0.0 111.92 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.5 m -63.86 -50.24 69.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.657 0.383 . . . . 0.0 110.34 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -54.92 -45.37 74.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.216 1.006 . . . . 0.0 112.058 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.34 -32.06 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.543 0.337 . . . . 0.0 110.671 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.99 -47.48 58.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.023 0.529 . . . . 0.0 110.096 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.585 ' HA ' HD21 ' A' ' 81' ' ' LEU . 13.2 pt20 -65.4 -22.16 66.75 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.757 0.823 . . . . 0.0 112.641 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -64.65 -19.24 65.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.741 0.816 . . . . 0.0 111.918 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -90.2 25.23 2.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.373 0.669 . . . . 0.0 112.33 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.22 49.85 1.67 Allowed Glycine 0 C--N 1.35 1.312 0 CA-C-O 120.218 -0.212 . . . . 0.0 113.493 170.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.585 HD21 ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -78.2 153.47 31.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.953 0.501 . . . . 0.0 109.701 173.428 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -71.08 164.78 53.9 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.949 0.9 . . . . 0.0 110.782 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.81 96.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.315 2.677 . . . . 0.0 112.615 165.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.37 -20.36 34.39 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.751 0.82 . . . . 0.0 111.748 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -69.5 -8.47 47.22 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.422 0.689 . . . . 0.0 112.118 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.42 -4.71 89.22 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 119.8 -0.445 . . . . 0.0 113.389 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.13 131.87 46.68 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.292 0.637 . . . . 0.0 110.075 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -77.27 167.94 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.37 0.668 . . . . 0.0 111.386 -177.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.9 t -68.54 -26.66 65.53 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.376 0.67 . . . . 0.0 111.909 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -87.53 81.12 7.86 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.176 0.512 . . . . 0.0 110.104 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -142.96 138.44 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.237 1.015 . . . . 0.0 108.852 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -103.79 98.81 8.61 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.117 0.567 . . . . 0.0 110.205 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.5 ' HZ2' ' HB3' ' A' ' 93' ' ' LYS . 3.4 mmmp? -103.75 101.11 10.94 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 168.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -72.78 79.47 1.13 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.934 0.874 . . . . 0.0 110.696 -177.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -71.8 -42.26 67.28 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.818 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.27 -34.08 74.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.473 1.109 . . . . 0.0 111.815 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.37 68.38 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.711 0.632 . . . . 0.0 110.696 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.464 ' HE2' HD21 ' A' ' 10' ' ' LEU . 30.4 ttm -65.45 -41.53 93.35 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.012 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.24 -48.29 68.33 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.388 1.075 . . . . 0.0 110.91 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.0 -26.85 57.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.426 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.7 t70 -65.72 -57.35 8.26 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.487 0.492 . . . . 0.0 110.212 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.9 -42.41 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.431 0.693 . . . . 0.0 111.551 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -28.38 69.13 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.22 47.74 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 110.326 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.426 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 30.7 mmmt -58.34 -40.46 82.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 mp -66.62 -34.47 77.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.537 1.135 . . . . 0.0 111.046 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . 0.435 ' HD2' ' HB2' ' A' ' 109' ' ' HIS . 13.1 t60 -81.28 -17.86 47.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.444 0.697 . . . . 0.0 110.562 174.738 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 69.96 13.45 7.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.569 1.547 . . . . 0.0 111.667 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.435 ' HB2' ' HD2' ' A' ' 107' ' ' HIS . 73.6 m80 -148.49 152.27 38.06 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 124.993 1.317 . . . . 0.0 108.777 -176.189 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -42.68 119.12 1.35 Allowed 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 123.991 3.127 . . . . 0.0 114.206 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.74 -4.3 65.58 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.371 -172.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.99 114.91 16.75 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -88.64 123.18 1.48 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.845 2.363 . . . . 0.0 112.83 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . 0.403 HG23 HD22 ' A' ' 116' ' ' LEU . 11.6 p -79.05 152.91 4.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -113.42 17.48 18.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.038 0.535 . . . . 0.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.403 HD22 HG23 ' A' ' 114' ' ' VAL . 4.4 pp -65.65 -24.26 66.98 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -114.59 -3.14 12.96 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.11 0.964 . . . . 0.0 110.865 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -72.29 -5.27 34.92 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.558 0.743 . . . . 0.0 112.707 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 4.0 mp -74.3 -7.42 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 C-N-CA 123.998 0.919 . . . . 0.0 109.648 175.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.2 mm 60.77 54.91 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.286 0 C-N-CA 125.12 1.368 . . . . 0.0 107.501 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -70.01 88.99 0.59 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 113.423 -1.717 . . . . 0.0 110.666 -164.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -82.7 132.77 35.17 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.69 -38.07 65.01 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.27 -158.24 22.82 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.958 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 C--O 1.252 1.193 0 C-N-CA 123.495 0.718 . . . . 0.0 109.352 179.493 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.408 HE21 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.3 132.22 3.09 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -174.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -139.39 -30.55 0.72 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.174 0.59 . . . . 0.0 110.094 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.461 ' HB2' ' HB3' ' A' ' 11' ' ' HIS . 76.6 mmm -128.18 102.69 6.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.543 1.137 . . . . 0.0 108.607 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -108.6 147.03 32.42 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.47 155.6 32.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.575 1.15 . . . . 0.0 108.304 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.72 90.83 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.285 1.99 . . . . 0.0 111.995 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.91 -26.3 3.01 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.721 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 26' ' ' HIS . 55.5 t-80 -150.53 151.63 32.94 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.196 0.498 . . . . 0.0 111.692 -170.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 53.8 tp -135.02 111.63 9.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 108.557 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.461 ' HB3' ' HB2' ' A' ' 4' ' ' MET . 11.6 t-160 -98.42 127.9 44.56 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.424 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -121.05 132.38 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.215 0.606 . . . . 0.0 109.931 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.09 165.13 29.7 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 166.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.4 t -113.45 115.15 27.59 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.3 mt -62.92 139.94 97.44 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.018 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -44.95 -69.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.824 3.016 . . . . 0.0 113.73 -168.836 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.21 -84.86 0.04 OUTLIER Glycine 0 C--N 1.343 0.929 0 O-C-N 123.355 0.409 . . . . 0.0 113.082 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.3 pt? -88.8 -40.05 13.45 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.86 0.864 . . . . 0.0 110.141 176.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -166.82 141.52 4.09 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.502 1.521 . . . . 0.0 108.701 -176.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -81.43 84.08 6.78 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.989 0.516 . . . . 0.0 109.734 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.94 141.29 31.36 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.05 65.83 8.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.852 0.834 . . . . 0.0 110.509 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.601 HD13 HD21 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -92.69 126.85 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.869 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.442 HD22 ' HG3' ' A' ' 48' ' ' GLU . 6.0 p30 -151.81 110.02 3.73 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.424 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 27.8 mt -132.32 137.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -168.195 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.532 ' O ' ' HA ' ' A' ' 45' ' ' MET . 4.7 m170 -99.53 128.52 45.65 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.564 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.551 HG12 ' HG2' ' A' ' 45' ' ' MET . 56.2 mt -121.9 109.62 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -96.18 124.84 40.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . 0.463 ' HB2' HG13 ' A' ' 41' ' ' VAL . 45.7 p90 -111.69 116.98 31.65 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.049 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -124.63 112.32 16.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.676 0.79 . . . . 0.0 109.29 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.501 HG23 HG21 ' A' ' 41' ' ' VAL . 56.3 t -75.9 126.64 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.771 0.428 . . . . 0.0 110.663 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -143.97 154.79 43.66 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.05 125.56 41.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.713 0.405 . . . . 0.0 111.132 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.532 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 1.5 p30 -100.1 147.08 26.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.635 1.174 . . . . 0.0 109.155 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.81 -10.94 60.51 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 122.954 0.501 . . . . 0.0 112.233 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.532 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 16.4 tt0 -75.81 -55.27 5.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.196 0.999 . . . . 0.0 112.012 -177.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.1 p -130.32 1.98 4.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.338 0.655 . . . . 0.0 112.263 -167.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.88 -106.27 3.4 Favored Glycine 0 C--O 1.213 -1.171 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 146.76 41.22 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.794 0.797 . . . . 0.0 111.887 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.442 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.5 p90 -152.85 173.53 15.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.501 HG21 HG23 ' A' ' 31' ' ' VAL . 23.5 t -128.7 130.85 68.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -89.03 110.95 21.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.424 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 63.3 m-85 -96.56 139.32 32.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.467 0.707 . . . . 0.0 109.181 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.421 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 34.1 t70 -135.04 127.95 31.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.358 0.663 . . . . 0.0 109.722 -177.151 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.551 ' HG2' HG12 ' A' ' 27' ' ' ILE . 83.4 mtp -123.91 131.17 53.53 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.919 0.888 . . . . 0.0 110.114 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -161.03 162.18 31.65 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.71 -128.03 2.6 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.442 ' HG3' HD22 ' A' ' 24' ' ' ASN . 10.3 pt-20 -156.59 165.43 36.31 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.198 0.599 . . . . 0.0 109.864 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 90.6 mt -155.98 103.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 -161.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.16 37.43 20.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.687 0.795 . . . . 0.0 110.1 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.12 -21.03 7.32 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.312 -0.858 . . . . 0.0 115.239 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -79.65 120.23 79.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 117.621 0.711 . . . . 0.0 110.825 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.61 157.05 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.017 2.478 . . . . 0.0 113.266 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -154.7 161.51 41.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.679 0.392 . . . . 0.0 111.279 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.5 p -141.89 116.26 9.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.431 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.35 144.31 31.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.244 1.018 . . . . 0.0 108.861 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.3 p -148.12 149.59 32.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.452 0.569 . . . . 0.0 110.753 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -141.46 151.32 43.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.558 0.743 . . . . 0.0 110.571 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.76 132.56 54.29 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.55 0.74 . . . . 0.0 109.863 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.424 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 95.7 mt -127.53 139.05 34.15 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.374 0.67 . . . . 0.0 109.791 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.44 158.54 40.36 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.053 2.502 . . . . 0.0 112.02 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -41.36 -34.83 0.56 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.126 1.37 . . . . 0.0 114.65 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.86 -19.88 62.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.625 0.77 . . . . 0.0 112.416 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.3 p -131.7 10.1 4.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.829 0.852 . . . . 0.0 110.231 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.57 96.79 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.493 0.717 . . . . 0.0 111.36 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -70.05 -22.19 63.1 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.549 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -80.6 -8.76 59.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.809 0.844 . . . . 0.0 109.545 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -53.04 -30.61 36.76 Favored 'General case' 0 C--O 1.205 -1.276 0 C-N-CA 123.949 0.899 . . . . 0.0 112.918 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 -34.16 20.77 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -69.52 -48.3 60.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.37 -57.04 10.45 Favored 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -43.55 -45.27 6.53 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.778 1.631 . . . . 0.0 113.461 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.4 m -68.75 -40.55 79.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.668 0.387 . . . . 0.0 110.892 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -68.59 -39.09 81.09 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.534 0.734 . . . . 0.0 111.828 -177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.98 -50.21 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.397 1.079 . . . . 0.0 109.451 173.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.417 ' HB1' HD23 ' A' ' 81' ' ' LEU . . . -60.74 -43.06 98.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.667 0.787 . . . . 0.0 111.622 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 3.3 pt20 -71.11 -35.52 71.82 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.638 0.375 . . . . 0.0 111.284 -176.273 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -65.1 -31.65 72.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.619 0.368 . . . . 0.0 110.697 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -89.38 5.38 45.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.234 0.613 . . . . 0.0 112.143 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.02 -27.09 2.45 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.601 HD21 HD13 ' A' ' 23' ' ' ILE . 9.8 mp -70.9 158.07 37.07 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.767 0.794 . . . . 0.0 111.955 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -142.04 74.46 21.55 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 162.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.415 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 42.4 Cg_endo -91.25 29.16 0.37 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.154 2.569 . . . . 0.0 111.494 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -67.05 -38.88 86.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.585 1.154 . . . . 0.0 112.313 -170.579 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -81.05 -42.64 20.75 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.56 -63.53 0.63 Allowed Glycine 0 C--N 1.347 1.155 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.218 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 75.7 -43.95 0.5 Allowed 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 125.938 1.695 . . . . 0.0 112.965 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.61 111.79 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.379 1.072 . . . . 0.0 110.248 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.0 m -67.95 -45.43 74.26 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.252 0.621 . . . . 0.0 111.283 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -79.66 76.26 6.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.063 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.46 114.87 2.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.634 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -77.15 94.44 4.08 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -94.47 21.94 6.66 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.888 0.875 . . . . 0.0 110.535 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -85.12 32.88 0.54 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.299 1.04 . . . . 0.0 110.536 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -64.34 -32.44 74.05 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.388 1.075 . . . . 0.0 110.2 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.47 -31.29 69.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.59 -48.88 53.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.991 0.516 . . . . 0.0 110.976 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.6 ptm -65.97 -31.44 72.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.505 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -56.48 -45.97 80.67 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.175 0.59 . . . . 0.0 110.828 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.554 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 12.3 pt-20 -76.75 -27.67 55.44 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.705 0.402 . . . . 0.0 111.934 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.51 -58.97 3.78 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.864 0.364 . . . . 0.0 110.028 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.413 ' O ' HD12 ' A' ' 106' ' ' LEU . 74.7 mt -57.16 -38.05 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.879 1.271 . . . . 0.0 112.361 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.554 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.69 -29.61 70.82 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.234 0.47 . . . . 0.0 111.611 177.849 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.82 -41.19 60.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.741 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -57.35 -45.09 84.71 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.789 0.836 . . . . 0.0 112.514 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.413 HD12 ' O ' ' A' ' 102' ' ' ILE . 9.7 mp -64.21 -24.95 67.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.871 0.869 . . . . 0.0 111.766 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -85.68 -16.91 37.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.319 0.648 . . . . 0.0 110.657 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.38 13.26 3.83 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.134 1.374 . . . . 0.0 111.608 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -147.88 137.25 12.0 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 124.243 1.017 . . . . 0.0 108.819 -176.586 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.06 106.49 1.54 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.501 2.134 . . . . 0.0 111.678 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.45 46.7 1.06 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -72.49 144.11 86.06 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.98 0.912 . . . . 0.0 110.167 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.21 148.81 69.45 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.994 2.462 . . . . 0.0 112.128 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.97 149.98 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -140.83 32.68 1.79 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.668 0.787 . . . . 0.0 110.105 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . 0.474 HD13 ' N ' ' A' ' 117' ' ' GLU . 4.5 pp -61.97 -43.03 99.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.813 0.445 . . . . 0.0 110.821 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.495 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -76.18 -22.48 55.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.757 1.223 . . . . 0.0 111.853 -178.296 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 tpp85 -50.36 -49.14 55.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.997 1.319 . . . . 0.0 112.246 -170.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.91 -29.19 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.754 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.3 -24.36 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.752 0.821 . . . . 0.0 111.628 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 31.0 mmm180 -63.71 82.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.396 0.679 . . . . 0.0 111.364 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -157.52 140.91 15.51 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.137 1.375 . . . . 0.0 109.439 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.07 81.16 1.0 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.772 0.829 . . . . 0.0 109.149 173.622 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.65 -72.2 1.2 Allowed Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 123.884 0.874 . . . . 0.0 108.78 178.303 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.69 -76.2 0.41 Allowed Glycine 0 C--N 1.352 1.45 0 O-C-N 123.488 0.493 . . . . 0.0 114.121 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -79.58 60.03 3.17 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.072 0.949 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttp -81.08 105.7 12.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.394 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -96.11 139.14 32.71 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.13 161.3 54.13 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.923 1.289 . . . . 0.0 108.451 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.495 ' HG3' ' HB3' ' A' ' 112' ' ' GLU . 29.8 Cg_exo -62.44 109.66 0.91 Allowed 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 121.859 1.706 . . . . 0.0 111.491 172.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.29 -13.83 33.45 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.896 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -155.12 146.79 23.23 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.542 0.671 . . . . 0.0 112.062 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.9 tp -136.35 128.93 30.55 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.641 1.176 . . . . 0.0 109.039 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -100.3 125.63 46.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.542 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 85.8 mt -107.17 134.82 49.71 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.269 0.628 . . . . 0.0 109.928 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.401 HG23 ' O ' ' A' ' 23' ' ' ILE . 13.8 p -148.58 165.99 4.36 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 t -73.52 104.38 4.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.744 1.156 . . . . 0.0 108.208 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 pp -78.4 157.38 77.77 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.894 0.878 . . . . 0.0 110.983 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -58.53 110.86 0.72 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.599 2.199 . . . . 0.0 110.908 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.02 -42.13 0.88 Allowed Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 mp -102.18 165.6 11.06 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.48 1.112 . . . . 0.0 110.044 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -65.49 138.76 58.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.288 0.635 . . . . 0.0 109.917 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -64.25 136.33 57.08 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.017 0.823 . . . . 0.0 111.26 -175.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.494 HE21 ' HB2' ' A' ' 50' ' ' ASP . 31.2 tt0 -150.49 154.9 38.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 170.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . 0.573 ' HB3' ' HA ' ' A' ' 50' ' ' ASP . 27.8 t70 -85.74 42.48 0.97 Allowed 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.488 1.137 . . . . 0.0 110.727 -173.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.625 HG22 HG21 ' A' ' 49' ' ' ILE . 44.3 pt -89.7 139.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.445 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.586 HD22 ' HG2' ' A' ' 48' ' ' GLU . 5.5 p30 -152.85 125.01 8.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 172.087 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.542 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 31.4 mt -132.43 132.79 60.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.174 -172.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.517 ' O ' ' HA ' ' A' ' 45' ' ' MET . 5.5 m170 -108.09 109.82 21.35 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -105.27 108.37 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -102.91 109.93 21.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -115.93 117.96 31.6 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.69 114.52 18.12 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.542 HG12 ' HB3' ' A' ' 105' ' ' LYS . 7.1 p -82.25 126.63 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.051 0.54 . . . . 0.0 109.726 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -141.16 166.49 24.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -109.49 117.13 33.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -91.65 156.96 17.23 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.681 0.793 . . . . 0.0 109.665 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.42 -20.76 62.08 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -84.72 -53.62 5.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.28 0.632 . . . . 0.0 111.438 -171.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -117.86 3.92 12.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.958 0.903 . . . . 0.0 111.537 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.44 -122.41 5.72 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.55 51.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.618 0.709 . . . . 0.0 111.994 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -157.75 170.65 21.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.002 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.07 130.35 69.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.49 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.0 t60 -88.27 129.8 35.27 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -115.07 135.12 54.55 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -137.99 141.36 40.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.517 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 91.3 mtp -135.19 131.59 36.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.564 0.746 . . . . 0.0 109.281 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -150.54 162.79 39.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.72 -144.08 12.8 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.586 ' HG2' HD22 ' A' ' 24' ' ' ASN . 1.9 pm0 -147.23 163.16 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.295 1.038 . . . . 0.0 108.547 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.625 HG21 HG22 ' A' ' 23' ' ' ILE . 38.0 mt -157.81 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 -160.855 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.573 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 37.3 t70 55.38 26.64 8.97 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 121.614 0.721 . . . . 0.0 111.394 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.22 50.97 4.33 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.212 -173.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 52.4 mtpt -146.11 108.41 4.26 Favored Pre-proline 0 N--CA 1.497 1.92 0 C-N-CA 123.564 0.746 . . . . 0.0 110.798 -176.382 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.91 121.44 4.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.863 2.375 . . . . 0.0 111.794 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -125.54 143.68 50.9 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.861 0.465 . . . . 0.0 110.687 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 p -139.92 110.55 6.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.312 0.645 . . . . 0.0 109.477 171.887 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.22 151.85 39.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.697 1.199 . . . . 0.0 109.299 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.8 p -151.43 123.16 8.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.909 0.483 . . . . 0.0 109.85 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.16 146.44 42.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.317 1.047 . . . . 0.0 108.98 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.49 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 49.6 mt-10 -123.89 141.29 52.17 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.077 0.551 . . . . 0.0 109.672 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -124.79 130.28 24.3 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -65.65 169.65 12.55 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.936 2.424 . . . . 0.0 112.193 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -41.5 -39.67 1.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.473 1.109 . . . . 0.0 113.617 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.04 -29.5 66.55 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.243 1.017 . . . . 0.0 112.526 -174.089 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -130.99 8.39 4.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.966 0.507 . . . . 0.0 111.376 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.83 70.95 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.531 0.732 . . . . 0.0 111.917 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.16 -21.55 66.79 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.898 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -72.76 3.26 5.33 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.406 0.683 . . . . 0.0 112.593 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.56 -20.61 61.29 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.402 1.081 . . . . 0.0 112.209 -173.012 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.16 -42.9 45.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.938 0.875 . . . . 0.0 108.844 -169.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -74.46 -39.62 62.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.155 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.417 ' O ' HG21 ' A' ' 75' ' ' VAL . 19.9 t70 -73.71 -59.1 2.87 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.016 0.526 . . . . 0.0 112.14 -171.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.45 66.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.559 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.533 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 95.4 m -65.81 -48.23 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 173.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -57.74 -34.33 69.4 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.545 0.738 . . . . 0.0 111.951 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.417 HG21 ' O ' ' A' ' 71' ' ' ASP . 94.0 t -68.8 -36.81 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.12 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.464 ' O ' HD13 ' A' ' 81' ' ' LEU . . . -68.44 -49.72 57.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.54 0.736 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.533 ' HG2' ' O ' ' A' ' 73' ' ' THR . 65.7 mm-40 -66.21 -25.08 66.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -60.13 -28.73 68.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.439 1.096 . . . . 0.0 111.363 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -91.66 12.13 22.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.648 0.779 . . . . 0.0 112.232 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.1 74.32 1.11 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 122.948 0.155 . . . . 0.0 113.292 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.766 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 11.2 mp -116.25 151.18 36.3 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.163 0.985 . . . . 0.0 109.681 170.427 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.416 ' CD2' ' HB2' ' A' ' 21' ' ' GLN . 44.9 m-70 -58.51 -47.52 98.61 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 117.848 -1.073 . . . . 0.0 112.46 173.077 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.766 ' HD2' ' HB3' ' A' ' 81' ' ' LEU . 51.2 Cg_exo -55.36 1.34 0.1 OUTLIER 'Trans proline' 0 C--N 1.404 3.475 0 C-N-CA 123.227 2.618 . . . . 0.0 116.59 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.6 -44.76 90.01 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.258 1.023 . . . . 0.0 110.873 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -70.48 -27.55 64.3 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.988 0.423 . . . . 0.0 110.243 175.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.84 70.84 2.66 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.926 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 153.22 29.31 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.2 mt 76.26 -38.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 125.02 1.328 . . . . 0.0 111.852 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 t -74.03 -20.47 60.3 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.499 -0.751 . . . . 0.0 111.166 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -73.77 -28.82 61.86 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.725 0.81 . . . . 0.0 110.442 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m -127.81 82.73 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.292 1.037 . . . . 0.0 109.435 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -84.31 42.27 0.88 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.915 0.886 . . . . 0.0 110.128 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 65.29 8.34 4.84 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.709 1.603 . . . . 0.0 112.908 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -12.39 60.25 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.535 0.734 . . . . 0.0 110.043 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -52.0 -41.13 61.96 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.356 1.463 . . . . 0.0 111.946 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.67 -30.45 70.7 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.199 0.937 . . . . 0.0 111.847 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.12 17.82 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.942 0.497 . . . . 0.0 110.893 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -70.96 -25.9 62.93 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.565 0.346 . . . . 0.0 111.869 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -50.97 -42.73 60.3 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.127 0.971 . . . . 0.0 110.303 164.066 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.463 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 35.0 mt-10 -79.33 -27.57 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.488 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.83 -50.31 30.68 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.8 -38.81 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.567 0.347 . . . . 0.0 111.648 173.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.463 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.42 -28.55 69.33 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.739 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.21 -40.6 62.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.053 0.541 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.542 ' HB3' HG12 ' A' ' 31' ' ' VAL . 9.5 mmpt? -58.44 -40.18 81.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.61 0.764 . . . . 0.0 112.059 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.25 -25.58 67.73 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.179 0.992 . . . . 0.0 111.162 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -80.68 -17.91 49.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 110.891 172.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 81.5 36.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.899 1.679 . . . . 0.0 111.628 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -145.89 163.5 30.61 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.238 1.015 . . . . 0.0 109.457 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -34.5 116.53 0.1 Allowed 'Trans proline' 0 C--N 1.402 3.392 0 C-N-CA 124.838 3.692 . . . . 0.0 115.894 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.37 57.61 0.49 Allowed Glycine 0 C--O 1.238 0.38 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . 0.495 ' HB3' ' HG3' ' A' ' 7' ' ' PRO . 1.1 mm-40 -96.9 114.2 64.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.35 94.28 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.437 2.091 . . . . 0.0 112.822 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.47 93.06 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.21 1.005 . . . . 0.0 109.009 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.99 43.45 1.12 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.3 -173.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.03 -27.82 69.67 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.814 0.445 . . . . 0.0 111.959 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . 0.408 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 42.5 tt0 -78.28 -22.07 48.82 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.964 0.506 . . . . 0.0 110.799 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -79.96 -17.09 53.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.985 0.514 . . . . 0.0 110.561 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.3 mm -78.97 91.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 124.063 0.945 . . . . 0.0 108.696 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.1 mt 82.41 -21.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.846 163.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . 0.408 ' HD3' ' HA ' ' A' ' 117' ' ' GLU . 15.8 mtp180 -65.86 109.61 2.55 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.744 0.418 . . . . 0.0 111.14 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -75.93 145.35 40.48 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -98.4 122.03 41.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.557 0.743 . . . . 0.0 110.264 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.88 17.84 3.41 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 CA--C 1.556 1.185 0 C-N-CA 124.566 1.147 . . . . 0.0 108.177 178.358 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.731 0.301 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.04 -35.64 0.02 OUTLIER Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.57 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -163.67 145.86 9.54 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.359 0.664 . . . . 0.0 110.118 -176.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.7 ttp -154.21 96.71 1.97 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -98.54 141.32 31.54 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.79 157.02 32.61 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.82 1.248 . . . . 0.0 108.02 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.19 89.84 0.39 Allowed 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.943 1.762 . . . . 0.0 110.554 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -14.43 3.78 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.928 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -164.59 153.08 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.955 0.877 . . . . 0.0 111.978 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.412 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 4.8 tt -143.26 132.83 23.63 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 175.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -114.55 134.09 55.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.279 0.632 . . . . 0.0 109.667 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 95.1 mt -111.1 128.83 56.01 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.6 t -135.36 90.1 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.317 0.58 . . . . 0.0 110.364 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -92.17 102.35 14.87 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 159.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.544 ' H ' HD21 ' A' ' 15' ' ' LEU . 1.8 pt? -79.56 155.25 76.26 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.285 1.034 . . . . 0.0 110.082 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.624 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 36.6 Cg_endo -62.9 -45.73 12.42 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.194 1.929 . . . . 0.0 112.769 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.66 -84.48 0.02 OUTLIER Glycine 0 N--CA 1.475 1.286 0 O-C-N 123.283 0.364 . . . . 0.0 113.135 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.7 mt -98.17 39.39 1.24 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.556 1.142 . . . . 0.0 110.407 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 64.54 54.61 1.44 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.611 1.164 . . . . 0.0 112.079 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.624 ' HB2' ' HA ' ' A' ' 16' ' ' PRO . 76.6 mt-30 -78.15 -156.44 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.969 165.102 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -101.94 140.19 36.56 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.92 112.38 23.24 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.95 138.65 38.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.411 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.95 127.7 10.21 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 165.171 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -137.81 128.87 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.717 0.807 . . . . 0.0 109.355 -163.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -93.82 131.65 39.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.428 HG12 ' HE2' ' A' ' 45' ' ' MET . 56.7 mt -120.36 103.99 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 171.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -91.96 140.17 29.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.31 137.8 19.74 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 111.197 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.25 130.77 37.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.848 0.859 . . . . 0.0 109.271 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.2 t -80.74 117.27 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 42.7 ttt180 -132.95 166.56 22.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.689 1.196 . . . . 0.0 108.144 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 25.7 mm-40 -106.34 127.67 53.43 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 118.349 0.522 . . . . 0.0 111.19 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 40' ' ' TYR . 3.2 p30 -102.95 146.54 28.17 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.825 1.25 . . . . 0.0 108.63 170.498 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.13 61.79 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.409 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 9.5 tp10 -77.37 -54.32 6.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.354 0.662 . . . . 0.0 112.008 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -113.55 -23.09 9.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.956 0.902 . . . . 0.0 111.218 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.16 -116.33 4.75 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 149.65 47.23 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.501 0.651 . . . . 0.0 111.724 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.428 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.1 p90 -159.05 173.74 16.0 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.992 0.917 . . . . 0.0 109.278 167.467 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.45 124.47 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -87.63 122.75 31.72 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -108.14 138.62 44.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.504 0.722 . . . . 0.0 110.18 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -130.48 120.46 24.18 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.329 1.052 . . . . 0.0 108.221 172.101 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.428 ' HE2' HG12 ' A' ' 27' ' ' ILE . 80.8 mtp -116.04 130.58 56.87 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.444 0.565 . . . . 0.0 109.702 178.924 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.8 161.73 40.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 159.48 -151.09 21.84 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 109.4 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.171 0.986 . . . . 0.0 110.426 175.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.454 HG22 ' O ' ' A' ' 80' ' ' GLY . 72.7 mt -99.47 123.9 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.135 174.82 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.6 t70 63.52 22.93 13.42 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.82 1.248 . . . . 0.0 110.079 -174.095 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.05 3.88 84.83 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.228 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -93.03 108.4 32.18 Favored Pre-proline 0 C--N 1.355 0.823 0 C-N-CA 123.453 0.701 . . . . 0.0 110.722 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.422 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 66.8 Cg_endo -72.26 128.36 13.69 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.476 2.117 . . . . 0.0 111.389 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -131.45 150.17 52.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.235 0.614 . . . . 0.0 109.88 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -139.39 125.83 20.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.033 0.533 . . . . 0.0 110.292 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -141.71 147.59 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.4 p -148.51 140.08 23.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.03 151.08 37.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.659 0.783 . . . . 0.0 109.931 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.54 131.6 51.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.861 0.865 . . . . 0.0 109.281 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.63 125.75 23.84 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -59.69 157.15 33.79 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.912 2.408 . . . . 0.0 111.382 172.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -44.8 -26.73 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.0 -28.64 62.49 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.779 . . . . 0.0 111.442 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.8 p -131.54 7.19 4.48 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.316 1.046 . . . . 0.0 111.11 -173.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.47 71.64 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.992 0.917 . . . . 0.0 111.401 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -70.91 -8.12 50.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.084 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -90.45 0.5 57.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.662 0.785 . . . . 0.0 110.05 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.471 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 6.4 p90 -52.94 -43.62 66.45 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -30.28 65.87 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.651 0.78 . . . . 0.0 112.604 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 t -73.03 -50.45 22.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 109.864 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.15 -45.5 63.41 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.87 0.468 . . . . 0.0 112.025 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.87 -38.93 11.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.717 0.807 . . . . 0.0 112.835 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -71.9 -38.28 69.97 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.62 0.368 . . . . 0.0 110.816 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -57.62 -48.53 79.18 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.912 0.885 . . . . 0.0 110.947 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.87 0.868 . . . . 0.0 110.358 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.72 -41.81 87.36 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.104 -172.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.445 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 13.8 pt20 -72.39 -36.11 68.61 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.243 0.617 . . . . 0.0 110.973 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -27.93 69.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.23 0.612 . . . . 0.0 111.336 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -98.09 7.36 46.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.824 0.45 . . . . 0.0 111.672 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.454 ' O ' HG22 ' A' ' 49' ' ' ILE . . . 102.12 93.0 2.21 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.062 0.226 . . . . 0.0 112.648 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.445 ' HB3' ' HA ' ' A' ' 77' ' ' GLN . 57.5 tp -143.02 146.08 33.52 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.371 0.585 . . . . 0.0 110.691 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.458 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 22.0 p-80 -122.49 82.7 47.11 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.378 1.071 . . . . 0.0 109.213 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.76 -27.47 14.84 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.233 2.622 . . . . 0.0 112.611 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -83.59 -49.98 8.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.424 0.69 . . . . 0.0 109.853 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.467 ' HE2' ' HG2' ' A' ' 20' ' ' GLN . 43.9 t80 -69.36 -17.93 63.74 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.116 -175.687 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.71 -31.37 71.18 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 120.156 -0.247 . . . . 0.0 113.283 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 64.08 16.52 10.03 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.516 1.127 . . . . 0.0 112.776 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 mm -75.59 110.28 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.8 p -71.48 -24.59 62.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.753 0.821 . . . . 0.0 111.248 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -82.38 155.92 24.46 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.931 0.892 . . . . 0.0 109.516 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.0 m 43.34 28.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 C-N-CA 125.406 1.483 . . . . 0.0 113.666 -175.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -88.23 -41.35 13.0 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.758 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -136.12 27.44 3.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.303 0.641 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -83.85 30.38 0.51 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.365 0.666 . . . . 0.0 111.931 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -53.62 -43.42 68.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.53 1.132 . . . . 0.0 110.138 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.37 -33.54 74.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.592 1.183 . . . . 0.0 112.959 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.09 -52.33 20.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.004 0.431 . . . . 0.0 110.839 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.471 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 1.1 mpt? -61.93 -34.18 75.62 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.787 173.819 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.4 -54.73 39.86 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.049 0.843 . . . . 0.0 110.203 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.95 -27.45 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.191 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.29 -58.55 6.22 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.394 0.616 . . . . 0.0 110.168 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.97 -38.22 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 114.526 -1.216 . . . . 0.0 113.179 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -34.57 78.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.291 0.95 . . . . 0.0 111.157 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.22 -46.8 48.19 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.212 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.429 ' HA ' ' HE2' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -57.68 -41.68 82.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.085 0.954 . . . . 0.0 111.926 174.618 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.71 -38.24 90.32 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.823 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -72.64 -31.21 64.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.439 0.296 . . . . 0.0 111.067 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 67.22 8.2 6.04 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.273 1.429 . . . . 0.0 114.036 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -142.24 151.44 58.43 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.657 0.783 . . . . 0.0 109.373 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.97 92.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.489 2.793 . . . . 0.0 113.197 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.56 29.28 0.56 Allowed Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.151 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.32 146.77 55.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.163 0.985 . . . . 0.0 110.812 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -88.36 -167.67 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.352 2.701 . . . . 0.0 111.87 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.37 144.77 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.322 0.649 . . . . 0.0 109.694 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.55 -4.95 59.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 113.345 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.24 -32.89 74.79 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.529 0.604 . . . . 0.0 111.35 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -85.43 -2.28 57.94 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.493 0.717 . . . . 0.0 110.982 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -86.16 -20.54 28.45 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.253 0.621 . . . . 0.0 110.709 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -81.19 -59.95 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.25 94.73 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -69.2 0.64 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -168.3 127.65 1.21 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.596 0.758 . . . . 0.0 110.111 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 20.52 -78.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 127.849 2.459 . . . . 0.0 115.967 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.64 29.55 0.36 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -171.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 C--O 1.252 1.197 0 C-N-CA 124.578 1.151 . . . . 0.0 109.461 179.728 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . 0.414 ' HA3' HG22 ' A' ' 13' ' ' VAL . . . 77.59 -81.79 1.22 Allowed Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.247 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -60.86 125.25 23.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.947 0.499 . . . . 0.0 110.793 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mtp -139.53 160.57 39.55 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.458 0.703 . . . . 0.0 110.122 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -149.08 131.1 15.31 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.334 1.054 . . . . 0.0 108.315 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.99 161.61 28.62 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.404 1.082 . . . . 0.0 109.236 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.77 100.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.747 2.298 . . . . 0.0 112.599 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.36 -6.87 32.13 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.775 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -158.86 151.92 22.37 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.207 1.004 . . . . 0.0 111.957 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.1 tt -146.75 149.27 33.07 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.607 1.563 . . . . 0.0 107.33 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -127.26 139.73 52.71 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.183 0.593 . . . . 0.0 110.452 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.561 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 96.9 mt -125.56 135.24 52.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.383 1.473 . . . . 0.0 108.14 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . 0.414 HG22 ' HA3' ' A' ' 2' ' ' GLY . 8.0 m -138.26 124.9 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.931 0.892 . . . . 0.0 110.691 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.446 ' HB3' HG13 ' A' ' 23' ' ' ILE . 17.5 p -37.22 115.28 0.38 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.618 165.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -129.68 161.59 58.34 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.222 1.009 . . . . 0.0 110.737 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -50.83 106.82 0.14 Allowed 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 123.917 3.078 . . . . 0.0 112.788 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.85 -37.01 0.67 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . 0.713 HD12 ' HA ' ' A' ' 83' ' ' PRO . 3.3 mm? -84.56 -83.99 0.15 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.049 0.94 . . . . 0.0 109.456 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 t70 176.76 177.78 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.261 1.824 . . . . 0.0 106.839 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -78.95 61.06 3.05 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.84 0.828 . . . . 0.0 111.099 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -112.56 145.57 40.09 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -94.87 87.8 5.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.615 0.366 . . . . 0.0 110.529 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.494 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.5 OUTLIER -106.76 128.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.448 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -137.12 131.4 32.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.561 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 71.1 mt -144.93 135.82 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -173.186 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -112.4 139.97 47.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -127.21 106.19 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -97.99 141.9 30.38 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -126.33 118.55 25.31 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.65 113.56 17.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.519 HG23 HG22 ' A' ' 41' ' ' VAL . 58.0 t -79.35 118.11 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.45 158.2 30.26 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -107.06 121.55 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.61 -0.681 . . . . 0.0 110.344 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.442 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 5.1 p30 -102.04 145.41 29.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.765 0.826 . . . . 0.0 108.858 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.29 -18.05 65.03 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.335 0.654 . . . . 0.0 112.57 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.442 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 28.5 tt0 -73.63 -47.09 42.7 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.743 0.817 . . . . 0.0 112.685 -173.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -134.91 -7.87 2.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.508 0.723 . . . . 0.0 111.594 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -123.39 7.76 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.25 128.81 37.38 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 117.062 0.431 . . . . 0.0 111.747 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -140.62 162.26 35.79 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.519 HG22 HG23 ' A' ' 31' ' ' VAL . 15.8 t -119.15 127.29 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.532 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 5.4 t-160 -84.76 108.34 17.4 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 166.467 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.439 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 89.6 m-85 -94.9 116.45 28.72 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -110.44 134.45 52.32 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.505 ' SD ' ' HA ' ' A' ' 72' ' ' ALA . 87.1 mtp -129.55 129.11 44.04 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 118.908 0.776 . . . . 0.0 110.531 175.488 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -149.99 153.53 36.71 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 0.0 109.763 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 171.37 -145.88 9.14 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.952 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.61 109.75 3.52 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.736 1.268 . . . . 0.0 112.088 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.528 HD11 ' HB3' ' A' ' 79' ' ' HIS . 50.3 mt -102.15 128.42 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.589 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . 0.579 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 38.7 t70 66.56 23.76 10.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.39 1.476 . . . . 0.0 108.618 -169.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 3.36 88.52 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.101 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.579 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 51.4 mtmt -97.77 110.18 54.22 Favored Pre-proline 0 C--O 1.245 0.826 0 C-N-CA 124.302 1.041 . . . . 0.0 110.843 -173.064 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 41.6 Cg_endo -63.67 143.56 87.26 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.889 2.393 . . . . 0.0 112.52 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.73 155.27 43.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.441 0.696 . . . . 0.0 109.724 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -148.83 131.21 15.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.324 0.65 . . . . 0.0 109.866 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.41 160.63 39.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.587 1.555 . . . . 0.0 109.168 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 m -148.91 138.51 21.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 109.811 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -136.77 132.86 35.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.532 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.6 mp0 -113.96 125.2 53.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . 0.439 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 75.3 mt -127.08 125.64 24.17 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -64.28 166.66 16.43 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.884 2.389 . . . . 0.0 112.164 176.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.49 ' HG3' HD11 ' A' ' 106' ' ' LEU . 74.2 ttt180 -47.62 -25.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.868 0.867 . . . . 0.0 112.923 174.107 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.83 -37.24 81.67 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.171 0.988 . . . . 0.0 112.678 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.2 p -129.39 4.97 5.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.422 0.689 . . . . 0.0 112.142 -170.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.76 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.186 0.994 . . . . 0.0 112.189 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -71.37 0.44 8.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.892 1.277 . . . . 0.0 113.975 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -93.3 -0.46 56.68 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.646 0.779 . . . . 0.0 110.999 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -54.35 -34.02 60.26 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.56 68.99 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.562 0.619 . . . . 0.0 112.582 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.8 m -73.54 -39.25 64.89 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.571 0.544 . . . . 0.0 109.99 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.15 -52.97 14.17 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.452 0.701 . . . . 0.0 111.271 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.505 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -48.98 -30.24 5.79 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.056 1.342 . . . . 0.0 113.106 172.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -81.66 -41.43 21.41 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.327 0.251 . . . . 0.0 110.665 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -63.73 -42.09 97.95 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.336 0.655 . . . . 0.0 111.612 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.21 -39.26 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.51 1.124 . . . . 0.0 110.401 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.92 83.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.003 0.921 . . . . 0.0 110.982 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.409 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 12.9 pt20 -78.85 -32.7 46.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.627 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -51.92 -48.11 64.34 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.77 1.228 . . . . 0.0 112.505 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.528 ' HB3' HD11 ' A' ' 49' ' ' ILE . 22.5 t60 -80.72 14.06 2.3 Favored 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.87 50.8 0.62 Allowed Glycine 0 C--N 1.349 1.265 0 O-C-N 122.051 -0.406 . . . . 0.0 112.865 170.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' HG ' ' HD3' ' A' ' 83' ' ' PRO . 65.5 tp -143.13 155.11 44.5 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.436 0.694 . . . . 0.0 109.716 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -158.13 82.13 2.87 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.713 ' HA ' HD12 ' A' ' 18' ' ' LEU . 94.8 Cg_endo -82.67 83.38 2.0 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.583 2.188 . . . . 0.0 111.883 -170.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.486 ' HB2' ' HZ3' ' A' ' 84' ' ' LYS . 10.5 mtmp? -75.61 -32.68 60.38 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.117 -179.59 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -84.02 -34.36 24.32 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.679 0.391 . . . . 0.0 110.271 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.11 -43.21 65.2 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.064 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.6 84.15 1.04 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.966 0.907 . . . . 0.0 110.071 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -35.78 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 122.861 0.464 . . . . 0.0 110.182 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.4 m -92.32 -9.12 43.09 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.434 0.694 . . . . 0.0 111.05 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? 74.08 -62.74 0.45 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.286 1.434 . . . . 0.0 110.416 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.8 p -74.76 104.38 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.503 0.668 . . . . 0.0 109.66 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.85 161.7 29.39 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.343 1.057 . . . . 0.0 110.512 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.512 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 22.7 pttp -66.7 177.59 1.56 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 169.105 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.512 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 6.6 pt-20 50.19 18.57 0.41 Allowed 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 124.795 1.238 . . . . 0.0 113.003 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -74.54 -31.86 62.27 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 124.532 1.133 . . . . 0.0 109.518 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.04 -30.33 71.29 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.766 0.827 . . . . 0.0 110.82 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.52 61.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.905 0.482 . . . . 0.0 110.532 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.2 ttt -62.17 -39.25 92.04 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.467 0.707 . . . . 0.0 111.353 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.51 -50.83 64.57 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.334 1.454 . . . . 0.0 110.106 174.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -65.61 -34.02 77.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.99 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.32 -50.2 64.41 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.11 0.564 . . . . 0.0 109.948 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.47 -39.94 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.727 0.811 . . . . 0.0 112.054 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -68.63 -30.7 69.48 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.96 0.41 . . . . 0.0 110.613 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.33 62.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.822 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.03 0.932 . . . . 0.0 112.43 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.49 HD11 ' HG3' ' A' ' 62' ' ' ARG . 26.6 mt -65.7 -27.17 68.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.977 0.911 . . . . 0.0 112.56 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -71.5 -16.85 62.36 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 66.67 28.39 9.13 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.843 1.257 . . . . 0.0 110.656 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -147.76 141.21 15.42 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.753 1.221 . . . . 0.0 108.647 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.14 93.06 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.774 2.316 . . . . 0.0 112.008 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.8 67.67 3.64 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.343 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.76 124.74 61.42 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.903 0.881 . . . . 0.0 110.342 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.97 168.33 23.61 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.952 2.435 . . . . 0.0 111.322 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.34 151.86 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.369 0.668 . . . . 0.0 109.578 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -117.54 69.19 0.77 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.72 -28.58 13.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.337 0.655 . . . . 0.0 110.825 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.69 -37.07 65.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -71.26 -14.18 62.15 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.077 0.551 . . . . 0.0 111.782 -171.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp -75.25 -53.28 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.591 0.756 . . . . 0.0 109.219 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.97 92.57 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.87 -49.63 2.09 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.937 -175.154 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -156.65 135.2 11.53 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.315 0.646 . . . . 0.0 110.516 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -101.3 -61.13 1.41 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.15 -160.04 9.56 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.737 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.254 1.319 0 C-N-CA 124.618 1.167 . . . . 0.0 110.682 -178.863 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.9 -65.87 0.27 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -135.81 105.26 6.05 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.0 ttp -119.61 108.88 15.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.313 0.645 . . . . 0.0 110.191 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -106.43 134.68 49.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 170.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.87 155.0 51.97 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.553 1.141 . . . . 0.0 108.601 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.69 108.97 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.643 2.229 . . . . 0.0 112.532 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.23 11.57 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.496 0.569 . . . . 0.0 113.354 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -148.28 141.95 25.55 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.632 0.73 . . . . 0.0 112.191 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.89 139.86 53.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.179 . . . . 0.0 108.347 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -128.56 117.5 21.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.558 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -120.6 110.05 15.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.837 0.855 . . . . 0.0 110.039 -179.11 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.25 171.1 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 168.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.8 t -93.55 128.87 39.88 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 171.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.96 143.45 87.82 Favored Pre-proline 0 CA--C 1.559 1.31 0 O-C-N 123.375 0.422 . . . . 0.0 111.305 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.22 -169.92 0.65 Allowed 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.99 2.46 . . . . 0.0 113.159 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.06 -63.29 0.33 Allowed Glycine 0 C--N 1.346 1.133 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -175.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.3 126.75 52.62 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.776 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.65 83.97 3.3 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -78.5 -76.4 0.19 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.147 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -154.45 148.25 25.48 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.97 59.08 4.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.503 0.721 . . . . 0.0 110.424 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.5 HG23 HG21 ' A' ' 49' ' ' ILE . 2.3 pp -89.9 121.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 173.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -150.65 116.58 5.57 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.558 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 25.8 mt -138.61 145.08 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.323 1.049 . . . . 0.0 108.181 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -132.44 127.14 34.68 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.537 HG12 ' HG2' ' A' ' 45' ' ' MET . 52.3 mt -109.74 123.44 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 108.675 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.44 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 14.0 mmm180 -109.54 117.89 35.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.863 0.865 . . . . 0.0 109.088 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -111.43 119.61 39.39 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -122.06 113.92 20.21 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.945 0.898 . . . . 0.0 109.346 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.69 121.72 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 122.701 0.4 . . . . 0.0 110.434 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -140.53 162.86 34.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.559 1.144 . . . . 0.0 108.102 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -111.19 117.56 33.56 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.832 0.453 . . . . 0.0 109.825 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.438 HD22 ' HB2' ' A' ' 37' ' ' SER . 0.1 OUTLIER -102.46 147.32 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.983 0.913 . . . . 0.0 109.93 172.046 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.24 -20.55 63.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.326 0.65 . . . . 0.0 111.692 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -70.15 -53.62 16.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.883 0.873 . . . . 0.0 111.626 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.438 ' HB2' HD22 ' A' ' 34' ' ' ASN . 13.9 m -119.21 0.88 11.28 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -170.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.3 -119.27 4.84 Favored Glycine 0 C--N 1.345 1.037 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.44 144.72 44.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.224 0.512 . . . . 0.0 110.473 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.443 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 p90 -158.36 169.88 23.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.5 0.5 . . . . 0.0 110.501 171.824 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.18 133.24 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -96.91 133.18 41.88 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -119.01 135.08 54.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.758 0.423 . . . . 0.0 110.036 -177.671 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.44 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 22.9 m-20 -115.85 139.47 50.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.45 1.1 . . . . 0.0 108.948 173.54 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.537 ' HG2' HG12 ' A' ' 27' ' ' ILE . 84.4 mtp -135.18 128.47 32.09 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 158.09 32.87 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.742 0.817 . . . . 0.0 109.046 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.92 -126.28 2.02 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -159.31 163.29 35.82 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.5 HG21 HG23 ' A' ' 23' ' ' ILE . 44.1 mt -157.32 107.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 -166.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.34 39.01 5.49 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.325 1.059 . . . . 0.0 108.493 -166.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.76 -17.96 2.54 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.27 123.03 69.3 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.011 0.905 . . . . 0.0 110.273 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.27 152.8 56.09 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.815 2.343 . . . . 0.0 113.437 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -144.67 146.68 32.36 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.75 0.82 . . . . 0.0 108.875 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -145.45 114.52 6.99 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.262 0.625 . . . . 0.0 109.421 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.53 160.23 38.08 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.079 1.352 . . . . 0.0 108.957 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 p -152.21 136.39 16.58 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.08 0.552 . . . . 0.0 110.01 172.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -136.56 141.48 43.34 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.162 0.985 . . . . 0.0 109.607 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -115.31 125.04 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.9 mt -115.06 125.56 28.81 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 123.389 0.676 . . . . 0.0 109.184 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.443 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 33.4 Cg_endo -60.79 156.52 42.8 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.888 2.392 . . . . 0.0 111.703 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -41.53 -44.85 3.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.919 1.288 . . . . 0.0 112.818 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.69 -25.4 66.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.749 1.22 . . . . 0.0 112.503 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.7 p -132.04 17.91 4.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.873 0.869 . . . . 0.0 110.728 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.34 -44.06 76.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.884 0.474 . . . . 0.0 111.453 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.26 -4.79 23.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.135 0.974 . . . . 0.0 112.674 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.51 4.6 15.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.88 0.872 . . . . 0.0 111.407 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -63.37 -19.47 64.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.432 1.093 . . . . 0.0 113.115 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.17 56.5 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.231 0.539 . . . . 0.0 109.926 -167.87 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -71.53 -39.07 70.97 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.366 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' HG21 ' A' ' 75' ' ' VAL . 21.6 t70 -74.6 -49.22 22.5 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.478 0.486 . . . . 0.0 111.375 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.94 83.05 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.513 0.725 . . . . 0.0 112.412 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 m -66.67 -43.39 84.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.649 0.38 . . . . 0.0 110.264 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.401 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.0 ttm180 -52.8 -38.63 61.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.133 0.973 . . . . 0.0 111.751 171.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG21 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -71.11 -38.88 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.346 0.658 . . . . 0.0 109.552 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.73 -49.64 51.21 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 -173.76 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -70.1 -24.36 63.2 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.863 -179.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.8 -30.0 69.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.353 0.661 . . . . 0.0 110.929 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.471 ' HB2' HD11 ' A' ' 49' ' ' ILE . 54.7 m80 -99.78 10.59 41.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.214 0.606 . . . . 0.0 110.85 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.59 43.9 5.37 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.935 174.247 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.7 tp -55.95 -54.33 46.01 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.292 0.568 . . . . 0.0 109.634 171.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 87' ' ' ALA . 17.6 m80 -156.43 153.75 25.63 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.717 1.607 . . . . 0.0 107.739 169.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.404 ' HB2' ' HD2' ' A' ' 85' ' ' PHE . 13.5 Cg_exo -70.51 -167.35 0.25 Allowed 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.991 2.461 . . . . 0.0 113.587 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -65.96 -7.6 17.79 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.326 1.051 . . . . 0.0 112.785 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . 0.404 ' HD2' ' HB2' ' A' ' 83' ' ' PRO . 92.7 m-85 -67.01 -25.57 66.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.743 0.817 . . . . 0.0 111.268 174.53 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 144.33 122.29 1.59 Allowed Glycine 0 C--N 1.351 1.362 0 CA-C-O 119.2 -0.778 . . . . 0.0 111.737 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.569 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . . . -64.53 -61.02 2.47 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.774 0.83 . . . . 0.0 110.302 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.5 pt -149.04 84.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.054 1.342 . . . . 0.0 107.967 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.8 m -74.71 -47.75 29.67 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.984 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -88.5 52.25 2.39 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.585 0.707 . . . . 0.0 109.571 172.232 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 p -70.01 132.49 33.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.368 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -77.0 139.57 40.12 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 51.41 1.84 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.627 0.727 . . . . 0.0 111.744 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -74.89 -8.89 57.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.842 0.857 . . . . 0.0 110.786 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -53.43 -41.22 65.83 Favored 'General case' 0 C--O 1.21 -1.017 0 C-N-CA 124.221 1.009 . . . . 0.0 111.004 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -57.91 -40.04 79.42 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.37 -45.58 54.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.419 0.288 . . . . 0.0 111.18 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.41 -34.05 76.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.537 0.735 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.49 -51.09 71.35 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.525 1.13 . . . . 0.0 109.824 172.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.485 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 34.1 mt-10 -69.52 -26.79 64.69 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.943 0.777 . . . . 0.0 111.429 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.435 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 14.3 t70 -70.98 -55.37 8.47 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.45 0.469 . . . . 0.0 109.803 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.19 -40.73 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.724 0.809 . . . . 0.0 112.056 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.485 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -63.01 -30.34 71.53 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.121 0.486 . . . . 0.0 110.521 177.106 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.405 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . . . -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.045 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.3 mmmt -59.24 -40.07 84.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.857 0.863 . . . . 0.0 112.009 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.71 -28.22 69.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.586 0.755 . . . . 0.0 111.917 174.348 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -77.64 -16.79 58.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.133 0.573 . . . . 0.0 111.146 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 84.96 -47.74 0.08 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 126.094 1.758 . . . . 0.0 110.413 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -95.88 107.53 34.85 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.405 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 94.4 Cg_endo -74.87 127.22 10.6 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.089 2.526 . . . . 0.0 113.943 -170.083 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.61 85.03 0.83 Allowed Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 169.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 128.11 90.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.562 0.745 . . . . 0.0 111.283 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.45 106.43 1.05 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.246 1.964 . . . . 0.0 112.206 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.26 148.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -124.67 18.09 8.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -171.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.47 -36.02 79.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.563 0.345 . . . . 0.0 111.565 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.61 -30.23 29.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.231 0.612 . . . . 0.0 110.666 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -66.16 -28.29 68.67 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.423 0.689 . . . . 0.0 111.336 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.76 -30.35 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.241 0.616 . . . . 0.0 109.998 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.7 mt -76.67 80.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.608 0.718 . . . . 0.0 109.609 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -119.99 94.66 4.46 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -66.02 126.85 29.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.585 0.354 . . . . 0.0 110.277 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -88.43 143.05 27.23 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.444 0.697 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.51 -50.87 0.02 OUTLIER Glycine 0 C--N 1.339 0.749 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.253 1.256 0 C-N-CA 123.646 0.779 . . . . 0.0 109.914 -175.9 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . 0.484 ' NE2' ' H1 ' ' A' ' 1' ' ' GLN . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.012 0.434 . . . . 0.0 110.01 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 163.71 20.13 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.242 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -98.27 22.91 8.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.819 0.447 . . . . 0.0 110.626 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' MET . . . . . 0.442 ' HA ' ' HE2' ' A' ' 4' ' ' MET . 5.1 tpt -98.62 174.64 6.33 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.984 0.914 . . . . 0.0 109.674 179.616 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -77.18 137.57 38.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.16 0.984 . . . . 0.0 109.391 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.78 153.48 70.44 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.309 1.044 . . . . 0.0 108.935 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.15 109.92 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.41 -8.4 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-O 120.25 -0.195 . . . . 0.0 112.666 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.568 ' HE2' ' HB3' ' A' ' 26' ' ' HIS . 11.3 t-160 -160.02 126.01 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.321 0.581 . . . . 0.0 110.437 -173.04 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 tp -100.95 145.63 28.41 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.49 1.116 . . . . 0.0 109.03 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . 0.459 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 2.6 t-160 -124.85 117.34 23.91 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 170.832 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.564 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 89.5 mt -89.91 110.04 21.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.7 t -126.37 149.82 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.513 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.9 t -77.73 160.46 28.41 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.55 139.72 6.07 Favored Pre-proline 0 CA--C 1.568 1.662 0 C-N-CA 124.641 1.176 . . . . 0.0 113.527 -176.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.61 -160.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.81 2.34 . . . . 0.0 112.104 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.45 -64.49 4.29 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.6 tp -122.78 122.52 38.89 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.289 1.036 . . . . 0.0 108.969 172.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.7 87.03 1.68 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.955 0.883 . . . . 0.0 109.13 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -78.02 -53.86 6.93 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.375 -170.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -147.41 147.67 30.5 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.82 55.12 3.24 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.014 0.912 . . . . 0.0 110.529 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 49' ' ' ILE . 2.2 pp -87.95 115.32 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.437 HD22 ' HG3' ' A' ' 48' ' ' GLU . 5.9 p30 -146.01 110.21 4.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.564 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.0 mt -130.01 141.21 46.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.613 -166.169 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.587 ' O ' ' HA ' ' A' ' 45' ' ' MET . 19.1 m170 -107.4 122.21 46.15 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.44 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -123.07 109.6 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.528 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 17.7 ttt180 -91.41 133.29 35.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -123.9 118.62 27.5 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.19 113.12 13.47 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.532 HG22 HG21 ' A' ' 41' ' ' VAL . 91.1 t -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.404 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 15.6 ttt180 -127.9 161.07 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.404 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.6 mm-40 -111.27 114.34 27.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -96.04 154.76 17.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.915 0.886 . . . . 0.0 110.503 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.32 -16.19 61.89 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.02 0.528 . . . . 0.0 111.952 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.08 -53.1 11.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.702 0.801 . . . . 0.0 111.981 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.8 t -126.55 -1.11 6.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.4 0.68 . . . . 0.0 112.461 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.57 -114.47 4.16 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 145.19 42.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.176 0.488 . . . . 0.0 110.817 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -153.27 171.91 17.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.437 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.532 HG21 HG22 ' A' ' 31' ' ' VAL . 7.1 t -124.32 128.02 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.477 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 8.5 t60 -84.48 123.4 30.22 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 94.0 m-85 -115.88 140.11 49.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.279 0.632 . . . . 0.0 109.47 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -143.41 137.9 28.98 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.346 172.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.587 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 83.7 mtp -123.17 136.91 54.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 111.114 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -163.47 162.77 24.85 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.125 0.57 . . . . 0.0 110.958 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.11 -130.47 3.73 Favored Glycine 0 N--CA 1.469 0.864 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.437 ' HG3' HD22 ' A' ' 24' ' ' ASN . 10.4 pt-20 -157.89 166.32 32.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.686 0.794 . . . . 0.0 110.08 173.173 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.521 HG22 HG22 ' A' ' 23' ' ' ILE . 97.3 mt -155.77 105.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -161.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 60.67 35.34 19.83 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.098 0.951 . . . . 0.0 108.739 -170.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.17 -22.26 8.73 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 114.563 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -77.84 113.75 35.43 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.891 0.877 . . . . 0.0 111.148 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.41 154.13 40.38 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.143 2.562 . . . . 0.0 113.122 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . 0.409 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 11.8 p90 -152.69 156.42 39.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.712 0.405 . . . . 0.0 111.282 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 p -153.11 124.52 7.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.858 0.863 . . . . 0.0 110.264 168.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -144.72 165.25 28.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.397 1.479 . . . . 0.0 108.524 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 p -153.2 142.06 21.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.723 0.409 . . . . 0.0 110.7 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -144.03 141.06 29.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.834 0.853 . . . . 0.0 110.154 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.477 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 44.6 mt-10 -125.55 125.38 43.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.23 132.54 24.19 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -171.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.78 160.86 34.86 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.646 2.231 . . . . 0.0 111.175 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -51.75 -28.4 15.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.03 -37.96 89.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.927 0.891 . . . . 0.0 112.161 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.7 p -126.72 12.84 7.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.098 0.559 . . . . 0.0 112.061 -171.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.46 76.48 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.201 0.6 . . . . 0.0 111.831 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -69.89 -11.49 60.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.384 1.074 . . . . 0.0 113.667 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -83.61 1.59 41.5 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.145 0.578 . . . . 0.0 111.73 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -54.89 -25.61 30.17 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.227 1.411 . . . . 0.0 113.937 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.22 -33.27 61.35 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -167.194 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 m -69.69 -38.24 76.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.473 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -72.09 -46.62 56.07 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.507 0.505 . . . . 0.0 110.027 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . 0.501 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -58.06 -50.81 72.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.56 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 m -69.15 -23.24 63.93 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 0.0 111.533 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.5 ttp-105 -74.46 -34.03 63.06 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.107 0.479 . . . . 0.0 110.465 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.77 -32.56 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 109.908 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.66 -54.35 7.11 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.043 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.428 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 21.2 mm-40 -62.49 -22.86 66.58 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.253 -1.339 . . . . 0.0 112.935 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -48.6 -36.45 15.7 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.209 0.604 . . . . 0.0 112.08 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -108.11 -31.27 8.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.738 0.245 . . . . 0.0 110.527 170.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.59 94.35 0.53 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 160.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.428 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 52.7 tp -77.15 72.59 3.71 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 110.109 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 49.61 49.94 8.28 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 125.051 1.34 . . . . 0.0 111.535 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.03 -14.08 21.17 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.291 2.661 . . . . 0.0 114.954 -160.008 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -73.08 -44.54 60.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -76.07 -36.48 58.97 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.741 0.816 . . . . 0.0 109.943 172.692 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.92 -117.53 8.13 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.346 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.77 32.11 2.73 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.019 0.928 . . . . 0.0 109.896 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.3 mm -77.15 84.83 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.548 0.689 . . . . 0.0 110.047 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 81.1 p -129.56 -24.03 2.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.224 1.01 . . . . 0.0 110.079 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 64.8 -72.48 0.07 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.828 1.651 . . . . 0.0 111.205 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.01 165.52 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.403 0.681 . . . . 0.0 109.677 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 m170 74.14 14.44 3.84 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.022 1.329 . . . . 0.0 111.433 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -80.42 79.56 7.0 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.477 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -91.45 33.43 1.0 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.319 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -61.56 -42.04 98.26 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.44 167.816 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.39 -33.7 76.11 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.008 0.817 . . . . 0.0 110.728 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.55 61.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.937 0.495 . . . . 0.0 110.961 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.6 ttm -68.04 -34.39 76.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.372 0.669 . . . . 0.0 111.459 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -55.26 -47.27 75.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.311 1.045 . . . . 0.0 110.044 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.3 -25.57 60.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.0 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.4 -60.85 2.67 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.423 HG21 HD23 ' A' ' 106' ' ' LEU . 72.6 mt -54.75 -40.99 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.084 0.954 . . . . 0.0 111.729 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -31.39 72.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 123.207 0.317 . . . . 0.0 111.61 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.08 -51.65 56.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.394 0.677 . . . . 0.0 111.535 -176.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -28.19 62.41 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.973 0.509 . . . . 0.0 110.542 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.423 HD23 HG21 ' A' ' 102' ' ' ILE . 6.0 mp -71.77 -28.76 63.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.572 0.349 . . . . 0.0 110.447 175.126 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -81.51 -17.06 49.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.252 1.021 . . . . 0.0 109.643 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 69.42 18.99 7.77 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -137.42 145.41 49.36 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.597 0.759 . . . . 0.0 109.839 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -58.96 139.1 89.37 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.261 2.641 . . . . 0.0 112.876 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.12 50.2 0.03 OUTLIER Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.58 159.99 69.37 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.257 1.023 . . . . 0.0 110.319 -172.079 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.62 124.99 15.15 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.674 2.249 . . . . 0.0 111.414 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.89 131.16 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 122.961 0.504 . . . . 0.0 109.902 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -94.88 3.05 55.42 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 118.439 -0.791 . . . . 0.0 113.009 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -53.11 -34.88 58.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.762 0.664 . . . . 0.0 111.416 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.54 87.34 2.34 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 166.223 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -133.39 29.62 3.94 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.9 mm -106.74 -53.39 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.296 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.9 mm -87.97 74.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -110.8 179.61 4.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.342 1.057 . . . . 0.0 109.699 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -144.95 129.83 18.28 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.666 0.786 . . . . 0.0 109.209 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -112.49 -52.8 2.76 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.025 0.53 . . . . 0.0 110.274 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -101.22 53.15 0.86 Allowed Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.801 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 123.352 0.661 . . . . 0.0 109.742 179.674 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.86 -56.31 3.72 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.719 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -76.2 76.85 3.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.634 0.774 . . . . 0.0 110.015 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtp -90.65 104.89 17.43 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.911 0.884 . . . . 0.0 110.517 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -96.75 138.65 33.99 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.461 0.704 . . . . 0.0 110.063 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.85 157.14 34.5 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.486 1.114 . . . . 0.0 108.356 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.71 102.78 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.919 1.746 . . . . 0.0 111.651 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.34 -8.62 24.61 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.338 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -157.8 151.66 24.09 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.529 0.664 . . . . 0.0 111.898 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.713 HD22 ' HE1' ' A' ' 98' ' ' MET . 59.7 tp -140.51 142.27 35.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.596 1.558 . . . . 0.0 108.382 176.385 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -111.7 138.25 48.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.587 0.755 . . . . 0.0 109.265 173.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.554 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 75.3 mt -118.53 126.65 52.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.076 0.95 . . . . 0.0 109.145 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.8 t -120.27 167.34 13.78 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 164.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.561 ' HB2' ' HB3' ' A' ' 20' ' ' GLN . 31.8 p -79.89 161.19 25.71 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 119.547 1.067 . . . . 0.0 109.501 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -49.47 135.45 17.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 O-C-N 124.15 0.907 . . . . 0.0 112.655 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -55.73 126.01 21.01 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.981 3.121 . . . . 0.0 113.287 -164.941 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.24 -19.97 11.54 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.466 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt 62.53 46.28 5.71 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.963 1.305 . . . . 0.0 111.528 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.52 -37.95 88.24 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.721 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 14' ' ' SER . 36.0 tp60 -74.75 170.59 15.56 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.489 1.116 . . . . 0.0 108.344 170.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -73.18 -176.83 2.28 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.201 0.455 . . . . 0.0 111.234 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.73 84.68 6.76 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 -171.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.46 HG23 HG21 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -106.97 145.71 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.432 -175.379 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -151.74 138.13 18.53 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.17 166.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.554 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 53.5 mt -142.64 136.49 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.4 m170 -107.34 136.19 47.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.7 mt -130.44 108.47 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.408 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 26.2 mtp180 -92.97 134.63 34.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.401 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -129.38 117.11 20.06 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -132.74 117.14 17.45 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.55 0.74 . . . . 0.0 109.438 -171.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 41' ' ' VAL . 48.0 t -80.03 115.67 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.435 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 24.5 ttt180 -120.98 162.4 19.97 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.435 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.3 mm-40 -106.55 124.85 50.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.054 -0.404 . . . . 0.0 110.277 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -94.98 144.25 25.83 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -12.84 61.87 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.467 0.707 . . . . 0.0 112.089 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -79.62 -49.91 11.45 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.006 0.922 . . . . 0.0 112.488 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t -128.8 -4.8 5.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.759 0.823 . . . . 0.0 111.543 -169.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.57 -118.34 5.55 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.96 138.01 47.72 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.049 0.54 . . . . 0.0 112.335 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.92 171.13 18.79 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.176 0.99 . . . . 0.0 109.083 170.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 31' ' ' VAL . 30.5 t -120.77 127.68 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 122.892 0.477 . . . . 0.0 110.169 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.41 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.6 t60 -88.93 108.67 19.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.53 135.39 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.408 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 24.7 t70 -125.82 136.05 52.68 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.384 1.073 . . . . 0.0 108.545 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.447 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 87.0 mtp -136.32 131.19 34.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.463 0.574 . . . . 0.0 110.496 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -155.62 162.2 40.67 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 122.772 0.429 . . . . 0.0 111.523 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.09 -151.07 21.94 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.66 111.07 4.7 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.122 0.961 . . . . 0.0 111.172 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.46 HG21 HG23 ' A' ' 23' ' ' ILE . 74.2 mt -97.61 125.47 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.605 177.474 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 63.24 25.57 14.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.11 1.364 . . . . 0.0 109.687 -170.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.2 4.35 90.5 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.294 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -94.59 110.44 49.11 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.899 0.88 . . . . 0.0 111.724 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.37 140.82 45.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.829 2.353 . . . . 0.0 112.209 -175.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.4 145.63 35.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.143 0.577 . . . . 0.0 109.958 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 p -140.56 115.15 9.47 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.93 152.45 39.44 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -174.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -147.57 155.9 42.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.136 0.575 . . . . 0.0 111.189 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.92 147.35 31.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.914 0.886 . . . . 0.0 109.88 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . 0.41 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 41.2 mt-10 -124.89 128.09 48.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.924 0.889 . . . . 0.0 109.273 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.58 123.87 21.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 123.913 0.885 . . . . 0.0 109.326 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.52 164.57 20.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.782 2.321 . . . . 0.0 112.199 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.679 ' HG3' ' HB3' ' A' ' 106' ' ' LEU . 37.6 ttt180 -44.66 -33.72 1.94 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.776 1.23 . . . . 0.0 113.773 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.31 -36.68 71.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.418 0.687 . . . . 0.0 111.569 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -118.53 9.65 12.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.465 0.706 . . . . 0.0 110.853 -170.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.48 -29.06 65.93 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.675 0.79 . . . . 0.0 111.235 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.11 -8.69 55.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.283 1.433 . . . . 0.0 113.294 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -90.69 8.03 36.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.113 0.965 . . . . 0.0 110.764 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -51.34 -45.4 62.29 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.34 71.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 m -65.98 -50.32 64.72 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.377 0.535 . . . . 0.0 110.336 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 12.5 m-20 -70.94 -48.93 50.75 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.425 -179.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.9 -51.01 56.1 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.171 0.988 . . . . 0.0 112.066 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.0 m -59.86 -43.56 94.62 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.456 0.703 . . . . 0.0 111.34 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.4 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 33.6 ttm180 -58.87 -48.48 81.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.892 0.877 . . . . 0.0 110.49 -176.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 63.6 t -62.66 -35.0 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.664 0.786 . . . . 0.0 110.429 -179.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.01 -53.41 14.89 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 110.704 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.506 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 14.0 pt20 -71.2 -34.29 70.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.778 -171.921 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.4 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 50.6 mtmt -60.86 -32.58 72.0 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.553 0.533 . . . . 0.0 110.759 173.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -92.58 15.47 14.2 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.15 0.58 . . . . 0.0 111.676 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.15 62.95 0.84 Allowed Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.506 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 3.5 mm? -123.79 -21.17 5.23 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 162.656 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 67.59 165.2 0.12 Allowed Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 124.607 1.163 . . . . 0.0 109.27 -164.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -47.41 102.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 122.354 2.036 . . . . 0.0 112.473 172.595 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -16.21 63.21 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.978 -175.637 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -81.45 -30.84 33.3 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.092 0.557 . . . . 0.0 109.6 173.407 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.86 -29.05 71.21 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.248 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.56 84.05 2.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.017 0.927 . . . . 0.0 108.613 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.7 pt -63.36 162.71 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.014 0.926 . . . . 0.0 113.175 -171.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.7 p -62.52 -44.13 97.12 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.199 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 74.82 -38.6 0.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.101 1.76 . . . . 0.0 111.311 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.23 -170.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.848 1.259 . . . . 0.0 111.768 167.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -54.88 140.64 36.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.246 0.618 . . . . 0.0 111.069 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -122.8 126.25 47.06 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.973 0.909 . . . . 0.0 108.869 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -107.74 21.5 17.34 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.443 0.697 . . . . 0.0 111.334 -171.531 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -62.03 -54.29 43.55 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-N 117.802 0.274 . . . . 0.0 110.625 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.934 0.771 . . . . 0.0 111.932 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.86 -49.77 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.713 ' HE1' HD22 ' A' ' 10' ' ' LEU . 48.3 ttm -64.2 -35.15 79.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 111.243 174.962 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -61.32 -51.41 68.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.498 1.119 . . . . 0.0 110.422 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.94 -28.67 67.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 37.6 t70 -71.67 -47.7 52.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . 0.474 ' O ' HD21 ' A' ' 106' ' ' LEU . 42.0 mt -58.74 -44.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.809 0.843 . . . . 0.0 111.563 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -62.89 -28.78 70.27 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.523 ' HB2' ' HD1' ' A' ' 109' ' ' HIS . . . -72.93 -52.36 14.92 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.814 0.846 . . . . 0.0 111.911 175.853 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.504 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.0 mmmt -58.86 -42.59 89.76 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.21 1.004 . . . . 0.0 112.43 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.679 ' HB3' ' HG3' ' A' ' 62' ' ' ARG . 4.4 mm? -71.52 -22.22 61.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.604 0.761 . . . . 0.0 112.067 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -75.23 -24.61 57.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.689 0.396 . . . . 0.0 110.474 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.61 91.26 0.08 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.701 1.6 . . . . 0.0 110.624 -174.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . 0.523 ' HD1' ' HB2' ' A' ' 104' ' ' ALA . 28.3 m170 -112.53 163.47 17.75 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 124.958 1.303 . . . . 0.0 109.593 172.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.16 76.16 0.92 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.406 2.071 . . . . 0.0 111.986 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.81 -80.07 1.37 Allowed Glycine 0 C--N 1.345 1.067 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.494 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.57 148.93 70.72 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -171.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -56.35 164.41 5.39 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.843 3.029 . . . . 0.0 114.123 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.53 122.48 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-O 121.459 0.647 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.53 27.83 1.06 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.832 0.853 . . . . 0.0 112.406 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.03 -30.22 71.18 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.471 0.308 . . . . 0.0 110.657 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.63 9.23 40.99 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.897 0.879 . . . . 0.0 111.929 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -76.43 -9.3 58.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.313 0.578 . . . . 0.0 111.412 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.76 -39.71 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.26 1.024 . . . . 0.0 109.681 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.1 mt -112.12 89.08 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -121.08 -172.15 2.34 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -124.53 128.13 48.48 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -34.27 41.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.202 1.001 . . . . 0.0 112.409 -172.944 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.59 122.59 7.44 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.493 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 119.911 -0.09 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.32 -87.28 0.7 Allowed Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.133 0.397 . . . . 0.0 113.997 172.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -153.62 165.94 34.33 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.975 0.91 . . . . 0.0 110.289 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.0 ttp -162.17 108.72 1.3 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.207 0.603 . . . . 0.0 109.523 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -105.46 141.51 36.82 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.087 0.555 . . . . 0.0 111.747 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.38 154.69 73.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 125.335 1.454 . . . . 0.0 107.894 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.82 99.45 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.284 1.99 . . . . 0.0 111.917 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.43 -18.49 6.84 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.542 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.539 ' NE2' ' HB3' ' A' ' 26' ' ' HIS . 20.8 t-80 -158.27 151.25 22.67 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.246 0.523 . . . . 0.0 111.793 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.522 HD23 HD13 ' A' ' 27' ' ' ILE . 54.4 tp -134.61 150.04 50.65 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.001 1.32 . . . . 0.0 108.509 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -124.15 139.67 53.71 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.534 0.734 . . . . 0.0 109.24 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.492 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.48 128.01 48.33 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 p -149.74 92.49 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-O 122.728 1.251 . . . . 0.0 112.526 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.478 ' OG ' ' HD3' ' A' ' 84' ' ' LYS . 38.8 t -73.63 106.46 5.4 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.166 163.234 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.61 138.3 70.51 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.165 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -86.62 -94.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 122.578 2.185 . . . . 0.0 112.156 170.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.94 -105.38 1.61 Allowed Glycine 0 C--N 1.36 1.882 0 CA-C-N 118.57 0.623 . . . . 0.0 112.359 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.19 -26.23 47.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.448 0.699 . . . . 0.0 109.912 173.165 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -84.51 163.66 19.27 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.912 0.885 . . . . 0.0 108.985 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -99.11 -36.86 9.55 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 122.904 0.481 . . . . 0.0 111.713 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.439 HE21 HG21 ' A' ' 23' ' ' ILE . 55.9 tp60 -77.0 107.69 9.52 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.748 1.261 . . . . 0.0 112.833 -170.16 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.49 113.33 26.02 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.886 173.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.439 HG21 HE21 ' A' ' 21' ' ' GLN . 0.6 OUTLIER -120.38 132.3 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.778 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -139.82 119.63 13.38 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.492 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.2 mt -143.66 151.52 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -170.335 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.539 ' HB3' ' NE2' ' A' ' 9' ' ' HIS . 15.1 m170 -126.61 146.53 50.13 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.522 HD13 HD23 ' A' ' 10' ' ' LEU . 60.2 mt -125.77 106.44 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -97.33 132.61 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.02 125.24 26.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -127.32 115.55 19.17 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.437 HG21 HG23 ' A' ' 41' ' ' VAL . 47.0 t -86.93 115.21 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.412 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 51.1 ttt85 -125.17 163.64 22.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.412 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.7 mm-40 -112.87 112.55 24.1 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.436 HD22 ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -95.42 144.34 26.02 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.343 0.657 . . . . 0.0 109.511 171.442 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -19.09 65.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.121 0.569 . . . . 0.0 111.432 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.81 -52.15 40.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.749 1.22 . . . . 0.0 112.091 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . 0.436 ' HB3' HD22 ' A' ' 34' ' ' ASN . 32.6 t -123.4 -14.52 7.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -172.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -125.97 8.69 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.67 134.53 50.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.817 0.447 . . . . 0.0 110.773 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.1 170.82 19.0 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.553 0.741 . . . . 0.0 109.21 170.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.437 HG23 HG21 ' A' ' 31' ' ' VAL . 4.8 t -127.69 121.9 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -89.52 121.34 31.64 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -107.39 137.93 44.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.402 0.681 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -126.9 123.3 36.92 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtp -118.88 130.03 55.52 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.279 0.491 . . . . 0.0 110.391 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.92 159.84 43.0 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 0.0 110.713 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.4 -147.11 12.49 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.424 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 0.8 OUTLIER -148.45 108.29 4.03 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.303 1.051 . . . . 0.0 111.653 172.666 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.59 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.22 16.67 9.37 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 124.545 1.153 . . . . 0.0 110.5 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.36 -15.22 59.08 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.088 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 95.6 mttt -83.28 109.93 20.76 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.816 0.847 . . . . 0.0 112.748 -173.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.2 138.67 33.77 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.324 2.016 . . . . 0.0 110.601 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -145.47 155.7 43.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.524 0.33 . . . . 0.0 110.824 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 p -150.56 130.06 13.01 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.978 0.911 . . . . 0.0 108.969 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -144.91 157.29 44.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -176.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 m -143.62 142.14 30.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.917 0.487 . . . . 0.0 110.969 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -141.11 146.58 37.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.882 0.873 . . . . 0.0 109.077 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.22 129.81 49.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.87 122.0 24.41 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.48 163.95 25.17 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.767 2.312 . . . . 0.0 111.089 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.474 ' HG3' HD13 ' A' ' 106' ' ' LEU . 61.7 ttt180 -48.6 -30.62 5.56 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.761 0.825 . . . . 0.0 111.568 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.77 -40.52 80.0 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.766 1.226 . . . . 0.0 112.726 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 p -128.36 14.23 6.62 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.594 0.758 . . . . 0.0 111.87 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . 0.407 ' O ' ' HB3' ' A' ' 68' ' ' PHE . . . -63.74 -29.38 70.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.541 0.737 . . . . 0.0 111.66 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . 0.633 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 71.6 m-85 -70.77 -1.13 10.53 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -96.53 5.42 50.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.958 0.903 . . . . 0.0 110.269 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.407 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 25.7 p90 -53.72 -49.66 67.64 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.632 1.173 . . . . 0.0 112.474 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.04 -29.8 60.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.591 0.756 . . . . 0.0 111.087 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -71.35 -45.34 63.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.003 0.814 . . . . 0.0 109.209 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.26 -41.01 64.16 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.878 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.55 56.33 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.504 0.722 . . . . 0.0 112.42 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' THR . . . . . 0.425 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 95.2 m -71.18 -43.24 67.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.708 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . 0.439 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 44.7 ttt180 -55.66 -53.21 59.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.515 1.126 . . . . 0.0 111.734 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 8.5 p -69.78 -32.17 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.489 0.716 . . . . 0.0 111.381 -178.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.04 82.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.415 0.626 . . . . 0.0 110.429 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . 0.776 ' HA ' HD23 ' A' ' 81' ' ' LEU . 96.3 mt-30 -76.32 -40.09 52.33 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.387 -1.278 . . . . 0.0 112.361 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . 0.439 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.7 mtpp -53.18 -35.63 60.04 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.024 0.93 . . . . 0.0 112.45 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -79.6 25.07 0.35 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.48 59.45 10.82 Favored Glycine 0 C--N 1.363 2.079 0 C-N-CA 123.275 0.464 . . . . 0.0 114.141 174.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.776 HD23 ' HA ' ' A' ' 77' ' ' GLN . 1.2 pt? -76.72 -29.14 56.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.658 -174.226 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.439 ' N ' HD22 ' A' ' 81' ' ' LEU . 19.3 t-160 55.88 93.63 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 123.876 0.87 . . . . 0.0 109.587 -172.195 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.12 89.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.195 2.597 . . . . 0.0 113.079 -171.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . 0.478 ' HD3' ' OG ' ' A' ' 14' ' ' SER . 83.0 tttt -73.77 -37.82 64.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.777 175.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -64.8 -18.34 65.01 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.018 0.927 . . . . 0.0 111.322 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.24 -113.5 4.71 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.32 79.47 0.45 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.866 0.867 . . . . 0.0 108.928 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 mm -90.89 95.15 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 81.7 p -83.95 -3.06 57.69 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.357 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -78.28 -39.71 39.14 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.479 1.112 . . . . 0.0 110.676 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.47 171.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.665 0.786 . . . . 0.0 111.659 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -77.4 85.4 3.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.202 0.525 . . . . 0.0 110.144 173.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.677 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -59.46 127.76 33.65 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.152 168.486 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.01 28.41 0.91 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.892 0.877 . . . . 0.0 112.296 -170.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -66.43 -56.09 12.63 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.97 -39.1 73.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.21 1.004 . . . . 0.0 112.085 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.29 -50.53 67.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.737 0.415 . . . . 0.0 110.813 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.477 ' HE3' HD21 ' A' ' 10' ' ' LEU . 37.1 ttm -70.76 -31.28 68.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.617 178.641 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.73 -56.11 18.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.431 ' HB3' ' HD3' ' A' ' 113' ' ' PRO . 6.0 mm-40 -69.82 -28.28 65.58 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.658 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.23 -49.35 61.3 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.93 -42.77 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.441 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . 0.633 ' HB3' ' HE1' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -65.94 -31.18 71.95 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.464 0.575 . . . . 0.0 111.563 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.91 84.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.528 ' HA ' ' HE3' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.66 -28.77 62.93 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.845 0.858 . . . . 0.0 112.805 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . 0.474 HD13 ' HG3' ' A' ' 62' ' ' ARG . 89.3 mt -63.98 -34.11 77.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.392 0.677 . . . . 0.0 110.572 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -68.69 -17.95 64.17 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.607 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 81.35 -60.08 0.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 126.379 1.871 . . . . 0.0 109.583 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -76.74 130.76 75.36 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 166.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.55 91.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.248 2.632 . . . . 0.0 114.118 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.27 70.07 2.9 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.72 159.38 83.32 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.241 1.016 . . . . 0.0 112.604 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 26.5 Cg_endo -59.13 96.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.237 2.625 . . . . 0.0 113.706 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -167.74 136.58 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.708 0.803 . . . . 0.0 109.75 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -127.5 41.83 3.44 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.075 0.95 . . . . 0.0 110.157 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.38 -35.61 77.96 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.726 0.81 . . . . 0.0 112.042 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.45 -6.43 52.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.862 0.865 . . . . 0.0 111.504 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -77.4 5.01 9.56 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 122.156 -0.34 . . . . 0.0 111.817 -174.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.6 mm -77.19 -64.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.396 0.679 . . . . 0.0 110.062 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.3 mt -108.74 105.82 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.906 0.882 . . . . 0.0 108.83 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 -128.4 74.46 1.56 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.66 0.784 . . . . 0.0 109.6 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -78.47 127.83 32.72 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.305 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -77.31 130.8 37.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.115 0.566 . . . . 0.0 109.524 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.72 -49.68 47.75 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.754 0.659 . . . . 0.0 112.888 -176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 C--O 1.249 1.043 0 C-N-CA 123.436 0.694 . . . . 0.0 110.112 -179.812 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.9 -134.81 16.73 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.367 -0.379 . . . . 0.0 112.762 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -81.02 115.32 20.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.4 mtm -142.62 145.63 33.69 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.351 0.66 . . . . 0.0 110.427 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -107.75 146.18 32.5 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.278 0.631 . . . . 0.0 109.979 171.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.04 152.33 23.41 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.342 1.057 . . . . 0.0 109.376 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.07 96.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.862 2.375 . . . . 0.0 112.749 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.57 -22.11 5.28 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.961 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' HIS . . . . . 0.417 ' HE2' ' HB3' ' A' ' 26' ' ' HIS . 54.5 t-80 -155.26 151.6 28.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -172.168 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.466 HD21 ' SD ' ' A' ' 98' ' ' MET . 55.4 tp -135.88 131.47 35.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.747 1.619 . . . . 0.0 107.411 176.204 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -113.82 139.96 48.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.554 0.741 . . . . 0.0 110.452 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 30.3 mt -134.15 124.72 26.54 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.02 155.77 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 120.192 1.36 . . . . 0.0 114.325 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' SER . . . . . 0.414 ' HB2' ' H ' ' A' ' 23' ' ' ILE . 22.8 t -61.63 102.85 0.28 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 112.235 -2.257 . . . . 0.0 106.947 164.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . 0.411 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 3.7 pp -115.73 168.82 7.76 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 124.329 1.052 . . . . 0.0 110.254 -165.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 15' ' ' LEU . 35.2 Cg_endo -60.19 91.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.635 2.223 . . . . 0.0 111.726 174.852 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 142.6 -40.24 1.28 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.516 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.0 tp -106.1 95.0 5.47 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.164 0.985 . . . . 0.0 109.276 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -127.9 6.85 6.08 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.184 0.993 . . . . 0.0 110.766 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -56.0 -46.65 78.68 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.184 0.593 . . . . 0.0 110.127 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . 0.431 ' HG3' HG23 ' A' ' 23' ' ' ILE . 20.1 pt20 -135.56 155.75 49.97 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 122.914 0.486 . . . . 0.0 110.257 173.912 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.52 100.94 7.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ILE . . . . . 0.431 HG23 ' HG3' ' A' ' 21' ' ' GLN . 19.2 pt -117.0 145.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.22 0.534 . . . . 0.0 109.954 169.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . 0.478 HD22 ' HG2' ' A' ' 48' ' ' GLU . 4.4 p30 -152.92 125.94 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 163.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ILE . . . . . 0.525 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.7 mt -139.32 116.3 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' HIS . . . . . 0.453 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.5 m170 -104.25 122.69 45.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ILE . . . . . 0.499 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 57.3 mt -114.88 105.34 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.422 ' HB3' ' O ' ' A' ' 44' ' ' ASP . 67.2 ttt180 -97.89 140.4 32.3 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.729 1.212 . . . . 0.0 108.478 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.41 136.38 36.21 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -131.52 116.04 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.375 1.07 . . . . 0.0 108.419 -172.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' VAL . . . . . 0.487 HG23 ' HB3' ' A' ' 105' ' ' LYS . 72.8 t -87.01 123.66 40.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ARG . . . . . 0.47 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 19.2 ttt180 -153.14 169.25 23.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.476 1.111 . . . . 0.0 108.759 -170.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLN . . . . . 0.47 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 23.2 mm-40 -106.68 127.0 53.0 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.32 0.648 . . . . 0.0 110.225 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.449 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 3.1 p30 -102.96 147.69 26.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.35 1.06 . . . . 0.0 108.896 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.16 -20.23 62.32 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' GLU . . . . . 0.449 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 10.6 tp10 -71.09 -48.18 53.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.9 0.88 . . . . 0.0 111.677 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.5 m -131.47 -6.91 3.73 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.492 0.717 . . . . 0.0 112.905 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.94 -124.17 8.08 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -68.5 137.14 54.16 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.403 0.602 . . . . 0.0 111.286 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -155.91 178.37 10.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.492 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . 0.407 HG23 HG22 ' A' ' 31' ' ' VAL . 20.2 t -133.44 127.85 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.778 0.831 . . . . 0.0 109.397 173.089 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -89.31 121.43 31.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.831 0.852 . . . . 0.0 108.912 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -102.8 133.22 48.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 108.913 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ASP . . . . . 0.422 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 27.1 t70 -133.48 114.15 13.3 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.023 0.929 . . . . 0.0 109.883 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.499 ' HG2' ' HA ' ' A' ' 27' ' ' ILE . 43.4 mtm -119.86 145.43 46.68 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.736 -0.603 . . . . 0.0 111.451 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -156.93 157.9 35.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.146 0.578 . . . . 0.0 111.24 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.85 -156.05 27.48 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.478 ' HG2' HD22 ' A' ' 24' ' ' ASN . 12.5 pt-20 -148.28 115.19 6.08 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.845 1.322 . . . . 0.0 111.411 173.289 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.503 HD13 ' HB2' ' A' ' 79' ' ' HIS . 50.5 mt -97.74 130.69 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.212 176.809 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.33 -69.88 0.1 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.159 1.783 . . . . 0.0 110.617 -168.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.27 47.21 0.11 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.597 -2.201 . . . . 0.0 107.597 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -137.07 104.29 8.82 Favored Pre-proline 0 C--N 1.35 0.592 0 CA-C-N 114.261 -0.97 . . . . 0.0 108.91 -172.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 136.75 33.83 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.381 2.054 . . . . 0.0 110.834 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -135.35 138.02 42.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.2 p -134.14 118.22 17.44 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -132.74 139.73 47.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.276 1.03 . . . . 0.0 109.385 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.7 p -140.54 124.0 16.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -136.55 142.1 43.4 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.814 0.846 . . . . 0.0 108.782 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -121.33 130.58 53.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.423 0.689 . . . . 0.0 109.772 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.29 130.32 23.57 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.79 155.64 36.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.716 2.277 . . . . 0.0 111.187 171.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 32.3 ptt180 -41.85 -26.08 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -85.53 -13.61 48.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.753 0.821 . . . . 0.0 111.621 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.0 p -132.49 -2.4 3.43 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.404 1.082 . . . . 0.0 111.222 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.94 -36.71 72.92 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.552 1.141 . . . . 0.0 111.988 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.88 -9.43 54.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.374 1.07 . . . . 0.0 112.761 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -91.73 -7.57 49.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.315 0.646 . . . . 0.0 110.514 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PHE . . . . . 0.515 ' HZ ' ' SD ' ' A' ' 98' ' ' MET . 4.0 p90 -54.12 -35.78 62.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.602 0.761 . . . . 0.0 112.769 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.43 -26.56 20.49 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -72.49 -52.66 14.81 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.4 ' O ' HG22 ' A' ' 75' ' ' VAL . 38.9 t0 -73.14 -54.28 8.88 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.472 0.709 . . . . 0.0 112.799 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.03 -38.43 4.83 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.3 1.04 . . . . 0.0 113.041 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.9 m -77.27 -37.69 52.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.462 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.7 -47.98 81.27 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.946 0.898 . . . . 0.0 111.402 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' VAL . . . . . 0.426 ' HB ' ' HE1' ' A' ' 45' ' ' MET . 41.5 t -61.25 -39.5 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.079 0.952 . . . . 0.0 110.264 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' HB2' HD12 ' A' ' 25' ' ' ILE . . . -66.67 -44.7 81.14 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.857 0.863 . . . . 0.0 110.953 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 5.3 pp0? -76.59 -26.85 55.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -175.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -59.77 -45.9 90.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.342 0.657 . . . . 0.0 111.968 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' HIS . . . . . 0.503 ' HB2' HD13 ' A' ' 49' ' ' ILE . 56.3 m80 -74.34 -30.35 61.98 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.42 80.34 0.04 OUTLIER Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 158.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 38.9 tp -139.26 153.31 47.78 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.574 ' H ' ' HD2' ' A' ' 83' ' ' PRO . 44.4 t-80 -167.64 -57.54 0.01 OUTLIER Pre-proline 0 CA--C 1.563 1.465 0 CA-C-O 117.504 -1.236 . . . . 0.0 110.261 175.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.574 ' HD2' ' H ' ' A' ' 82' ' ' HIS . 30.8 Cg_exo -3.8 -122.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.412 3.88 1 C-N-CA 127.229 5.286 . . . . 0.0 118.101 -166.367 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -83.0 -7.13 59.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.383 0.673 . . . . 0.0 111.962 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -76.68 -54.32 6.81 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.852 0.461 . . . . 0.0 110.212 -175.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 44.16 -121.96 4.15 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 124.422 1.076 . . . . 0.0 114.284 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -119.83 160.36 22.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.036 0.934 . . . . 0.0 109.847 176.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.2 pt -67.45 -23.74 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.734 0.814 . . . . 0.0 111.438 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.0 p -78.51 -33.98 47.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.866 0.866 . . . . 0.0 110.994 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -70.27 -59.68 2.73 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.953 0.501 . . . . 0.0 109.903 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.09 146.82 28.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 C-N-CA 124.373 1.069 . . . . 0.0 108.615 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -72.68 87.01 1.23 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.435 0.636 . . . . 0.0 109.574 174.061 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -90.03 43.43 1.15 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.871 1.268 . . . . 0.0 110.37 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 58.12 23.8 10.56 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.775 1.23 . . . . 0.0 113.014 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -65.46 -48.04 74.03 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 123.837 0.855 . . . . 0.0 111.435 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.0 -35.9 67.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.042 0.537 . . . . 0.0 111.942 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 -44.69 69.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.541 0.686 . . . . 0.0 110.854 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' MET . . . . . 0.515 ' SD ' ' HZ ' ' A' ' 68' ' ' PHE . 39.7 ttp -60.46 -34.45 74.04 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.759 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -69.53 -53.87 16.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.153 0.981 . . . . 0.0 109.859 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.7 -28.68 69.58 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.941 0.776 . . . . 0.0 112.785 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.58 -54.78 16.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.936 0.495 . . . . 0.0 109.982 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.4 mt -62.43 -42.02 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.545 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.14 -31.38 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.7 0.682 . . . . 0.0 110.907 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ALA . . . . . 0.569 ' HB3' ' HA ' ' A' ' 110' ' ' PRO . . . -72.88 -41.61 64.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.593 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.487 ' HB3' HG23 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.69 -47.94 80.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.646 0.779 . . . . 0.0 112.133 174.883 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.44 -39.04 88.67 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.683 0.615 . . . . 0.0 110.468 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -59.1 -31.9 69.33 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.244 1.017 . . . . 0.0 111.196 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 73.27 12.9 4.77 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.397 1.479 . . . . 0.0 110.679 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -143.63 122.66 7.31 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PRO . . . . . 0.569 ' HA ' ' HB3' ' A' ' 104' ' ' ALA . 3.2 Cg_exo -74.4 130.57 14.08 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 123.171 2.58 . . . . 0.0 112.366 -173.154 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.04 69.39 3.26 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.17 154.73 94.35 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.627 1.171 . . . . 0.0 111.969 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.66 148.08 58.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.582 2.188 . . . . 0.0 111.945 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.73 152.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.728 0.811 . . . . 0.0 109.4 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.51 26.8 10.28 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.741 0.816 . . . . 0.0 111.651 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.5 -29.55 67.21 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.84 -2.23 53.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.302 0.641 . . . . 0.0 111.846 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.98 -9.48 58.65 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.588 0.755 . . . . 0.0 112.425 -170.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ILE . . . . . 0.401 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.3 mp -88.51 67.42 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 121.524 0.678 . . . . 0.0 109.628 -174.59 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 mt 52.95 35.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 125.396 1.478 . . . . 0.0 112.528 166.311 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -74.12 134.03 42.85 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.397 -0.814 . . . . 0.0 110.439 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -142.95 127.1 17.49 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -77.2 -25.37 51.71 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.155 0.582 . . . . 0.0 110.844 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.11 72.09 0.31 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 C--O 1.255 1.372 0 C-N-CA 123.754 0.822 . . . . 0.0 111.136 -176.874 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 t80 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.912 0.387 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.01 152.54 55.26 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 125.309 1.444 . . . . 0.0 107.929 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.3 97.15 0.29 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.769 1.646 . . . . 0.0 111.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.4 -15.3 6.08 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.636 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -160.83 153.75 21.22 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 117.378 0.589 . . . . 0.0 112.202 -172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt -135.6 125.74 26.2 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -98.1 139.83 33.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.315 1.046 . . . . 0.0 110.148 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -132.26 117.89 18.78 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.728 0.811 . . . . 0.0 110.809 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 162.489 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 . . . . . 0 C--O 1.244 0.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.78 82.7 4.98 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.483 HG22 HG23 ' A' ' 49' ' ' ILE . 1.3 pp -109.83 128.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 p30 -150.86 123.59 8.58 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 46.1 mt -140.47 140.52 34.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 45' ' ' MET . 6.6 m170 -114.24 134.29 55.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 171.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.418 HG12 ' HG2' ' A' ' 45' ' ' MET . 58.2 mt -123.5 105.76 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -102.87 132.69 48.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -129.25 123.73 32.68 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.2 116.45 20.64 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 41' ' ' VAL . 79.2 t -79.11 117.14 24.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -118.76 159.51 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -107.93 119.35 39.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.7 0.4 . . . . 0.0 109.928 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 35.9 p-10 -99.53 148.8 23.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.252 1.021 . . . . 0.0 109.152 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.61 60.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.981 0.513 . . . . 0.0 111.972 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 35.5 tt0 -75.99 -55.29 5.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.841 0.856 . . . . 0.0 111.823 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -114.63 -6.97 12.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.236 0.614 . . . . 0.0 111.668 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.41 -108.23 3.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -172.168 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.19 141.73 45.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.117 0.459 . . . . 0.0 111.289 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 7.7 p90 -156.64 166.87 32.15 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.929 0.891 . . . . 0.0 108.796 168.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 31' ' ' VAL . 3.9 t -115.8 126.51 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 122.066 -0.396 . . . . 0.0 110.219 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 63.9 t60 -90.69 120.54 31.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.228 1.011 . . . . 0.0 108.7 170.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -107.75 145.05 34.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.1 0.56 . . . . 0.0 110.336 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -128.64 128.6 44.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.603 1.161 . . . . 0.0 108.672 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 82.7 mtp -123.82 129.41 50.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.1 0.409 . . . . 0.0 110.352 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -154.16 147.44 24.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.854 0.462 . . . . 0.0 111.425 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.44 -151.18 16.75 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.83 108.73 3.7 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.895 1.348 . . . . 0.0 111.022 171.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.483 HG23 HG22 ' A' ' 23' ' ' ILE . 68.4 mt -100.76 127.97 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.485 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 63.22 22.16 13.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.004 1.321 . . . . 0.0 109.167 -170.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.48 -3.41 87.07 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.558 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.51 109.98 28.14 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 112.003 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.68 141.95 31.62 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.868 2.378 . . . . 0.0 111.96 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.09 147.92 39.32 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.141 0.577 . . . . 0.0 110.072 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.4 p -138.68 116.51 11.54 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.87 147.13 51.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.591 1.157 . . . . 0.0 108.964 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.9 m -142.63 129.59 20.67 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -138.81 143.43 38.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.737 0.815 . . . . 0.0 109.019 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 62.4 mt-10 -126.38 133.6 51.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.365 0.666 . . . . 0.0 110.202 -174.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt -124.2 128.86 24.92 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 124.159 0.983 . . . . 0.0 109.231 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 44.7 Cg_endo -63.99 161.76 31.91 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.75 2.3 . . . . 0.0 111.466 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -44.91 -32.27 1.55 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.934 0.894 . . . . 0.0 113.161 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -70.53 -29.6 66.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.742 1.217 . . . . 0.0 112.443 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.6 p -130.49 16.29 5.43 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.854 0.861 . . . . 0.0 110.319 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.18 98.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.353 0.661 . . . . 0.0 111.053 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -73.46 -2.51 22.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.482 1.113 . . . . 0.0 112.566 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -88.48 2.08 53.54 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.686 0.794 . . . . 0.0 110.41 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.548 ' HE2' ' SD ' ' A' ' 98' ' ' MET . 12.3 p90 -54.39 -49.97 68.64 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.225 1.01 . . . . 0.0 112.528 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.14 -28.44 39.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -71.79 -51.88 20.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.768 0.427 . . . . 0.0 110.146 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -52.24 13.95 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.4 13.8 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.865 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 m -75.8 -44.59 40.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -56.02 -45.19 79.18 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.789 1.236 . . . . 0.0 112.002 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.05 -31.65 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.765 0.826 . . . . 0.0 110.937 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.77 -43.15 80.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.127 0.571 . . . . 0.0 110.618 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.61 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 18.3 pt20 -78.71 -25.82 44.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.258 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -65.76 -25.13 67.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.184 0.594 . . . . 0.0 110.422 169.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.415 ' HB3' HD12 ' A' ' 49' ' ' ILE . 26.2 m80 -86.67 0.73 54.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.302 0.641 . . . . 0.0 112.595 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.39 43.47 0.64 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 4.4 mm? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 165.809 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.1 t80 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.36 -32.9 72.81 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.747 0.654 . . . . 0.0 111.811 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.73 -44.59 66.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.381 0.673 . . . . 0.0 111.17 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.548 ' SD ' ' HE2' ' A' ' 68' ' ' PHE . 28.6 ttm -63.76 -39.83 95.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.397 0.679 . . . . 0.0 111.844 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.52 -50.29 74.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.416 1.486 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 11.9 pt-20 -70.55 -30.91 67.76 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.67 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.47 -54.4 47.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.67 -38.03 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.62 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.585 HH11 ' HB2' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -69.74 -31.15 68.98 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.202 0.91 . . . . 0.0 111.46 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB2' HH11 ' A' ' 103' ' ' ARG . . . -75.09 -44.7 45.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.561 0.345 . . . . 0.0 110.469 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -59.26 -42.78 91.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.924 1.29 . . . . 0.0 113.117 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.94 -32.14 72.53 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.712 0.805 . . . . 0.0 111.412 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -80.7 -19.91 44.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 110.676 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 C-N-CA 126.689 1.996 . . . . 0.0 110.884 179.019 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.374 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -97.54 118.64 64.04 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.087 0.955 . . . . 0.0 109.945 -175.544 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.47 114.91 2.19 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.288 2.659 . . . . 0.0 112.982 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.0 p -71.75 139.91 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.641 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.57 1.63 13.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -63.07 -33.83 76.29 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.876 0.762 . . . . 0.0 111.801 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.63 -39.35 73.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.219 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -60.34 -21.32 61.92 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.429 1.092 . . . . 0.0 111.535 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.97 -33.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.366 0.603 . . . . 0.0 109.472 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.49 -27.11 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.893 0.877 . . . . 0.0 110.123 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 . . . . . 0 N--CA 1.482 1.153 0 C-N-CA 123.262 0.625 . . . . 0.0 111.745 -177.014 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.48 151.61 25.81 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.96 0.904 . . . . 0.0 109.03 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -56.42 92.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.654 2.236 . . . . 0.0 112.127 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.54 -40.61 1.03 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.896 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -154.69 144.16 21.36 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.209 0.603 . . . . 0.0 111.832 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.8 tp -126.91 134.58 50.42 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.863 1.265 . . . . 0.0 108.869 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -98.72 115.54 28.96 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 1.3 tm? -97.51 110.14 22.76 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.069 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -127.07 103.78 7.63 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.577 HG21 ' HG ' ' A' ' 81' ' ' LEU . 1.7 pp -120.31 149.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -153.52 120.77 5.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.32 0.648 . . . . 0.0 109.862 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 55.8 mt -139.14 141.37 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.659 0.784 . . . . 0.0 109.601 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.1 m170 -104.26 112.42 25.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.2 mt -112.23 109.78 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.62 123.99 51.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.874 1.27 . . . . 0.0 107.679 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -121.04 128.28 52.5 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -119.52 113.3 20.53 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 92.1 t -77.54 115.84 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -145.51 167.58 22.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 108.734 -170.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -111.4 121.62 45.7 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.744 0.417 . . . . 0.0 110.495 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.435 ' H ' HD22 ' A' ' 34' ' ' ASN . 0.6 OUTLIER -99.78 153.53 19.05 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.521 1.129 . . . . 0.0 110.317 173.125 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.86 -24.48 61.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.204 0.601 . . . . 0.0 111.991 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -73.57 -49.34 26.8 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.222 1.009 . . . . 0.0 112.273 -172.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -133.89 17.13 3.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.352 0.661 . . . . 0.0 111.187 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.09 -111.97 3.4 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.007 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -78.43 147.48 34.0 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 117.298 0.549 . . . . 0.0 110.451 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -159.6 179.54 8.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 t -132.64 130.59 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 4.6 t60 -88.42 109.0 19.66 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.174 0.99 . . . . 0.0 108.59 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 56.4 m-85 -94.91 127.49 40.98 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.16 127.83 28.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.413 0.685 . . . . 0.0 109.296 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 84.1 mtp -133.79 145.05 49.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.92 0.888 . . . . 0.0 110.861 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.18 165.53 17.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.436 0.694 . . . . 0.0 109.846 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.79 -134.4 5.25 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.9 172.19 17.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.186 0.594 . . . . 0.0 110.157 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 79' ' ' HIS . 58.4 mt -155.27 101.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 -166.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 54.39 41.13 32.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.483 0.713 . . . . 0.0 111.189 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.26 16.26 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.543 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.77 109.9 12.4 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.167 0.987 . . . . 0.0 111.369 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -81.35 152.44 18.02 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.028 2.486 . . . . 0.0 113.73 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.07 160.52 41.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 p -141.03 118.11 11.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.972 0.909 . . . . 0.0 109.358 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -139.62 150.0 44.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.884 0.874 . . . . 0.0 109.799 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 p -150.68 137.53 19.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.956 0.502 . . . . 0.0 109.904 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.91 145.04 45.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 0.0 108.738 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 39.6 mt-10 -124.55 123.91 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -175.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.1 mt -120.63 133.49 24.07 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.188 0.595 . . . . 0.0 109.398 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.01 163.97 6.94 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.317 2.678 . . . . 0.0 113.286 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 31.4 ptt85 -45.46 -37.12 4.91 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.821 1.248 . . . . 0.0 112.537 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.07 -28.09 68.58 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.817 1.247 . . . . 0.0 112.886 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.4 p -130.55 15.28 5.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.674 0.79 . . . . 0.0 111.16 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.7 73.54 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.072 0.549 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.03 -23.97 64.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.501 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -77.29 -2.45 34.86 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.587 0.755 . . . . 0.0 111.64 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -66.0 -21.14 66.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.43 62.35 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 -161.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 p -67.62 -33.63 75.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.228 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.468 ' O ' HG23 ' A' ' 75' ' ' VAL . 5.1 m-20 -72.27 -56.8 4.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.433 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.02 67.04 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.673 1.189 . . . . 0.0 112.41 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.8 m -67.06 -50.24 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.249 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -56.93 -35.51 69.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.104 0.962 . . . . 0.0 112.795 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 71' ' ' ASP . 53.4 t -57.93 -44.86 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.74 0.816 . . . . 0.0 109.676 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.75 74.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.903 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 11.0 mm100 -60.14 -38.32 82.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.295 0.638 . . . . 0.0 111.364 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.91 -30.32 70.11 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.079 0.951 . . . . 0.0 111.982 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.46 ' HB3' HD12 ' A' ' 49' ' ' ILE . 63.4 t60 -91.69 24.84 2.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.872 0.469 . . . . 0.0 111.515 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.2 49.48 2.83 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 111.846 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' HG21 ' A' ' 23' ' ' ILE . 1.7 tt . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 . . . . . 0 C--O 1.213 -0.855 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.72 -45.5 74.07 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.599 0.76 . . . . 0.0 112.35 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.64 -48.34 60.23 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.995 0.518 . . . . 0.0 110.45 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.16 -38.02 81.91 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.963 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -53.91 -45.63 71.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.545 1.138 . . . . 0.0 110.142 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -71.15 -28.77 64.51 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.382 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 28.2 t70 -68.19 -54.18 19.69 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.358 0.411 . . . . 0.0 110.044 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.33 -47.59 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.947 0.899 . . . . 0.0 111.481 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -63.59 -28.27 69.81 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.565 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.59 -54.47 6.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.807 0.843 . . . . 0.0 112.439 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 14.1 mmmm -67.85 -37.36 81.77 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.66 -24.56 63.63 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.516 0.326 . . . . 0.0 111.181 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -76.99 -17.91 58.56 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.914 0.886 . . . . 0.0 109.699 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 C-N-CA 126.293 1.837 . . . . 0.0 112.572 175.656 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.076 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -147.94 154.28 43.21 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.94 0.896 . . . . 0.0 109.323 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.42 148.94 92.33 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.49 2.126 . . . . 0.0 111.132 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.92 142.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.92 20.81 15.46 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.099 0.559 . . . . 0.0 111.98 -173.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 117' ' ' GLU . 4.4 pp -57.15 -37.62 72.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.529 0.732 . . . . 0.0 112.289 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' N ' HD12 ' A' ' 116' ' ' LEU . 26.4 tt0 -87.27 -14.79 39.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.472 0.709 . . . . 0.0 110.947 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -80.68 -11.92 59.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.083 0.553 . . . . 0.0 110.543 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.56 -35.99 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.1 mt -86.05 14.54 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 124.215 1.006 . . . . 0.0 110.57 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 . . . . . 0 CA--C 1.555 1.14 0 O-C-N 121.187 -0.945 . . . . 0.0 109.911 175.204 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.2 t80 . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 120.839 0.352 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -143.47 154.6 60.34 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.275 1.03 . . . . 0.0 108.681 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.76 101.4 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.698 2.266 . . . . 0.0 112.644 174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.62 -14.24 11.75 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.936 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -158.01 122.46 4.23 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.509 0.655 . . . . 0.0 112.182 -175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.6 tp -102.98 120.98 41.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.58 1.152 . . . . 0.0 108.848 168.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -99.49 121.97 41.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.5 mt -98.92 137.26 37.74 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.733 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 165.82 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.64 69.34 0.97 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.643 0.735 . . . . 0.0 110.834 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.02 134.63 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -156.11 111.07 2.89 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.746 0.784 . . . . 0.0 109.443 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 60.1 mt -124.47 143.87 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.591 1.156 . . . . 0.0 110.041 -168.245 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.6 m170 -104.68 111.47 24.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 45' ' ' MET . 61.8 mt -109.98 109.19 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -115.17 119.66 37.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 47.8 p90 -121.11 131.73 54.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.013 0.525 . . . . 0.0 110.307 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.78 122.45 28.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.419 0.688 . . . . 0.0 110.018 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 HG22 ' A' ' 41' ' ' VAL . 59.2 t -70.86 124.74 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 43.9 ttt180 -146.12 165.08 30.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.064 0.946 . . . . 0.0 109.278 -175.232 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.471 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 24.1 mm-40 -114.74 115.57 27.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.803 0.841 . . . . 0.0 108.872 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.432 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 31.5 p-10 -101.93 147.77 26.15 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.173 0.589 . . . . 0.0 110.002 170.362 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.18 65.2 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.989 0.516 . . . . 0.0 111.29 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.432 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 32.6 tt0 -66.84 -54.63 20.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.91 0.884 . . . . 0.0 112.293 -177.31 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 m -120.26 4.16 10.81 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.245 0.618 . . . . 0.0 112.09 -168.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -134.83 12.87 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -73.6 141.59 46.59 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.789 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -161.4 178.69 8.92 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.023 0.44 . . . . 0.0 110.788 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.44 HG22 HG22 ' A' ' 31' ' ' VAL . 23.8 t -125.97 132.8 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 48.0 t60 -92.88 129.56 38.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.479 1.112 . . . . 0.0 108.593 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 50.8 m-85 -119.18 143.28 47.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.264 0.626 . . . . 0.0 110.447 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 41.5 m-20 -130.23 141.53 50.62 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.054 0.942 . . . . 0.0 109.183 174.738 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.481 ' HG2' HG12 ' A' ' 27' ' ' ILE . 87.5 mtp -132.97 128.51 36.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.882 0.873 . . . . 0.0 108.784 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.86 161.19 31.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.502 0.321 . . . . 0.0 110.488 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.64 -122.89 2.47 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.93 164.11 38.9 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.749 0.82 . . . . 0.0 110.001 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -155.58 113.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -169.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.48 40.14 29.69 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.221 1.01 . . . . 0.0 110.383 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.99 -39.0 3.04 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.608 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -79.69 129.4 71.31 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 123.851 0.86 . . . . 0.0 111.754 -169.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.64 164.22 23.5 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.26 2.64 . . . . 0.0 113.879 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.94 159.92 37.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.616 0.766 . . . . 0.0 110.688 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.5 p -144.22 112.95 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.529 0.732 . . . . 0.0 110.459 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 154.38 51.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.85 1.26 . . . . 0.0 109.643 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.8 p -152.97 139.71 18.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.979 0.512 . . . . 0.0 109.799 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.1 150.25 44.07 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.596 0.758 . . . . 0.0 110.126 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.45 125.68 38.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.779 0.831 . . . . 0.0 109.36 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.9 mt -119.38 134.43 23.77 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.459 0.704 . . . . 0.0 109.812 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.67 158.8 48.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.04 2.493 . . . . 0.0 112.225 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 26.1 ptt180 -41.64 -38.24 1.34 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.172 1.389 . . . . 0.0 114.2 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.85 -25.59 62.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.788 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 p -131.83 8.44 4.48 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.558 0.743 . . . . 0.0 111.494 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.23 88.09 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -68.03 -14.26 62.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.04 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -79.55 2.01 23.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.412 0.685 . . . . 0.0 111.697 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -65.0 -14.41 60.29 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 124.127 0.971 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.17 -36.78 66.67 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -73.2 -40.99 64.32 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.01 -52.21 60.59 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.255 0.622 . . . . 0.0 110.662 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -55.08 -49.32 71.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.51 1.124 . . . . 0.0 112.01 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -64.84 -29.1 70.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.851 0.461 . . . . 0.0 111.454 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.6 tpp180 -72.3 -41.56 66.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.038 0.535 . . . . 0.0 110.238 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.81 -31.78 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.397 1.079 . . . . 0.0 109.9 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.455 ' HB1' HD23 ' A' ' 81' ' ' LEU . . . -71.41 -49.89 37.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.54 0.736 . . . . 0.0 109.799 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.588 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 46.4 mt-30 -70.09 -28.87 65.76 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.753 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.71 -29.9 68.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.475 0.71 . . . . 0.0 110.453 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -105.97 21.36 17.44 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 111.214 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.16 40.08 5.57 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 121.969 -0.457 . . . . 0.0 113.951 166.293 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.588 ' HB3' ' HG2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER . . . . . 0 CA--C 1.552 1.032 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.767 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.2 t80 . . . . . 0 C--O 1.217 -0.657 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.23 -39.98 93.46 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.545 0.738 . . . . 0.0 111.735 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.01 70.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.266 0.627 . . . . 0.0 111.114 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.426 ' HE2' ' HB3' ' A' ' 98' ' ' MET . 53.2 ttp -64.4 -43.0 95.79 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.401 1.08 . . . . 0.0 112.323 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.07 -50.09 49.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.703 1.201 . . . . 0.0 111.492 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.85 -28.37 50.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.646 0.591 . . . . 0.0 110.687 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.68 -59.98 3.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.707 0.803 . . . . 0.0 111.299 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.411 ' O ' HD13 ' A' ' 106' ' ' LEU . 56.2 mt -63.79 -36.42 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.38 0.672 . . . . 0.0 111.372 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -29.16 70.0 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.13 -38.14 63.87 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.327 0.651 . . . . 0.0 110.689 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -65.61 -35.84 81.99 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 112.179 173.588 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 102' ' ' ILE . 9.8 mp -65.3 -32.71 74.5 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.59 0.756 . . . . 0.0 110.728 170.276 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.62 -16.4 59.58 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.349 1.059 . . . . 0.0 111.216 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 C-N-CA 127.599 2.359 . . . . 0.0 112.248 175.289 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 143.29 94.51 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.207 0.603 . . . . 0.0 111.906 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -93.31 105.95 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.029 2.486 . . . . 0.0 112.22 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.79 107.49 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 CA-C-O 122.36 1.076 . . . . 0.0 109.491 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.91 21.35 1.61 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.475 1.11 . . . . 0.0 111.983 -163.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.78 -27.5 68.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.268 0.627 . . . . 0.0 110.792 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -68.05 -11.59 59.26 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.973 1.309 . . . . 0.0 111.39 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -87.77 -19.86 26.95 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.052 0.941 . . . . 0.0 112.4 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.16 74.0 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.8 mt 72.15 -5.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 C-N-CA 125.323 1.449 . . . . 0.0 112.364 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 . . . . . 0 N--CA 1.483 1.216 0 O-C-N 121.822 -0.549 . . . . 0.0 109.709 -174.764 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.5 t80 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.48 157.13 63.16 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 125.126 1.37 . . . . 0.0 108.858 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.61 102.34 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.279 1.986 . . . . 0.0 111.33 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.01 -25.15 5.85 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.569 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -152.81 142.04 21.48 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.56 0.68 . . . . 0.0 112.118 -171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.7 tp -131.51 133.33 44.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.643 1.577 . . . . 0.0 108.55 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -107.56 117.99 35.55 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 80.7 mt -88.74 128.77 35.63 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.634 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.246 0.912 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 159.102 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 C--O 1.224 -0.287 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -114.73 101.39 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.274 1.03 . . . . 0.0 108.935 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG22 HG23 ' A' ' 49' ' ' ILE . 2.1 pp -113.95 143.86 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 171.548 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -144.36 108.65 4.81 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.8 mt -131.68 139.19 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.57 0.748 . . . . 0.0 110.411 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.4 m170 -104.65 111.04 23.59 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.534 HG12 ' HG2' ' A' ' 45' ' ' MET . 37.4 mt -112.08 119.84 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.59 123.64 50.35 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -112.01 115.79 29.5 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.83 111.92 16.06 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.817 0.447 . . . . 0.0 109.991 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 105' ' ' LYS . 89.0 t -81.5 119.69 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.805 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -131.93 145.77 51.7 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -103.1 113.17 26.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.48 HD22 ' HD1' ' A' ' 40' ' ' TYR . 3.5 p30 -99.95 142.32 31.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.63 -16.8 63.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.265 0.626 . . . . 0.0 112.162 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.406 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 14.2 tp10 -75.22 -46.66 32.51 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.759 0.823 . . . . 0.0 111.675 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.6 t -126.77 -11.71 6.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.356 0.663 . . . . 0.0 112.06 -168.55 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.96 -139.41 14.38 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.3 143.58 57.1 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.434 0.617 . . . . 0.0 111.257 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.48 ' HD1' HD22 ' A' ' 34' ' ' ASN . 8.8 p90 -148.15 165.37 31.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 31' ' ' VAL . 10.1 t -130.38 134.71 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.562 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 57.5 t60 -94.36 113.46 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.857 1.263 . . . . 0.0 108.863 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.445 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 71.4 m-85 -104.12 115.45 30.44 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.814 . . . . 0.0 108.945 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -120.93 119.32 32.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.534 ' HG2' HG12 ' A' ' 27' ' ' ILE . 81.2 mtp -126.09 134.84 51.25 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.159 0.583 . . . . 0.0 111.086 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -165.37 177.31 7.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.085 0.554 . . . . 0.0 110.181 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.43 -123.7 2.98 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 10.1 pt-20 -152.96 167.35 29.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.387 1.075 . . . . 0.0 109.868 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.531 HG23 HG22 ' A' ' 23' ' ' ILE . 36.8 mt -157.15 105.31 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -172.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.547 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 3.2 m-20 64.03 40.76 6.91 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.193 0.997 . . . . 0.0 109.838 -174.447 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.23 -23.56 3.89 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.638 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 44.4 mtmt -82.88 116.57 64.8 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.159 0.984 . . . . 0.0 110.413 -171.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 88.8 Cg_endo -74.92 162.26 37.58 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.049 2.5 . . . . 0.0 113.841 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -158.3 165.68 34.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.715 0.806 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.9 p -153.13 121.66 6.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.283 1.033 . . . . 0.0 109.819 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -155.4 145.04 21.25 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.96 0.904 . . . . 0.0 110.047 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 t -146.58 146.73 30.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.095 0.558 . . . . 0.0 110.653 -170.16 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -142.19 149.78 40.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.34 1.056 . . . . 0.0 110.297 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.3 mp0 -118.6 135.48 54.41 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 89.7 mt -124.45 124.97 25.68 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.68 168.91 12.33 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.108 2.539 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.551 ' HG3' HD23 ' A' ' 106' ' ' LEU . 76.4 ttt180 -47.06 -35.96 7.5 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.222 1.009 . . . . 0.0 112.504 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -58.6 -35.34 72.27 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.554 1.142 . . . . 0.0 112.632 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -129.11 8.03 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 0.0 112.104 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.08 90.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.506 0.722 . . . . 0.0 112.094 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.47 -12.57 61.39 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.832 -1.077 . . . . 0.0 113.216 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -80.69 5.63 15.12 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.55 0.74 . . . . 0.0 111.66 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 5.9 p90 -73.52 -27.13 61.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.2 1.0 . . . . 0.0 113.334 -172.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.89 -45.32 36.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.364 0.602 . . . . 0.0 109.511 -164.379 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -74.33 -33.35 63.12 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.159 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 75' ' ' VAL . 22.6 t70 -72.97 -51.61 17.67 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.913 0.485 . . . . 0.0 111.501 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.73 -41.23 66.83 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.155 0.982 . . . . 0.0 112.091 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.4 m -61.81 -48.45 80.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.972 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.414 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.9 ttm180 -53.73 -45.06 70.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.689 1.196 . . . . 0.0 111.61 174.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 71' ' ' ASP . 43.5 t -61.46 -41.04 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.756 1.222 . . . . 0.0 110.204 -177.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.85 -42.25 70.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.71 -26.49 66.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.035 0.934 . . . . 0.0 111.811 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -65.54 -22.4 66.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.307 0.643 . . . . 0.0 111.177 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -106.74 20.98 18.22 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.441 0.696 . . . . 0.0 110.39 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.59 39.32 8.97 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 121.724 -0.61 . . . . 0.0 113.441 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.452 HD22 HG21 ' A' ' 23' ' ' ILE . 2.1 tm? . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 123.829 0.852 . . . . 0.0 110.322 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.6 t80 . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.76 -34.81 78.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 110.856 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.24 -49.5 49.3 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.226 0.61 . . . . 0.0 110.442 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.51 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 84.4 mmm -60.95 -42.94 99.21 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.644 0.778 . . . . 0.0 112.983 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -49.79 -46.56 50.94 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.789 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.455 ' HA ' ' CG ' ' A' ' 103' ' ' ARG . 3.7 mt-10 -80.06 -25.82 39.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.618 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.0 -58.76 4.31 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.943 0.897 . . . . 0.0 110.107 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.9 mt -60.53 -41.13 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.528 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 100' ' ' GLU . 4.8 ppt_? -64.63 -30.22 71.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.444 0.566 . . . . 0.0 110.34 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 107' ' ' HIS . . . -71.25 -47.25 58.24 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.5 ' HB3' HG21 ' A' ' 31' ' ' VAL . 6.2 tmtp? -69.78 -30.56 68.15 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.998 0.519 . . . . 0.0 111.847 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 62' ' ' ARG . 2.2 mp -63.9 -23.82 67.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.839 0.855 . . . . 0.0 111.717 172.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . 0.456 ' HB3' ' O ' ' A' ' 104' ' ' ALA . 85.2 t60 -72.57 -15.15 61.76 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.571 1.148 . . . . 0.0 110.907 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.761 0 C-N-CA 126.528 1.931 . . . . 0.0 112.509 178.966 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.436 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.73 143.44 27.05 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.26 1.024 . . . . 0.0 109.514 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.81 132.29 22.95 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.012 2.474 . . . . 0.0 112.19 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.525 HG22 ' HG ' ' A' ' 116' ' ' LEU . 7.8 p -77.02 121.81 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.05 -21.56 58.95 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 122.078 -0.389 . . . . 0.0 111.982 -168.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.525 ' HG ' HG22 ' A' ' 114' ' ' VAL . 4.3 pp -59.47 -26.6 65.38 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.311 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.14 -35.65 81.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.219 1.008 . . . . 0.0 110.815 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.9 -27.06 66.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.318 1.047 . . . . 0.0 111.085 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.531 HG22 HG13 ' A' ' 120' ' ' ILE . 2.3 mp -74.67 -57.8 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.319 0.648 . . . . 0.0 109.676 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 119' ' ' ILE . 78.2 mt -116.7 101.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 123.658 0.783 . . . . 0.0 109.411 175.045 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 C--O 1.241 0.634 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.0 153.74 60.88 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.055 0.942 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.34 106.28 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.319 2.013 . . . . 0.0 112.112 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.88 -22.02 9.34 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.014 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -153.89 124.58 7.16 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.304 0.574 . . . . 0.0 112.474 -170.947 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.583 HD23 HD12 ' A' ' 27' ' ' ILE . 56.8 tp -103.5 148.13 26.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.898 0.879 . . . . 0.0 108.78 165.082 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.78 116.6 23.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.939 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.621 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 71.6 mt -89.29 109.59 20.47 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.17 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.318 -0.787 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.099 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' H ' ' HA ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER -101.45 70.71 1.31 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.15 119.6 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.303 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -142.52 109.78 5.63 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 49.1 mt -133.53 129.8 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.732 0.813 . . . . 0.0 109.194 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 45' ' ' MET . 14.7 m170 -100.11 108.69 20.89 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.583 HD12 HD23 ' A' ' 10' ' ' LEU . 41.5 mt -103.22 108.5 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -109.5 112.61 24.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -111.07 118.11 35.13 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -124.31 115.03 20.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.036 0.934 . . . . 0.0 109.09 -172.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.99 120.69 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.594 0.711 . . . . 0.0 109.567 170.352 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -138.4 154.79 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.78 120.6 41.3 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.625 0.25 . . . . 0.0 111.224 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.482 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 37.1 p-10 -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.609 1.164 . . . . 0.0 110.419 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.07 61.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.094 0.558 . . . . 0.0 111.449 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 11.7 tp10 -67.23 -54.61 19.46 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.258 1.023 . . . . 0.0 111.755 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -120.94 5.91 10.4 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.226 0.611 . . . . 0.0 111.812 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.68 -101.09 1.5 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.556 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -83.78 145.36 28.74 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.961 0.505 . . . . 0.0 110.706 171.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -151.48 174.32 13.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -125.73 132.57 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -96.94 134.16 40.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.195 0.998 . . . . 0.0 108.613 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -120.66 125.75 48.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 109.829 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 30.4 m-20 -108.13 148.74 29.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.646 0.779 . . . . 0.0 109.505 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 21.4 mtm -141.4 132.53 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.587 1.155 . . . . 0.0 108.469 171.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -167.53 159.55 12.3 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.266 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.78 -121.1 1.36 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 11.8 pt-20 -142.08 171.01 14.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 mt -154.95 103.79 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' HA ' ' H ' ' A' ' 22' ' ' ASP . 36.6 t70 58.37 46.13 15.81 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 122.345 1.069 . . . . 0.0 109.467 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.16 -36.22 3.53 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.177 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.01 111.95 23.93 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.568 1.147 . . . . 0.0 112.312 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 Cg_exo -61.3 146.83 96.91 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.795 2.997 . . . . 0.0 113.099 175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 4.3 p90 -151.22 163.92 37.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.442 0.297 . . . . 0.0 110.683 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -153.58 117.43 4.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.288 0.635 . . . . 0.0 111.206 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -130.32 159.27 37.47 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.687 1.195 . . . . 0.0 109.751 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -157.19 133.46 9.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.731 0.413 . . . . 0.0 110.61 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.3 145.95 50.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.826 0.85 . . . . 0.0 109.635 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -114.08 143.57 44.56 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.74 138.95 27.65 Favored Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.6 149.27 91.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.523 2.149 . . . . 0.0 110.797 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.556 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 30.8 ptt85 -42.14 -39.29 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.15 -19.77 61.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.557 0.743 . . . . 0.0 112.744 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.1 p -130.48 9.66 5.13 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.55 0.74 . . . . 0.0 109.91 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.76 71.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.948 0.899 . . . . 0.0 111.048 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -69.11 -11.33 60.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.393 1.077 . . . . 0.0 113.046 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -80.62 3.87 20.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.294 0.637 . . . . 0.0 111.195 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -67.88 -21.18 65.16 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 124.324 1.05 . . . . 0.0 112.571 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.12 19.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -69.61 -35.23 75.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.841 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 -54.55 10.31 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.498 0.719 . . . . 0.0 111.602 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.15 -44.72 64.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.24 1.016 . . . . 0.0 111.947 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -63.02 -49.24 75.42 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.418 0.449 . . . . 0.0 110.312 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.506 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 18.3 ttp85 -51.15 -52.78 40.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.322 1.049 . . . . 0.0 111.999 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.92 -32.39 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.862 0.465 . . . . 0.0 110.551 -175.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.0 -41.56 74.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 96.4 mt-30 -54.27 -30.77 51.84 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.604 1.162 . . . . 0.0 112.969 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 13.8 mptt -75.2 -7.64 54.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.53 0.732 . . . . 0.0 111.175 -176.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -93.11 7.57 43.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.587 0.755 . . . . 0.0 110.684 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.26 64.51 1.02 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.265 0.466 . . . . 0.0 114.265 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 11.0 mp . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 168.028 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.1 t80 . . . . . 0 C--O 1.204 -1.326 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.32 -33.9 63.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.028 0.531 . . . . 0.0 111.458 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.66 -50.34 63.22 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.445 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.461 ' HE1' HD22 ' A' ' 10' ' ' LEU . 28.3 ttm -71.87 -37.21 70.23 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.757 0.823 . . . . 0.0 112.541 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -51.12 -48.22 61.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.465 1.506 . . . . 0.0 110.301 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.569 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 23.2 mt-10 -77.84 -28.75 50.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.287 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.53 -50.53 69.2 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.2 0.6 . . . . 0.0 110.423 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.449 ' O ' HD13 ' A' ' 106' ' ' LEU . 56.0 mt -61.02 -49.15 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.998 0.919 . . . . 0.0 111.597 175.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 1.2 ppt_? -61.85 -30.63 70.97 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.146 0.43 . . . . 0.0 111.31 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.26 -44.76 58.78 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.033 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -65.6 -33.68 76.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.25 1.02 . . . . 0.0 111.787 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 102' ' ' ILE . 6.8 mp -70.52 -22.16 62.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.506 1.122 . . . . 0.0 111.338 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -89.25 -18.7 26.5 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.15 0.58 . . . . 0.0 109.854 170.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 C-N-CA 126.001 1.72 . . . . 0.0 111.526 176.322 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.96 0 N-CA-C 112.698 -0.161 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -127.45 145.26 53.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.293 1.037 . . . . 0.0 109.634 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.66 105.23 1.59 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.667 2.245 . . . . 0.0 110.126 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 100' ' ' GLU . 7.3 p -67.97 125.35 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.39 0.614 . . . . 0.0 110.491 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.24 7.93 8.42 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.893 0.877 . . . . 0.0 112.52 -166.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 117' ' ' GLU . 3.1 pp -55.88 -26.83 49.03 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 116' ' ' LEU . 44.2 tt0 -72.76 -33.2 66.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.504 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -81.61 -7.45 59.59 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.691 -167.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.1 -19.82 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.703 0.801 . . . . 0.0 110.519 170.104 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.8 mt 81.26 112.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.802 2.041 . . . . 0.0 109.081 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 124.803 1.241 . . . . 0.0 110.195 -174.266 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.2 t80 . . . . . 0 C--O 1.239 0.522 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.33 154.22 78.5 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.27 1.428 . . . . 0.0 107.834 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.1 110.19 0.42 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.276 1.984 . . . . 0.0 111.658 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.2 -21.56 10.06 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 123.057 0.36 . . . . 0.0 112.736 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -150.93 119.83 6.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.255 0.622 . . . . 0.0 111.434 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.461 HD23 HD12 ' A' ' 27' ' ' ILE . 59.9 tp -102.35 143.21 32.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.346 1.058 . . . . 0.0 108.912 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -120.71 124.67 45.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.234 0.613 . . . . 0.0 110.298 174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.8 mt -102.0 128.31 48.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.882 0.473 . . . . 0.0 109.921 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 159.043 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 . . . . . 0 C--O 1.24 0.579 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -87.41 70.65 9.94 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.462 0.648 . . . . 0.0 109.799 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.86 142.15 20.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.363 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.487 ' OD1' ' HG2' ' A' ' 48' ' ' GLU . 4.4 p-10 -151.78 128.71 11.0 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 67.3 mt -127.99 129.23 69.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -171.708 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' MET . 0.1 OUTLIER -102.05 109.02 20.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 177.723 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.461 HD12 HD23 ' A' ' 10' ' ' LEU . 53.8 mt -101.75 105.52 18.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 27.0 mtp-105 -101.59 108.8 20.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.335 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -111.83 116.97 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.21 111.21 17.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 41' ' ' VAL . 44.3 t -83.94 116.52 27.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -127.61 155.15 44.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.116 0.966 . . . . 0.0 108.51 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -105.87 111.84 24.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 29.9 p-10 -97.64 146.94 24.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.828 0.851 . . . . 0.0 110.087 173.238 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.45 -18.05 62.33 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.922 0.489 . . . . 0.0 111.694 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 11.8 tp10 -69.04 -53.32 21.1 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.01 0.924 . . . . 0.0 111.555 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.3 t -124.96 5.71 7.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.05 0.54 . . . . 0.0 112.294 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.92 -114.77 3.98 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 137.98 36.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.021 0.529 . . . . 0.0 110.129 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 4.3 p90 -152.84 166.96 30.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 31' ' ' VAL . 10.8 t -124.02 122.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -81.09 116.6 21.1 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -100.26 135.53 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 25.5 t70 -137.9 141.52 40.65 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.757 0.823 . . . . 0.0 108.831 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 86.6 mtp -138.46 131.91 30.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 0.0 110.0 -174.613 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -150.48 176.42 10.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.017 0.527 . . . . 0.0 109.92 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.08 -135.34 7.43 Favored Glycine 0 N--CA 1.465 0.599 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 8.0 pt-20 -151.63 168.06 26.17 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 mt -157.66 109.29 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -166.562 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t70 61.65 32.98 18.36 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.798 0.808 . . . . 0.0 109.431 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.35 -25.41 9.25 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -82.15 118.94 73.83 Favored Pre-proline 0 N--CA 1.484 1.252 0 CA-C-N 117.831 0.816 . . . . 0.0 111.708 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -69.89 148.21 63.73 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.639 2.226 . . . . 0.0 112.887 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -142.8 150.52 40.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.313 0.645 . . . . 0.0 109.959 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 m -146.75 122.49 10.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.442 0.697 . . . . 0.0 110.348 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.89 152.62 36.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.127 0.971 . . . . 0.0 109.175 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.0 p -147.98 137.2 22.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.217 0.607 . . . . 0.0 110.699 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.47 140.18 41.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 0.0 109.71 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -112.86 129.58 56.4 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.19 129.01 25.1 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.581 0.753 . . . . 0.0 109.332 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 40.2 Cg_endo -63.73 164.75 20.33 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.042 2.495 . . . . 0.0 112.126 173.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.13 -32.61 7.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.223 1.009 . . . . 0.0 113.467 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.74 -31.51 66.76 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.344 1.058 . . . . 0.0 112.191 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -125.73 12.48 7.94 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.338 0.655 . . . . 0.0 110.517 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.18 89.97 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.826 0.85 . . . . 0.0 112.116 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.23 -8.05 46.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.476 1.11 . . . . 0.0 113.096 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -80.55 1.2 30.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.785 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -66.1 -18.97 65.69 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.722 1.209 . . . . 0.0 113.058 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -50.78 14.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.437 0.637 . . . . 0.0 109.734 -162.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.9 p -73.28 -31.41 64.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.309 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 75' ' ' VAL . 14.2 t70 -70.78 -58.22 3.85 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.282 0.633 . . . . 0.0 111.35 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.27 -47.58 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.251 1.02 . . . . 0.0 112.547 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.3 m -57.59 -47.08 83.11 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.866 0.467 . . . . 0.0 110.758 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HA ' ' HG2' ' A' ' 77' ' ' GLN . 39.4 ttp180 -57.96 -38.77 76.61 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.949 0.781 . . . . 0.0 112.508 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -59.63 -47.78 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.116 0.566 . . . . 0.0 109.758 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HB3' HD22 ' A' ' 81' ' ' LEU . . . -72.22 -40.09 68.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.896 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 20.8 pt20 -73.56 -22.69 60.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -66.13 -21.25 66.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 121.951 0.101 . . . . 0.0 110.732 166.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -99.56 6.16 45.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.857 0.863 . . . . 0.0 110.537 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.44 -95.85 0.43 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD13 HD11 ' A' ' 25' ' ' ILE . 32.5 tp . . . . . 0 CA--C 1.549 0.904 0 C-N-CA 126.466 1.906 . . . . 0.0 112.952 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.9 t80 . . . . . 0 C--O 1.222 -0.36 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.85 -32.62 65.97 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.071 0.857 . . . . 0.0 112.182 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.24 -47.95 63.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 tpp -65.51 -40.79 93.41 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -55.04 -51.82 65.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.982 1.313 . . . . 0.0 111.311 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 10.1 pt-20 -69.7 -30.37 68.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.67 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.11 -45.62 59.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.311 0.244 . . . . 0.0 110.889 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.87 -45.35 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.396 0.678 . . . . 0.0 110.683 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -64.56 -29.84 70.86 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 120.614 0.245 . . . . 0.0 110.568 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.59 -45.72 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.439 0.696 . . . . 0.0 110.619 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -69.88 -29.88 67.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.941 0.496 . . . . 0.0 112.243 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.2 -31.37 68.78 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.065 0.946 . . . . 0.0 110.486 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -72.76 -18.0 61.54 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.905 0.882 . . . . 0.0 110.493 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 C-N-CA 126.268 1.827 . . . . 0.0 112.619 176.642 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.295 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 11.6 pt-20 -77.68 172.02 10.91 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.915 0.886 . . . . 0.0 109.742 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 112' ' ' GLU . 95.8 Cg_endo -76.95 48.75 2.58 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.654 2.236 . . . . 0.0 112.882 172.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.19 130.0 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.08 29.7 5.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.2 0.6 . . . . 0.0 111.009 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -55.3 -30.62 60.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 112.317 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 121' ' ' ARG . 34.1 tt0 -80.45 -32.91 37.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.458 0.703 . . . . 0.0 110.789 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.03 -18.55 65.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.299 1.04 . . . . 0.0 112.27 -168.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.541 HG22 HG12 ' A' ' 120' ' ' ILE . 3.9 mp -67.28 -52.83 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.541 HG12 HG22 ' A' ' 119' ' ' ILE . 33.3 mm -133.99 96.99 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.555 0.742 . . . . 0.0 109.567 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.479 ' HG2' ' HG2' ' A' ' 117' ' ' GLU . 52.2 mtp180 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.043 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.5 t80 . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.95 156.02 55.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.192 1.397 . . . . 0.0 108.363 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.72 105.76 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.109 1.872 . . . . 0.0 111.397 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.11 -20.61 11.36 Favored Glycine 0 N--CA 1.473 1.126 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.243 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -153.04 143.88 22.87 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.413 0.607 . . . . 0.0 111.584 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.2 tp -129.33 141.26 51.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.237 1.415 . . . . 0.0 108.276 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -127.57 121.18 29.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.563 0.745 . . . . 0.0 109.211 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 79.3 mt -100.53 128.9 46.45 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.419 0.687 . . . . 0.0 109.865 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 166.742 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.92 53.65 2.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.839 0.828 . . . . 0.0 111.102 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.544 HG21 HD23 ' A' ' 81' ' ' LEU . 2.2 pp -90.54 116.03 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -139.14 107.85 5.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 59.1 mt -133.18 133.43 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.643 0.777 . . . . 0.0 109.966 -163.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.7 m170 -104.8 113.87 27.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.8 mt -112.5 107.74 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 ttp-105 -102.54 110.12 21.96 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -111.57 123.62 50.6 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -118.73 114.46 22.73 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.541 0.737 . . . . 0.0 109.15 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG11 ' HG3' ' A' ' 105' ' ' LYS . 98.0 t -77.71 117.38 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -140.43 159.86 41.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.899 0.879 . . . . 0.0 109.103 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -110.68 113.48 26.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.502 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 32.0 p-10 -95.57 148.77 22.16 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.722 0.809 . . . . 0.0 109.598 170.987 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.22 -19.36 63.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.872 0.469 . . . . 0.0 111.432 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.502 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 39.3 tt0 -71.05 -44.93 64.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.284 1.034 . . . . 0.0 112.323 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -133.73 1.93 3.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.83 -115.5 4.12 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.01 143.52 43.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.26 0.53 . . . . 0.0 110.359 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.418 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.9 p90 -160.3 172.79 16.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.439 0.696 . . . . 0.0 109.148 169.123 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.01 130.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -88.68 116.45 26.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.866 0.866 . . . . 0.0 108.884 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.59 110.39 22.43 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -105.11 139.69 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.799 0.84 . . . . 0.0 109.165 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 40.5 mtm -141.71 140.19 33.1 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.906 0.482 . . . . 0.0 110.833 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -164.1 158.61 19.51 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.424 0.69 . . . . 0.0 109.724 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.18 -127.56 2.16 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.052 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -156.82 160.35 39.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.414 1.085 . . . . 0.0 109.27 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 23' ' ' ILE . 47.7 mt -158.04 107.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.185 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 60.24 42.12 15.63 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.531 1.158 . . . . 0.0 109.348 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.99 -28.76 3.19 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.382 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -82.57 121.41 78.03 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.147 0.979 . . . . 0.0 111.19 -169.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.26 152.21 76.01 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.833 2.356 . . . . 0.0 113.231 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -146.98 146.39 30.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.313 0.645 . . . . 0.0 109.369 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.7 m -142.63 118.9 10.82 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.003 0.521 . . . . 0.0 110.153 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.24 154.92 37.76 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.073 0.949 . . . . 0.0 109.917 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.4 p -145.74 144.91 30.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.853 0.461 . . . . 0.0 110.41 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.64 136.95 39.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.09 0.956 . . . . 0.0 109.555 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -112.92 124.53 52.83 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.25 128.98 25.65 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 30.6 Cg_endo -60.38 159.26 27.86 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.075 2.517 . . . . 0.0 112.069 171.294 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -42.63 -40.02 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.944 1.298 . . . . 0.0 114.262 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.79 -15.12 60.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.777 0.831 . . . . 0.0 112.552 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -132.03 4.55 4.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.698 0.799 . . . . 0.0 111.778 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.15 71.64 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.947 0.899 . . . . 0.0 111.789 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -65.34 -24.39 67.24 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.261 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -73.96 -2.06 22.45 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.599 0.76 . . . . 0.0 112.294 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -70.9 -18.01 62.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.88 -43.78 57.46 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -167.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 p -76.11 -35.77 59.17 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.206 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.8 t70 -71.17 -57.12 4.8 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.345 0.658 . . . . 0.0 112.071 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.36 -43.29 43.89 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.212 1.005 . . . . 0.0 112.454 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -64.44 -46.66 82.19 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.256 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 68.6 ttt180 -53.76 -44.21 69.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.75 0.82 . . . . 0.0 111.729 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 71' ' ' ASP . 57.4 t -60.75 -38.82 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.083 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.16 -41.69 73.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.783 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -60.61 -34.04 73.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.214 1.006 . . . . 0.0 111.363 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.3 mtpp -61.51 -36.76 81.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.743 . . . . 0.0 111.809 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -87.53 -33.19 19.04 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.81 41.32 0.02 OUTLIER Glycine 0 C--N 1.358 1.788 0 C-N-CA 121.591 -0.338 . . . . 0.0 113.395 156.057 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.544 HD23 HG21 ' A' ' 23' ' ' ILE . 1.6 tm? . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.9 t80 . . . . . 0 C--O 1.214 -0.769 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.18 -37.96 78.65 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.163 0.985 . . . . 0.0 112.663 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.85 -48.81 23.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.509 0.323 . . . . 0.0 111.317 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.2 ttm -65.55 -32.62 74.31 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.174 0.59 . . . . 0.0 111.523 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -50.31 -45.76 54.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.275 1.03 . . . . 0.0 109.683 169.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 27.0 mm-40 -74.9 -28.22 60.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.061 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.51 -55.31 12.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 120.793 0.33 . . . . 0.0 110.357 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.32 -42.0 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.531 1.133 . . . . 0.0 112.211 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.39 -31.27 72.39 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.863 0.363 . . . . 0.0 110.444 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.47 -52.39 10.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.566 0.746 . . . . 0.0 110.526 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.484 ' HG3' HG11 ' A' ' 31' ' ' VAL . 17.7 tppt? -55.46 -52.97 61.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.769 1.228 . . . . 0.0 113.134 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.07 -26.95 69.08 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.276 0.63 . . . . 0.0 111.872 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -68.6 -31.92 71.43 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.652 0.595 . . . . 0.0 109.457 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 125.608 1.563 . . . . 0.0 113.298 169.04 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.424 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.14 152.32 90.46 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.6 91.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.536 2.158 . . . . 0.0 111.52 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.7 p -79.81 142.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.613 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 118' ' ' ARG . 29.0 m-20 -99.21 43.24 1.07 Allowed 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.975 0.91 . . . . 0.0 110.579 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.63 -33.64 73.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.466 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -117.2 85.72 2.38 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.341 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 1.8 tmm_? -133.2 14.8 4.19 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 165.491 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.66 -63.6 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.772 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.8 mt -88.5 70.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.991 0.9 . . . . 0.0 108.979 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 121' ' ' ARG . 12.9 mmt180 . . . . . 0 N--CA 1.469 0.488 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.322 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.3 t80 . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 121.002 0.429 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.44 153.45 58.97 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.038 1.335 . . . . 0.0 108.28 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.75 96.98 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.139 1.893 . . . . 0.0 111.824 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.09 -25.59 4.09 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.384 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -151.91 147.24 26.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.177 0.591 . . . . 0.0 111.219 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 27' ' ' ILE . 41.9 tp -126.84 134.59 50.5 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.126 1.37 . . . . 0.0 107.863 173.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -97.47 138.48 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.58 110.58 14.61 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.262 0.625 . . . . 0.0 109.504 175.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.249 1.057 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 160.582 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 . . . . . 0 C--O 1.245 0.822 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -77.33 82.71 3.79 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.804 0.69 . . . . 0.0 109.237 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.601 HG22 HG23 ' A' ' 49' ' ' ILE . 1.6 pp -110.36 126.57 67.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -147.09 117.61 7.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 43.1 mt -144.85 145.94 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.308 1.043 . . . . 0.0 108.381 -168.271 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 45' ' ' MET . 9.2 m-70 -108.73 145.66 34.74 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.565 HD12 HD23 ' A' ' 10' ' ' LEU . 55.9 mt -131.75 109.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 99.5 mtt180 -98.59 140.1 33.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 168.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -121.65 116.85 25.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 165.551 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -123.96 111.89 16.56 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 41' ' ' VAL . 90.2 t -90.15 118.75 36.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.29 0.636 . . . . 0.0 110.337 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 26.5 ttt180 -114.58 153.24 30.45 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.965 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -111.42 111.41 22.43 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -105.24 136.81 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.37 -20.17 66.01 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.04 0.536 . . . . 0.0 112.308 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -68.97 -45.59 70.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.589 1.156 . . . . 0.0 111.508 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -115.54 -40.71 3.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.865 0.466 . . . . 0.0 111.205 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.76 -148.17 17.22 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.09 129.19 37.92 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.401 0.68 . . . . 0.0 110.867 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 3.4 p90 -144.45 166.29 25.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 31' ' ' VAL . 2.3 t -122.11 128.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.943 0.497 . . . . 0.0 110.329 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.552 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 78.1 t60 -88.92 112.32 23.16 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 164.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 91.8 m-85 -95.12 121.3 36.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 19.7 t70 -120.43 114.67 22.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.859 0.864 . . . . 0.0 109.517 -170.012 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.413 ' HG2' HG12 ' A' ' 27' ' ' ILE . 85.8 mtp -119.31 144.3 46.9 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.546 0.739 . . . . 0.0 110.881 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -156.05 164.48 38.38 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.459 0.704 . . . . 0.0 109.461 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.62 -158.6 31.54 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 118.843 -0.976 . . . . 0.0 111.458 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -145.79 109.97 4.95 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.301 1.051 . . . . 0.0 110.589 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 23' ' ' ILE . 49.0 mt -99.78 128.0 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.901 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 62.04 17.62 9.23 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.821 1.248 . . . . 0.0 111.846 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 -20.25 40.86 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.629 -0.54 . . . . 0.0 113.495 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.8 111.17 27.44 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.96 0.904 . . . . 0.0 112.513 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.65 143.39 33.91 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.535 2.157 . . . . 0.0 111.979 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -148.85 161.77 41.16 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -146.65 121.32 9.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -138.52 145.67 41.02 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 p -144.26 144.66 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.749 0.42 . . . . 0.0 111.154 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -137.53 137.15 38.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.069 0.947 . . . . 0.0 108.701 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 6.4 mp0 -113.84 126.5 55.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.386 -177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 94.2 mt -129.32 125.85 22.73 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 40' ' ' TYR . 57.2 Cg_endo -67.19 163.91 32.38 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.635 2.223 . . . . 0.0 111.555 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -45.78 -37.43 6.02 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.678 1.191 . . . . 0.0 113.384 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.87 -29.85 71.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.194 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.0 p -129.76 12.27 5.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.882 0.873 . . . . 0.0 111.02 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -27.95 68.71 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.655 0.782 . . . . 0.0 111.73 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.469 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 27.1 m-85 -70.46 -2.49 14.07 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.361 1.064 . . . . 0.0 113.79 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -95.3 4.94 52.93 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.604 0.761 . . . . 0.0 110.581 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -55.59 -49.16 73.5 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 124.27 1.028 . . . . 0.0 112.899 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.05 -35.2 61.89 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 123.162 0.585 . . . . 0.0 111.777 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -71.51 -40.12 70.36 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.728 0.643 . . . . 0.0 109.359 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.59 -56.64 9.84 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.307 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.49 -40.61 12.76 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.878 1.271 . . . . 0.0 113.429 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -71.03 -46.36 62.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.182 0.593 . . . . 0.0 110.327 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -61.71 -51.01 70.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.849 0.859 . . . . 0.0 111.343 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.98 -34.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.789 0.836 . . . . 0.0 110.689 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.04 84.35 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.18 0.514 . . . . 0.0 110.142 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.7 -36.73 59.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.45 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -64.05 -34.74 78.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.431 0.692 . . . . 0.0 111.094 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -80.17 3.02 21.95 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.04 -31.92 2.32 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 118.927 0.785 . . . . 0.0 113.605 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 23' ' ' ILE . 17.8 tp . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 124.019 0.928 . . . . 0.0 110.766 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.5 t80 . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.688 ' HB2' HH12 ' A' ' 118' ' ' ARG . 4.7 m-20 -55.77 -42.83 76.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 111.985 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.79 89.22 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.081 0.863 . . . . 0.0 110.746 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.0 ttm -61.15 -51.63 68.25 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.237 1.015 . . . . 0.0 111.397 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -51.19 -52.13 47.26 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.828 1.651 . . . . 0.0 112.21 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.502 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 pt-20 -82.26 -27.44 32.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.295 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.91 -36.55 83.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.3 mt -58.96 -55.65 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.549 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.11 -28.1 64.33 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.343 0.52 . . . . 0.0 111.448 -178.551 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ALA . . . . . 0.427 ' HB2' HH11 ' A' ' 103' ' ' ARG . . . -71.99 -48.03 47.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.753 0.821 . . . . 0.0 110.677 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -58.52 -35.01 71.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.928 0.891 . . . . 0.0 112.246 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.3 mm? -64.29 -22.55 66.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.436 0.694 . . . . 0.0 112.851 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.83 -17.88 61.51 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 173.064 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.456 0 C-N-CA 126.476 1.91 . . . . 0.0 111.886 177.199 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.21 146.03 97.84 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.354 1.062 . . . . 0.0 111.574 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.38 -179.26 5.11 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.29 1.993 . . . . 0.0 112.567 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.57 117.25 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.26 45.34 2.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.919 0.888 . . . . 0.0 109.122 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.48 -36.34 82.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.056 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.14 -19.92 60.41 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.534 0.734 . . . . 0.0 111.229 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.688 HH12 ' HB2' ' A' ' 96' ' ' ASP . 7.6 ttt180 -71.52 -28.13 63.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.034 0.534 . . . . 0.0 111.144 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.58 -31.38 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.414 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.29 -18.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.194 0.998 . . . . 0.0 111.82 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 118' ' ' ARG . 19.3 mmm180 . . . . . 0 N--CA 1.491 1.605 0 C-N-CA 123.697 0.799 . . . . 0.0 111.73 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' A' ' 98' ' ' MET . 67.8 t80 . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 121.43 0.633 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.55 154.42 69.28 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.968 1.307 . . . . 0.0 109.94 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.43 100.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.81 2.34 . . . . 0.0 113.202 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.55 -24.38 6.5 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.68 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -147.65 150.75 34.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.625 . . . . 0.0 110.411 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 42.6 tp -124.18 129.61 51.11 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.978 1.311 . . . . 0.0 107.627 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.67 134.87 40.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.642 0.377 . . . . 0.0 110.137 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 69.2 mt -125.46 113.09 17.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.474 0.709 . . . . 0.0 110.446 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 159.893 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -73.29 78.05 1.33 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.588 HG22 HG23 ' A' ' 49' ' ' ILE . 1.5 pp -123.97 138.47 53.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.052 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -152.68 126.63 9.02 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.525 HD11 HD11 ' A' ' 49' ' ' ILE . 36.2 mt -142.92 142.04 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.293 1.037 . . . . 0.0 108.271 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.7 m170 -103.56 141.99 35.06 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.221 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 33.1 mt -126.62 108.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 119.27 0.941 . . . . 0.0 109.089 169.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 18.5 mtp180 -95.39 138.56 32.91 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.236 1.014 . . . . 0.0 108.397 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -124.43 117.29 24.1 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.275 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.66 111.23 16.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 41' ' ' VAL . 74.7 t -85.43 117.06 29.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -131.32 158.84 39.59 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.079 0.951 . . . . 0.0 110.012 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -115.89 110.53 19.14 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.548 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 33.7 p-10 -98.96 152.09 20.18 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.982 0.513 . . . . 0.0 110.85 172.525 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.38 -25.96 63.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.693 0.797 . . . . 0.0 110.965 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.548 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 37.6 tt0 -66.51 -53.45 34.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.317 1.047 . . . . 0.0 112.275 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 m -126.68 -0.44 6.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -168.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.22 -133.94 12.11 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 117.741 0.246 . . . . 0.0 112.632 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -82.27 131.13 35.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.906 0.482 . . . . 0.0 110.256 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -156.99 173.66 16.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.784 0.433 . . . . 0.0 110.773 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 31' ' ' VAL . 20.9 t -132.45 125.65 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.393 0.677 . . . . 0.0 109.526 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.432 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 73.2 t60 -87.91 119.35 28.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 109.581 172.722 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 74.0 m-85 -102.79 127.94 49.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.0 t70 -130.26 123.87 31.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.084 0.554 . . . . 0.0 110.589 -170.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 79.1 mtp -122.59 132.38 54.27 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.018 0.927 . . . . 0.0 111.097 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -154.38 154.23 32.93 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 0.0 110.965 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 162.24 -151.94 22.09 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 118.588 -1.118 . . . . 0.0 110.403 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -145.65 110.5 5.16 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.096 1.448 . . . . 0.0 111.72 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.588 HG23 HG22 ' A' ' 23' ' ' ILE . 68.8 mt -98.64 124.3 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.603 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 7.7 m-20 63.98 24.45 13.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.909 1.283 . . . . 0.0 109.822 -170.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.47 10.38 86.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.39 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.519 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 51.3 mtmt -94.78 108.37 37.12 Favored Pre-proline 0 C--N 1.354 0.771 0 C-N-CA 123.494 0.717 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 37.5 Cg_endo -63.86 133.54 39.4 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.796 2.331 . . . . 0.0 111.732 176.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -137.76 147.39 44.65 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.2 p -132.71 113.1 12.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.77 136.59 34.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.2 p -148.95 145.7 27.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.736 0.303 . . . . 0.0 110.593 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -137.87 142.46 40.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.307 1.043 . . . . 0.0 109.325 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 7.4 mp0 -116.13 140.44 49.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.3 mt -132.87 135.93 26.81 Favored Pre-proline 0 C--O 1.237 0.435 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 165.26 19.95 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.495 2.13 . . . . 0.0 111.713 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.594 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 24.6 ptt180 -38.76 -36.91 0.3 Allowed 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 125.404 1.482 . . . . 0.0 114.15 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -78.78 -19.14 52.91 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 p -130.53 3.05 4.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.339 0.656 . . . . 0.0 111.307 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.51 70.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.29 1.036 . . . . 0.0 112.178 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -71.15 -17.74 62.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.059 0.944 . . . . 0.0 112.366 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.95 -3.84 57.54 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.869 0.467 . . . . 0.0 111.103 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -51.65 -44.11 62.89 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.026 0.93 . . . . 0.0 112.963 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.22 30.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -172.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -67.69 -47.55 69.12 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.975 0.51 . . . . 0.0 109.855 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.44 -47.5 33.23 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.778 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.51 -39.18 10.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.008 1.323 . . . . 0.0 112.477 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.1 m -73.77 -44.03 57.27 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.982 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -61.67 -46.99 87.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.041 0.936 . . . . 0.0 112.464 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.53 -31.92 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.415 0.686 . . . . 0.0 110.805 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.21 85.79 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.984 0.514 . . . . 0.0 110.594 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.471 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 20.0 pt20 -76.84 -25.76 53.56 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.217 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -68.03 -27.87 66.91 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.032 0.933 . . . . 0.0 110.669 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.79 6.65 20.52 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.636 0.774 . . . . 0.0 111.448 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.4 54.13 2.02 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 114.701 0.64 . . . . 0.0 114.701 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.471 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 30.6 mt . . . . . 0 N--CA 1.485 1.297 0 CA-C-N 118.089 0.945 . . . . 0.0 109.575 165.312 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.5 t80 . . . . . 0 C--O 1.21 -0.979 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -53.27 -41.71 65.79 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.28 29.19 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.135 0.574 . . . . 0.0 110.268 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.4 ' SD ' ' CE1' ' A' ' 5' ' ' PHE . 8.6 tpt -51.69 -42.12 61.95 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.824 1.249 . . . . 0.0 111.686 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -58.99 -53.26 60.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.335 1.454 . . . . 0.0 110.839 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.72 -27.6 66.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.827 0.704 . . . . 0.0 112.101 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.08 -55.69 8.83 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 123.335 0.397 . . . . 0.0 110.243 176.652 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.8 -37.03 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.914 0.325 . . . . 0.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.4 62.39 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.072 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -61.94 -38.82 89.91 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.321 1.048 . . . . 0.0 112.898 174.014 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.31 -38.66 92.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.241 0.616 . . . . 0.0 110.802 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -66.81 -29.32 69.22 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.737 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.439 0 C-N-CA 125.839 1.656 . . . . 0.0 112.081 177.562 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.619 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.15 129.14 68.23 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.337 1.055 . . . . 0.0 109.561 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.87 105.13 1.09 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.735 2.29 . . . . 0.0 110.687 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.84 143.99 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 0.0 111.944 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.79 -30.63 69.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.302 1.041 . . . . 0.0 111.891 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.22 -6.15 22.04 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.169 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.78 -43.66 2.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.663 0.785 . . . . 0.0 110.89 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -75.49 -31.56 60.25 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.667 0.787 . . . . 0.0 111.578 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.39 -28.75 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 120' ' ' ILE . 2.0 mp -88.28 83.82 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.74 0.816 . . . . 0.0 109.092 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.488 1.428 0 C-N-CA 123.516 0.726 . . . . 0.0 111.324 176.112 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.13 157.2 37.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.455 1.502 . . . . 0.0 107.865 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.57 105.14 0.34 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 121.876 1.717 . . . . 0.0 111.122 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.1 -16.2 12.0 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.866 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -158.36 151.61 22.96 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.74 0.77 . . . . 0.0 112.307 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -140.22 143.15 35.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.045 1.738 . . . . 0.0 107.972 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -124.41 137.55 54.44 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -136.47 118.55 15.41 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.577 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.246 0.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.973 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.569 ' HG3' HG23 ' A' ' 23' ' ' ILE . 19.0 pt20 . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.2 57.82 4.7 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.152 0.581 . . . . 0.0 111.648 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.569 HG23 ' HG3' ' A' ' 21' ' ' GLN . 2.0 pp -90.54 119.91 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.25 118.62 12.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.406 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 19.2 mt -140.53 139.42 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.36 0.664 . . . . 0.0 109.715 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -107.3 131.93 53.67 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.467 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.6 mt -128.11 110.19 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -99.88 139.66 35.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -122.58 116.17 23.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 164.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -123.86 113.17 18.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 41' ' ' VAL . 87.2 t -80.22 131.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 30.3 ttt180 -146.83 161.24 41.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.444 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.1 mm-40 -109.74 119.41 39.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.037 0.535 . . . . 0.0 110.419 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 26.3 p-10 -96.61 146.76 24.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.776 0.831 . . . . 0.0 110.311 170.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.83 62.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.403 0.681 . . . . 0.0 111.82 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.447 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 35.2 tt0 -71.96 -55.34 7.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.893 0.877 . . . . 0.0 112.171 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -121.13 0.69 10.21 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.167 0.587 . . . . 0.0 111.859 -168.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.74 -113.78 4.15 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -78.87 144.07 35.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.866 0.466 . . . . 0.0 111.279 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 32' ' ' ARG . 9.3 p90 -154.85 177.42 11.29 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 108.666 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 31' ' ' VAL . 16.3 t -128.3 124.13 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -84.02 122.52 28.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.641 1.176 . . . . 0.0 108.983 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -106.95 126.72 52.68 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -125.89 115.03 19.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.809 0.843 . . . . 0.0 110.02 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.467 ' SD ' HG12 ' A' ' 27' ' ' ILE . 38.9 mtm -120.95 148.09 44.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.566 0.746 . . . . 0.0 111.004 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -167.79 166.36 13.68 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.213 1.005 . . . . 0.0 109.94 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.11 -144.78 10.03 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-O 118.708 -1.051 . . . . 0.0 110.7 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.99 110.06 3.27 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.582 1.182 . . . . 0.0 111.549 171.375 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 23' ' ' ILE . 70.3 mt -100.22 127.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.015 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 65.09 23.53 12.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.088 1.355 . . . . 0.0 109.206 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.48 -0.63 84.67 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.401 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -86.37 109.13 21.0 Favored Pre-proline 0 C--N 1.353 0.745 0 C-N-CA 124.092 0.957 . . . . 0.0 111.48 -175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.24 129.84 18.89 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.849 2.366 . . . . 0.0 111.902 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -138.49 160.25 40.02 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -147.77 129.06 14.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 169.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -130.87 142.02 50.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.374 1.069 . . . . 0.0 109.102 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -143.25 133.62 24.7 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.538 0.335 . . . . 0.0 110.425 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.86 144.71 33.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.72 0.808 . . . . 0.0 109.231 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -126.1 127.25 45.49 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 65' ' ' ALA . 80.8 mt -124.7 129.87 24.46 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -175.73 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -59.32 156.31 36.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.951 2.434 . . . . 0.0 111.215 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 30.1 ptt180 -45.53 -26.88 0.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.38 -21.79 45.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.373 0.669 . . . . 0.0 111.809 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -128.65 2.87 5.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.833 0.853 . . . . 0.0 110.977 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . . . -55.32 -37.37 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.448 1.099 . . . . 0.0 112.545 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.52 0.7 7.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.202 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.16 3.82 47.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.482 0.713 . . . . 0.0 110.241 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -57.76 -52.03 67.14 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.998 0.919 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.57 -31.1 63.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.5 m -73.44 -50.83 19.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.977 0.511 . . . . 0.0 110.333 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.21 -55.6 15.45 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.745 0.818 . . . . 0.0 111.383 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.36 -46.75 13.28 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.986 1.314 . . . . 0.0 113.059 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.1 m -70.6 -33.15 70.74 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.913 0.485 . . . . 0.0 111.028 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -67.33 -40.77 85.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.396 0.679 . . . . 0.0 111.003 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.93 -33.21 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 110.727 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.96 -47.92 73.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.323 0.582 . . . . 0.0 109.548 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 3.6 pt20 -69.63 -31.89 70.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.825 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -53.69 -41.66 67.16 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 110.876 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -90.79 8.66 33.57 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.075 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.47 -10.02 4.66 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 8.7 mp . . . . . 0 N--CA 1.49 1.544 0 CA-C-N 118.898 1.349 . . . . 0.0 111.215 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.7 t80 . . . . . 0 C--O 1.221 -0.442 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.0 -34.73 72.19 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.962 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.34 64.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.564 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mmt -72.27 -30.74 65.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.623 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -51.92 -52.4 50.28 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.087 0.955 . . . . 0.0 110.625 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.78 -28.76 61.82 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.798 0.686 . . . . 0.0 112.241 -173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.24 -44.81 58.82 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.382 0.273 . . . . 0.0 110.811 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.442 ' O ' HD13 ' A' ' 106' ' ' LEU . 97.6 mt -63.47 -46.52 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.688 0.795 . . . . 0.0 111.648 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -59.69 -31.5 69.64 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.349 0.595 . . . . 0.0 110.496 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.93 56.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.573 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.458 ' HG2' HG21 ' A' ' 31' ' ' VAL . 1.9 tpmt? -64.63 -32.67 74.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.475 0.71 . . . . 0.0 111.873 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -67.83 -20.96 65.22 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.679 1.192 . . . . 0.0 111.149 171.377 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -88.24 -17.18 31.35 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.126 0.97 . . . . 0.0 110.202 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 C-N-CA 126.916 2.086 . . . . 0.0 112.638 173.812 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.806 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 139.4 73.39 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.033 0.933 . . . . 0.0 112.436 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.22 66.02 8.85 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.382 2.722 . . . . 0.0 112.531 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.54 72.44 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 122.845 1.307 . . . . 0.0 109.532 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.68 41.24 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.779 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 117' ' ' GLU . 3.9 pp -63.23 -29.69 70.98 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.325 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.413 ' N ' HD12 ' A' ' 116' ' ' LEU . 31.7 tt0 -73.65 -19.17 60.92 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.496 0.718 . . . . 0.0 111.43 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -68.53 -16.46 63.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.958 0.503 . . . . 0.0 111.407 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.3 mm -71.64 -35.3 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.112 0.565 . . . . 0.0 109.805 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 120' ' ' ILE . 3.4 mp -84.36 78.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 122.261 1.029 . . . . 0.0 108.246 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.792 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.861 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.82 156.91 62.35 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.824 1.25 . . . . 0.0 108.504 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.61 105.03 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.538 2.159 . . . . 0.0 112.242 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.63 -19.89 13.95 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.691 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -150.97 135.33 16.96 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.524 0.678 . . . . 0.0 112.363 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.403 HD22 ' HE1' ' A' ' 98' ' ' MET . 46.2 tp -114.8 141.02 48.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.583 1.553 . . . . 0.0 108.957 170.557 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.532 0.733 . . . . 0.0 109.349 168.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.574 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -123.29 110.21 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.644 0.735 . . . . 0.0 110.529 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.248 1.015 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 164.47 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -85.95 53.17 2.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.625 0.726 . . . . 0.0 110.255 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.543 HG22 HG23 ' A' ' 49' ' ' ILE . 2.0 pp -89.67 115.57 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -138.2 106.39 5.75 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.574 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 48.6 mt -127.6 132.98 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -166.069 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -107.35 119.17 38.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.502 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -120.55 114.1 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 18.4 mtp180 -104.11 135.34 45.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 108.234 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -121.88 116.06 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 167.357 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.6 111.8 17.67 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 41' ' ' VAL . 52.1 t -82.37 118.33 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.03 159.0 30.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -109.27 119.39 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.722 0.409 . . . . 0.0 110.35 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -95.04 154.9 16.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.877 0.871 . . . . 0.0 109.232 167.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.75 -27.65 64.1 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.714 0.406 . . . . 0.0 111.454 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.21 -54.38 7.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.862 0.865 . . . . 0.0 112.348 -173.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 t -108.57 -1.92 19.25 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.11 0.564 . . . . 0.0 111.532 -173.609 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.84 -110.31 3.06 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 138.34 37.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.9 0.48 . . . . 0.0 110.567 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.5 166.79 26.2 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 31' ' ' VAL . 7.6 t -127.81 127.12 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.578 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 55.4 t60 -86.18 114.41 23.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.462 1.105 . . . . 0.0 108.859 171.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 76.0 m-85 -99.73 111.38 23.72 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 27.1 t70 -107.13 124.58 49.9 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 109.408 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.502 ' HG2' HG12 ' A' ' 27' ' ' ILE . 79.4 mtp -124.58 140.34 53.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.259 0.624 . . . . 0.0 110.286 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.04 170.0 21.38 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.739 0.815 . . . . 0.0 109.663 173.913 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.16 -137.78 6.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 119.429 -0.651 . . . . 0.0 112.002 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 9.7 pt-20 -152.55 157.73 41.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.756 1.222 . . . . 0.0 108.546 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.543 HG23 HG22 ' A' ' 23' ' ' ILE . 51.2 mt -156.46 105.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -168.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 26.9 t70 59.14 47.96 11.14 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.216 1.007 . . . . 0.0 108.994 -170.752 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.97 -35.05 3.13 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 114.836 -1.075 . . . . 0.0 114.384 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -86.94 128.88 54.31 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.218 1.007 . . . . 0.0 112.053 -168.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 89.6 Cg_endo -74.17 161.07 41.47 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.064 2.509 . . . . 0.0 113.821 -177.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.415 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 8.9 p90 -152.86 148.9 27.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.903 0.881 . . . . 0.0 109.021 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -142.54 113.83 7.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.154 0.582 . . . . 0.0 110.278 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -127.21 143.09 51.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.295 1.038 . . . . 0.0 109.186 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 t -143.53 134.43 25.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.013 0.435 . . . . 0.0 110.093 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -146.97 148.81 32.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.853 0.861 . . . . 0.0 109.703 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 4.7 mp0 -118.94 138.72 52.59 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 73.4 mt -128.89 134.36 26.23 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.71 160.85 34.66 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.641 2.227 . . . . 0.0 111.373 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -36.2 9.96 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.57 -23.73 61.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.056 0.942 . . . . 0.0 112.258 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -125.3 7.2 7.77 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.952 0.901 . . . . 0.0 110.779 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.04 80.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.029 0.931 . . . . 0.0 112.282 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.83 -6.51 38.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.086 0.954 . . . . 0.0 113.186 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -78.57 -6.3 55.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.414 0.685 . . . . 0.0 111.131 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -64.14 -24.13 67.57 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 124.542 1.137 . . . . 0.0 113.06 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.7 -49.06 16.98 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.252 0.549 . . . . 0.0 109.693 -162.48 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 m -72.41 -31.01 65.17 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.283 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.07 -54.24 13.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.182 0.993 . . . . 0.0 110.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.02 74.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.631 1.172 . . . . 0.0 111.92 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.5 m -63.86 -50.24 69.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.657 0.383 . . . . 0.0 110.34 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -54.92 -45.37 74.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.216 1.006 . . . . 0.0 112.058 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.34 -32.06 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.543 0.337 . . . . 0.0 110.671 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.99 -47.48 58.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.023 0.529 . . . . 0.0 110.096 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.611 ' HA ' HD23 ' A' ' 81' ' ' LEU . 13.2 pt20 -65.4 -22.16 66.75 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.757 0.823 . . . . 0.0 112.641 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -64.65 -19.24 65.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.741 0.816 . . . . 0.0 111.918 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -90.2 25.23 2.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.373 0.669 . . . . 0.0 112.33 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.22 49.85 1.67 Allowed Glycine 0 C--N 1.35 1.312 0 CA-C-O 120.218 -0.212 . . . . 0.0 113.493 170.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 C-N-CA 122.953 0.501 . . . . 0.0 109.701 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 t80 . . . . . 0 C--O 1.223 -0.298 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.27 -34.08 74.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.473 1.109 . . . . 0.0 111.815 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.37 68.38 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.711 0.632 . . . . 0.0 110.696 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.403 ' HE1' HD22 ' A' ' 10' ' ' LEU . 30.4 ttm -65.45 -41.53 93.35 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.012 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.24 -48.29 68.33 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.388 1.075 . . . . 0.0 110.91 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.0 -26.85 57.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.7 t70 -65.72 -57.35 8.26 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.487 0.492 . . . . 0.0 110.212 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.9 -42.41 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.431 0.693 . . . . 0.0 111.551 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -28.38 69.13 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.22 47.74 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 110.326 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 30.7 mmmt -58.34 -40.46 82.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 mp -66.62 -34.47 77.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.537 1.135 . . . . 0.0 111.046 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -81.28 -17.86 47.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.444 0.697 . . . . 0.0 110.562 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 C-N-CA 125.569 1.547 . . . . 0.0 111.667 -179.362 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.729 0 CA-C-O 119.445 -0.641 . . . . 0.0 113.371 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.99 114.91 16.75 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -88.64 123.18 1.48 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.845 2.363 . . . . 0.0 112.83 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' VAL . . . . . 0.416 HG21 HD23 ' A' ' 116' ' ' LEU . 11.6 p -79.05 152.91 4.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -113.42 17.48 18.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.038 0.535 . . . . 0.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.416 HD23 HG21 ' A' ' 114' ' ' VAL . 4.4 pp -65.65 -24.26 66.98 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -114.59 -3.14 12.96 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.11 0.964 . . . . 0.0 110.865 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -72.29 -5.27 34.92 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.558 0.743 . . . . 0.0 112.707 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.476 HD12 ' H ' ' A' ' 119' ' ' ILE . 4.0 mp -74.3 -7.42 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 C-N-CA 123.998 0.919 . . . . 0.0 109.648 175.201 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.2 mm 60.77 54.91 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.286 0 C-N-CA 125.12 1.368 . . . . 0.0 107.501 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 . . . . . 0 C--O 1.24 0.553 0 CA-C-N 113.423 -1.717 . . . . 0.0 110.666 -164.499 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.47 155.6 32.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.575 1.15 . . . . 0.0 108.304 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.72 90.83 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.285 1.99 . . . . 0.0 111.995 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.91 -26.3 3.01 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.721 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -150.53 151.63 32.94 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.196 0.498 . . . . 0.0 111.692 -170.287 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 53.8 tp -135.02 111.63 9.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 108.557 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -98.42 127.9 44.56 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -121.05 132.38 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.215 0.606 . . . . 0.0 109.931 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.248 1.009 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 166.329 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.05 65.83 8.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.852 0.834 . . . . 0.0 110.509 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.625 HD13 HD21 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -92.69 126.85 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.869 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.484 HD21 ' HG3' ' A' ' 48' ' ' GLU . 6.0 p30 -151.81 110.02 3.73 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.411 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 27.8 mt -132.32 137.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -168.195 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' MET . 4.7 m170 -99.53 128.52 45.65 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.565 HG12 ' HG2' ' A' ' 45' ' ' MET . 56.2 mt -121.9 109.62 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -96.18 124.84 40.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . 0.462 ' HB2' HG11 ' A' ' 41' ' ' VAL . 45.7 p90 -111.69 116.98 31.65 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.049 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -124.63 112.32 16.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.676 0.79 . . . . 0.0 109.29 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 41' ' ' VAL . 56.3 t -75.9 126.64 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.771 0.428 . . . . 0.0 110.663 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -143.97 154.79 43.66 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.05 125.56 41.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.713 0.405 . . . . 0.0 111.132 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 1.5 p30 -100.1 147.08 26.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.635 1.174 . . . . 0.0 109.155 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.81 -10.94 60.51 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 122.954 0.501 . . . . 0.0 112.233 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 16.4 tt0 -75.81 -55.27 5.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.196 0.999 . . . . 0.0 112.012 -177.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.1 p -130.32 1.98 4.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.338 0.655 . . . . 0.0 112.263 -167.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.88 -106.27 3.4 Favored Glycine 0 C--O 1.213 -1.171 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 146.76 41.22 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.794 0.797 . . . . 0.0 111.887 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.442 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.5 p90 -152.85 173.53 15.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 31' ' ' VAL . 23.5 t -128.7 130.85 68.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -89.03 110.95 21.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 63.3 m-85 -96.56 139.32 32.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.467 0.707 . . . . 0.0 109.181 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -135.04 127.95 31.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.358 0.663 . . . . 0.0 109.722 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.565 ' HG2' HG12 ' A' ' 27' ' ' ILE . 83.4 mtp -123.91 131.17 53.53 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.919 0.888 . . . . 0.0 110.114 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -161.03 162.18 31.65 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.71 -128.03 2.6 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.484 ' HG3' HD21 ' A' ' 24' ' ' ASN . 10.3 pt-20 -156.59 165.43 36.31 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.198 0.599 . . . . 0.0 109.864 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 90.6 mt -155.98 103.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 -161.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.16 37.43 20.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.687 0.795 . . . . 0.0 110.1 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.12 -21.03 7.32 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.312 -0.858 . . . . 0.0 115.239 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -79.65 120.23 79.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 117.621 0.711 . . . . 0.0 110.825 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.61 157.05 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.017 2.478 . . . . 0.0 113.266 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -154.7 161.51 41.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.679 0.392 . . . . 0.0 111.279 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.5 p -141.89 116.26 9.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.431 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.35 144.31 31.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.244 1.018 . . . . 0.0 108.861 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.3 p -148.12 149.59 32.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.452 0.569 . . . . 0.0 110.753 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -141.46 151.32 43.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.558 0.743 . . . . 0.0 110.571 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.76 132.56 54.29 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.55 0.74 . . . . 0.0 109.863 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 95.7 mt -127.53 139.05 34.15 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.374 0.67 . . . . 0.0 109.791 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.44 158.54 40.36 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.053 2.502 . . . . 0.0 112.02 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -41.36 -34.83 0.56 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.126 1.37 . . . . 0.0 114.65 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.86 -19.88 62.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.625 0.77 . . . . 0.0 112.416 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.3 p -131.7 10.1 4.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.829 0.852 . . . . 0.0 110.231 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.57 96.79 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.493 0.717 . . . . 0.0 111.36 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -70.05 -22.19 63.1 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.549 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -80.6 -8.76 59.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.809 0.844 . . . . 0.0 109.545 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -53.04 -30.61 36.76 Favored 'General case' 0 C--O 1.205 -1.276 0 C-N-CA 123.949 0.899 . . . . 0.0 112.918 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 -34.16 20.77 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -69.52 -48.3 60.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.37 -57.04 10.45 Favored 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -43.55 -45.27 6.53 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.778 1.631 . . . . 0.0 113.461 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.4 m -68.75 -40.55 79.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.668 0.387 . . . . 0.0 110.892 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HA ' ' HG2' ' A' ' 77' ' ' GLN . 31.4 ttp180 -68.59 -39.09 81.09 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.534 0.734 . . . . 0.0 111.828 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.98 -50.21 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.397 1.079 . . . . 0.0 109.451 173.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HB1' HD22 ' A' ' 81' ' ' LEU . . . -60.74 -43.06 98.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.667 0.787 . . . . 0.0 111.622 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 14.0 pt20 -71.11 -35.52 71.82 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.638 0.375 . . . . 0.0 111.284 -176.273 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -65.1 -31.65 72.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.619 0.368 . . . . 0.0 110.697 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -89.38 5.38 45.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.234 0.613 . . . . 0.0 112.143 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.02 -27.09 2.45 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.625 HD21 HD13 ' A' ' 23' ' ' ILE . 9.8 mp . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 121.767 0.794 . . . . 0.0 111.955 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.47 -31.29 69.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.59 -48.88 53.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.991 0.516 . . . . 0.0 110.976 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.6 ptm -65.97 -31.44 72.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.505 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -56.48 -45.97 80.67 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.175 0.59 . . . . 0.0 110.828 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.564 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 12.3 pt-20 -76.75 -27.67 55.44 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.705 0.402 . . . . 0.0 111.934 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.51 -58.97 3.78 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.864 0.364 . . . . 0.0 110.028 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 106' ' ' LEU . 74.7 mt -57.16 -38.05 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.879 1.271 . . . . 0.0 112.361 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.564 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.69 -29.61 70.82 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.234 0.47 . . . . 0.0 111.611 177.849 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.82 -41.19 60.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.741 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -57.35 -45.09 84.71 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.789 0.836 . . . . 0.0 112.514 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 102' ' ' ILE . 9.7 mp -64.21 -24.95 67.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.871 0.869 . . . . 0.0 111.766 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -85.68 -16.91 37.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.319 0.648 . . . . 0.0 110.657 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 125.134 1.374 . . . . 0.0 111.608 175.72 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.711 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -72.49 144.11 86.06 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.98 0.912 . . . . 0.0 110.167 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.21 148.81 69.45 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.994 2.462 . . . . 0.0 112.128 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.97 149.98 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -140.83 32.68 1.79 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.668 0.787 . . . . 0.0 110.105 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 117' ' ' GLU . 4.5 pp -61.97 -43.03 99.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.813 0.445 . . . . 0.0 110.821 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -76.18 -22.48 55.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.757 1.223 . . . . 0.0 111.853 -178.296 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 tpp85 -50.36 -49.14 55.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.997 1.319 . . . . 0.0 112.246 -170.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.91 -29.19 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.754 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.3 -24.36 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.752 0.821 . . . . 0.0 111.628 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 31.0 mmm180 . . . . . 0 N--CA 1.49 1.536 0 C-N-CA 123.396 0.679 . . . . 0.0 111.364 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.1 t80 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.13 161.3 54.13 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.923 1.289 . . . . 0.0 108.451 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.512 ' HG3' ' HB3' ' A' ' 112' ' ' GLU . 29.8 Cg_exo -62.44 109.66 0.91 Allowed 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 121.859 1.706 . . . . 0.0 111.491 172.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.29 -13.83 33.45 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.896 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -155.12 146.79 23.23 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.542 0.671 . . . . 0.0 112.062 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.9 tp -136.35 128.93 30.55 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.641 1.176 . . . . 0.0 109.039 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -100.3 125.63 46.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 85.8 mt -107.17 134.82 49.71 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.269 0.628 . . . . 0.0 109.928 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 23' ' ' ILE . 13.8 p . . . . . 0 C--O 1.249 1.038 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.082 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 . . . . . 0 C--O 1.238 0.46 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ASP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 50' ' ' ASP . 27.8 t70 -85.74 42.48 0.97 Allowed 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.488 1.137 . . . . 0.0 110.727 -173.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.69 HG22 HG23 ' A' ' 49' ' ' ILE . 44.3 pt -89.7 139.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.445 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -152.85 125.01 8.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 31.4 mt -132.43 132.79 60.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.174 -172.077 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 45' ' ' MET . 5.5 m170 -108.09 109.82 21.35 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -105.27 108.37 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -102.91 109.93 21.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -115.93 117.96 31.6 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.69 114.52 18.12 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.567 HG11 ' HB3' ' A' ' 105' ' ' LYS . 7.1 p -82.25 126.63 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.051 0.54 . . . . 0.0 109.726 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -141.16 166.49 24.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -109.49 117.13 33.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -91.65 156.96 17.23 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.681 0.793 . . . . 0.0 109.665 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.42 -20.76 62.08 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -84.72 -53.62 5.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.28 0.632 . . . . 0.0 111.438 -171.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -117.86 3.92 12.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.958 0.903 . . . . 0.0 111.537 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.44 -122.41 5.72 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.55 51.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.618 0.709 . . . . 0.0 111.994 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -157.75 170.65 21.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.002 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.07 130.35 69.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.079 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.505 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.0 t60 -88.27 129.8 35.27 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -115.07 135.12 54.55 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -137.99 141.36 40.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 91.3 mtp -135.19 131.59 36.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.564 0.746 . . . . 0.0 109.281 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -150.54 162.79 39.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.72 -144.08 12.8 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 1.9 pm0 -147.23 163.16 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.295 1.038 . . . . 0.0 108.547 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 23' ' ' ILE . 38.0 mt -157.81 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 -160.855 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.565 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 37.3 t70 55.38 26.64 8.97 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 121.614 0.721 . . . . 0.0 111.394 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.22 50.97 4.33 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.212 -173.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 52.4 mtpt -146.11 108.41 4.26 Favored Pre-proline 0 N--CA 1.497 1.92 0 C-N-CA 123.564 0.746 . . . . 0.0 110.798 -176.382 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.91 121.44 4.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.863 2.375 . . . . 0.0 111.794 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -125.54 143.68 50.9 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.861 0.465 . . . . 0.0 110.687 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 p -139.92 110.55 6.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.312 0.645 . . . . 0.0 109.477 171.887 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.22 151.85 39.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.697 1.199 . . . . 0.0 109.299 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.8 p -151.43 123.16 8.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.909 0.483 . . . . 0.0 109.85 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.16 146.44 42.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.317 1.047 . . . . 0.0 108.98 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 49.6 mt-10 -123.89 141.29 52.17 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.077 0.551 . . . . 0.0 109.672 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -124.79 130.28 24.3 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -65.65 169.65 12.55 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.936 2.424 . . . . 0.0 112.193 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -41.5 -39.67 1.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.473 1.109 . . . . 0.0 113.617 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.04 -29.5 66.55 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.243 1.017 . . . . 0.0 112.526 -174.089 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -130.99 8.39 4.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.966 0.507 . . . . 0.0 111.376 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.83 70.95 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.531 0.732 . . . . 0.0 111.917 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.16 -21.55 66.79 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.898 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -72.76 3.26 5.33 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.406 0.683 . . . . 0.0 112.593 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.56 -20.61 61.29 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.402 1.081 . . . . 0.0 112.209 -173.012 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.16 -42.9 45.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.938 0.875 . . . . 0.0 108.844 -169.815 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -74.46 -39.62 62.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.155 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.9 t70 -73.71 -59.1 2.87 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.016 0.526 . . . . 0.0 112.14 -171.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.45 66.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.559 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 95.4 m -65.81 -48.23 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 173.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -57.74 -34.33 69.4 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.545 0.738 . . . . 0.0 111.951 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 71' ' ' ASP . 94.0 t -68.8 -36.81 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.12 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' HD13 ' A' ' 81' ' ' LEU . . . -68.44 -49.72 57.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.54 0.736 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 73' ' ' THR . 65.7 mm-40 -66.21 -25.08 66.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -60.13 -28.73 68.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.439 1.096 . . . . 0.0 111.363 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -91.66 12.13 22.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.648 0.779 . . . . 0.0 112.232 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.1 74.32 1.11 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 122.948 0.155 . . . . 0.0 113.292 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HG ' HG21 ' A' ' 23' ' ' ILE . 11.2 mp . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 124.163 0.985 . . . . 0.0 109.681 170.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.3 t80 . . . . . 0 C--O 1.221 -0.414 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.67 -30.45 70.7 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.199 0.937 . . . . 0.0 111.847 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.12 17.82 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.942 0.497 . . . . 0.0 110.893 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -70.96 -25.9 62.93 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.565 0.346 . . . . 0.0 111.869 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -50.97 -42.73 60.3 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.127 0.971 . . . . 0.0 110.303 164.066 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 35.0 mt-10 -79.33 -27.57 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.488 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.83 -50.31 30.68 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.8 -38.81 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.567 0.347 . . . . 0.0 111.648 173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.42 -28.55 69.33 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.739 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.21 -40.6 62.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.053 0.541 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.567 ' HB3' HG11 ' A' ' 31' ' ' VAL . 9.5 mmpt? -58.44 -40.18 81.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.61 0.764 . . . . 0.0 112.059 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.25 -25.58 67.73 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.179 0.992 . . . . 0.0 111.162 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -80.68 -17.91 49.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 110.891 172.488 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 125.899 1.679 . . . . 0.0 111.628 174.856 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.38 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLU . . . . . 0.512 ' HB3' ' HG3' ' A' ' 7' ' ' PRO . 1.1 mm-40 -96.9 114.2 64.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.35 94.28 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.437 2.091 . . . . 0.0 112.822 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.47 93.06 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.21 1.005 . . . . 0.0 109.009 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.99 43.45 1.12 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.3 -173.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.03 -27.82 69.67 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.814 0.445 . . . . 0.0 111.959 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 42.5 tt0 -78.28 -22.07 48.82 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.964 0.506 . . . . 0.0 110.799 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -79.96 -17.09 53.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.985 0.514 . . . . 0.0 110.561 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.3 mm -78.97 91.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 124.063 0.945 . . . . 0.0 108.696 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.1 mt 82.41 -21.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.846 163.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ARG . . . . . 0.455 ' HD3' ' HA ' ' A' ' 117' ' ' GLU . 15.8 mtp180 . . . . . 0 N--CA 1.478 0.97 0 C-N-CA 122.744 0.418 . . . . 0.0 111.14 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.79 157.02 32.61 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.82 1.248 . . . . 0.0 108.02 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.19 89.84 0.39 Allowed 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.943 1.762 . . . . 0.0 110.554 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -14.43 3.78 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.928 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -164.59 153.08 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.955 0.877 . . . . 0.0 111.978 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 4.8 tt -143.26 132.83 23.63 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 175.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -114.55 134.09 55.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.279 0.632 . . . . 0.0 109.667 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 95.1 mt -111.1 128.83 56.01 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 121.317 0.58 . . . . 0.0 110.364 176.979 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 . . . . . 0 C--O 1.242 0.671 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.92 112.38 23.24 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.95 138.65 38.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 24.0 p-10 -151.95 127.7 10.21 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 165.171 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -137.81 128.87 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.717 0.807 . . . . 0.0 109.355 -163.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -93.82 131.65 39.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 56.7 mt -120.36 103.99 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 171.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -91.96 140.17 29.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.31 137.8 19.74 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 111.197 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.25 130.77 37.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.848 0.859 . . . . 0.0 109.271 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.2 t -80.74 117.27 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 42.7 ttt180 -132.95 166.56 22.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.689 1.196 . . . . 0.0 108.144 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.416 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 11.4 mm100 -106.34 127.67 53.43 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 118.349 0.522 . . . . 0.0 111.19 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 40' ' ' TYR . 3.2 p30 -102.95 146.54 28.17 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.825 1.25 . . . . 0.0 108.63 170.498 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.13 61.79 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 9.5 tp10 -77.37 -54.32 6.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.354 0.662 . . . . 0.0 112.008 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -113.55 -23.09 9.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.956 0.902 . . . . 0.0 111.218 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.16 -116.33 4.75 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 149.65 47.23 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.501 0.651 . . . . 0.0 111.724 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.428 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.1 p90 -159.05 173.74 16.0 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.992 0.917 . . . . 0.0 109.278 167.467 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.45 124.47 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -87.63 122.75 31.72 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -108.14 138.62 44.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.504 0.722 . . . . 0.0 110.18 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -130.48 120.46 24.18 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.329 1.052 . . . . 0.0 108.221 172.101 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 80.8 mtp -116.04 130.58 56.87 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.444 0.565 . . . . 0.0 109.702 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.8 161.73 40.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 159.48 -151.09 21.84 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 109.4 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.171 0.986 . . . . 0.0 110.426 175.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 80' ' ' GLY . 72.7 mt -99.47 123.9 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.135 174.82 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.6 t70 63.52 22.93 13.42 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.82 1.248 . . . . 0.0 110.079 -174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.05 3.88 84.83 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.228 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -93.03 108.4 32.18 Favored Pre-proline 0 C--N 1.355 0.823 0 C-N-CA 123.453 0.701 . . . . 0.0 110.722 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 66.8 Cg_endo -72.26 128.36 13.69 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.476 2.117 . . . . 0.0 111.389 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -131.45 150.17 52.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.235 0.614 . . . . 0.0 109.88 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -139.39 125.83 20.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.033 0.533 . . . . 0.0 110.292 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -141.71 147.59 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.4 p -148.51 140.08 23.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.03 151.08 37.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.659 0.783 . . . . 0.0 109.931 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.54 131.6 51.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.861 0.865 . . . . 0.0 109.281 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.63 125.75 23.84 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 30.6 Cg_endo -59.69 157.15 33.79 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.912 2.408 . . . . 0.0 111.382 172.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -44.8 -26.73 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.0 -28.64 62.49 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.779 . . . . 0.0 111.442 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.8 p -131.54 7.19 4.48 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.316 1.046 . . . . 0.0 111.11 -173.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.47 71.64 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.992 0.917 . . . . 0.0 111.401 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -70.91 -8.12 50.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.084 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -90.45 0.5 57.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.662 0.785 . . . . 0.0 110.05 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 6.4 p90 -52.94 -43.62 66.45 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -30.28 65.87 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.651 0.78 . . . . 0.0 112.604 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 t -73.03 -50.45 22.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 109.864 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.15 -45.5 63.41 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.87 0.468 . . . . 0.0 112.025 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.87 -38.93 11.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.717 0.807 . . . . 0.0 112.835 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -71.9 -38.28 69.97 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.62 0.368 . . . . 0.0 110.816 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -57.62 -48.53 79.18 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.912 0.885 . . . . 0.0 110.947 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.87 0.868 . . . . 0.0 110.358 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB1' HD22 ' A' ' 81' ' ' LEU . . . -66.72 -41.81 87.36 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.104 -172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.442 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 13.8 pt20 -72.39 -36.11 68.61 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.243 0.617 . . . . 0.0 110.973 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -27.93 69.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.23 0.612 . . . . 0.0 111.336 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -98.09 7.36 46.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.824 0.45 . . . . 0.0 111.672 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.476 ' O ' HG21 ' A' ' 49' ' ' ILE . . . 102.12 93.0 2.21 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.062 0.226 . . . . 0.0 112.648 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 77' ' ' GLN . 57.5 tp . . . . . 0 N--CA 1.475 0.784 0 CA-C-N 117.371 0.585 . . . . 0.0 110.691 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.8 t80 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.37 -33.54 74.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.592 1.183 . . . . 0.0 112.959 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.09 -52.33 20.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.004 0.431 . . . . 0.0 110.839 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.48 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 1.1 mpt? -61.93 -34.18 75.62 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.787 173.819 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.4 -54.73 39.86 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.049 0.843 . . . . 0.0 110.203 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.95 -27.45 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.191 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.29 -58.55 6.22 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.394 0.616 . . . . 0.0 110.168 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.97 -38.22 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 114.526 -1.216 . . . . 0.0 113.179 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -34.57 78.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.291 0.95 . . . . 0.0 111.157 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.22 -46.8 48.19 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.212 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -41.68 82.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.085 0.954 . . . . 0.0 111.926 174.618 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.71 -38.24 90.32 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.823 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -72.64 -31.21 64.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.439 0.296 . . . . 0.0 111.067 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 125.273 1.429 . . . . 0.0 114.036 172.273 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.606 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.32 146.77 55.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.163 0.985 . . . . 0.0 110.812 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -88.36 -167.67 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.352 2.701 . . . . 0.0 111.87 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.37 144.77 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.322 0.649 . . . . 0.0 109.694 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.55 -4.95 59.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 113.345 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.24 -32.89 74.79 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.529 0.604 . . . . 0.0 111.35 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -85.43 -2.28 57.94 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.493 0.717 . . . . 0.0 110.982 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -86.16 -20.54 28.45 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.253 0.621 . . . . 0.0 110.709 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -81.19 -59.95 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.25 94.73 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.99 161.61 28.62 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.404 1.082 . . . . 0.0 109.236 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.77 100.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.747 2.298 . . . . 0.0 112.599 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.36 -6.87 32.13 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.775 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -158.86 151.92 22.37 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.207 1.004 . . . . 0.0 111.957 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.1 tt -146.75 149.27 33.07 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.607 1.563 . . . . 0.0 107.33 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 1.5 t60 -127.26 139.73 52.71 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.183 0.593 . . . . 0.0 110.452 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 96.9 mt -125.56 135.24 52.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.383 1.473 . . . . 0.0 108.14 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.479 1.009 0 C-N-CA 123.931 0.892 . . . . 0.0 110.691 178.198 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -94.87 87.8 5.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.615 0.366 . . . . 0.0 110.529 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -106.76 128.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.448 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -137.12 131.4 32.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 71.1 mt -144.93 135.82 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -173.186 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -112.4 139.97 47.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -127.21 106.19 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -97.99 141.9 30.38 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -126.33 118.55 25.31 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.65 113.56 17.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 41' ' ' VAL . 58.0 t -79.35 118.11 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.45 158.2 30.26 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.06 121.55 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.61 -0.681 . . . . 0.0 110.344 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.445 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 5.1 p30 -102.04 145.41 29.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.765 0.826 . . . . 0.0 108.858 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.29 -18.05 65.03 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.335 0.654 . . . . 0.0 112.57 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 28.5 tt0 -73.63 -47.09 42.7 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.743 0.817 . . . . 0.0 112.685 -173.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -134.91 -7.87 2.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.508 0.723 . . . . 0.0 111.594 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -123.39 7.76 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.25 128.81 37.38 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 117.062 0.431 . . . . 0.0 111.747 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 10.8 p90 -140.62 162.26 35.79 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 31' ' ' VAL . 15.8 t -119.15 127.29 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.544 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 5.4 t-160 -84.76 108.34 17.4 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 166.467 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.441 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 89.6 m-85 -94.9 116.45 28.72 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -110.44 134.45 52.32 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.511 ' SD ' ' HA ' ' A' ' 72' ' ' ALA . 87.1 mtp -129.55 129.11 44.04 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 118.908 0.776 . . . . 0.0 110.531 175.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -149.99 153.53 36.71 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 0.0 109.763 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 171.37 -145.88 9.14 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.952 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.61 109.75 3.52 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.736 1.268 . . . . 0.0 112.088 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 79' ' ' HIS . 50.3 mt -102.15 128.42 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.589 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ASP . . . . . 0.596 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 38.7 t70 66.56 23.76 10.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.39 1.476 . . . . 0.0 108.618 -169.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 3.36 88.52 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.101 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 51.4 mtmt -97.77 110.18 54.22 Favored Pre-proline 0 C--O 1.245 0.826 0 C-N-CA 124.302 1.041 . . . . 0.0 110.843 -173.064 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 41.6 Cg_endo -63.67 143.56 87.26 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.889 2.393 . . . . 0.0 112.52 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB3' ' CE1' ' A' ' 79' ' ' HIS . 31.2 p90 -144.73 155.27 43.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.441 0.696 . . . . 0.0 109.724 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -148.83 131.21 15.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.324 0.65 . . . . 0.0 109.866 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.41 160.63 39.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.587 1.555 . . . . 0.0 109.168 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 m -148.91 138.51 21.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 109.811 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -136.77 132.86 35.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.6 mp0 -113.96 125.2 53.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.441 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 75.3 mt -127.08 125.64 24.17 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 40' ' ' TYR . 55.6 Cg_endo -64.28 166.66 16.43 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.884 2.389 . . . . 0.0 112.164 176.376 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HG3' HD13 ' A' ' 106' ' ' LEU . 74.2 ttt180 -47.62 -25.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.868 0.867 . . . . 0.0 112.923 174.107 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.83 -37.24 81.67 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.171 0.988 . . . . 0.0 112.678 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.2 p -129.39 4.97 5.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.422 0.689 . . . . 0.0 112.142 -170.243 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.76 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.186 0.994 . . . . 0.0 112.189 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -71.37 0.44 8.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.892 1.277 . . . . 0.0 113.975 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -93.3 -0.46 56.68 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.646 0.779 . . . . 0.0 110.999 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -54.35 -34.02 60.26 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.56 68.99 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.562 0.619 . . . . 0.0 112.582 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.8 m -73.54 -39.25 64.89 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.571 0.544 . . . . 0.0 109.99 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.15 -52.97 14.17 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.452 0.701 . . . . 0.0 111.271 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -48.98 -30.24 5.79 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.056 1.342 . . . . 0.0 113.106 172.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -81.66 -41.43 21.41 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.327 0.251 . . . . 0.0 110.665 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -63.73 -42.09 97.95 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.336 0.655 . . . . 0.0 111.612 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.21 -39.26 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.51 1.124 . . . . 0.0 110.401 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.92 83.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.003 0.921 . . . . 0.0 110.982 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 12.9 pt20 -78.85 -32.7 46.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.627 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -51.92 -48.11 64.34 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.77 1.228 . . . . 0.0 112.505 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.554 ' HB3' HD12 ' A' ' 49' ' ' ILE . 16.5 t-80 -80.72 14.06 2.3 Favored 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.87 50.8 0.62 Allowed Glycine 0 C--N 1.349 1.265 0 O-C-N 122.051 -0.406 . . . . 0.0 112.865 170.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD13 HG12 ' A' ' 23' ' ' ILE . 65.5 tp . . . . . 0 CA--C 1.543 0.684 0 C-N-CA 123.436 0.694 . . . . 0.0 109.716 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.9 t80 . . . . . 0 C--O 1.219 -0.526 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.04 -30.33 71.29 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.766 0.827 . . . . 0.0 110.82 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.52 61.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.905 0.482 . . . . 0.0 110.532 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.2 ttt -62.17 -39.25 92.04 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.467 0.707 . . . . 0.0 111.353 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.51 -50.83 64.57 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.334 1.454 . . . . 0.0 110.106 174.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -65.61 -34.02 77.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.99 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.32 -50.2 64.41 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.11 0.564 . . . . 0.0 109.948 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.47 -39.94 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.727 0.811 . . . . 0.0 112.054 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -68.63 -30.7 69.48 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.96 0.41 . . . . 0.0 110.613 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.33 62.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.822 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.03 0.932 . . . . 0.0 112.43 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.508 HD13 ' HG3' ' A' ' 62' ' ' ARG . 26.6 mt -65.7 -27.17 68.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.977 0.911 . . . . 0.0 112.56 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -71.5 -16.85 62.36 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.445 0 C-N-CA 124.843 1.257 . . . . 0.0 110.656 -179.19 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.713 0 CA-C-O 121.184 0.325 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.76 124.74 61.42 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.903 0.881 . . . . 0.0 110.342 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.97 168.33 23.61 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.952 2.435 . . . . 0.0 111.322 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.34 151.86 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.369 0.668 . . . . 0.0 109.578 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -117.54 69.19 0.77 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.72 -28.58 13.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.337 0.655 . . . . 0.0 110.825 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.69 -37.07 65.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -71.26 -14.18 62.15 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.077 0.551 . . . . 0.0 111.782 -171.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp -75.25 -53.28 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.591 0.756 . . . . 0.0 109.219 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.97 92.57 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.937 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.9 t80 . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.87 155.0 51.97 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.553 1.141 . . . . 0.0 108.601 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.69 108.97 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.643 2.229 . . . . 0.0 112.532 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.23 11.57 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.496 0.569 . . . . 0.0 113.354 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -148.28 141.95 25.55 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.632 0.73 . . . . 0.0 112.191 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.89 139.86 53.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.179 . . . . 0.0 108.347 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -128.56 117.5 21.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -120.6 110.05 15.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.837 0.855 . . . . 0.0 110.039 -179.11 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 168.31 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 . . . . . 0 C--O 1.241 0.634 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.97 59.08 4.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.503 0.721 . . . . 0.0 110.424 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.508 HG22 HG23 ' A' ' 49' ' ' ILE . 2.3 pp -89.9 121.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 173.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -150.65 116.58 5.57 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.547 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 25.8 mt -138.61 145.08 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.323 1.049 . . . . 0.0 108.181 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -132.44 127.14 34.68 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.55 HG12 ' HG2' ' A' ' 45' ' ' MET . 52.3 mt -109.74 123.44 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 108.675 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 14.0 mmm180 -109.54 117.89 35.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.863 0.865 . . . . 0.0 109.088 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -111.43 119.61 39.39 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -122.06 113.92 20.21 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.945 0.898 . . . . 0.0 109.346 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.69 121.72 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 122.701 0.4 . . . . 0.0 110.434 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -140.53 162.86 34.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.559 1.144 . . . . 0.0 108.102 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -111.19 117.56 33.56 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.832 0.453 . . . . 0.0 109.825 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.474 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 26.1 p-10 -102.46 147.32 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.983 0.913 . . . . 0.0 109.93 172.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.24 -20.55 63.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.326 0.65 . . . . 0.0 111.692 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 13.9 tp10 -70.15 -53.62 16.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.883 0.873 . . . . 0.0 111.626 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.9 m -119.21 0.88 11.28 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -170.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.3 -119.27 4.84 Favored Glycine 0 C--N 1.345 1.037 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.44 144.72 44.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.224 0.512 . . . . 0.0 110.473 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 p90 -158.36 169.88 23.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.5 0.5 . . . . 0.0 110.501 171.824 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.18 133.24 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -96.91 133.18 41.88 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 83.8 m-85 -119.01 135.08 54.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.758 0.423 . . . . 0.0 110.036 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 22.9 m-20 -115.85 139.47 50.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.45 1.1 . . . . 0.0 108.948 173.54 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.55 ' HG2' HG12 ' A' ' 27' ' ' ILE . 84.4 mtp -135.18 128.47 32.09 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 158.09 32.87 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.742 0.817 . . . . 0.0 109.046 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.92 -126.28 2.02 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -159.31 163.29 35.82 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 23' ' ' ILE . 44.1 mt -157.32 107.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 -166.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.34 39.01 5.49 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.325 1.059 . . . . 0.0 108.493 -166.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.76 -17.96 2.54 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.27 123.03 69.3 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.011 0.905 . . . . 0.0 110.273 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.27 152.8 56.09 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.815 2.343 . . . . 0.0 113.437 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -144.67 146.68 32.36 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.75 0.82 . . . . 0.0 108.875 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -145.45 114.52 6.99 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.262 0.625 . . . . 0.0 109.421 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.53 160.23 38.08 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.079 1.352 . . . . 0.0 108.957 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 p -152.21 136.39 16.58 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.08 0.552 . . . . 0.0 110.01 172.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -136.56 141.48 43.34 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.162 0.985 . . . . 0.0 109.607 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -115.31 125.04 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' LEU . . . . . 0.4 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 96.9 mt -115.06 125.56 28.81 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 123.389 0.676 . . . . 0.0 109.184 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 33.4 Cg_endo -60.79 156.52 42.8 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.888 2.392 . . . . 0.0 111.703 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -41.53 -44.85 3.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.919 1.288 . . . . 0.0 112.818 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.69 -25.4 66.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.749 1.22 . . . . 0.0 112.503 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.7 p -132.04 17.91 4.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.873 0.869 . . . . 0.0 110.728 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.34 -44.06 76.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.884 0.474 . . . . 0.0 111.453 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.26 -4.79 23.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.135 0.974 . . . . 0.0 112.674 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.51 4.6 15.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.88 0.872 . . . . 0.0 111.407 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -63.37 -19.47 64.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.432 1.093 . . . . 0.0 113.115 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.17 56.5 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.231 0.539 . . . . 0.0 109.926 -167.87 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -71.53 -39.07 70.97 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.366 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 75' ' ' VAL . 21.6 t70 -74.6 -49.22 22.5 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.478 0.486 . . . . 0.0 111.375 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.94 83.05 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.513 0.725 . . . . 0.0 112.412 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 m -66.67 -43.39 84.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.649 0.38 . . . . 0.0 110.264 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.0 ttm180 -52.8 -38.63 61.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.133 0.973 . . . . 0.0 111.751 171.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -71.11 -38.88 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.346 0.658 . . . . 0.0 109.552 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.73 -49.64 51.21 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 -173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.437 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 21.1 pt20 -70.1 -24.36 63.2 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.863 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.8 -30.0 69.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.353 0.661 . . . . 0.0 110.929 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.492 ' HB2' HD12 ' A' ' 49' ' ' ILE . 54.7 m80 -99.78 10.59 41.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.214 0.606 . . . . 0.0 110.85 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.59 43.9 5.37 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.935 174.247 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.437 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 38.7 tp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.292 0.568 . . . . 0.0 109.634 171.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.4 t80 . . . . . 0 C--O 1.21 -1.017 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -57.91 -40.04 79.42 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.37 -45.58 54.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.419 0.288 . . . . 0.0 111.18 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.41 -34.05 76.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.537 0.735 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.49 -51.09 71.35 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.525 1.13 . . . . 0.0 109.824 172.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.482 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 34.1 mt-10 -69.52 -26.79 64.69 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.943 0.777 . . . . 0.0 111.429 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 14.3 t70 -70.98 -55.37 8.47 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.45 0.469 . . . . 0.0 109.803 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.19 -40.73 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.724 0.809 . . . . 0.0 112.056 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -63.01 -30.34 71.53 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.121 0.486 . . . . 0.0 110.521 177.106 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.045 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.3 mmmt -59.24 -40.07 84.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.857 0.863 . . . . 0.0 112.009 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.71 -28.22 69.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.586 0.755 . . . . 0.0 111.917 174.348 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -77.64 -16.79 58.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.133 0.573 . . . . 0.0 111.146 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 126.094 1.758 . . . . 0.0 110.413 179.664 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.338 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 128.11 90.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.562 0.745 . . . . 0.0 111.283 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.45 106.43 1.05 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.246 1.964 . . . . 0.0 112.206 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.26 148.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -124.67 18.09 8.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -171.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.47 -36.02 79.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.563 0.345 . . . . 0.0 111.565 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.61 -30.23 29.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.231 0.612 . . . . 0.0 110.666 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -66.16 -28.29 68.67 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.423 0.689 . . . . 0.0 111.336 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.76 -30.35 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.241 0.616 . . . . 0.0 109.998 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.7 mt -76.67 80.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.608 0.718 . . . . 0.0 109.609 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 . . . . . 0 C--O 1.243 0.738 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.094 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.78 153.48 70.44 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.309 1.044 . . . . 0.0 108.935 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.15 109.92 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.41 -8.4 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-O 120.25 -0.195 . . . . 0.0 112.666 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.547 ' NE2' ' HB3' ' A' ' 26' ' ' HIS . 11.3 t-160 -160.02 126.01 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.321 0.581 . . . . 0.0 110.437 -173.04 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 tp -100.95 145.63 28.41 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.49 1.116 . . . . 0.0 109.03 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 2.6 t-160 -124.85 117.34 23.91 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 170.832 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 89.5 mt -89.91 110.04 21.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.513 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.82 55.12 3.24 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.014 0.912 . . . . 0.0 110.529 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.542 HG22 HG23 ' A' ' 49' ' ' ILE . 2.2 pp -87.95 115.32 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . 0.464 HD21 ' HG3' ' A' ' 48' ' ' GLU . 5.9 p30 -146.01 110.21 4.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.0 mt -130.01 141.21 46.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.613 -166.169 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 45' ' ' MET . 19.1 m170 -107.4 122.21 46.15 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.449 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -123.07 109.6 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 17.7 ttt180 -91.41 133.29 35.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -123.9 118.62 27.5 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.19 113.12 13.47 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 41' ' ' VAL . 91.1 t -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 15.6 ttt180 -127.9 161.07 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.41 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.6 mm-40 -111.27 114.34 27.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -96.04 154.76 17.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.915 0.886 . . . . 0.0 110.503 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.32 -16.19 61.89 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.02 0.528 . . . . 0.0 111.952 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.08 -53.1 11.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.702 0.801 . . . . 0.0 111.981 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.8 t -126.55 -1.11 6.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.4 0.68 . . . . 0.0 112.461 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.57 -114.47 4.16 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 145.19 42.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.176 0.488 . . . . 0.0 110.817 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -153.27 171.91 17.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.437 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 31' ' ' VAL . 7.1 t -124.32 128.02 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 8.5 t60 -84.48 123.4 30.22 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 94.0 m-85 -115.88 140.11 49.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.279 0.632 . . . . 0.0 109.47 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -143.41 137.9 28.98 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.346 172.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.595 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 83.7 mtp -123.17 136.91 54.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 111.114 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -163.47 162.77 24.85 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.125 0.57 . . . . 0.0 110.958 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.11 -130.47 3.73 Favored Glycine 0 N--CA 1.469 0.864 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.464 ' HG3' HD21 ' A' ' 24' ' ' ASN . 10.4 pt-20 -157.89 166.32 32.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.686 0.794 . . . . 0.0 110.08 173.173 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 23' ' ' ILE . 97.3 mt -155.77 105.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -161.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 60.67 35.34 19.83 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.098 0.951 . . . . 0.0 108.739 -170.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.17 -22.26 8.73 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 114.563 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -77.84 113.75 35.43 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.891 0.877 . . . . 0.0 111.148 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.41 154.13 40.38 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.143 2.562 . . . . 0.0 113.122 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PHE . . . . . 0.423 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 11.8 p90 -152.69 156.42 39.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.712 0.405 . . . . 0.0 111.282 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 p -153.11 124.52 7.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.858 0.863 . . . . 0.0 110.264 168.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -144.72 165.25 28.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.397 1.479 . . . . 0.0 108.524 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 p -153.2 142.06 21.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.723 0.409 . . . . 0.0 110.7 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -144.03 141.06 29.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.834 0.853 . . . . 0.0 110.154 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 44.6 mt-10 -125.55 125.38 43.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.23 132.54 24.19 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -171.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.78 160.86 34.86 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.646 2.231 . . . . 0.0 111.175 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -51.75 -28.4 15.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.03 -37.96 89.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.927 0.891 . . . . 0.0 112.161 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.7 p -126.72 12.84 7.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.098 0.559 . . . . 0.0 112.061 -171.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.46 76.48 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.201 0.6 . . . . 0.0 111.831 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -69.89 -11.49 60.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.384 1.074 . . . . 0.0 113.667 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -83.61 1.59 41.5 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.145 0.578 . . . . 0.0 111.73 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -54.89 -25.61 30.17 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.227 1.411 . . . . 0.0 113.937 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.22 -33.27 61.35 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -167.194 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 m -69.69 -38.24 76.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.473 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -72.09 -46.62 56.07 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.507 0.505 . . . . 0.0 110.027 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -58.06 -50.81 72.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.56 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 m -69.15 -23.24 63.93 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 0.0 111.533 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.5 ttp-105 -74.46 -34.03 63.06 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.107 0.479 . . . . 0.0 110.465 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.77 -32.56 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 109.908 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.66 -54.35 7.11 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.043 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.435 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 21.2 mm-40 -62.49 -22.86 66.58 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.253 -1.339 . . . . 0.0 112.935 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -48.6 -36.45 15.7 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.209 0.604 . . . . 0.0 112.08 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -108.11 -31.27 8.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.738 0.245 . . . . 0.0 110.527 170.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.59 94.35 0.53 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 160.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 52.7 tp . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 110.109 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.6 t80 . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.39 -33.7 76.11 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.008 0.817 . . . . 0.0 110.728 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.55 61.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.937 0.495 . . . . 0.0 110.961 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.6 ttm -68.04 -34.39 76.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.372 0.669 . . . . 0.0 111.459 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -55.26 -47.27 75.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.311 1.045 . . . . 0.0 110.044 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.3 -25.57 60.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.0 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.4 -60.85 2.67 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.432 HG22 HD22 ' A' ' 106' ' ' LEU . 72.6 mt -54.75 -40.99 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.084 0.954 . . . . 0.0 111.729 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -31.39 72.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 123.207 0.317 . . . . 0.0 111.61 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.08 -51.65 56.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.394 0.677 . . . . 0.0 111.535 -176.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -28.19 62.41 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.973 0.509 . . . . 0.0 110.542 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.432 HD22 HG22 ' A' ' 102' ' ' ILE . 6.0 mp -71.77 -28.76 63.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.572 0.349 . . . . 0.0 110.447 175.126 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -81.51 -17.06 49.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.252 1.021 . . . . 0.0 109.643 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -177.681 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.446 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.58 159.99 69.37 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.257 1.023 . . . . 0.0 110.319 -172.079 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.62 124.99 15.15 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.674 2.249 . . . . 0.0 111.414 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.89 131.16 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 122.961 0.504 . . . . 0.0 109.902 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -94.88 3.05 55.42 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 118.439 -0.791 . . . . 0.0 113.009 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -53.11 -34.88 58.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.762 0.664 . . . . 0.0 111.416 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.54 87.34 2.34 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 166.223 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -133.39 29.62 3.94 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.9 mm -106.74 -53.39 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.296 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.9 mm -87.97 74.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.342 1.057 . . . . 0.0 109.699 177.214 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.7 t80 . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.85 157.14 34.5 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.486 1.114 . . . . 0.0 108.356 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.71 102.78 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.919 1.746 . . . . 0.0 111.651 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.34 -8.62 24.61 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.338 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -157.8 151.66 24.09 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.529 0.664 . . . . 0.0 111.898 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.7 tp -140.51 142.27 35.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.596 1.558 . . . . 0.0 108.382 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -111.7 138.25 48.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.587 0.755 . . . . 0.0 109.265 173.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 75.3 mt -118.53 126.65 52.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.076 0.95 . . . . 0.0 109.145 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 C--O 1.248 1.012 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 164.933 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.735 0.303 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.73 84.68 6.76 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 -171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.488 HG22 HG23 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -106.97 145.71 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.432 -175.379 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -151.74 138.13 18.53 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.17 166.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 53.5 mt -142.64 136.49 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.4 m170 -107.34 136.19 47.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.7 mt -130.44 108.47 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 26.2 mtp180 -92.97 134.63 34.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.401 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -129.38 117.11 20.06 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -132.74 117.14 17.45 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.55 0.74 . . . . 0.0 109.438 -171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 41' ' ' VAL . 48.0 t -80.03 115.67 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 24.5 ttt180 -120.98 162.4 19.97 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.436 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.3 mm-40 -106.55 124.85 50.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.054 -0.404 . . . . 0.0 110.277 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -94.98 144.25 25.83 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -12.84 61.87 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.467 0.707 . . . . 0.0 112.089 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -79.62 -49.91 11.45 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.006 0.922 . . . . 0.0 112.488 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t -128.8 -4.8 5.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.759 0.823 . . . . 0.0 111.543 -169.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.57 -118.34 5.55 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.96 138.01 47.72 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.049 0.54 . . . . 0.0 112.335 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.92 171.13 18.79 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.176 0.99 . . . . 0.0 109.083 170.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 31' ' ' VAL . 30.5 t -120.77 127.68 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 122.892 0.477 . . . . 0.0 110.169 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.432 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.6 t60 -88.93 108.67 19.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.53 135.39 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 24.7 t70 -125.82 136.05 52.68 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.384 1.073 . . . . 0.0 108.545 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 87.0 mtp -136.32 131.19 34.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.463 0.574 . . . . 0.0 110.496 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -155.62 162.2 40.67 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 122.772 0.429 . . . . 0.0 111.523 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.09 -151.07 21.94 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.66 111.07 4.7 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.122 0.961 . . . . 0.0 111.172 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.488 HG23 HG22 ' A' ' 23' ' ' ILE . 74.2 mt -97.61 125.47 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.605 177.474 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 63.24 25.57 14.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.11 1.364 . . . . 0.0 109.687 -170.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.2 4.35 90.5 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.294 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -94.59 110.44 49.11 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.899 0.88 . . . . 0.0 111.724 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.37 140.82 45.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.829 2.353 . . . . 0.0 112.209 -175.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.4 145.63 35.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.143 0.577 . . . . 0.0 109.958 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 p -140.56 115.15 9.47 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.93 152.45 39.44 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -174.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -147.57 155.9 42.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.136 0.575 . . . . 0.0 111.189 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.92 147.35 31.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.914 0.886 . . . . 0.0 109.88 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 41.2 mt-10 -124.89 128.09 48.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.924 0.889 . . . . 0.0 109.273 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.58 123.87 21.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 123.913 0.885 . . . . 0.0 109.326 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.52 164.57 20.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.782 2.321 . . . . 0.0 112.199 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.682 ' HG3' ' HB3' ' A' ' 106' ' ' LEU . 37.6 ttt180 -44.66 -33.72 1.94 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.776 1.23 . . . . 0.0 113.773 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.31 -36.68 71.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.418 0.687 . . . . 0.0 111.569 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -118.53 9.65 12.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.465 0.706 . . . . 0.0 110.853 -170.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.48 -29.06 65.93 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.675 0.79 . . . . 0.0 111.235 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.11 -8.69 55.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.283 1.433 . . . . 0.0 113.294 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -90.69 8.03 36.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.113 0.965 . . . . 0.0 110.764 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -51.34 -45.4 62.29 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.34 71.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 m -65.98 -50.32 64.72 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.377 0.535 . . . . 0.0 110.336 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.5 m-20 -70.94 -48.93 50.75 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.425 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.9 -51.01 56.1 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.171 0.988 . . . . 0.0 112.066 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.0 m -59.86 -43.56 94.62 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.456 0.703 . . . . 0.0 111.34 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -58.87 -48.48 81.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.892 0.877 . . . . 0.0 110.49 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 71' ' ' ASP . 63.6 t -62.66 -35.0 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.664 0.786 . . . . 0.0 110.429 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.01 -53.41 14.89 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 110.704 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.502 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 14.0 pt20 -71.2 -34.29 70.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.778 -171.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -60.86 -32.58 72.0 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.553 0.533 . . . . 0.0 110.759 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -92.58 15.47 14.2 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.15 0.58 . . . . 0.0 111.676 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.15 62.95 0.84 Allowed Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 3.5 mm? . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 162.656 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 119.645 -0.216 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.934 0.771 . . . . 0.0 111.932 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.86 -49.77 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.3 ttm -64.2 -35.15 79.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 111.243 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -61.32 -51.41 68.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.498 1.119 . . . . 0.0 110.422 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.94 -28.67 67.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 37.6 t70 -71.67 -47.7 52.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ILE . . . . . 0.464 ' O ' HD23 ' A' ' 106' ' ' LEU . 42.0 mt -58.74 -44.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.809 0.843 . . . . 0.0 111.563 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -62.89 -28.78 70.27 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.36 14.92 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.814 0.846 . . . . 0.0 111.911 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.0 mmmt -58.86 -42.59 89.76 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.21 1.004 . . . . 0.0 112.43 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.682 ' HB3' ' HG3' ' A' ' 62' ' ' ARG . 4.4 mm? -71.52 -22.22 61.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.604 0.761 . . . . 0.0 112.067 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -75.23 -24.61 57.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.689 0.396 . . . . 0.0 110.474 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.832 0 C-N-CA 125.701 1.6 . . . . 0.0 110.624 -174.944 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.725 0 N-CA-C 113.494 0.157 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.57 148.93 70.72 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -171.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -56.35 164.41 5.39 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.843 3.029 . . . . 0.0 114.123 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.53 122.48 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-O 121.459 0.647 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.53 27.83 1.06 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.832 0.853 . . . . 0.0 112.406 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.03 -30.22 71.18 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.471 0.308 . . . . 0.0 110.657 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.63 9.23 40.99 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.897 0.879 . . . . 0.0 111.929 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -76.43 -9.3 58.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.313 0.578 . . . . 0.0 111.412 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.76 -39.71 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.26 1.024 . . . . 0.0 109.681 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.1 mt -112.12 89.08 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.702 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 t80 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.082 0.468 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.38 154.69 73.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 125.335 1.454 . . . . 0.0 107.894 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.82 99.45 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.284 1.99 . . . . 0.0 111.917 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.43 -18.49 6.84 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.542 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' HIS . . . . . 0.543 ' NE2' ' HB3' ' A' ' 26' ' ' HIS . 20.8 t-80 -158.27 151.25 22.67 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.246 0.523 . . . . 0.0 111.793 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 27' ' ' ILE . 54.4 tp -134.61 150.04 50.65 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.001 1.32 . . . . 0.0 108.509 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -124.15 139.67 53.71 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.534 0.734 . . . . 0.0 109.24 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.48 128.01 48.33 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.554 1.131 0 CA-C-O 122.728 1.251 . . . . 0.0 112.526 -175.0 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 . . . . . 0 CA--C 1.543 0.701 0 CA-C-O 122.748 1.261 . . . . 0.0 112.833 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.49 113.33 26.02 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.886 173.932 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -120.38 132.3 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -139.82 119.63 13.38 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.2 mt -143.66 151.52 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -170.335 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.543 ' HB3' ' NE2' ' A' ' 9' ' ' HIS . 15.1 m170 -126.61 146.53 50.13 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.551 HD12 HD23 ' A' ' 10' ' ' LEU . 60.2 mt -125.77 106.44 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -97.33 132.61 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.02 125.24 26.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -127.32 115.55 19.17 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 41' ' ' VAL . 47.0 t -86.93 115.21 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 51.1 ttt85 -125.17 163.64 22.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.7 mm-40 -112.87 112.55 24.1 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 35.5 p-10 -95.42 144.34 26.02 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.343 0.657 . . . . 0.0 109.511 171.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -19.09 65.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.121 0.569 . . . . 0.0 111.432 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 36.3 tt0 -67.81 -52.15 40.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.749 1.22 . . . . 0.0 112.091 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -123.4 -14.52 7.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -172.617 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -125.97 8.69 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.67 134.53 50.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.817 0.447 . . . . 0.0 110.773 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.1 170.82 19.0 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.553 0.741 . . . . 0.0 109.21 170.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 31' ' ' VAL . 4.8 t -127.69 121.9 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -89.52 121.34 31.64 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -107.39 137.93 44.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.402 0.681 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -126.9 123.3 36.92 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtp -118.88 130.03 55.52 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.279 0.491 . . . . 0.0 110.391 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.92 159.84 43.0 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 0.0 110.713 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.4 -147.11 12.49 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 0.8 OUTLIER -148.45 108.29 4.03 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.303 1.051 . . . . 0.0 111.653 172.666 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.59 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.22 16.67 9.37 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 124.545 1.153 . . . . 0.0 110.5 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.36 -15.22 59.08 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.088 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 95.6 mttt -83.28 109.93 20.76 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.816 0.847 . . . . 0.0 112.748 -173.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.2 138.67 33.77 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.324 2.016 . . . . 0.0 110.601 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -145.47 155.7 43.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.524 0.33 . . . . 0.0 110.824 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 p -150.56 130.06 13.01 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.978 0.911 . . . . 0.0 108.969 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -144.91 157.29 44.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -176.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 m -143.62 142.14 30.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.917 0.487 . . . . 0.0 110.969 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -141.11 146.58 37.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.882 0.873 . . . . 0.0 109.077 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.22 129.81 49.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.87 122.0 24.41 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.48 163.95 25.17 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.767 2.312 . . . . 0.0 111.089 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.487 ' HG3' HD13 ' A' ' 106' ' ' LEU . 61.7 ttt180 -48.6 -30.62 5.56 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.761 0.825 . . . . 0.0 111.568 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.77 -40.52 80.0 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.766 1.226 . . . . 0.0 112.726 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 p -128.36 14.23 6.62 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.594 0.758 . . . . 0.0 111.87 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' PHE . . . -63.74 -29.38 70.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.541 0.737 . . . . 0.0 111.66 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PHE . . . . . 0.653 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 71.6 m-85 -70.77 -1.13 10.53 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -96.53 5.42 50.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.958 0.903 . . . . 0.0 110.269 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 25.7 p90 -53.72 -49.66 67.64 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.632 1.173 . . . . 0.0 112.474 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.04 -29.8 60.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.591 0.756 . . . . 0.0 111.087 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -71.35 -45.34 63.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.003 0.814 . . . . 0.0 109.209 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.26 -41.01 64.16 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.878 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.55 56.33 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.504 0.722 . . . . 0.0 112.42 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 95.2 m -71.18 -43.24 67.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.708 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 44.7 ttt180 -55.66 -53.21 59.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.515 1.126 . . . . 0.0 111.734 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 8.5 p -69.78 -32.17 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.489 0.716 . . . . 0.0 111.381 -178.223 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.04 82.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.415 0.626 . . . . 0.0 110.429 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.789 ' HA ' HD22 ' A' ' 81' ' ' LEU . 96.3 mt-30 -76.32 -40.09 52.33 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.387 -1.278 . . . . 0.0 112.361 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.7 mtpp -53.18 -35.63 60.04 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.024 0.93 . . . . 0.0 112.45 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -79.6 25.07 0.35 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.48 59.45 10.82 Favored Glycine 0 C--N 1.363 2.079 0 C-N-CA 123.275 0.464 . . . . 0.0 114.141 174.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.789 HD22 ' HA ' ' A' ' 77' ' ' GLN . 1.2 pt? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.658 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--O 1.218 -0.565 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.97 -39.1 73.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.21 1.004 . . . . 0.0 112.085 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.29 -50.53 67.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.737 0.415 . . . . 0.0 110.813 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.1 ttm -70.76 -31.28 68.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.617 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.73 -56.11 18.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 6.0 mm-40 -69.82 -28.28 65.58 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.658 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.23 -49.35 61.3 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.93 -42.77 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.441 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ARG . . . . . 0.653 ' HB3' ' HE1' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -65.94 -31.18 71.95 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.464 0.575 . . . . 0.0 111.563 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.91 84.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.66 -28.77 62.93 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.845 0.858 . . . . 0.0 112.805 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 106' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 62' ' ' ARG . 89.3 mt -63.98 -34.11 77.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.392 0.677 . . . . 0.0 110.572 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -68.69 -17.95 64.17 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.607 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 126.379 1.871 . . . . 0.0 109.583 -175.712 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.468 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.72 159.38 83.32 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.241 1.016 . . . . 0.0 112.604 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 26.5 Cg_endo -59.13 96.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.237 2.625 . . . . 0.0 113.706 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -167.74 136.58 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.708 0.803 . . . . 0.0 109.75 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -127.5 41.83 3.44 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.075 0.95 . . . . 0.0 110.157 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.38 -35.61 77.96 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.726 0.81 . . . . 0.0 112.042 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.45 -6.43 52.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.862 0.865 . . . . 0.0 111.504 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -77.4 5.01 9.56 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 122.156 -0.34 . . . . 0.0 111.817 -174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.6 mm -77.19 -64.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.396 0.679 . . . . 0.0 110.062 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.3 mt -108.74 105.82 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.906 0.882 . . . . 0.0 108.83 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 123.66 0.784 . . . . 0.0 109.6 177.819 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.2 t80 . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.04 152.33 23.41 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.342 1.057 . . . . 0.0 109.376 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.07 96.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.862 2.375 . . . . 0.0 112.749 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.57 -22.11 5.28 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.961 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -155.26 151.6 28.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.473 HD22 ' SD ' ' A' ' 98' ' ' MET . 55.4 tp -135.88 131.47 35.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.747 1.619 . . . . 0.0 107.411 176.204 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -113.82 139.96 48.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.554 0.741 . . . . 0.0 110.452 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 30.3 mt -134.15 124.72 26.54 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.487 1.389 0 CA-C-N 120.192 1.36 . . . . 0.0 114.325 -174.345 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HG3' HG23 ' A' ' 23' ' ' ILE . 20.1 pt20 . . . . . 0 C--O 1.244 0.793 0 CA-C-O 120.932 0.396 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.52 100.94 7.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ILE . . . . . 0.438 HG23 ' HG3' ' A' ' 21' ' ' GLN . 19.2 pt -117.0 145.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.22 0.534 . . . . 0.0 109.954 169.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -152.92 125.94 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 163.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.7 mt -139.32 116.3 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.5 m170 -104.25 122.69 45.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ILE . . . . . 0.516 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 57.3 mt -114.88 105.34 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 44' ' ' ASP . 67.2 ttt180 -97.89 140.4 32.3 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.729 1.212 . . . . 0.0 108.478 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.41 136.38 36.21 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -131.52 116.04 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.375 1.07 . . . . 0.0 108.419 -172.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 105' ' ' LYS . 72.8 t -87.01 123.66 40.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 19.2 ttt180 -153.14 169.25 23.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.476 1.111 . . . . 0.0 108.759 -170.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLN . . . . . 0.473 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 10.8 mm100 -106.68 127.0 53.0 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.32 0.648 . . . . 0.0 110.225 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . 0.452 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 3.1 p30 -102.96 147.69 26.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.35 1.06 . . . . 0.0 108.896 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.16 -20.23 62.32 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' GLU . . . . . 0.452 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 10.6 tp10 -71.09 -48.18 53.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.9 0.88 . . . . 0.0 111.677 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.5 m -131.47 -6.91 3.73 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.492 0.717 . . . . 0.0 112.905 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.94 -124.17 8.08 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -68.5 137.14 54.16 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.403 0.602 . . . . 0.0 111.286 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -155.91 178.37 10.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.492 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 31' ' ' VAL . 20.2 t -133.44 127.85 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.778 0.831 . . . . 0.0 109.397 173.089 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -89.31 121.43 31.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.831 0.852 . . . . 0.0 108.912 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -102.8 133.22 48.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 108.913 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 27.1 t70 -133.48 114.15 13.3 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.023 0.929 . . . . 0.0 109.883 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' A' ' 27' ' ' ILE . 43.4 mtm -119.86 145.43 46.68 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.736 -0.603 . . . . 0.0 111.451 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -156.93 157.9 35.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.146 0.578 . . . . 0.0 111.24 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.85 -156.05 27.48 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.28 115.19 6.08 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.845 1.322 . . . . 0.0 111.411 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 79' ' ' HIS . 50.5 mt -97.74 130.69 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.212 176.809 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.33 -69.88 0.1 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.159 1.783 . . . . 0.0 110.617 -168.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.27 47.21 0.11 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.597 -2.201 . . . . 0.0 107.597 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -137.07 104.29 8.82 Favored Pre-proline 0 C--N 1.35 0.592 0 CA-C-N 114.261 -0.97 . . . . 0.0 108.91 -172.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 136.75 33.83 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.381 2.054 . . . . 0.0 110.834 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -135.35 138.02 42.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.2 p -134.14 118.22 17.44 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -132.74 139.73 47.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.276 1.03 . . . . 0.0 109.385 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.7 p -140.54 124.0 16.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -136.55 142.1 43.4 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.814 0.846 . . . . 0.0 108.782 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -121.33 130.58 53.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.423 0.689 . . . . 0.0 109.772 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.29 130.32 23.57 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.79 155.64 36.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.716 2.277 . . . . 0.0 111.187 171.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 32.3 ptt180 -41.85 -26.08 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -85.53 -13.61 48.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.753 0.821 . . . . 0.0 111.621 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.0 p -132.49 -2.4 3.43 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.404 1.082 . . . . 0.0 111.222 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.94 -36.71 72.92 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.552 1.141 . . . . 0.0 111.988 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.88 -9.43 54.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.374 1.07 . . . . 0.0 112.761 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -91.73 -7.57 49.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.315 0.646 . . . . 0.0 110.514 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PHE . . . . . 0.514 ' HZ ' ' SD ' ' A' ' 98' ' ' MET . 4.0 p90 -54.12 -35.78 62.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.602 0.761 . . . . 0.0 112.769 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.43 -26.56 20.49 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -72.49 -52.66 14.81 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 75' ' ' VAL . 38.9 t0 -73.14 -54.28 8.88 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.472 0.709 . . . . 0.0 112.799 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.03 -38.43 4.83 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.3 1.04 . . . . 0.0 113.041 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.9 m -77.27 -37.69 52.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.462 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.7 -47.98 81.27 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.946 0.898 . . . . 0.0 111.402 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 71' ' ' ASP . 41.5 t -61.25 -39.5 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.079 0.952 . . . . 0.0 110.264 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 25' ' ' ILE . . . -66.67 -44.7 81.14 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.857 0.863 . . . . 0.0 110.953 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLN . . . . . 0.415 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 5.3 pp0? -76.59 -26.85 55.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -59.77 -45.9 90.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.342 0.657 . . . . 0.0 111.968 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' HIS . . . . . 0.533 ' HB2' HD12 ' A' ' 49' ' ' ILE . 56.3 m80 -74.34 -30.35 61.98 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.42 80.34 0.04 OUTLIER Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 158.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 38.9 tp . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 C--O 1.214 -0.804 0 CA-C-O 119.288 -0.386 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.0 -35.9 67.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.042 0.537 . . . . 0.0 111.942 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 -44.69 69.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.541 0.686 . . . . 0.0 110.854 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' MET . . . . . 0.514 ' SD ' ' HZ ' ' A' ' 68' ' ' PHE . 39.7 ttp -60.46 -34.45 74.04 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.759 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -69.53 -53.87 16.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.153 0.981 . . . . 0.0 109.859 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.7 -28.68 69.58 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.941 0.776 . . . . 0.0 112.785 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.58 -54.78 16.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.936 0.495 . . . . 0.0 109.982 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.4 mt -62.43 -42.02 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.545 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.14 -31.38 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.7 0.682 . . . . 0.0 110.907 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.61 64.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.593 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' LYS . . . . . 0.478 ' HB3' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.69 -47.94 80.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.646 0.779 . . . . 0.0 112.133 174.883 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.44 -39.04 88.67 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.683 0.615 . . . . 0.0 110.468 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -59.1 -31.9 69.33 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.244 1.017 . . . . 0.0 111.196 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 C-N-CA 125.397 1.479 . . . . 0.0 110.679 -176.236 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.17 154.73 94.35 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.627 1.171 . . . . 0.0 111.969 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.66 148.08 58.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.582 2.188 . . . . 0.0 111.945 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.73 152.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.728 0.811 . . . . 0.0 109.4 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.51 26.8 10.28 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.741 0.816 . . . . 0.0 111.651 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.5 -29.55 67.21 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.84 -2.23 53.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.302 0.641 . . . . 0.0 111.846 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.98 -9.48 58.65 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.588 0.755 . . . . 0.0 112.425 -170.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.3 mp -88.51 67.42 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 121.524 0.678 . . . . 0.0 109.628 -174.59 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 mt 52.95 35.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 125.396 1.478 . . . . 0.0 112.528 166.311 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 . . . . . 0 N--CA 1.483 1.202 0 O-C-N 121.397 -0.814 . . . . 0.0 110.439 -178.437 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.447 ' HA2' ' HB ' ' A' ' 13' ' ' VAL . . . 71.61 -85.11 0.44 Allowed Glycine 0 C--N 1.355 1.598 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -84.41 141.76 30.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.287 0.635 . . . . 0.0 109.329 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.462 ' HB3' ' HB3' ' A' ' 11' ' ' HIS . 56.8 ttp -153.04 144.26 23.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.219 1.008 . . . . 0.0 108.682 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -125.34 144.47 50.48 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.912 0.387 . . . . 0.0 110.491 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.01 152.54 55.26 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 125.309 1.444 . . . . 0.0 107.929 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.3 97.15 0.29 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.769 1.646 . . . . 0.0 111.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.4 -15.3 6.08 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.636 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -160.83 153.75 21.22 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 117.378 0.589 . . . . 0.0 112.202 -172.462 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt -135.6 125.74 26.2 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 11.4 t-160 -98.1 139.83 33.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.315 1.046 . . . . 0.0 110.148 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -132.26 117.89 18.78 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.728 0.811 . . . . 0.0 110.809 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.447 ' HB ' ' HA2' ' A' ' 2' ' ' GLY . 84.3 t -135.98 160.82 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 162.489 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.8 t -92.2 125.45 36.88 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 120.068 1.304 . . . . 0.0 107.49 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.06 138.64 87.41 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.88 133.4 47.47 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.751 2.301 . . . . 0.0 111.962 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.87 -31.79 7.87 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.913 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -77.75 -64.62 1.11 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.28 0.632 . . . . 0.0 110.263 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -156.79 109.6 2.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.389 0.676 . . . . 0.0 109.416 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.74 82.65 6.68 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.627 0.727 . . . . 0.0 109.798 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.2 tt0 -146.05 148.72 32.97 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.78 82.7 4.98 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.483 HG22 HG23 ' A' ' 49' ' ' ILE . 1.3 pp -109.83 128.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 p30 -150.86 123.59 8.58 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 46.1 mt -140.47 140.52 34.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 45' ' ' MET . 6.6 m170 -114.24 134.29 55.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 171.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.418 HG12 ' HG2' ' A' ' 45' ' ' MET . 58.2 mt -123.5 105.76 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -102.87 132.69 48.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -129.25 123.73 32.68 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.2 116.45 20.64 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 41' ' ' VAL . 79.2 t -79.11 117.14 24.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -118.76 159.51 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -107.93 119.35 39.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.7 0.4 . . . . 0.0 109.928 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.531 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 35.9 p-10 -99.53 148.8 23.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.252 1.021 . . . . 0.0 109.152 168.655 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.61 60.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.981 0.513 . . . . 0.0 111.972 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.531 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 35.5 tt0 -75.99 -55.29 5.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.841 0.856 . . . . 0.0 111.823 -179.193 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.7 t -114.63 -6.97 12.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.236 0.614 . . . . 0.0 111.668 -174.554 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.41 -108.23 3.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -172.168 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.19 141.73 45.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.117 0.459 . . . . 0.0 111.289 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 7.7 p90 -156.64 166.87 32.15 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.929 0.891 . . . . 0.0 108.796 168.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 31' ' ' VAL . 3.9 t -115.8 126.51 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 122.066 -0.396 . . . . 0.0 110.219 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 63.9 t60 -90.69 120.54 31.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.228 1.011 . . . . 0.0 108.7 170.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -107.75 145.05 34.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.1 0.56 . . . . 0.0 110.336 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -128.64 128.6 44.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.603 1.161 . . . . 0.0 108.672 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 82.7 mtp -123.82 129.41 50.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.1 0.409 . . . . 0.0 110.352 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -154.16 147.44 24.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.854 0.462 . . . . 0.0 111.425 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.44 -151.18 16.75 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.83 108.73 3.7 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.895 1.348 . . . . 0.0 111.022 171.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.483 HG23 HG22 ' A' ' 23' ' ' ILE . 68.4 mt -100.76 127.97 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.485 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 63.22 22.16 13.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.004 1.321 . . . . 0.0 109.167 -170.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.48 -3.41 87.07 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.558 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.51 109.98 28.14 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 112.003 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.68 141.95 31.62 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.868 2.378 . . . . 0.0 111.96 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.09 147.92 39.32 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.141 0.577 . . . . 0.0 110.072 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.4 p -138.68 116.51 11.54 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.87 147.13 51.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.591 1.157 . . . . 0.0 108.964 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.9 m -142.63 129.59 20.67 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -138.81 143.43 38.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.737 0.815 . . . . 0.0 109.019 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 62.4 mt-10 -126.38 133.6 51.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.365 0.666 . . . . 0.0 110.202 -174.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt -124.2 128.86 24.92 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 124.159 0.983 . . . . 0.0 109.231 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 44.7 Cg_endo -63.99 161.76 31.91 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.75 2.3 . . . . 0.0 111.466 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -44.91 -32.27 1.55 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.934 0.894 . . . . 0.0 113.161 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -70.53 -29.6 66.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.742 1.217 . . . . 0.0 112.443 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.6 p -130.49 16.29 5.43 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.854 0.861 . . . . 0.0 110.319 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.18 98.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.353 0.661 . . . . 0.0 111.053 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -73.46 -2.51 22.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.482 1.113 . . . . 0.0 112.566 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 4.7 m-20 -88.48 2.08 53.54 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.686 0.794 . . . . 0.0 110.41 173.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.548 ' HE2' ' SD ' ' A' ' 98' ' ' MET . 12.3 p90 -54.39 -49.97 68.64 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.225 1.01 . . . . 0.0 112.528 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.14 -28.44 39.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -71.79 -51.88 20.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.768 0.427 . . . . 0.0 110.146 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -52.24 13.95 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.4 13.8 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.865 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 m -75.8 -44.59 40.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -56.02 -45.19 79.18 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.789 1.236 . . . . 0.0 112.002 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.05 -31.65 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.765 0.826 . . . . 0.0 110.937 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.77 -43.15 80.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.127 0.571 . . . . 0.0 110.618 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.61 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 18.3 pt20 -78.71 -25.82 44.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.258 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -65.76 -25.13 67.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.184 0.594 . . . . 0.0 110.422 169.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.415 ' HB3' HD12 ' A' ' 49' ' ' ILE . 26.2 m80 -86.67 0.73 54.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.302 0.641 . . . . 0.0 112.595 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.39 43.47 0.64 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 4.4 mm? -115.96 138.54 51.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 165.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -95.61 153.39 39.45 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.272 0.629 . . . . 0.0 109.545 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.03 -15.14 26.29 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.239 2.626 . . . . 0.0 114.006 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.16 -28.98 69.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.813 0.845 . . . . 0.0 111.019 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -61.05 -32.16 71.79 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.607 1.163 . . . . 0.0 111.222 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.82 46.44 4.53 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 -172.579 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.68 -74.27 0.16 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.988 0.515 . . . . 0.0 110.53 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 tt -101.11 -18.3 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.414 0.686 . . . . 0.0 110.368 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.9 p -84.8 -2.15 57.32 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.314 1.046 . . . . 0.0 112.646 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -103.16 118.77 37.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.6 m -69.8 97.12 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -66.13 107.02 1.79 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -73.5 -28.89 62.15 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.234 0.614 . . . . 0.0 110.795 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -86.12 5.92 31.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.926 0.89 . . . . 0.0 111.701 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -59.18 -38.72 80.51 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 122.899 0.479 . . . . 0.0 110.048 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.36 -32.9 72.81 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.747 0.654 . . . . 0.0 111.811 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.73 -44.59 66.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.381 0.673 . . . . 0.0 111.17 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.548 ' SD ' ' HE2' ' A' ' 68' ' ' PHE . 28.6 ttm -63.76 -39.83 95.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.397 0.679 . . . . 0.0 111.844 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.52 -50.29 74.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.416 1.486 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 11.9 pt-20 -70.55 -30.91 67.76 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.67 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.47 -54.4 47.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.67 -38.03 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.62 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.585 HH11 ' HB2' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -69.74 -31.15 68.98 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.202 0.91 . . . . 0.0 111.46 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB2' HH11 ' A' ' 103' ' ' ARG . . . -75.09 -44.7 45.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.561 0.345 . . . . 0.0 110.469 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -59.26 -42.78 91.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.924 1.29 . . . . 0.0 113.117 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.94 -32.14 72.53 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.712 0.805 . . . . 0.0 111.412 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -80.7 -19.91 44.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 110.676 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 83.74 -46.74 0.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.689 1.996 . . . . 0.0 110.884 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -92.15 143.24 27.24 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.85 160.14 49.69 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.66 2.24 . . . . 0.0 112.34 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.73 64.66 0.16 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.416 ' CD ' ' H ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -97.54 118.64 64.04 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.087 0.955 . . . . 0.0 109.945 -175.544 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.47 114.91 2.19 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.288 2.659 . . . . 0.0 112.982 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.0 p -71.75 139.91 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.641 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.57 1.63 13.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -63.07 -33.83 76.29 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.876 0.762 . . . . 0.0 111.801 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.63 -39.35 73.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.219 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -60.34 -21.32 61.92 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.429 1.092 . . . . 0.0 111.535 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.97 -33.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.366 0.603 . . . . 0.0 109.472 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.49 -27.11 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.893 0.877 . . . . 0.0 110.123 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -62.9 90.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.262 0.625 . . . . 0.0 111.745 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -167.69 174.67 7.5 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.73 1.612 . . . . 0.0 108.888 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -153.85 117.31 4.62 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.974 0.509 . . . . 0.0 109.904 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.87 -67.88 0.06 OUTLIER Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.885 0.374 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.18 149.78 21.47 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -127.81 -77.83 0.57 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.377 0.589 . . . . 0.0 110.115 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.6 ttp -75.09 105.97 6.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.963 0.505 . . . . 0.0 109.792 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -127.99 140.01 52.23 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.917 0.887 . . . . 0.0 109.389 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.48 151.61 25.81 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.96 0.904 . . . . 0.0 109.03 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -56.42 92.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.654 2.236 . . . . 0.0 112.127 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.54 -40.61 1.03 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.896 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -154.69 144.16 21.36 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.209 0.603 . . . . 0.0 111.832 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.8 tp -126.91 134.58 50.42 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.863 1.265 . . . . 0.0 108.869 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -98.72 115.54 28.96 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 1.3 tm? -97.51 110.14 22.76 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.35 139.44 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.7 t -85.02 154.35 22.16 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.413 ' HB2' HD13 ' A' ' 88' ' ' ILE . 58.8 mt -73.16 109.51 6.5 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 63.4 Cg_endo -71.19 -30.95 15.27 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.525 2.15 . . . . 0.0 112.8 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.43 -95.2 0.25 Allowed Glycine 0 C--N 1.35 1.33 0 O-C-N 123.761 0.663 . . . . 0.0 112.058 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.05 19.7 15.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.729 0.812 . . . . 0.0 109.774 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 16' ' ' PRO . 5.6 m-20 61.59 87.83 0.09 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.318 1.447 . . . . 0.0 111.738 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 13.7 mm100 -114.05 -42.2 3.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.375 0.67 . . . . 0.0 110.498 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -129.78 150.5 51.06 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -127.07 103.78 7.63 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.577 HG21 ' HG ' ' A' ' 81' ' ' LEU . 1.7 pp -120.31 149.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -153.52 120.77 5.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.32 0.648 . . . . 0.0 109.862 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 55.8 mt -139.14 141.37 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.659 0.784 . . . . 0.0 109.601 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.1 m170 -104.26 112.42 25.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.2 mt -112.23 109.78 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.62 123.99 51.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.874 1.27 . . . . 0.0 107.679 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -121.04 128.28 52.5 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -119.52 113.3 20.53 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 92.1 t -77.54 115.84 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -145.51 167.58 22.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 108.734 -170.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -111.4 121.62 45.7 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.744 0.417 . . . . 0.0 110.495 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.435 ' H ' HD22 ' A' ' 34' ' ' ASN . 0.6 OUTLIER -99.78 153.53 19.05 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.521 1.129 . . . . 0.0 110.317 173.125 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.86 -24.48 61.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.204 0.601 . . . . 0.0 111.991 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -73.57 -49.34 26.8 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.222 1.009 . . . . 0.0 112.273 -172.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -133.89 17.13 3.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.352 0.661 . . . . 0.0 111.187 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.09 -111.97 3.4 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.007 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -78.43 147.48 34.0 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 117.298 0.549 . . . . 0.0 110.451 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -159.6 179.54 8.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 t -132.64 130.59 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 4.6 t60 -88.42 109.0 19.66 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.174 0.99 . . . . 0.0 108.59 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 56.4 m-85 -94.91 127.49 40.98 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.16 127.83 28.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.413 0.685 . . . . 0.0 109.296 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 84.1 mtp -133.79 145.05 49.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.92 0.888 . . . . 0.0 110.861 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.18 165.53 17.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.436 0.694 . . . . 0.0 109.846 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.79 -134.4 5.25 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.9 172.19 17.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.186 0.594 . . . . 0.0 110.157 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 79' ' ' HIS . 58.4 mt -155.27 101.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 -166.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 54.39 41.13 32.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.483 0.713 . . . . 0.0 111.189 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.26 16.26 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.543 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.77 109.9 12.4 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.167 0.987 . . . . 0.0 111.369 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -81.35 152.44 18.02 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.028 2.486 . . . . 0.0 113.73 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.07 160.52 41.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 p -141.03 118.11 11.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.972 0.909 . . . . 0.0 109.358 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -139.62 150.0 44.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.884 0.874 . . . . 0.0 109.799 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 p -150.68 137.53 19.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.956 0.502 . . . . 0.0 109.904 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.91 145.04 45.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 0.0 108.738 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 39.6 mt-10 -124.55 123.91 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -175.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.1 mt -120.63 133.49 24.07 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.188 0.595 . . . . 0.0 109.398 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.01 163.97 6.94 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.317 2.678 . . . . 0.0 113.286 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 31.4 ptt85 -45.46 -37.12 4.91 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.821 1.248 . . . . 0.0 112.537 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.07 -28.09 68.58 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.817 1.247 . . . . 0.0 112.886 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.4 p -130.55 15.28 5.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.674 0.79 . . . . 0.0 111.16 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.7 73.54 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.072 0.549 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.03 -23.97 64.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.501 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -77.29 -2.45 34.86 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.587 0.755 . . . . 0.0 111.64 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -66.0 -21.14 66.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.43 62.35 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 -161.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 p -67.62 -33.63 75.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.228 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.468 ' O ' HG23 ' A' ' 75' ' ' VAL . 5.1 m-20 -72.27 -56.8 4.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.433 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.02 67.04 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.673 1.189 . . . . 0.0 112.41 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.8 m -67.06 -50.24 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.249 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -56.93 -35.51 69.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.104 0.962 . . . . 0.0 112.795 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 71' ' ' ASP . 53.4 t -57.93 -44.86 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.74 0.816 . . . . 0.0 109.676 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.75 74.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.903 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 11.0 mm100 -60.14 -38.32 82.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.295 0.638 . . . . 0.0 111.364 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.91 -30.32 70.11 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.079 0.951 . . . . 0.0 111.982 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.46 ' HB3' HD12 ' A' ' 49' ' ' ILE . 63.4 t60 -91.69 24.84 2.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.872 0.469 . . . . 0.0 111.515 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.2 49.48 2.83 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 111.846 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' HG21 ' A' ' 23' ' ' ILE . 1.7 tt -134.39 128.42 33.56 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -175.36 94.57 0.27 Allowed Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.26 91.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.851 2.367 . . . . 0.0 112.133 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.21 -30.59 54.75 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.861 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -74.75 -21.28 59.43 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.295 168.317 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.17 81.18 0.14 Allowed Glycine 0 C--N 1.351 1.363 0 O-C-N 124.074 0.859 . . . . 0.0 113.675 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.42 -12.72 59.99 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.218 1.007 . . . . 0.0 110.355 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.413 HD13 ' HB2' ' A' ' 15' ' ' LEU . 19.4 pt -55.1 100.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 125.128 1.371 . . . . 0.0 111.63 170.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.8 t -104.75 -25.24 12.75 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.151 0.58 . . . . 0.0 110.619 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -89.08 20.8 3.46 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.636 0.774 . . . . 0.0 111.935 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.3 m -93.9 67.69 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 124.116 0.967 . . . . 0.0 110.205 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.64 133.02 55.12 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.291 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -77.91 2.65 16.72 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.873 0.869 . . . . 0.0 110.917 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 61.96 39.33 13.57 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 124.959 1.304 . . . . 0.0 110.652 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -58.54 -35.34 72.17 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.345 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.72 -45.5 74.07 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.599 0.76 . . . . 0.0 112.35 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.64 -48.34 60.23 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.995 0.518 . . . . 0.0 110.45 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.16 -38.02 81.91 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.963 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -53.91 -45.63 71.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.545 1.138 . . . . 0.0 110.142 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -71.15 -28.77 64.51 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.382 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 28.2 t70 -68.19 -54.18 19.69 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.358 0.411 . . . . 0.0 110.044 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.33 -47.59 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.947 0.899 . . . . 0.0 111.481 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -63.59 -28.27 69.81 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.565 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.59 -54.47 6.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.807 0.843 . . . . 0.0 112.439 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 14.1 mmmm -67.85 -37.36 81.77 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.66 -24.56 63.63 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.516 0.326 . . . . 0.0 111.181 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 60.3 t-80 -76.99 -17.91 58.56 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.914 0.886 . . . . 0.0 109.699 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.86 10.86 3.82 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.293 1.837 . . . . 0.0 112.572 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 65.2 m80 -148.42 143.62 17.62 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -52.87 139.85 59.15 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 122.862 2.375 . . . . 0.0 112.834 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.59 -20.93 59.81 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.823 0.702 . . . . 0.0 114.573 -170.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -147.94 154.28 43.21 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.94 0.896 . . . . 0.0 109.323 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.42 148.94 92.33 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.49 2.126 . . . . 0.0 111.132 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.92 142.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.92 20.81 15.46 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.099 0.559 . . . . 0.0 111.98 -173.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 117' ' ' GLU . 4.4 pp -57.15 -37.62 72.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.529 0.732 . . . . 0.0 112.289 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' N ' HD12 ' A' ' 116' ' ' LEU . 26.4 tt0 -87.27 -14.79 39.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.472 0.709 . . . . 0.0 110.947 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -80.68 -11.92 59.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.083 0.553 . . . . 0.0 110.543 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.56 -35.99 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.1 mt -86.05 14.54 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 124.215 1.006 . . . . 0.0 110.57 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -77.68 94.76 4.47 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 121.187 -0.945 . . . . 0.0 109.911 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -156.57 134.1 10.8 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.765 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -113.24 -55.1 2.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.831 0.852 . . . . 0.0 108.917 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.8 26.51 0.02 OUTLIER Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.107 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 CA--C 1.552 1.052 0 C-N-CA 123.923 0.889 . . . . 0.0 108.944 -179.284 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.21 -40.02 95.28 Favored Glycine 0 C--N 1.352 1.445 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 -169.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -138.29 105.03 5.35 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 117.047 0.424 . . . . 0.0 110.82 -171.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.423 ' HB3' ' HB3' ' A' ' 11' ' ' HIS . 8.7 tmm? -114.55 128.25 56.23 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 170.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -133.64 137.77 45.57 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.112 0.415 . . . . 0.0 110.672 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -143.47 154.6 60.34 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.275 1.03 . . . . 0.0 108.681 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.76 101.4 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.698 2.266 . . . . 0.0 112.644 174.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.62 -14.24 11.75 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.936 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -158.01 122.46 4.23 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.509 0.655 . . . . 0.0 112.182 -175.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.6 tp -102.98 120.98 41.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.58 1.152 . . . . 0.0 108.848 168.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 21.7 t-160 -99.49 121.97 41.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.032 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.5 mt -98.92 137.26 37.74 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.733 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.83 170.02 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 165.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.553 ' OG ' HG13 ' A' ' 23' ' ' ILE . 16.5 m -93.0 160.09 15.02 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.143 -1.598 . . . . 0.0 109.688 168.39 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -115.03 101.67 54.6 Favored Pre-proline 0 N--CA 1.48 1.072 0 O-C-N 122.049 -0.407 . . . . 0.0 110.855 173.733 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 15' ' ' LEU . 24.3 Cg_endo -54.94 119.06 5.87 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.448 2.765 . . . . 0.0 112.727 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.85 -60.69 0.6 Allowed Glycine 0 C--N 1.344 1.018 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.97 13.54 34.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.916 0.887 . . . . 0.0 109.302 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.53 134.79 9.26 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -127.73 43.17 3.18 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.482 0.713 . . . . 0.0 110.141 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -151.35 155.57 38.96 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.219 0.608 . . . . 0.0 109.456 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.64 69.34 0.97 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.643 0.735 . . . . 0.0 110.834 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.553 HG13 ' OG ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -89.02 134.63 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.922 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -156.11 111.07 2.89 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.746 0.784 . . . . 0.0 109.443 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 60.1 mt -124.47 143.87 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.591 1.156 . . . . 0.0 110.041 -168.245 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.6 m170 -104.68 111.47 24.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 45' ' ' MET . 61.8 mt -109.98 109.19 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -115.17 119.66 37.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 47.8 p90 -121.11 131.73 54.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.013 0.525 . . . . 0.0 110.307 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.78 122.45 28.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.419 0.688 . . . . 0.0 110.018 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 HG22 ' A' ' 41' ' ' VAL . 59.2 t -70.86 124.74 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 43.9 ttt180 -146.12 165.08 30.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.064 0.946 . . . . 0.0 109.278 -175.232 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.471 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 24.1 mm-40 -114.74 115.57 27.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.803 0.841 . . . . 0.0 108.872 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.432 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 31.5 p-10 -101.93 147.77 26.15 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.173 0.589 . . . . 0.0 110.002 170.362 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.18 65.2 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.989 0.516 . . . . 0.0 111.29 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.432 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 32.6 tt0 -66.84 -54.63 20.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.91 0.884 . . . . 0.0 112.293 -177.31 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.1 m -120.26 4.16 10.81 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.245 0.618 . . . . 0.0 112.09 -168.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -134.83 12.87 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -73.6 141.59 46.59 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.789 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -161.4 178.69 8.92 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.023 0.44 . . . . 0.0 110.788 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.44 HG22 HG22 ' A' ' 31' ' ' VAL . 23.8 t -125.97 132.8 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 48.0 t60 -92.88 129.56 38.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.479 1.112 . . . . 0.0 108.593 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 50.8 m-85 -119.18 143.28 47.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.264 0.626 . . . . 0.0 110.447 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 41.5 m-20 -130.23 141.53 50.62 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.054 0.942 . . . . 0.0 109.183 174.738 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.481 ' HG2' HG12 ' A' ' 27' ' ' ILE . 87.5 mtp -132.97 128.51 36.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.882 0.873 . . . . 0.0 108.784 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.86 161.19 31.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.502 0.321 . . . . 0.0 110.488 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.64 -122.89 2.47 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.93 164.11 38.9 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.749 0.82 . . . . 0.0 110.001 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -155.58 113.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -169.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.48 40.14 29.69 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.221 1.01 . . . . 0.0 110.383 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.99 -39.0 3.04 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.608 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -79.69 129.4 71.31 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 123.851 0.86 . . . . 0.0 111.754 -169.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.64 164.22 23.5 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.26 2.64 . . . . 0.0 113.879 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.94 159.92 37.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.616 0.766 . . . . 0.0 110.688 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.5 p -144.22 112.95 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.529 0.732 . . . . 0.0 110.459 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 154.38 51.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.85 1.26 . . . . 0.0 109.643 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.8 p -152.97 139.71 18.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.979 0.512 . . . . 0.0 109.799 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.1 150.25 44.07 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.596 0.758 . . . . 0.0 110.126 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.45 125.68 38.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.779 0.831 . . . . 0.0 109.36 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.9 mt -119.38 134.43 23.77 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.459 0.704 . . . . 0.0 109.812 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.67 158.8 48.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.04 2.493 . . . . 0.0 112.225 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 26.1 ptt180 -41.64 -38.24 1.34 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.172 1.389 . . . . 0.0 114.2 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.85 -25.59 62.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.788 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 p -131.83 8.44 4.48 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.558 0.743 . . . . 0.0 111.494 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.23 88.09 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -68.03 -14.26 62.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.04 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 18.4 m120 -79.55 2.01 23.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.412 0.685 . . . . 0.0 111.697 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -65.0 -14.41 60.29 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 124.127 0.971 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.17 -36.78 66.67 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -73.2 -40.99 64.32 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.01 -52.21 60.59 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.255 0.622 . . . . 0.0 110.662 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -55.08 -49.32 71.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.51 1.124 . . . . 0.0 112.01 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -64.84 -29.1 70.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.851 0.461 . . . . 0.0 111.454 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.6 tpp180 -72.3 -41.56 66.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.038 0.535 . . . . 0.0 110.238 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.81 -31.78 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.397 1.079 . . . . 0.0 109.9 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.455 ' HB1' HD23 ' A' ' 81' ' ' LEU . . . -71.41 -49.89 37.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.54 0.736 . . . . 0.0 109.799 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.588 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 46.4 mt-30 -70.09 -28.87 65.76 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.753 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.71 -29.9 68.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.475 0.71 . . . . 0.0 110.453 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -105.97 21.36 17.44 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 111.214 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.16 40.08 5.57 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 121.969 -0.457 . . . . 0.0 113.951 166.293 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.588 ' HB3' ' HG2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -69.82 -38.99 76.75 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.767 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.8 m80 77.34 165.79 0.13 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 125.95 1.7 . . . . 0.0 112.258 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.71 53.44 2.3 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.252 2.634 . . . . 0.0 110.165 160.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -68.71 -46.54 68.7 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.126 -1.397 . . . . 0.0 113.044 -159.716 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -60.92 -33.53 73.29 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.424 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.01 22.38 60.27 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.38 -173.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.8 26.12 0.12 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.642 0.777 . . . . 0.0 111.149 -169.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.2 pt -75.57 -6.19 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 122.328 0.251 . . . . 0.0 110.549 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.6 p -56.11 -46.42 79.12 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.563 1.145 . . . . 0.0 111.164 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -114.38 121.99 45.29 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.693 0.797 . . . . 0.0 109.683 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.02 146.19 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.236 1.014 . . . . 0.0 109.201 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -73.47 131.63 42.01 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -104.02 115.29 30.18 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.151 0.58 . . . . 0.0 109.805 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -104.87 19.83 19.84 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.029 0.932 . . . . 0.0 110.382 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -64.13 -40.82 97.01 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 123.871 0.868 . . . . 0.0 111.0 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.23 -39.98 93.46 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.545 0.738 . . . . 0.0 111.735 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.01 70.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.266 0.627 . . . . 0.0 111.114 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.426 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 53.2 ttp -64.4 -43.0 95.79 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.401 1.08 . . . . 0.0 112.323 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.07 -50.09 49.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.703 1.201 . . . . 0.0 111.492 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.85 -28.37 50.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.646 0.591 . . . . 0.0 110.687 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.68 -59.98 3.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.707 0.803 . . . . 0.0 111.299 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.411 ' O ' HD13 ' A' ' 106' ' ' LEU . 56.2 mt -63.79 -36.42 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.38 0.672 . . . . 0.0 111.372 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -29.16 70.0 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.622 ' HB1' ' HA ' ' A' ' 110' ' ' PRO . . . -74.13 -38.14 63.87 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.327 0.651 . . . . 0.0 110.689 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.45 ' HA ' ' HE3' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -65.61 -35.84 81.99 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 112.179 173.588 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 102' ' ' ILE . 9.8 mp -65.3 -32.71 74.5 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.59 0.756 . . . . 0.0 110.728 170.276 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.62 -16.4 59.58 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.349 1.059 . . . . 0.0 111.216 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 98.04 -27.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 127.599 2.359 . . . . 0.0 112.248 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -138.7 148.82 59.99 Favored Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 123.098 0.559 . . . . 0.0 110.562 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.622 ' HA ' ' HB1' ' A' ' 104' ' ' ALA . 56.7 Cg_endo -68.02 94.94 0.41 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.737 2.292 . . . . 0.0 112.135 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.09 96.66 0.8 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 143.29 94.51 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.207 0.603 . . . . 0.0 111.906 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -93.31 105.95 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.029 2.486 . . . . 0.0 112.22 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.79 107.49 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 CA-C-O 122.36 1.076 . . . . 0.0 109.491 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.91 21.35 1.61 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.475 1.11 . . . . 0.0 111.983 -163.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.78 -27.5 68.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.268 0.627 . . . . 0.0 110.792 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -68.05 -11.59 59.26 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.973 1.309 . . . . 0.0 111.39 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -87.77 -19.86 26.95 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.052 0.941 . . . . 0.0 112.4 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.16 74.0 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.8 mt 72.15 -5.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 C-N-CA 125.323 1.449 . . . . 0.0 112.364 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -70.41 -54.78 11.02 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.822 -0.549 . . . . 0.0 109.709 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -112.67 137.93 50.23 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 166.762 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.2 -36.8 0.1 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.201 1.0 . . . . 0.0 109.899 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.93 -119.28 10.85 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.862 0.726 . . . . 0.0 114.143 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.252 1.231 0 C-N-CA 124.619 1.168 . . . . 0.0 108.602 177.531 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.74 -132.57 10.17 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.543 -0.587 . . . . 0.0 111.981 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.2 m80 59.6 21.25 9.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.002 1.321 . . . . 0.0 111.882 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.468 ' HB2' ' HB3' ' A' ' 11' ' ' HIS . 86.9 mtp -74.26 97.94 3.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.492 0.717 . . . . 0.0 110.155 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -131.49 128.85 40.23 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.31 0.644 . . . . 0.0 109.456 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.48 157.13 63.16 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 125.126 1.37 . . . . 0.0 108.858 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.61 102.34 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.279 1.986 . . . . 0.0 111.33 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.01 -25.15 5.85 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.569 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -152.81 142.04 21.48 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.56 0.68 . . . . 0.0 112.118 -171.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.7 tp -131.51 133.33 44.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.643 1.577 . . . . 0.0 108.55 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 4' ' ' MET . 2.3 t60 -107.56 117.99 35.55 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 80.7 mt -88.74 128.77 35.63 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.634 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m -127.52 160.29 36.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 159.102 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.534 ' HB3' HG13 ' A' ' 23' ' ' ILE . 65.7 p -75.48 164.91 25.87 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.79 -0.569 . . . . 0.0 111.406 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.47 143.75 13.26 Favored Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 124.057 0.943 . . . . 0.0 113.011 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.35 -153.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.173 2.582 . . . . 0.0 112.687 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.32 -111.38 3.46 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.897 -0.391 . . . . 0.0 112.794 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.2 mt -73.15 -31.26 64.15 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.376 0.671 . . . . 0.0 110.709 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 56.92 79.45 0.19 Allowed 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.598 1.186 . . . . 0.0 109.604 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -56.86 -35.19 68.59 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.814 0.846 . . . . 0.0 111.424 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -150.28 159.33 44.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.896 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -114.73 101.39 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.274 1.03 . . . . 0.0 108.935 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 14' ' ' SER . 2.1 pp -113.95 143.86 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 171.548 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -144.36 108.65 4.81 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.8 mt -131.68 139.19 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.57 0.748 . . . . 0.0 110.411 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.4 m170 -104.65 111.04 23.59 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.534 HG12 ' HG2' ' A' ' 45' ' ' MET . 37.4 mt -112.08 119.84 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.59 123.64 50.35 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -112.01 115.79 29.5 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.83 111.92 16.06 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.817 0.447 . . . . 0.0 109.991 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 105' ' ' LYS . 89.0 t -81.5 119.69 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.805 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -131.93 145.77 51.7 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -103.1 113.17 26.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.48 HD22 ' HD1' ' A' ' 40' ' ' TYR . 3.5 p30 -99.95 142.32 31.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.63 -16.8 63.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.265 0.626 . . . . 0.0 112.162 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.406 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 14.2 tp10 -75.22 -46.66 32.51 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.759 0.823 . . . . 0.0 111.675 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.6 t -126.77 -11.71 6.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.356 0.663 . . . . 0.0 112.06 -168.55 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.96 -139.41 14.38 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.3 143.58 57.1 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.434 0.617 . . . . 0.0 111.257 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' HD1' HD22 ' A' ' 34' ' ' ASN . 8.8 p90 -148.15 165.37 31.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 31' ' ' VAL . 10.1 t -130.38 134.71 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.562 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 57.5 t60 -94.36 113.46 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.857 1.263 . . . . 0.0 108.863 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 71.4 m-85 -104.12 115.45 30.44 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.814 . . . . 0.0 108.945 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -120.93 119.32 32.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.534 ' HG2' HG12 ' A' ' 27' ' ' ILE . 81.2 mtp -126.09 134.84 51.25 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.159 0.583 . . . . 0.0 111.086 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -165.37 177.31 7.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.085 0.554 . . . . 0.0 110.181 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.43 -123.7 2.98 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 10.1 pt-20 -152.96 167.35 29.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.387 1.075 . . . . 0.0 109.868 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.531 HG23 HG22 ' A' ' 23' ' ' ILE . 36.8 mt -157.15 105.31 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -172.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.547 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 3.2 m-20 64.03 40.76 6.91 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.193 0.997 . . . . 0.0 109.838 -174.447 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.23 -23.56 3.89 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.638 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 44.4 mtmt -82.88 116.57 64.8 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.159 0.984 . . . . 0.0 110.413 -171.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 88.8 Cg_endo -74.92 162.26 37.58 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.049 2.5 . . . . 0.0 113.841 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -158.3 165.68 34.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.715 0.806 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.9 p -153.13 121.66 6.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.283 1.033 . . . . 0.0 109.819 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -155.4 145.04 21.25 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.96 0.904 . . . . 0.0 110.047 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 t -146.58 146.73 30.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.095 0.558 . . . . 0.0 110.653 -170.16 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -142.19 149.78 40.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.34 1.056 . . . . 0.0 110.297 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.3 mp0 -118.6 135.48 54.41 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 89.7 mt -124.45 124.97 25.68 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.68 168.91 12.33 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.108 2.539 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.551 ' HG3' HD23 ' A' ' 106' ' ' LEU . 76.4 ttt180 -47.06 -35.96 7.5 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.222 1.009 . . . . 0.0 112.504 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -58.6 -35.34 72.27 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.554 1.142 . . . . 0.0 112.632 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -129.11 8.03 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 0.0 112.104 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.08 90.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.506 0.722 . . . . 0.0 112.094 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.47 -12.57 61.39 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.832 -1.077 . . . . 0.0 113.216 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -80.69 5.63 15.12 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.55 0.74 . . . . 0.0 111.66 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 5.9 p90 -73.52 -27.13 61.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.2 1.0 . . . . 0.0 113.334 -172.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.89 -45.32 36.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.364 0.602 . . . . 0.0 109.511 -164.379 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -74.33 -33.35 63.12 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.159 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 75' ' ' VAL . 22.6 t70 -72.97 -51.61 17.67 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.913 0.485 . . . . 0.0 111.501 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.73 -41.23 66.83 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.155 0.982 . . . . 0.0 112.091 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.4 m -61.81 -48.45 80.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.972 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.414 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.9 ttm180 -53.73 -45.06 70.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.689 1.196 . . . . 0.0 111.61 174.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 71' ' ' ASP . 43.5 t -61.46 -41.04 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.756 1.222 . . . . 0.0 110.204 -177.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.85 -42.25 70.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 96.8 mt-30 -67.71 -26.49 66.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.035 0.934 . . . . 0.0 111.811 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -65.54 -22.4 66.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.307 0.643 . . . . 0.0 111.177 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -106.74 20.98 18.22 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.441 0.696 . . . . 0.0 110.39 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.59 39.32 8.97 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 121.724 -0.61 . . . . 0.0 113.441 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.452 HD22 HG21 ' A' ' 23' ' ' ILE . 2.1 tm? -64.52 -46.73 81.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.829 0.852 . . . . 0.0 110.322 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 63.71 109.67 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.244 1.418 . . . . 0.0 109.655 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.574 ' HB3' ' HA2' ' A' ' 86' ' ' GLY . 21.9 Cg_exo -33.28 101.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.389 2.702 0 C-N-CA 124.769 3.646 . . . . 0.0 114.423 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -52.34 -64.26 0.87 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.52 1.128 . . . . 0.0 111.2 -173.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.49 ' HE2' ' HB2' ' A' ' 90' ' ' ARG . 52.5 t80 -90.61 -38.21 13.29 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 83' ' ' PRO . . . 98.49 -88.34 0.87 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.507 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.21 88.37 6.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.839 0.455 . . . . 0.0 109.885 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -61.93 -22.44 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 123.516 0.726 . . . . 0.0 110.744 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' THR . . . . . 0.761 ' HA ' ' HD3' ' A' ' 93' ' ' LYS . 24.7 p -65.19 -22.51 66.91 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.711 1.204 . . . . 0.0 112.816 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.49 ' HB2' ' HE2' ' A' ' 85' ' ' PHE . 23.6 mmm180 -76.84 -78.5 0.12 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.972 0.509 . . . . 0.0 109.671 174.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.9 t -118.26 149.88 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.8 m80 68.82 33.65 3.57 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.569 1.148 . . . . 0.0 110.391 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.761 ' HD3' ' HA ' ' A' ' 89' ' ' THR . 27.2 tptp -83.37 38.48 0.61 Allowed 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 125.11 1.364 . . . . 0.0 109.344 175.353 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.95 29.42 2.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.5 1.52 . . . . 0.0 109.074 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -60.33 -34.27 73.59 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.523 1.129 . . . . 0.0 109.879 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.76 -34.81 78.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 110.856 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.24 -49.5 49.3 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.226 0.61 . . . . 0.0 110.442 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.51 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 84.4 mmm -60.95 -42.94 99.21 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.644 0.778 . . . . 0.0 112.983 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -49.79 -46.56 50.94 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.789 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.455 ' HA ' ' CG ' ' A' ' 103' ' ' ARG . 3.7 mt-10 -80.06 -25.82 39.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.618 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.0 -58.76 4.31 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.943 0.897 . . . . 0.0 110.107 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.9 mt -60.53 -41.13 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.528 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 100' ' ' GLU . 4.8 ppt_? -64.63 -30.22 71.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.444 0.566 . . . . 0.0 110.34 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 107' ' ' HIS . . . -71.25 -47.25 58.24 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.5 ' HB3' HG21 ' A' ' 31' ' ' VAL . 6.2 tmtp? -69.78 -30.56 68.15 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.998 0.519 . . . . 0.0 111.847 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 62' ' ' ARG . 2.2 mp -63.9 -23.82 67.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.839 0.855 . . . . 0.0 111.717 172.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . 0.456 ' HB3' ' O ' ' A' ' 104' ' ' ALA . 85.2 t60 -72.57 -15.15 61.76 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.571 1.148 . . . . 0.0 110.907 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 79.42 5.75 2.08 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.528 1.931 . . . . 0.0 112.509 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -151.17 134.17 8.77 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.0 84.52 0.53 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.581 2.187 . . . . 0.0 112.503 -169.128 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.29 54.68 4.22 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.73 143.44 27.05 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.26 1.024 . . . . 0.0 109.514 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.81 132.29 22.95 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.012 2.474 . . . . 0.0 112.19 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.525 HG22 ' HG ' ' A' ' 116' ' ' LEU . 7.8 p -77.02 121.81 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.05 -21.56 58.95 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 122.078 -0.389 . . . . 0.0 111.982 -168.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.525 ' HG ' HG22 ' A' ' 114' ' ' VAL . 4.3 pp -59.47 -26.6 65.38 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.311 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.14 -35.65 81.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.219 1.008 . . . . 0.0 110.815 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.9 -27.06 66.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.318 1.047 . . . . 0.0 111.085 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.531 HG22 HG13 ' A' ' 120' ' ' ILE . 2.3 mp -74.67 -57.8 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.319 0.648 . . . . 0.0 109.676 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 119' ' ' ILE . 78.2 mt -116.7 101.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -103.14 -61.11 1.45 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.658 0.783 . . . . 0.0 109.411 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -167.16 149.77 6.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.925 0.89 . . . . 0.0 109.576 -174.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -67.76 104.07 1.57 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.55 -26.41 66.52 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.67 0.607 . . . . 0.0 113.544 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 123.973 0.909 . . . . 0.0 109.261 174.839 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.08 105.27 2.21 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -64.15 -43.25 95.79 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.353 0.661 . . . . 0.0 110.549 -171.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.1 mtp -125.06 97.46 5.26 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 173.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -119.35 125.76 49.81 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 170.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.0 153.74 60.88 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.055 0.942 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.34 106.28 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.319 2.013 . . . . 0.0 112.112 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.88 -22.02 9.34 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.014 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -153.89 124.58 7.16 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.304 0.574 . . . . 0.0 112.474 -170.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.583 HD23 HD12 ' A' ' 27' ' ' ILE . 56.8 tp -103.5 148.13 26.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.898 0.879 . . . . 0.0 108.78 165.082 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 0.8 OUTLIER -122.78 116.6 23.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.621 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 71.6 mt -89.29 109.59 20.47 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.17 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.55 169.28 17.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.8 t -136.08 160.29 39.09 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 162.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.5 pp -52.32 122.6 25.43 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-N 118.108 0.413 . . . . 0.0 111.572 -172.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.66 155.82 58.33 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.744 2.962 . . . . 0.0 113.359 -163.103 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.16 -7.36 0.18 Allowed Glycine 0 C--N 1.342 0.875 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.663 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.6 mt 73.9 -47.99 0.66 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.257 1.423 . . . . 0.0 112.302 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.63 -28.19 69.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.151 1.38 . . . . 0.0 112.698 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.402 ' O ' ' HB2' ' A' ' 21' ' ' GLN . 0.4 OUTLIER -83.54 -19.22 36.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.167 0.587 . . . . 0.0 111.529 177.911 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 20' ' ' GLN . 20.4 mt-30 101.14 121.25 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.318 2.647 . . . . 0.0 108.103 -171.464 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.427 ' H ' ' HA ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER -101.45 70.71 1.31 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.15 119.6 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.303 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -142.52 109.78 5.63 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 49.1 mt -133.53 129.8 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.732 0.813 . . . . 0.0 109.194 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 45' ' ' MET . 14.7 m170 -100.11 108.69 20.89 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.583 HD12 HD23 ' A' ' 10' ' ' LEU . 41.5 mt -103.22 108.5 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -109.5 112.61 24.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -111.07 118.11 35.13 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -124.31 115.03 20.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.036 0.934 . . . . 0.0 109.09 -172.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.99 120.69 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.594 0.711 . . . . 0.0 109.567 170.352 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -138.4 154.79 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.78 120.6 41.3 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.625 0.25 . . . . 0.0 111.224 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.482 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 37.1 p-10 -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.609 1.164 . . . . 0.0 110.419 169.703 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.07 61.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.094 0.558 . . . . 0.0 111.449 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.482 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 11.7 tp10 -67.23 -54.61 19.46 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.258 1.023 . . . . 0.0 111.755 -177.449 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 35.5 t -120.94 5.91 10.4 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.226 0.611 . . . . 0.0 111.812 -171.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.68 -101.09 1.5 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.556 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -83.78 145.36 28.74 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.961 0.505 . . . . 0.0 110.706 171.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -151.48 174.32 13.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -125.73 132.57 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -96.94 134.16 40.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.195 0.998 . . . . 0.0 108.613 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -120.66 125.75 48.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 109.829 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 30.4 m-20 -108.13 148.74 29.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.646 0.779 . . . . 0.0 109.505 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 21.4 mtm -141.4 132.53 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.587 1.155 . . . . 0.0 108.469 171.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -167.53 159.55 12.3 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.266 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.78 -121.1 1.36 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 11.8 pt-20 -142.08 171.01 14.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 mt -154.95 103.79 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' HA ' ' H ' ' A' ' 22' ' ' ASP . 36.6 t70 58.37 46.13 15.81 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 122.345 1.069 . . . . 0.0 109.467 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.16 -36.22 3.53 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.177 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.01 111.95 23.93 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.568 1.147 . . . . 0.0 112.312 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 Cg_exo -61.3 146.83 96.91 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.795 2.997 . . . . 0.0 113.099 175.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 4.3 p90 -151.22 163.92 37.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.442 0.297 . . . . 0.0 110.683 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -153.58 117.43 4.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.288 0.635 . . . . 0.0 111.206 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -130.32 159.27 37.47 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.687 1.195 . . . . 0.0 109.751 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -157.19 133.46 9.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.731 0.413 . . . . 0.0 110.61 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.3 145.95 50.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.826 0.85 . . . . 0.0 109.635 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -114.08 143.57 44.56 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.74 138.95 27.65 Favored Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.6 149.27 91.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.523 2.149 . . . . 0.0 110.797 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.556 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 30.8 ptt85 -42.14 -39.29 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.15 -19.77 61.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.557 0.743 . . . . 0.0 112.744 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.1 p -130.48 9.66 5.13 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.55 0.74 . . . . 0.0 109.91 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.76 71.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.948 0.899 . . . . 0.0 111.048 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -69.11 -11.33 60.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.393 1.077 . . . . 0.0 113.046 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -80.62 3.87 20.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.294 0.637 . . . . 0.0 111.195 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -67.88 -21.18 65.16 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 124.324 1.05 . . . . 0.0 112.571 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.12 19.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -69.61 -35.23 75.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.841 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 -54.55 10.31 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.498 0.719 . . . . 0.0 111.602 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.15 -44.72 64.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.24 1.016 . . . . 0.0 111.947 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -63.02 -49.24 75.42 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.418 0.449 . . . . 0.0 110.312 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.506 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 18.3 ttp85 -51.15 -52.78 40.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.322 1.049 . . . . 0.0 111.999 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.92 -32.39 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.862 0.465 . . . . 0.0 110.551 -175.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.0 -41.56 74.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 96.4 mt-30 -54.27 -30.77 51.84 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.604 1.162 . . . . 0.0 112.969 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 13.8 mptt -75.2 -7.64 54.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.53 0.732 . . . . 0.0 111.175 -176.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -93.11 7.57 43.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.587 0.755 . . . . 0.0 110.684 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.26 64.51 1.02 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.265 0.466 . . . . 0.0 114.265 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 11.0 mp -103.56 142.5 34.17 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 168.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 73.0 m80 -111.49 98.89 42.28 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 168.143 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.18 -5.92 4.54 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.675 2.917 . . . . 0.0 114.005 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -59.14 -38.32 79.38 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.501 1.121 . . . . 0.0 110.275 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -89.72 -21.09 22.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.136 0.174 . . . . 0.0 111.134 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.72 -129.51 0.16 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.195 0.426 . . . . 0.0 113.726 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.34 94.48 2.46 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 117.383 0.591 . . . . 0.0 110.041 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.9 tt -98.91 -41.72 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.521 0.729 . . . . 0.0 110.689 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -89.97 -33.69 16.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.815 0.846 . . . . 0.0 110.229 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -75.93 86.1 2.87 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.366 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.54 92.4 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -73.77 116.55 14.49 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.684 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -77.48 12.78 1.44 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.962 0.905 . . . . 0.0 111.818 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.39 -24.14 67.53 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.834 0.853 . . . . 0.0 110.364 167.134 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -62.64 -48.98 77.0 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.406 168.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.32 -33.9 63.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.028 0.531 . . . . 0.0 111.458 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.66 -50.34 63.22 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.445 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.461 ' HE1' HD22 ' A' ' 10' ' ' LEU . 28.3 ttm -71.87 -37.21 70.23 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.757 0.823 . . . . 0.0 112.541 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -51.12 -48.22 61.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.465 1.506 . . . . 0.0 110.301 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 23.2 mt-10 -77.84 -28.75 50.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.287 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.53 -50.53 69.2 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.2 0.6 . . . . 0.0 110.423 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.449 ' O ' HD13 ' A' ' 106' ' ' LEU . 56.0 mt -61.02 -49.15 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.998 0.919 . . . . 0.0 111.597 175.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 1.2 ppt_? -61.85 -30.63 70.97 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.146 0.43 . . . . 0.0 111.31 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.26 -44.76 58.78 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.033 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -65.6 -33.68 76.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.25 1.02 . . . . 0.0 111.787 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 102' ' ' ILE . 6.8 mp -70.52 -22.16 62.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.506 1.122 . . . . 0.0 111.338 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 37.5 t-80 -89.25 -18.7 26.5 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.15 0.58 . . . . 0.0 109.854 170.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 72.87 -70.36 0.16 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.001 1.72 . . . . 0.0 111.526 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -72.0 133.35 83.97 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.953 0.901 . . . . 0.0 109.436 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.01 79.33 1.69 Allowed 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.95 2.433 . . . . 0.0 111.297 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.61 -20.72 55.77 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.698 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -127.45 145.26 53.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.293 1.037 . . . . 0.0 109.634 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.66 105.23 1.59 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.667 2.245 . . . . 0.0 110.126 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 100' ' ' GLU . 7.3 p -67.97 125.35 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.39 0.614 . . . . 0.0 110.491 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.24 7.93 8.42 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.893 0.877 . . . . 0.0 112.52 -166.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 117' ' ' GLU . 3.1 pp -55.88 -26.83 49.03 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 116' ' ' LEU . 44.2 tt0 -72.76 -33.2 66.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.504 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -81.61 -7.45 59.59 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.691 -167.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.1 -19.82 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.703 0.801 . . . . 0.0 110.519 170.104 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.8 mt 81.26 112.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.802 2.041 . . . . 0.0 109.081 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -140.81 15.1 2.31 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.803 1.241 . . . . 0.0 110.195 -174.266 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -68.53 131.93 46.09 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 123.057 0.543 . . . . 0.0 110.386 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -113.27 -40.47 3.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.828 0.851 . . . . 0.0 110.241 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.8 -166.22 36.69 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.686 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 C--O 1.249 1.068 0 C-N-CA 124.043 0.937 . . . . 0.0 109.073 178.161 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.24 171.82 36.81 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 123.562 0.539 . . . . 0.0 111.903 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -86.15 168.66 13.81 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.975 0.51 . . . . 0.0 110.786 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.1 tpt -137.31 172.14 13.43 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.387 1.075 . . . . 0.0 109.095 -171.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -80.26 127.31 32.2 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.33 154.22 78.5 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.27 1.428 . . . . 0.0 107.834 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.1 110.19 0.42 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.276 1.984 . . . . 0.0 111.658 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.2 -21.56 10.06 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 123.057 0.36 . . . . 0.0 112.736 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -150.93 119.83 6.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.255 0.622 . . . . 0.0 111.434 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.461 HD23 HD12 ' A' ' 27' ' ' ILE . 59.9 tp -102.35 143.21 32.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.346 1.058 . . . . 0.0 108.912 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -120.71 124.67 45.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.234 0.613 . . . . 0.0 110.298 174.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.8 mt -102.0 128.31 48.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.882 0.473 . . . . 0.0 109.921 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.78 159.71 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 159.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.9 t -67.45 129.02 38.59 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.838 0.455 . . . . 0.0 110.585 -170.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.2 108.74 2.26 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.999 0.92 . . . . 0.0 110.088 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.5 141.68 81.51 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.614 2.876 . . . . 0.0 113.705 -163.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.89 -24.9 5.94 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.85 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.1 mt -92.14 -71.99 0.61 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.286 0.634 . . . . 0.0 110.774 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -153.51 126.06 8.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.17 0.988 . . . . 0.0 108.711 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.57 69.69 10.38 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -80.92 144.55 31.83 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.456 168.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -87.41 70.65 9.94 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.462 0.648 . . . . 0.0 109.799 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.86 142.15 20.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.363 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.487 ' OD1' ' HG2' ' A' ' 48' ' ' GLU . 4.4 p-10 -151.78 128.71 11.0 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 67.3 mt -127.99 129.23 69.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -171.708 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' MET . 0.1 OUTLIER -102.05 109.02 20.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 177.723 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.461 HD12 HD23 ' A' ' 10' ' ' LEU . 53.8 mt -101.75 105.52 18.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 176.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 27.0 mtp-105 -101.59 108.8 20.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.335 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -111.83 116.97 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.21 111.21 17.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 41' ' ' VAL . 44.3 t -83.94 116.52 27.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -127.61 155.15 44.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.116 0.966 . . . . 0.0 108.51 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -105.87 111.84 24.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.46 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 29.9 p-10 -97.64 146.94 24.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.828 0.851 . . . . 0.0 110.087 173.238 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.45 -18.05 62.33 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.922 0.489 . . . . 0.0 111.694 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.46 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 11.8 tp10 -69.04 -53.32 21.1 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.01 0.924 . . . . 0.0 111.555 179.32 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.3 t -124.96 5.71 7.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.05 0.54 . . . . 0.0 112.294 -169.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.92 -114.77 3.98 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 137.98 36.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.021 0.529 . . . . 0.0 110.129 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 4.3 p90 -152.84 166.96 30.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 31' ' ' VAL . 10.8 t -124.02 122.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -81.09 116.6 21.1 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -100.26 135.53 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 25.5 t70 -137.9 141.52 40.65 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.757 0.823 . . . . 0.0 108.831 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 86.6 mtp -138.46 131.91 30.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 0.0 110.0 -174.613 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -150.48 176.42 10.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.017 0.527 . . . . 0.0 109.92 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.08 -135.34 7.43 Favored Glycine 0 N--CA 1.465 0.599 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 8.0 pt-20 -151.63 168.06 26.17 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 mt -157.66 109.29 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -166.562 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t70 61.65 32.98 18.36 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.798 0.808 . . . . 0.0 109.431 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.35 -25.41 9.25 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -82.15 118.94 73.83 Favored Pre-proline 0 N--CA 1.484 1.252 0 CA-C-N 117.831 0.816 . . . . 0.0 111.708 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -69.89 148.21 63.73 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.639 2.226 . . . . 0.0 112.887 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -142.8 150.52 40.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.313 0.645 . . . . 0.0 109.959 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 m -146.75 122.49 10.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.442 0.697 . . . . 0.0 110.348 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.89 152.62 36.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.127 0.971 . . . . 0.0 109.175 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.0 p -147.98 137.2 22.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.217 0.607 . . . . 0.0 110.699 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.47 140.18 41.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 0.0 109.71 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -112.86 129.58 56.4 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.19 129.01 25.1 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.581 0.753 . . . . 0.0 109.332 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 40.2 Cg_endo -63.73 164.75 20.33 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.042 2.495 . . . . 0.0 112.126 173.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.13 -32.61 7.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.223 1.009 . . . . 0.0 113.467 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.74 -31.51 66.76 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.344 1.058 . . . . 0.0 112.191 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -125.73 12.48 7.94 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.338 0.655 . . . . 0.0 110.517 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.18 89.97 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.826 0.85 . . . . 0.0 112.116 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.23 -8.05 46.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.476 1.11 . . . . 0.0 113.096 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -80.55 1.2 30.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.785 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -66.1 -18.97 65.69 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.722 1.209 . . . . 0.0 113.058 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -50.78 14.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.437 0.637 . . . . 0.0 109.734 -162.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.9 p -73.28 -31.41 64.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.309 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 75' ' ' VAL . 14.2 t70 -70.78 -58.22 3.85 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.282 0.633 . . . . 0.0 111.35 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.27 -47.58 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.251 1.02 . . . . 0.0 112.547 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.3 m -57.59 -47.08 83.11 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.866 0.467 . . . . 0.0 110.758 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HA ' ' HG2' ' A' ' 77' ' ' GLN . 39.4 ttp180 -57.96 -38.77 76.61 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.949 0.781 . . . . 0.0 112.508 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -59.63 -47.78 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.116 0.566 . . . . 0.0 109.758 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HB3' HD22 ' A' ' 81' ' ' LEU . . . -72.22 -40.09 68.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.896 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 20.8 pt20 -73.56 -22.69 60.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -66.13 -21.25 66.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 121.951 0.101 . . . . 0.0 110.732 166.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -99.56 6.16 45.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.857 0.863 . . . . 0.0 110.537 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.44 -95.85 0.43 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD13 HD11 ' A' ' 25' ' ' ILE . 32.5 tp 52.32 -80.22 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.466 1.906 . . . . 0.0 112.952 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -148.82 157.87 40.17 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.256 1.022 . . . . 0.0 109.983 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.8 -167.67 0.53 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.481 2.12 . . . . 0.0 111.986 171.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -63.1 -36.08 82.42 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.636 0.774 . . . . 0.0 110.485 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -59.48 -29.41 67.81 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.515 0.726 . . . . 0.0 111.67 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.14 66.44 3.79 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 123.345 0.403 . . . . 0.0 112.437 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.23 85.75 7.34 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.043 0.537 . . . . 0.0 109.794 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.1 tt -76.24 -28.0 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.092 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.5 p -78.42 -13.19 59.95 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.993 0.917 . . . . 0.0 111.789 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -63.28 -42.86 99.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.437 0.695 . . . . 0.0 109.445 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.39 150.82 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.117 0.967 . . . . 0.0 108.913 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -84.46 86.63 7.26 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 172.08 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -79.26 71.68 5.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.8 0.81 . . . . 0.0 109.144 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 56.69 26.26 11.07 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.144 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -63.24 -41.97 99.15 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.962 0.905 . . . . 0.0 110.279 175.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.85 -32.62 65.97 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.071 0.857 . . . . 0.0 112.182 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.24 -47.95 63.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 tpp -65.51 -40.79 93.41 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -55.04 -51.82 65.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.982 1.313 . . . . 0.0 111.311 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 10.1 pt-20 -69.7 -30.37 68.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.67 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.11 -45.62 59.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.311 0.244 . . . . 0.0 110.889 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.87 -45.35 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.396 0.678 . . . . 0.0 110.683 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -64.56 -29.84 70.86 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 120.614 0.245 . . . . 0.0 110.568 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.59 -45.72 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.439 0.696 . . . . 0.0 110.619 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -69.88 -29.88 67.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.941 0.496 . . . . 0.0 112.243 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.2 -31.37 68.78 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.065 0.946 . . . . 0.0 110.486 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -72.76 -18.0 61.54 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.905 0.882 . . . . 0.0 110.493 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 80.56 -6.32 1.68 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.268 1.827 . . . . 0.0 112.619 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -138.98 142.75 34.5 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.368 1.067 . . . . 0.0 108.465 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.18 128.31 22.21 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.57 2.847 . . . . 0.0 112.866 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.08 83.9 0.2 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -174.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 11.6 pt-20 -77.68 172.02 10.91 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.915 0.886 . . . . 0.0 109.742 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 112' ' ' GLU . 95.8 Cg_endo -76.95 48.75 2.58 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.654 2.236 . . . . 0.0 112.882 172.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.19 130.0 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.08 29.7 5.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.2 0.6 . . . . 0.0 111.009 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -55.3 -30.62 60.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 112.317 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 121' ' ' ARG . 34.1 tt0 -80.45 -32.91 37.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.458 0.703 . . . . 0.0 110.789 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.03 -18.55 65.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.299 1.04 . . . . 0.0 112.27 -168.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.541 HG22 HG12 ' A' ' 120' ' ' ILE . 3.9 mp -67.28 -52.83 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.541 HG12 HG22 ' A' ' 119' ' ' ILE . 33.3 mm -133.99 96.99 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.555 0.742 . . . . 0.0 109.567 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.479 ' HG2' ' HG2' ' A' ' 117' ' ' GLU . 52.2 mtp180 -102.33 -45.75 5.01 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -160.97 145.63 13.88 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.686 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 71.46 148.19 0.08 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.926 1.29 . . . . 0.0 110.72 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.53 -56.2 1.2 Allowed Glycine 0 C--N 1.343 0.952 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.9 p . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 123.157 0.583 . . . . 0.0 109.563 177.946 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.464 ' HA3' HD23 ' A' ' 15' ' ' LEU . . . 98.88 -60.87 0.83 Allowed Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -171.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.503 ' HB2' HD11 ' A' ' 10' ' ' LEU . 47.3 p-80 -171.32 101.59 0.2 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.126 0.971 . . . . 0.0 109.428 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -86.48 97.24 10.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -101.25 141.46 34.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.735 0.814 . . . . 0.0 110.887 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.95 156.02 55.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.192 1.397 . . . . 0.0 108.363 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.72 105.76 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.109 1.872 . . . . 0.0 111.397 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.11 -20.61 11.36 Favored Glycine 0 N--CA 1.473 1.126 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.243 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -153.04 143.88 22.87 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.413 0.607 . . . . 0.0 111.584 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 3' ' ' HIS . 40.2 tp -129.33 141.26 51.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.237 1.415 . . . . 0.0 108.276 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -127.57 121.18 29.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.563 0.745 . . . . 0.0 109.211 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 79.3 mt -100.53 128.9 46.45 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.419 0.687 . . . . 0.0 109.865 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t -137.06 151.13 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 166.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.7 t -86.2 115.28 23.66 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.766 1.621 . . . . 0.0 108.216 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.464 HD23 ' HA3' ' A' ' 2' ' ' GLY . 4.5 pp -71.43 144.07 88.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 119.107 -0.473 . . . . 0.0 109.943 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.94 122.93 10.09 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.026 1.817 . . . . 0.0 111.396 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 140.35 -69.24 0.47 Allowed Glycine 0 C--N 1.346 1.128 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.73 -46.67 62.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.381 0.61 . . . . 0.0 109.91 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -140.13 -177.68 5.11 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.218 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -166.22 104.79 0.65 Allowed 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.567 0.747 . . . . 0.0 109.004 168.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -158.29 165.23 35.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.697 1.199 . . . . 0.0 108.643 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.92 53.65 2.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.839 0.828 . . . . 0.0 111.102 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.544 HG21 HD23 ' A' ' 81' ' ' LEU . 2.2 pp -90.54 116.03 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 m120 -139.14 107.85 5.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 59.1 mt -133.18 133.43 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.643 0.777 . . . . 0.0 109.966 -163.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.7 m170 -104.8 113.87 27.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.8 mt -112.5 107.74 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 ttp-105 -102.54 110.12 21.96 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -111.57 123.62 50.6 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -118.73 114.46 22.73 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.541 0.737 . . . . 0.0 109.15 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG11 ' HG3' ' A' ' 105' ' ' LYS . 98.0 t -77.71 117.38 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -140.43 159.86 41.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.899 0.879 . . . . 0.0 109.103 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -110.68 113.48 26.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.483 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.502 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 32.0 p-10 -95.57 148.77 22.16 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.722 0.809 . . . . 0.0 109.598 170.987 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.22 -19.36 63.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.872 0.469 . . . . 0.0 111.432 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.502 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 39.3 tt0 -71.05 -44.93 64.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.284 1.034 . . . . 0.0 112.323 -176.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -133.73 1.93 3.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.83 -115.5 4.12 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.01 143.52 43.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.26 0.53 . . . . 0.0 110.359 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.418 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.9 p90 -160.3 172.79 16.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.439 0.696 . . . . 0.0 109.148 169.123 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.01 130.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -88.68 116.45 26.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.866 0.866 . . . . 0.0 108.884 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.59 110.39 22.43 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -105.11 139.69 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.799 0.84 . . . . 0.0 109.165 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 40.5 mtm -141.71 140.19 33.1 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.906 0.482 . . . . 0.0 110.833 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -164.1 158.61 19.51 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.424 0.69 . . . . 0.0 109.724 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.18 -127.56 2.16 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.052 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -156.82 160.35 39.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.414 1.085 . . . . 0.0 109.27 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 23' ' ' ILE . 47.7 mt -158.04 107.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.185 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 60.24 42.12 15.63 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.531 1.158 . . . . 0.0 109.348 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.99 -28.76 3.19 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.382 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -82.57 121.41 78.03 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.147 0.979 . . . . 0.0 111.19 -169.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.26 152.21 76.01 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.833 2.356 . . . . 0.0 113.231 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -146.98 146.39 30.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.313 0.645 . . . . 0.0 109.369 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.7 m -142.63 118.9 10.82 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.003 0.521 . . . . 0.0 110.153 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.24 154.92 37.76 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.073 0.949 . . . . 0.0 109.917 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.4 p -145.74 144.91 30.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.853 0.461 . . . . 0.0 110.41 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.64 136.95 39.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.09 0.956 . . . . 0.0 109.555 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -112.92 124.53 52.83 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.25 128.98 25.65 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 30.6 Cg_endo -60.38 159.26 27.86 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.075 2.517 . . . . 0.0 112.069 171.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -42.63 -40.02 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.944 1.298 . . . . 0.0 114.262 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.79 -15.12 60.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.777 0.831 . . . . 0.0 112.552 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -132.03 4.55 4.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.698 0.799 . . . . 0.0 111.778 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.15 71.64 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.947 0.899 . . . . 0.0 111.789 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -65.34 -24.39 67.24 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.261 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -73.96 -2.06 22.45 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.599 0.76 . . . . 0.0 112.294 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -70.9 -18.01 62.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.88 -43.78 57.46 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -167.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 p -76.11 -35.77 59.17 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.206 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.8 t70 -71.17 -57.12 4.8 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.345 0.658 . . . . 0.0 112.071 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.36 -43.29 43.89 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.212 1.005 . . . . 0.0 112.454 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -64.44 -46.66 82.19 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.256 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 68.6 ttt180 -53.76 -44.21 69.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.75 0.82 . . . . 0.0 111.729 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 71' ' ' ASP . 57.4 t -60.75 -38.82 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.083 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.16 -41.69 73.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.783 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -60.61 -34.04 73.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.214 1.006 . . . . 0.0 111.363 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.3 mtpp -61.51 -36.76 81.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.743 . . . . 0.0 111.809 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 54.7 t-80 -87.53 -33.19 19.04 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.81 41.32 0.02 OUTLIER Glycine 0 C--N 1.358 1.788 0 C-N-CA 121.591 -0.338 . . . . 0.0 113.395 156.057 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.544 HD23 HG21 ' A' ' 23' ' ' ILE . 1.6 tm? -83.03 132.48 35.13 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -61.26 129.25 90.64 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.291 1.036 . . . . 0.0 111.034 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.09 90.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.569 2.179 . . . . 0.0 110.683 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -58.07 -27.73 63.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.992 1.317 . . . . 0.0 112.082 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -54.77 -52.02 63.89 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.997 0.919 . . . . 0.0 111.444 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.75 -92.22 0.08 OUTLIER Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.224 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.88 96.34 1.23 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.906 0.882 . . . . 0.0 108.977 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.1 tt -152.45 126.01 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 122.949 0.5 . . . . 0.0 110.563 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.6 p -90.77 -34.31 15.38 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.849 0.86 . . . . 0.0 110.993 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -82.99 71.08 10.1 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.518 0.727 . . . . 0.0 110.751 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.66 141.81 14.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.71 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -86.97 147.06 25.91 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 36.0 mtmm -76.41 84.87 3.15 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.163 0.506 . . . . 0.0 112.128 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -81.08 -52.08 7.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.051 0.94 . . . . 0.0 109.379 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -57.93 -48.52 79.66 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.514 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.733 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . 23.9 t70 -59.18 -37.96 78.65 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.163 0.985 . . . . 0.0 112.663 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.85 -48.81 23.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.509 0.323 . . . . 0.0 111.317 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.2 ttm -65.55 -32.62 74.31 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.174 0.59 . . . . 0.0 111.523 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -50.31 -45.76 54.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.275 1.03 . . . . 0.0 109.683 169.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 27.0 mm-40 -74.9 -28.22 60.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.061 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.51 -55.31 12.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 120.793 0.33 . . . . 0.0 110.357 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.32 -42.0 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.531 1.133 . . . . 0.0 112.211 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.39 -31.27 72.39 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.863 0.363 . . . . 0.0 110.444 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.47 -52.39 10.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.566 0.746 . . . . 0.0 110.526 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.484 ' HG3' HG11 ' A' ' 31' ' ' VAL . 17.7 tppt? -55.46 -52.97 61.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.769 1.228 . . . . 0.0 113.134 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.07 -26.95 69.08 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.276 0.63 . . . . 0.0 111.872 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -68.6 -31.92 71.43 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.652 0.595 . . . . 0.0 109.457 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.0 -1.63 3.01 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.608 1.563 . . . . 0.0 113.298 169.04 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -135.25 129.08 18.67 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.23 81.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.83 2.353 . . . . 0.0 111.709 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -124.38 53.0 0.77 Allowed Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.237 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.14 152.32 90.46 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.6 91.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.536 2.158 . . . . 0.0 111.52 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.7 p -79.81 142.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.613 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 118' ' ' ARG . 29.0 m-20 -99.21 43.24 1.07 Allowed 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.975 0.91 . . . . 0.0 110.579 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.63 -33.64 73.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.466 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -117.2 85.72 2.38 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.341 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 1.8 tmm_? -133.2 14.8 4.19 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 165.491 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.66 -63.6 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.772 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.8 mt -88.5 70.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.991 0.9 . . . . 0.0 108.979 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 121' ' ' ARG . 12.9 mmt180 -107.38 84.43 1.97 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.322 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -150.32 176.21 11.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.291 1.036 . . . . 0.0 110.532 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -140.07 151.59 45.5 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.09 0.956 . . . . 0.0 110.197 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.92 -90.14 1.08 Allowed Glycine 0 C--N 1.346 1.111 0 CA-C-N 116.33 -0.396 . . . . 0.0 113.112 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.247 0.959 0 C-N-CA 123.979 0.912 . . . . 0.0 109.19 -179.43 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.944 0.402 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.62 -133.99 27.9 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.107 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -100.99 59.87 0.92 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 122.201 1.001 . . . . 0.0 108.939 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.2 ttp -73.91 143.73 45.64 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.168 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -106.32 146.56 30.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.279 0.631 . . . . 0.0 110.048 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.44 153.45 58.97 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.038 1.335 . . . . 0.0 108.28 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.75 96.98 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.139 1.893 . . . . 0.0 111.824 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.09 -25.59 4.09 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.384 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -151.91 147.24 26.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.177 0.591 . . . . 0.0 111.219 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 27' ' ' ILE . 41.9 tp -126.84 134.59 50.5 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.126 1.37 . . . . 0.0 107.863 173.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -97.47 138.48 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.58 110.58 14.61 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.262 0.625 . . . . 0.0 109.504 175.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.98 169.25 22.21 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 160.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.5 t -104.03 138.14 41.0 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -69.13 126.35 92.67 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.08 147.56 79.75 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.467 2.111 . . . . 0.0 112.032 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.42 -76.71 0.19 Allowed Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.9 tp -140.55 16.53 2.36 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.701 0.762 . . . . 0.0 109.359 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.52 31.52 5.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.962 0.905 . . . . 0.0 109.055 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -86.95 45.38 1.26 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.469 0.707 . . . . 0.0 112.278 -164.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -83.28 138.27 33.64 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 163.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -77.33 82.71 3.79 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.804 0.69 . . . . 0.0 109.237 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.601 HG22 HG23 ' A' ' 49' ' ' ILE . 1.6 pp -110.36 126.57 67.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -147.09 117.61 7.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 43.1 mt -144.85 145.94 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.308 1.043 . . . . 0.0 108.381 -168.271 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 45' ' ' MET . 9.2 m-70 -108.73 145.66 34.74 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.565 HD12 HD23 ' A' ' 10' ' ' LEU . 55.9 mt -131.75 109.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 99.5 mtt180 -98.59 140.1 33.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 168.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -121.65 116.85 25.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 165.551 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -123.96 111.89 16.56 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 41' ' ' VAL . 90.2 t -90.15 118.75 36.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.29 0.636 . . . . 0.0 110.337 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 26.5 ttt180 -114.58 153.24 30.45 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -111.42 111.41 22.43 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -105.24 136.81 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.34 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.37 -20.17 66.01 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.04 0.536 . . . . 0.0 112.308 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -68.97 -45.59 70.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.589 1.156 . . . . 0.0 111.508 -178.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -115.54 -40.71 3.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.865 0.466 . . . . 0.0 111.205 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.76 -148.17 17.22 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.09 129.19 37.92 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.401 0.68 . . . . 0.0 110.867 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 3.4 p90 -144.45 166.29 25.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 31' ' ' VAL . 2.3 t -122.11 128.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.943 0.497 . . . . 0.0 110.329 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.552 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 78.1 t60 -88.92 112.32 23.16 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 164.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 91.8 m-85 -95.12 121.3 36.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 19.7 t70 -120.43 114.67 22.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.859 0.864 . . . . 0.0 109.517 -170.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.413 ' HG2' HG12 ' A' ' 27' ' ' ILE . 85.8 mtp -119.31 144.3 46.9 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.546 0.739 . . . . 0.0 110.881 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -156.05 164.48 38.38 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.459 0.704 . . . . 0.0 109.461 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.62 -158.6 31.54 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 118.843 -0.976 . . . . 0.0 111.458 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -145.79 109.97 4.95 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.301 1.051 . . . . 0.0 110.589 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 23' ' ' ILE . 49.0 mt -99.78 128.0 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.901 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 62.04 17.62 9.23 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.821 1.248 . . . . 0.0 111.846 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 -20.25 40.86 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.629 -0.54 . . . . 0.0 113.495 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.8 111.17 27.44 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.96 0.904 . . . . 0.0 112.513 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.65 143.39 33.91 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.535 2.157 . . . . 0.0 111.979 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -148.85 161.77 41.16 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -146.65 121.32 9.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -138.52 145.67 41.02 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -174.238 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 p -144.26 144.66 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.749 0.42 . . . . 0.0 111.154 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -137.53 137.15 38.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.069 0.947 . . . . 0.0 108.701 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 6.4 mp0 -113.84 126.5 55.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.386 -177.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 94.2 mt -129.32 125.85 22.73 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 40' ' ' TYR . 57.2 Cg_endo -67.19 163.91 32.38 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.635 2.223 . . . . 0.0 111.555 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -45.78 -37.43 6.02 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.678 1.191 . . . . 0.0 113.384 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.87 -29.85 71.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.194 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.0 p -129.76 12.27 5.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.882 0.873 . . . . 0.0 111.02 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -27.95 68.71 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.655 0.782 . . . . 0.0 111.73 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.469 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 27.1 m-85 -70.46 -2.49 14.07 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.361 1.064 . . . . 0.0 113.79 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -95.3 4.94 52.93 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.604 0.761 . . . . 0.0 110.581 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -55.59 -49.16 73.5 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 124.27 1.028 . . . . 0.0 112.899 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.05 -35.2 61.89 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 123.162 0.585 . . . . 0.0 111.777 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -71.51 -40.12 70.36 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.728 0.643 . . . . 0.0 109.359 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.59 -56.64 9.84 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.307 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.49 -40.61 12.76 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.878 1.271 . . . . 0.0 113.429 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -71.03 -46.36 62.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.182 0.593 . . . . 0.0 110.327 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -61.71 -51.01 70.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.849 0.859 . . . . 0.0 111.343 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.98 -34.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.789 0.836 . . . . 0.0 110.689 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.04 84.35 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.18 0.514 . . . . 0.0 110.142 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.7 -36.73 59.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.45 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -64.05 -34.74 78.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.431 0.692 . . . . 0.0 111.094 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -80.17 3.02 21.95 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.04 -31.92 2.32 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 118.927 0.785 . . . . 0.0 113.605 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 23' ' ' ILE . 17.8 tp -56.71 122.67 12.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.019 0.928 . . . . 0.0 110.766 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -130.55 85.57 55.71 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HD3' ' HG ' ' A' ' 81' ' ' LEU . 81.4 Cg_endo -82.3 143.58 12.58 Favored 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 122.272 1.982 . . . . 0.0 112.537 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -71.59 -12.14 61.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.307 0.643 . . . . 0.0 109.666 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -57.22 -49.82 74.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.898 0.879 . . . . 0.0 109.271 165.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.36 -72.4 1.44 Allowed Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.968 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.41 4.46 0.91 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.019 0.928 . . . . 0.0 111.172 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.4 pt -92.57 146.62 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -76.72 -39.36 52.13 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.066 0.546 . . . . 0.0 111.215 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 71.12 -57.09 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.72 1.608 . . . . 0.0 111.168 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.97 157.41 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.526 1.131 . . . . 0.0 109.519 167.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -57.87 135.66 56.9 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.565 0.346 . . . . 0.0 110.338 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -64.07 119.48 10.22 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.309 0.381 . . . . 0.0 110.034 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 11.53 16.79 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.727 0.811 . . . . 0.0 109.577 167.264 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.22 -41.74 80.04 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 124.909 1.284 . . . . 0.0 112.426 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.688 ' HB2' HH12 ' A' ' 118' ' ' ARG . 4.7 m-20 -55.77 -42.83 76.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 111.985 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.79 89.22 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.081 0.863 . . . . 0.0 110.746 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.0 ttm -61.15 -51.63 68.25 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.237 1.015 . . . . 0.0 111.397 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -51.19 -52.13 47.26 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.828 1.651 . . . . 0.0 112.21 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.502 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 pt-20 -82.26 -27.44 32.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.295 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.91 -36.55 83.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.3 mt -58.96 -55.65 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.549 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.11 -28.1 64.33 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.343 0.52 . . . . 0.0 111.448 -178.551 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.427 ' HB2' HH11 ' A' ' 103' ' ' ARG . . . -71.99 -48.03 47.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.753 0.821 . . . . 0.0 110.677 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -58.52 -35.01 71.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.928 0.891 . . . . 0.0 112.246 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.3 mm? -64.29 -22.55 66.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.436 0.694 . . . . 0.0 112.851 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.83 -17.88 61.51 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 173.064 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 84.05 11.17 0.4 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 126.476 1.91 . . . . 0.0 111.886 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -143.83 137.72 14.53 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.639 1.176 . . . . 0.0 108.28 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.15 94.63 0.57 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.718 2.278 . . . . 0.0 113.524 -170.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.37 54.97 3.17 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 170.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.21 146.03 97.84 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.354 1.062 . . . . 0.0 111.574 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.38 -179.26 5.11 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.29 1.993 . . . . 0.0 112.567 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.57 117.25 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.26 45.34 2.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.919 0.888 . . . . 0.0 109.122 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.48 -36.34 82.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.056 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.14 -19.92 60.41 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.534 0.734 . . . . 0.0 111.229 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.688 HH12 ' HB2' ' A' ' 96' ' ' ASP . 7.6 ttt180 -71.52 -28.13 63.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.034 0.534 . . . . 0.0 111.144 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.58 -31.38 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.414 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.29 -18.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.194 0.998 . . . . 0.0 111.82 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 118' ' ' ARG . 19.3 mmm180 -51.6 104.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.697 0.799 . . . . 0.0 111.73 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -87.02 127.01 35.11 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -149.18 118.38 6.81 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.07 62.3 0.35 Allowed Glycine 0 C--N 1.338 0.681 0 O-C-N 123.726 0.641 . . . . 0.0 111.561 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.248 0.98 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.289 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.36 -112.84 0.56 Allowed Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -152.62 9.77 0.47 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 117.312 0.556 . . . . 0.0 111.722 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.9 mmt -118.78 175.54 5.7 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.838 0.855 . . . . 0.0 111.593 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' A' ' 98' ' ' MET . 67.8 t80 -80.39 147.9 30.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.426 1.09 . . . . 0.0 111.447 -168.785 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.55 154.42 69.28 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.968 1.307 . . . . 0.0 109.94 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.43 100.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.81 2.34 . . . . 0.0 113.202 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.55 -24.38 6.5 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.68 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -147.65 150.75 34.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.625 . . . . 0.0 110.411 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 42.6 tp -124.18 129.61 51.11 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.978 1.311 . . . . 0.0 107.627 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.67 134.87 40.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.642 0.377 . . . . 0.0 110.137 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 69.2 mt -125.46 113.09 17.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.474 0.709 . . . . 0.0 110.446 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.93 168.74 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 159.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 t -81.69 132.5 35.29 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.22 121.17 80.13 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.82 95.18 0.34 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.348 2.032 . . . . 0.0 112.081 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.98 -56.93 0.19 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.91 -65.63 0.99 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.344 0.658 . . . . 0.0 109.699 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.03 144.47 46.53 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.361 1.065 . . . . 0.0 108.702 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -138.08 103.99 5.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -151.13 159.95 44.16 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.055 0.542 . . . . 0.0 109.59 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -73.29 78.05 1.33 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.588 HG22 HG23 ' A' ' 49' ' ' ILE . 1.5 pp -123.97 138.47 53.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.052 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -152.68 126.63 9.02 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.525 HD11 HD11 ' A' ' 49' ' ' ILE . 36.2 mt -142.92 142.04 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.293 1.037 . . . . 0.0 108.271 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.7 m170 -103.56 141.99 35.06 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.221 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 33.1 mt -126.62 108.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 119.27 0.941 . . . . 0.0 109.089 169.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 18.5 mtp180 -95.39 138.56 32.91 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.236 1.014 . . . . 0.0 108.397 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -124.43 117.29 24.1 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.275 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.66 111.23 16.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 41' ' ' VAL . 74.7 t -85.43 117.06 29.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -131.32 158.84 39.59 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.079 0.951 . . . . 0.0 110.012 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -115.89 110.53 19.14 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.548 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 33.7 p-10 -98.96 152.09 20.18 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.982 0.513 . . . . 0.0 110.85 172.525 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.38 -25.96 63.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.693 0.797 . . . . 0.0 110.965 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.548 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 37.6 tt0 -66.51 -53.45 34.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.317 1.047 . . . . 0.0 112.275 -177.645 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 m -126.68 -0.44 6.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -168.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.22 -133.94 12.11 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 117.741 0.246 . . . . 0.0 112.632 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -82.27 131.13 35.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.906 0.482 . . . . 0.0 110.256 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -156.99 173.66 16.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.784 0.433 . . . . 0.0 110.773 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 31' ' ' VAL . 20.9 t -132.45 125.65 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.393 0.677 . . . . 0.0 109.526 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.432 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 73.2 t60 -87.91 119.35 28.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 109.581 172.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 74.0 m-85 -102.79 127.94 49.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.0 t70 -130.26 123.87 31.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.084 0.554 . . . . 0.0 110.589 -170.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 79.1 mtp -122.59 132.38 54.27 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.018 0.927 . . . . 0.0 111.097 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -154.38 154.23 32.93 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 0.0 110.965 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 162.24 -151.94 22.09 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 118.588 -1.118 . . . . 0.0 110.403 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -145.65 110.5 5.16 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.096 1.448 . . . . 0.0 111.72 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.588 HG23 HG22 ' A' ' 23' ' ' ILE . 68.8 mt -98.64 124.3 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.603 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 7.7 m-20 63.98 24.45 13.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.909 1.283 . . . . 0.0 109.822 -170.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.47 10.38 86.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.39 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.519 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 51.3 mtmt -94.78 108.37 37.12 Favored Pre-proline 0 C--N 1.354 0.771 0 C-N-CA 123.494 0.717 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 37.5 Cg_endo -63.86 133.54 39.4 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.796 2.331 . . . . 0.0 111.732 176.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -137.76 147.39 44.65 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.2 p -132.71 113.1 12.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.77 136.59 34.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.2 p -148.95 145.7 27.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.736 0.303 . . . . 0.0 110.593 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -137.87 142.46 40.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.307 1.043 . . . . 0.0 109.325 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 7.4 mp0 -116.13 140.44 49.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.3 mt -132.87 135.93 26.81 Favored Pre-proline 0 C--O 1.237 0.435 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 165.26 19.95 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.495 2.13 . . . . 0.0 111.713 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.594 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 24.6 ptt180 -38.76 -36.91 0.3 Allowed 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 125.404 1.482 . . . . 0.0 114.15 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -78.78 -19.14 52.91 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 p -130.53 3.05 4.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.339 0.656 . . . . 0.0 111.307 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.51 70.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.29 1.036 . . . . 0.0 112.178 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -71.15 -17.74 62.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.059 0.944 . . . . 0.0 112.366 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 -82.95 -3.84 57.54 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.869 0.467 . . . . 0.0 111.103 -179.069 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -51.65 -44.11 62.89 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.026 0.93 . . . . 0.0 112.963 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.22 30.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -172.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -67.69 -47.55 69.12 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.975 0.51 . . . . 0.0 109.855 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.44 -47.5 33.23 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.778 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.51 -39.18 10.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.008 1.323 . . . . 0.0 112.477 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.1 m -73.77 -44.03 57.27 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.982 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -61.67 -46.99 87.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.041 0.936 . . . . 0.0 112.464 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.53 -31.92 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.415 0.686 . . . . 0.0 110.805 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.21 85.79 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.984 0.514 . . . . 0.0 110.594 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.471 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 20.0 pt20 -76.84 -25.76 53.56 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.217 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -68.03 -27.87 66.91 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.032 0.933 . . . . 0.0 110.669 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.79 6.65 20.52 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.636 0.774 . . . . 0.0 111.448 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.4 54.13 2.02 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 114.701 0.64 . . . . 0.0 114.701 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 30.6 mt -85.06 148.57 26.09 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 118.089 0.945 . . . . 0.0 109.575 165.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.2 m170 73.63 135.52 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 125.49 1.516 . . . . 0.0 111.666 168.269 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.01 177.51 0.69 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.358 2.705 . . . . 0.0 113.859 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -67.75 -17.0 64.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.144 0.577 . . . . 0.0 111.904 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -64.16 -43.5 95.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 168.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.12 -174.19 27.26 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.272 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.44 108.08 0.92 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.53 0.732 . . . . 0.0 109.129 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.23 118.63 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.8 t -70.51 -48.75 54.09 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.999 -0.524 . . . . 0.0 110.029 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 46.12 -78.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.026 1.73 . . . . 0.0 113.401 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.8 m -55.6 150.88 2.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 C-N-CA 124.307 1.043 . . . . 0.0 111.667 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -66.23 124.97 24.1 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -83.15 59.54 5.02 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.522 0.514 . . . . 0.0 109.967 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 52.02 28.46 5.3 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 125.451 1.5 . . . . 0.0 112.727 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -68.15 -43.28 78.61 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.953 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -53.27 -41.71 65.79 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.28 29.19 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.135 0.574 . . . . 0.0 110.268 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.4 ' SD ' ' CE1' ' A' ' 5' ' ' PHE . 8.6 tpt -51.69 -42.12 61.95 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.824 1.249 . . . . 0.0 111.686 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -58.99 -53.26 60.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.335 1.454 . . . . 0.0 110.839 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.72 -27.6 66.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.827 0.704 . . . . 0.0 112.101 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.08 -55.69 8.83 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 123.335 0.397 . . . . 0.0 110.243 176.652 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.8 -37.03 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.914 0.325 . . . . 0.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.4 62.39 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.072 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -61.94 -38.82 89.91 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.321 1.048 . . . . 0.0 112.898 174.014 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.31 -38.66 92.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.241 0.616 . . . . 0.0 110.802 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -66.81 -29.32 69.22 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.737 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.39 0.4 3.58 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.839 1.656 . . . . 0.0 112.081 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -161.33 143.79 9.16 Favored Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 125.887 1.675 . . . . 0.0 108.072 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -59.01 -26.73 82.74 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.449 2.099 . . . . 0.0 112.597 167.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.01 -36.57 3.89 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.241 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.15 129.14 68.23 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.337 1.055 . . . . 0.0 109.561 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.87 105.13 1.09 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.735 2.29 . . . . 0.0 110.687 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.84 143.99 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 0.0 111.944 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.79 -30.63 69.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.302 1.041 . . . . 0.0 111.891 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.22 -6.15 22.04 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.169 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.78 -43.66 2.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.663 0.785 . . . . 0.0 110.89 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -75.49 -31.56 60.25 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.667 0.787 . . . . 0.0 111.578 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.39 -28.75 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 120' ' ' ILE . 2.0 mp -88.28 83.82 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.74 0.816 . . . . 0.0 109.092 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.68 -40.12 0.71 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.516 0.726 . . . . 0.0 111.324 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -154.49 129.18 9.3 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.942 0.897 . . . . 0.0 110.667 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.4 150.28 25.0 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.022 0.929 . . . . 0.0 110.338 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.02 -77.42 0.17 Allowed Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 123.429 0.692 . . . . 0.0 109.552 176.573 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.6 -105.84 0.01 OUTLIER Glycine 0 C--N 1.356 1.678 0 N-CA-C 115.646 1.018 . . . . 0.0 115.646 -166.637 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 11' ' ' HIS . 14.7 t-80 -78.72 87.6 4.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.715 0.757 . . . . 0.0 109.419 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.5 ttp -124.63 131.05 53.49 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.162 0.985 . . . . 0.0 109.396 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -116.21 148.58 40.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.911 0.885 . . . . 0.0 109.923 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.13 157.2 37.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.455 1.502 . . . . 0.0 107.865 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.57 105.14 0.34 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 121.876 1.717 . . . . 0.0 111.122 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.1 -16.2 12.0 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.866 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -158.36 151.61 22.96 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.74 0.77 . . . . 0.0 112.307 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -140.22 143.15 35.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.045 1.738 . . . . 0.0 107.972 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 3' ' ' HIS . 11.4 t-160 -124.41 137.55 54.44 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.411 HD23 ' N ' ' A' ' 12' ' ' LEU . 0.6 OUTLIER -136.47 118.55 15.41 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.577 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 m -104.33 173.7 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.604 ' HB2' HG13 ' A' ' 23' ' ' ILE . 42.4 t -81.69 102.91 11.02 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.23 144.34 98.13 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.826 0.85 . . . . 0.0 111.031 -173.118 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.44 88.85 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.734 2.289 . . . . 0.0 111.004 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.1 -37.23 0.37 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.725 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.94 86.77 2.61 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.705 0.802 . . . . 0.0 109.464 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 65.94 161.35 0.14 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.268 1.427 . . . . 0.0 113.838 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -122.4 97.56 5.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.999 0.92 . . . . 0.0 109.033 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.569 ' HG3' HG23 ' A' ' 23' ' ' ILE . 19.0 pt20 -157.1 159.11 37.55 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.802 0.841 . . . . 0.0 109.177 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.2 57.82 4.7 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.152 0.581 . . . . 0.0 111.648 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.604 HG13 ' HB2' ' A' ' 14' ' ' SER . 2.0 pp -90.54 119.91 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.25 118.62 12.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.406 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 19.2 mt -140.53 139.42 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.36 0.664 . . . . 0.0 109.715 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -107.3 131.93 53.67 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.467 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.6 mt -128.11 110.19 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -99.88 139.66 35.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -122.58 116.17 23.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 164.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -123.86 113.17 18.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -169.77 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 41' ' ' VAL . 87.2 t -80.22 131.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 30.3 ttt180 -146.83 161.24 41.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.444 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.1 mm-40 -109.74 119.41 39.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.037 0.535 . . . . 0.0 110.419 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.447 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 26.3 p-10 -96.61 146.76 24.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.776 0.831 . . . . 0.0 110.311 170.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.83 62.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.403 0.681 . . . . 0.0 111.82 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.447 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 35.2 tt0 -71.96 -55.34 7.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.893 0.877 . . . . 0.0 112.171 -179.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -121.13 0.69 10.21 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.167 0.587 . . . . 0.0 111.859 -168.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.74 -113.78 4.15 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -78.87 144.07 35.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.866 0.466 . . . . 0.0 111.279 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 32' ' ' ARG . 9.3 p90 -154.85 177.42 11.29 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 108.666 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 31' ' ' VAL . 16.3 t -128.3 124.13 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -84.02 122.52 28.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.641 1.176 . . . . 0.0 108.983 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -106.95 126.72 52.68 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -125.89 115.03 19.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.809 0.843 . . . . 0.0 110.02 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.467 ' SD ' HG12 ' A' ' 27' ' ' ILE . 38.9 mtm -120.95 148.09 44.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.566 0.746 . . . . 0.0 111.004 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -167.79 166.36 13.68 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.213 1.005 . . . . 0.0 109.94 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.11 -144.78 10.03 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-O 118.708 -1.051 . . . . 0.0 110.7 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.99 110.06 3.27 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.582 1.182 . . . . 0.0 111.549 171.375 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 23' ' ' ILE . 70.3 mt -100.22 127.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.015 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 65.09 23.53 12.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.088 1.355 . . . . 0.0 109.206 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.48 -0.63 84.67 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.401 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -86.37 109.13 21.0 Favored Pre-proline 0 C--N 1.353 0.745 0 C-N-CA 124.092 0.957 . . . . 0.0 111.48 -175.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.24 129.84 18.89 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.849 2.366 . . . . 0.0 111.902 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -138.49 160.25 40.02 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -147.77 129.06 14.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 169.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -130.87 142.02 50.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.374 1.069 . . . . 0.0 109.102 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -143.25 133.62 24.7 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.538 0.335 . . . . 0.0 110.425 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.86 144.71 33.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.72 0.808 . . . . 0.0 109.231 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -126.1 127.25 45.49 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 65' ' ' ALA . 80.8 mt -124.7 129.87 24.46 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -175.73 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -59.32 156.31 36.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.951 2.434 . . . . 0.0 111.215 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 30.1 ptt180 -45.53 -26.88 0.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.38 -21.79 45.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.373 0.669 . . . . 0.0 111.809 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -128.65 2.87 5.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.833 0.853 . . . . 0.0 110.977 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . . . -55.32 -37.37 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.448 1.099 . . . . 0.0 112.545 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.52 0.7 7.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.202 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.16 3.82 47.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.482 0.713 . . . . 0.0 110.241 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -57.76 -52.03 67.14 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.998 0.919 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.57 -31.1 63.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.5 m -73.44 -50.83 19.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.977 0.511 . . . . 0.0 110.333 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.21 -55.6 15.45 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.745 0.818 . . . . 0.0 111.383 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.36 -46.75 13.28 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.986 1.314 . . . . 0.0 113.059 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.1 m -70.6 -33.15 70.74 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.913 0.485 . . . . 0.0 111.028 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -67.33 -40.77 85.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.396 0.679 . . . . 0.0 111.003 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.93 -33.21 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 110.727 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.96 -47.92 73.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.323 0.582 . . . . 0.0 109.548 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 3.6 pt20 -69.63 -31.89 70.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.825 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -53.69 -41.66 67.16 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 110.876 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -90.79 8.66 33.57 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.075 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.47 -10.02 4.66 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 8.7 mp -83.03 65.66 8.25 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 118.898 1.349 . . . . 0.0 111.215 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -84.71 108.26 14.34 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.27 104.12 0.12 Allowed 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.848 2.365 . . . . 0.0 111.492 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -69.03 -33.56 73.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.539 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.471 ' H ' ' HD1' ' A' ' 85' ' ' PHE . 1.3 p90 -78.3 -6.17 54.27 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.386 0.674 . . . . 0.0 111.643 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.65 -51.96 4.4 Favored Glycine 0 C--N 1.353 1.479 0 C-N-CA 123.073 0.368 . . . . 0.0 113.08 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.44 -173.84 3.52 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.94 0.896 . . . . 0.0 111.42 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.455 HG13 ' HB2' ' A' ' 90' ' ' ARG . 33.4 pt -135.75 -172.31 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.463 1.105 . . . . 0.0 108.807 173.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.4 p -66.01 -57.99 6.53 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.715 0.806 . . . . 0.0 110.749 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HB2' HG13 ' A' ' 88' ' ' ILE . 28.1 ttm-85 60.63 -77.21 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 126.04 1.736 . . . . 0.0 114.246 171.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 m -60.04 79.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 124.964 1.306 . . . . 0.0 113.272 -169.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' HIS . . . . . 0.586 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 23.1 m-70 -157.77 153.63 26.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.395 1.478 . . . . 0.0 108.63 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.33 18.26 20.05 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.551 0.74 . . . . 0.0 110.067 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.586 ' HG2' ' HB3' ' A' ' 92' ' ' HIS . 6.0 mm-40 -71.24 -30.4 66.28 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.169 0.588 . . . . 0.0 110.677 -174.312 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -65.8 -46.63 77.95 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.94 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.0 -34.73 72.19 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.962 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.34 64.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.564 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mmt -72.27 -30.74 65.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.623 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -51.92 -52.4 50.28 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.087 0.955 . . . . 0.0 110.625 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.78 -28.76 61.82 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.798 0.686 . . . . 0.0 112.241 -173.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.24 -44.81 58.82 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.382 0.273 . . . . 0.0 110.811 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.442 ' O ' HD13 ' A' ' 106' ' ' LEU . 97.6 mt -63.47 -46.52 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.688 0.795 . . . . 0.0 111.648 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -59.69 -31.5 69.64 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.349 0.595 . . . . 0.0 110.496 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.93 56.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.573 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.458 ' HG2' HG21 ' A' ' 31' ' ' VAL . 1.9 tpmt? -64.63 -32.67 74.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.475 0.71 . . . . 0.0 111.873 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -67.83 -20.96 65.22 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.679 1.192 . . . . 0.0 111.149 171.377 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -88.24 -17.18 31.35 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.126 0.97 . . . . 0.0 110.202 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 89.96 14.64 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.916 2.086 . . . . 0.0 112.638 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -138.66 127.74 14.32 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.063 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.34 153.51 65.14 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.113 2.542 . . . . 0.0 113.74 -172.772 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.24 62.15 0.54 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 139.4 73.39 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.033 0.933 . . . . 0.0 112.436 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.22 66.02 8.85 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.382 2.722 . . . . 0.0 112.531 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.54 72.44 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 122.845 1.307 . . . . 0.0 109.532 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.68 41.24 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.779 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 117' ' ' GLU . 3.9 pp -63.23 -29.69 70.98 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.325 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.413 ' N ' HD12 ' A' ' 116' ' ' LEU . 31.7 tt0 -73.65 -19.17 60.92 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.496 0.718 . . . . 0.0 111.43 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -68.53 -16.46 63.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.958 0.503 . . . . 0.0 111.407 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.3 mm -71.64 -35.3 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.112 0.565 . . . . 0.0 109.805 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 120' ' ' ILE . 3.4 mp -84.36 78.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 122.261 1.029 . . . . 0.0 108.246 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.02 -13.73 0.63 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.861 175.058 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -68.89 126.75 30.77 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.66 0.784 . . . . 0.0 109.308 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.57 159.18 16.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.326 0.65 . . . . 0.0 109.678 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.67 66.74 2.99 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.192 0.307 . . . . 0.0 112.476 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.047 0.939 . . . . 0.0 109.306 -178.473 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.68 -165.76 36.46 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 123.618 0.574 . . . . 0.0 114.164 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -74.14 118.75 17.46 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.2 ttt -120.84 130.9 54.14 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.559 0.744 . . . . 0.0 109.691 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -141.7 136.23 30.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.235 0.614 . . . . 0.0 109.801 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.82 156.91 62.35 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.824 1.25 . . . . 0.0 108.504 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.61 105.03 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.538 2.159 . . . . 0.0 112.242 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.63 -19.89 13.95 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.691 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -150.97 135.33 16.96 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.524 0.678 . . . . 0.0 112.363 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.403 HD22 ' HE1' ' A' ' 98' ' ' MET . 46.2 tp -114.8 141.02 48.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.583 1.553 . . . . 0.0 108.957 170.557 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.532 0.733 . . . . 0.0 109.349 168.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.574 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -123.29 110.21 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.644 0.735 . . . . 0.0 110.529 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.6 158.29 5.53 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 164.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.552 ' HB3' HG13 ' A' ' 23' ' ' ILE . 94.8 p -71.6 136.96 47.62 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.877 0.762 . . . . 0.0 110.555 -171.324 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.93 113.98 44.89 Favored Pre-proline 0 CA--C 1.553 1.08 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.89 126.74 13.57 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.177 2.584 . . . . 0.0 113.059 -172.293 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.2 -66.88 0.2 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -91.93 -34.45 14.48 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.367 0.667 . . . . 0.0 109.749 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -144.46 131.98 20.98 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.589 0.756 . . . . 0.0 110.583 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.52 41.54 3.45 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.179 0.991 . . . . 0.0 109.515 173.659 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.432 HE21 ' HB2' ' A' ' 50' ' ' ASP . 35.2 tt0 -69.34 158.3 35.32 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -85.95 53.17 2.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.625 0.726 . . . . 0.0 110.255 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.552 HG13 ' HB3' ' A' ' 14' ' ' SER . 2.0 pp -89.67 115.57 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -138.2 106.39 5.75 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.574 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 48.6 mt -127.6 132.98 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -166.069 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -107.35 119.17 38.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.502 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -120.55 114.1 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 18.4 mtp180 -104.11 135.34 45.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 108.234 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -121.88 116.06 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 167.357 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.6 111.8 17.67 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 41' ' ' VAL . 52.1 t -82.37 118.33 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.03 159.0 30.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -109.27 119.39 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.722 0.409 . . . . 0.0 110.35 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.3 p30 -95.04 154.9 16.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.877 0.871 . . . . 0.0 109.232 167.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.75 -27.65 64.1 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.714 0.406 . . . . 0.0 111.454 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.21 -54.38 7.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.862 0.865 . . . . 0.0 112.348 -173.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 t -108.57 -1.92 19.25 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.11 0.564 . . . . 0.0 111.532 -173.609 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.84 -110.31 3.06 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 138.34 37.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.9 0.48 . . . . 0.0 110.567 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.5 166.79 26.2 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 31' ' ' VAL . 7.6 t -127.81 127.12 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.578 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 55.4 t60 -86.18 114.41 23.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.462 1.105 . . . . 0.0 108.859 171.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 76.0 m-85 -99.73 111.38 23.72 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 27.1 t70 -107.13 124.58 49.9 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 109.408 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.502 ' HG2' HG12 ' A' ' 27' ' ' ILE . 79.4 mtp -124.58 140.34 53.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.259 0.624 . . . . 0.0 110.286 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.04 170.0 21.38 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.739 0.815 . . . . 0.0 109.663 173.913 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.16 -137.78 6.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 119.429 -0.651 . . . . 0.0 112.002 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 9.7 pt-20 -152.55 157.73 41.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.756 1.222 . . . . 0.0 108.546 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.543 HG23 HG22 ' A' ' 23' ' ' ILE . 51.2 mt -156.46 105.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -168.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' HB2' HE21 ' A' ' 21' ' ' GLN . 26.9 t70 59.14 47.96 11.14 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.216 1.007 . . . . 0.0 108.994 -170.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.97 -35.05 3.13 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 114.836 -1.075 . . . . 0.0 114.384 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -86.94 128.88 54.31 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.218 1.007 . . . . 0.0 112.053 -168.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 89.6 Cg_endo -74.17 161.07 41.47 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.064 2.509 . . . . 0.0 113.821 -177.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.415 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 8.9 p90 -152.86 148.9 27.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.903 0.881 . . . . 0.0 109.021 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -142.54 113.83 7.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.154 0.582 . . . . 0.0 110.278 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -127.21 143.09 51.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.295 1.038 . . . . 0.0 109.186 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 t -143.53 134.43 25.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.013 0.435 . . . . 0.0 110.093 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -146.97 148.81 32.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.853 0.861 . . . . 0.0 109.703 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 4.7 mp0 -118.94 138.72 52.59 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 73.4 mt -128.89 134.36 26.23 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.71 160.85 34.66 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.641 2.227 . . . . 0.0 111.373 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -36.2 9.96 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.57 -23.73 61.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.056 0.942 . . . . 0.0 112.258 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -125.3 7.2 7.77 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.952 0.901 . . . . 0.0 110.779 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.04 80.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.029 0.931 . . . . 0.0 112.282 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.83 -6.51 38.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.086 0.954 . . . . 0.0 113.186 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -78.57 -6.3 55.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.414 0.685 . . . . 0.0 111.131 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -64.14 -24.13 67.57 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 124.542 1.137 . . . . 0.0 113.06 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.7 -49.06 16.98 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.252 0.549 . . . . 0.0 109.693 -162.48 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 m -72.41 -31.01 65.17 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.283 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.07 -54.24 13.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.182 0.993 . . . . 0.0 110.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.02 74.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.631 1.172 . . . . 0.0 111.92 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.5 m -63.86 -50.24 69.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.657 0.383 . . . . 0.0 110.34 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -54.92 -45.37 74.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.216 1.006 . . . . 0.0 112.058 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.34 -32.06 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.543 0.337 . . . . 0.0 110.671 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.99 -47.48 58.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.023 0.529 . . . . 0.0 110.096 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.611 ' HA ' HD23 ' A' ' 81' ' ' LEU . 13.2 pt20 -65.4 -22.16 66.75 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.757 0.823 . . . . 0.0 112.641 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -64.65 -19.24 65.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.741 0.816 . . . . 0.0 111.918 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -90.2 25.23 2.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.373 0.669 . . . . 0.0 112.33 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.22 49.85 1.67 Allowed Glycine 0 C--N 1.35 1.312 0 CA-C-O 120.218 -0.212 . . . . 0.0 113.493 170.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -78.2 153.47 31.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.953 0.501 . . . . 0.0 109.701 173.428 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -71.08 164.78 53.9 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.949 0.9 . . . . 0.0 110.782 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.81 96.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.315 2.677 . . . . 0.0 112.615 165.243 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.37 -20.36 34.39 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.751 0.82 . . . . 0.0 111.748 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -69.5 -8.47 47.22 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.422 0.689 . . . . 0.0 112.118 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.42 -4.71 89.22 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 119.8 -0.445 . . . . 0.0 113.389 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.13 131.87 46.68 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.292 0.637 . . . . 0.0 110.075 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -77.27 167.94 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.37 0.668 . . . . 0.0 111.386 -177.836 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.9 t -68.54 -26.66 65.53 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.376 0.67 . . . . 0.0 111.909 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -87.53 81.12 7.86 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.176 0.512 . . . . 0.0 110.104 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -142.96 138.44 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.237 1.015 . . . . 0.0 108.852 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -103.79 98.81 8.61 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.117 0.567 . . . . 0.0 110.205 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -103.75 101.11 10.94 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 168.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -72.78 79.47 1.13 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.934 0.874 . . . . 0.0 110.696 -177.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -71.8 -42.26 67.28 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.818 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.27 -34.08 74.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.473 1.109 . . . . 0.0 111.815 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.37 68.38 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.711 0.632 . . . . 0.0 110.696 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.403 ' HE1' HD22 ' A' ' 10' ' ' LEU . 30.4 ttm -65.45 -41.53 93.35 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.012 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.24 -48.29 68.33 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.388 1.075 . . . . 0.0 110.91 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.0 -26.85 57.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.7 t70 -65.72 -57.35 8.26 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.487 0.492 . . . . 0.0 110.212 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.9 -42.41 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.431 0.693 . . . . 0.0 111.551 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -28.38 69.13 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.22 47.74 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 110.326 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 30.7 mmmt -58.34 -40.46 82.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 mp -66.62 -34.47 77.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.537 1.135 . . . . 0.0 111.046 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 34.6 t-80 -81.28 -17.86 47.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.444 0.697 . . . . 0.0 110.562 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 69.96 13.45 7.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.569 1.547 . . . . 0.0 111.667 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.6 m80 -148.49 152.27 38.06 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 124.993 1.317 . . . . 0.0 108.777 -176.189 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -42.68 119.12 1.35 Allowed 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 123.991 3.127 . . . . 0.0 114.206 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.74 -4.3 65.58 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.371 -172.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.99 114.91 16.75 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -88.64 123.18 1.48 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.845 2.363 . . . . 0.0 112.83 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' VAL . . . . . 0.416 HG21 HD23 ' A' ' 116' ' ' LEU . 11.6 p -79.05 152.91 4.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -113.42 17.48 18.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.038 0.535 . . . . 0.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.416 HD23 HG21 ' A' ' 114' ' ' VAL . 4.4 pp -65.65 -24.26 66.98 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -114.59 -3.14 12.96 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.11 0.964 . . . . 0.0 110.865 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -72.29 -5.27 34.92 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.558 0.743 . . . . 0.0 112.707 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.476 HD12 ' H ' ' A' ' 119' ' ' ILE . 4.0 mp -74.3 -7.42 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 C-N-CA 123.998 0.919 . . . . 0.0 109.648 175.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.2 mm 60.77 54.91 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.286 0 C-N-CA 125.12 1.368 . . . . 0.0 107.501 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -70.01 88.99 0.59 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 113.423 -1.717 . . . . 0.0 110.666 -164.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -82.7 132.77 35.17 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.69 -38.07 65.01 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.27 -158.24 22.82 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.958 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 C--O 1.252 1.193 0 C-N-CA 123.495 0.718 . . . . 0.0 109.352 179.493 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.3 132.22 3.09 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -174.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -139.39 -30.55 0.72 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.174 0.59 . . . . 0.0 110.094 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' MET . . . . . 0.474 ' HB2' ' HB3' ' A' ' 11' ' ' HIS . 76.6 mmm -128.18 102.69 6.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.543 1.137 . . . . 0.0 108.607 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -108.6 147.03 32.42 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.47 155.6 32.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.575 1.15 . . . . 0.0 108.304 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.72 90.83 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.285 1.99 . . . . 0.0 111.995 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.91 -26.3 3.01 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.721 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -150.53 151.63 32.94 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.196 0.498 . . . . 0.0 111.692 -170.287 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 53.8 tp -135.02 111.63 9.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 108.557 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 4' ' ' MET . 11.6 t-160 -98.42 127.9 44.56 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -121.05 132.38 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.215 0.606 . . . . 0.0 109.931 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.09 165.13 29.7 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 166.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.4 t -113.45 115.15 27.59 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.3 mt -62.92 139.94 97.44 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.018 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -44.95 -69.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.824 3.016 . . . . 0.0 113.73 -168.836 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.21 -84.86 0.04 OUTLIER Glycine 0 C--N 1.343 0.929 0 O-C-N 123.355 0.409 . . . . 0.0 113.082 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 19' ' ' ASP . 2.3 pt? -88.8 -40.05 13.45 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.86 0.864 . . . . 0.0 110.141 176.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASP . . . . . 0.401 ' H ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -166.82 141.52 4.09 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.502 1.521 . . . . 0.0 108.701 -176.058 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -81.43 84.08 6.78 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.989 0.516 . . . . 0.0 109.734 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.94 141.29 31.36 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.05 65.83 8.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.852 0.834 . . . . 0.0 110.509 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.625 HD13 HD21 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -92.69 126.85 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.869 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.484 HD21 ' HG3' ' A' ' 48' ' ' GLU . 6.0 p30 -151.81 110.02 3.73 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.411 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 27.8 mt -132.32 137.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -168.195 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' MET . 4.7 m170 -99.53 128.52 45.65 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.565 HG12 ' HG2' ' A' ' 45' ' ' MET . 56.2 mt -121.9 109.62 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -96.18 124.84 40.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' HB2' HG11 ' A' ' 41' ' ' VAL . 45.7 p90 -111.69 116.98 31.65 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.049 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -124.63 112.32 16.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.676 0.79 . . . . 0.0 109.29 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 41' ' ' VAL . 56.3 t -75.9 126.64 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.771 0.428 . . . . 0.0 110.663 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -143.97 154.79 43.66 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.05 125.56 41.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.713 0.405 . . . . 0.0 111.132 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 1.5 p30 -100.1 147.08 26.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.635 1.174 . . . . 0.0 109.155 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.81 -10.94 60.51 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 122.954 0.501 . . . . 0.0 112.233 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 16.4 tt0 -75.81 -55.27 5.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.196 0.999 . . . . 0.0 112.012 -177.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.1 p -130.32 1.98 4.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.338 0.655 . . . . 0.0 112.263 -167.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.88 -106.27 3.4 Favored Glycine 0 C--O 1.213 -1.171 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 146.76 41.22 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.794 0.797 . . . . 0.0 111.887 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.442 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.5 p90 -152.85 173.53 15.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 31' ' ' VAL . 23.5 t -128.7 130.85 68.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -89.03 110.95 21.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 63.3 m-85 -96.56 139.32 32.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.467 0.707 . . . . 0.0 109.181 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -135.04 127.95 31.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.358 0.663 . . . . 0.0 109.722 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.565 ' HG2' HG12 ' A' ' 27' ' ' ILE . 83.4 mtp -123.91 131.17 53.53 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.919 0.888 . . . . 0.0 110.114 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -161.03 162.18 31.65 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.71 -128.03 2.6 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.484 ' HG3' HD21 ' A' ' 24' ' ' ASN . 10.3 pt-20 -156.59 165.43 36.31 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.198 0.599 . . . . 0.0 109.864 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 90.6 mt -155.98 103.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 -161.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.16 37.43 20.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.687 0.795 . . . . 0.0 110.1 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.12 -21.03 7.32 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.312 -0.858 . . . . 0.0 115.239 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -79.65 120.23 79.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 117.621 0.711 . . . . 0.0 110.825 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.61 157.05 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.017 2.478 . . . . 0.0 113.266 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -154.7 161.51 41.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.679 0.392 . . . . 0.0 111.279 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.5 p -141.89 116.26 9.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.431 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.35 144.31 31.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.244 1.018 . . . . 0.0 108.861 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.3 p -148.12 149.59 32.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.452 0.569 . . . . 0.0 110.753 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -141.46 151.32 43.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.558 0.743 . . . . 0.0 110.571 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.76 132.56 54.29 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.55 0.74 . . . . 0.0 109.863 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 95.7 mt -127.53 139.05 34.15 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.374 0.67 . . . . 0.0 109.791 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.44 158.54 40.36 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.053 2.502 . . . . 0.0 112.02 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -41.36 -34.83 0.56 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.126 1.37 . . . . 0.0 114.65 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.86 -19.88 62.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.625 0.77 . . . . 0.0 112.416 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.3 p -131.7 10.1 4.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.829 0.852 . . . . 0.0 110.231 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.57 96.79 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.493 0.717 . . . . 0.0 111.36 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -70.05 -22.19 63.1 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.549 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -80.6 -8.76 59.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.809 0.844 . . . . 0.0 109.545 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -53.04 -30.61 36.76 Favored 'General case' 0 C--O 1.205 -1.276 0 C-N-CA 123.949 0.899 . . . . 0.0 112.918 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 -34.16 20.77 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -69.52 -48.3 60.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.37 -57.04 10.45 Favored 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -43.55 -45.27 6.53 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.778 1.631 . . . . 0.0 113.461 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.4 m -68.75 -40.55 79.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.668 0.387 . . . . 0.0 110.892 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HA ' ' HG2' ' A' ' 77' ' ' GLN . 31.4 ttp180 -68.59 -39.09 81.09 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.534 0.734 . . . . 0.0 111.828 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.98 -50.21 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.397 1.079 . . . . 0.0 109.451 173.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HB1' HD22 ' A' ' 81' ' ' LEU . . . -60.74 -43.06 98.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.667 0.787 . . . . 0.0 111.622 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 14.0 pt20 -71.11 -35.52 71.82 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.638 0.375 . . . . 0.0 111.284 -176.273 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -65.1 -31.65 72.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.619 0.368 . . . . 0.0 110.697 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -89.38 5.38 45.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.234 0.613 . . . . 0.0 112.143 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.02 -27.09 2.45 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.625 HD21 HD13 ' A' ' 23' ' ' ILE . 9.8 mp -70.9 158.07 37.07 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.767 0.794 . . . . 0.0 111.955 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -142.04 74.46 21.55 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 162.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 42.4 Cg_endo -91.25 29.16 0.37 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.154 2.569 . . . . 0.0 111.494 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -67.05 -38.88 86.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.585 1.154 . . . . 0.0 112.313 -170.579 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -81.05 -42.64 20.75 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.56 -63.53 0.63 Allowed Glycine 0 C--N 1.347 1.155 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.218 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 75.7 -43.95 0.5 Allowed 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 125.938 1.695 . . . . 0.0 112.965 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.61 111.79 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.379 1.072 . . . . 0.0 110.248 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.0 m -67.95 -45.43 74.26 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.252 0.621 . . . . 0.0 111.283 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -79.66 76.26 6.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.063 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.46 114.87 2.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.634 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -77.15 94.44 4.08 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -94.47 21.94 6.66 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.888 0.875 . . . . 0.0 110.535 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -85.12 32.88 0.54 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.299 1.04 . . . . 0.0 110.536 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -64.34 -32.44 74.05 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.388 1.075 . . . . 0.0 110.2 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.47 -31.29 69.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.59 -48.88 53.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.991 0.516 . . . . 0.0 110.976 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.6 ptm -65.97 -31.44 72.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.505 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -56.48 -45.97 80.67 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.175 0.59 . . . . 0.0 110.828 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.564 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 12.3 pt-20 -76.75 -27.67 55.44 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.705 0.402 . . . . 0.0 111.934 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.51 -58.97 3.78 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.864 0.364 . . . . 0.0 110.028 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 106' ' ' LEU . 74.7 mt -57.16 -38.05 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.879 1.271 . . . . 0.0 112.361 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.564 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.69 -29.61 70.82 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.234 0.47 . . . . 0.0 111.611 177.849 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.82 -41.19 60.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.741 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -57.35 -45.09 84.71 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.789 0.836 . . . . 0.0 112.514 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 102' ' ' ILE . 9.7 mp -64.21 -24.95 67.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.871 0.869 . . . . 0.0 111.766 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 46.1 t-80 -85.68 -16.91 37.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.319 0.648 . . . . 0.0 110.657 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.38 13.26 3.83 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.134 1.374 . . . . 0.0 111.608 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -147.88 137.25 12.0 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 124.243 1.017 . . . . 0.0 108.819 -176.586 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.06 106.49 1.54 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.501 2.134 . . . . 0.0 111.678 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.45 46.7 1.06 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -72.49 144.11 86.06 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.98 0.912 . . . . 0.0 110.167 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.21 148.81 69.45 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.994 2.462 . . . . 0.0 112.128 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.97 149.98 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -140.83 32.68 1.79 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.668 0.787 . . . . 0.0 110.105 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 117' ' ' GLU . 4.5 pp -61.97 -43.03 99.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.813 0.445 . . . . 0.0 110.821 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -76.18 -22.48 55.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.757 1.223 . . . . 0.0 111.853 -178.296 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 tpp85 -50.36 -49.14 55.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.997 1.319 . . . . 0.0 112.246 -170.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.91 -29.19 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.754 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.3 -24.36 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.752 0.821 . . . . 0.0 111.628 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 31.0 mmm180 -63.71 82.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.396 0.679 . . . . 0.0 111.364 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -157.52 140.91 15.51 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.137 1.375 . . . . 0.0 109.439 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.07 81.16 1.0 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.772 0.829 . . . . 0.0 109.149 173.622 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.65 -72.2 1.2 Allowed Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 123.884 0.874 . . . . 0.0 108.78 178.303 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.69 -76.2 0.41 Allowed Glycine 0 C--N 1.352 1.45 0 O-C-N 123.488 0.493 . . . . 0.0 114.121 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -79.58 60.03 3.17 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.072 0.949 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttp -81.08 105.7 12.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.394 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -96.11 139.14 32.71 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.13 161.3 54.13 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.923 1.289 . . . . 0.0 108.451 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.512 ' HG3' ' HB3' ' A' ' 112' ' ' GLU . 29.8 Cg_exo -62.44 109.66 0.91 Allowed 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 121.859 1.706 . . . . 0.0 111.491 172.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.29 -13.83 33.45 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.896 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -155.12 146.79 23.23 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.542 0.671 . . . . 0.0 112.062 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.9 tp -136.35 128.93 30.55 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.641 1.176 . . . . 0.0 109.039 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -100.3 125.63 46.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 85.8 mt -107.17 134.82 49.71 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.269 0.628 . . . . 0.0 109.928 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 23' ' ' ILE . 13.8 p -148.58 165.99 4.36 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 t -73.52 104.38 4.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.744 1.156 . . . . 0.0 108.208 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 pp -78.4 157.38 77.77 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.894 0.878 . . . . 0.0 110.983 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -58.53 110.86 0.72 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.599 2.199 . . . . 0.0 110.908 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.02 -42.13 0.88 Allowed Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 mp -102.18 165.6 11.06 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.48 1.112 . . . . 0.0 110.044 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -65.49 138.76 58.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.288 0.635 . . . . 0.0 109.917 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -64.25 136.33 57.08 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.017 0.823 . . . . 0.0 111.26 -175.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.541 HE21 ' HB2' ' A' ' 50' ' ' ASP . 31.2 tt0 -150.49 154.9 38.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 170.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ASP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 50' ' ' ASP . 27.8 t70 -85.74 42.48 0.97 Allowed 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.488 1.137 . . . . 0.0 110.727 -173.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.69 HG22 HG23 ' A' ' 49' ' ' ILE . 44.3 pt -89.7 139.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.445 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -152.85 125.01 8.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 172.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 31.4 mt -132.43 132.79 60.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.174 -172.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 45' ' ' MET . 5.5 m170 -108.09 109.82 21.35 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -105.27 108.37 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -102.91 109.93 21.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -115.93 117.96 31.6 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.69 114.52 18.12 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.567 HG11 ' HB3' ' A' ' 105' ' ' LYS . 7.1 p -82.25 126.63 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.051 0.54 . . . . 0.0 109.726 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -141.16 166.49 24.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -109.49 117.13 33.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -91.65 156.96 17.23 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.681 0.793 . . . . 0.0 109.665 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.42 -20.76 62.08 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -84.72 -53.62 5.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.28 0.632 . . . . 0.0 111.438 -171.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -117.86 3.92 12.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.958 0.903 . . . . 0.0 111.537 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.44 -122.41 5.72 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.55 51.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.618 0.709 . . . . 0.0 111.994 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -157.75 170.65 21.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.002 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.07 130.35 69.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.505 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.0 t60 -88.27 129.8 35.27 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -115.07 135.12 54.55 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -137.99 141.36 40.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 91.3 mtp -135.19 131.59 36.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.564 0.746 . . . . 0.0 109.281 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -150.54 162.79 39.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.72 -144.08 12.8 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.418 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 1.9 pm0 -147.23 163.16 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.295 1.038 . . . . 0.0 108.547 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 23' ' ' ILE . 38.0 mt -157.81 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 -160.855 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.565 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 37.3 t70 55.38 26.64 8.97 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 121.614 0.721 . . . . 0.0 111.394 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.22 50.97 4.33 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.212 -173.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 52.4 mtpt -146.11 108.41 4.26 Favored Pre-proline 0 N--CA 1.497 1.92 0 C-N-CA 123.564 0.746 . . . . 0.0 110.798 -176.382 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.91 121.44 4.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.863 2.375 . . . . 0.0 111.794 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -125.54 143.68 50.9 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.861 0.465 . . . . 0.0 110.687 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 p -139.92 110.55 6.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.312 0.645 . . . . 0.0 109.477 171.887 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.22 151.85 39.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.697 1.199 . . . . 0.0 109.299 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.8 p -151.43 123.16 8.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.909 0.483 . . . . 0.0 109.85 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.16 146.44 42.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.317 1.047 . . . . 0.0 108.98 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 49.6 mt-10 -123.89 141.29 52.17 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.077 0.551 . . . . 0.0 109.672 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -124.79 130.28 24.3 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -65.65 169.65 12.55 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.936 2.424 . . . . 0.0 112.193 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -41.5 -39.67 1.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.473 1.109 . . . . 0.0 113.617 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.04 -29.5 66.55 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.243 1.017 . . . . 0.0 112.526 -174.089 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -130.99 8.39 4.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.966 0.507 . . . . 0.0 111.376 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.83 70.95 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.531 0.732 . . . . 0.0 111.917 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.16 -21.55 66.79 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.898 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -72.76 3.26 5.33 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.406 0.683 . . . . 0.0 112.593 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.56 -20.61 61.29 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.402 1.081 . . . . 0.0 112.209 -173.012 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.16 -42.9 45.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.938 0.875 . . . . 0.0 108.844 -169.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -74.46 -39.62 62.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.155 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.9 t70 -73.71 -59.1 2.87 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.016 0.526 . . . . 0.0 112.14 -171.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.45 66.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.559 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 95.4 m -65.81 -48.23 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 173.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -57.74 -34.33 69.4 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.545 0.738 . . . . 0.0 111.951 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 71' ' ' ASP . 94.0 t -68.8 -36.81 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.12 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' HD13 ' A' ' 81' ' ' LEU . . . -68.44 -49.72 57.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.54 0.736 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 73' ' ' THR . 65.7 mm-40 -66.21 -25.08 66.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -60.13 -28.73 68.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.439 1.096 . . . . 0.0 111.363 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -91.66 12.13 22.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.648 0.779 . . . . 0.0 112.232 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.1 74.32 1.11 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 122.948 0.155 . . . . 0.0 113.292 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.778 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 11.2 mp -116.25 151.18 36.3 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.163 0.985 . . . . 0.0 109.681 170.427 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.428 ' CD2' ' HB2' ' A' ' 21' ' ' GLN . 44.9 m-70 -58.51 -47.52 98.61 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 117.848 -1.073 . . . . 0.0 112.46 173.077 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' ' 81' ' ' LEU . 51.2 Cg_exo -55.36 1.34 0.1 OUTLIER 'Trans proline' 0 C--N 1.404 3.475 0 C-N-CA 123.227 2.618 . . . . 0.0 116.59 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.6 -44.76 90.01 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.258 1.023 . . . . 0.0 110.873 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -70.48 -27.55 64.3 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.988 0.423 . . . . 0.0 110.243 175.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.84 70.84 2.66 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.926 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 153.22 29.31 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.2 mt 76.26 -38.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 125.02 1.328 . . . . 0.0 111.852 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 t -74.03 -20.47 60.3 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.499 -0.751 . . . . 0.0 111.166 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -73.77 -28.82 61.86 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.725 0.81 . . . . 0.0 110.442 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m -127.81 82.73 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.292 1.037 . . . . 0.0 109.435 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -84.31 42.27 0.88 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.915 0.886 . . . . 0.0 110.128 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 65.29 8.34 4.84 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.709 1.603 . . . . 0.0 112.908 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -12.39 60.25 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.535 0.734 . . . . 0.0 110.043 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -52.0 -41.13 61.96 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.356 1.463 . . . . 0.0 111.946 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.67 -30.45 70.7 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.199 0.937 . . . . 0.0 111.847 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.12 17.82 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.942 0.497 . . . . 0.0 110.893 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -70.96 -25.9 62.93 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.565 0.346 . . . . 0.0 111.869 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -50.97 -42.73 60.3 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.127 0.971 . . . . 0.0 110.303 164.066 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 35.0 mt-10 -79.33 -27.57 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.488 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.83 -50.31 30.68 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.8 -38.81 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.567 0.347 . . . . 0.0 111.648 173.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.42 -28.55 69.33 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.739 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.21 -40.6 62.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.053 0.541 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.567 ' HB3' HG11 ' A' ' 31' ' ' VAL . 9.5 mmpt? -58.44 -40.18 81.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.61 0.764 . . . . 0.0 112.059 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.25 -25.58 67.73 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.179 0.992 . . . . 0.0 111.162 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -80.68 -17.91 49.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 110.891 172.488 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 81.5 36.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.899 1.679 . . . . 0.0 111.628 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -145.89 163.5 30.61 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.238 1.015 . . . . 0.0 109.457 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -34.5 116.53 0.1 Allowed 'Trans proline' 0 C--N 1.402 3.392 0 C-N-CA 124.838 3.692 . . . . 0.0 115.894 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.37 57.61 0.49 Allowed Glycine 0 C--O 1.238 0.38 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLU . . . . . 0.512 ' HB3' ' HG3' ' A' ' 7' ' ' PRO . 1.1 mm-40 -96.9 114.2 64.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.35 94.28 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.437 2.091 . . . . 0.0 112.822 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.47 93.06 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.21 1.005 . . . . 0.0 109.009 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.99 43.45 1.12 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.3 -173.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.03 -27.82 69.67 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.814 0.445 . . . . 0.0 111.959 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 42.5 tt0 -78.28 -22.07 48.82 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.964 0.506 . . . . 0.0 110.799 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -79.96 -17.09 53.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.985 0.514 . . . . 0.0 110.561 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.3 mm -78.97 91.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 124.063 0.945 . . . . 0.0 108.696 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.1 mt 82.41 -21.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.846 163.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ARG . . . . . 0.455 ' HD3' ' HA ' ' A' ' 117' ' ' GLU . 15.8 mtp180 -65.86 109.61 2.55 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.744 0.418 . . . . 0.0 111.14 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -75.93 145.35 40.48 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -98.4 122.03 41.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.557 0.743 . . . . 0.0 110.264 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.88 17.84 3.41 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 CA--C 1.556 1.185 0 C-N-CA 124.566 1.147 . . . . 0.0 108.177 178.358 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.731 0.301 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.04 -35.64 0.02 OUTLIER Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.57 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -163.67 145.86 9.54 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.359 0.664 . . . . 0.0 110.118 -176.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.7 ttp -154.21 96.71 1.97 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -98.54 141.32 31.54 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.79 157.02 32.61 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.82 1.248 . . . . 0.0 108.02 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.19 89.84 0.39 Allowed 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.943 1.762 . . . . 0.0 110.554 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -14.43 3.78 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.928 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -164.59 153.08 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.955 0.877 . . . . 0.0 111.978 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 4.8 tt -143.26 132.83 23.63 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 175.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -114.55 134.09 55.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.279 0.632 . . . . 0.0 109.667 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 95.1 mt -111.1 128.83 56.01 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.6 t -135.36 90.1 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.317 0.58 . . . . 0.0 110.364 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -92.17 102.35 14.87 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 159.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.626 ' H ' HD23 ' A' ' 15' ' ' LEU . 1.8 pt? -79.56 155.25 76.26 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.285 1.034 . . . . 0.0 110.082 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.639 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 36.6 Cg_endo -62.9 -45.73 12.42 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.194 1.929 . . . . 0.0 112.769 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.66 -84.48 0.02 OUTLIER Glycine 0 N--CA 1.475 1.286 0 O-C-N 123.283 0.364 . . . . 0.0 113.135 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.7 mt -98.17 39.39 1.24 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.556 1.142 . . . . 0.0 110.407 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 64.54 54.61 1.44 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.611 1.164 . . . . 0.0 112.079 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HB2' ' HA ' ' A' ' 16' ' ' PRO . 76.6 mt-30 -78.15 -156.44 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.969 165.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.5 tt0 -101.94 140.19 36.56 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.92 112.38 23.24 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.95 138.65 38.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 24.0 p-10 -151.95 127.7 10.21 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 165.171 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -137.81 128.87 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.717 0.807 . . . . 0.0 109.355 -163.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -93.82 131.65 39.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 56.7 mt -120.36 103.99 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 171.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -91.96 140.17 29.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.31 137.8 19.74 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 111.197 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.25 130.77 37.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.848 0.859 . . . . 0.0 109.271 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.2 t -80.74 117.27 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 42.7 ttt180 -132.95 166.56 22.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.689 1.196 . . . . 0.0 108.144 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.416 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 11.4 mm100 -106.34 127.67 53.43 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 118.349 0.522 . . . . 0.0 111.19 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 40' ' ' TYR . 3.2 p30 -102.95 146.54 28.17 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.825 1.25 . . . . 0.0 108.63 170.498 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.13 61.79 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 9.5 tp10 -77.37 -54.32 6.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.354 0.662 . . . . 0.0 112.008 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -113.55 -23.09 9.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.956 0.902 . . . . 0.0 111.218 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.16 -116.33 4.75 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 149.65 47.23 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.501 0.651 . . . . 0.0 111.724 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.428 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.1 p90 -159.05 173.74 16.0 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.992 0.917 . . . . 0.0 109.278 167.467 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.45 124.47 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -87.63 122.75 31.72 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -108.14 138.62 44.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.504 0.722 . . . . 0.0 110.18 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -130.48 120.46 24.18 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.329 1.052 . . . . 0.0 108.221 172.101 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 80.8 mtp -116.04 130.58 56.87 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.444 0.565 . . . . 0.0 109.702 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.8 161.73 40.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 159.48 -151.09 21.84 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 109.4 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.171 0.986 . . . . 0.0 110.426 175.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 80' ' ' GLY . 72.7 mt -99.47 123.9 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.135 174.82 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.6 t70 63.52 22.93 13.42 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.82 1.248 . . . . 0.0 110.079 -174.095 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.05 3.88 84.83 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.228 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -93.03 108.4 32.18 Favored Pre-proline 0 C--N 1.355 0.823 0 C-N-CA 123.453 0.701 . . . . 0.0 110.722 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 66.8 Cg_endo -72.26 128.36 13.69 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.476 2.117 . . . . 0.0 111.389 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -131.45 150.17 52.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.235 0.614 . . . . 0.0 109.88 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -139.39 125.83 20.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.033 0.533 . . . . 0.0 110.292 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -141.71 147.59 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.4 p -148.51 140.08 23.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.03 151.08 37.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.659 0.783 . . . . 0.0 109.931 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.54 131.6 51.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.861 0.865 . . . . 0.0 109.281 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.63 125.75 23.84 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 30.6 Cg_endo -59.69 157.15 33.79 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.912 2.408 . . . . 0.0 111.382 172.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -44.8 -26.73 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.0 -28.64 62.49 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.779 . . . . 0.0 111.442 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.8 p -131.54 7.19 4.48 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.316 1.046 . . . . 0.0 111.11 -173.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.47 71.64 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.992 0.917 . . . . 0.0 111.401 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -70.91 -8.12 50.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.084 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -90.45 0.5 57.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.662 0.785 . . . . 0.0 110.05 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 6.4 p90 -52.94 -43.62 66.45 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -30.28 65.87 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.651 0.78 . . . . 0.0 112.604 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 t -73.03 -50.45 22.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 109.864 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.15 -45.5 63.41 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.87 0.468 . . . . 0.0 112.025 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.87 -38.93 11.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.717 0.807 . . . . 0.0 112.835 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -71.9 -38.28 69.97 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.62 0.368 . . . . 0.0 110.816 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -57.62 -48.53 79.18 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.912 0.885 . . . . 0.0 110.947 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.87 0.868 . . . . 0.0 110.358 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB1' HD22 ' A' ' 81' ' ' LEU . . . -66.72 -41.81 87.36 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.104 -172.505 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.442 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 13.8 pt20 -72.39 -36.11 68.61 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.243 0.617 . . . . 0.0 110.973 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -27.93 69.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.23 0.612 . . . . 0.0 111.336 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -98.09 7.36 46.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.824 0.45 . . . . 0.0 111.672 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.476 ' O ' HG21 ' A' ' 49' ' ' ILE . . . 102.12 93.0 2.21 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.062 0.226 . . . . 0.0 112.648 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 77' ' ' GLN . 57.5 tp -143.02 146.08 33.52 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.371 0.585 . . . . 0.0 110.691 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 22.0 p-80 -122.49 82.7 47.11 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.378 1.071 . . . . 0.0 109.213 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.76 -27.47 14.84 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.233 2.622 . . . . 0.0 112.611 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -83.59 -49.98 8.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.424 0.69 . . . . 0.0 109.853 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.463 ' HE2' ' HG2' ' A' ' 20' ' ' GLN . 43.9 t80 -69.36 -17.93 63.74 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.116 -175.687 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.71 -31.37 71.18 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 120.156 -0.247 . . . . 0.0 113.283 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 64.08 16.52 10.03 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.516 1.127 . . . . 0.0 112.776 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 mm -75.59 110.28 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.8 p -71.48 -24.59 62.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.753 0.821 . . . . 0.0 111.248 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -82.38 155.92 24.46 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.931 0.892 . . . . 0.0 109.516 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.0 m 43.34 28.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 C-N-CA 125.406 1.483 . . . . 0.0 113.666 -175.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -88.23 -41.35 13.0 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.758 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -136.12 27.44 3.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.303 0.641 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -83.85 30.38 0.51 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.365 0.666 . . . . 0.0 111.931 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -53.62 -43.42 68.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.53 1.132 . . . . 0.0 110.138 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.37 -33.54 74.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.592 1.183 . . . . 0.0 112.959 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.09 -52.33 20.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.004 0.431 . . . . 0.0 110.839 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.48 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 1.1 mpt? -61.93 -34.18 75.62 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.787 173.819 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.4 -54.73 39.86 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.049 0.843 . . . . 0.0 110.203 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.95 -27.45 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.191 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.29 -58.55 6.22 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.394 0.616 . . . . 0.0 110.168 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.97 -38.22 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 114.526 -1.216 . . . . 0.0 113.179 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -34.57 78.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.291 0.95 . . . . 0.0 111.157 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.22 -46.8 48.19 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.212 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -41.68 82.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.085 0.954 . . . . 0.0 111.926 174.618 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.71 -38.24 90.32 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.823 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -72.64 -31.21 64.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.439 0.296 . . . . 0.0 111.067 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 67.22 8.2 6.04 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.273 1.429 . . . . 0.0 114.036 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -142.24 151.44 58.43 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.657 0.783 . . . . 0.0 109.373 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.97 92.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.489 2.793 . . . . 0.0 113.197 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.56 29.28 0.56 Allowed Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.151 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.32 146.77 55.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.163 0.985 . . . . 0.0 110.812 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -88.36 -167.67 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.352 2.701 . . . . 0.0 111.87 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.37 144.77 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.322 0.649 . . . . 0.0 109.694 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.55 -4.95 59.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 113.345 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.24 -32.89 74.79 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.529 0.604 . . . . 0.0 111.35 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -85.43 -2.28 57.94 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.493 0.717 . . . . 0.0 110.982 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -86.16 -20.54 28.45 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.253 0.621 . . . . 0.0 110.709 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -81.19 -59.95 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.25 94.73 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -69.2 0.64 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -168.3 127.65 1.21 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.596 0.758 . . . . 0.0 110.111 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 20.52 -78.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 127.849 2.459 . . . . 0.0 115.967 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.64 29.55 0.36 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -171.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 C--O 1.252 1.197 0 C-N-CA 124.578 1.151 . . . . 0.0 109.461 179.728 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLY . . . . . 0.449 ' HA3' HG21 ' A' ' 13' ' ' VAL . . . 77.59 -81.79 1.22 Allowed Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.247 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -60.86 125.25 23.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.947 0.499 . . . . 0.0 110.793 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mtp -139.53 160.57 39.55 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.458 0.703 . . . . 0.0 110.122 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -149.08 131.1 15.31 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.334 1.054 . . . . 0.0 108.315 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.99 161.61 28.62 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.404 1.082 . . . . 0.0 109.236 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.77 100.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.747 2.298 . . . . 0.0 112.599 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.36 -6.87 32.13 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.775 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -158.86 151.92 22.37 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.207 1.004 . . . . 0.0 111.957 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.1 tt -146.75 149.27 33.07 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.607 1.563 . . . . 0.0 107.33 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -127.26 139.73 52.71 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.183 0.593 . . . . 0.0 110.452 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 96.9 mt -125.56 135.24 52.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.383 1.473 . . . . 0.0 108.14 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . 0.449 HG21 ' HA3' ' A' ' 2' ' ' GLY . 8.0 m -138.26 124.9 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.931 0.892 . . . . 0.0 110.691 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.453 ' HB3' HG13 ' A' ' 23' ' ' ILE . 17.5 p -37.22 115.28 0.38 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.618 165.491 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -129.68 161.59 58.34 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.222 1.009 . . . . 0.0 110.737 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -50.83 106.82 0.14 Allowed 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 123.917 3.078 . . . . 0.0 112.788 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.85 -37.01 0.67 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' A' ' 83' ' ' PRO . 3.3 mm? -84.56 -83.99 0.15 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.049 0.94 . . . . 0.0 109.456 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 t70 176.76 177.78 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.261 1.824 . . . . 0.0 106.839 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -78.95 61.06 3.05 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.84 0.828 . . . . 0.0 111.099 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -112.56 145.57 40.09 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -94.87 87.8 5.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.615 0.366 . . . . 0.0 110.529 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -106.76 128.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.448 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -137.12 131.4 32.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 71.1 mt -144.93 135.82 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -173.186 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -112.4 139.97 47.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -127.21 106.19 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -97.99 141.9 30.38 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -126.33 118.55 25.31 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.65 113.56 17.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 41' ' ' VAL . 58.0 t -79.35 118.11 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.45 158.2 30.26 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 10.7 mm100 -107.06 121.55 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.61 -0.681 . . . . 0.0 110.344 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.445 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 5.1 p30 -102.04 145.41 29.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.765 0.826 . . . . 0.0 108.858 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.29 -18.05 65.03 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.335 0.654 . . . . 0.0 112.57 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 28.5 tt0 -73.63 -47.09 42.7 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.743 0.817 . . . . 0.0 112.685 -173.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -134.91 -7.87 2.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.508 0.723 . . . . 0.0 111.594 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -123.39 7.76 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.25 128.81 37.38 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 117.062 0.431 . . . . 0.0 111.747 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 10.8 p90 -140.62 162.26 35.79 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 31' ' ' VAL . 15.8 t -119.15 127.29 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.544 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 5.4 t-160 -84.76 108.34 17.4 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 166.467 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 89.6 m-85 -94.9 116.45 28.72 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -110.44 134.45 52.32 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.511 ' SD ' ' HA ' ' A' ' 72' ' ' ALA . 87.1 mtp -129.55 129.11 44.04 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 118.908 0.776 . . . . 0.0 110.531 175.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -149.99 153.53 36.71 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 0.0 109.763 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 171.37 -145.88 9.14 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.952 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.61 109.75 3.52 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.736 1.268 . . . . 0.0 112.088 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 79' ' ' HIS . 50.3 mt -102.15 128.42 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.589 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ASP . . . . . 0.596 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 38.7 t70 66.56 23.76 10.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.39 1.476 . . . . 0.0 108.618 -169.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 3.36 88.52 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.101 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 51.4 mtmt -97.77 110.18 54.22 Favored Pre-proline 0 C--O 1.245 0.826 0 C-N-CA 124.302 1.041 . . . . 0.0 110.843 -173.064 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 41.6 Cg_endo -63.67 143.56 87.26 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.889 2.393 . . . . 0.0 112.52 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.411 ' HB3' ' CE1' ' A' ' 79' ' ' HIS . 31.2 p90 -144.73 155.27 43.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.441 0.696 . . . . 0.0 109.724 -178.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -148.83 131.21 15.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.324 0.65 . . . . 0.0 109.866 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.41 160.63 39.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.587 1.555 . . . . 0.0 109.168 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 m -148.91 138.51 21.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 109.811 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -136.77 132.86 35.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.6 mp0 -113.96 125.2 53.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.441 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 75.3 mt -127.08 125.64 24.17 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 40' ' ' TYR . 55.6 Cg_endo -64.28 166.66 16.43 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.884 2.389 . . . . 0.0 112.164 176.376 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HG3' HD13 ' A' ' 106' ' ' LEU . 74.2 ttt180 -47.62 -25.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.868 0.867 . . . . 0.0 112.923 174.107 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.83 -37.24 81.67 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.171 0.988 . . . . 0.0 112.678 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.2 p -129.39 4.97 5.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.422 0.689 . . . . 0.0 112.142 -170.243 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.76 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.186 0.994 . . . . 0.0 112.189 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -71.37 0.44 8.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.892 1.277 . . . . 0.0 113.975 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -93.3 -0.46 56.68 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.646 0.779 . . . . 0.0 110.999 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -54.35 -34.02 60.26 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.56 68.99 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.562 0.619 . . . . 0.0 112.582 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.8 m -73.54 -39.25 64.89 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.571 0.544 . . . . 0.0 109.99 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.15 -52.97 14.17 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.452 0.701 . . . . 0.0 111.271 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -48.98 -30.24 5.79 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.056 1.342 . . . . 0.0 113.106 172.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -81.66 -41.43 21.41 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.327 0.251 . . . . 0.0 110.665 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -63.73 -42.09 97.95 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.336 0.655 . . . . 0.0 111.612 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.21 -39.26 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.51 1.124 . . . . 0.0 110.401 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.92 83.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.003 0.921 . . . . 0.0 110.982 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 12.9 pt20 -78.85 -32.7 46.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.627 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -51.92 -48.11 64.34 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.77 1.228 . . . . 0.0 112.505 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.554 ' HB3' HD12 ' A' ' 49' ' ' ILE . 16.5 t-80 -80.72 14.06 2.3 Favored 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.87 50.8 0.62 Allowed Glycine 0 C--N 1.349 1.265 0 O-C-N 122.051 -0.406 . . . . 0.0 112.865 170.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.462 ' HG ' ' HD3' ' A' ' 83' ' ' PRO . 65.5 tp -143.13 155.11 44.5 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.436 0.694 . . . . 0.0 109.716 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -158.13 82.13 2.87 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.714 ' HA ' HD11 ' A' ' 18' ' ' LEU . 94.8 Cg_endo -82.67 83.38 2.0 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.583 2.188 . . . . 0.0 111.883 -170.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -75.61 -32.68 60.38 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.117 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -84.02 -34.36 24.32 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.679 0.391 . . . . 0.0 110.271 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.11 -43.21 65.2 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.064 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.6 84.15 1.04 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.966 0.907 . . . . 0.0 110.071 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -35.78 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 122.861 0.464 . . . . 0.0 110.182 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.4 m -92.32 -9.12 43.09 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.434 0.694 . . . . 0.0 111.05 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? 74.08 -62.74 0.45 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.286 1.434 . . . . 0.0 110.416 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.8 p -74.76 104.38 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.503 0.668 . . . . 0.0 109.66 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.85 161.7 29.39 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.343 1.057 . . . . 0.0 110.512 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 22.7 pttp -66.7 177.59 1.56 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 169.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 6.6 pt-20 50.19 18.57 0.41 Allowed 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 124.795 1.238 . . . . 0.0 113.003 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -74.54 -31.86 62.27 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 124.532 1.133 . . . . 0.0 109.518 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.04 -30.33 71.29 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.766 0.827 . . . . 0.0 110.82 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.52 61.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.905 0.482 . . . . 0.0 110.532 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.2 ttt -62.17 -39.25 92.04 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.467 0.707 . . . . 0.0 111.353 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.51 -50.83 64.57 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.334 1.454 . . . . 0.0 110.106 174.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -65.61 -34.02 77.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.99 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.32 -50.2 64.41 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.11 0.564 . . . . 0.0 109.948 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.47 -39.94 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.727 0.811 . . . . 0.0 112.054 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -68.63 -30.7 69.48 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.96 0.41 . . . . 0.0 110.613 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.33 62.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.822 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.03 0.932 . . . . 0.0 112.43 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.508 HD13 ' HG3' ' A' ' 62' ' ' ARG . 26.6 mt -65.7 -27.17 68.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.977 0.911 . . . . 0.0 112.56 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -71.5 -16.85 62.36 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 66.67 28.39 9.13 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.843 1.257 . . . . 0.0 110.656 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -147.76 141.21 15.42 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.753 1.221 . . . . 0.0 108.647 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.14 93.06 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.774 2.316 . . . . 0.0 112.008 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.8 67.67 3.64 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.343 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.76 124.74 61.42 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.903 0.881 . . . . 0.0 110.342 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.97 168.33 23.61 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.952 2.435 . . . . 0.0 111.322 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.34 151.86 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.369 0.668 . . . . 0.0 109.578 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -117.54 69.19 0.77 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.72 -28.58 13.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.337 0.655 . . . . 0.0 110.825 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.69 -37.07 65.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -71.26 -14.18 62.15 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.077 0.551 . . . . 0.0 111.782 -171.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp -75.25 -53.28 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.591 0.756 . . . . 0.0 109.219 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.97 92.57 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.87 -49.63 2.09 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.937 -175.154 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -156.65 135.2 11.53 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.315 0.646 . . . . 0.0 110.516 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -101.3 -61.13 1.41 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.15 -160.04 9.56 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.737 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.254 1.319 0 C-N-CA 124.618 1.167 . . . . 0.0 110.682 -178.863 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.9 -65.87 0.27 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -135.81 105.26 6.05 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.0 ttp -119.61 108.88 15.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.313 0.645 . . . . 0.0 110.191 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -106.43 134.68 49.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 170.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.87 155.0 51.97 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.553 1.141 . . . . 0.0 108.601 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.69 108.97 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.643 2.229 . . . . 0.0 112.532 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.23 11.57 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.496 0.569 . . . . 0.0 113.354 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -148.28 141.95 25.55 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.632 0.73 . . . . 0.0 112.191 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.89 139.86 53.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.179 . . . . 0.0 108.347 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -128.56 117.5 21.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -120.6 110.05 15.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.837 0.855 . . . . 0.0 110.039 -179.11 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.25 171.1 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 168.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.8 t -93.55 128.87 39.88 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 171.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.96 143.45 87.82 Favored Pre-proline 0 CA--C 1.559 1.31 0 O-C-N 123.375 0.422 . . . . 0.0 111.305 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.22 -169.92 0.65 Allowed 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.99 2.46 . . . . 0.0 113.159 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.06 -63.29 0.33 Allowed Glycine 0 C--N 1.346 1.133 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -175.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.3 126.75 52.62 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.776 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.65 83.97 3.3 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -78.5 -76.4 0.19 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.147 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -154.45 148.25 25.48 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.97 59.08 4.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.503 0.721 . . . . 0.0 110.424 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG22 HG23 ' A' ' 49' ' ' ILE . 2.3 pp -89.9 121.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 173.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -150.65 116.58 5.57 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.547 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 25.8 mt -138.61 145.08 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.323 1.049 . . . . 0.0 108.181 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -132.44 127.14 34.68 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.55 HG12 ' HG2' ' A' ' 45' ' ' MET . 52.3 mt -109.74 123.44 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 108.675 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 14.0 mmm180 -109.54 117.89 35.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.863 0.865 . . . . 0.0 109.088 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -111.43 119.61 39.39 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -122.06 113.92 20.21 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.945 0.898 . . . . 0.0 109.346 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.69 121.72 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 122.701 0.4 . . . . 0.0 110.434 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -140.53 162.86 34.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.559 1.144 . . . . 0.0 108.102 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -111.19 117.56 33.56 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.832 0.453 . . . . 0.0 109.825 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.474 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 26.1 p-10 -102.46 147.32 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.983 0.913 . . . . 0.0 109.93 172.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.24 -20.55 63.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.326 0.65 . . . . 0.0 111.692 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.474 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 13.9 tp10 -70.15 -53.62 16.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.883 0.873 . . . . 0.0 111.626 -178.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.9 m -119.21 0.88 11.28 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -170.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.3 -119.27 4.84 Favored Glycine 0 C--N 1.345 1.037 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.44 144.72 44.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.224 0.512 . . . . 0.0 110.473 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 p90 -158.36 169.88 23.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.5 0.5 . . . . 0.0 110.501 171.824 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.18 133.24 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -96.91 133.18 41.88 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 83.8 m-85 -119.01 135.08 54.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.758 0.423 . . . . 0.0 110.036 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 22.9 m-20 -115.85 139.47 50.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.45 1.1 . . . . 0.0 108.948 173.54 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.55 ' HG2' HG12 ' A' ' 27' ' ' ILE . 84.4 mtp -135.18 128.47 32.09 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 158.09 32.87 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.742 0.817 . . . . 0.0 109.046 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.92 -126.28 2.02 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -159.31 163.29 35.82 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 23' ' ' ILE . 44.1 mt -157.32 107.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 -166.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.34 39.01 5.49 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.325 1.059 . . . . 0.0 108.493 -166.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.76 -17.96 2.54 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.27 123.03 69.3 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.011 0.905 . . . . 0.0 110.273 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.27 152.8 56.09 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.815 2.343 . . . . 0.0 113.437 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -144.67 146.68 32.36 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.75 0.82 . . . . 0.0 108.875 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -145.45 114.52 6.99 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.262 0.625 . . . . 0.0 109.421 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.53 160.23 38.08 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.079 1.352 . . . . 0.0 108.957 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 p -152.21 136.39 16.58 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.08 0.552 . . . . 0.0 110.01 172.509 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -136.56 141.48 43.34 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.162 0.985 . . . . 0.0 109.607 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -115.31 125.04 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' LEU . . . . . 0.4 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 96.9 mt -115.06 125.56 28.81 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 123.389 0.676 . . . . 0.0 109.184 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 33.4 Cg_endo -60.79 156.52 42.8 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.888 2.392 . . . . 0.0 111.703 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -41.53 -44.85 3.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.919 1.288 . . . . 0.0 112.818 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.69 -25.4 66.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.749 1.22 . . . . 0.0 112.503 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.7 p -132.04 17.91 4.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.873 0.869 . . . . 0.0 110.728 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.34 -44.06 76.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.884 0.474 . . . . 0.0 111.453 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.26 -4.79 23.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.135 0.974 . . . . 0.0 112.674 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.51 4.6 15.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.88 0.872 . . . . 0.0 111.407 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -63.37 -19.47 64.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.432 1.093 . . . . 0.0 113.115 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.17 56.5 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.231 0.539 . . . . 0.0 109.926 -167.87 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -71.53 -39.07 70.97 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.366 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 75' ' ' VAL . 21.6 t70 -74.6 -49.22 22.5 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.478 0.486 . . . . 0.0 111.375 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.94 83.05 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.513 0.725 . . . . 0.0 112.412 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 m -66.67 -43.39 84.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.649 0.38 . . . . 0.0 110.264 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.0 ttm180 -52.8 -38.63 61.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.133 0.973 . . . . 0.0 111.751 171.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -71.11 -38.88 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.346 0.658 . . . . 0.0 109.552 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.73 -49.64 51.21 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 -173.76 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.437 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 21.1 pt20 -70.1 -24.36 63.2 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.863 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.8 -30.0 69.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.353 0.661 . . . . 0.0 110.929 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.492 ' HB2' HD12 ' A' ' 49' ' ' ILE . 54.7 m80 -99.78 10.59 41.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.214 0.606 . . . . 0.0 110.85 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.59 43.9 5.37 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.935 174.247 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.437 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 38.7 tp -55.95 -54.33 46.01 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.292 0.568 . . . . 0.0 109.634 171.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 87' ' ' ALA . 17.6 m80 -156.43 153.75 25.63 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.717 1.607 . . . . 0.0 107.739 169.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 85' ' ' PHE . 13.5 Cg_exo -70.51 -167.35 0.25 Allowed 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.991 2.461 . . . . 0.0 113.587 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -65.96 -7.6 17.79 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.326 1.051 . . . . 0.0 112.785 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' PHE . . . . . 0.406 ' HD2' ' HB2' ' A' ' 83' ' ' PRO . 92.7 m-85 -67.01 -25.57 66.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.743 0.817 . . . . 0.0 111.268 174.53 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 144.33 122.29 1.59 Allowed Glycine 0 C--N 1.351 1.362 0 CA-C-O 119.2 -0.778 . . . . 0.0 111.737 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . . . -64.53 -61.02 2.47 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.774 0.83 . . . . 0.0 110.302 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.5 pt -149.04 84.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.054 1.342 . . . . 0.0 107.967 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.8 m -74.71 -47.75 29.67 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.984 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -88.5 52.25 2.39 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.585 0.707 . . . . 0.0 109.571 172.232 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 p -70.01 132.49 33.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.368 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -77.0 139.57 40.12 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 51.41 1.84 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.627 0.727 . . . . 0.0 111.744 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -74.89 -8.89 57.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.842 0.857 . . . . 0.0 110.786 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -53.43 -41.22 65.83 Favored 'General case' 0 C--O 1.21 -1.017 0 C-N-CA 124.221 1.009 . . . . 0.0 111.004 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -57.91 -40.04 79.42 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.37 -45.58 54.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.419 0.288 . . . . 0.0 111.18 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.41 -34.05 76.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.537 0.735 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.49 -51.09 71.35 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.525 1.13 . . . . 0.0 109.824 172.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.482 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 34.1 mt-10 -69.52 -26.79 64.69 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.943 0.777 . . . . 0.0 111.429 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 14.3 t70 -70.98 -55.37 8.47 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.45 0.469 . . . . 0.0 109.803 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.19 -40.73 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.724 0.809 . . . . 0.0 112.056 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -63.01 -30.34 71.53 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.121 0.486 . . . . 0.0 110.521 177.106 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 110' ' ' PRO . . . -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.045 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.3 mmmt -59.24 -40.07 84.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.857 0.863 . . . . 0.0 112.009 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.71 -28.22 69.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.586 0.755 . . . . 0.0 111.917 174.348 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -77.64 -16.79 58.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.133 0.573 . . . . 0.0 111.146 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 84.96 -47.74 0.08 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 126.094 1.758 . . . . 0.0 110.413 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -95.88 107.53 34.85 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.469 ' HA ' ' HB1' ' A' ' 104' ' ' ALA . 94.4 Cg_endo -74.87 127.22 10.6 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.089 2.526 . . . . 0.0 113.943 -170.083 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.61 85.03 0.83 Allowed Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 169.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 128.11 90.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.562 0.745 . . . . 0.0 111.283 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.45 106.43 1.05 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.246 1.964 . . . . 0.0 112.206 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.26 148.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -124.67 18.09 8.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -171.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.47 -36.02 79.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.563 0.345 . . . . 0.0 111.565 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.61 -30.23 29.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.231 0.612 . . . . 0.0 110.666 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -66.16 -28.29 68.67 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.423 0.689 . . . . 0.0 111.336 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.76 -30.35 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.241 0.616 . . . . 0.0 109.998 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.7 mt -76.67 80.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.608 0.718 . . . . 0.0 109.609 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -119.99 94.66 4.46 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -66.02 126.85 29.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.585 0.354 . . . . 0.0 110.277 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -88.43 143.05 27.23 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.444 0.697 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.51 -50.87 0.02 OUTLIER Glycine 0 C--N 1.339 0.749 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.253 1.256 0 C-N-CA 123.646 0.779 . . . . 0.0 109.914 -175.9 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.012 0.434 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 163.71 20.13 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.242 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -98.27 22.91 8.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.819 0.447 . . . . 0.0 110.626 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.1 tpt -98.62 174.64 6.33 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.984 0.914 . . . . 0.0 109.674 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -77.18 137.57 38.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.16 0.984 . . . . 0.0 109.391 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.78 153.48 70.44 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.309 1.044 . . . . 0.0 108.935 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.15 109.92 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.41 -8.4 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-O 120.25 -0.195 . . . . 0.0 112.666 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.547 ' NE2' ' HB3' ' A' ' 26' ' ' HIS . 11.3 t-160 -160.02 126.01 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.321 0.581 . . . . 0.0 110.437 -173.04 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 tp -100.95 145.63 28.41 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.49 1.116 . . . . 0.0 109.03 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 2.6 t-160 -124.85 117.34 23.91 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 170.832 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 89.5 mt -89.91 110.04 21.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.7 t -126.37 149.82 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.513 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.9 t -77.73 160.46 28.41 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.55 139.72 6.07 Favored Pre-proline 0 CA--C 1.568 1.662 0 C-N-CA 124.641 1.176 . . . . 0.0 113.527 -176.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.61 -160.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.81 2.34 . . . . 0.0 112.104 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.45 -64.49 4.29 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.6 tp -122.78 122.52 38.89 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.289 1.036 . . . . 0.0 108.969 172.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.7 87.03 1.68 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.955 0.883 . . . . 0.0 109.13 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -78.02 -53.86 6.93 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.375 -170.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -147.41 147.67 30.5 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.82 55.12 3.24 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.014 0.912 . . . . 0.0 110.529 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.542 HG22 HG23 ' A' ' 49' ' ' ILE . 2.2 pp -87.95 115.32 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . 0.464 HD21 ' HG3' ' A' ' 48' ' ' GLU . 5.9 p30 -146.01 110.21 4.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.0 mt -130.01 141.21 46.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.613 -166.169 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 45' ' ' MET . 19.1 m170 -107.4 122.21 46.15 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.449 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -123.07 109.6 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 17.7 ttt180 -91.41 133.29 35.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -123.9 118.62 27.5 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.19 113.12 13.47 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 41' ' ' VAL . 91.1 t -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 15.6 ttt180 -127.9 161.07 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.41 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.6 mm-40 -111.27 114.34 27.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -96.04 154.76 17.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.915 0.886 . . . . 0.0 110.503 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.32 -16.19 61.89 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.02 0.528 . . . . 0.0 111.952 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.08 -53.1 11.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.702 0.801 . . . . 0.0 111.981 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.8 t -126.55 -1.11 6.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.4 0.68 . . . . 0.0 112.461 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.57 -114.47 4.16 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 145.19 42.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.176 0.488 . . . . 0.0 110.817 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -153.27 171.91 17.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.437 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 31' ' ' VAL . 7.1 t -124.32 128.02 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 8.5 t60 -84.48 123.4 30.22 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 94.0 m-85 -115.88 140.11 49.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.279 0.632 . . . . 0.0 109.47 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -143.41 137.9 28.98 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.346 172.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.595 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 83.7 mtp -123.17 136.91 54.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 111.114 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -163.47 162.77 24.85 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.125 0.57 . . . . 0.0 110.958 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.11 -130.47 3.73 Favored Glycine 0 N--CA 1.469 0.864 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.464 ' HG3' HD21 ' A' ' 24' ' ' ASN . 10.4 pt-20 -157.89 166.32 32.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.686 0.794 . . . . 0.0 110.08 173.173 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 23' ' ' ILE . 97.3 mt -155.77 105.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -161.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 60.67 35.34 19.83 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.098 0.951 . . . . 0.0 108.739 -170.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.17 -22.26 8.73 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 114.563 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -77.84 113.75 35.43 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.891 0.877 . . . . 0.0 111.148 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.41 154.13 40.38 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.143 2.562 . . . . 0.0 113.122 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PHE . . . . . 0.423 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 11.8 p90 -152.69 156.42 39.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.712 0.405 . . . . 0.0 111.282 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 p -153.11 124.52 7.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.858 0.863 . . . . 0.0 110.264 168.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -144.72 165.25 28.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.397 1.479 . . . . 0.0 108.524 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 p -153.2 142.06 21.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.723 0.409 . . . . 0.0 110.7 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -144.03 141.06 29.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.834 0.853 . . . . 0.0 110.154 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 44.6 mt-10 -125.55 125.38 43.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.23 132.54 24.19 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -171.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.78 160.86 34.86 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.646 2.231 . . . . 0.0 111.175 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -51.75 -28.4 15.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.03 -37.96 89.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.927 0.891 . . . . 0.0 112.161 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.7 p -126.72 12.84 7.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.098 0.559 . . . . 0.0 112.061 -171.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.46 76.48 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.201 0.6 . . . . 0.0 111.831 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -69.89 -11.49 60.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.384 1.074 . . . . 0.0 113.667 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -83.61 1.59 41.5 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.145 0.578 . . . . 0.0 111.73 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -54.89 -25.61 30.17 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.227 1.411 . . . . 0.0 113.937 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.22 -33.27 61.35 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -167.194 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 m -69.69 -38.24 76.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.473 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -72.09 -46.62 56.07 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.507 0.505 . . . . 0.0 110.027 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -58.06 -50.81 72.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.56 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 m -69.15 -23.24 63.93 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 0.0 111.533 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.5 ttp-105 -74.46 -34.03 63.06 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.107 0.479 . . . . 0.0 110.465 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.77 -32.56 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 109.908 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.66 -54.35 7.11 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.043 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.435 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 21.2 mm-40 -62.49 -22.86 66.58 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.253 -1.339 . . . . 0.0 112.935 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -48.6 -36.45 15.7 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.209 0.604 . . . . 0.0 112.08 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -108.11 -31.27 8.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.738 0.245 . . . . 0.0 110.527 170.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.59 94.35 0.53 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 160.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 52.7 tp -77.15 72.59 3.71 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 110.109 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 49.61 49.94 8.28 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 125.051 1.34 . . . . 0.0 111.535 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.03 -14.08 21.17 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.291 2.661 . . . . 0.0 114.954 -160.008 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -73.08 -44.54 60.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -76.07 -36.48 58.97 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.741 0.816 . . . . 0.0 109.943 172.692 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.92 -117.53 8.13 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.346 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.77 32.11 2.73 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.019 0.928 . . . . 0.0 109.896 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.3 mm -77.15 84.83 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.548 0.689 . . . . 0.0 110.047 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 81.1 p -129.56 -24.03 2.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.224 1.01 . . . . 0.0 110.079 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 64.8 -72.48 0.07 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.828 1.651 . . . . 0.0 111.205 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.01 165.52 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.403 0.681 . . . . 0.0 109.677 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 3.4 m80 74.14 14.44 3.84 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.022 1.329 . . . . 0.0 111.433 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -80.42 79.56 7.0 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.477 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -91.45 33.43 1.0 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.319 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -61.56 -42.04 98.26 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.44 167.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.39 -33.7 76.11 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.008 0.817 . . . . 0.0 110.728 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.55 61.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.937 0.495 . . . . 0.0 110.961 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.6 ttm -68.04 -34.39 76.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.372 0.669 . . . . 0.0 111.459 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -55.26 -47.27 75.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.311 1.045 . . . . 0.0 110.044 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.3 -25.57 60.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.0 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.4 -60.85 2.67 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.432 HG22 HD22 ' A' ' 106' ' ' LEU . 72.6 mt -54.75 -40.99 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.084 0.954 . . . . 0.0 111.729 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -31.39 72.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 123.207 0.317 . . . . 0.0 111.61 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.08 -51.65 56.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.394 0.677 . . . . 0.0 111.535 -176.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -28.19 62.41 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.973 0.509 . . . . 0.0 110.542 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.432 HD22 HG22 ' A' ' 102' ' ' ILE . 6.0 mp -71.77 -28.76 63.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.572 0.349 . . . . 0.0 110.447 175.126 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 65.5 t-80 -81.51 -17.06 49.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.252 1.021 . . . . 0.0 109.643 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 69.42 18.99 7.77 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -137.42 145.41 49.36 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.597 0.759 . . . . 0.0 109.839 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -58.96 139.1 89.37 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.261 2.641 . . . . 0.0 112.876 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.12 50.2 0.03 OUTLIER Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.58 159.99 69.37 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.257 1.023 . . . . 0.0 110.319 -172.079 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.62 124.99 15.15 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.674 2.249 . . . . 0.0 111.414 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.89 131.16 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 122.961 0.504 . . . . 0.0 109.902 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -94.88 3.05 55.42 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 118.439 -0.791 . . . . 0.0 113.009 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -53.11 -34.88 58.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.762 0.664 . . . . 0.0 111.416 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.54 87.34 2.34 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 166.223 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -133.39 29.62 3.94 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.9 mm -106.74 -53.39 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.296 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.9 mm -87.97 74.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -110.8 179.61 4.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.342 1.057 . . . . 0.0 109.699 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -144.95 129.83 18.28 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.666 0.786 . . . . 0.0 109.209 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -112.49 -52.8 2.76 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.025 0.53 . . . . 0.0 110.274 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -101.22 53.15 0.86 Allowed Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.801 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 123.352 0.661 . . . . 0.0 109.742 179.674 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.86 -56.31 3.72 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.719 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -76.2 76.85 3.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.634 0.774 . . . . 0.0 110.015 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtp -90.65 104.89 17.43 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.911 0.884 . . . . 0.0 110.517 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -96.75 138.65 33.99 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.461 0.704 . . . . 0.0 110.063 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.85 157.14 34.5 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.486 1.114 . . . . 0.0 108.356 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.71 102.78 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.919 1.746 . . . . 0.0 111.651 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.34 -8.62 24.61 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.338 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -157.8 151.66 24.09 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.529 0.664 . . . . 0.0 111.898 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.7 tp -140.51 142.27 35.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.596 1.558 . . . . 0.0 108.382 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -111.7 138.25 48.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.587 0.755 . . . . 0.0 109.265 173.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 75.3 mt -118.53 126.65 52.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.076 0.95 . . . . 0.0 109.145 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.8 t -120.27 167.34 13.78 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 164.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 20' ' ' GLN . 31.8 p -79.89 161.19 25.71 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 119.547 1.067 . . . . 0.0 109.501 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -49.47 135.45 17.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 O-C-N 124.15 0.907 . . . . 0.0 112.655 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -55.73 126.01 21.01 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.981 3.121 . . . . 0.0 113.287 -164.941 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.24 -19.97 11.54 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.466 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt 62.53 46.28 5.71 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.963 1.305 . . . . 0.0 111.528 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.52 -37.95 88.24 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.721 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 14' ' ' SER . 36.0 tp60 -74.75 170.59 15.56 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.489 1.116 . . . . 0.0 108.344 170.853 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -73.18 -176.83 2.28 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.201 0.455 . . . . 0.0 111.234 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.73 84.68 6.76 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 -171.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.488 HG22 HG23 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -106.97 145.71 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.432 -175.379 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -151.74 138.13 18.53 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.17 166.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 53.5 mt -142.64 136.49 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.4 m170 -107.34 136.19 47.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.7 mt -130.44 108.47 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 26.2 mtp180 -92.97 134.63 34.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.401 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -129.38 117.11 20.06 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -132.74 117.14 17.45 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.55 0.74 . . . . 0.0 109.438 -171.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 41' ' ' VAL . 48.0 t -80.03 115.67 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 24.5 ttt180 -120.98 162.4 19.97 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.436 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.3 mm-40 -106.55 124.85 50.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.054 -0.404 . . . . 0.0 110.277 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -94.98 144.25 25.83 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -12.84 61.87 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.467 0.707 . . . . 0.0 112.089 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -79.62 -49.91 11.45 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.006 0.922 . . . . 0.0 112.488 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t -128.8 -4.8 5.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.759 0.823 . . . . 0.0 111.543 -169.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.57 -118.34 5.55 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.96 138.01 47.72 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.049 0.54 . . . . 0.0 112.335 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.92 171.13 18.79 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.176 0.99 . . . . 0.0 109.083 170.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 31' ' ' VAL . 30.5 t -120.77 127.68 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 122.892 0.477 . . . . 0.0 110.169 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.432 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.6 t60 -88.93 108.67 19.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.53 135.39 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 24.7 t70 -125.82 136.05 52.68 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.384 1.073 . . . . 0.0 108.545 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 87.0 mtp -136.32 131.19 34.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.463 0.574 . . . . 0.0 110.496 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -155.62 162.2 40.67 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 122.772 0.429 . . . . 0.0 111.523 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.09 -151.07 21.94 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.66 111.07 4.7 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.122 0.961 . . . . 0.0 111.172 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.488 HG23 HG22 ' A' ' 23' ' ' ILE . 74.2 mt -97.61 125.47 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.605 177.474 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 63.24 25.57 14.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.11 1.364 . . . . 0.0 109.687 -170.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.2 4.35 90.5 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.294 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -94.59 110.44 49.11 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.899 0.88 . . . . 0.0 111.724 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.37 140.82 45.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.829 2.353 . . . . 0.0 112.209 -175.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.4 145.63 35.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.143 0.577 . . . . 0.0 109.958 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 p -140.56 115.15 9.47 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.93 152.45 39.44 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -174.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -147.57 155.9 42.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.136 0.575 . . . . 0.0 111.189 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.92 147.35 31.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.914 0.886 . . . . 0.0 109.88 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 41.2 mt-10 -124.89 128.09 48.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.924 0.889 . . . . 0.0 109.273 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.58 123.87 21.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 123.913 0.885 . . . . 0.0 109.326 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.52 164.57 20.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.782 2.321 . . . . 0.0 112.199 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.682 ' HG3' ' HB3' ' A' ' 106' ' ' LEU . 37.6 ttt180 -44.66 -33.72 1.94 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.776 1.23 . . . . 0.0 113.773 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.31 -36.68 71.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.418 0.687 . . . . 0.0 111.569 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -118.53 9.65 12.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.465 0.706 . . . . 0.0 110.853 -170.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.48 -29.06 65.93 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.675 0.79 . . . . 0.0 111.235 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.11 -8.69 55.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.283 1.433 . . . . 0.0 113.294 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -90.69 8.03 36.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.113 0.965 . . . . 0.0 110.764 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -51.34 -45.4 62.29 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.34 71.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 m -65.98 -50.32 64.72 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.377 0.535 . . . . 0.0 110.336 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.5 m-20 -70.94 -48.93 50.75 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.425 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.9 -51.01 56.1 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.171 0.988 . . . . 0.0 112.066 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.0 m -59.86 -43.56 94.62 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.456 0.703 . . . . 0.0 111.34 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -58.87 -48.48 81.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.892 0.877 . . . . 0.0 110.49 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 71' ' ' ASP . 63.6 t -62.66 -35.0 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.664 0.786 . . . . 0.0 110.429 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.01 -53.41 14.89 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 110.704 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.502 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 14.0 pt20 -71.2 -34.29 70.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.778 -171.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -60.86 -32.58 72.0 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.553 0.533 . . . . 0.0 110.759 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -92.58 15.47 14.2 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.15 0.58 . . . . 0.0 111.676 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.15 62.95 0.84 Allowed Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 3.5 mm? -123.79 -21.17 5.23 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 162.656 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 67.59 165.2 0.12 Allowed Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 124.607 1.163 . . . . 0.0 109.27 -164.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -47.41 102.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 122.354 2.036 . . . . 0.0 112.473 172.595 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -16.21 63.21 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.978 -175.637 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -81.45 -30.84 33.3 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.092 0.557 . . . . 0.0 109.6 173.407 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.86 -29.05 71.21 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.248 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.56 84.05 2.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.017 0.927 . . . . 0.0 108.613 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.7 pt -63.36 162.71 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.014 0.926 . . . . 0.0 113.175 -171.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.7 p -62.52 -44.13 97.12 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.199 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 74.82 -38.6 0.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.101 1.76 . . . . 0.0 111.311 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.23 -170.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.848 1.259 . . . . 0.0 111.768 167.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -54.88 140.64 36.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.246 0.618 . . . . 0.0 111.069 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -122.8 126.25 47.06 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.973 0.909 . . . . 0.0 108.869 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -107.74 21.5 17.34 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.443 0.697 . . . . 0.0 111.334 -171.531 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -62.03 -54.29 43.55 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-N 117.802 0.274 . . . . 0.0 110.625 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.934 0.771 . . . . 0.0 111.932 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.86 -49.77 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.3 ttm -64.2 -35.15 79.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 111.243 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -61.32 -51.41 68.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.498 1.119 . . . . 0.0 110.422 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.94 -28.67 67.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 37.6 t70 -71.67 -47.7 52.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ILE . . . . . 0.464 ' O ' HD23 ' A' ' 106' ' ' LEU . 42.0 mt -58.74 -44.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.809 0.843 . . . . 0.0 111.563 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -62.89 -28.78 70.27 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.36 14.92 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.814 0.846 . . . . 0.0 111.911 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.0 mmmt -58.86 -42.59 89.76 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.21 1.004 . . . . 0.0 112.43 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.682 ' HB3' ' HG3' ' A' ' 62' ' ' ARG . 4.4 mm? -71.52 -22.22 61.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.604 0.761 . . . . 0.0 112.067 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -75.23 -24.61 57.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.689 0.396 . . . . 0.0 110.474 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.61 91.26 0.08 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.701 1.6 . . . . 0.0 110.624 -174.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -112.53 163.47 17.75 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 124.958 1.303 . . . . 0.0 109.593 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.16 76.16 0.92 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.406 2.071 . . . . 0.0 111.986 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.81 -80.07 1.37 Allowed Glycine 0 C--N 1.345 1.067 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.494 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.57 148.93 70.72 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -171.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -56.35 164.41 5.39 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.843 3.029 . . . . 0.0 114.123 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.53 122.48 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-O 121.459 0.647 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.53 27.83 1.06 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.832 0.853 . . . . 0.0 112.406 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.03 -30.22 71.18 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.471 0.308 . . . . 0.0 110.657 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.63 9.23 40.99 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.897 0.879 . . . . 0.0 111.929 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -76.43 -9.3 58.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.313 0.578 . . . . 0.0 111.412 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.76 -39.71 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.26 1.024 . . . . 0.0 109.681 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.1 mt -112.12 89.08 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -121.08 -172.15 2.34 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -124.53 128.13 48.48 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -34.27 41.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.202 1.001 . . . . 0.0 112.409 -172.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.59 122.59 7.44 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.493 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 119.911 -0.09 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.32 -87.28 0.7 Allowed Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.133 0.397 . . . . 0.0 113.997 172.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -153.62 165.94 34.33 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.975 0.91 . . . . 0.0 110.289 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.0 ttp -162.17 108.72 1.3 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.207 0.603 . . . . 0.0 109.523 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -105.46 141.51 36.82 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.087 0.555 . . . . 0.0 111.747 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.38 154.69 73.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 125.335 1.454 . . . . 0.0 107.894 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.82 99.45 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.284 1.99 . . . . 0.0 111.917 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.43 -18.49 6.84 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.542 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' HIS . . . . . 0.543 ' NE2' ' HB3' ' A' ' 26' ' ' HIS . 20.8 t-80 -158.27 151.25 22.67 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.246 0.523 . . . . 0.0 111.793 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 27' ' ' ILE . 54.4 tp -134.61 150.04 50.65 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.001 1.32 . . . . 0.0 108.509 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -124.15 139.67 53.71 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.534 0.734 . . . . 0.0 109.24 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.48 128.01 48.33 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 p -149.74 92.49 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-O 122.728 1.251 . . . . 0.0 112.526 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.519 ' H ' HG13 ' A' ' 23' ' ' ILE . 38.8 t -73.63 106.46 5.4 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.166 163.234 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.61 138.3 70.51 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.165 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -86.62 -94.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 122.578 2.185 . . . . 0.0 112.156 170.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.94 -105.38 1.61 Allowed Glycine 0 C--N 1.36 1.882 0 CA-C-N 118.57 0.623 . . . . 0.0 112.359 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.19 -26.23 47.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.448 0.699 . . . . 0.0 109.912 173.165 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -84.51 163.66 19.27 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.912 0.885 . . . . 0.0 108.985 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -99.11 -36.86 9.55 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 122.904 0.481 . . . . 0.0 111.713 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 10.7 tp-100 -77.0 107.69 9.52 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.748 1.261 . . . . 0.0 112.833 -170.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.49 113.33 26.02 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.886 173.932 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.519 HG13 ' H ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -120.38 132.3 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.778 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -139.82 119.63 13.38 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.2 mt -143.66 151.52 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -170.335 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.543 ' HB3' ' NE2' ' A' ' 9' ' ' HIS . 15.1 m170 -126.61 146.53 50.13 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.551 HD12 HD23 ' A' ' 10' ' ' LEU . 60.2 mt -125.77 106.44 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -97.33 132.61 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.02 125.24 26.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -127.32 115.55 19.17 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 41' ' ' VAL . 47.0 t -86.93 115.21 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 51.1 ttt85 -125.17 163.64 22.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.7 mm-40 -112.87 112.55 24.1 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.526 ' ND2' ' HB3' ' A' ' 36' ' ' GLU . 35.5 p-10 -95.42 144.34 26.02 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.343 0.657 . . . . 0.0 109.511 171.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -19.09 65.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.121 0.569 . . . . 0.0 111.432 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.526 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 36.3 tt0 -67.81 -52.15 40.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.749 1.22 . . . . 0.0 112.091 -179.196 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -123.4 -14.52 7.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -172.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -125.97 8.69 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.67 134.53 50.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.817 0.447 . . . . 0.0 110.773 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.1 170.82 19.0 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.553 0.741 . . . . 0.0 109.21 170.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 31' ' ' VAL . 4.8 t -127.69 121.9 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -89.52 121.34 31.64 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -107.39 137.93 44.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.402 0.681 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -126.9 123.3 36.92 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtp -118.88 130.03 55.52 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.279 0.491 . . . . 0.0 110.391 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.92 159.84 43.0 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 0.0 110.713 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.4 -147.11 12.49 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 0.8 OUTLIER -148.45 108.29 4.03 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.303 1.051 . . . . 0.0 111.653 172.666 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.59 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.22 16.67 9.37 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 124.545 1.153 . . . . 0.0 110.5 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.36 -15.22 59.08 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.088 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 95.6 mttt -83.28 109.93 20.76 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.816 0.847 . . . . 0.0 112.748 -173.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.2 138.67 33.77 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.324 2.016 . . . . 0.0 110.601 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -145.47 155.7 43.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.524 0.33 . . . . 0.0 110.824 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 p -150.56 130.06 13.01 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.978 0.911 . . . . 0.0 108.969 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -144.91 157.29 44.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -176.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 m -143.62 142.14 30.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.917 0.487 . . . . 0.0 110.969 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -141.11 146.58 37.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.882 0.873 . . . . 0.0 109.077 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.22 129.81 49.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.87 122.0 24.41 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.48 163.95 25.17 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.767 2.312 . . . . 0.0 111.089 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.487 ' HG3' HD13 ' A' ' 106' ' ' LEU . 61.7 ttt180 -48.6 -30.62 5.56 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.761 0.825 . . . . 0.0 111.568 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.77 -40.52 80.0 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.766 1.226 . . . . 0.0 112.726 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 p -128.36 14.23 6.62 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.594 0.758 . . . . 0.0 111.87 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' PHE . . . -63.74 -29.38 70.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.541 0.737 . . . . 0.0 111.66 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PHE . . . . . 0.653 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 71.6 m-85 -70.77 -1.13 10.53 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -96.53 5.42 50.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.958 0.903 . . . . 0.0 110.269 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 25.7 p90 -53.72 -49.66 67.64 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.632 1.173 . . . . 0.0 112.474 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.04 -29.8 60.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.591 0.756 . . . . 0.0 111.087 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -71.35 -45.34 63.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.003 0.814 . . . . 0.0 109.209 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.26 -41.01 64.16 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.878 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.55 56.33 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.504 0.722 . . . . 0.0 112.42 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 95.2 m -71.18 -43.24 67.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.708 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 44.7 ttt180 -55.66 -53.21 59.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.515 1.126 . . . . 0.0 111.734 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 8.5 p -69.78 -32.17 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.489 0.716 . . . . 0.0 111.381 -178.223 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.04 82.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.415 0.626 . . . . 0.0 110.429 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.789 ' HA ' HD22 ' A' ' 81' ' ' LEU . 96.3 mt-30 -76.32 -40.09 52.33 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.387 -1.278 . . . . 0.0 112.361 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.7 mtpp -53.18 -35.63 60.04 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.024 0.93 . . . . 0.0 112.45 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 72.4 m80 -79.6 25.07 0.35 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.48 59.45 10.82 Favored Glycine 0 C--N 1.363 2.079 0 C-N-CA 123.275 0.464 . . . . 0.0 114.141 174.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.789 HD22 ' HA ' ' A' ' 77' ' ' GLN . 1.2 pt? -76.72 -29.14 56.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.658 -174.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.439 ' N ' HD23 ' A' ' 81' ' ' LEU . 19.3 t-160 55.88 93.63 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 123.876 0.87 . . . . 0.0 109.587 -172.195 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.12 89.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.195 2.597 . . . . 0.0 113.079 -171.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LYS . . . . . 0.495 ' HD3' ' OG ' ' A' ' 14' ' ' SER . 83.0 tttt -73.77 -37.82 64.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.777 175.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -64.8 -18.34 65.01 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.018 0.927 . . . . 0.0 111.322 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.24 -113.5 4.71 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.32 79.47 0.45 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.866 0.867 . . . . 0.0 108.928 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 mm -90.89 95.15 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 81.7 p -83.95 -3.06 57.69 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.357 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -78.28 -39.71 39.14 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.479 1.112 . . . . 0.0 110.676 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.47 171.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.665 0.786 . . . . 0.0 111.659 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -77.4 85.4 3.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.202 0.525 . . . . 0.0 110.144 173.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.748 ' HD3' ' H ' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -59.46 127.76 33.65 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.152 168.486 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.01 28.41 0.91 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.892 0.877 . . . . 0.0 112.296 -170.852 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -66.43 -56.09 12.63 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.97 -39.1 73.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.21 1.004 . . . . 0.0 112.085 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.29 -50.53 67.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.737 0.415 . . . . 0.0 110.813 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.1 ttm -70.76 -31.28 68.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.617 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.73 -56.11 18.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 6.0 mm-40 -69.82 -28.28 65.58 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.658 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.23 -49.35 61.3 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.93 -42.77 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.441 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ARG . . . . . 0.653 ' HB3' ' HE1' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -65.94 -31.18 71.95 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.464 0.575 . . . . 0.0 111.563 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.91 84.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HA ' ' HE3' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.66 -28.77 62.93 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.845 0.858 . . . . 0.0 112.805 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 106' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 62' ' ' ARG . 89.3 mt -63.98 -34.11 77.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.392 0.677 . . . . 0.0 110.572 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -68.69 -17.95 64.17 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.607 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 81.35 -60.08 0.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 126.379 1.871 . . . . 0.0 109.583 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -76.74 130.76 75.36 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 166.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.55 91.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.248 2.632 . . . . 0.0 114.118 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.27 70.07 2.9 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.72 159.38 83.32 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.241 1.016 . . . . 0.0 112.604 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 26.5 Cg_endo -59.13 96.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.237 2.625 . . . . 0.0 113.706 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -167.74 136.58 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.708 0.803 . . . . 0.0 109.75 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -127.5 41.83 3.44 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.075 0.95 . . . . 0.0 110.157 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.38 -35.61 77.96 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.726 0.81 . . . . 0.0 112.042 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.45 -6.43 52.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.862 0.865 . . . . 0.0 111.504 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -77.4 5.01 9.56 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 122.156 -0.34 . . . . 0.0 111.817 -174.532 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.6 mm -77.19 -64.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.396 0.679 . . . . 0.0 110.062 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.3 mt -108.74 105.82 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.906 0.882 . . . . 0.0 108.83 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 -128.4 74.46 1.56 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.66 0.784 . . . . 0.0 109.6 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -78.47 127.83 32.72 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.305 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -77.31 130.8 37.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.115 0.566 . . . . 0.0 109.524 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.72 -49.68 47.75 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.754 0.659 . . . . 0.0 112.888 -176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 C--O 1.249 1.043 0 C-N-CA 123.436 0.694 . . . . 0.0 110.112 -179.812 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.9 -134.81 16.73 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.367 -0.379 . . . . 0.0 112.762 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -81.02 115.32 20.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.4 mtm -142.62 145.63 33.69 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.351 0.66 . . . . 0.0 110.427 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -107.75 146.18 32.5 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.278 0.631 . . . . 0.0 109.979 171.399 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.04 152.33 23.41 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.342 1.057 . . . . 0.0 109.376 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.07 96.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.862 2.375 . . . . 0.0 112.749 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.57 -22.11 5.28 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.961 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -155.26 151.6 28.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.473 HD22 ' SD ' ' A' ' 98' ' ' MET . 55.4 tp -135.88 131.47 35.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.747 1.619 . . . . 0.0 107.411 176.204 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -113.82 139.96 48.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.554 0.741 . . . . 0.0 110.452 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 30.3 mt -134.15 124.72 26.54 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.02 155.77 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 120.192 1.36 . . . . 0.0 114.325 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' SER . . . . . 0.485 ' HB2' ' H ' ' A' ' 23' ' ' ILE . 22.8 t -61.63 102.85 0.28 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 112.235 -2.257 . . . . 0.0 106.947 164.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 3.7 pp -115.73 168.82 7.76 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 124.329 1.052 . . . . 0.0 110.254 -165.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 15' ' ' LEU . 35.2 Cg_endo -60.19 91.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.635 2.223 . . . . 0.0 111.726 174.852 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 142.6 -40.24 1.28 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.516 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.0 tp -106.1 95.0 5.47 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.164 0.985 . . . . 0.0 109.276 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -127.9 6.85 6.08 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.184 0.993 . . . . 0.0 110.766 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -56.0 -46.65 78.68 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.184 0.593 . . . . 0.0 110.127 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HG3' HG23 ' A' ' 23' ' ' ILE . 20.1 pt20 -135.56 155.75 49.97 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 122.914 0.486 . . . . 0.0 110.257 173.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.52 100.94 7.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ILE . . . . . 0.485 ' H ' ' HB2' ' A' ' 14' ' ' SER . 19.2 pt -117.0 145.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.22 0.534 . . . . 0.0 109.954 169.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 8.4 p-10 -152.92 125.94 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 163.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.7 mt -139.32 116.3 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.5 m170 -104.25 122.69 45.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 57.3 mt -114.88 105.34 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 44' ' ' ASP . 67.2 ttt180 -97.89 140.4 32.3 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.729 1.212 . . . . 0.0 108.478 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.41 136.38 36.21 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -131.52 116.04 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.375 1.07 . . . . 0.0 108.419 -172.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 105' ' ' LYS . 72.8 t -87.01 123.66 40.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 19.2 ttt180 -153.14 169.25 23.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.476 1.111 . . . . 0.0 108.759 -170.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLN . . . . . 0.473 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 10.8 mm100 -106.68 127.0 53.0 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.32 0.648 . . . . 0.0 110.225 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . 0.452 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 3.1 p30 -102.96 147.69 26.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.35 1.06 . . . . 0.0 108.896 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.16 -20.23 62.32 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' GLU . . . . . 0.452 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 10.6 tp10 -71.09 -48.18 53.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.9 0.88 . . . . 0.0 111.677 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.5 m -131.47 -6.91 3.73 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.492 0.717 . . . . 0.0 112.905 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.94 -124.17 8.08 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -68.5 137.14 54.16 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.403 0.602 . . . . 0.0 111.286 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -155.91 178.37 10.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.492 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 31' ' ' VAL . 20.2 t -133.44 127.85 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.778 0.831 . . . . 0.0 109.397 173.089 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -89.31 121.43 31.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.831 0.852 . . . . 0.0 108.912 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -102.8 133.22 48.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 108.913 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 27.1 t70 -133.48 114.15 13.3 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.023 0.929 . . . . 0.0 109.883 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' A' ' 27' ' ' ILE . 43.4 mtm -119.86 145.43 46.68 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.736 -0.603 . . . . 0.0 111.451 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -156.93 157.9 35.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.146 0.578 . . . . 0.0 111.24 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.85 -156.05 27.48 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -148.28 115.19 6.08 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.845 1.322 . . . . 0.0 111.411 173.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 79' ' ' HIS . 50.5 mt -97.74 130.69 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.212 176.809 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.33 -69.88 0.1 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.159 1.783 . . . . 0.0 110.617 -168.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.27 47.21 0.11 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.597 -2.201 . . . . 0.0 107.597 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -137.07 104.29 8.82 Favored Pre-proline 0 C--N 1.35 0.592 0 CA-C-N 114.261 -0.97 . . . . 0.0 108.91 -172.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 136.75 33.83 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.381 2.054 . . . . 0.0 110.834 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -135.35 138.02 42.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.2 p -134.14 118.22 17.44 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -132.74 139.73 47.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.276 1.03 . . . . 0.0 109.385 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.7 p -140.54 124.0 16.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -136.55 142.1 43.4 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.814 0.846 . . . . 0.0 108.782 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -121.33 130.58 53.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.423 0.689 . . . . 0.0 109.772 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.29 130.32 23.57 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.79 155.64 36.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.716 2.277 . . . . 0.0 111.187 171.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 32.3 ptt180 -41.85 -26.08 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -85.53 -13.61 48.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.753 0.821 . . . . 0.0 111.621 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.0 p -132.49 -2.4 3.43 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.404 1.082 . . . . 0.0 111.222 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.94 -36.71 72.92 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.552 1.141 . . . . 0.0 111.988 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.88 -9.43 54.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.374 1.07 . . . . 0.0 112.761 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -91.73 -7.57 49.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.315 0.646 . . . . 0.0 110.514 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' HZ ' ' SD ' ' A' ' 98' ' ' MET . 4.0 p90 -54.12 -35.78 62.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.602 0.761 . . . . 0.0 112.769 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.43 -26.56 20.49 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -72.49 -52.66 14.81 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 75' ' ' VAL . 38.9 t0 -73.14 -54.28 8.88 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.472 0.709 . . . . 0.0 112.799 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.03 -38.43 4.83 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.3 1.04 . . . . 0.0 113.041 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.9 m -77.27 -37.69 52.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.462 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.7 -47.98 81.27 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.946 0.898 . . . . 0.0 111.402 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 71' ' ' ASP . 41.5 t -61.25 -39.5 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.079 0.952 . . . . 0.0 110.264 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 25' ' ' ILE . . . -66.67 -44.7 81.14 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.857 0.863 . . . . 0.0 110.953 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLN . . . . . 0.415 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 5.3 pp0? -76.59 -26.85 55.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -175.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -59.77 -45.9 90.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.342 0.657 . . . . 0.0 111.968 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' HIS . . . . . 0.533 ' HB2' HD12 ' A' ' 49' ' ' ILE . 56.3 m80 -74.34 -30.35 61.98 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.42 80.34 0.04 OUTLIER Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 158.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 38.9 tp -139.26 153.31 47.78 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.624 ' H ' ' HD2' ' A' ' 83' ' ' PRO . 44.4 t-80 -167.64 -57.54 0.01 OUTLIER Pre-proline 0 CA--C 1.563 1.465 0 CA-C-O 117.504 -1.236 . . . . 0.0 110.261 175.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HD2' ' H ' ' A' ' 82' ' ' HIS . 30.8 Cg_exo -3.8 -122.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.412 3.88 1 C-N-CA 127.229 5.286 . . . . 0.0 118.101 -166.367 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -83.0 -7.13 59.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.383 0.673 . . . . 0.0 111.962 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -76.68 -54.32 6.81 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.852 0.461 . . . . 0.0 110.212 -175.56 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 44.16 -121.96 4.15 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 124.422 1.076 . . . . 0.0 114.284 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -119.83 160.36 22.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.036 0.934 . . . . 0.0 109.847 176.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.2 pt -67.45 -23.74 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.734 0.814 . . . . 0.0 111.438 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.0 p -78.51 -33.98 47.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.866 0.866 . . . . 0.0 110.994 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -70.27 -59.68 2.73 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.953 0.501 . . . . 0.0 109.903 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.09 146.82 28.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 C-N-CA 124.373 1.069 . . . . 0.0 108.615 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -72.68 87.01 1.23 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.435 0.636 . . . . 0.0 109.574 174.061 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -90.03 43.43 1.15 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.871 1.268 . . . . 0.0 110.37 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 58.12 23.8 10.56 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.775 1.23 . . . . 0.0 113.014 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -65.46 -48.04 74.03 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 123.837 0.855 . . . . 0.0 111.435 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.0 -35.9 67.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.042 0.537 . . . . 0.0 111.942 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 -44.69 69.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.541 0.686 . . . . 0.0 110.854 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' MET . . . . . 0.514 ' SD ' ' HZ ' ' A' ' 68' ' ' PHE . 39.7 ttp -60.46 -34.45 74.04 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.759 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -69.53 -53.87 16.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.153 0.981 . . . . 0.0 109.859 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.7 -28.68 69.58 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.941 0.776 . . . . 0.0 112.785 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.58 -54.78 16.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.936 0.495 . . . . 0.0 109.982 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.4 mt -62.43 -42.02 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.545 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.14 -31.38 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.7 0.682 . . . . 0.0 110.907 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ALA . . . . . 0.59 ' HB1' ' HA ' ' A' ' 110' ' ' PRO . . . -72.88 -41.61 64.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.593 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.478 ' HB3' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.69 -47.94 80.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.646 0.779 . . . . 0.0 112.133 174.883 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.44 -39.04 88.67 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.683 0.615 . . . . 0.0 110.468 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -59.1 -31.9 69.33 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.244 1.017 . . . . 0.0 111.196 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 73.27 12.9 4.77 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.397 1.479 . . . . 0.0 110.679 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -143.63 122.66 7.31 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PRO . . . . . 0.59 ' HA ' ' HB1' ' A' ' 104' ' ' ALA . 3.2 Cg_exo -74.4 130.57 14.08 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 123.171 2.58 . . . . 0.0 112.366 -173.154 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.04 69.39 3.26 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.17 154.73 94.35 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.627 1.171 . . . . 0.0 111.969 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.66 148.08 58.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.582 2.188 . . . . 0.0 111.945 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.73 152.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.728 0.811 . . . . 0.0 109.4 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.51 26.8 10.28 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.741 0.816 . . . . 0.0 111.651 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.5 -29.55 67.21 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.84 -2.23 53.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.302 0.641 . . . . 0.0 111.846 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.98 -9.48 58.65 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.588 0.755 . . . . 0.0 112.425 -170.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.3 mp -88.51 67.42 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 121.524 0.678 . . . . 0.0 109.628 -174.59 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 mt 52.95 35.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 125.396 1.478 . . . . 0.0 112.528 166.311 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -74.12 134.03 42.85 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.397 -0.814 . . . . 0.0 110.439 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -142.95 127.1 17.49 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -77.2 -25.37 51.71 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.155 0.582 . . . . 0.0 110.844 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.11 72.09 0.31 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 C--O 1.255 1.372 0 C-N-CA 123.754 0.822 . . . . 0.0 111.136 -176.874 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 t80 . . . . . 0 N--CA 1.477 0.887 0 CA-C-O 120.912 0.387 . . . . 0.0 110.491 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.01 152.54 55.26 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 125.309 1.444 . . . . 0.0 107.929 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.3 97.15 0.29 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.769 1.646 . . . . 0.0 111.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.4 -15.3 6.08 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.636 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -160.83 153.75 21.22 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 117.378 0.589 . . . . 0.0 112.202 -172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt -135.6 125.74 26.2 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -98.1 139.83 33.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.315 1.046 . . . . 0.0 110.148 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -132.26 117.89 18.78 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.728 0.811 . . . . 0.0 110.809 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.3 t . . . . . 0 N--CA 1.487 1.413 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 162.489 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 . . . . . 0 C--O 1.244 0.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.78 82.7 4.98 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.483 HG22 HG23 ' A' ' 49' ' ' ILE . 1.3 pp -109.83 128.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 p30 -150.86 123.59 8.58 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 46.1 mt -140.47 140.52 34.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 45' ' ' MET . 6.6 m170 -114.24 134.29 55.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 171.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.418 HG12 ' HG2' ' A' ' 45' ' ' MET . 58.2 mt -123.5 105.76 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -102.87 132.69 48.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -129.25 123.73 32.68 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.2 116.45 20.64 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 41' ' ' VAL . 79.2 t -79.11 117.14 24.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -118.76 159.51 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -107.93 119.35 39.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.7 0.4 . . . . 0.0 109.928 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.559 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -99.53 148.8 23.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.252 1.021 . . . . 0.0 109.152 168.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.61 60.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.981 0.513 . . . . 0.0 111.972 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.99 -55.29 5.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.841 0.856 . . . . 0.0 111.823 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.479 ' HB3' HD21 ' A' ' 34' ' ' ASN . 35.7 t -114.63 -6.97 12.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.236 0.614 . . . . 0.0 111.668 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.41 -108.23 3.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -172.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.19 141.73 45.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.117 0.459 . . . . 0.0 111.289 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 7.7 p90 -156.64 166.87 32.15 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.929 0.891 . . . . 0.0 108.796 168.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 31' ' ' VAL . 3.9 t -115.8 126.51 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 122.066 -0.396 . . . . 0.0 110.219 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 63.9 t60 -90.69 120.54 31.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.228 1.011 . . . . 0.0 108.7 170.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -107.75 145.05 34.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.1 0.56 . . . . 0.0 110.336 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -128.64 128.6 44.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.603 1.161 . . . . 0.0 108.672 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 82.7 mtp -123.82 129.41 50.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.1 0.409 . . . . 0.0 110.352 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -154.16 147.44 24.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.854 0.462 . . . . 0.0 111.425 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.44 -151.18 16.75 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.83 108.73 3.7 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.895 1.348 . . . . 0.0 111.022 171.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.483 HG23 HG22 ' A' ' 23' ' ' ILE . 68.4 mt -100.76 127.97 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.485 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 63.22 22.16 13.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.004 1.321 . . . . 0.0 109.167 -170.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.48 -3.41 87.07 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.558 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.51 109.98 28.14 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 112.003 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.68 141.95 31.62 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.868 2.378 . . . . 0.0 111.96 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.09 147.92 39.32 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.141 0.577 . . . . 0.0 110.072 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.4 p -138.68 116.51 11.54 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.87 147.13 51.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.591 1.157 . . . . 0.0 108.964 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.9 m -142.63 129.59 20.67 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -138.81 143.43 38.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.737 0.815 . . . . 0.0 109.019 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 62.4 mt-10 -126.38 133.6 51.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.365 0.666 . . . . 0.0 110.202 -174.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt -124.2 128.86 24.92 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 124.159 0.983 . . . . 0.0 109.231 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 44.7 Cg_endo -63.99 161.76 31.91 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.75 2.3 . . . . 0.0 111.466 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -44.91 -32.27 1.55 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.934 0.894 . . . . 0.0 113.161 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -70.53 -29.6 66.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.742 1.217 . . . . 0.0 112.443 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.6 p -130.49 16.29 5.43 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.854 0.861 . . . . 0.0 110.319 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.18 98.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.353 0.661 . . . . 0.0 111.053 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -73.46 -2.51 22.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.482 1.113 . . . . 0.0 112.566 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.48 2.08 53.54 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.686 0.794 . . . . 0.0 110.41 173.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.548 ' HE2' ' SD ' ' A' ' 98' ' ' MET . 12.3 p90 -54.39 -49.97 68.64 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.225 1.01 . . . . 0.0 112.528 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.14 -28.44 39.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -71.79 -51.88 20.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.768 0.427 . . . . 0.0 110.146 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -52.24 13.95 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.4 13.8 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.865 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 m -75.8 -44.59 40.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -56.02 -45.19 79.18 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.789 1.236 . . . . 0.0 112.002 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.05 -31.65 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.765 0.826 . . . . 0.0 110.937 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.77 -43.15 80.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.127 0.571 . . . . 0.0 110.618 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.61 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 18.3 pt20 -78.71 -25.82 44.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.258 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -65.76 -25.13 67.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.184 0.594 . . . . 0.0 110.422 169.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.415 ' HB3' HD12 ' A' ' 49' ' ' ILE . 26.2 m80 -86.67 0.73 54.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.302 0.641 . . . . 0.0 112.595 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.39 43.47 0.64 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 4.4 mm? . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 165.809 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.1 t80 . . . . . 0 N--CA 1.474 0.747 0 N-CA-C 110.048 -0.353 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.36 -32.9 72.81 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.747 0.654 . . . . 0.0 111.811 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.73 -44.59 66.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.381 0.673 . . . . 0.0 111.17 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.548 ' SD ' ' HE2' ' A' ' 68' ' ' PHE . 28.6 ttm -63.76 -39.83 95.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.397 0.679 . . . . 0.0 111.844 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.52 -50.29 74.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.416 1.486 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 11.9 pt-20 -70.55 -30.91 67.76 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.67 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.47 -54.4 47.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.67 -38.03 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.62 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.585 HH11 ' HB2' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -69.74 -31.15 68.98 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.202 0.91 . . . . 0.0 111.46 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB2' HH11 ' A' ' 103' ' ' ARG . . . -75.09 -44.7 45.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.561 0.345 . . . . 0.0 110.469 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -59.26 -42.78 91.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.924 1.29 . . . . 0.0 113.117 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.94 -32.14 72.53 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.712 0.805 . . . . 0.0 111.412 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -80.7 -19.91 44.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 110.676 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.317 0 C-N-CA 126.689 1.996 . . . . 0.0 110.884 179.019 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.462 0.374 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -97.54 118.64 64.04 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.087 0.955 . . . . 0.0 109.945 -175.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.47 114.91 2.19 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.288 2.659 . . . . 0.0 112.982 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.0 p -71.75 139.91 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.641 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.57 1.63 13.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -63.07 -33.83 76.29 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.876 0.762 . . . . 0.0 111.801 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.63 -39.35 73.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.219 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -60.34 -21.32 61.92 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.429 1.092 . . . . 0.0 111.535 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.97 -33.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.366 0.603 . . . . 0.0 109.472 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.49 -27.11 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.893 0.877 . . . . 0.0 110.123 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 . . . . . 0 N--CA 1.482 1.153 0 C-N-CA 123.262 0.625 . . . . 0.0 111.745 -177.014 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 . . . . . 0 N--CA 1.466 0.375 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.48 151.61 25.81 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.96 0.904 . . . . 0.0 109.03 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -56.42 92.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.654 2.236 . . . . 0.0 112.127 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.54 -40.61 1.03 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.896 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -154.69 144.16 21.36 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.209 0.603 . . . . 0.0 111.832 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.8 tp -126.91 134.58 50.42 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.863 1.265 . . . . 0.0 108.869 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -98.72 115.54 28.96 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 1.3 tm? -97.51 110.14 22.76 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.069 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -127.07 103.78 7.63 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.577 HG21 ' HG ' ' A' ' 81' ' ' LEU . 1.7 pp -120.31 149.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -153.52 120.77 5.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.32 0.648 . . . . 0.0 109.862 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 55.8 mt -139.14 141.37 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.659 0.784 . . . . 0.0 109.601 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.1 m170 -104.26 112.42 25.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.2 mt -112.23 109.78 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.62 123.99 51.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.874 1.27 . . . . 0.0 107.679 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -121.04 128.28 52.5 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -119.52 113.3 20.53 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 92.1 t -77.54 115.84 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -145.51 167.58 22.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 108.734 -170.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -111.4 121.62 45.7 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.744 0.417 . . . . 0.0 110.495 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.435 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -99.78 153.53 19.05 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.521 1.129 . . . . 0.0 110.317 173.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.86 -24.48 61.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.204 0.601 . . . . 0.0 111.991 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -73.57 -49.34 26.8 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.222 1.009 . . . . 0.0 112.273 -172.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -133.89 17.13 3.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.352 0.661 . . . . 0.0 111.187 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.09 -111.97 3.4 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.007 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -78.43 147.48 34.0 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 117.298 0.549 . . . . 0.0 110.451 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -159.6 179.54 8.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 t -132.64 130.59 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 4.6 t60 -88.42 109.0 19.66 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.174 0.99 . . . . 0.0 108.59 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 56.4 m-85 -94.91 127.49 40.98 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.16 127.83 28.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.413 0.685 . . . . 0.0 109.296 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 84.1 mtp -133.79 145.05 49.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.92 0.888 . . . . 0.0 110.861 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.18 165.53 17.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.436 0.694 . . . . 0.0 109.846 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.79 -134.4 5.25 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.9 172.19 17.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.186 0.594 . . . . 0.0 110.157 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 79' ' ' HIS . 58.4 mt -155.27 101.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 -166.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 54.39 41.13 32.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.483 0.713 . . . . 0.0 111.189 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.26 16.26 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.543 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.77 109.9 12.4 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.167 0.987 . . . . 0.0 111.369 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -81.35 152.44 18.02 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.028 2.486 . . . . 0.0 113.73 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.07 160.52 41.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 p -141.03 118.11 11.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.972 0.909 . . . . 0.0 109.358 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -139.62 150.0 44.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.884 0.874 . . . . 0.0 109.799 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 p -150.68 137.53 19.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.956 0.502 . . . . 0.0 109.904 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.91 145.04 45.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 0.0 108.738 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 39.6 mt-10 -124.55 123.91 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -175.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.1 mt -120.63 133.49 24.07 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.188 0.595 . . . . 0.0 109.398 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.01 163.97 6.94 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.317 2.678 . . . . 0.0 113.286 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 31.4 ptt85 -45.46 -37.12 4.91 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.821 1.248 . . . . 0.0 112.537 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.07 -28.09 68.58 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.817 1.247 . . . . 0.0 112.886 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.4 p -130.55 15.28 5.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.674 0.79 . . . . 0.0 111.16 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.7 73.54 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.072 0.549 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.03 -23.97 64.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.501 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -77.29 -2.45 34.86 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.587 0.755 . . . . 0.0 111.64 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -66.0 -21.14 66.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.43 62.35 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 -161.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 p -67.62 -33.63 75.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.228 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.468 ' O ' HG23 ' A' ' 75' ' ' VAL . 5.1 m-20 -72.27 -56.8 4.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.433 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.02 67.04 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.673 1.189 . . . . 0.0 112.41 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.8 m -67.06 -50.24 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.249 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -56.93 -35.51 69.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.104 0.962 . . . . 0.0 112.795 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 71' ' ' ASP . 53.4 t -57.93 -44.86 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.74 0.816 . . . . 0.0 109.676 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.75 74.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.903 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 11.0 mm100 -60.14 -38.32 82.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.295 0.638 . . . . 0.0 111.364 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.91 -30.32 70.11 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.079 0.951 . . . . 0.0 111.982 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.46 ' HB3' HD12 ' A' ' 49' ' ' ILE . 63.4 t60 -91.69 24.84 2.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.872 0.469 . . . . 0.0 111.515 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.2 49.48 2.83 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 111.846 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' HG21 ' A' ' 23' ' ' ILE . 1.7 tt . . . . . 0 CA--C 1.541 0.627 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -177.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 . . . . . 0 C--O 1.213 -0.855 0 CA-C-O 119.229 -0.415 . . . . 0.0 111.345 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.72 -45.5 74.07 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.599 0.76 . . . . 0.0 112.35 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.64 -48.34 60.23 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.995 0.518 . . . . 0.0 110.45 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.16 -38.02 81.91 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.963 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -53.91 -45.63 71.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.545 1.138 . . . . 0.0 110.142 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -71.15 -28.77 64.51 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.382 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 28.2 t70 -68.19 -54.18 19.69 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.358 0.411 . . . . 0.0 110.044 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.33 -47.59 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.947 0.899 . . . . 0.0 111.481 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -63.59 -28.27 69.81 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.565 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.59 -54.47 6.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.807 0.843 . . . . 0.0 112.439 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 14.1 mmmm -67.85 -37.36 81.77 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.66 -24.56 63.63 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.516 0.326 . . . . 0.0 111.181 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 34.2 t60 -76.99 -17.91 58.56 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.914 0.886 . . . . 0.0 109.699 169.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.511 0 C-N-CA 126.293 1.837 . . . . 0.0 112.572 175.656 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 1.076 0 N-CA-C 114.573 0.589 . . . . 0.0 114.573 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -147.94 154.28 43.21 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.94 0.896 . . . . 0.0 109.323 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.42 148.94 92.33 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.49 2.126 . . . . 0.0 111.132 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.92 142.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.92 20.81 15.46 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.099 0.559 . . . . 0.0 111.98 -173.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 117' ' ' GLU . 4.4 pp -57.15 -37.62 72.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.529 0.732 . . . . 0.0 112.289 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.474 ' N ' HD12 ' A' ' 116' ' ' LEU . 26.4 tt0 -87.27 -14.79 39.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.472 0.709 . . . . 0.0 110.947 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -80.68 -11.92 59.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.083 0.553 . . . . 0.0 110.543 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.56 -35.99 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.1 mt -86.05 14.54 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 124.215 1.006 . . . . 0.0 110.57 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 . . . . . 0 CA--C 1.555 1.14 0 O-C-N 121.187 -0.945 . . . . 0.0 109.911 175.204 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.2 t80 . . . . . 0 N--CA 1.476 0.862 0 CA-C-O 120.839 0.352 . . . . 0.0 110.672 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -143.47 154.6 60.34 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.275 1.03 . . . . 0.0 108.681 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.76 101.4 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.698 2.266 . . . . 0.0 112.644 174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.62 -14.24 11.75 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.936 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -158.01 122.46 4.23 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.509 0.655 . . . . 0.0 112.182 -175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.6 tp -102.98 120.98 41.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.58 1.152 . . . . 0.0 108.848 168.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.7 t-160 -99.49 121.97 41.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.5 mt -98.92 137.26 37.74 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t . . . . . 0 N--CA 1.484 1.249 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 165.82 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 N--CA 1.486 1.327 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.64 69.34 0.97 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.643 0.735 . . . . 0.0 110.834 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -89.02 134.63 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -156.11 111.07 2.89 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.746 0.784 . . . . 0.0 109.443 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 60.1 mt -124.47 143.87 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.591 1.156 . . . . 0.0 110.041 -168.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.6 m170 -104.68 111.47 24.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 45' ' ' MET . 61.8 mt -109.98 109.19 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -115.17 119.66 37.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 47.8 p90 -121.11 131.73 54.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.013 0.525 . . . . 0.0 110.307 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.78 122.45 28.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.419 0.688 . . . . 0.0 110.018 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 HG22 ' A' ' 41' ' ' VAL . 59.2 t -70.86 124.74 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 43.9 ttt180 -146.12 165.08 30.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.064 0.946 . . . . 0.0 109.278 -175.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.471 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 24.1 mm-40 -114.74 115.57 27.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.803 0.841 . . . . 0.0 108.872 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.547 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -101.93 147.77 26.15 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.173 0.589 . . . . 0.0 110.002 170.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.18 65.2 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.989 0.516 . . . . 0.0 111.29 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.84 -54.63 20.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.91 0.884 . . . . 0.0 112.293 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.458 ' HB2' HD21 ' A' ' 34' ' ' ASN . 23.1 m -120.26 4.16 10.81 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.245 0.618 . . . . 0.0 112.09 -168.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -134.83 12.87 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -73.6 141.59 46.59 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -161.4 178.69 8.92 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.023 0.44 . . . . 0.0 110.788 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.44 HG22 HG22 ' A' ' 31' ' ' VAL . 23.8 t -125.97 132.8 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 48.0 t60 -92.88 129.56 38.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.479 1.112 . . . . 0.0 108.593 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 50.8 m-85 -119.18 143.28 47.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.264 0.626 . . . . 0.0 110.447 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 41.5 m-20 -130.23 141.53 50.62 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.054 0.942 . . . . 0.0 109.183 174.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.481 ' HG2' HG12 ' A' ' 27' ' ' ILE . 87.5 mtp -132.97 128.51 36.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.882 0.873 . . . . 0.0 108.784 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.86 161.19 31.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.502 0.321 . . . . 0.0 110.488 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.64 -122.89 2.47 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.93 164.11 38.9 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.749 0.82 . . . . 0.0 110.001 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -155.58 113.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -169.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.48 40.14 29.69 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.221 1.01 . . . . 0.0 110.383 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.99 -39.0 3.04 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.608 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -79.69 129.4 71.31 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 123.851 0.86 . . . . 0.0 111.754 -169.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.64 164.22 23.5 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.26 2.64 . . . . 0.0 113.879 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.94 159.92 37.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.616 0.766 . . . . 0.0 110.688 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.5 p -144.22 112.95 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.529 0.732 . . . . 0.0 110.459 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 154.38 51.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.85 1.26 . . . . 0.0 109.643 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.8 p -152.97 139.71 18.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.979 0.512 . . . . 0.0 109.799 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.1 150.25 44.07 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.596 0.758 . . . . 0.0 110.126 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.45 125.68 38.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.779 0.831 . . . . 0.0 109.36 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.9 mt -119.38 134.43 23.77 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.459 0.704 . . . . 0.0 109.812 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.67 158.8 48.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.04 2.493 . . . . 0.0 112.225 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 26.1 ptt180 -41.64 -38.24 1.34 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.172 1.389 . . . . 0.0 114.2 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.85 -25.59 62.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.788 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 p -131.83 8.44 4.48 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.558 0.743 . . . . 0.0 111.494 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.23 88.09 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -68.03 -14.26 62.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.04 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -79.55 2.01 23.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.412 0.685 . . . . 0.0 111.697 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -65.0 -14.41 60.29 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 124.127 0.971 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.17 -36.78 66.67 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -73.2 -40.99 64.32 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.01 -52.21 60.59 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.255 0.622 . . . . 0.0 110.662 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -55.08 -49.32 71.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.51 1.124 . . . . 0.0 112.01 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -64.84 -29.1 70.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.851 0.461 . . . . 0.0 111.454 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.6 tpp180 -72.3 -41.56 66.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.038 0.535 . . . . 0.0 110.238 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.81 -31.78 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.397 1.079 . . . . 0.0 109.9 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.455 ' HB1' HD23 ' A' ' 81' ' ' LEU . . . -71.41 -49.89 37.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.54 0.736 . . . . 0.0 109.799 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.588 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 46.4 mt-30 -70.09 -28.87 65.76 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.753 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.71 -29.9 68.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.475 0.71 . . . . 0.0 110.453 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -105.97 21.36 17.44 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 111.214 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.16 40.08 5.57 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 121.969 -0.457 . . . . 0.0 113.951 166.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.588 ' HB3' ' HG2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER . . . . . 0 CA--C 1.552 1.032 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.767 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.2 t80 . . . . . 0 C--O 1.217 -0.657 0 CA-C-O 119.22 -0.419 . . . . 0.0 111.0 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.23 -39.98 93.46 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.545 0.738 . . . . 0.0 111.735 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.01 70.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.266 0.627 . . . . 0.0 111.114 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.426 ' HB3' ' HE2' ' A' ' 98' ' ' MET . 53.2 ttp -64.4 -43.0 95.79 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.401 1.08 . . . . 0.0 112.323 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.07 -50.09 49.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.703 1.201 . . . . 0.0 111.492 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.85 -28.37 50.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.646 0.591 . . . . 0.0 110.687 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.68 -59.98 3.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.707 0.803 . . . . 0.0 111.299 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.411 ' O ' HD13 ' A' ' 106' ' ' LEU . 56.2 mt -63.79 -36.42 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.38 0.672 . . . . 0.0 111.372 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -29.16 70.0 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.13 -38.14 63.87 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.327 0.651 . . . . 0.0 110.689 176.541 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -65.61 -35.84 81.99 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 112.179 173.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 102' ' ' ILE . 9.8 mp -65.3 -32.71 74.5 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.59 0.756 . . . . 0.0 110.728 170.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.62 -16.4 59.58 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.349 1.059 . . . . 0.0 111.216 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.495 1.813 0 C-N-CA 127.599 2.359 . . . . 0.0 112.248 175.289 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.715 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 143.29 94.51 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.207 0.603 . . . . 0.0 111.906 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -93.31 105.95 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.029 2.486 . . . . 0.0 112.22 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.79 107.49 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 CA-C-O 122.36 1.076 . . . . 0.0 109.491 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.91 21.35 1.61 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.475 1.11 . . . . 0.0 111.983 -163.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.78 -27.5 68.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.268 0.627 . . . . 0.0 110.792 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -68.05 -11.59 59.26 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.973 1.309 . . . . 0.0 111.39 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -87.77 -19.86 26.95 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.052 0.941 . . . . 0.0 112.4 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.16 74.0 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.8 mt 72.15 -5.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 C-N-CA 125.323 1.449 . . . . 0.0 112.364 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 . . . . . 0 N--CA 1.483 1.216 0 O-C-N 121.822 -0.549 . . . . 0.0 109.709 -174.764 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.5 t80 . . . . . 0 C--O 1.238 0.466 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.48 157.13 63.16 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 125.126 1.37 . . . . 0.0 108.858 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.61 102.34 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.279 1.986 . . . . 0.0 111.33 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.01 -25.15 5.85 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.569 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -152.81 142.04 21.48 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.56 0.68 . . . . 0.0 112.118 -171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.7 tp -131.51 133.33 44.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.643 1.577 . . . . 0.0 108.55 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.3 t-160 -107.56 117.99 35.55 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.557 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 80.7 mt -88.74 128.77 35.63 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m . . . . . 0 C--O 1.246 0.912 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 159.102 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 C--O 1.224 -0.287 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -114.73 101.39 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.274 1.03 . . . . 0.0 108.935 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.531 HG22 HG23 ' A' ' 49' ' ' ILE . 2.1 pp -113.95 143.86 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 171.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -144.36 108.65 4.81 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.8 mt -131.68 139.19 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.57 0.748 . . . . 0.0 110.411 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.4 m170 -104.65 111.04 23.59 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.534 HG12 ' HG2' ' A' ' 45' ' ' MET . 37.4 mt -112.08 119.84 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.59 123.64 50.35 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -112.01 115.79 29.5 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.83 111.92 16.06 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.817 0.447 . . . . 0.0 109.991 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 105' ' ' LYS . 89.0 t -81.5 119.69 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.805 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -131.93 145.77 51.7 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -103.1 113.17 26.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.48 HD22 ' HD1' ' A' ' 40' ' ' TYR . 3.5 p30 -99.95 142.32 31.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.63 -16.8 63.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.265 0.626 . . . . 0.0 112.162 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.406 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 14.2 tp10 -75.22 -46.66 32.51 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.759 0.823 . . . . 0.0 111.675 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.6 t -126.77 -11.71 6.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.356 0.663 . . . . 0.0 112.06 -168.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.96 -139.41 14.38 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.3 143.58 57.1 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.434 0.617 . . . . 0.0 111.257 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.48 ' HD1' HD22 ' A' ' 34' ' ' ASN . 8.8 p90 -148.15 165.37 31.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 31' ' ' VAL . 10.1 t -130.38 134.71 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.562 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 57.5 t60 -94.36 113.46 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.857 1.263 . . . . 0.0 108.863 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.445 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 71.4 m-85 -104.12 115.45 30.44 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.814 . . . . 0.0 108.945 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -120.93 119.32 32.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.534 ' HG2' HG12 ' A' ' 27' ' ' ILE . 81.2 mtp -126.09 134.84 51.25 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.159 0.583 . . . . 0.0 111.086 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -165.37 177.31 7.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.085 0.554 . . . . 0.0 110.181 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.43 -123.7 2.98 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 10.1 pt-20 -152.96 167.35 29.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.387 1.075 . . . . 0.0 109.868 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.531 HG23 HG22 ' A' ' 23' ' ' ILE . 36.8 mt -157.15 105.31 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -172.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.547 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 3.2 m-20 64.03 40.76 6.91 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.193 0.997 . . . . 0.0 109.838 -174.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.23 -23.56 3.89 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.638 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 44.4 mtmt -82.88 116.57 64.8 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.159 0.984 . . . . 0.0 110.413 -171.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 88.8 Cg_endo -74.92 162.26 37.58 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.049 2.5 . . . . 0.0 113.841 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -158.3 165.68 34.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.715 0.806 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.9 p -153.13 121.66 6.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.283 1.033 . . . . 0.0 109.819 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -155.4 145.04 21.25 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.96 0.904 . . . . 0.0 110.047 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 t -146.58 146.73 30.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.095 0.558 . . . . 0.0 110.653 -170.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -142.19 149.78 40.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.34 1.056 . . . . 0.0 110.297 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.3 mp0 -118.6 135.48 54.41 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 89.7 mt -124.45 124.97 25.68 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.68 168.91 12.33 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.108 2.539 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.551 ' HG3' HD23 ' A' ' 106' ' ' LEU . 76.4 ttt180 -47.06 -35.96 7.5 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.222 1.009 . . . . 0.0 112.504 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -58.6 -35.34 72.27 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.554 1.142 . . . . 0.0 112.632 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -129.11 8.03 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 0.0 112.104 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.08 90.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.506 0.722 . . . . 0.0 112.094 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.47 -12.57 61.39 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.832 -1.077 . . . . 0.0 113.216 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -80.69 5.63 15.12 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.55 0.74 . . . . 0.0 111.66 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.51 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 5.9 p90 -73.52 -27.13 61.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.2 1.0 . . . . 0.0 113.334 -172.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.89 -45.32 36.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.364 0.602 . . . . 0.0 109.511 -164.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -74.33 -33.35 63.12 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.159 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 75' ' ' VAL . 22.6 t70 -72.97 -51.61 17.67 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.913 0.485 . . . . 0.0 111.501 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.73 -41.23 66.83 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.155 0.982 . . . . 0.0 112.091 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.4 m -61.81 -48.45 80.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.972 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.414 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.9 ttm180 -53.73 -45.06 70.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.689 1.196 . . . . 0.0 111.61 174.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 71' ' ' ASP . 43.5 t -61.46 -41.04 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.756 1.222 . . . . 0.0 110.204 -177.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.85 -42.25 70.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -67.71 -26.49 66.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.035 0.934 . . . . 0.0 111.811 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -65.54 -22.4 66.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.307 0.643 . . . . 0.0 111.177 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -106.74 20.98 18.22 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.441 0.696 . . . . 0.0 110.39 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.59 39.32 8.97 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 121.724 -0.61 . . . . 0.0 113.441 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.452 HD22 HG21 ' A' ' 23' ' ' ILE . 2.1 tm? . . . . . 0 N--CA 1.477 0.899 0 C-N-CA 123.829 0.852 . . . . 0.0 110.322 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.6 t80 . . . . . 0 N--CA 1.468 0.461 0 N-CA-C 109.879 -0.415 . . . . 0.0 109.879 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.76 -34.81 78.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 110.856 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.24 -49.5 49.3 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.226 0.61 . . . . 0.0 110.442 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.51 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 84.4 mmm -60.95 -42.94 99.21 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.644 0.778 . . . . 0.0 112.983 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -49.79 -46.56 50.94 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.789 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.455 ' HA ' ' CG ' ' A' ' 103' ' ' ARG . 3.7 mt-10 -80.06 -25.82 39.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.618 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.0 -58.76 4.31 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.943 0.897 . . . . 0.0 110.107 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.9 mt -60.53 -41.13 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.528 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 100' ' ' GLU . 4.8 ppt_? -64.63 -30.22 71.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.444 0.566 . . . . 0.0 110.34 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 107' ' ' HIS . . . -71.25 -47.25 58.24 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.5 ' HB3' HG21 ' A' ' 31' ' ' VAL . 6.2 tmtp? -69.78 -30.56 68.15 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.998 0.519 . . . . 0.0 111.847 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 62' ' ' ARG . 2.2 mp -63.9 -23.82 67.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.839 0.855 . . . . 0.0 111.717 172.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . 0.456 ' HB3' ' O ' ' A' ' 104' ' ' ALA . 85.2 t60 -72.57 -15.15 61.76 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.571 1.148 . . . . 0.0 110.907 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.494 1.761 0 C-N-CA 126.528 1.931 . . . . 0.0 112.509 178.966 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.436 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.73 143.44 27.05 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.26 1.024 . . . . 0.0 109.514 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.81 132.29 22.95 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.012 2.474 . . . . 0.0 112.19 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.525 HG22 ' HG ' ' A' ' 116' ' ' LEU . 7.8 p -77.02 121.81 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.05 -21.56 58.95 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 122.078 -0.389 . . . . 0.0 111.982 -168.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.525 ' HG ' HG22 ' A' ' 114' ' ' VAL . 4.3 pp -59.47 -26.6 65.38 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.311 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.14 -35.65 81.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.219 1.008 . . . . 0.0 110.815 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.9 -27.06 66.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.318 1.047 . . . . 0.0 111.085 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.531 HG22 HG13 ' A' ' 120' ' ' ILE . 2.3 mp -74.67 -57.8 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.319 0.648 . . . . 0.0 109.676 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 119' ' ' ILE . 78.2 mt -116.7 101.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 . . . . . 0 N--CA 1.476 0.848 0 C-N-CA 123.658 0.783 . . . . 0.0 109.411 175.045 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.6 t80 . . . . . 0 C--O 1.241 0.634 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.0 153.74 60.88 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.055 0.942 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.34 106.28 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.319 2.013 . . . . 0.0 112.112 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.88 -22.02 9.34 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.014 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -153.89 124.58 7.16 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.304 0.574 . . . . 0.0 112.474 -170.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.583 HD23 HD12 ' A' ' 27' ' ' ILE . 56.8 tp -103.5 148.13 26.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.898 0.879 . . . . 0.0 108.78 165.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -122.78 116.6 23.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.621 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 71.6 mt -89.29 109.59 20.47 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.9 m . . . . . 0 C--N 1.318 -0.787 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.099 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.4 mt-30 . . . . . 0 N--CA 1.48 1.057 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.427 ' H ' ' HA ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER -101.45 70.71 1.31 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.15 119.6 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.303 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -142.52 109.78 5.63 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 49.1 mt -133.53 129.8 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.732 0.813 . . . . 0.0 109.194 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 45' ' ' MET . 14.7 m170 -100.11 108.69 20.89 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.583 HD12 HD23 ' A' ' 10' ' ' LEU . 41.5 mt -103.22 108.5 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -109.5 112.61 24.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -111.07 118.11 35.13 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -124.31 115.03 20.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.036 0.934 . . . . 0.0 109.09 -172.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.99 120.69 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.594 0.711 . . . . 0.0 109.567 170.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -138.4 154.79 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.78 120.6 41.3 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.625 0.25 . . . . 0.0 111.224 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.585 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.609 1.164 . . . . 0.0 110.419 169.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.07 61.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.094 0.558 . . . . 0.0 111.449 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -67.23 -54.61 19.46 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.258 1.023 . . . . 0.0 111.755 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.422 ' HB3' HD21 ' A' ' 34' ' ' ASN . 35.5 t -120.94 5.91 10.4 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.226 0.611 . . . . 0.0 111.812 -171.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.68 -101.09 1.5 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.556 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -83.78 145.36 28.74 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.961 0.505 . . . . 0.0 110.706 171.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -151.48 174.32 13.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -125.73 132.57 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -96.94 134.16 40.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.195 0.998 . . . . 0.0 108.613 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -120.66 125.75 48.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 109.829 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 30.4 m-20 -108.13 148.74 29.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.646 0.779 . . . . 0.0 109.505 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 21.4 mtm -141.4 132.53 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.587 1.155 . . . . 0.0 108.469 171.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -167.53 159.55 12.3 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.266 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.78 -121.1 1.36 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 11.8 pt-20 -142.08 171.01 14.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 mt -154.95 103.79 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.427 ' HA ' ' H ' ' A' ' 22' ' ' ASP . 36.6 t70 58.37 46.13 15.81 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 122.345 1.069 . . . . 0.0 109.467 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.16 -36.22 3.53 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.177 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.01 111.95 23.93 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.568 1.147 . . . . 0.0 112.312 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 Cg_exo -61.3 146.83 96.91 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.795 2.997 . . . . 0.0 113.099 175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 4.3 p90 -151.22 163.92 37.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.442 0.297 . . . . 0.0 110.683 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -153.58 117.43 4.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.288 0.635 . . . . 0.0 111.206 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -130.32 159.27 37.47 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.687 1.195 . . . . 0.0 109.751 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -157.19 133.46 9.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.731 0.413 . . . . 0.0 110.61 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.3 145.95 50.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.826 0.85 . . . . 0.0 109.635 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -114.08 143.57 44.56 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.74 138.95 27.65 Favored Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.6 149.27 91.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.523 2.149 . . . . 0.0 110.797 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.556 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 30.8 ptt85 -42.14 -39.29 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.15 -19.77 61.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.557 0.743 . . . . 0.0 112.744 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.1 p -130.48 9.66 5.13 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.55 0.74 . . . . 0.0 109.91 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.76 71.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.948 0.899 . . . . 0.0 111.048 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -69.11 -11.33 60.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.393 1.077 . . . . 0.0 113.046 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -80.62 3.87 20.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.294 0.637 . . . . 0.0 111.195 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -67.88 -21.18 65.16 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 124.324 1.05 . . . . 0.0 112.571 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.12 19.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -69.61 -35.23 75.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.841 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 -54.55 10.31 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.498 0.719 . . . . 0.0 111.602 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.15 -44.72 64.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.24 1.016 . . . . 0.0 111.947 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -63.02 -49.24 75.42 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.418 0.449 . . . . 0.0 110.312 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.506 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 18.3 ttp85 -51.15 -52.78 40.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.322 1.049 . . . . 0.0 111.999 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.92 -32.39 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.862 0.465 . . . . 0.0 110.551 -175.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.0 -41.56 74.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 96.4 mt-30 -54.27 -30.77 51.84 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.604 1.162 . . . . 0.0 112.969 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 13.8 mptt -75.2 -7.64 54.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.53 0.732 . . . . 0.0 111.175 -176.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -93.11 7.57 43.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.587 0.755 . . . . 0.0 110.684 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.26 64.51 1.02 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.265 0.466 . . . . 0.0 114.265 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 11.0 mp . . . . . 0 N--CA 1.488 1.432 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 168.028 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.1 t80 . . . . . 0 C--O 1.204 -1.326 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.406 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.32 -33.9 63.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.028 0.531 . . . . 0.0 111.458 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.66 -50.34 63.22 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.445 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.461 ' HE1' HD22 ' A' ' 10' ' ' LEU . 28.3 ttm -71.87 -37.21 70.23 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.757 0.823 . . . . 0.0 112.541 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -51.12 -48.22 61.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.465 1.506 . . . . 0.0 110.301 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.569 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 23.2 mt-10 -77.84 -28.75 50.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.287 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.53 -50.53 69.2 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.2 0.6 . . . . 0.0 110.423 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.449 ' O ' HD13 ' A' ' 106' ' ' LEU . 56.0 mt -61.02 -49.15 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.998 0.919 . . . . 0.0 111.597 175.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 1.2 ppt_? -61.85 -30.63 70.97 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.146 0.43 . . . . 0.0 111.31 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.26 -44.76 58.78 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.033 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -65.6 -33.68 76.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.25 1.02 . . . . 0.0 111.787 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 102' ' ' ILE . 6.8 mp -70.52 -22.16 62.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.506 1.122 . . . . 0.0 111.338 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -89.25 -18.7 26.5 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.15 0.58 . . . . 0.0 109.854 170.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.479 1.003 0 C-N-CA 126.001 1.72 . . . . 0.0 111.526 176.322 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.96 0 N-CA-C 112.698 -0.161 . . . . 0.0 112.698 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -127.45 145.26 53.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.293 1.037 . . . . 0.0 109.634 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.66 105.23 1.59 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.667 2.245 . . . . 0.0 110.126 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 100' ' ' GLU . 7.3 p -67.97 125.35 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.39 0.614 . . . . 0.0 110.491 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.24 7.93 8.42 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.893 0.877 . . . . 0.0 112.52 -166.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 117' ' ' GLU . 3.1 pp -55.88 -26.83 49.03 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 116' ' ' LEU . 44.2 tt0 -72.76 -33.2 66.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.504 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -81.61 -7.45 59.59 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.691 -167.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.1 -19.82 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.703 0.801 . . . . 0.0 110.519 170.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.8 mt 81.26 112.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.802 2.041 . . . . 0.0 109.081 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 . . . . . 0 CA--C 1.543 0.702 0 C-N-CA 124.803 1.241 . . . . 0.0 110.195 -174.266 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.2 t80 . . . . . 0 C--O 1.239 0.522 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.33 154.22 78.5 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.27 1.428 . . . . 0.0 107.834 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.1 110.19 0.42 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.276 1.984 . . . . 0.0 111.658 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.2 -21.56 10.06 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 123.057 0.36 . . . . 0.0 112.736 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -150.93 119.83 6.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.255 0.622 . . . . 0.0 111.434 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.461 HD23 HD12 ' A' ' 27' ' ' ILE . 59.9 tp -102.35 143.21 32.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.346 1.058 . . . . 0.0 108.912 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -120.71 124.67 45.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.234 0.613 . . . . 0.0 110.298 174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.8 mt -102.0 128.31 48.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.882 0.473 . . . . 0.0 109.921 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.8 m . . . . . 0 N--CA 1.483 1.214 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 159.043 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 . . . . . 0 C--O 1.24 0.579 0 N-CA-C 109.456 -0.572 . . . . 0.0 109.456 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -87.41 70.65 9.94 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.462 0.648 . . . . 0.0 109.799 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.86 142.15 20.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.363 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.692 HD21 ' HG2' ' A' ' 48' ' ' GLU . 8.1 p30 -151.78 128.71 11.0 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 67.3 mt -127.99 129.23 69.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -171.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' MET . 1.5 m170 -102.05 109.02 20.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.461 HD12 HD23 ' A' ' 10' ' ' LEU . 53.8 mt -101.75 105.52 18.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 27.0 mtp-105 -101.59 108.8 20.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.335 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -111.83 116.97 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.21 111.21 17.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 41' ' ' VAL . 44.3 t -83.94 116.52 27.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -127.61 155.15 44.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.116 0.966 . . . . 0.0 108.51 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -105.87 111.84 24.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.539 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -97.64 146.94 24.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.828 0.851 . . . . 0.0 110.087 173.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.45 -18.05 62.33 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.922 0.489 . . . . 0.0 111.694 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -69.04 -53.32 21.1 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.01 0.924 . . . . 0.0 111.555 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.434 ' HB3' HD21 ' A' ' 34' ' ' ASN . 26.3 t -124.96 5.71 7.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.05 0.54 . . . . 0.0 112.294 -169.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.92 -114.77 3.98 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 137.98 36.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.021 0.529 . . . . 0.0 110.129 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.404 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 4.3 p90 -152.84 166.96 30.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 31' ' ' VAL . 10.8 t -124.02 122.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -81.09 116.6 21.1 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -100.26 135.53 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 25.5 t70 -137.9 141.52 40.65 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.757 0.823 . . . . 0.0 108.831 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 86.6 mtp -138.46 131.91 30.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 0.0 110.0 -174.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -150.48 176.42 10.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.017 0.527 . . . . 0.0 109.92 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.08 -135.34 7.43 Favored Glycine 0 N--CA 1.465 0.599 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.692 ' HG2' HD21 ' A' ' 24' ' ' ASN . 8.0 pt-20 -151.63 168.06 26.17 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 mt -157.66 109.29 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -166.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t70 61.65 32.98 18.36 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.798 0.808 . . . . 0.0 109.431 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.35 -25.41 9.25 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -82.15 118.94 73.83 Favored Pre-proline 0 N--CA 1.484 1.252 0 CA-C-N 117.831 0.816 . . . . 0.0 111.708 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -69.89 148.21 63.73 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.639 2.226 . . . . 0.0 112.887 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -142.8 150.52 40.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.313 0.645 . . . . 0.0 109.959 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 m -146.75 122.49 10.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.442 0.697 . . . . 0.0 110.348 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.89 152.62 36.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.127 0.971 . . . . 0.0 109.175 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.0 p -147.98 137.2 22.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.217 0.607 . . . . 0.0 110.699 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.47 140.18 41.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 0.0 109.71 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -112.86 129.58 56.4 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.19 129.01 25.1 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.581 0.753 . . . . 0.0 109.332 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 40.2 Cg_endo -63.73 164.75 20.33 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.042 2.495 . . . . 0.0 112.126 173.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.13 -32.61 7.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.223 1.009 . . . . 0.0 113.467 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.74 -31.51 66.76 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.344 1.058 . . . . 0.0 112.191 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -125.73 12.48 7.94 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.338 0.655 . . . . 0.0 110.517 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.18 89.97 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.826 0.85 . . . . 0.0 112.116 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.23 -8.05 46.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.476 1.11 . . . . 0.0 113.096 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -80.55 1.2 30.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.785 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -66.1 -18.97 65.69 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.722 1.209 . . . . 0.0 113.058 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -50.78 14.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.437 0.637 . . . . 0.0 109.734 -162.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.9 p -73.28 -31.41 64.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.309 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 75' ' ' VAL . 14.2 t70 -70.78 -58.22 3.85 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.282 0.633 . . . . 0.0 111.35 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.27 -47.58 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.251 1.02 . . . . 0.0 112.547 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.3 m -57.59 -47.08 83.11 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.866 0.467 . . . . 0.0 110.758 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HA ' ' HG2' ' A' ' 77' ' ' GLN . 39.4 ttp180 -57.96 -38.77 76.61 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.949 0.781 . . . . 0.0 112.508 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -59.63 -47.78 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.116 0.566 . . . . 0.0 109.758 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HB3' HD22 ' A' ' 81' ' ' LEU . . . -72.22 -40.09 68.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.896 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 20.8 pt20 -73.56 -22.69 60.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -66.13 -21.25 66.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 121.951 0.101 . . . . 0.0 110.732 166.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -99.56 6.16 45.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.857 0.863 . . . . 0.0 110.537 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.44 -95.85 0.43 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD13 HD11 ' A' ' 25' ' ' ILE . 32.5 tp . . . . . 0 CA--C 1.549 0.904 0 C-N-CA 126.466 1.906 . . . . 0.0 112.952 178.468 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.9 t80 . . . . . 0 C--O 1.222 -0.36 0 N-CA-C 110.279 -0.267 . . . . 0.0 110.279 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.85 -32.62 65.97 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.071 0.857 . . . . 0.0 112.182 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.24 -47.95 63.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 tpp -65.51 -40.79 93.41 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -55.04 -51.82 65.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.982 1.313 . . . . 0.0 111.311 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 10.1 pt-20 -69.7 -30.37 68.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.67 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.11 -45.62 59.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.311 0.244 . . . . 0.0 110.889 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.87 -45.35 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.396 0.678 . . . . 0.0 110.683 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -64.56 -29.84 70.86 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 120.614 0.245 . . . . 0.0 110.568 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.59 -45.72 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.439 0.696 . . . . 0.0 110.619 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -69.88 -29.88 67.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.941 0.496 . . . . 0.0 112.243 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.2 -31.37 68.78 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.065 0.946 . . . . 0.0 110.486 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -72.76 -18.0 61.54 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.905 0.882 . . . . 0.0 110.493 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.312 0 C-N-CA 126.268 1.827 . . . . 0.0 112.619 176.642 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.46 0.295 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 11.6 pt-20 -77.68 172.02 10.91 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.915 0.886 . . . . 0.0 109.742 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 112' ' ' GLU . 95.8 Cg_endo -76.95 48.75 2.58 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.654 2.236 . . . . 0.0 112.882 172.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.19 130.0 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.08 29.7 5.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.2 0.6 . . . . 0.0 111.009 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -55.3 -30.62 60.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 112.317 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 121' ' ' ARG . 34.1 tt0 -80.45 -32.91 37.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.458 0.703 . . . . 0.0 110.789 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.03 -18.55 65.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.299 1.04 . . . . 0.0 112.27 -168.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.541 HG22 HG12 ' A' ' 120' ' ' ILE . 3.9 mp -67.28 -52.83 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.541 HG12 HG22 ' A' ' 119' ' ' ILE . 33.3 mm -133.99 96.99 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.555 0.742 . . . . 0.0 109.567 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.479 ' HG2' ' HG2' ' A' ' 117' ' ' GLU . 52.2 mtp180 . . . . . 0 N--CA 1.477 0.921 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.043 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.5 t80 . . . . . 0 CA--C 1.536 0.438 0 CA-C-O 121.154 0.502 . . . . 0.0 110.887 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.95 156.02 55.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.192 1.397 . . . . 0.0 108.363 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.72 105.76 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.109 1.872 . . . . 0.0 111.397 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.11 -20.61 11.36 Favored Glycine 0 N--CA 1.473 1.126 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.243 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -153.04 143.88 22.87 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.413 0.607 . . . . 0.0 111.584 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 40.2 tp -129.33 141.26 51.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.237 1.415 . . . . 0.0 108.276 176.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -127.57 121.18 29.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.563 0.745 . . . . 0.0 109.211 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 79.3 mt -100.53 128.9 46.45 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.419 0.687 . . . . 0.0 109.865 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t . . . . . 0 N--CA 1.485 1.308 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 166.742 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 . . . . . 0 N--CA 1.473 0.713 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.92 53.65 2.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.839 0.828 . . . . 0.0 111.102 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.544 HG21 HD23 ' A' ' 81' ' ' LEU . 2.2 pp -90.54 116.03 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -139.14 107.85 5.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 59.1 mt -133.18 133.43 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.643 0.777 . . . . 0.0 109.966 -163.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.7 m170 -104.8 113.87 27.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.8 mt -112.5 107.74 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 ttp-105 -102.54 110.12 21.96 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -111.57 123.62 50.6 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -118.73 114.46 22.73 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.541 0.737 . . . . 0.0 109.15 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.484 HG11 ' HG3' ' A' ' 105' ' ' LYS . 98.0 t -77.71 117.38 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -140.43 159.86 41.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.899 0.879 . . . . 0.0 109.103 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -110.68 113.48 26.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.519 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -95.57 148.77 22.16 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.722 0.809 . . . . 0.0 109.598 170.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.22 -19.36 63.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.872 0.469 . . . . 0.0 111.432 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.05 -44.93 64.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.284 1.034 . . . . 0.0 112.323 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -133.73 1.93 3.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.83 -115.5 4.12 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.01 143.52 43.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.26 0.53 . . . . 0.0 110.359 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.418 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.9 p90 -160.3 172.79 16.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.439 0.696 . . . . 0.0 109.148 169.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.01 130.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -88.68 116.45 26.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.866 0.866 . . . . 0.0 108.884 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.59 110.39 22.43 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -105.11 139.69 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.799 0.84 . . . . 0.0 109.165 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 40.5 mtm -141.71 140.19 33.1 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.906 0.482 . . . . 0.0 110.833 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -164.1 158.61 19.51 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.424 0.69 . . . . 0.0 109.724 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.18 -127.56 2.16 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.052 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -156.82 160.35 39.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.414 1.085 . . . . 0.0 109.27 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 23' ' ' ILE . 47.7 mt -158.04 107.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 60.24 42.12 15.63 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.531 1.158 . . . . 0.0 109.348 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.99 -28.76 3.19 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.382 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -82.57 121.41 78.03 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.147 0.979 . . . . 0.0 111.19 -169.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.26 152.21 76.01 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.833 2.356 . . . . 0.0 113.231 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -146.98 146.39 30.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.313 0.645 . . . . 0.0 109.369 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.7 m -142.63 118.9 10.82 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.003 0.521 . . . . 0.0 110.153 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.24 154.92 37.76 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.073 0.949 . . . . 0.0 109.917 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.4 p -145.74 144.91 30.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.853 0.461 . . . . 0.0 110.41 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.64 136.95 39.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.09 0.956 . . . . 0.0 109.555 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -112.92 124.53 52.83 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.25 128.98 25.65 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 30.6 Cg_endo -60.38 159.26 27.86 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.075 2.517 . . . . 0.0 112.069 171.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -42.63 -40.02 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.944 1.298 . . . . 0.0 114.262 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.79 -15.12 60.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.777 0.831 . . . . 0.0 112.552 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -132.03 4.55 4.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.698 0.799 . . . . 0.0 111.778 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.15 71.64 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.947 0.899 . . . . 0.0 111.789 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -65.34 -24.39 67.24 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.261 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -73.96 -2.06 22.45 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.599 0.76 . . . . 0.0 112.294 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -70.9 -18.01 62.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.88 -43.78 57.46 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -167.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 p -76.11 -35.77 59.17 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.206 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.8 t70 -71.17 -57.12 4.8 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.345 0.658 . . . . 0.0 112.071 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.36 -43.29 43.89 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.212 1.005 . . . . 0.0 112.454 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -64.44 -46.66 82.19 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.256 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 68.6 ttt180 -53.76 -44.21 69.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.75 0.82 . . . . 0.0 111.729 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 71' ' ' ASP . 57.4 t -60.75 -38.82 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.083 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.16 -41.69 73.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.783 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -60.61 -34.04 73.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.214 1.006 . . . . 0.0 111.363 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.3 mtpp -61.51 -36.76 81.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.743 . . . . 0.0 111.809 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.429 ' CD2' ' HB ' ' A' ' 49' ' ' ILE . 14.5 t60 -87.53 -33.19 19.04 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.81 41.32 0.02 OUTLIER Glycine 0 C--N 1.358 1.788 0 C-N-CA 121.591 -0.338 . . . . 0.0 113.395 156.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.544 HD23 HG21 ' A' ' 23' ' ' ILE . 1.6 tm? . . . . . 0 N--CA 1.486 1.341 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.9 t80 . . . . . 0 C--O 1.214 -0.769 0 N-CA-C 110.514 -0.18 . . . . 0.0 110.514 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -59.18 -37.96 78.65 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.163 0.985 . . . . 0.0 112.663 -177.358 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.85 -48.81 23.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.509 0.323 . . . . 0.0 111.317 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.2 ttm -65.55 -32.62 74.31 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.174 0.59 . . . . 0.0 111.523 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -50.31 -45.76 54.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.275 1.03 . . . . 0.0 109.683 169.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 27.0 mm-40 -74.9 -28.22 60.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.061 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.51 -55.31 12.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 120.793 0.33 . . . . 0.0 110.357 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.32 -42.0 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.531 1.133 . . . . 0.0 112.211 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.39 -31.27 72.39 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.863 0.363 . . . . 0.0 110.444 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.47 -52.39 10.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.566 0.746 . . . . 0.0 110.526 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.484 ' HG3' HG11 ' A' ' 31' ' ' VAL . 17.7 tppt? -55.46 -52.97 61.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.769 1.228 . . . . 0.0 113.134 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.07 -26.95 69.08 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.276 0.63 . . . . 0.0 111.872 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -68.6 -31.92 71.43 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.652 0.595 . . . . 0.0 109.457 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.523 0 C-N-CA 125.608 1.563 . . . . 0.0 113.298 169.04 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.507 -0.424 0 N-CA-C 112.237 -0.345 . . . . 0.0 112.237 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.14 152.32 90.46 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.6 91.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.536 2.158 . . . . 0.0 111.52 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.7 p -79.81 142.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.613 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 118' ' ' ARG . 29.0 m-20 -99.21 43.24 1.07 Allowed 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.975 0.91 . . . . 0.0 110.579 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.63 -33.64 73.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.466 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -117.2 85.72 2.38 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.341 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 1.8 tmm_? -133.2 14.8 4.19 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 165.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.66 -63.6 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.772 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.8 mt -88.5 70.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.991 0.9 . . . . 0.0 108.979 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 121' ' ' ARG . 12.9 mmt180 . . . . . 0 N--CA 1.469 0.488 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.322 -179.544 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.3 t80 . . . . . 0 CA--C 1.543 0.682 0 CA-C-O 121.002 0.429 . . . . 0.0 110.048 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.44 153.45 58.97 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.038 1.335 . . . . 0.0 108.28 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.75 96.98 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.139 1.893 . . . . 0.0 111.824 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.09 -25.59 4.09 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.384 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -151.91 147.24 26.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.177 0.591 . . . . 0.0 111.219 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 27' ' ' ILE . 41.9 tp -126.84 134.59 50.5 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.126 1.37 . . . . 0.0 107.863 173.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -97.47 138.48 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.58 110.58 14.61 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.262 0.625 . . . . 0.0 109.504 175.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m . . . . . 0 C--O 1.249 1.057 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 160.582 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 . . . . . 0 C--O 1.245 0.822 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -77.33 82.71 3.79 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.804 0.69 . . . . 0.0 109.237 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.601 HG22 HG23 ' A' ' 49' ' ' ILE . 1.6 pp -110.36 126.57 67.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -147.09 117.61 7.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 43.1 mt -144.85 145.94 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.308 1.043 . . . . 0.0 108.381 -168.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 45' ' ' MET . 9.2 m-70 -108.73 145.66 34.74 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.565 HD12 HD23 ' A' ' 10' ' ' LEU . 55.9 mt -131.75 109.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 99.5 mtt180 -98.59 140.1 33.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 168.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -121.65 116.85 25.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 165.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -123.96 111.89 16.56 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 41' ' ' VAL . 90.2 t -90.15 118.75 36.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.29 0.636 . . . . 0.0 110.337 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 26.5 ttt180 -114.58 153.24 30.45 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -111.42 111.41 22.43 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.637 HD22 ' HB3' ' A' ' 36' ' ' GLU . 9.4 p-10 -105.24 136.81 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.37 -20.17 66.01 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.04 0.536 . . . . 0.0 112.308 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.637 ' HB3' HD22 ' A' ' 34' ' ' ASN . 5.7 tm-20 -68.97 -45.59 70.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.589 1.156 . . . . 0.0 111.508 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -115.54 -40.71 3.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.865 0.466 . . . . 0.0 111.205 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.76 -148.17 17.22 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.09 129.19 37.92 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.401 0.68 . . . . 0.0 110.867 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 3.4 p90 -144.45 166.29 25.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 31' ' ' VAL . 2.3 t -122.11 128.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.943 0.497 . . . . 0.0 110.329 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.552 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 78.1 t60 -88.92 112.32 23.16 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 164.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 91.8 m-85 -95.12 121.3 36.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 19.7 t70 -120.43 114.67 22.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.859 0.864 . . . . 0.0 109.517 -170.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.413 ' HG2' HG12 ' A' ' 27' ' ' ILE . 85.8 mtp -119.31 144.3 46.9 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.546 0.739 . . . . 0.0 110.881 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -156.05 164.48 38.38 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.459 0.704 . . . . 0.0 109.461 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.62 -158.6 31.54 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 118.843 -0.976 . . . . 0.0 111.458 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -145.79 109.97 4.95 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.301 1.051 . . . . 0.0 110.589 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 23' ' ' ILE . 49.0 mt -99.78 128.0 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.901 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 62.04 17.62 9.23 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.821 1.248 . . . . 0.0 111.846 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 -20.25 40.86 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.629 -0.54 . . . . 0.0 113.495 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.8 111.17 27.44 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.96 0.904 . . . . 0.0 112.513 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.65 143.39 33.91 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.535 2.157 . . . . 0.0 111.979 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -148.85 161.77 41.16 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -146.65 121.32 9.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -138.52 145.67 41.02 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 p -144.26 144.66 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.749 0.42 . . . . 0.0 111.154 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -137.53 137.15 38.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.069 0.947 . . . . 0.0 108.701 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 6.4 mp0 -113.84 126.5 55.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.386 -177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 94.2 mt -129.32 125.85 22.73 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 40' ' ' TYR . 57.2 Cg_endo -67.19 163.91 32.38 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.635 2.223 . . . . 0.0 111.555 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -45.78 -37.43 6.02 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.678 1.191 . . . . 0.0 113.384 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.87 -29.85 71.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.194 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.0 p -129.76 12.27 5.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.882 0.873 . . . . 0.0 111.02 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -27.95 68.71 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.655 0.782 . . . . 0.0 111.73 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.469 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 27.1 m-85 -70.46 -2.49 14.07 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.361 1.064 . . . . 0.0 113.79 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -95.3 4.94 52.93 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.604 0.761 . . . . 0.0 110.581 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -55.59 -49.16 73.5 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 124.27 1.028 . . . . 0.0 112.899 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.05 -35.2 61.89 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 123.162 0.585 . . . . 0.0 111.777 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -71.51 -40.12 70.36 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.728 0.643 . . . . 0.0 109.359 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.59 -56.64 9.84 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.307 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.49 -40.61 12.76 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.878 1.271 . . . . 0.0 113.429 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -71.03 -46.36 62.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.182 0.593 . . . . 0.0 110.327 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -61.71 -51.01 70.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.849 0.859 . . . . 0.0 111.343 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.98 -34.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.789 0.836 . . . . 0.0 110.689 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.04 84.35 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.18 0.514 . . . . 0.0 110.142 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.7 -36.73 59.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.45 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -64.05 -34.74 78.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.431 0.692 . . . . 0.0 111.094 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -80.17 3.02 21.95 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.04 -31.92 2.32 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 118.927 0.785 . . . . 0.0 113.605 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 23' ' ' ILE . 17.8 tp . . . . . 0 N--CA 1.475 0.794 0 C-N-CA 124.019 0.928 . . . . 0.0 110.766 179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.5 t80 . . . . . 0 N--CA 1.467 0.38 0 N-CA-C 112.426 0.528 . . . . 0.0 112.426 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.688 ' HB2' HH12 ' A' ' 118' ' ' ARG . 4.7 m-20 -55.77 -42.83 76.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 111.985 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.79 89.22 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.081 0.863 . . . . 0.0 110.746 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.0 ttm -61.15 -51.63 68.25 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.237 1.015 . . . . 0.0 111.397 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -51.19 -52.13 47.26 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.828 1.651 . . . . 0.0 112.21 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.502 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 pt-20 -82.26 -27.44 32.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.295 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.91 -36.55 83.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.3 mt -58.96 -55.65 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.549 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.11 -28.1 64.33 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.343 0.52 . . . . 0.0 111.448 -178.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . 0.427 ' HB2' HH11 ' A' ' 103' ' ' ARG . . . -71.99 -48.03 47.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.753 0.821 . . . . 0.0 110.677 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -58.52 -35.01 71.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.928 0.891 . . . . 0.0 112.246 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.437 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.3 mm? -64.29 -22.55 66.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.436 0.694 . . . . 0.0 112.851 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.83 -17.88 61.51 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 173.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.456 0 C-N-CA 126.476 1.91 . . . . 0.0 111.886 177.199 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.878 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.21 146.03 97.84 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.354 1.062 . . . . 0.0 111.574 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.38 -179.26 5.11 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.29 1.993 . . . . 0.0 112.567 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.57 117.25 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.26 45.34 2.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.919 0.888 . . . . 0.0 109.122 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.48 -36.34 82.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.056 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.14 -19.92 60.41 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.534 0.734 . . . . 0.0 111.229 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.688 HH12 ' HB2' ' A' ' 96' ' ' ASP . 7.6 ttt180 -71.52 -28.13 63.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.034 0.534 . . . . 0.0 111.144 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.58 -31.38 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.414 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.29 -18.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.194 0.998 . . . . 0.0 111.82 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 118' ' ' ARG . 19.3 mmm180 . . . . . 0 N--CA 1.491 1.605 0 C-N-CA 123.697 0.799 . . . . 0.0 111.73 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' A' ' 98' ' ' MET . 67.8 t80 . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 121.43 0.633 . . . . 0.0 111.447 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.55 154.42 69.28 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.968 1.307 . . . . 0.0 109.94 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.43 100.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.81 2.34 . . . . 0.0 113.202 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.55 -24.38 6.5 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.68 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -147.65 150.75 34.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.625 . . . . 0.0 110.411 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 42.6 tp -124.18 129.61 51.11 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.978 1.311 . . . . 0.0 107.627 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.67 134.87 40.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.642 0.377 . . . . 0.0 110.137 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 69.2 mt -125.46 113.09 17.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.474 0.709 . . . . 0.0 110.446 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.2 m . . . . . 0 N--CA 1.479 0.985 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 159.893 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 . . . . . 0 N--CA 1.474 0.745 0 N-CA-C 109.59 -0.522 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -73.29 78.05 1.33 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.588 HG22 HG23 ' A' ' 49' ' ' ILE . 1.5 pp -123.97 138.47 53.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.052 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -152.68 126.63 9.02 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.525 HD11 HD11 ' A' ' 49' ' ' ILE . 36.2 mt -142.92 142.04 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.293 1.037 . . . . 0.0 108.271 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.7 m170 -103.56 141.99 35.06 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 33.1 mt -126.62 108.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 119.27 0.941 . . . . 0.0 109.089 169.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 18.5 mtp180 -95.39 138.56 32.91 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.236 1.014 . . . . 0.0 108.397 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -124.43 117.29 24.1 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.66 111.23 16.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 41' ' ' VAL . 74.7 t -85.43 117.06 29.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -131.32 158.84 39.59 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.079 0.951 . . . . 0.0 110.012 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -115.89 110.53 19.14 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.512 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -98.96 152.09 20.18 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.982 0.513 . . . . 0.0 110.85 172.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.38 -25.96 63.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.693 0.797 . . . . 0.0 110.965 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -66.51 -53.45 34.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.317 1.047 . . . . 0.0 112.275 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 m -126.68 -0.44 6.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -168.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.22 -133.94 12.11 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 117.741 0.246 . . . . 0.0 112.632 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -82.27 131.13 35.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.906 0.482 . . . . 0.0 110.256 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -156.99 173.66 16.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.784 0.433 . . . . 0.0 110.773 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 31' ' ' VAL . 20.9 t -132.45 125.65 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.393 0.677 . . . . 0.0 109.526 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.432 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 73.2 t60 -87.91 119.35 28.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 109.581 172.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 74.0 m-85 -102.79 127.94 49.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.0 t70 -130.26 123.87 31.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.084 0.554 . . . . 0.0 110.589 -170.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 79.1 mtp -122.59 132.38 54.27 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.018 0.927 . . . . 0.0 111.097 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -154.38 154.23 32.93 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 0.0 110.965 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 162.24 -151.94 22.09 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 118.588 -1.118 . . . . 0.0 110.403 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -145.65 110.5 5.16 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.096 1.448 . . . . 0.0 111.72 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.588 HG23 HG22 ' A' ' 23' ' ' ILE . 68.8 mt -98.64 124.3 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.603 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 7.7 m-20 63.98 24.45 13.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.909 1.283 . . . . 0.0 109.822 -170.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.47 10.38 86.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.39 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.519 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 51.3 mtmt -94.78 108.37 37.12 Favored Pre-proline 0 C--N 1.354 0.771 0 C-N-CA 123.494 0.717 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 37.5 Cg_endo -63.86 133.54 39.4 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.796 2.331 . . . . 0.0 111.732 176.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -137.76 147.39 44.65 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.2 p -132.71 113.1 12.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.77 136.59 34.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.2 p -148.95 145.7 27.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.736 0.303 . . . . 0.0 110.593 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -137.87 142.46 40.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.307 1.043 . . . . 0.0 109.325 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 7.4 mp0 -116.13 140.44 49.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.3 mt -132.87 135.93 26.81 Favored Pre-proline 0 C--O 1.237 0.435 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 165.26 19.95 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.495 2.13 . . . . 0.0 111.713 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.594 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 24.6 ptt180 -38.76 -36.91 0.3 Allowed 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 125.404 1.482 . . . . 0.0 114.15 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -78.78 -19.14 52.91 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 p -130.53 3.05 4.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.339 0.656 . . . . 0.0 111.307 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.51 70.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.29 1.036 . . . . 0.0 112.178 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -71.15 -17.74 62.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.059 0.944 . . . . 0.0 112.366 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.95 -3.84 57.54 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.869 0.467 . . . . 0.0 111.103 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -51.65 -44.11 62.89 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.026 0.93 . . . . 0.0 112.963 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.22 30.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -172.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -67.69 -47.55 69.12 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.975 0.51 . . . . 0.0 109.855 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.44 -47.5 33.23 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.778 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.51 -39.18 10.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.008 1.323 . . . . 0.0 112.477 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.1 m -73.77 -44.03 57.27 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.982 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -61.67 -46.99 87.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.041 0.936 . . . . 0.0 112.464 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.53 -31.92 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.415 0.686 . . . . 0.0 110.805 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.21 85.79 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.984 0.514 . . . . 0.0 110.594 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.471 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 9.6 pt20 -76.84 -25.76 53.56 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.217 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -68.03 -27.87 66.91 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.032 0.933 . . . . 0.0 110.669 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.79 6.65 20.52 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.636 0.774 . . . . 0.0 111.448 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.4 54.13 2.02 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 114.701 0.64 . . . . 0.0 114.701 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.471 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 30.6 mt . . . . . 0 N--CA 1.485 1.297 0 CA-C-N 118.089 0.945 . . . . 0.0 109.575 165.312 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.5 t80 . . . . . 0 C--O 1.21 -0.979 0 CA-C-O 118.934 -0.555 . . . . 0.0 110.953 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -53.27 -41.71 65.79 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.28 29.19 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.135 0.574 . . . . 0.0 110.268 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.4 ' SD ' ' CE1' ' A' ' 5' ' ' PHE . 8.6 tpt -51.69 -42.12 61.95 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.824 1.249 . . . . 0.0 111.686 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -58.99 -53.26 60.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.335 1.454 . . . . 0.0 110.839 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.72 -27.6 66.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.827 0.704 . . . . 0.0 112.101 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.08 -55.69 8.83 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 123.335 0.397 . . . . 0.0 110.243 176.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.8 -37.03 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.914 0.325 . . . . 0.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.4 62.39 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.072 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -61.94 -38.82 89.91 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.321 1.048 . . . . 0.0 112.898 174.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.31 -38.66 92.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.241 0.616 . . . . 0.0 110.802 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -66.81 -29.32 69.22 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.737 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.439 0 C-N-CA 125.839 1.656 . . . . 0.0 112.081 177.562 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.619 0 N-CA-C 111.241 -0.744 . . . . 0.0 111.241 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.15 129.14 68.23 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.337 1.055 . . . . 0.0 109.561 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.87 105.13 1.09 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.735 2.29 . . . . 0.0 110.687 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.84 143.99 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 0.0 111.944 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.79 -30.63 69.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.302 1.041 . . . . 0.0 111.891 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.22 -6.15 22.04 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.169 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.78 -43.66 2.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.663 0.785 . . . . 0.0 110.89 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -75.49 -31.56 60.25 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.667 0.787 . . . . 0.0 111.578 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.39 -28.75 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 120' ' ' ILE . 2.0 mp -88.28 83.82 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.74 0.816 . . . . 0.0 109.092 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 . . . . . 0 N--CA 1.488 1.428 0 C-N-CA 123.516 0.726 . . . . 0.0 111.324 176.112 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.7 t80 . . . . . 0 N--CA 1.469 0.482 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.13 157.2 37.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.455 1.502 . . . . 0.0 107.865 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.57 105.14 0.34 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 121.876 1.717 . . . . 0.0 111.122 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.1 -16.2 12.0 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.866 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -158.36 151.61 22.96 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.74 0.77 . . . . 0.0 112.307 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -140.22 143.15 35.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.045 1.738 . . . . 0.0 107.972 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.4 t-160 -124.41 137.55 54.44 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -136.47 118.55 15.41 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.577 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 m . . . . . 0 C--O 1.246 0.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.973 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.569 ' HG3' HG23 ' A' ' 23' ' ' ILE . 19.0 pt20 . . . . . 0 N--CA 1.476 0.867 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.2 57.82 4.7 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.152 0.581 . . . . 0.0 111.648 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.569 HG23 ' HG3' ' A' ' 21' ' ' GLN . 2.0 pp -90.54 119.91 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.25 118.62 12.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.406 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 19.2 mt -140.53 139.42 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.36 0.664 . . . . 0.0 109.715 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -107.3 131.93 53.67 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.467 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.6 mt -128.11 110.19 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -99.88 139.66 35.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -122.58 116.17 23.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 164.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -123.86 113.17 18.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 41' ' ' VAL . 87.2 t -80.22 131.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 30.3 ttt180 -146.83 161.24 41.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.444 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.1 mm-40 -109.74 119.41 39.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.037 0.535 . . . . 0.0 110.419 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.571 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -96.61 146.76 24.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.776 0.831 . . . . 0.0 110.311 170.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.83 62.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.403 0.681 . . . . 0.0 111.82 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -71.96 -55.34 7.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.893 0.877 . . . . 0.0 112.171 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -121.13 0.69 10.21 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.167 0.587 . . . . 0.0 111.859 -168.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.74 -113.78 4.15 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -78.87 144.07 35.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.866 0.466 . . . . 0.0 111.279 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 32' ' ' ARG . 9.3 p90 -154.85 177.42 11.29 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 108.666 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 31' ' ' VAL . 16.3 t -128.3 124.13 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -84.02 122.52 28.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.641 1.176 . . . . 0.0 108.983 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -106.95 126.72 52.68 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -125.89 115.03 19.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.809 0.843 . . . . 0.0 110.02 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.467 ' SD ' HG12 ' A' ' 27' ' ' ILE . 38.9 mtm -120.95 148.09 44.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.566 0.746 . . . . 0.0 111.004 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -167.79 166.36 13.68 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.213 1.005 . . . . 0.0 109.94 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.11 -144.78 10.03 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-O 118.708 -1.051 . . . . 0.0 110.7 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.99 110.06 3.27 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.582 1.182 . . . . 0.0 111.549 171.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 23' ' ' ILE . 70.3 mt -100.22 127.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.015 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 65.09 23.53 12.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.088 1.355 . . . . 0.0 109.206 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.48 -0.63 84.67 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.401 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -86.37 109.13 21.0 Favored Pre-proline 0 C--N 1.353 0.745 0 C-N-CA 124.092 0.957 . . . . 0.0 111.48 -175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.24 129.84 18.89 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.849 2.366 . . . . 0.0 111.902 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -138.49 160.25 40.02 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -147.77 129.06 14.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 169.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -130.87 142.02 50.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.374 1.069 . . . . 0.0 109.102 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -143.25 133.62 24.7 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.538 0.335 . . . . 0.0 110.425 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.86 144.71 33.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.72 0.808 . . . . 0.0 109.231 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -126.1 127.25 45.49 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 65' ' ' ALA . 80.8 mt -124.7 129.87 24.46 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -175.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -59.32 156.31 36.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.951 2.434 . . . . 0.0 111.215 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 30.1 ptt180 -45.53 -26.88 0.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.38 -21.79 45.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.373 0.669 . . . . 0.0 111.809 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -128.65 2.87 5.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.833 0.853 . . . . 0.0 110.977 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . . . -55.32 -37.37 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.448 1.099 . . . . 0.0 112.545 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.52 0.7 7.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.202 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.16 3.82 47.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.482 0.713 . . . . 0.0 110.241 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -57.76 -52.03 67.14 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.998 0.919 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.57 -31.1 63.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.5 m -73.44 -50.83 19.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.977 0.511 . . . . 0.0 110.333 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.21 -55.6 15.45 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.745 0.818 . . . . 0.0 111.383 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.36 -46.75 13.28 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.986 1.314 . . . . 0.0 113.059 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.1 m -70.6 -33.15 70.74 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.913 0.485 . . . . 0.0 111.028 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -67.33 -40.77 85.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.396 0.679 . . . . 0.0 111.003 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.93 -33.21 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 110.727 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.96 -47.92 73.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.323 0.582 . . . . 0.0 109.548 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 3.6 pt20 -69.63 -31.89 70.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.825 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -53.69 -41.66 67.16 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 110.876 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -90.79 8.66 33.57 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.075 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.47 -10.02 4.66 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 8.7 mp . . . . . 0 N--CA 1.49 1.544 0 CA-C-N 118.898 1.349 . . . . 0.0 111.215 -179.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.7 t80 . . . . . 0 C--O 1.221 -0.442 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.0 -34.73 72.19 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.962 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.34 64.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.564 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mmt -72.27 -30.74 65.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.623 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -51.92 -52.4 50.28 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.087 0.955 . . . . 0.0 110.625 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.78 -28.76 61.82 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.798 0.686 . . . . 0.0 112.241 -173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.24 -44.81 58.82 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.382 0.273 . . . . 0.0 110.811 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.442 ' O ' HD13 ' A' ' 106' ' ' LEU . 97.6 mt -63.47 -46.52 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.688 0.795 . . . . 0.0 111.648 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -59.69 -31.5 69.64 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.349 0.595 . . . . 0.0 110.496 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.93 56.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.573 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.458 ' HG2' HG21 ' A' ' 31' ' ' VAL . 1.9 tpmt? -64.63 -32.67 74.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.475 0.71 . . . . 0.0 111.873 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -67.83 -20.96 65.22 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.679 1.192 . . . . 0.0 111.149 171.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -88.24 -17.18 31.35 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.126 0.97 . . . . 0.0 110.202 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 1.628 0 C-N-CA 126.916 2.086 . . . . 0.0 112.638 173.812 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.806 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 139.4 73.39 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.033 0.933 . . . . 0.0 112.436 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.22 66.02 8.85 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.382 2.722 . . . . 0.0 112.531 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.54 72.44 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 122.845 1.307 . . . . 0.0 109.532 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.68 41.24 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.779 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 117' ' ' GLU . 3.9 pp -63.23 -29.69 70.98 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.325 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.413 ' N ' HD12 ' A' ' 116' ' ' LEU . 31.7 tt0 -73.65 -19.17 60.92 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.496 0.718 . . . . 0.0 111.43 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -68.53 -16.46 63.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.958 0.503 . . . . 0.0 111.407 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.3 mm -71.64 -35.3 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.112 0.565 . . . . 0.0 109.805 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.413 ' N ' HD12 ' A' ' 120' ' ' ILE . 3.4 mp -84.36 78.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 122.261 1.029 . . . . 0.0 108.246 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.475 0.792 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.861 175.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 . . . . . 0 N--CA 1.468 0.446 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.82 156.91 62.35 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.824 1.25 . . . . 0.0 108.504 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.61 105.03 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.538 2.159 . . . . 0.0 112.242 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.63 -19.89 13.95 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.691 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -150.97 135.33 16.96 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.524 0.678 . . . . 0.0 112.363 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.403 HD22 ' HE1' ' A' ' 98' ' ' MET . 46.2 tp -114.8 141.02 48.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.583 1.553 . . . . 0.0 108.957 170.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.532 0.733 . . . . 0.0 109.349 168.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.574 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -123.29 110.21 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.644 0.735 . . . . 0.0 110.529 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p . . . . . 0 C--O 1.248 1.015 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 164.47 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.432 HE21 ' HB2' ' A' ' 50' ' ' ASP . 35.2 tt0 . . . . . 0 N--CA 1.485 1.284 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -85.95 53.17 2.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.625 0.726 . . . . 0.0 110.255 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.543 HG22 HG23 ' A' ' 49' ' ' ILE . 2.0 pp -89.67 115.57 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -138.2 106.39 5.75 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.574 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 48.6 mt -127.6 132.98 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -166.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -107.35 119.17 38.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.502 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -120.55 114.1 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 18.4 mtp180 -104.11 135.34 45.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 108.234 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -121.88 116.06 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 167.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.6 111.8 17.67 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 41' ' ' VAL . 52.1 t -82.37 118.33 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.03 159.0 30.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -109.27 119.39 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.722 0.409 . . . . 0.0 110.35 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.04 154.9 16.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.877 0.871 . . . . 0.0 109.232 167.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.75 -27.65 64.1 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.714 0.406 . . . . 0.0 111.454 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.21 -54.38 7.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.862 0.865 . . . . 0.0 112.348 -173.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 t -108.57 -1.92 19.25 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.11 0.564 . . . . 0.0 111.532 -173.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.84 -110.31 3.06 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 138.34 37.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.9 0.48 . . . . 0.0 110.567 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.5 166.79 26.2 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 31' ' ' VAL . 7.6 t -127.81 127.12 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.578 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 55.4 t60 -86.18 114.41 23.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.462 1.105 . . . . 0.0 108.859 171.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.448 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 76.0 m-85 -99.73 111.38 23.72 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 27.1 t70 -107.13 124.58 49.9 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 109.408 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.502 ' HG2' HG12 ' A' ' 27' ' ' ILE . 79.4 mtp -124.58 140.34 53.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.259 0.624 . . . . 0.0 110.286 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.04 170.0 21.38 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.739 0.815 . . . . 0.0 109.663 173.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.16 -137.78 6.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 119.429 -0.651 . . . . 0.0 112.002 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 9.7 pt-20 -152.55 157.73 41.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.756 1.222 . . . . 0.0 108.546 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.543 HG23 HG22 ' A' ' 23' ' ' ILE . 51.2 mt -156.46 105.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -168.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.432 ' HB2' HE21 ' A' ' 21' ' ' GLN . 26.9 t70 59.14 47.96 11.14 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.216 1.007 . . . . 0.0 108.994 -170.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.97 -35.05 3.13 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 114.836 -1.075 . . . . 0.0 114.384 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -86.94 128.88 54.31 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.218 1.007 . . . . 0.0 112.053 -168.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 89.6 Cg_endo -74.17 161.07 41.47 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.064 2.509 . . . . 0.0 113.821 -177.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.415 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 8.9 p90 -152.86 148.9 27.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.903 0.881 . . . . 0.0 109.021 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -142.54 113.83 7.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.154 0.582 . . . . 0.0 110.278 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -127.21 143.09 51.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.295 1.038 . . . . 0.0 109.186 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 t -143.53 134.43 25.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.013 0.435 . . . . 0.0 110.093 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -146.97 148.81 32.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.853 0.861 . . . . 0.0 109.703 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 4.7 mp0 -118.94 138.72 52.59 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 73.4 mt -128.89 134.36 26.23 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.71 160.85 34.66 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.641 2.227 . . . . 0.0 111.373 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -36.2 9.96 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.57 -23.73 61.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.056 0.942 . . . . 0.0 112.258 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -125.3 7.2 7.77 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.952 0.901 . . . . 0.0 110.779 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.04 80.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.029 0.931 . . . . 0.0 112.282 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.83 -6.51 38.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.086 0.954 . . . . 0.0 113.186 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -78.57 -6.3 55.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.414 0.685 . . . . 0.0 111.131 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -64.14 -24.13 67.57 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 124.542 1.137 . . . . 0.0 113.06 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.7 -49.06 16.98 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.252 0.549 . . . . 0.0 109.693 -162.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 m -72.41 -31.01 65.17 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.283 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.07 -54.24 13.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.182 0.993 . . . . 0.0 110.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.02 74.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.631 1.172 . . . . 0.0 111.92 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.5 m -63.86 -50.24 69.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.657 0.383 . . . . 0.0 110.34 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -54.92 -45.37 74.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.216 1.006 . . . . 0.0 112.058 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.34 -32.06 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.543 0.337 . . . . 0.0 110.671 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.99 -47.48 58.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.023 0.529 . . . . 0.0 110.096 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.611 ' HA ' HD23 ' A' ' 81' ' ' LEU . 13.2 pt20 -65.4 -22.16 66.75 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.757 0.823 . . . . 0.0 112.641 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -64.65 -19.24 65.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.741 0.816 . . . . 0.0 111.918 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -90.2 25.23 2.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.373 0.669 . . . . 0.0 112.33 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.22 49.85 1.67 Allowed Glycine 0 C--N 1.35 1.312 0 CA-C-O 120.218 -0.212 . . . . 0.0 113.493 170.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER . . . . . 0 N--CA 1.474 0.733 0 C-N-CA 122.953 0.501 . . . . 0.0 109.701 173.428 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 t80 . . . . . 0 C--O 1.223 -0.298 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.27 -34.08 74.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.473 1.109 . . . . 0.0 111.815 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.37 68.38 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.711 0.632 . . . . 0.0 110.696 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.403 ' HE1' HD22 ' A' ' 10' ' ' LEU . 30.4 ttm -65.45 -41.53 93.35 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.012 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.24 -48.29 68.33 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.388 1.075 . . . . 0.0 110.91 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.0 -26.85 57.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.7 t70 -65.72 -57.35 8.26 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.487 0.492 . . . . 0.0 110.212 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.9 -42.41 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.431 0.693 . . . . 0.0 111.551 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -28.38 69.13 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.22 47.74 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 110.326 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 30.7 mmmt -58.34 -40.46 82.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 mp -66.62 -34.47 77.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.537 1.135 . . . . 0.0 111.046 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.1 t60 -81.28 -17.86 47.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.444 0.697 . . . . 0.0 110.562 174.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.409 0 C-N-CA 125.569 1.547 . . . . 0.0 111.667 -179.362 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.729 0 CA-C-O 119.445 -0.641 . . . . 0.0 113.371 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.99 114.91 16.75 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -88.64 123.18 1.48 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.845 2.363 . . . . 0.0 112.83 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . 0.416 HG21 HD23 ' A' ' 116' ' ' LEU . 11.6 p -79.05 152.91 4.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -113.42 17.48 18.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.038 0.535 . . . . 0.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.416 HD23 HG21 ' A' ' 114' ' ' VAL . 4.4 pp -65.65 -24.26 66.98 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -114.59 -3.14 12.96 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.11 0.964 . . . . 0.0 110.865 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -72.29 -5.27 34.92 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.558 0.743 . . . . 0.0 112.707 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.476 ' H ' HD12 ' A' ' 119' ' ' ILE . 4.0 mp -74.3 -7.42 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 C-N-CA 123.998 0.919 . . . . 0.0 109.648 175.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.2 mm 60.77 54.91 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.286 0 C-N-CA 125.12 1.368 . . . . 0.0 107.501 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 . . . . . 0 C--O 1.24 0.553 0 CA-C-N 113.423 -1.717 . . . . 0.0 110.666 -164.499 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 . . . . . 0 N--CA 1.477 0.885 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.47 155.6 32.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.575 1.15 . . . . 0.0 108.304 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.72 90.83 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.285 1.99 . . . . 0.0 111.995 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.91 -26.3 3.01 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.721 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -150.53 151.63 32.94 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.196 0.498 . . . . 0.0 111.692 -170.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 53.8 tp -135.02 111.63 9.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 108.557 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 11.6 t-160 -98.42 127.9 44.56 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.176 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.411 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.3 OUTLIER -121.05 132.38 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.215 0.606 . . . . 0.0 109.931 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 m . . . . . 0 C--O 1.248 1.009 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 166.329 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 . . . . . 0 N--CA 1.476 0.829 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.05 65.83 8.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.852 0.834 . . . . 0.0 110.509 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.625 HD13 HD21 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -92.69 126.85 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.484 HD21 ' HG3' ' A' ' 48' ' ' GLU . 6.0 p30 -151.81 110.02 3.73 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.411 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 27.8 mt -132.32 137.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -168.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' MET . 4.7 m170 -99.53 128.52 45.65 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.565 HG12 ' HG2' ' A' ' 45' ' ' MET . 56.2 mt -121.9 109.62 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -96.18 124.84 40.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . 0.462 ' HB2' HG11 ' A' ' 41' ' ' VAL . 45.7 p90 -111.69 116.98 31.65 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -124.63 112.32 16.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.676 0.79 . . . . 0.0 109.29 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 41' ' ' VAL . 56.3 t -75.9 126.64 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.771 0.428 . . . . 0.0 110.663 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -143.97 154.79 43.66 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.05 125.56 41.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.713 0.405 . . . . 0.0 111.132 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 1.5 p30 -100.1 147.08 26.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.635 1.174 . . . . 0.0 109.155 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.81 -10.94 60.51 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 122.954 0.501 . . . . 0.0 112.233 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 16.4 tt0 -75.81 -55.27 5.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.196 0.999 . . . . 0.0 112.012 -177.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.1 p -130.32 1.98 4.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.338 0.655 . . . . 0.0 112.263 -167.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.88 -106.27 3.4 Favored Glycine 0 C--O 1.213 -1.171 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 146.76 41.22 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.794 0.797 . . . . 0.0 111.887 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.442 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.5 p90 -152.85 173.53 15.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 31' ' ' VAL . 23.5 t -128.7 130.85 68.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -89.03 110.95 21.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 63.3 m-85 -96.56 139.32 32.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.467 0.707 . . . . 0.0 109.181 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -135.04 127.95 31.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.358 0.663 . . . . 0.0 109.722 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.565 ' HG2' HG12 ' A' ' 27' ' ' ILE . 83.4 mtp -123.91 131.17 53.53 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.919 0.888 . . . . 0.0 110.114 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -161.03 162.18 31.65 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.71 -128.03 2.6 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.484 ' HG3' HD21 ' A' ' 24' ' ' ASN . 10.3 pt-20 -156.59 165.43 36.31 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.198 0.599 . . . . 0.0 109.864 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 90.6 mt -155.98 103.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 -161.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.16 37.43 20.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.687 0.795 . . . . 0.0 110.1 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.12 -21.03 7.32 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.312 -0.858 . . . . 0.0 115.239 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -79.65 120.23 79.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 117.621 0.711 . . . . 0.0 110.825 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.61 157.05 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.017 2.478 . . . . 0.0 113.266 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -154.7 161.51 41.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.679 0.392 . . . . 0.0 111.279 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.5 p -141.89 116.26 9.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.431 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.35 144.31 31.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.244 1.018 . . . . 0.0 108.861 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.3 p -148.12 149.59 32.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.452 0.569 . . . . 0.0 110.753 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -141.46 151.32 43.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.558 0.743 . . . . 0.0 110.571 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.76 132.56 54.29 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.55 0.74 . . . . 0.0 109.863 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 95.7 mt -127.53 139.05 34.15 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.374 0.67 . . . . 0.0 109.791 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.44 158.54 40.36 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.053 2.502 . . . . 0.0 112.02 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -41.36 -34.83 0.56 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.126 1.37 . . . . 0.0 114.65 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.86 -19.88 62.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.625 0.77 . . . . 0.0 112.416 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.3 p -131.7 10.1 4.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.829 0.852 . . . . 0.0 110.231 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.57 96.79 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.493 0.717 . . . . 0.0 111.36 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -70.05 -22.19 63.1 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.549 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -80.6 -8.76 59.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.809 0.844 . . . . 0.0 109.545 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -53.04 -30.61 36.76 Favored 'General case' 0 C--O 1.205 -1.276 0 C-N-CA 123.949 0.899 . . . . 0.0 112.918 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 -34.16 20.77 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -69.52 -48.3 60.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.37 -57.04 10.45 Favored 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -43.55 -45.27 6.53 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.778 1.631 . . . . 0.0 113.461 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.4 m -68.75 -40.55 79.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.668 0.387 . . . . 0.0 110.892 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HA ' ' HG2' ' A' ' 77' ' ' GLN . 31.4 ttp180 -68.59 -39.09 81.09 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.534 0.734 . . . . 0.0 111.828 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.98 -50.21 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.397 1.079 . . . . 0.0 109.451 173.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HB1' HD22 ' A' ' 81' ' ' LEU . . . -60.74 -43.06 98.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.667 0.787 . . . . 0.0 111.622 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 3.3 pt20 -71.11 -35.52 71.82 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.638 0.375 . . . . 0.0 111.284 -176.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -65.1 -31.65 72.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.619 0.368 . . . . 0.0 110.697 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -89.38 5.38 45.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.234 0.613 . . . . 0.0 112.143 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.02 -27.09 2.45 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.625 HD21 HD13 ' A' ' 23' ' ' ILE . 9.8 mp . . . . . 0 N--CA 1.485 1.311 0 CA-C-O 121.767 0.794 . . . . 0.0 111.955 -176.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 . . . . . 0 CA--C 1.538 0.503 0 N-CA-C 110.2 -0.296 . . . . 0.0 110.2 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.47 -31.29 69.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.59 -48.88 53.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.991 0.516 . . . . 0.0 110.976 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.6 ptm -65.97 -31.44 72.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.505 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -56.48 -45.97 80.67 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.175 0.59 . . . . 0.0 110.828 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.564 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 12.3 pt-20 -76.75 -27.67 55.44 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.705 0.402 . . . . 0.0 111.934 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.51 -58.97 3.78 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.864 0.364 . . . . 0.0 110.028 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 106' ' ' LEU . 74.7 mt -57.16 -38.05 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.879 1.271 . . . . 0.0 112.361 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.564 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.69 -29.61 70.82 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.234 0.47 . . . . 0.0 111.611 177.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.82 -41.19 60.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.741 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -57.35 -45.09 84.71 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.789 0.836 . . . . 0.0 112.514 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 102' ' ' ILE . 9.7 mp -64.21 -24.95 67.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.871 0.869 . . . . 0.0 111.766 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -85.68 -16.91 37.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.319 0.648 . . . . 0.0 110.657 174.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.337 0 C-N-CA 125.134 1.374 . . . . 0.0 111.608 175.72 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.711 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -72.49 144.11 86.06 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.98 0.912 . . . . 0.0 110.167 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.21 148.81 69.45 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.994 2.462 . . . . 0.0 112.128 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.97 149.98 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -140.83 32.68 1.79 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.668 0.787 . . . . 0.0 110.105 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 117' ' ' GLU . 4.5 pp -61.97 -43.03 99.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.813 0.445 . . . . 0.0 110.821 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -76.18 -22.48 55.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.757 1.223 . . . . 0.0 111.853 -178.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 tpp85 -50.36 -49.14 55.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.997 1.319 . . . . 0.0 112.246 -170.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.91 -29.19 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.754 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.3 -24.36 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.752 0.821 . . . . 0.0 111.628 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 31.0 mmm180 . . . . . 0 N--CA 1.49 1.536 0 C-N-CA 123.396 0.679 . . . . 0.0 111.364 -176.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.1 t80 . . . . . 0 CA--C 1.538 0.491 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.13 161.3 54.13 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.923 1.289 . . . . 0.0 108.451 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.512 ' HG3' ' HB3' ' A' ' 112' ' ' GLU . 29.8 Cg_exo -62.44 109.66 0.91 Allowed 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 121.859 1.706 . . . . 0.0 111.491 172.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.29 -13.83 33.45 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.896 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -155.12 146.79 23.23 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.542 0.671 . . . . 0.0 112.062 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.9 tp -136.35 128.93 30.55 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.641 1.176 . . . . 0.0 109.039 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -100.3 125.63 46.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 85.8 mt -107.17 134.82 49.71 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.269 0.628 . . . . 0.0 109.928 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 23' ' ' ILE . 13.8 p . . . . . 0 C--O 1.249 1.038 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.082 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.541 HE21 ' HB2' ' A' ' 50' ' ' ASP . 31.2 tt0 . . . . . 0 C--O 1.238 0.46 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 50' ' ' ASP . 27.8 t70 -85.74 42.48 0.97 Allowed 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.488 1.137 . . . . 0.0 110.727 -173.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.69 HG22 HG23 ' A' ' 49' ' ' ILE . 44.3 pt -89.7 139.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.445 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.618 HD21 ' HG2' ' A' ' 48' ' ' GLU . 5.5 p30 -152.85 125.01 8.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 172.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 31.4 mt -132.43 132.79 60.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.174 -172.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 45' ' ' MET . 5.5 m170 -108.09 109.82 21.35 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -105.27 108.37 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -102.91 109.93 21.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -115.93 117.96 31.6 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.69 114.52 18.12 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.567 HG11 ' HB3' ' A' ' 105' ' ' LYS . 7.1 p -82.25 126.63 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.051 0.54 . . . . 0.0 109.726 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -141.16 166.49 24.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -109.49 117.13 33.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -91.65 156.96 17.23 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.681 0.793 . . . . 0.0 109.665 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.42 -20.76 62.08 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -84.72 -53.62 5.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.28 0.632 . . . . 0.0 111.438 -171.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -117.86 3.92 12.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.958 0.903 . . . . 0.0 111.537 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.44 -122.41 5.72 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.55 51.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.618 0.709 . . . . 0.0 111.994 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -157.75 170.65 21.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.002 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.07 130.35 69.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.505 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.0 t60 -88.27 129.8 35.27 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -115.07 135.12 54.55 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -137.99 141.36 40.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 91.3 mtp -135.19 131.59 36.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.564 0.746 . . . . 0.0 109.281 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -150.54 162.79 39.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.72 -144.08 12.8 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.618 ' HG2' HD21 ' A' ' 24' ' ' ASN . 1.9 pm0 -147.23 163.16 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.295 1.038 . . . . 0.0 108.547 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 23' ' ' ILE . 38.0 mt -157.81 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 -160.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.565 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 37.3 t70 55.38 26.64 8.97 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 121.614 0.721 . . . . 0.0 111.394 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.22 50.97 4.33 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.212 -173.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 52.4 mtpt -146.11 108.41 4.26 Favored Pre-proline 0 N--CA 1.497 1.92 0 C-N-CA 123.564 0.746 . . . . 0.0 110.798 -176.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.91 121.44 4.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.863 2.375 . . . . 0.0 111.794 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -125.54 143.68 50.9 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.861 0.465 . . . . 0.0 110.687 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 p -139.92 110.55 6.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.312 0.645 . . . . 0.0 109.477 171.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.22 151.85 39.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.697 1.199 . . . . 0.0 109.299 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.8 p -151.43 123.16 8.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.909 0.483 . . . . 0.0 109.85 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.16 146.44 42.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.317 1.047 . . . . 0.0 108.98 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 49.6 mt-10 -123.89 141.29 52.17 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.077 0.551 . . . . 0.0 109.672 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -124.79 130.28 24.3 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -65.65 169.65 12.55 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.936 2.424 . . . . 0.0 112.193 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -41.5 -39.67 1.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.473 1.109 . . . . 0.0 113.617 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.04 -29.5 66.55 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.243 1.017 . . . . 0.0 112.526 -174.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -130.99 8.39 4.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.966 0.507 . . . . 0.0 111.376 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.83 70.95 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.531 0.732 . . . . 0.0 111.917 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.16 -21.55 66.79 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.898 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -72.76 3.26 5.33 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.406 0.683 . . . . 0.0 112.593 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.56 -20.61 61.29 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.402 1.081 . . . . 0.0 112.209 -173.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.16 -42.9 45.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.938 0.875 . . . . 0.0 108.844 -169.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -74.46 -39.62 62.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.155 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.9 t70 -73.71 -59.1 2.87 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.016 0.526 . . . . 0.0 112.14 -171.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.45 66.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.559 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 95.4 m -65.81 -48.23 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 173.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -57.74 -34.33 69.4 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.545 0.738 . . . . 0.0 111.951 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 71' ' ' ASP . 94.0 t -68.8 -36.81 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' HD13 ' A' ' 81' ' ' LEU . . . -68.44 -49.72 57.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.54 0.736 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 73' ' ' THR . 65.7 mm-40 -66.21 -25.08 66.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -60.13 -28.73 68.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.439 1.096 . . . . 0.0 111.363 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -91.66 12.13 22.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.648 0.779 . . . . 0.0 112.232 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.1 74.32 1.11 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 122.948 0.155 . . . . 0.0 113.292 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.503 ' HG ' HG21 ' A' ' 23' ' ' ILE . 11.2 mp . . . . . 0 N--CA 1.485 1.306 0 C-N-CA 124.163 0.985 . . . . 0.0 109.681 170.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.3 t80 . . . . . 0 C--O 1.221 -0.414 0 N-CA-C 111.946 0.35 . . . . 0.0 111.946 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.67 -30.45 70.7 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.199 0.937 . . . . 0.0 111.847 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.12 17.82 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.942 0.497 . . . . 0.0 110.893 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -70.96 -25.9 62.93 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.565 0.346 . . . . 0.0 111.869 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -50.97 -42.73 60.3 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.127 0.971 . . . . 0.0 110.303 164.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 35.0 mt-10 -79.33 -27.57 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.488 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.83 -50.31 30.68 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.8 -38.81 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.567 0.347 . . . . 0.0 111.648 173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.42 -28.55 69.33 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.21 -40.6 62.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.053 0.541 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.567 ' HB3' HG11 ' A' ' 31' ' ' VAL . 9.5 mmpt? -58.44 -40.18 81.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.61 0.764 . . . . 0.0 112.059 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.25 -25.58 67.73 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.179 0.992 . . . . 0.0 111.162 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -80.68 -17.91 49.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 110.891 172.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.515 0 C-N-CA 125.899 1.679 . . . . 0.0 111.628 174.856 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.238 0.38 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . 0.512 ' HB3' ' HG3' ' A' ' 7' ' ' PRO . 1.1 mm-40 -96.9 114.2 64.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.35 94.28 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.437 2.091 . . . . 0.0 112.822 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.47 93.06 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.21 1.005 . . . . 0.0 109.009 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.99 43.45 1.12 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.3 -173.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.03 -27.82 69.67 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.814 0.445 . . . . 0.0 111.959 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 42.5 tt0 -78.28 -22.07 48.82 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.964 0.506 . . . . 0.0 110.799 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -79.96 -17.09 53.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.985 0.514 . . . . 0.0 110.561 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.3 mm -78.97 91.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 124.063 0.945 . . . . 0.0 108.696 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.1 mt 82.41 -21.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.846 163.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . 0.455 ' HD3' ' HA ' ' A' ' 117' ' ' GLU . 15.8 mtp180 . . . . . 0 N--CA 1.478 0.97 0 C-N-CA 122.744 0.418 . . . . 0.0 111.14 -176.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 . . . . . 0 N--CA 1.474 0.741 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.79 157.02 32.61 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.82 1.248 . . . . 0.0 108.02 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.19 89.84 0.39 Allowed 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.943 1.762 . . . . 0.0 110.554 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -14.43 3.78 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.928 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -164.59 153.08 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.955 0.877 . . . . 0.0 111.978 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 4.8 tt -143.26 132.83 23.63 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 175.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -114.55 134.09 55.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.279 0.632 . . . . 0.0 109.667 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 95.1 mt -111.1 128.83 56.01 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.6 t . . . . . 0 N--CA 1.487 1.396 0 CA-C-O 121.317 0.58 . . . . 0.0 110.364 176.979 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 . . . . . 0 C--O 1.242 0.671 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.92 112.38 23.24 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.95 138.65 38.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.95 127.7 10.21 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 165.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -137.81 128.87 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.717 0.807 . . . . 0.0 109.355 -163.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -93.82 131.65 39.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 56.7 mt -120.36 103.99 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 171.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -91.96 140.17 29.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.31 137.8 19.74 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 111.197 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.25 130.77 37.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.848 0.859 . . . . 0.0 109.271 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.2 t -80.74 117.27 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 42.7 ttt180 -132.95 166.56 22.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.689 1.196 . . . . 0.0 108.144 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.416 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 25.7 mm-40 -106.34 127.67 53.43 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 118.349 0.522 . . . . 0.0 111.19 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 40' ' ' TYR . 3.2 p30 -102.95 146.54 28.17 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.825 1.25 . . . . 0.0 108.63 170.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.13 61.79 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 9.5 tp10 -77.37 -54.32 6.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.354 0.662 . . . . 0.0 112.008 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -113.55 -23.09 9.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.956 0.902 . . . . 0.0 111.218 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.16 -116.33 4.75 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 149.65 47.23 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.501 0.651 . . . . 0.0 111.724 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.428 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.1 p90 -159.05 173.74 16.0 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.992 0.917 . . . . 0.0 109.278 167.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.45 124.47 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -87.63 122.75 31.72 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -108.14 138.62 44.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.504 0.722 . . . . 0.0 110.18 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -130.48 120.46 24.18 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.329 1.052 . . . . 0.0 108.221 172.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 80.8 mtp -116.04 130.58 56.87 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.444 0.565 . . . . 0.0 109.702 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.8 161.73 40.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 159.48 -151.09 21.84 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 109.4 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.171 0.986 . . . . 0.0 110.426 175.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 80' ' ' GLY . 72.7 mt -99.47 123.9 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.135 174.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.6 t70 63.52 22.93 13.42 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.82 1.248 . . . . 0.0 110.079 -174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.05 3.88 84.83 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.228 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -93.03 108.4 32.18 Favored Pre-proline 0 C--N 1.355 0.823 0 C-N-CA 123.453 0.701 . . . . 0.0 110.722 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 66.8 Cg_endo -72.26 128.36 13.69 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.476 2.117 . . . . 0.0 111.389 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -131.45 150.17 52.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.235 0.614 . . . . 0.0 109.88 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -139.39 125.83 20.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.033 0.533 . . . . 0.0 110.292 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -141.71 147.59 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.4 p -148.51 140.08 23.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.03 151.08 37.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.659 0.783 . . . . 0.0 109.931 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.54 131.6 51.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.861 0.865 . . . . 0.0 109.281 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.63 125.75 23.84 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 30.6 Cg_endo -59.69 157.15 33.79 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.912 2.408 . . . . 0.0 111.382 172.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -44.8 -26.73 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.0 -28.64 62.49 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.779 . . . . 0.0 111.442 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.8 p -131.54 7.19 4.48 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.316 1.046 . . . . 0.0 111.11 -173.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.47 71.64 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.992 0.917 . . . . 0.0 111.401 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -70.91 -8.12 50.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.084 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -90.45 0.5 57.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.662 0.785 . . . . 0.0 110.05 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.48 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 6.4 p90 -52.94 -43.62 66.45 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -30.28 65.87 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.651 0.78 . . . . 0.0 112.604 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 t -73.03 -50.45 22.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 109.864 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.15 -45.5 63.41 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.87 0.468 . . . . 0.0 112.025 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.87 -38.93 11.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.717 0.807 . . . . 0.0 112.835 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -71.9 -38.28 69.97 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.62 0.368 . . . . 0.0 110.816 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -57.62 -48.53 79.18 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.912 0.885 . . . . 0.0 110.947 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.87 0.868 . . . . 0.0 110.358 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB1' HD22 ' A' ' 81' ' ' LEU . . . -66.72 -41.81 87.36 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.104 -172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.442 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 13.8 pt20 -72.39 -36.11 68.61 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.243 0.617 . . . . 0.0 110.973 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -27.93 69.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.23 0.612 . . . . 0.0 111.336 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -98.09 7.36 46.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.824 0.45 . . . . 0.0 111.672 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.476 ' O ' HG21 ' A' ' 49' ' ' ILE . . . 102.12 93.0 2.21 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.062 0.226 . . . . 0.0 112.648 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 77' ' ' GLN . 57.5 tp . . . . . 0 N--CA 1.475 0.784 0 CA-C-N 117.371 0.585 . . . . 0.0 110.691 177.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.8 t80 . . . . . 0 N--CA 1.473 0.705 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.37 -33.54 74.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.592 1.183 . . . . 0.0 112.959 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.09 -52.33 20.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.004 0.431 . . . . 0.0 110.839 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.48 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 1.1 mpt? -61.93 -34.18 75.62 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.787 173.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.4 -54.73 39.86 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.049 0.843 . . . . 0.0 110.203 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.95 -27.45 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.191 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.29 -58.55 6.22 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.394 0.616 . . . . 0.0 110.168 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.97 -38.22 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 114.526 -1.216 . . . . 0.0 113.179 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -34.57 78.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.291 0.95 . . . . 0.0 111.157 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.22 -46.8 48.19 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.212 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -41.68 82.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.085 0.954 . . . . 0.0 111.926 174.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.71 -38.24 90.32 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.823 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -72.64 -31.21 64.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.439 0.296 . . . . 0.0 111.067 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.402 0 C-N-CA 125.273 1.429 . . . . 0.0 114.036 172.273 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.606 0 N-CA-C 111.151 -0.78 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.32 146.77 55.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.163 0.985 . . . . 0.0 110.812 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -88.36 -167.67 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.352 2.701 . . . . 0.0 111.87 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.37 144.77 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.322 0.649 . . . . 0.0 109.694 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.55 -4.95 59.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 113.345 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.24 -32.89 74.79 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.529 0.604 . . . . 0.0 111.35 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -85.43 -2.28 57.94 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.493 0.717 . . . . 0.0 110.982 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -86.16 -20.54 28.45 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.253 0.621 . . . . 0.0 110.709 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -81.19 -59.95 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.25 94.73 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.476 0.849 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.685 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 . . . . . 0 N--CA 1.469 0.48 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.99 161.61 28.62 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.404 1.082 . . . . 0.0 109.236 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.77 100.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.747 2.298 . . . . 0.0 112.599 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.36 -6.87 32.13 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.775 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -158.86 151.92 22.37 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.207 1.004 . . . . 0.0 111.957 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.1 tt -146.75 149.27 33.07 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.607 1.563 . . . . 0.0 107.33 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -127.26 139.73 52.71 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.183 0.593 . . . . 0.0 110.452 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 96.9 mt -125.56 135.24 52.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.383 1.473 . . . . 0.0 108.14 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 m . . . . . 0 N--CA 1.479 1.009 0 C-N-CA 123.931 0.892 . . . . 0.0 110.691 178.198 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 . . . . . 0 N--CA 1.475 0.805 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -94.87 87.8 5.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.615 0.366 . . . . 0.0 110.529 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -106.76 128.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -137.12 131.4 32.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 71.1 mt -144.93 135.82 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -173.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -112.4 139.97 47.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -127.21 106.19 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -97.99 141.9 30.38 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -126.33 118.55 25.31 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.65 113.56 17.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 41' ' ' VAL . 58.0 t -79.35 118.11 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.45 158.2 30.26 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -107.06 121.55 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.61 -0.681 . . . . 0.0 110.344 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.445 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 5.1 p30 -102.04 145.41 29.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.765 0.826 . . . . 0.0 108.858 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.29 -18.05 65.03 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.335 0.654 . . . . 0.0 112.57 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 28.5 tt0 -73.63 -47.09 42.7 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.743 0.817 . . . . 0.0 112.685 -173.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -134.91 -7.87 2.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.508 0.723 . . . . 0.0 111.594 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -123.39 7.76 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.25 128.81 37.38 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 117.062 0.431 . . . . 0.0 111.747 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 10.8 p90 -140.62 162.26 35.79 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 31' ' ' VAL . 15.8 t -119.15 127.29 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.544 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 5.4 t-160 -84.76 108.34 17.4 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 166.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.441 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 89.6 m-85 -94.9 116.45 28.72 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -110.44 134.45 52.32 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.511 ' SD ' ' HA ' ' A' ' 72' ' ' ALA . 87.1 mtp -129.55 129.11 44.04 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 118.908 0.776 . . . . 0.0 110.531 175.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -149.99 153.53 36.71 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 0.0 109.763 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 171.37 -145.88 9.14 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.952 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.61 109.75 3.52 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.736 1.268 . . . . 0.0 112.088 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 79' ' ' HIS . 50.3 mt -102.15 128.42 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.589 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . 0.596 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 38.7 t70 66.56 23.76 10.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.39 1.476 . . . . 0.0 108.618 -169.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 3.36 88.52 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.101 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 51.4 mtmt -97.77 110.18 54.22 Favored Pre-proline 0 C--O 1.245 0.826 0 C-N-CA 124.302 1.041 . . . . 0.0 110.843 -173.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 41.6 Cg_endo -63.67 143.56 87.26 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.889 2.393 . . . . 0.0 112.52 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.73 155.27 43.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.441 0.696 . . . . 0.0 109.724 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -148.83 131.21 15.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.324 0.65 . . . . 0.0 109.866 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.41 160.63 39.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.587 1.555 . . . . 0.0 109.168 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 m -148.91 138.51 21.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 109.811 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -136.77 132.86 35.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.6 mp0 -113.96 125.2 53.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.441 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 75.3 mt -127.08 125.64 24.17 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 40' ' ' TYR . 55.6 Cg_endo -64.28 166.66 16.43 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.884 2.389 . . . . 0.0 112.164 176.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HG3' HD13 ' A' ' 106' ' ' LEU . 74.2 ttt180 -47.62 -25.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.868 0.867 . . . . 0.0 112.923 174.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.83 -37.24 81.67 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.171 0.988 . . . . 0.0 112.678 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.2 p -129.39 4.97 5.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.422 0.689 . . . . 0.0 112.142 -170.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.76 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.186 0.994 . . . . 0.0 112.189 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -71.37 0.44 8.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.892 1.277 . . . . 0.0 113.975 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -93.3 -0.46 56.68 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.646 0.779 . . . . 0.0 110.999 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -54.35 -34.02 60.26 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.56 68.99 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.562 0.619 . . . . 0.0 112.582 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.8 m -73.54 -39.25 64.89 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.571 0.544 . . . . 0.0 109.99 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.15 -52.97 14.17 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.452 0.701 . . . . 0.0 111.271 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -48.98 -30.24 5.79 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.056 1.342 . . . . 0.0 113.106 172.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -81.66 -41.43 21.41 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.327 0.251 . . . . 0.0 110.665 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -63.73 -42.09 97.95 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.336 0.655 . . . . 0.0 111.612 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.21 -39.26 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.51 1.124 . . . . 0.0 110.401 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.92 83.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.003 0.921 . . . . 0.0 110.982 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 12.9 pt20 -78.85 -32.7 46.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.627 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -51.92 -48.11 64.34 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.77 1.228 . . . . 0.0 112.505 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.554 ' HB3' HD12 ' A' ' 49' ' ' ILE . 22.5 t60 -80.72 14.06 2.3 Favored 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.87 50.8 0.62 Allowed Glycine 0 C--N 1.349 1.265 0 O-C-N 122.051 -0.406 . . . . 0.0 112.865 170.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.403 HD13 HG12 ' A' ' 23' ' ' ILE . 65.5 tp . . . . . 0 CA--C 1.543 0.684 0 C-N-CA 123.436 0.694 . . . . 0.0 109.716 -178.031 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.9 t80 . . . . . 0 C--O 1.219 -0.526 0 N-CA-C 109.518 -0.549 . . . . 0.0 109.518 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.04 -30.33 71.29 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.766 0.827 . . . . 0.0 110.82 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.52 61.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.905 0.482 . . . . 0.0 110.532 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.2 ttt -62.17 -39.25 92.04 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.467 0.707 . . . . 0.0 111.353 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.51 -50.83 64.57 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.334 1.454 . . . . 0.0 110.106 174.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -65.61 -34.02 77.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.99 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.32 -50.2 64.41 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.11 0.564 . . . . 0.0 109.948 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.47 -39.94 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.727 0.811 . . . . 0.0 112.054 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -68.63 -30.7 69.48 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.96 0.41 . . . . 0.0 110.613 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.33 62.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.822 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.03 0.932 . . . . 0.0 112.43 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.508 HD13 ' HG3' ' A' ' 62' ' ' ARG . 26.6 mt -65.7 -27.17 68.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.977 0.911 . . . . 0.0 112.56 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -71.5 -16.85 62.36 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.445 0 C-N-CA 124.843 1.257 . . . . 0.0 110.656 -179.19 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.713 0 CA-C-O 121.184 0.325 . . . . 0.0 112.343 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.76 124.74 61.42 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.903 0.881 . . . . 0.0 110.342 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.97 168.33 23.61 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.952 2.435 . . . . 0.0 111.322 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.34 151.86 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.369 0.668 . . . . 0.0 109.578 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -117.54 69.19 0.77 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.72 -28.58 13.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.337 0.655 . . . . 0.0 110.825 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.69 -37.07 65.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -71.26 -14.18 62.15 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.077 0.551 . . . . 0.0 111.782 -171.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp -75.25 -53.28 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.591 0.756 . . . . 0.0 109.219 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.97 92.57 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.485 1.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.937 -175.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.9 t80 . . . . . 0 CA--C 1.537 0.474 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.87 155.0 51.97 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.553 1.141 . . . . 0.0 108.601 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.69 108.97 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.643 2.229 . . . . 0.0 112.532 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.23 11.57 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.496 0.569 . . . . 0.0 113.354 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -148.28 141.95 25.55 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.632 0.73 . . . . 0.0 112.191 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.89 139.86 53.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.179 . . . . 0.0 108.347 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -128.56 117.5 21.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -120.6 110.05 15.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.837 0.855 . . . . 0.0 110.039 -179.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m . . . . . 0 N--CA 1.482 1.125 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 168.31 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 . . . . . 0 C--O 1.241 0.634 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.97 59.08 4.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.503 0.721 . . . . 0.0 110.424 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.508 HG22 HG23 ' A' ' 49' ' ' ILE . 2.3 pp -89.9 121.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 173.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -150.65 116.58 5.57 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.547 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 25.8 mt -138.61 145.08 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.323 1.049 . . . . 0.0 108.181 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -132.44 127.14 34.68 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.55 HG12 ' HG2' ' A' ' 45' ' ' MET . 52.3 mt -109.74 123.44 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 108.675 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 14.0 mmm180 -109.54 117.89 35.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.863 0.865 . . . . 0.0 109.088 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -111.43 119.61 39.39 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -122.06 113.92 20.21 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.945 0.898 . . . . 0.0 109.346 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.69 121.72 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 122.701 0.4 . . . . 0.0 110.434 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -140.53 162.86 34.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.559 1.144 . . . . 0.0 108.102 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -111.19 117.56 33.56 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.832 0.453 . . . . 0.0 109.825 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.579 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -102.46 147.32 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.983 0.913 . . . . 0.0 109.93 172.046 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.24 -20.55 63.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.326 0.65 . . . . 0.0 111.692 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -70.15 -53.62 16.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.883 0.873 . . . . 0.0 111.626 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.472 ' HB2' HD21 ' A' ' 34' ' ' ASN . 13.9 m -119.21 0.88 11.28 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -170.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.3 -119.27 4.84 Favored Glycine 0 C--N 1.345 1.037 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.44 144.72 44.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.224 0.512 . . . . 0.0 110.473 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 p90 -158.36 169.88 23.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.5 0.5 . . . . 0.0 110.501 171.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.18 133.24 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -96.91 133.18 41.88 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.4 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 83.8 m-85 -119.01 135.08 54.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.758 0.423 . . . . 0.0 110.036 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 22.9 m-20 -115.85 139.47 50.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.45 1.1 . . . . 0.0 108.948 173.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.55 ' HG2' HG12 ' A' ' 27' ' ' ILE . 84.4 mtp -135.18 128.47 32.09 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 158.09 32.87 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.742 0.817 . . . . 0.0 109.046 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.92 -126.28 2.02 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -159.31 163.29 35.82 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 23' ' ' ILE . 44.1 mt -157.32 107.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 -166.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.34 39.01 5.49 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.325 1.059 . . . . 0.0 108.493 -166.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.76 -17.96 2.54 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.27 123.03 69.3 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.011 0.905 . . . . 0.0 110.273 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.27 152.8 56.09 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.815 2.343 . . . . 0.0 113.437 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -144.67 146.68 32.36 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.75 0.82 . . . . 0.0 108.875 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -145.45 114.52 6.99 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.262 0.625 . . . . 0.0 109.421 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.53 160.23 38.08 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.079 1.352 . . . . 0.0 108.957 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 p -152.21 136.39 16.58 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.08 0.552 . . . . 0.0 110.01 172.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -136.56 141.48 43.34 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.162 0.985 . . . . 0.0 109.607 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -115.31 125.04 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . 0.4 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 96.9 mt -115.06 125.56 28.81 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 123.389 0.676 . . . . 0.0 109.184 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 33.4 Cg_endo -60.79 156.52 42.8 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.888 2.392 . . . . 0.0 111.703 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -41.53 -44.85 3.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.919 1.288 . . . . 0.0 112.818 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.69 -25.4 66.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.749 1.22 . . . . 0.0 112.503 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.7 p -132.04 17.91 4.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.873 0.869 . . . . 0.0 110.728 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.34 -44.06 76.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.884 0.474 . . . . 0.0 111.453 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.26 -4.79 23.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.135 0.974 . . . . 0.0 112.674 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.51 4.6 15.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.88 0.872 . . . . 0.0 111.407 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -63.37 -19.47 64.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.432 1.093 . . . . 0.0 113.115 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.17 56.5 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.231 0.539 . . . . 0.0 109.926 -167.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -71.53 -39.07 70.97 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.366 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 75' ' ' VAL . 21.6 t70 -74.6 -49.22 22.5 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.478 0.486 . . . . 0.0 111.375 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.94 83.05 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.513 0.725 . . . . 0.0 112.412 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 m -66.67 -43.39 84.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.649 0.38 . . . . 0.0 110.264 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.0 ttm180 -52.8 -38.63 61.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.133 0.973 . . . . 0.0 111.751 171.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -71.11 -38.88 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.346 0.658 . . . . 0.0 109.552 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.73 -49.64 51.21 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 -173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.437 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 21.1 pt20 -70.1 -24.36 63.2 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.863 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.8 -30.0 69.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.353 0.661 . . . . 0.0 110.929 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.492 ' HB2' HD12 ' A' ' 49' ' ' ILE . 54.7 m80 -99.78 10.59 41.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.214 0.606 . . . . 0.0 110.85 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.59 43.9 5.37 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.935 174.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.437 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 38.7 tp . . . . . 0 N--CA 1.482 1.128 0 CA-C-O 121.292 0.568 . . . . 0.0 109.634 171.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.4 t80 . . . . . 0 C--O 1.21 -1.017 0 CA-C-O 118.619 -0.705 . . . . 0.0 111.004 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -57.91 -40.04 79.42 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.37 -45.58 54.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.419 0.288 . . . . 0.0 111.18 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.41 -34.05 76.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.537 0.735 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.49 -51.09 71.35 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.525 1.13 . . . . 0.0 109.824 172.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.482 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 34.1 mt-10 -69.52 -26.79 64.69 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.943 0.777 . . . . 0.0 111.429 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 14.3 t70 -70.98 -55.37 8.47 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.45 0.469 . . . . 0.0 109.803 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.19 -40.73 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.724 0.809 . . . . 0.0 112.056 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -63.01 -30.34 71.53 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.121 0.486 . . . . 0.0 110.521 177.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.045 179.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.3 mmmt -59.24 -40.07 84.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.857 0.863 . . . . 0.0 112.009 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.71 -28.22 69.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.586 0.755 . . . . 0.0 111.917 174.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -77.64 -16.79 58.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.133 0.573 . . . . 0.0 111.146 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.454 0 C-N-CA 126.094 1.758 . . . . 0.0 110.413 179.664 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.237 0.338 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 128.11 90.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.562 0.745 . . . . 0.0 111.283 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.45 106.43 1.05 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.246 1.964 . . . . 0.0 112.206 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.26 148.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -124.67 18.09 8.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -171.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.47 -36.02 79.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.563 0.345 . . . . 0.0 111.565 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.61 -30.23 29.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.231 0.612 . . . . 0.0 110.666 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -66.16 -28.29 68.67 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.423 0.689 . . . . 0.0 111.336 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.76 -30.35 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.241 0.616 . . . . 0.0 109.998 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.7 mt -76.67 80.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.608 0.718 . . . . 0.0 109.609 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 . . . . . 0 C--O 1.243 0.738 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.094 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 t80 . . . . . 0 N--CA 1.47 0.548 0 N-CA-C 109.391 -0.596 . . . . 0.0 109.391 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.78 153.48 70.44 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.309 1.044 . . . . 0.0 108.935 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.15 109.92 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.41 -8.4 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-O 120.25 -0.195 . . . . 0.0 112.666 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.547 ' NE2' ' HB3' ' A' ' 26' ' ' HIS . 11.3 t-160 -160.02 126.01 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.321 0.581 . . . . 0.0 110.437 -173.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 tp -100.95 145.63 28.41 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.49 1.116 . . . . 0.0 109.03 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 2.6 t-160 -124.85 117.34 23.91 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 170.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 89.5 mt -89.91 110.04 21.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.7 t . . . . . 0 N--CA 1.481 1.121 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.513 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 N--CA 1.485 1.321 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.82 55.12 3.24 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.014 0.912 . . . . 0.0 110.529 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.542 HG22 HG23 ' A' ' 49' ' ' ILE . 2.2 pp -87.95 115.32 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.464 HD21 ' HG3' ' A' ' 48' ' ' GLU . 5.9 p30 -146.01 110.21 4.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.0 mt -130.01 141.21 46.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.613 -166.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 45' ' ' MET . 19.1 m170 -107.4 122.21 46.15 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.449 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -123.07 109.6 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 17.7 ttt180 -91.41 133.29 35.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -123.9 118.62 27.5 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.19 113.12 13.47 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 41' ' ' VAL . 91.1 t -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 15.6 ttt180 -127.9 161.07 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.41 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.6 mm-40 -111.27 114.34 27.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -96.04 154.76 17.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.915 0.886 . . . . 0.0 110.503 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.32 -16.19 61.89 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.02 0.528 . . . . 0.0 111.952 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.08 -53.1 11.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.702 0.801 . . . . 0.0 111.981 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.8 t -126.55 -1.11 6.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.4 0.68 . . . . 0.0 112.461 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.57 -114.47 4.16 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 145.19 42.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.176 0.488 . . . . 0.0 110.817 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -153.27 171.91 17.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 31' ' ' VAL . 7.1 t -124.32 128.02 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 8.5 t60 -84.48 123.4 30.22 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 94.0 m-85 -115.88 140.11 49.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.279 0.632 . . . . 0.0 109.47 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -143.41 137.9 28.98 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.346 172.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.595 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 83.7 mtp -123.17 136.91 54.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 111.114 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -163.47 162.77 24.85 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.125 0.57 . . . . 0.0 110.958 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.11 -130.47 3.73 Favored Glycine 0 N--CA 1.469 0.864 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.464 ' HG3' HD21 ' A' ' 24' ' ' ASN . 10.4 pt-20 -157.89 166.32 32.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.686 0.794 . . . . 0.0 110.08 173.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 23' ' ' ILE . 97.3 mt -155.77 105.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -161.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 60.67 35.34 19.83 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.098 0.951 . . . . 0.0 108.739 -170.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.17 -22.26 8.73 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 114.563 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -77.84 113.75 35.43 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.891 0.877 . . . . 0.0 111.148 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.41 154.13 40.38 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.143 2.562 . . . . 0.0 113.122 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . 0.423 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 11.8 p90 -152.69 156.42 39.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.712 0.405 . . . . 0.0 111.282 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 p -153.11 124.52 7.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.858 0.863 . . . . 0.0 110.264 168.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -144.72 165.25 28.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.397 1.479 . . . . 0.0 108.524 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 p -153.2 142.06 21.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.723 0.409 . . . . 0.0 110.7 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -144.03 141.06 29.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.834 0.853 . . . . 0.0 110.154 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 44.6 mt-10 -125.55 125.38 43.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.23 132.54 24.19 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -171.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.78 160.86 34.86 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.646 2.231 . . . . 0.0 111.175 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -51.75 -28.4 15.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.03 -37.96 89.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.927 0.891 . . . . 0.0 112.161 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.7 p -126.72 12.84 7.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.098 0.559 . . . . 0.0 112.061 -171.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.46 76.48 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.201 0.6 . . . . 0.0 111.831 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -69.89 -11.49 60.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.384 1.074 . . . . 0.0 113.667 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -83.61 1.59 41.5 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.145 0.578 . . . . 0.0 111.73 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -54.89 -25.61 30.17 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.227 1.411 . . . . 0.0 113.937 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.22 -33.27 61.35 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -167.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 m -69.69 -38.24 76.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.473 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -72.09 -46.62 56.07 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.507 0.505 . . . . 0.0 110.027 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -58.06 -50.81 72.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.56 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 m -69.15 -23.24 63.93 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 0.0 111.533 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.5 ttp-105 -74.46 -34.03 63.06 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.107 0.479 . . . . 0.0 110.465 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.77 -32.56 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 109.908 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.66 -54.35 7.11 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.043 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.435 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 21.2 mm-40 -62.49 -22.86 66.58 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.253 -1.339 . . . . 0.0 112.935 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -48.6 -36.45 15.7 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.209 0.604 . . . . 0.0 112.08 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -108.11 -31.27 8.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.738 0.245 . . . . 0.0 110.527 170.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.59 94.35 0.53 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 160.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.435 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 52.7 tp . . . . . 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 110.109 179.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.6 t80 . . . . . 0 CA--C 1.537 0.476 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.39 -33.7 76.11 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.008 0.817 . . . . 0.0 110.728 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.55 61.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.937 0.495 . . . . 0.0 110.961 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.6 ttm -68.04 -34.39 76.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.372 0.669 . . . . 0.0 111.459 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -55.26 -47.27 75.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.311 1.045 . . . . 0.0 110.044 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.3 -25.57 60.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.0 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.4 -60.85 2.67 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.432 HG22 HD22 ' A' ' 106' ' ' LEU . 72.6 mt -54.75 -40.99 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.084 0.954 . . . . 0.0 111.729 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -31.39 72.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 123.207 0.317 . . . . 0.0 111.61 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.08 -51.65 56.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.394 0.677 . . . . 0.0 111.535 -176.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -28.19 62.41 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.973 0.509 . . . . 0.0 110.542 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.432 HD22 HG22 ' A' ' 102' ' ' ILE . 6.0 mp -71.77 -28.76 63.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.572 0.349 . . . . 0.0 110.447 175.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -81.51 -17.06 49.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.252 1.021 . . . . 0.0 109.643 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.256 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -177.681 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.521 0.446 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.58 159.99 69.37 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.257 1.023 . . . . 0.0 110.319 -172.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.62 124.99 15.15 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.674 2.249 . . . . 0.0 111.414 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.89 131.16 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 122.961 0.504 . . . . 0.0 109.902 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -94.88 3.05 55.42 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 118.439 -0.791 . . . . 0.0 113.009 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -53.11 -34.88 58.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.762 0.664 . . . . 0.0 111.416 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.54 87.34 2.34 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 166.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -133.39 29.62 3.94 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.9 mm -106.74 -53.39 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.296 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.9 mm -87.97 74.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? . . . . . 0 N--CA 1.476 0.842 0 C-N-CA 124.342 1.057 . . . . 0.0 109.699 177.214 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.7 t80 . . . . . 0 N--CA 1.47 0.575 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.85 157.14 34.5 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.486 1.114 . . . . 0.0 108.356 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.71 102.78 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.919 1.746 . . . . 0.0 111.651 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.34 -8.62 24.61 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.338 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -157.8 151.66 24.09 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.529 0.664 . . . . 0.0 111.898 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.7 tp -140.51 142.27 35.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.596 1.558 . . . . 0.0 108.382 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -111.7 138.25 48.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.587 0.755 . . . . 0.0 109.265 173.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 75.3 mt -118.53 126.65 52.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.076 0.95 . . . . 0.0 109.145 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.8 t . . . . . 0 C--O 1.248 1.012 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 164.933 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 . . . . . 0 N--CA 1.483 1.222 0 CA-C-O 120.735 0.303 . . . . 0.0 111.234 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.73 84.68 6.76 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 -171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.488 HG22 HG23 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -106.97 145.71 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.432 -175.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -151.74 138.13 18.53 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.17 166.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 53.5 mt -142.64 136.49 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.4 m170 -107.34 136.19 47.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.7 mt -130.44 108.47 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 26.2 mtp180 -92.97 134.63 34.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -129.38 117.11 20.06 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -132.74 117.14 17.45 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.55 0.74 . . . . 0.0 109.438 -171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 41' ' ' VAL . 48.0 t -80.03 115.67 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 24.5 ttt180 -120.98 162.4 19.97 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.436 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.3 mm-40 -106.55 124.85 50.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.054 -0.404 . . . . 0.0 110.277 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -94.98 144.25 25.83 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -12.84 61.87 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.467 0.707 . . . . 0.0 112.089 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -79.62 -49.91 11.45 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.006 0.922 . . . . 0.0 112.488 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t -128.8 -4.8 5.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.759 0.823 . . . . 0.0 111.543 -169.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.57 -118.34 5.55 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.96 138.01 47.72 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.049 0.54 . . . . 0.0 112.335 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.92 171.13 18.79 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.176 0.99 . . . . 0.0 109.083 170.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 31' ' ' VAL . 30.5 t -120.77 127.68 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 122.892 0.477 . . . . 0.0 110.169 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.432 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.6 t60 -88.93 108.67 19.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.53 135.39 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 24.7 t70 -125.82 136.05 52.68 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.384 1.073 . . . . 0.0 108.545 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 87.0 mtp -136.32 131.19 34.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.463 0.574 . . . . 0.0 110.496 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -155.62 162.2 40.67 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 122.772 0.429 . . . . 0.0 111.523 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.09 -151.07 21.94 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.66 111.07 4.7 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.122 0.961 . . . . 0.0 111.172 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.488 HG23 HG22 ' A' ' 23' ' ' ILE . 74.2 mt -97.61 125.47 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.605 177.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 63.24 25.57 14.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.11 1.364 . . . . 0.0 109.687 -170.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.2 4.35 90.5 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.294 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -94.59 110.44 49.11 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.899 0.88 . . . . 0.0 111.724 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.37 140.82 45.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.829 2.353 . . . . 0.0 112.209 -175.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.4 145.63 35.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.143 0.577 . . . . 0.0 109.958 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 p -140.56 115.15 9.47 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.93 152.45 39.44 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -174.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -147.57 155.9 42.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.136 0.575 . . . . 0.0 111.189 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.92 147.35 31.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.914 0.886 . . . . 0.0 109.88 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 41.2 mt-10 -124.89 128.09 48.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.924 0.889 . . . . 0.0 109.273 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.58 123.87 21.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 123.913 0.885 . . . . 0.0 109.326 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.52 164.57 20.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.782 2.321 . . . . 0.0 112.199 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.682 ' HG3' ' HB3' ' A' ' 106' ' ' LEU . 37.6 ttt180 -44.66 -33.72 1.94 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.776 1.23 . . . . 0.0 113.773 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.31 -36.68 71.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.418 0.687 . . . . 0.0 111.569 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -118.53 9.65 12.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.465 0.706 . . . . 0.0 110.853 -170.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.48 -29.06 65.93 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.675 0.79 . . . . 0.0 111.235 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.11 -8.69 55.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.283 1.433 . . . . 0.0 113.294 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -90.69 8.03 36.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.113 0.965 . . . . 0.0 110.764 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -51.34 -45.4 62.29 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.34 71.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 m -65.98 -50.32 64.72 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.377 0.535 . . . . 0.0 110.336 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.5 m-20 -70.94 -48.93 50.75 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.425 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.9 -51.01 56.1 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.171 0.988 . . . . 0.0 112.066 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.0 m -59.86 -43.56 94.62 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.456 0.703 . . . . 0.0 111.34 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -58.87 -48.48 81.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.892 0.877 . . . . 0.0 110.49 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 71' ' ' ASP . 63.6 t -62.66 -35.0 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.664 0.786 . . . . 0.0 110.429 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.01 -53.41 14.89 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 110.704 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.502 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 14.0 pt20 -71.2 -34.29 70.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.778 -171.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -60.86 -32.58 72.0 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.553 0.533 . . . . 0.0 110.759 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -92.58 15.47 14.2 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.15 0.58 . . . . 0.0 111.676 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.15 62.95 0.84 Allowed Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 3.5 mm? . . . . . 0 N--CA 1.484 1.254 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 162.656 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 N--CA 1.478 0.934 0 CA-C-O 119.645 -0.216 . . . . 0.0 110.625 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.934 0.771 . . . . 0.0 111.932 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.86 -49.77 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.3 ttm -64.2 -35.15 79.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 111.243 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -61.32 -51.41 68.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.498 1.119 . . . . 0.0 110.422 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.94 -28.67 67.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 37.6 t70 -71.67 -47.7 52.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . 0.464 ' O ' HD23 ' A' ' 106' ' ' LEU . 42.0 mt -58.74 -44.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.809 0.843 . . . . 0.0 111.563 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -62.89 -28.78 70.27 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.36 14.92 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.814 0.846 . . . . 0.0 111.911 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.0 mmmt -58.86 -42.59 89.76 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.21 1.004 . . . . 0.0 112.43 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.682 ' HB3' ' HG3' ' A' ' 62' ' ' ARG . 4.4 mm? -71.52 -22.22 61.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.604 0.761 . . . . 0.0 112.067 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -75.23 -24.61 57.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.689 0.396 . . . . 0.0 110.474 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.832 0 C-N-CA 125.701 1.6 . . . . 0.0 110.624 -174.944 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.526 0.725 0 N-CA-C 113.494 0.157 . . . . 0.0 113.494 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.57 148.93 70.72 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -171.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -56.35 164.41 5.39 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.843 3.029 . . . . 0.0 114.123 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.53 122.48 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-O 121.459 0.647 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.53 27.83 1.06 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.832 0.853 . . . . 0.0 112.406 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.03 -30.22 71.18 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.471 0.308 . . . . 0.0 110.657 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.63 9.23 40.99 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.897 0.879 . . . . 0.0 111.929 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -76.43 -9.3 58.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.313 0.578 . . . . 0.0 111.412 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.76 -39.71 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.26 1.024 . . . . 0.0 109.681 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.1 mt -112.12 89.08 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 . . . . . 0 N--CA 1.483 1.182 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.702 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 t80 . . . . . 0 N--CA 1.478 0.952 0 CA-C-O 121.082 0.468 . . . . 0.0 111.747 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.38 154.69 73.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 125.335 1.454 . . . . 0.0 107.894 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.82 99.45 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.284 1.99 . . . . 0.0 111.917 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.43 -18.49 6.84 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.542 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . 0.543 ' NE2' ' HB3' ' A' ' 26' ' ' HIS . 20.8 t-80 -158.27 151.25 22.67 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.246 0.523 . . . . 0.0 111.793 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 27' ' ' ILE . 54.4 tp -134.61 150.04 50.65 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.001 1.32 . . . . 0.0 108.509 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -124.15 139.67 53.71 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.534 0.734 . . . . 0.0 109.24 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.48 128.01 48.33 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 p . . . . . 0 CA--C 1.554 1.131 0 CA-C-O 122.728 1.251 . . . . 0.0 112.526 -175.0 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.496 HE21 HG22 ' A' ' 23' ' ' ILE . 55.9 tp60 . . . . . 0 CA--C 1.543 0.701 0 CA-C-O 122.748 1.261 . . . . 0.0 112.833 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.49 113.33 26.02 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.886 173.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.496 HG22 HE21 ' A' ' 21' ' ' GLN . 0.6 OUTLIER -120.38 132.3 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -139.82 119.63 13.38 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.2 mt -143.66 151.52 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -170.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.543 ' HB3' ' NE2' ' A' ' 9' ' ' HIS . 15.1 m170 -126.61 146.53 50.13 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.551 HD12 HD23 ' A' ' 10' ' ' LEU . 60.2 mt -125.77 106.44 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -97.33 132.61 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.02 125.24 26.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -127.32 115.55 19.17 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 41' ' ' VAL . 47.0 t -86.93 115.21 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 51.1 ttt85 -125.17 163.64 22.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.7 mm-40 -112.87 112.55 24.1 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.483 HD21 ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -95.42 144.34 26.02 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.343 0.657 . . . . 0.0 109.511 171.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -19.09 65.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.121 0.569 . . . . 0.0 111.432 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.81 -52.15 40.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.749 1.22 . . . . 0.0 112.091 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.483 ' HB3' HD21 ' A' ' 34' ' ' ASN . 32.6 t -123.4 -14.52 7.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -172.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -125.97 8.69 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.67 134.53 50.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.817 0.447 . . . . 0.0 110.773 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.1 170.82 19.0 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.553 0.741 . . . . 0.0 109.21 170.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 31' ' ' VAL . 4.8 t -127.69 121.9 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -89.52 121.34 31.64 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -107.39 137.93 44.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.402 0.681 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -126.9 123.3 36.92 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtp -118.88 130.03 55.52 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.279 0.491 . . . . 0.0 110.391 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.92 159.84 43.0 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 0.0 110.713 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.4 -147.11 12.49 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 0.8 OUTLIER -148.45 108.29 4.03 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.303 1.051 . . . . 0.0 111.653 172.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.59 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.22 16.67 9.37 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 124.545 1.153 . . . . 0.0 110.5 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.36 -15.22 59.08 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.088 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 95.6 mttt -83.28 109.93 20.76 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.816 0.847 . . . . 0.0 112.748 -173.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.2 138.67 33.77 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.324 2.016 . . . . 0.0 110.601 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -145.47 155.7 43.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.524 0.33 . . . . 0.0 110.824 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 p -150.56 130.06 13.01 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.978 0.911 . . . . 0.0 108.969 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -144.91 157.29 44.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -176.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 m -143.62 142.14 30.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.917 0.487 . . . . 0.0 110.969 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -141.11 146.58 37.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.882 0.873 . . . . 0.0 109.077 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.22 129.81 49.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.87 122.0 24.41 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.48 163.95 25.17 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.767 2.312 . . . . 0.0 111.089 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.487 ' HG3' HD13 ' A' ' 106' ' ' LEU . 61.7 ttt180 -48.6 -30.62 5.56 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.761 0.825 . . . . 0.0 111.568 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.77 -40.52 80.0 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.766 1.226 . . . . 0.0 112.726 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 p -128.36 14.23 6.62 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.594 0.758 . . . . 0.0 111.87 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' PHE . . . -63.74 -29.38 70.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.541 0.737 . . . . 0.0 111.66 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . 0.653 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 71.6 m-85 -70.77 -1.13 10.53 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -96.53 5.42 50.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.958 0.903 . . . . 0.0 110.269 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 25.7 p90 -53.72 -49.66 67.64 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.632 1.173 . . . . 0.0 112.474 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.04 -29.8 60.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.591 0.756 . . . . 0.0 111.087 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -71.35 -45.34 63.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.003 0.814 . . . . 0.0 109.209 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.26 -41.01 64.16 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.878 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.55 56.33 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.504 0.722 . . . . 0.0 112.42 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 95.2 m -71.18 -43.24 67.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.708 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 44.7 ttt180 -55.66 -53.21 59.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.515 1.126 . . . . 0.0 111.734 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 8.5 p -69.78 -32.17 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.489 0.716 . . . . 0.0 111.381 -178.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.04 82.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.415 0.626 . . . . 0.0 110.429 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.789 ' HA ' HD22 ' A' ' 81' ' ' LEU . 96.3 mt-30 -76.32 -40.09 52.33 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.387 -1.278 . . . . 0.0 112.361 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.7 mtpp -53.18 -35.63 60.04 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.024 0.93 . . . . 0.0 112.45 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -79.6 25.07 0.35 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.48 59.45 10.82 Favored Glycine 0 C--N 1.363 2.079 0 C-N-CA 123.275 0.464 . . . . 0.0 114.141 174.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.789 HD22 ' HA ' ' A' ' 77' ' ' GLN . 1.2 pt? . . . . . 0 N--CA 1.475 0.808 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.658 -174.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 . . . . . 0 C--O 1.218 -0.565 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.97 -39.1 73.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.21 1.004 . . . . 0.0 112.085 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.29 -50.53 67.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.737 0.415 . . . . 0.0 110.813 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.1 ttm -70.76 -31.28 68.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.617 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.73 -56.11 18.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 6.0 mm-40 -69.82 -28.28 65.58 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.658 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.23 -49.35 61.3 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.93 -42.77 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.441 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . 0.653 ' HB3' ' HE1' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -65.94 -31.18 71.95 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.464 0.575 . . . . 0.0 111.563 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.91 84.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.66 -28.77 62.93 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.845 0.858 . . . . 0.0 112.805 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 62' ' ' ARG . 89.3 mt -63.98 -34.11 77.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.392 0.677 . . . . 0.0 110.572 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -68.69 -17.95 64.17 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.607 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.449 0 C-N-CA 126.379 1.871 . . . . 0.0 109.583 -175.712 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.463 0.468 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.72 159.38 83.32 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.241 1.016 . . . . 0.0 112.604 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 26.5 Cg_endo -59.13 96.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.237 2.625 . . . . 0.0 113.706 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -167.74 136.58 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.708 0.803 . . . . 0.0 109.75 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -127.5 41.83 3.44 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.075 0.95 . . . . 0.0 110.157 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.38 -35.61 77.96 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.726 0.81 . . . . 0.0 112.042 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.45 -6.43 52.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.862 0.865 . . . . 0.0 111.504 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -77.4 5.01 9.56 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 122.156 -0.34 . . . . 0.0 111.817 -174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.6 mm -77.19 -64.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.396 0.679 . . . . 0.0 110.062 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.3 mt -108.74 105.82 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.906 0.882 . . . . 0.0 108.83 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 . . . . . 0 N--CA 1.472 0.665 0 C-N-CA 123.66 0.784 . . . . 0.0 109.6 177.819 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.2 t80 . . . . . 0 N--CA 1.478 0.956 0 N-CA-C 109.979 -0.378 . . . . 0.0 109.979 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.04 152.33 23.41 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.342 1.057 . . . . 0.0 109.376 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.07 96.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.862 2.375 . . . . 0.0 112.749 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.57 -22.11 5.28 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.961 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -155.26 151.6 28.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.473 HD22 ' SD ' ' A' ' 98' ' ' MET . 55.4 tp -135.88 131.47 35.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.747 1.619 . . . . 0.0 107.411 176.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -113.82 139.96 48.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.554 0.741 . . . . 0.0 110.452 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 30.3 mt -134.15 124.72 26.54 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p . . . . . 0 N--CA 1.487 1.389 0 CA-C-N 120.192 1.36 . . . . 0.0 114.325 -174.345 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HG3' HG23 ' A' ' 23' ' ' ILE . 20.1 pt20 . . . . . 0 C--O 1.244 0.793 0 CA-C-O 120.932 0.396 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.52 100.94 7.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ILE . . . . . 0.438 HG23 ' HG3' ' A' ' 21' ' ' GLN . 19.2 pt -117.0 145.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.22 0.534 . . . . 0.0 109.954 169.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . 0.52 HD21 ' HG2' ' A' ' 48' ' ' GLU . 4.4 p30 -152.92 125.94 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 163.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.7 mt -139.32 116.3 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.5 m170 -104.25 122.69 45.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ILE . . . . . 0.516 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 57.3 mt -114.88 105.34 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 44' ' ' ASP . 67.2 ttt180 -97.89 140.4 32.3 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.729 1.212 . . . . 0.0 108.478 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.41 136.38 36.21 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -131.52 116.04 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.375 1.07 . . . . 0.0 108.419 -172.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 105' ' ' LYS . 72.8 t -87.01 123.66 40.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 19.2 ttt180 -153.14 169.25 23.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.476 1.111 . . . . 0.0 108.759 -170.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLN . . . . . 0.473 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 23.2 mm-40 -106.68 127.0 53.0 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.32 0.648 . . . . 0.0 110.225 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . 0.452 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 3.1 p30 -102.96 147.69 26.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.35 1.06 . . . . 0.0 108.896 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.16 -20.23 62.32 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' GLU . . . . . 0.452 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 10.6 tp10 -71.09 -48.18 53.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.9 0.88 . . . . 0.0 111.677 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.5 m -131.47 -6.91 3.73 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.492 0.717 . . . . 0.0 112.905 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.94 -124.17 8.08 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -68.5 137.14 54.16 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.403 0.602 . . . . 0.0 111.286 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -155.91 178.37 10.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.492 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 31' ' ' VAL . 20.2 t -133.44 127.85 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.778 0.831 . . . . 0.0 109.397 173.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -89.31 121.43 31.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.831 0.852 . . . . 0.0 108.912 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -102.8 133.22 48.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 108.913 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 27.1 t70 -133.48 114.15 13.3 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.023 0.929 . . . . 0.0 109.883 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' A' ' 27' ' ' ILE . 43.4 mtm -119.86 145.43 46.68 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.736 -0.603 . . . . 0.0 111.451 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -156.93 157.9 35.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.146 0.578 . . . . 0.0 111.24 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.85 -156.05 27.48 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLU . . . . . 0.52 ' HG2' HD21 ' A' ' 24' ' ' ASN . 12.5 pt-20 -148.28 115.19 6.08 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.845 1.322 . . . . 0.0 111.411 173.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 79' ' ' HIS . 50.5 mt -97.74 130.69 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.212 176.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.33 -69.88 0.1 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.159 1.783 . . . . 0.0 110.617 -168.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.27 47.21 0.11 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.597 -2.201 . . . . 0.0 107.597 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -137.07 104.29 8.82 Favored Pre-proline 0 C--N 1.35 0.592 0 CA-C-N 114.261 -0.97 . . . . 0.0 108.91 -172.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 136.75 33.83 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.381 2.054 . . . . 0.0 110.834 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -135.35 138.02 42.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.2 p -134.14 118.22 17.44 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -132.74 139.73 47.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.276 1.03 . . . . 0.0 109.385 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.7 p -140.54 124.0 16.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -136.55 142.1 43.4 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.814 0.846 . . . . 0.0 108.782 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -121.33 130.58 53.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.423 0.689 . . . . 0.0 109.772 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.29 130.32 23.57 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.79 155.64 36.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.716 2.277 . . . . 0.0 111.187 171.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 32.3 ptt180 -41.85 -26.08 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -85.53 -13.61 48.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.753 0.821 . . . . 0.0 111.621 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.0 p -132.49 -2.4 3.43 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.404 1.082 . . . . 0.0 111.222 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.94 -36.71 72.92 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.552 1.141 . . . . 0.0 111.988 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.88 -9.43 54.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.374 1.07 . . . . 0.0 112.761 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -91.73 -7.57 49.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.315 0.646 . . . . 0.0 110.514 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PHE . . . . . 0.514 ' HZ ' ' SD ' ' A' ' 98' ' ' MET . 4.0 p90 -54.12 -35.78 62.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.602 0.761 . . . . 0.0 112.769 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.43 -26.56 20.49 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -72.49 -52.66 14.81 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 75' ' ' VAL . 38.9 t0 -73.14 -54.28 8.88 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.472 0.709 . . . . 0.0 112.799 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.03 -38.43 4.83 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.3 1.04 . . . . 0.0 113.041 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.9 m -77.27 -37.69 52.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.462 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.7 -47.98 81.27 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.946 0.898 . . . . 0.0 111.402 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 71' ' ' ASP . 41.5 t -61.25 -39.5 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.079 0.952 . . . . 0.0 110.264 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 25' ' ' ILE . . . -66.67 -44.7 81.14 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.857 0.863 . . . . 0.0 110.953 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLN . . . . . 0.415 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 5.3 pp0? -76.59 -26.85 55.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -59.77 -45.9 90.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.342 0.657 . . . . 0.0 111.968 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' HIS . . . . . 0.533 ' HB2' HD12 ' A' ' 49' ' ' ILE . 56.3 m80 -74.34 -30.35 61.98 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.42 80.34 0.04 OUTLIER Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 158.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 38.9 tp . . . . . 0 N--CA 1.477 0.906 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 178.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 . . . . . 0 C--O 1.214 -0.804 0 CA-C-O 119.288 -0.386 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.0 -35.9 67.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.042 0.537 . . . . 0.0 111.942 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 -44.69 69.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.541 0.686 . . . . 0.0 110.854 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' MET . . . . . 0.514 ' SD ' ' HZ ' ' A' ' 68' ' ' PHE . 39.7 ttp -60.46 -34.45 74.04 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.759 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -69.53 -53.87 16.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.153 0.981 . . . . 0.0 109.859 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.7 -28.68 69.58 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.941 0.776 . . . . 0.0 112.785 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.58 -54.78 16.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.936 0.495 . . . . 0.0 109.982 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.4 mt -62.43 -42.02 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.545 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.14 -31.38 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.7 0.682 . . . . 0.0 110.907 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.88 -41.61 64.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.593 177.654 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' LYS . . . . . 0.478 ' HB3' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.69 -47.94 80.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.646 0.779 . . . . 0.0 112.133 174.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.44 -39.04 88.67 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.683 0.615 . . . . 0.0 110.468 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -59.1 -31.9 69.33 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.244 1.017 . . . . 0.0 111.196 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.403 0 C-N-CA 125.397 1.479 . . . . 0.0 110.679 -176.236 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.973 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.17 154.73 94.35 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.627 1.171 . . . . 0.0 111.969 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.66 148.08 58.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.582 2.188 . . . . 0.0 111.945 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.73 152.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.728 0.811 . . . . 0.0 109.4 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.51 26.8 10.28 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.741 0.816 . . . . 0.0 111.651 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.5 -29.55 67.21 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.84 -2.23 53.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.302 0.641 . . . . 0.0 111.846 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.98 -9.48 58.65 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.588 0.755 . . . . 0.0 112.425 -170.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ILE . . . . . 0.41 ' N ' HD12 ' A' ' 119' ' ' ILE . 3.3 mp -88.51 67.42 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 121.524 0.678 . . . . 0.0 109.628 -174.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 mt 52.95 35.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 125.396 1.478 . . . . 0.0 112.528 166.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 . . . . . 0 N--CA 1.483 1.202 0 O-C-N 121.397 -0.814 . . . . 0.0 110.439 -178.437 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 20.1 pt20 . . . . . 0 N--CA 1.485 1.316 0 N-CA-C 111.93 0.345 . . . . 0.0 111.93 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.447 ' HA2' ' HB ' ' A' ' 13' ' ' VAL . . . 71.61 -85.11 0.44 Allowed Glycine 0 C--N 1.355 1.598 0 N-CA-C 111.778 -0.529 . . . . 0.0 111.778 179.385 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -84.41 141.76 30.61 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.287 0.635 . . . . 0.0 109.329 174.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.462 ' HB3' ' HB3' ' A' ' 11' ' ' HIS . 56.8 ttp -153.04 144.26 23.14 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 124.219 1.008 . . . . 0.0 108.682 -177.019 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -125.34 144.47 50.48 Favored 'General case' 0 N--CA 1.477 0.887 0 CA-C-O 120.912 0.387 . . . . 0.0 110.491 174.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -144.01 152.54 55.26 Favored Pre-proline 0 CA--C 1.554 1.125 0 C-N-CA 125.309 1.444 . . . . 0.0 107.929 175.19 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -65.3 97.15 0.29 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 121.769 1.646 . . . . 0.0 111.313 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.4 -15.3 6.08 Favored Glycine 0 CA--C 1.534 1.263 0 CA-C-N 115.725 -0.671 . . . . 0.0 113.636 -179.755 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.3 t-80 -160.83 153.75 21.22 Favored 'General case' 0 N--CA 1.489 1.51 0 CA-C-N 117.378 0.589 . . . . 0.0 112.202 -172.462 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.1 tt -135.6 125.74 26.2 Favored 'General case' 0 CA--C 1.552 1.056 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.462 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 11.4 t-160 -98.1 139.83 33.33 Favored 'General case' 0 N--CA 1.482 1.156 0 C-N-CA 124.315 1.046 . . . . 0.0 110.148 177.419 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.571 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 87.1 mt -132.26 117.89 18.78 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.728 0.811 . . . . 0.0 110.809 179.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.447 ' HB ' ' HA2' ' A' ' 2' ' ' GLY . 84.3 t -135.98 160.82 38.72 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.413 0 N-CA-C 105.628 -1.989 . . . . 0.0 105.628 162.489 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 25.8 t -92.2 125.45 36.88 Favored 'General case' 0 C--N 1.352 0.716 0 CA-C-N 120.068 1.304 . . . . 0.0 107.49 -176.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.2 pp -70.06 138.64 87.41 Favored Pre-proline 0 CA--C 1.554 1.125 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 -179.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -60.88 133.4 47.47 Favored 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 122.751 2.301 . . . . 0.0 111.962 -177.445 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 106.87 -31.79 7.87 Favored Glycine 0 C--N 1.34 0.773 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.913 -173.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 54.0 tp -77.75 -64.62 1.11 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 123.28 0.632 . . . . 0.0 110.263 -179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 34.0 t70 -156.79 109.6 2.55 Favored 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 123.389 0.676 . . . . 0.0 109.416 -178.838 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 1.9 mp0 -80.74 82.65 6.68 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-O 121.627 0.727 . . . . 0.0 109.798 179.188 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 29.6 tt0 -146.05 148.72 32.97 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 176.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -78.78 82.7 4.98 Favored 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 -178.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.483 HG22 HG23 ' A' ' 49' ' ' ILE . 1.3 pp -109.83 128.39 65.97 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 171.661 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 4.6 p30 -150.86 123.59 8.58 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 108.385 -0.969 . . . . 0.0 108.385 176.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.571 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 46.1 mt -140.47 140.52 34.1 Favored 'Isoleucine or valine' 0 C--O 1.238 0.492 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -171.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.526 ' O ' ' HA ' ' A' ' 45' ' ' MET . 6.6 m170 -114.24 134.29 55.03 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 106.085 -1.82 . . . . 0.0 106.085 171.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.418 HG12 ' HG2' ' A' ' 45' ' ' MET . 58.2 mt -123.5 105.76 16.2 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.853 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.18 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -102.87 132.69 48.9 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 179.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 50.3 p90 -129.25 123.73 32.68 Favored 'General case' 0 C--O 1.239 0.523 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 175.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -127.2 116.45 20.64 Favored 'General case' 0 C--O 1.235 0.32 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 41' ' ' VAL . 79.2 t -79.11 117.14 24.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -118.76 159.51 23.57 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.4 mm-40 -107.93 119.35 39.21 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 122.7 0.4 . . . . 0.0 109.928 178.097 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.559 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -99.53 148.8 23.89 Favored 'General case' 0 N--CA 1.483 1.188 0 C-N-CA 124.252 1.021 . . . . 0.0 109.152 168.655 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.49 -11.61 60.96 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 122.981 0.513 . . . . 0.0 111.972 178.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -75.99 -55.29 5.74 Favored 'General case' 0 CA--C 1.548 0.868 0 C-N-CA 123.841 0.856 . . . . 0.0 111.823 -179.193 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.479 ' HB3' HD21 ' A' ' 34' ' ' ASN . 35.7 t -114.63 -6.97 12.77 Favored 'General case' 0 N--CA 1.491 1.614 0 C-N-CA 123.236 0.614 . . . . 0.0 111.668 -174.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.41 -108.23 3.19 Favored Glycine 0 C--N 1.336 0.579 0 N-CA-C 109.571 -1.411 . . . . 0.0 109.571 -172.168 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.19 141.73 45.47 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 117.117 0.459 . . . . 0.0 111.289 174.264 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 7.7 p90 -156.64 166.87 32.15 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 123.929 0.891 . . . . 0.0 108.796 168.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.55 HG22 HG22 ' A' ' 31' ' ' VAL . 3.9 t -115.8 126.51 73.35 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.859 0 O-C-N 122.066 -0.396 . . . . 0.0 110.219 177.267 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.434 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 63.9 t60 -90.69 120.54 31.84 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.228 1.011 . . . . 0.0 108.7 170.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 -107.75 145.05 34.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.1 0.56 . . . . 0.0 110.336 179.114 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 23.1 m-20 -128.64 128.6 44.47 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 124.603 1.161 . . . . 0.0 108.672 171.703 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.526 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 82.7 mtp -123.82 129.41 50.98 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 118.1 0.409 . . . . 0.0 110.352 173.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -154.16 147.44 24.85 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 122.854 0.462 . . . . 0.0 111.425 -174.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 169.44 -151.18 16.75 Favored Glycine 0 N--CA 1.477 1.415 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 179.14 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -150.83 108.73 3.7 Favored 'General case' 0 N--CA 1.477 0.877 0 CA-C-N 118.895 1.348 . . . . 0.0 111.022 171.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.483 HG23 HG22 ' A' ' 23' ' ' ILE . 68.4 mt -100.76 127.97 53.35 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.263 0 CA-C-N 114.903 -1.044 . . . . 0.0 111.485 178.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 31.4 t70 63.22 22.16 13.21 Favored 'General case' 0 CA--C 1.554 1.103 0 C-N-CA 125.004 1.321 . . . . 0.0 109.167 -170.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.48 -3.41 87.07 Favored Glycine 0 C--N 1.354 1.556 0 CA-C-N 115.106 -0.952 . . . . 0.0 113.558 -175.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -86.51 109.98 28.14 Favored Pre-proline 0 C--N 1.354 0.786 0 C-N-CA 123.762 0.825 . . . . 0.0 112.003 -177.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 93.8 Cg_endo -73.68 141.95 31.62 Favored 'Trans proline' 0 C--N 1.376 1.995 0 C-N-CA 122.868 2.378 . . . . 0.0 111.96 -177.829 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 45.5 p90 -141.09 147.92 39.32 Favored 'General case' 0 N--CA 1.468 0.458 0 C-N-CA 123.141 0.577 . . . . 0.0 110.072 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 66.4 p -138.68 116.51 11.54 Favored 'General case' 0 C--O 1.239 0.527 0 N-CA-C 107.652 -1.24 . . . . 0.0 107.652 172.253 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -129.87 147.13 51.6 Favored 'General case' 0 N--CA 1.47 0.564 0 C-N-CA 124.591 1.157 . . . . 0.0 108.964 -171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 21.9 m -142.63 129.59 20.67 Favored 'General case' 0 N--CA 1.469 0.477 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 174.345 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 32.3 p90 -138.81 143.43 38.88 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.737 0.815 . . . . 0.0 109.019 178.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.434 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 62.4 mt-10 -126.38 133.6 51.26 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.365 0.666 . . . . 0.0 110.202 -174.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 72.0 mt -124.2 128.86 24.92 Favored Pre-proline 0 N--CA 1.47 0.556 0 C-N-CA 124.159 0.983 . . . . 0.0 109.231 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.435 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 44.7 Cg_endo -63.99 161.76 31.91 Favored 'Trans proline' 0 C--N 1.377 2.027 0 C-N-CA 122.75 2.3 . . . . 0.0 111.466 174.546 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 23.1 ptt-85 -44.91 -32.27 1.55 Allowed 'General case' 0 CA--C 1.563 1.473 0 C-N-CA 123.934 0.894 . . . . 0.0 113.161 176.383 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -70.53 -29.6 66.13 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 124.742 1.217 . . . . 0.0 112.443 -176.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.6 p -130.49 16.29 5.43 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.854 0.861 . . . . 0.0 110.319 -175.785 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.35 -43.18 98.44 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 123.353 0.661 . . . . 0.0 111.053 179.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 42.1 m-85 -73.46 -2.51 22.8 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.482 1.113 . . . . 0.0 112.566 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -88.48 2.08 53.54 Favored 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 123.686 0.794 . . . . 0.0 110.41 173.609 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.548 ' HE2' ' SD ' ' A' ' 98' ' ' MET . 12.3 p90 -54.39 -49.97 68.64 Favored 'General case' 0 C--N 1.357 0.919 0 C-N-CA 124.225 1.01 . . . . 0.0 112.528 -177.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -54.14 -28.44 39.99 Favored 'General case' 0 N--CA 1.482 1.158 0 N-CA-C 113.812 1.042 . . . . 0.0 113.812 -175.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 19.8 m -71.79 -51.88 20.4 Favored 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 122.768 0.427 . . . . 0.0 110.146 174.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 25.7 t70 -73.69 -52.24 13.95 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 112.53 0.567 . . . . 0.0 112.53 -174.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -48.23 -36.4 13.8 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 124.643 1.177 . . . . 0.0 112.865 175.311 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 71.4 m -75.8 -44.59 40.51 Favored 'General case' 0 CA--C 1.549 0.927 0 CA-C-N 116.132 -0.485 . . . . 0.0 111.0 174.303 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 28.2 ttt180 -56.02 -45.19 79.18 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.789 1.236 . . . . 0.0 112.002 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.05 -31.65 36.11 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.822 0 C-N-CA 123.765 0.826 . . . . 0.0 110.937 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.77 -43.15 80.49 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.127 0.571 . . . . 0.0 110.618 -179.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.61 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 18.3 pt20 -78.71 -25.82 44.76 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.295 -0.866 . . . . 0.0 111.258 -179.23 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.5 ttmm -65.76 -25.13 67.13 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.184 0.594 . . . . 0.0 110.422 169.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.415 ' HB3' HD12 ' A' ' 49' ' ' ILE . 26.2 m80 -86.67 0.73 54.0 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.302 0.641 . . . . 0.0 112.595 176.249 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 116.39 43.47 0.64 Allowed Glycine 0 N--CA 1.481 1.67 0 N-CA-C 115.542 0.977 . . . . 0.0 115.542 176.041 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.61 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 4.4 mm? -115.96 138.54 51.1 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 108.404 -0.961 . . . . 0.0 108.404 165.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 44.3 m170 -95.61 153.39 39.45 Favored Pre-proline 0 CA--C 1.547 0.836 0 C-N-CA 123.272 0.629 . . . . 0.0 109.545 171.669 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -59.03 -15.14 26.29 Favored 'Trans proline' 0 C--N 1.38 2.232 0 C-N-CA 123.239 2.626 . . . . 0.0 114.006 176.035 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 14.1 mmmm -66.16 -28.98 69.19 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.813 0.845 . . . . 0.0 111.019 177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 94.3 t80 -61.05 -32.16 71.79 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.607 1.163 . . . . 0.0 111.222 172.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 88.82 46.44 4.53 Favored Glycine 0 C--N 1.342 0.914 0 N-CA-C 111.004 -0.839 . . . . 0.0 111.004 -172.579 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -71.68 -74.27 0.16 Allowed 'General case' 0 CA--C 1.546 0.823 0 C-N-CA 122.988 0.515 . . . . 0.0 110.53 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.8 tt -101.11 -18.3 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.254 0 C-N-CA 123.414 0.686 . . . . 0.0 110.368 179.215 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 17.9 p -84.8 -2.15 57.32 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.314 1.046 . . . . 0.0 112.646 -175.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 20.9 tpt180 -103.16 118.77 37.53 Favored 'General case' 0 N--CA 1.473 0.721 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 18.6 m -69.8 97.12 0.47 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.834 0 N-CA-C 109.09 -0.708 . . . . 0.0 109.09 174.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 91.4 m-70 -66.13 107.02 1.79 Allowed 'General case' 0 C--N 1.35 0.592 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -179.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 10.3 mtmp? -73.5 -28.89 62.15 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 123.234 0.614 . . . . 0.0 110.795 -175.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -86.12 5.92 31.58 Favored 'General case' 0 N--CA 1.475 0.793 0 C-N-CA 123.926 0.89 . . . . 0.0 111.701 176.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 43.1 t80 -59.18 -38.72 80.51 Favored 'General case' 0 C--N 1.358 0.947 0 C-N-CA 122.899 0.479 . . . . 0.0 110.048 171.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -61.36 -32.9 72.81 Favored 'General case' 0 N--CA 1.479 1.004 0 O-C-N 123.747 0.654 . . . . 0.0 111.811 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.73 -44.59 66.53 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 123.381 0.673 . . . . 0.0 111.17 178.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.548 ' SD ' ' HE2' ' A' ' 68' ' ' PHE . 28.6 ttm -63.76 -39.83 95.21 Favored 'General case' 0 N--CA 1.483 1.221 0 C-N-CA 123.397 0.679 . . . . 0.0 111.844 172.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 73.8 t80 -58.52 -50.29 74.29 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 125.416 1.486 . . . . 0.0 110.679 179.477 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.506 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 11.9 pt-20 -70.55 -30.91 67.76 Favored 'General case' 0 CA--C 1.545 0.76 0 CA-C-N 115.742 -0.663 . . . . 0.0 111.67 -178.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.2 t70 -59.47 -54.4 47.11 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 173.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 61.9 mt -63.67 -38.03 81.21 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.064 0 C-N-CA 124.133 0.973 . . . . 0.0 112.62 -178.395 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.585 HH11 ' HB2' ' A' ' 104' ' ' ALA . 0.0 OUTLIER -69.74 -31.15 68.98 Favored 'General case' 0 N--CA 1.497 1.887 0 CA-C-N 119.202 0.91 . . . . 0.0 111.46 179.728 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.585 ' HB2' HH11 ' A' ' 103' ' ' ARG . . . -75.09 -44.7 45.89 Favored 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 122.561 0.345 . . . . 0.0 110.469 176.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 19.7 tptm -59.26 -42.78 91.96 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.924 1.29 . . . . 0.0 113.117 176.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.1 mp -61.94 -32.14 72.53 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.712 0.805 . . . . 0.0 111.412 173.42 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 t60 -80.7 -19.91 44.05 Favored 'General case' 0 CA--C 1.55 0.954 0 C-N-CA 122.962 0.505 . . . . 0.0 110.676 175.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 83.74 -46.74 0.12 Allowed 'General case' 0 N--CA 1.485 1.317 0 C-N-CA 126.689 1.996 . . . . 0.0 110.884 179.019 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 36.0 m-70 -92.15 143.24 27.24 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 175.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -67.85 160.14 49.69 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.66 2.24 . . . . 0.0 112.34 -179.102 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -170.73 64.66 0.16 Allowed Glycine 0 C--N 1.34 0.782 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -175.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.416 ' H ' ' CD ' ' A' ' 112' ' ' GLU . 0.4 OUTLIER -97.54 118.64 64.04 Favored Pre-proline 0 CA--C 1.55 0.975 0 C-N-CA 124.087 0.955 . . . . 0.0 109.945 -175.544 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -58.47 114.91 2.19 Favored 'Trans proline' 0 C--N 1.381 2.275 0 C-N-CA 123.288 2.659 . . . . 0.0 112.982 177.185 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 6.0 p -71.75 139.91 19.01 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.88 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.641 172.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -75.57 1.63 13.84 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.713 1.005 . . . . 0.0 113.713 -170.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -63.07 -33.83 76.29 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 118.876 0.762 . . . . 0.0 111.801 -175.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -70.63 -39.35 73.73 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.809 0.338 . . . . 0.0 110.219 174.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 8.9 tmm_? -60.34 -21.32 61.92 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 124.429 1.092 . . . . 0.0 111.535 -177.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 36.2 mm -75.97 -33.2 24.6 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.931 0 CA-C-O 121.366 0.603 . . . . 0.0 109.472 179.348 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.8 mp -82.49 -27.11 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.812 0 C-N-CA 123.893 0.877 . . . . 0.0 110.123 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 30.8 mmm180 -62.9 90.28 0.04 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.262 0.625 . . . . 0.0 111.745 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 1.5 p-80 -167.69 174.67 7.5 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 125.73 1.612 . . . . 0.0 108.888 177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -153.85 117.31 4.62 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 122.974 0.509 . . . . 0.0 109.904 179.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -176.87 -67.88 0.06 OUTLIER Glycine 0 C--N 1.342 0.913 0 N-CA-C 111.236 -0.746 . . . . 0.0 111.236 177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 CA--C 1.553 1.07 0 N-CA-C 108.158 -1.052 . . . . 0.0 108.158 177.605 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 120.885 0.374 . . . . 0.0 110.711 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 103.18 149.78 21.47 Favored Glycine 0 C--N 1.345 1.065 0 N-CA-C 110.728 -0.949 . . . . 0.0 110.728 -175.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 63.7 m80 -127.81 -77.83 0.57 Allowed 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 117.377 0.589 . . . . 0.0 110.115 -179.901 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 47.6 ttp -75.09 105.97 6.37 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.963 0.505 . . . . 0.0 109.792 -176.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 41.1 t80 -127.99 140.01 52.23 Favored 'General case' 0 N--CA 1.466 0.375 0 C-N-CA 123.917 0.887 . . . . 0.0 109.389 -178.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.48 151.61 25.81 Favored Pre-proline 0 CA--C 1.543 0.679 0 C-N-CA 123.96 0.904 . . . . 0.0 109.03 176.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_exo -56.42 92.92 0.05 OUTLIER 'Trans proline' 0 C--N 1.37 1.664 0 C-N-CA 122.654 2.236 . . . . 0.0 112.127 168.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 146.54 -40.61 1.03 Allowed Glycine 0 C--N 1.344 1.013 0 CA-C-N 115.369 -0.832 . . . . 0.0 111.896 -177.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 35.2 t-80 -154.69 144.16 21.36 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.209 0.603 . . . . 0.0 111.832 -172.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 35.8 tp -126.91 134.58 50.42 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.863 1.265 . . . . 0.0 108.869 170.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 22.7 t-160 -98.72 115.54 28.96 Favored 'General case' 0 C--O 1.243 0.719 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 166.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.663 ' HB3' ' HB ' ' A' ' 25' ' ' ILE . 1.3 tm? -97.51 110.14 22.76 Favored 'General case' 0 CA--C 1.542 0.654 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 -173.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 53.7 t -136.35 139.44 45.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 175.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.7 t -85.02 154.35 22.16 Favored 'General case' 0 N--CA 1.472 0.626 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 -178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.413 ' HB2' HD13 ' A' ' 88' ' ' ILE . 58.8 mt -73.16 109.51 6.5 Favored Pre-proline 0 CA--C 1.543 0.71 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 -179.484 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.452 ' HB2' ' HA ' ' A' ' 19' ' ' ASP . 63.4 Cg_endo -71.19 -30.95 15.27 Favored 'Trans proline' 0 C--N 1.371 1.711 0 C-N-CA 122.525 2.15 . . . . 0.0 112.8 -174.302 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 66.43 -95.2 0.25 Allowed Glycine 0 C--N 1.35 1.33 0 O-C-N 123.761 0.663 . . . . 0.0 112.058 -175.615 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 6.8 mp -100.05 19.7 15.82 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.729 0.812 . . . . 0.0 109.774 173.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.452 ' HA ' ' HB2' ' A' ' 16' ' ' PRO . 5.6 m-20 61.59 87.83 0.09 Allowed 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 125.318 1.447 . . . . 0.0 111.738 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 70.2 mm-40 -114.05 -42.2 3.41 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.375 0.67 . . . . 0.0 110.498 179.354 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -129.78 150.5 51.06 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 174.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -127.07 103.78 7.63 Favored 'General case' 0 C--O 1.213 -0.866 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 -178.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.577 HG21 ' HG ' ' A' ' 81' ' ' LEU . 1.7 pp -120.31 149.27 23.09 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 174.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.8 p30 -153.52 120.77 5.8 Favored 'General case' 0 N--CA 1.475 0.823 0 C-N-CA 123.32 0.648 . . . . 0.0 109.862 -177.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.663 ' HB ' ' HB3' ' A' ' 12' ' ' LEU . 55.8 mt -139.14 141.37 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.659 0.784 . . . . 0.0 109.601 -168.442 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.48 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.1 m170 -104.26 112.42 25.44 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.323 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 42.2 mt -112.23 109.78 29.8 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 N-CA-C 109.132 -0.692 . . . . 0.0 109.132 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -110.62 123.99 51.03 Favored 'General case' 0 N--CA 1.473 0.695 0 C-N-CA 124.874 1.27 . . . . 0.0 107.679 178.042 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 42.1 p90 -121.04 128.28 52.5 Favored 'General case' 0 N--CA 1.471 0.612 0 N-CA-C 109.022 -0.732 . . . . 0.0 109.022 174.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -119.52 113.3 20.53 Favored 'General case' 0 N--CA 1.475 0.809 0 N-CA-C 109.185 -0.672 . . . . 0.0 109.185 -173.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 92.1 t -77.54 115.84 20.07 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 176.432 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 14.2 ttt180 -145.51 167.58 22.66 Favored 'General case' 0 N--CA 1.471 0.6 0 C-N-CA 124.135 0.974 . . . . 0.0 108.734 -170.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 28.8 mm-40 -111.4 121.62 45.7 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 122.744 0.417 . . . . 0.0 110.495 179.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.435 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.6 OUTLIER -99.78 153.53 19.05 Favored 'General case' 0 N--CA 1.484 1.268 0 C-N-CA 124.521 1.129 . . . . 0.0 110.317 173.125 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.86 -24.48 61.69 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.204 0.601 . . . . 0.0 111.991 -179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -73.57 -49.34 26.8 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.222 1.009 . . . . 0.0 112.273 -172.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 11.2 t -133.89 17.13 3.86 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 123.352 0.661 . . . . 0.0 111.187 -169.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 77.09 -111.97 3.4 Favored Glycine 0 C--N 1.342 0.912 0 CA-C-N 116.117 -0.492 . . . . 0.0 112.007 176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.555 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -78.43 147.48 34.0 Favored 'General case' 0 CA--C 1.541 0.635 0 CA-C-N 117.298 0.549 . . . . 0.0 110.451 175.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 3.7 p90 -159.6 179.54 8.8 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.393 0.677 . . . . 0.0 109.807 175.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 18.4 t -132.64 130.59 59.52 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.831 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 171.504 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.486 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 4.6 t60 -88.42 109.0 19.66 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.174 0.99 . . . . 0.0 108.59 177.082 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.409 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 56.4 m-85 -94.91 127.49 40.98 Favored 'General case' 0 N--CA 1.475 0.797 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 176.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -136.16 127.83 28.96 Favored 'General case' 0 N--CA 1.474 0.752 0 C-N-CA 123.413 0.685 . . . . 0.0 109.296 -171.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.48 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 84.1 mtp -133.79 145.05 49.41 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 123.92 0.888 . . . . 0.0 110.861 -170.531 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.3 p-10 -166.18 165.53 17.53 Favored 'General case' 0 N--CA 1.483 1.201 0 C-N-CA 123.436 0.694 . . . . 0.0 109.846 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.79 -134.4 5.25 Favored Glycine 0 N--CA 1.468 0.805 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 178.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -153.9 172.19 17.8 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.186 0.594 . . . . 0.0 110.157 179.221 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.46 HD12 ' HB3' ' A' ' 79' ' ' HIS . 58.4 mt -155.27 101.33 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 N-CA-C 104.451 -2.426 . . . . 0.0 104.451 -166.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 54.39 41.13 32.15 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.483 0.713 . . . . 0.0 111.189 -174.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 91.55 -25.26 16.26 Favored Glycine 0 C--N 1.35 1.347 0 CA-C-N 115.151 -0.931 . . . . 0.0 114.543 -178.216 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 58.0 mttm -78.77 109.9 12.4 Favored Pre-proline 0 CA--C 1.557 1.221 0 C-N-CA 124.167 0.987 . . . . 0.0 111.369 -175.127 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 75.4 Cg_endo -81.35 152.44 18.02 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.028 2.486 . . . . 0.0 113.73 -177.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -155.07 160.52 41.07 Favored 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 123.19 0.596 . . . . 0.0 111.185 176.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 63.6 p -141.03 118.11 11.24 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 123.972 0.909 . . . . 0.0 109.358 170.257 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -139.62 150.0 44.46 Favored 'General case' 0 N--CA 1.483 1.224 0 C-N-CA 123.884 0.874 . . . . 0.0 109.799 -177.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 66.5 p -150.68 137.53 19.07 Favored 'General case' 0 N--CA 1.47 0.55 0 C-N-CA 122.956 0.502 . . . . 0.0 109.904 176.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 39.7 p90 -135.91 145.04 45.85 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.23 1.012 . . . . 0.0 108.738 178.747 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.486 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 39.6 mt-10 -124.55 123.91 41.12 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 -175.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.409 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.1 mt -120.63 133.49 24.07 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 123.188 0.595 . . . . 0.0 109.398 -175.357 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.01 163.97 6.94 Favored 'Trans proline' 0 C--N 1.377 2.075 0 C-N-CA 123.317 2.678 . . . . 0.0 113.286 174.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 31.4 ptt85 -45.46 -37.12 4.91 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 124.821 1.248 . . . . 0.0 112.537 171.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -66.07 -28.09 68.58 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.817 1.247 . . . . 0.0 112.886 -179.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 71.4 p -130.55 15.28 5.46 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.674 0.79 . . . . 0.0 111.16 -173.232 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -67.69 -32.7 73.54 Favored 'General case' 0 N--CA 1.487 1.384 0 C-N-CA 123.072 0.549 . . . . 0.0 110.779 179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 33.0 m-85 -69.03 -23.97 64.14 Favored 'General case' 0 CA--C 1.55 0.97 0 CA-C-N 114.856 -1.066 . . . . 0.0 111.501 173.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 13.0 m120 -77.29 -2.45 34.86 Favored 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 123.587 0.755 . . . . 0.0 111.64 -178.573 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -66.0 -21.14 66.39 Favored 'General case' 0 N--CA 1.473 0.698 0 N-CA-C 113.236 0.828 . . . . 0.0 113.236 -175.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.81 -41.43 62.35 Favored 'General case' 0 N--CA 1.478 0.935 0 CA-C-O 121.252 0.549 . . . . 0.0 109.711 -161.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.4 p -67.62 -33.63 75.37 Favored 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 114.207 -1.36 . . . . 0.0 110.228 175.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.468 ' O ' HG23 ' A' ' 75' ' ' VAL . 5.1 m-20 -72.27 -56.8 4.9 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 123.917 0.887 . . . . 0.0 111.433 -174.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.54 -42.02 67.04 Favored 'General case' 0 N--CA 1.486 1.363 0 C-N-CA 124.673 1.189 . . . . 0.0 112.41 -179.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.8 m -67.06 -50.24 62.49 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.249 176.167 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 42.7 ttp180 -56.93 -35.51 69.15 Favored 'General case' 0 N--CA 1.485 1.319 0 C-N-CA 124.104 0.962 . . . . 0.0 112.795 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 71' ' ' ASP . 53.4 t -57.93 -44.86 87.48 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.31 0 C-N-CA 123.74 0.816 . . . . 0.0 109.676 177.164 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.42 -42.75 74.62 Favored 'General case' 0 CA--C 1.535 0.373 0 CA-C-N 114.988 -1.006 . . . . 0.0 110.903 -179.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.522 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 11.0 mm100 -60.14 -38.32 82.74 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 123.295 0.638 . . . . 0.0 111.364 -178.514 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 58.0 mtpt -60.91 -30.32 70.11 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.079 0.951 . . . . 0.0 111.982 176.742 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.46 ' HB3' HD12 ' A' ' 49' ' ' ILE . 63.4 t60 -91.69 24.84 2.93 Favored 'General case' 0 CA--C 1.556 1.176 0 C-N-CA 122.872 0.469 . . . . 0.0 111.515 -176.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 92.2 49.48 2.83 Favored Glycine 0 C--N 1.34 0.8 0 O-C-N 121.646 -0.659 . . . . 0.0 111.846 171.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.577 ' HG ' HG21 ' A' ' 23' ' ' ILE . 1.7 tt -134.39 128.42 33.56 Favored 'General case' 0 CA--C 1.541 0.627 0 N-CA-C 108.098 -1.075 . . . . 0.0 108.098 -177.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 61.2 t60 -175.36 94.57 0.27 Allowed Pre-proline 0 CA--C 1.539 0.548 0 N-CA-C 106.993 -1.484 . . . . 0.0 106.993 176.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_exo -59.26 91.87 0.08 OUTLIER 'Trans proline' 0 C--N 1.376 1.982 0 C-N-CA 122.851 2.367 . . . . 0.0 112.133 179.442 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 37.7 ttmt -77.21 -30.59 54.75 Favored 'General case' 0 N--CA 1.475 0.79 0 CA-C-N 115.155 -0.929 . . . . 0.0 109.861 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 21.5 p90 -74.75 -21.28 59.43 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 115.481 -0.782 . . . . 0.0 110.295 168.317 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -67.17 81.18 0.14 Allowed Glycine 0 C--N 1.351 1.363 0 O-C-N 124.074 0.859 . . . . 0.0 113.675 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -77.42 -12.72 59.99 Favored 'General case' 0 CA--C 1.546 0.816 0 C-N-CA 124.218 1.007 . . . . 0.0 110.355 172.842 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.413 HD13 ' HB2' ' A' ' 15' ' ' LEU . 19.4 pt -55.1 100.03 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.262 0 C-N-CA 125.128 1.371 . . . . 0.0 111.63 170.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 12.8 t -104.75 -25.24 12.75 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.151 0.58 . . . . 0.0 110.619 176.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 37.1 mmt180 -89.08 20.8 3.46 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.636 0.774 . . . . 0.0 111.935 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 14.3 m -93.9 67.69 0.49 Allowed 'Isoleucine or valine' 0 C--O 1.241 0.635 0 C-N-CA 124.116 0.967 . . . . 0.0 110.205 178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -61.64 133.02 55.12 Favored 'General case' 0 CA--C 1.544 0.713 0 CA-C-N 114.74 -1.118 . . . . 0.0 110.291 -179.306 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 29.1 ttpt -77.91 2.65 16.72 Favored 'General case' 0 CA--C 1.553 1.091 0 C-N-CA 123.873 0.869 . . . . 0.0 110.917 -176.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 48.5 mt-10 61.96 39.33 13.57 Favored 'General case' 0 C--N 1.361 1.095 0 C-N-CA 124.959 1.304 . . . . 0.0 110.652 175.703 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -58.54 -35.34 72.17 Favored 'General case' 0 C--O 1.213 -0.855 0 CA-C-N 114.034 -1.439 . . . . 0.0 111.345 178.455 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -54.72 -45.5 74.07 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.599 0.76 . . . . 0.0 112.35 173.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.64 -48.34 60.23 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 122.995 0.518 . . . . 0.0 110.45 -179.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 15.1 tpt -60.16 -38.02 81.91 Favored 'General case' 0 CA--C 1.554 1.128 0 CA-C-N 115.217 -0.902 . . . . 0.0 111.963 177.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -53.91 -45.63 71.21 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 124.545 1.138 . . . . 0.0 110.142 176.031 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 23.1 mm-40 -71.15 -28.77 64.51 Favored 'General case' 0 C--O 1.241 0.645 0 CA-C-N 115.352 -0.84 . . . . 0.0 112.382 -179.374 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.439 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 28.2 t70 -68.19 -54.18 19.69 Favored 'General case' 0 N--CA 1.472 0.636 0 O-C-N 123.358 0.411 . . . . 0.0 110.044 174.682 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 79.0 mt -55.33 -47.59 77.78 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.271 0 C-N-CA 123.947 0.899 . . . . 0.0 111.481 179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.7 ppt_? -63.59 -28.27 69.81 Favored 'General case' 0 N--CA 1.481 1.118 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.565 -177.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -76.59 -54.47 6.64 Favored 'General case' 0 CA--C 1.549 0.931 0 C-N-CA 123.807 0.843 . . . . 0.0 112.439 176.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.439 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 14.1 mmmm -67.85 -37.36 81.77 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 113.457 0.91 . . . . 0.0 113.457 -173.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -69.66 -24.56 63.63 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 122.516 0.326 . . . . 0.0 111.181 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.401 ' HD2' ' HB2' ' A' ' 109' ' ' HIS . 34.2 t60 -76.99 -17.91 58.56 Favored 'General case' 0 N--CA 1.489 1.507 0 C-N-CA 123.914 0.886 . . . . 0.0 109.699 169.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.86 10.86 3.82 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 126.293 1.837 . . . . 0.0 112.572 175.656 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.401 ' HB2' ' HD2' ' A' ' 107' ' ' HIS . 65.2 m80 -148.42 143.62 17.62 Favored Pre-proline 0 CA--C 1.55 0.969 0 N-CA-C 107.712 -1.218 . . . . 0.0 107.712 -177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -52.87 139.85 59.15 Favored 'Trans proline' 0 C--N 1.387 2.56 0 C-N-CA 122.862 2.375 . . . . 0.0 112.834 -177.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -61.59 -20.93 59.81 Favored Glycine 0 C--N 1.349 1.292 0 O-C-N 123.823 0.702 . . . . 0.0 114.573 -170.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -147.94 154.28 43.21 Favored Pre-proline 0 C--O 1.243 0.713 0 C-N-CA 123.94 0.896 . . . . 0.0 109.323 177.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_exo -63.42 148.94 92.33 Favored 'Trans proline' 0 C--N 1.374 1.908 0 C-N-CA 122.49 2.126 . . . . 0.0 111.132 169.435 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.3 p -68.92 142.79 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -178.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 11.2 p-10 -113.92 20.81 15.46 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 123.099 0.559 . . . . 0.0 111.98 -173.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.474 HD12 ' N ' ' A' ' 117' ' ' GLU . 4.4 pp -57.15 -37.62 72.33 Favored 'General case' 0 N--CA 1.486 1.371 0 C-N-CA 123.529 0.732 . . . . 0.0 112.289 -175.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.474 ' N ' HD12 ' A' ' 116' ' ' LEU . 26.4 tt0 -87.27 -14.79 39.96 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.472 0.709 . . . . 0.0 110.947 -178.063 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 11.8 tpt180 -80.68 -11.92 59.56 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.083 0.553 . . . . 0.0 110.543 -172.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -85.56 -35.99 10.29 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 166.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 19.1 mt -86.05 14.54 0.74 Allowed 'Isoleucine or valine' 0 CA--C 1.57 1.726 0 C-N-CA 124.215 1.006 . . . . 0.0 110.57 -175.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 7.4 ptm180 -77.68 94.76 4.47 Favored 'General case' 0 CA--C 1.555 1.14 0 O-C-N 121.187 -0.945 . . . . 0.0 109.911 175.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 3.9 p80 -156.57 134.1 10.8 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 115.883 -0.599 . . . . 0.0 109.765 177.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.9 mm-40 -113.24 -55.1 2.56 Favored 'General case' 0 N--CA 1.472 0.648 0 C-N-CA 123.831 0.852 . . . . 0.0 108.917 177.574 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 167.8 26.51 0.02 OUTLIER Glycine 0 C--N 1.347 1.181 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.107 178.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 26.5 m . . . . . 0 CA--C 1.552 1.052 0 C-N-CA 123.923 0.889 . . . . 0.0 108.944 -179.284 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 74.1 mt-30 . . . . . 0 N--CA 1.482 1.137 0 N-CA-C 109.919 -0.4 . . . . 0.0 109.919 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -59.21 -40.02 95.28 Favored Glycine 0 C--N 1.352 1.445 0 N-CA-C 115.428 0.931 . . . . 0.0 115.428 -169.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -138.29 105.03 5.35 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 117.047 0.424 . . . . 0.0 110.82 -171.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.423 ' HB3' ' HB3' ' A' ' 11' ' ' HIS . 8.7 tmm? -114.55 128.25 56.23 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 170.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -133.64 137.77 45.57 Favored 'General case' 0 N--CA 1.476 0.862 0 CA-C-N 118.112 0.415 . . . . 0.0 110.672 -177.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -143.47 154.6 60.34 Favored Pre-proline 0 CA--C 1.551 0.998 0 C-N-CA 124.275 1.03 . . . . 0.0 108.681 175.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_exo -57.76 101.4 0.11 Allowed 'Trans proline' 0 C--N 1.377 2.052 0 C-N-CA 122.698 2.266 . . . . 0.0 112.644 174.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.62 -14.24 11.75 Favored Glycine 0 C--N 1.346 1.132 0 CA-C-O 119.644 -0.531 . . . . 0.0 113.936 178.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 38.3 t-80 -158.01 122.46 4.23 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 117.509 0.655 . . . . 0.0 112.182 -175.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.6 tp -102.98 120.98 41.61 Favored 'General case' 0 CA--C 1.545 0.761 0 C-N-CA 124.58 1.152 . . . . 0.0 108.848 168.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.423 ' HB3' ' HB3' ' A' ' 4' ' ' MET . 21.7 t-160 -99.49 121.97 41.91 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 174.032 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.516 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.5 mt -98.92 137.26 37.74 Favored 'General case' 0 CA--C 1.535 0.386 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 171.733 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 60.0 t -140.83 170.02 14.59 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 N-CA-C 104.879 -2.267 . . . . 0.0 104.879 165.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.553 ' OG ' HG13 ' A' ' 23' ' ' ILE . 16.5 m -93.0 160.09 15.02 Favored 'General case' 0 CA--C 1.551 0.992 0 O-C-N 120.143 -1.598 . . . . 0.0 109.688 168.39 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.441 ' HA ' ' HD2' ' A' ' 16' ' ' PRO . 0.5 OUTLIER -115.03 101.67 54.6 Favored Pre-proline 0 N--CA 1.48 1.072 0 O-C-N 122.049 -0.407 . . . . 0.0 110.855 173.733 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.441 ' HD2' ' HA ' ' A' ' 15' ' ' LEU . 24.3 Cg_endo -54.94 119.06 5.87 Favored 'Trans proline' 0 C--N 1.378 2.09 0 C-N-CA 123.448 2.765 . . . . 0.0 112.727 -178.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 137.85 -60.69 0.6 Allowed Glycine 0 C--N 1.344 1.018 0 N-CA-C 110.241 -1.144 . . . . 0.0 110.241 -174.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.97 13.54 34.83 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 123.916 0.887 . . . . 0.0 109.302 173.125 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.53 134.79 9.26 Favored 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -176.567 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 28.3 mp0 -127.73 43.17 3.18 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.482 0.713 . . . . 0.0 110.141 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -151.35 155.57 38.96 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.219 0.608 . . . . 0.0 109.456 179.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 18.3 t70 -103.64 69.34 0.97 Allowed 'General case' 0 N--CA 1.482 1.158 0 CA-C-O 121.643 0.735 . . . . 0.0 110.834 -173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.553 HG13 ' OG ' ' A' ' 14' ' ' SER . 0.7 OUTLIER -89.02 134.63 27.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.001 0 N-CA-C 107.544 -1.28 . . . . 0.0 107.544 173.922 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.0 p30 -156.11 111.07 2.89 Favored 'General case' 0 CA--C 1.545 0.775 0 CA-C-O 121.746 0.784 . . . . 0.0 109.443 176.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.516 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 60.1 mt -124.47 143.87 36.35 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 C-N-CA 124.591 1.156 . . . . 0.0 110.041 -168.245 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.46 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.6 m170 -104.68 111.47 24.19 Favored 'General case' 0 N--CA 1.468 0.473 0 N-CA-C 107.23 -1.396 . . . . 0.0 107.23 174.52 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.481 HG12 ' HG2' ' A' ' 45' ' ' MET . 61.8 mt -109.98 109.19 27.5 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 175.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 5.2 tmm_? -115.17 119.66 37.14 Favored 'General case' 0 N--CA 1.47 0.552 0 N-CA-C 108.291 -1.003 . . . . 0.0 108.291 -178.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.442 ' HA ' ' O ' ' A' ' 42' ' ' HIS . 47.8 p90 -121.11 131.73 54.44 Favored 'General case' 0 N--CA 1.473 0.685 0 C-N-CA 123.013 0.525 . . . . 0.0 110.307 -179.085 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -129.78 122.45 28.83 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.419 0.688 . . . . 0.0 110.018 178.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.44 HG22 HG22 ' A' ' 41' ' ' VAL . 59.2 t -70.86 124.74 27.77 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.768 0 N-CA-C 109.428 -0.582 . . . . 0.0 109.428 172.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.471 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 43.9 ttt180 -146.12 165.08 30.19 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.064 0.946 . . . . 0.0 109.278 -175.232 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.471 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 24.1 mm-40 -114.74 115.57 27.26 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 123.803 0.841 . . . . 0.0 108.872 174.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.547 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -101.93 147.77 26.15 Favored 'General case' 0 N--CA 1.495 1.783 0 C-N-CA 123.173 0.589 . . . . 0.0 110.002 170.362 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -68.64 -26.18 65.2 Favored 'General case' 0 N--CA 1.482 1.16 0 C-N-CA 122.989 0.516 . . . . 0.0 111.29 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.6 tt0 -66.84 -54.63 20.44 Favored 'General case' 0 CA--C 1.547 0.861 0 C-N-CA 123.91 0.884 . . . . 0.0 112.293 -177.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.458 ' HB2' HD21 ' A' ' 34' ' ' ASN . 23.1 m -120.26 4.16 10.81 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.245 0.618 . . . . 0.0 112.09 -168.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 85.8 -134.83 12.87 Favored Glycine 0 C--N 1.35 1.34 0 N-CA-C 112.184 -0.366 . . . . 0.0 112.184 177.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.513 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -73.6 141.59 46.59 Favored 'General case' 0 C--O 1.24 0.562 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 170.789 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.6 p90 -161.4 178.69 8.92 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 121.023 0.44 . . . . 0.0 110.788 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.44 HG22 HG22 ' A' ' 31' ' ' VAL . 23.8 t -125.97 132.8 70.24 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 170.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.442 ' O ' ' HA ' ' A' ' 29' ' ' TYR . 48.0 t60 -92.88 129.56 38.76 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 124.479 1.112 . . . . 0.0 108.593 178.06 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.423 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 50.8 m-85 -119.18 143.28 47.33 Favored 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 123.264 0.626 . . . . 0.0 110.447 -177.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.45 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 41.5 m-20 -130.23 141.53 50.62 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.054 0.942 . . . . 0.0 109.183 174.738 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.481 ' HG2' HG12 ' A' ' 27' ' ' ILE . 87.5 mtp -132.97 128.51 36.57 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 123.882 0.873 . . . . 0.0 108.784 170.873 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -160.86 161.19 31.79 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.502 0.321 . . . . 0.0 110.488 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.64 -122.89 2.47 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.721 -0.952 . . . . 0.0 110.721 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -155.93 164.11 38.9 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.749 0.82 . . . . 0.0 110.001 -179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 64.8 mt -155.58 113.07 0.26 Allowed 'Isoleucine or valine' 0 N--CA 1.482 1.138 0 N-CA-C 103.998 -2.593 . . . . 0.0 103.998 -169.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.6 t70 56.48 40.14 29.69 Favored 'General case' 0 CA--C 1.562 1.436 0 CA-C-O 122.221 1.01 . . . . 0.0 110.383 -177.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.99 -39.0 3.04 Favored Glycine 0 C--N 1.348 1.211 0 CA-C-N 115.127 -0.942 . . . . 0.0 114.608 -177.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 93.0 mttt -79.69 129.4 71.31 Favored Pre-proline 0 N--CA 1.475 0.794 0 C-N-CA 123.851 0.86 . . . . 0.0 111.754 -169.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 67.9 Cg_endo -79.64 164.22 23.5 Favored 'Trans proline' 0 C--N 1.376 1.975 0 C-N-CA 123.26 2.64 . . . . 0.0 113.879 179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -157.94 159.92 37.02 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.616 0.766 . . . . 0.0 110.688 176.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 51.5 p -144.22 112.95 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.529 0.732 . . . . 0.0 110.459 169.651 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -134.03 154.38 51.18 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.85 1.26 . . . . 0.0 109.643 179.164 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 55.8 p -152.97 139.71 18.94 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 122.979 0.512 . . . . 0.0 109.799 175.029 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 37.1 p90 -140.1 150.25 44.07 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.596 0.758 . . . . 0.0 110.126 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -128.45 125.68 38.99 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.779 0.831 . . . . 0.0 109.36 -178.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.423 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 87.9 mt -119.38 134.43 23.77 Favored Pre-proline 0 N--CA 1.479 0.997 0 C-N-CA 123.459 0.704 . . . . 0.0 109.812 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_endo -64.67 158.8 48.32 Favored 'Trans proline' 0 C--N 1.38 2.23 0 C-N-CA 123.04 2.493 . . . . 0.0 112.225 175.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 26.1 ptt180 -41.64 -38.24 1.34 Allowed 'General case' 0 N--CA 1.493 1.692 0 C-N-CA 125.172 1.389 . . . . 0.0 114.2 -179.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.8 t70 -70.85 -25.59 62.89 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 123.845 0.858 . . . . 0.0 112.788 -175.306 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 36.5 p -131.83 8.44 4.48 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.558 0.743 . . . . 0.0 111.494 -172.303 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.1 -38.23 88.09 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 123.7 0.8 . . . . 0.0 111.992 -177.183 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 14.2 m-85 -68.03 -14.26 62.83 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 114.341 -1.299 . . . . 0.0 113.04 -177.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 45.2 m-80 -79.55 2.01 23.81 Favored 'General case' 0 N--CA 1.483 1.206 0 C-N-CA 123.412 0.685 . . . . 0.0 111.697 177.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 5.9 p90 -65.0 -14.41 60.29 Favored 'General case' 0 C--N 1.354 0.774 0 C-N-CA 124.127 0.971 . . . . 0.0 112.294 -175.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.17 -36.78 66.67 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 -177.069 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -73.2 -40.99 64.32 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.882 175.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -64.01 -52.21 60.59 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 123.255 0.622 . . . . 0.0 110.662 -179.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.435 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -55.08 -49.32 71.97 Favored 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.51 1.124 . . . . 0.0 112.01 176.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 88.1 m -64.84 -29.1 70.05 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 122.851 0.461 . . . . 0.0 111.454 176.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 25.6 tpp180 -72.3 -41.56 66.48 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.038 0.535 . . . . 0.0 110.238 178.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 73.4 t -70.81 -31.78 46.82 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 C-N-CA 124.397 1.079 . . . . 0.0 109.9 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.455 ' HB1' HD23 ' A' ' 81' ' ' LEU . . . -71.41 -49.89 37.32 Favored 'General case' 0 CA--C 1.542 0.637 0 C-N-CA 123.54 0.736 . . . . 0.0 109.799 -178.928 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.588 ' HG2' ' HB3' ' A' ' 81' ' ' LEU . 46.4 mt-30 -70.09 -28.87 65.76 Favored 'General case' 0 N--CA 1.485 1.317 0 CA-C-N 115.059 -0.973 . . . . 0.0 111.753 178.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -59.71 -29.9 68.43 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.475 0.71 . . . . 0.0 110.453 171.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 39.3 t-80 -105.97 21.36 17.44 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 123.016 0.526 . . . . 0.0 111.214 -179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.16 40.08 5.57 Favored Glycine 0 C--N 1.347 1.173 0 O-C-N 121.969 -0.457 . . . . 0.0 113.951 166.293 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.588 ' HB3' ' HG2' ' A' ' 77' ' ' GLN . 0.2 OUTLIER -69.82 -38.99 76.75 Favored 'General case' 0 CA--C 1.552 1.032 0 N-CA-C 108.175 -1.046 . . . . 0.0 108.175 169.767 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 27.8 m80 77.34 165.79 0.13 Allowed Pre-proline 0 N--CA 1.494 1.746 0 C-N-CA 125.95 1.7 . . . . 0.0 112.258 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -72.71 53.44 2.3 Favored 'Trans proline' 0 C--N 1.388 2.651 0 C-N-CA 123.252 2.634 . . . . 0.0 110.165 160.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.5 ttmt -68.71 -46.54 68.7 Favored 'General case' 0 C--O 1.241 0.638 0 CA-C-N 114.126 -1.397 . . . . 0.0 113.044 -159.716 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -60.92 -33.53 73.29 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.105 -0.952 . . . . 0.0 111.424 -175.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 61.01 22.38 60.27 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 115.969 -0.559 . . . . 0.0 112.38 -173.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -161.8 26.12 0.12 Allowed 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 123.642 0.777 . . . . 0.0 111.149 -169.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.2 pt -75.57 -6.19 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 C-N-CA 122.328 0.251 . . . . 0.0 110.549 173.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 45.6 p -56.11 -46.42 79.12 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.563 1.145 . . . . 0.0 111.164 174.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.6 mmp_? -114.38 121.99 45.29 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.693 0.797 . . . . 0.0 109.683 173.587 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 7.2 p -164.02 146.19 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.928 0 C-N-CA 124.236 1.014 . . . . 0.0 109.201 -176.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 55.3 p-80 -73.47 131.63 42.01 Favored 'General case' 0 CA--C 1.546 0.815 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 175.331 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 28.3 mtpp -104.02 115.29 30.18 Favored 'General case' 0 N--CA 1.474 0.744 0 C-N-CA 123.151 0.58 . . . . 0.0 109.805 -179.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -104.87 19.83 19.84 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.029 0.932 . . . . 0.0 110.382 178.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -64.13 -40.82 97.01 Favored 'General case' 0 C--O 1.217 -0.657 0 C-N-CA 123.871 0.868 . . . . 0.0 111.0 -175.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 13.1 m-20 -65.23 -39.98 93.46 Favored 'General case' 0 N--CA 1.486 1.341 0 C-N-CA 123.545 0.738 . . . . 0.0 111.735 179.279 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.65 -48.01 70.75 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.266 0.627 . . . . 0.0 111.114 -176.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.426 ' HE2' ' HB3' ' A' ' 98' ' ' MET . 53.2 ttp -64.4 -43.0 95.79 Favored 'General case' 0 CA--C 1.553 1.085 0 C-N-CA 124.401 1.08 . . . . 0.0 112.323 173.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.07 -50.09 49.13 Favored 'General case' 0 N--CA 1.49 1.535 0 C-N-CA 124.703 1.201 . . . . 0.0 111.492 175.281 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -77.85 -28.37 50.1 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 123.646 0.591 . . . . 0.0 110.687 -176.099 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -63.68 -59.98 3.9 Favored 'General case' 0 N--CA 1.472 0.661 0 C-N-CA 123.707 0.803 . . . . 0.0 111.299 178.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.411 ' O ' HD13 ' A' ' 106' ' ' LEU . 56.2 mt -63.79 -36.42 76.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 C-N-CA 123.38 0.672 . . . . 0.0 111.372 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -29.16 70.0 Favored 'General case' 0 N--CA 1.485 1.309 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.622 ' HB1' ' HA ' ' A' ' 110' ' ' PRO . . . -74.13 -38.14 63.87 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.327 0.651 . . . . 0.0 110.689 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.45 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.1 OUTLIER -65.61 -35.84 81.99 Favored 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 123.163 0.585 . . . . 0.0 112.179 173.588 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.411 HD13 ' O ' ' A' ' 102' ' ' ILE . 9.8 mp -65.3 -32.71 74.5 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.59 0.756 . . . . 0.0 110.728 170.276 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -76.62 -16.4 59.58 Favored 'General case' 0 CA--C 1.561 1.366 0 C-N-CA 124.349 1.059 . . . . 0.0 111.216 173.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 98.04 -27.97 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.813 0 C-N-CA 127.599 2.359 . . . . 0.0 112.248 175.289 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -138.7 148.82 59.99 Favored Pre-proline 0 N--CA 1.49 1.536 0 C-N-CA 123.098 0.559 . . . . 0.0 110.562 -179.115 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.622 ' HA ' ' HB1' ' A' ' 104' ' ' ALA . 56.7 Cg_endo -68.02 94.94 0.41 Allowed 'Trans proline' 0 C--N 1.384 2.447 0 C-N-CA 122.737 2.292 . . . . 0.0 112.135 176.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -114.09 96.66 0.8 Allowed Glycine 0 C--N 1.343 0.939 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 174.166 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -61.87 143.29 94.51 Favored Pre-proline 0 N--CA 1.487 1.403 0 C-N-CA 123.207 0.603 . . . . 0.0 111.906 -178.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_endo -93.31 105.95 0.17 Allowed 'Trans proline' 0 C--N 1.373 1.859 0 C-N-CA 123.029 2.486 . . . . 0.0 112.22 178.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.4 p -70.79 107.49 2.15 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.176 0 CA-C-O 122.36 1.076 . . . . 0.0 109.491 -179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -84.91 21.35 1.61 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 124.475 1.11 . . . . 0.0 111.983 -163.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 3.9 pp -64.78 -27.5 68.93 Favored 'General case' 0 N--CA 1.483 1.212 0 C-N-CA 123.268 0.627 . . . . 0.0 110.792 172.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 14.5 tp10 -68.05 -11.59 59.26 Favored 'General case' 0 CA--C 1.557 1.232 0 C-N-CA 124.973 1.309 . . . . 0.0 111.39 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 20.2 tpp180 -87.77 -19.86 26.95 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 124.052 0.941 . . . . 0.0 112.4 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.9 mp -85.16 74.0 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.353 0.754 0 N-CA-C 108.11 -1.071 . . . . 0.0 108.11 -177.17 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 33.8 mt 72.15 -5.28 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.567 1.606 0 C-N-CA 125.323 1.449 . . . . 0.0 112.364 172.096 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 15.4 mmm180 -70.41 -54.78 11.02 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.822 -0.549 . . . . 0.0 109.709 -174.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 33.5 m170 -112.67 137.93 50.23 Favored 'General case' 0 C--O 1.243 0.734 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 166.762 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -153.2 -36.8 0.1 Allowed 'General case' 0 CA--C 1.545 0.776 0 C-N-CA 124.201 1.0 . . . . 0.0 109.899 178.015 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 53.93 -119.28 10.85 Favored Glycine 0 C--N 1.351 1.406 0 O-C-N 123.862 0.726 . . . . 0.0 114.143 174.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.7 p . . . . . 0 C--O 1.252 1.231 0 C-N-CA 124.619 1.168 . . . . 0.0 108.602 177.531 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 . . . . . 0 N--CA 1.478 0.928 0 N-CA-C 109.549 -0.538 . . . . 0.0 109.549 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 116.74 -132.57 10.17 Favored Glycine 0 C--N 1.341 0.829 0 CA-C-O 119.543 -0.587 . . . . 0.0 111.981 178.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 42.2 m80 59.6 21.25 9.84 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 125.002 1.321 . . . . 0.0 111.882 -176.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.468 ' HB2' ' HB3' ' A' ' 11' ' ' HIS . 86.9 mtp -74.26 97.94 3.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.492 0.717 . . . . 0.0 110.155 -176.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -131.49 128.85 40.23 Favored 'General case' 0 C--O 1.238 0.466 0 C-N-CA 123.31 0.644 . . . . 0.0 109.456 176.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -142.48 157.13 63.16 Favored Pre-proline 0 CA--C 1.553 1.087 0 C-N-CA 125.126 1.37 . . . . 0.0 108.858 -177.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -61.61 102.34 0.23 Allowed 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.279 1.986 . . . . 0.0 111.33 172.661 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.01 -25.15 5.85 Favored Glycine 0 C--N 1.348 1.215 0 CA-C-N 116.004 -0.544 . . . . 0.0 113.569 -178.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 28.7 t-80 -152.81 142.04 21.48 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 117.56 0.68 . . . . 0.0 112.118 -171.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 39.7 tp -131.51 133.33 44.99 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 125.643 1.577 . . . . 0.0 108.55 170.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 4' ' ' MET . 21.3 t-160 -107.56 117.99 35.55 Favored 'General case' 0 N--CA 1.47 0.569 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 172.557 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.532 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 80.7 mt -88.74 128.77 35.63 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 109.159 -0.682 . . . . 0.0 109.159 174.634 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.9 m -127.52 160.29 36.95 Favored 'Isoleucine or valine' 0 C--O 1.246 0.912 0 N-CA-C 106.227 -1.768 . . . . 0.0 106.227 159.102 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.534 ' HB3' HG13 ' A' ' 23' ' ' ILE . 65.7 p -75.48 164.91 25.87 Favored 'General case' 0 N--CA 1.472 0.649 0 O-C-N 121.79 -0.569 . . . . 0.0 111.406 -177.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -50.47 143.75 13.26 Favored Pre-proline 0 CA--C 1.567 1.628 0 C-N-CA 124.057 0.943 . . . . 0.0 113.011 176.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 86.3 Cg_endo -77.35 -153.49 0.04 OUTLIER 'Trans proline' 0 C--N 1.377 2.041 0 C-N-CA 123.173 2.582 . . . . 0.0 112.687 177.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 73.32 -111.38 3.46 Favored Glycine 0 C--N 1.349 1.268 0 CA-C-O 119.897 -0.391 . . . . 0.0 112.794 175.328 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 94.2 mt -73.15 -31.26 64.15 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.376 0.671 . . . . 0.0 110.709 175.316 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 19.8 t70 56.92 79.45 0.19 Allowed 'General case' 0 C--N 1.357 0.893 0 O-C-N 124.598 1.186 . . . . 0.0 109.604 -175.018 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 15.5 mm100 -56.86 -35.19 68.59 Favored 'General case' 0 N--CA 1.483 1.216 0 C-N-CA 123.814 0.846 . . . . 0.0 111.424 -178.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -150.28 159.33 44.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.896 -177.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -114.73 101.39 9.03 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.274 1.03 . . . . 0.0 108.935 178.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.534 HG13 ' HB3' ' A' ' 14' ' ' SER . 2.1 pp -113.95 143.86 22.77 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.863 0 N-CA-C 108.62 -0.882 . . . . 0.0 108.62 171.548 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -144.36 108.65 4.81 Favored 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.532 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.8 mt -131.68 139.19 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.236 0 C-N-CA 123.57 0.748 . . . . 0.0 110.411 -170.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.454 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.4 m170 -104.65 111.04 23.59 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.534 HG12 ' HG2' ' A' ' 45' ' ' MET . 37.4 mt -112.08 119.84 61.03 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.055 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 1.6 mpt_? -110.59 123.64 50.35 Favored 'General case' 0 N--CA 1.474 0.739 0 N-CA-C 107.428 -1.323 . . . . 0.0 107.428 171.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 30.9 p90 -112.01 115.79 29.5 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 106.471 -1.677 . . . . 0.0 106.471 170.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 -124.83 111.92 16.06 Favored 'General case' 0 N--CA 1.471 0.601 0 C-N-CA 122.817 0.447 . . . . 0.0 109.991 -170.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 105' ' ' LYS . 89.0 t -81.5 119.69 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.543 0 C-N-CA 123.347 0.659 . . . . 0.0 109.805 -178.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.6 tmt_? -131.93 145.77 51.7 Favored 'General case' 0 N--CA 1.466 0.353 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 176.647 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 22.2 mm-40 -103.1 113.17 26.43 Favored 'General case' 0 CA--C 1.54 0.564 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 -175.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.48 HD22 ' HD1' ' A' ' 40' ' ' TYR . 3.5 p30 -99.95 142.32 31.58 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 176.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -69.63 -16.8 63.44 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.265 0.626 . . . . 0.0 112.162 -178.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.406 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 14.2 tp10 -75.22 -46.66 32.51 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 123.759 0.823 . . . . 0.0 111.675 -175.965 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 27.6 t -126.77 -11.71 6.05 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 123.356 0.663 . . . . 0.0 112.06 -168.55 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 100.96 -139.41 14.38 Favored Glycine 0 C--N 1.344 1.023 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 -175.416 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -66.3 143.58 57.1 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 117.434 0.617 . . . . 0.0 111.257 173.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' HD1' HD22 ' A' ' 34' ' ' ASN . 8.8 p90 -148.15 165.37 31.09 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 170.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 31' ' ' VAL . 10.1 t -130.38 134.71 62.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 -179.042 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.562 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 57.5 t60 -94.36 113.46 25.35 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.857 1.263 . . . . 0.0 108.863 176.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.445 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 71.4 m-85 -104.12 115.45 30.44 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.736 0.814 . . . . 0.0 108.945 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 10.8 t70 -120.93 119.32 32.25 Favored 'General case' 0 N--CA 1.472 0.657 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 -169.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.534 ' HG2' HG12 ' A' ' 27' ' ' ILE . 81.2 mtp -126.09 134.84 51.25 Favored 'General case' 0 N--CA 1.488 1.44 0 C-N-CA 123.159 0.583 . . . . 0.0 111.086 -174.018 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.1 p-10 -165.37 177.31 7.61 Favored 'General case' 0 N--CA 1.483 1.196 0 C-N-CA 123.085 0.554 . . . . 0.0 110.181 175.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 136.43 -123.7 2.98 Favored Glycine 0 C--N 1.339 0.698 0 N-CA-C 110.859 -0.896 . . . . 0.0 110.859 175.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 10.1 pt-20 -152.96 167.35 29.44 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 124.387 1.075 . . . . 0.0 109.868 179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.531 HG23 HG22 ' A' ' 23' ' ' ILE . 36.8 mt -157.15 105.31 0.11 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.121 0 N-CA-C 103.764 -2.68 . . . . 0.0 103.764 -172.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.547 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 3.2 m-20 64.03 40.76 6.91 Favored 'General case' 0 N--CA 1.491 1.59 0 C-N-CA 124.193 0.997 . . . . 0.0 109.838 -174.447 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.23 -23.56 3.89 Favored Glycine 0 CA--C 1.533 1.191 0 CA-C-N 115.355 -0.839 . . . . 0.0 114.638 -175.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.547 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 44.4 mtmt -82.88 116.57 64.8 Favored Pre-proline 0 CA--C 1.545 0.781 0 C-N-CA 124.159 0.984 . . . . 0.0 110.413 -171.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 88.8 Cg_endo -74.92 162.26 37.58 Favored 'Trans proline' 0 C--N 1.375 1.944 0 C-N-CA 123.049 2.5 . . . . 0.0 113.841 -175.04 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 13.7 p90 -158.3 165.68 34.17 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.715 0.806 . . . . 0.0 111.115 175.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 42.9 p -153.13 121.66 6.34 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 124.283 1.033 . . . . 0.0 109.819 170.405 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 23.6 t0 -155.4 145.04 21.25 Favored 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 123.96 0.904 . . . . 0.0 110.047 177.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 35.4 t -146.58 146.73 30.55 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 123.095 0.558 . . . . 0.0 110.653 -170.16 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 33.5 p90 -142.19 149.78 40.16 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.34 1.056 . . . . 0.0 110.297 179.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.3 mp0 -118.6 135.48 54.41 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 108.705 -0.85 . . . . 0.0 108.705 175.747 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.445 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 89.7 mt -124.45 124.97 25.68 Favored Pre-proline 0 CA--C 1.542 0.659 0 N-CA-C 108.794 -0.817 . . . . 0.0 108.794 175.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.5 Cg_endo -64.68 168.91 12.33 Favored 'Trans proline' 0 C--N 1.378 2.096 0 C-N-CA 123.108 2.539 . . . . 0.0 111.779 171.896 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.551 ' HG3' HD23 ' A' ' 106' ' ' LEU . 76.4 ttt180 -47.06 -35.96 7.5 Favored 'General case' 0 N--CA 1.495 1.775 0 C-N-CA 124.222 1.009 . . . . 0.0 112.504 176.68 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -58.6 -35.34 72.27 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.554 1.142 . . . . 0.0 112.632 178.609 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 43.7 p -129.11 8.03 5.55 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.647 0.779 . . . . 0.0 112.104 -172.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.62 -40.08 90.57 Favored 'General case' 0 N--CA 1.486 1.356 0 C-N-CA 123.506 0.722 . . . . 0.0 112.094 -173.034 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 23.1 m-85 -68.47 -12.57 61.39 Favored 'General case' 0 N--CA 1.483 1.194 0 CA-C-N 114.832 -1.077 . . . . 0.0 113.216 -178.614 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 81.4 m-20 -80.69 5.63 15.12 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.55 0.74 . . . . 0.0 111.66 177.238 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.51 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 5.9 p90 -73.52 -27.13 61.2 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 124.2 1.0 . . . . 0.0 113.334 -172.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.89 -45.32 36.1 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-O 121.364 0.602 . . . . 0.0 109.511 -164.379 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 23.7 m -74.33 -33.35 63.12 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-N 114.186 -1.37 . . . . 0.0 110.159 176.358 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 75' ' ' VAL . 22.6 t70 -72.97 -51.61 17.67 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 122.913 0.485 . . . . 0.0 111.501 -176.386 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.73 -41.23 66.83 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 124.155 0.982 . . . . 0.0 112.091 174.319 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.4 m -61.81 -48.45 80.55 Favored 'General case' 0 CA--C 1.549 0.912 0 CA-C-N 116.208 -0.451 . . . . 0.0 109.972 174.62 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.414 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.9 ttm180 -53.73 -45.06 70.38 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.689 1.196 . . . . 0.0 111.61 174.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 71' ' ' ASP . 43.5 t -61.46 -41.04 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.228 0 C-N-CA 124.756 1.222 . . . . 0.0 110.204 -177.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.85 -42.25 70.37 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.932 178.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -67.71 -26.49 66.19 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 124.035 0.934 . . . . 0.0 111.811 -178.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -65.54 -22.4 66.7 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 123.307 0.643 . . . . 0.0 111.177 171.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 45.6 t-80 -106.74 20.98 18.22 Favored 'General case' 0 CA--C 1.556 1.198 0 C-N-CA 123.441 0.696 . . . . 0.0 110.39 175.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 84.59 39.32 8.97 Favored Glycine 0 C--N 1.349 1.291 0 O-C-N 121.724 -0.61 . . . . 0.0 113.441 167.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.452 HD22 HG21 ' A' ' 23' ' ' ILE . 2.1 tm? -64.52 -46.73 81.66 Favored 'General case' 0 N--CA 1.477 0.899 0 C-N-CA 123.829 0.852 . . . . 0.0 110.322 178.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 55.3 m-70 63.71 109.67 0.03 OUTLIER Pre-proline 0 N--CA 1.479 1.019 0 C-N-CA 125.244 1.418 . . . . 0.0 109.655 -168.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.574 ' HB3' ' HA2' ' A' ' 86' ' ' GLY . 21.9 Cg_exo -33.28 101.83 0.03 OUTLIER 'Trans proline' 0 C--N 1.389 2.702 0 C-N-CA 124.769 3.646 . . . . 0.0 114.423 -178.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 74.6 tttt -52.34 -64.26 0.87 Allowed 'General case' 0 N--CA 1.482 1.166 0 C-N-CA 124.52 1.128 . . . . 0.0 111.2 -173.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.49 ' HE2' ' HB2' ' A' ' 90' ' ' ARG . 52.5 t80 -90.61 -38.21 13.29 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 171.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . 0.574 ' HA2' ' HB3' ' A' ' 83' ' ' PRO . . . 98.49 -88.34 0.87 Allowed Glycine 0 C--N 1.342 0.901 0 CA-C-N 115.494 -0.776 . . . . 0.0 111.507 -179.685 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -81.21 88.37 6.04 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 122.839 0.455 . . . . 0.0 109.885 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.3 tt -61.93 -22.44 28.7 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.227 0 C-N-CA 123.516 0.726 . . . . 0.0 110.744 177.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . 0.761 ' HA ' ' HD3' ' A' ' 93' ' ' LYS . 24.7 p -65.19 -22.51 66.91 Favored 'General case' 0 CA--C 1.549 0.906 0 C-N-CA 124.711 1.204 . . . . 0.0 112.816 176.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.49 ' HB2' ' HE2' ' A' ' 85' ' ' PHE . 23.6 mmm180 -76.84 -78.5 0.12 Allowed 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.972 0.509 . . . . 0.0 109.671 174.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 49.9 t -118.26 149.88 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.96 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -179.67 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.8 m80 68.82 33.65 3.57 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.569 1.148 . . . . 0.0 110.391 -169.606 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.761 ' HD3' ' HA ' ' A' ' 89' ' ' THR . 27.2 tptp -83.37 38.48 0.61 Allowed 'General case' 0 CA--C 1.559 1.302 0 C-N-CA 125.11 1.364 . . . . 0.0 109.344 175.353 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -94.95 29.42 2.4 Favored 'General case' 0 CA--C 1.545 0.758 0 C-N-CA 125.5 1.52 . . . . 0.0 109.074 177.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -60.33 -34.27 73.59 Favored 'General case' 0 C--N 1.35 0.613 0 C-N-CA 124.523 1.129 . . . . 0.0 109.879 172.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.76 -34.81 78.72 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 124.042 0.937 . . . . 0.0 110.856 176.674 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.24 -49.5 49.3 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 123.226 0.61 . . . . 0.0 110.442 179.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.51 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 84.4 mmm -60.95 -42.94 99.21 Favored 'General case' 0 N--CA 1.49 1.568 0 C-N-CA 123.644 0.778 . . . . 0.0 112.983 175.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.1 t80 -49.79 -46.56 50.94 Favored 'General case' 0 N--CA 1.483 1.224 0 CA-C-N 115.036 -0.984 . . . . 0.0 109.789 171.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.455 ' HA ' ' CG ' ' A' ' 103' ' ' ARG . 3.7 mt-10 -80.06 -25.82 39.93 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 115.402 -0.817 . . . . 0.0 112.618 -177.075 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -67.0 -58.76 4.31 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.943 0.897 . . . . 0.0 110.107 178.246 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 17.9 mt -60.53 -41.13 86.62 Favored 'Isoleucine or valine' 0 CA--C 1.557 1.218 0 CA-C-N 115.334 -0.848 . . . . 0.0 112.528 175.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.455 ' CG ' ' HA ' ' A' ' 100' ' ' GLU . 4.8 ppt_? -64.63 -30.22 71.24 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 118.444 0.566 . . . . 0.0 110.34 179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.456 ' O ' ' HB3' ' A' ' 107' ' ' HIS . . . -71.25 -47.25 58.24 Favored 'General case' 0 C--N 1.349 0.556 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.25 -179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.5 ' HB3' HG21 ' A' ' 31' ' ' VAL . 6.2 tmtp? -69.78 -30.56 68.15 Favored 'General case' 0 CA--C 1.56 1.345 0 C-N-CA 122.998 0.519 . . . . 0.0 111.847 177.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.551 HD23 ' HG3' ' A' ' 62' ' ' ARG . 2.2 mp -63.9 -23.82 67.49 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 123.839 0.855 . . . . 0.0 111.717 172.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.456 ' HB3' ' O ' ' A' ' 104' ' ' ALA . 85.2 t60 -72.57 -15.15 61.76 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.571 1.148 . . . . 0.0 110.907 172.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 79.42 5.75 2.08 Favored 'General case' 0 N--CA 1.494 1.761 0 C-N-CA 126.528 1.931 . . . . 0.0 112.509 178.966 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.4 m80 -151.17 134.17 8.77 Favored Pre-proline 0 N--CA 1.474 0.759 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 172.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -69.0 84.52 0.53 Allowed 'Trans proline' 0 C--N 1.379 2.171 0 C-N-CA 122.581 2.187 . . . . 0.0 112.503 -169.128 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -88.29 54.68 4.22 Favored Glycine 0 C--N 1.346 1.109 0 N-CA-C 110.641 -0.984 . . . . 0.0 110.641 175.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -92.73 143.44 27.05 Favored Pre-proline 0 CA--C 1.545 0.763 0 C-N-CA 124.26 1.024 . . . . 0.0 109.514 -174.54 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -69.81 132.29 22.95 Favored 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 123.012 2.474 . . . . 0.0 112.19 179.844 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.525 HG22 ' HG ' ' A' ' 116' ' ' LEU . 7.8 p -77.02 121.81 30.2 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.086 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 174.076 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 35.8 t70 -75.05 -21.56 58.95 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 122.078 -0.389 . . . . 0.0 111.982 -168.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.525 ' HG ' HG22 ' A' ' 114' ' ' VAL . 4.3 pp -59.47 -26.6 65.38 Favored 'General case' 0 N--CA 1.487 1.395 0 CA-C-O 120.9 0.381 . . . . 0.0 111.311 -179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 11.3 tp10 -64.14 -35.65 81.47 Favored 'General case' 0 C--N 1.352 0.697 0 C-N-CA 124.219 1.008 . . . . 0.0 110.815 177.762 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 23.8 tpt180 -67.9 -27.06 66.33 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 124.318 1.047 . . . . 0.0 111.085 -173.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.531 HG22 HG13 ' A' ' 120' ' ' ILE . 2.3 mp -74.67 -57.8 5.87 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.755 0 C-N-CA 123.319 0.648 . . . . 0.0 109.676 -179.027 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.531 HG13 HG22 ' A' ' 119' ' ' ILE . 78.2 mt -116.7 101.89 12.79 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.136 0 N-CA-C 109.206 -0.665 . . . . 0.0 109.206 178.744 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 67.3 mtm180 -103.14 -61.11 1.45 Allowed 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 123.658 0.783 . . . . 0.0 109.411 175.045 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -167.16 149.77 6.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.925 0.89 . . . . 0.0 109.576 -174.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.9 mm-40 -67.76 104.07 1.57 Allowed 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 173.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -61.55 -26.41 66.52 Favored Glycine 0 C--N 1.352 1.431 0 O-C-N 123.67 0.607 . . . . 0.0 113.544 -179.144 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 25.2 m . . . . . 0 C--O 1.252 1.206 0 C-N-CA 123.973 0.909 . . . . 0.0 109.261 174.839 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 2.1 mp0 . . . . . 0 N--CA 1.477 0.883 0 N-CA-C 108.973 -0.751 . . . . 0.0 108.973 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -79.08 105.27 2.21 Favored Glycine 0 C--N 1.346 1.127 0 N-CA-C 110.194 -1.162 . . . . 0.0 110.194 175.291 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 5.8 t-160 -64.15 -43.25 95.79 Favored 'General case' 0 N--CA 1.474 0.773 0 C-N-CA 123.353 0.661 . . . . 0.0 110.549 -171.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 88.1 mtp -125.06 97.46 5.26 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 109.4 -0.592 . . . . 0.0 109.4 173.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.6 t80 -119.35 125.76 49.81 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 170.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -143.0 153.74 60.88 Favored Pre-proline 0 CA--C 1.549 0.92 0 C-N-CA 124.055 0.942 . . . . 0.0 109.586 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -59.34 106.28 0.3 Allowed 'Trans proline' 0 C--N 1.376 2.005 0 C-N-CA 122.319 2.013 . . . . 0.0 112.112 175.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.88 -22.02 9.34 Favored Glycine 0 C--N 1.348 1.209 0 CA-C-N 116.226 -0.443 . . . . 0.0 113.014 -178.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -153.89 124.58 7.16 Favored 'General case' 0 CA--C 1.55 0.953 0 CA-C-O 121.304 0.574 . . . . 0.0 112.474 -170.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.583 HD23 HD12 ' A' ' 27' ' ' ILE . 56.8 tp -103.5 148.13 26.32 Favored 'General case' 0 N--CA 1.473 0.686 0 C-N-CA 123.898 0.879 . . . . 0.0 108.78 165.082 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 15.8 t-160 -122.78 116.6 23.99 Favored 'General case' 0 N--CA 1.471 0.62 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 167.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.621 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 71.6 mt -89.29 109.59 20.47 Favored 'General case' 0 C--N 1.35 0.621 0 N-CA-C 108.203 -1.036 . . . . 0.0 108.203 175.17 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 19.9 m -125.55 169.28 17.16 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 N-CA-C 108.223 -1.029 . . . . 0.0 108.223 169.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 10.8 t -136.08 160.29 39.09 Favored 'General case' 0 C--O 1.246 0.873 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 162.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.594 HD12 HE21 ' A' ' 20' ' ' GLN . 2.5 pp -52.32 122.6 25.43 Favored Pre-proline 0 CA--C 1.566 1.562 0 CA-C-N 118.108 0.413 . . . . 0.0 111.572 -172.196 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 91.4 Cg_endo -71.66 155.82 58.33 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 123.744 2.962 . . . . 0.0 113.359 -163.103 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 158.16 -7.36 0.18 Allowed Glycine 0 C--N 1.342 0.875 0 CA-C-O 118.566 -1.13 . . . . 0.0 113.663 178.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 76.6 mt 73.9 -47.99 0.66 Allowed 'General case' 0 N--CA 1.495 1.816 0 C-N-CA 125.257 1.423 . . . . 0.0 112.302 -178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -63.63 -28.19 69.75 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.151 1.38 . . . . 0.0 112.698 -176.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.594 HE21 HD12 ' A' ' 15' ' ' LEU . 0.4 OUTLIER -83.54 -19.22 36.05 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 123.167 0.587 . . . . 0.0 111.529 177.911 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.402 ' HB2' ' O ' ' A' ' 20' ' ' GLN . 20.4 mt-30 101.14 121.25 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 128.318 2.647 . . . . 0.0 108.103 -171.464 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.427 ' H ' ' HA ' ' A' ' 50' ' ' ASP . 0.4 OUTLIER -101.45 70.71 1.31 Allowed 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 -170.524 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 2.5 pp -88.15 119.6 35.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.435 0 CA-C-N 114.88 -1.055 . . . . 0.0 108.303 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 33.8 m-80 -142.52 109.78 5.63 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 -172.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.621 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 49.1 mt -133.53 129.8 56.14 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 C-N-CA 123.732 0.813 . . . . 0.0 109.194 -167.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.465 ' O ' ' HA ' ' A' ' 45' ' ' MET . 14.7 m170 -100.11 108.69 20.89 Favored 'General case' 0 C--O 1.226 -0.15 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 178.537 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.583 HD12 HD23 ' A' ' 10' ' ' LEU . 41.5 mt -103.22 108.5 24.53 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.615 0 N-CA-C 108.152 -1.055 . . . . 0.0 108.152 -179.666 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 48.8 ttp180 -109.5 112.61 24.8 Favored 'General case' 0 C--O 1.234 0.253 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 178.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.7 p90 -111.07 118.11 35.13 Favored 'General case' 0 CA--C 1.535 0.379 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -124.31 115.03 20.35 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.036 0.934 . . . . 0.0 109.09 -172.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 7.1 p -69.99 120.69 18.15 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.86 0 CA-C-O 121.594 0.711 . . . . 0.0 109.567 170.352 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -138.4 154.79 48.9 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 26.5 mm-40 -103.78 120.6 41.3 Favored 'General case' 0 N--CA 1.476 0.854 0 CA-C-O 120.625 0.25 . . . . 0.0 111.224 -173.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.585 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -103.62 154.02 19.97 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 124.609 1.164 . . . . 0.0 110.419 169.703 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.58 -23.07 61.67 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.094 0.558 . . . . 0.0 111.449 177.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -67.23 -54.61 19.46 Favored 'General case' 0 CA--C 1.547 0.849 0 C-N-CA 124.258 1.023 . . . . 0.0 111.755 -177.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.422 ' HB3' HD21 ' A' ' 34' ' ' ASN . 35.5 t -120.94 5.91 10.4 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 123.226 0.611 . . . . 0.0 111.812 -171.101 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 76.68 -101.09 1.5 Allowed Glycine 0 C--N 1.339 0.727 0 N-CA-C 110.317 -1.113 . . . . 0.0 110.317 -174.689 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.556 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -83.78 145.36 28.74 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 122.961 0.505 . . . . 0.0 110.706 171.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 12.5 p90 -151.48 174.32 13.53 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 16.8 t -125.73 132.57 70.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 175.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 61.7 t60 -96.94 134.16 40.65 Favored 'General case' 0 N--CA 1.469 0.507 0 C-N-CA 124.195 0.998 . . . . 0.0 108.613 173.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -120.66 125.75 48.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.122 0.569 . . . . 0.0 109.829 -176.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.481 ' O ' ' HA ' ' A' ' 27' ' ' ILE . 30.4 m-20 -108.13 148.74 29.43 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 123.646 0.779 . . . . 0.0 109.505 172.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.465 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 21.4 mtm -141.4 132.53 26.33 Favored 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 124.587 1.155 . . . . 0.0 108.469 171.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.4 p-10 -167.53 159.55 12.3 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 120.863 0.363 . . . . 0.0 111.266 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.78 -121.1 1.36 Allowed Glycine 0 C--N 1.335 0.511 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 11.8 pt-20 -142.08 171.01 14.64 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 172.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 mt -154.95 103.79 0.14 Allowed 'Isoleucine or valine' 0 C--O 1.249 1.071 0 N-CA-C 104.747 -2.316 . . . . 0.0 104.747 -176.733 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.427 ' HA ' ' H ' ' A' ' 22' ' ' ASP . 36.6 t70 58.37 46.13 15.81 Favored 'General case' 0 CA--C 1.557 1.239 0 CA-C-O 122.345 1.069 . . . . 0.0 109.467 -178.13 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 89.16 -36.22 3.53 Favored Glycine 0 CA--C 1.535 1.311 0 CA-C-N 114.661 -1.154 . . . . 0.0 114.177 -177.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 29.8 mtmm -79.01 111.95 23.93 Favored Pre-proline 0 N--CA 1.479 1.013 0 C-N-CA 124.568 1.147 . . . . 0.0 112.312 -171.625 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.487 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 31.6 Cg_exo -61.3 146.83 96.91 Favored 'Trans proline' 0 C--N 1.377 2.066 0 C-N-CA 123.795 2.997 . . . . 0.0 113.099 175.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.416 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 4.3 p90 -151.22 163.92 37.76 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 122.442 0.297 . . . . 0.0 110.683 -178.835 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 56.2 p -153.58 117.43 4.75 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.288 0.635 . . . . 0.0 111.206 171.696 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -130.32 159.27 37.47 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.687 1.195 . . . . 0.0 109.751 174.852 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 51.8 p -157.19 133.46 9.72 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.731 0.413 . . . . 0.0 110.61 173.123 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -133.3 145.95 50.91 Favored 'General case' 0 N--CA 1.47 0.56 0 C-N-CA 123.826 0.85 . . . . 0.0 109.635 -178.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -114.08 143.57 44.56 Favored 'General case' 0 N--CA 1.479 0.987 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 95.7 mt -136.74 138.95 27.65 Favored Pre-proline 0 N--CA 1.472 0.648 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 178.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -63.6 149.27 91.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.523 2.149 . . . . 0.0 110.797 172.273 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.556 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 30.8 ptt85 -42.14 -39.29 1.96 Allowed 'General case' 0 N--CA 1.491 1.623 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -177.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -73.15 -19.77 61.06 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.557 0.743 . . . . 0.0 112.744 -174.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.1 p -130.48 9.66 5.13 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.55 0.74 . . . . 0.0 109.91 -176.438 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -64.25 -30.76 71.8 Favored 'General case' 0 N--CA 1.475 0.78 0 C-N-CA 123.948 0.899 . . . . 0.0 111.048 177.875 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 41.4 m-85 -69.11 -11.33 60.69 Favored 'General case' 0 N--CA 1.477 0.9 0 C-N-CA 124.393 1.077 . . . . 0.0 113.046 179.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.4 m-20 -80.62 3.87 20.49 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.294 0.637 . . . . 0.0 111.195 174.69 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.3 p90 -67.88 -21.18 65.16 Favored 'General case' 0 C--O 1.212 -0.883 0 C-N-CA 124.324 1.05 . . . . 0.0 112.571 -175.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -77.86 -47.12 19.53 Favored 'General case' 0 N--CA 1.474 0.728 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 -169.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.3 m -69.61 -35.23 75.1 Favored 'General case' 0 CA--C 1.539 0.526 0 CA-C-N 114.055 -1.43 . . . . 0.0 109.841 176.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 19.6 t70 -71.41 -54.55 10.31 Favored 'General case' 0 C--N 1.355 0.81 0 C-N-CA 123.498 0.719 . . . . 0.0 111.602 -178.247 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -52.15 -44.72 64.71 Favored 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 124.24 1.016 . . . . 0.0 111.947 176.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 92.3 m -63.02 -49.24 75.42 Favored 'General case' 0 CA--C 1.544 0.715 0 O-C-N 123.418 0.449 . . . . 0.0 110.312 174.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.506 ' O ' ' HD3' ' A' ' 78' ' ' LYS . 18.3 ttp85 -51.15 -52.78 40.66 Favored 'General case' 0 N--CA 1.482 1.134 0 C-N-CA 124.322 1.049 . . . . 0.0 111.999 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 6.2 p -72.92 -32.39 39.7 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 122.862 0.465 . . . . 0.0 110.551 -175.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.0 -41.56 74.21 Favored 'General case' 0 N--CA 1.475 0.783 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 -177.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.572 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 96.4 mt-30 -54.27 -30.77 51.84 Favored 'General case' 0 N--CA 1.488 1.474 0 C-N-CA 124.604 1.162 . . . . 0.0 112.969 178.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.506 ' HD3' ' O ' ' A' ' 74' ' ' ARG . 13.8 mptt -75.2 -7.64 54.41 Favored 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 123.53 0.732 . . . . 0.0 111.175 -176.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 69.5 m80 -93.11 7.57 43.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 123.587 0.755 . . . . 0.0 110.684 174.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 94.26 64.51 1.02 Allowed Glycine 0 C--N 1.352 1.424 0 N-CA-C 114.265 0.466 . . . . 0.0 114.265 -179.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 11.0 mp -103.56 142.5 34.17 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 168.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -111.49 98.89 42.28 Favored Pre-proline 0 CA--C 1.54 0.575 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 168.143 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_exo -60.18 -5.92 4.54 Favored 'Trans proline' 0 C--N 1.386 2.512 0 C-N-CA 123.675 2.917 . . . . 0.0 114.005 176.069 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 9.1 tmtm? -59.14 -38.32 79.38 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 124.501 1.121 . . . . 0.0 110.275 172.672 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -89.72 -21.09 22.87 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.136 0.174 . . . . 0.0 111.134 173.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -73.72 -129.51 0.16 Allowed Glycine 0 CA--C 1.537 1.412 0 C-N-CA 123.195 0.426 . . . . 0.0 113.726 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.34 94.48 2.46 Favored 'General case' 0 N--CA 1.477 0.89 0 CA-C-N 117.383 0.591 . . . . 0.0 110.041 -178.792 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.9 tt -98.91 -41.72 10.26 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.127 0 C-N-CA 123.521 0.729 . . . . 0.0 110.689 -178.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 24.8 m -89.97 -33.69 16.29 Favored 'General case' 0 N--CA 1.477 0.898 0 C-N-CA 123.815 0.846 . . . . 0.0 110.229 177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.3 mmt180 -75.93 86.1 2.87 Favored 'General case' 0 C--O 1.243 0.73 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.366 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 24.8 t -76.54 92.4 1.0 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.663 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -73.77 116.55 14.49 Favored 'General case' 0 CA--C 1.55 0.943 0 CA-C-N 115.036 -0.984 . . . . 0.0 111.684 -174.503 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 62.0 pttt -77.48 12.78 1.44 Allowed 'General case' 0 N--CA 1.487 1.385 0 C-N-CA 123.962 0.905 . . . . 0.0 111.818 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -64.39 -24.14 67.53 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 123.834 0.853 . . . . 0.0 110.364 167.134 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -62.64 -48.98 77.0 Favored 'General case' 0 C--O 1.204 -1.326 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.406 168.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -55.32 -33.9 63.73 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 123.028 0.531 . . . . 0.0 111.458 178.73 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.66 -50.34 63.22 Favored 'General case' 0 CA--C 1.548 0.903 0 CA-C-N 115.554 -0.748 . . . . 0.0 111.445 176.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.461 ' HE1' HD22 ' A' ' 10' ' ' LEU . 28.3 ttm -71.87 -37.21 70.23 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.757 0.823 . . . . 0.0 112.541 -177.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 70.3 t80 -51.12 -48.22 61.8 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 125.465 1.506 . . . . 0.0 110.301 171.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 23.2 mt-10 -77.84 -28.75 50.24 Favored 'General case' 0 C--N 1.344 0.357 0 CA-C-N 115.09 -0.959 . . . . 0.0 112.287 -179.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -63.53 -50.53 69.2 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 123.2 0.6 . . . . 0.0 110.423 176.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.449 ' O ' HD13 ' A' ' 106' ' ' LEU . 56.0 mt -61.02 -49.15 85.89 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 C-N-CA 123.998 0.919 . . . . 0.0 111.597 175.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.569 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 1.2 ppt_? -61.85 -30.63 70.97 Favored 'General case' 0 N--CA 1.495 1.78 0 CA-C-N 118.146 0.43 . . . . 0.0 111.31 -177.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.26 -44.76 58.78 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 115.725 -0.67 . . . . 0.0 110.033 178.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 1.7 tpmt? -65.6 -33.68 76.48 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.25 1.02 . . . . 0.0 111.787 177.38 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.449 HD13 ' O ' ' A' ' 102' ' ' ILE . 6.8 mp -70.52 -22.16 62.66 Favored 'General case' 0 N--CA 1.482 1.165 0 C-N-CA 124.506 1.122 . . . . 0.0 111.338 174.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 49.2 t60 -89.25 -18.7 26.5 Favored 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 123.15 0.58 . . . . 0.0 109.854 170.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 72.87 -70.36 0.16 Allowed 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 126.001 1.72 . . . . 0.0 111.526 176.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 13.5 m-70 -72.0 133.35 83.97 Favored Pre-proline 0 CA--C 1.548 0.895 0 C-N-CA 123.953 0.901 . . . . 0.0 109.436 178.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 7.7 Cg_exo -72.01 79.33 1.69 Allowed 'Trans proline' 0 C--N 1.374 1.903 0 C-N-CA 122.95 2.433 . . . . 0.0 111.297 176.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -85.61 -20.72 55.77 Favored Glycine 0 C--N 1.346 1.095 0 CA-C-N 115.255 -0.884 . . . . 0.0 112.698 179.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -127.45 145.26 53.89 Favored Pre-proline 0 CA--C 1.548 0.867 0 C-N-CA 124.293 1.037 . . . . 0.0 109.634 179.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -70.66 105.23 1.59 Allowed 'Trans proline' 0 C--N 1.377 2.056 0 C-N-CA 122.667 2.245 . . . . 0.0 110.126 171.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.523 HG23 ' HB3' ' A' ' 100' ' ' GLU . 7.3 p -67.97 125.35 25.44 Favored 'Isoleucine or valine' 0 CA--C 1.554 1.126 0 CA-C-O 121.39 0.614 . . . . 0.0 110.491 -177.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -80.24 7.93 8.42 Favored 'General case' 0 CA--C 1.555 1.146 0 C-N-CA 123.893 0.877 . . . . 0.0 112.52 -166.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 117' ' ' GLU . 3.1 pp -55.88 -26.83 49.03 Favored 'General case' 0 N--CA 1.489 1.511 0 N-CA-C 112.958 0.725 . . . . 0.0 112.958 179.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.423 ' N ' HD12 ' A' ' 116' ' ' LEU . 44.2 tt0 -72.76 -33.2 66.18 Favored 'General case' 0 C--O 1.24 0.604 0 CA-C-N 115.61 -0.723 . . . . 0.0 111.504 -178.83 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 7.0 ttm180 -81.61 -7.45 59.59 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.691 -167.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -63.1 -19.82 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.563 1.451 0 C-N-CA 123.703 0.801 . . . . 0.0 110.519 170.104 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 46.8 mt 81.26 112.16 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 C-N-CA 126.802 2.041 . . . . 0.0 109.081 -172.12 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 8.9 ptp180 -140.81 15.1 2.31 Favored 'General case' 0 CA--C 1.543 0.702 0 C-N-CA 124.803 1.241 . . . . 0.0 110.195 -174.266 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 66.7 t60 -68.53 131.93 46.09 Favored 'General case' 0 C--N 1.358 0.942 0 C-N-CA 123.057 0.543 . . . . 0.0 110.386 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -113.27 -40.47 3.89 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 123.828 0.851 . . . . 0.0 110.241 178.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.8 -166.22 36.69 Favored Glycine 0 C--N 1.347 1.162 0 CA-C-N 116.346 -0.388 . . . . 0.0 112.686 -178.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 29.7 m . . . . . 0 C--O 1.249 1.068 0 C-N-CA 124.043 0.937 . . . . 0.0 109.073 178.161 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.3 mm-40 . . . . . 0 N--CA 1.477 0.901 0 N-CA-C 110.164 -0.31 . . . . 0.0 110.164 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 171.24 171.82 36.81 Favored Glycine 0 C--N 1.34 0.794 0 O-C-N 123.562 0.539 . . . . 0.0 111.903 -178.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 41.0 m-70 -86.15 168.66 13.81 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.975 0.51 . . . . 0.0 110.786 -179.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 6.1 tpt -137.31 172.14 13.43 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 124.387 1.075 . . . . 0.0 109.095 -171.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 50.2 t80 -80.26 127.31 32.2 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 173.503 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -135.33 154.22 78.5 Favored Pre-proline 0 CA--C 1.541 0.618 0 C-N-CA 125.27 1.428 . . . . 0.0 107.834 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -52.1 110.19 0.42 Allowed 'Trans proline' 0 C--N 1.365 1.432 0 C-N-CA 122.276 1.984 . . . . 0.0 111.658 167.294 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.2 -21.56 10.06 Favored Glycine 0 N--CA 1.471 0.979 0 C-N-CA 123.057 0.36 . . . . 0.0 112.736 -179.778 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 25.9 t-80 -150.93 119.83 6.64 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.255 0.622 . . . . 0.0 111.434 -172.892 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.461 HD23 HD12 ' A' ' 27' ' ' ILE . 59.9 tp -102.35 143.21 32.39 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 124.346 1.058 . . . . 0.0 108.912 172.453 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.8 t-160 -120.71 124.67 45.74 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.234 0.613 . . . . 0.0 110.298 174.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.52 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 70.8 mt -102.0 128.31 48.49 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 122.882 0.473 . . . . 0.0 109.921 174.595 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 18.8 m -124.78 159.71 30.84 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.214 0 N-CA-C 107.326 -1.361 . . . . 0.0 107.326 159.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 30.9 t -67.45 129.02 38.59 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 122.838 0.455 . . . . 0.0 110.585 -170.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 82.3 mt -65.2 108.74 2.26 Favored Pre-proline 0 CA--C 1.546 0.815 0 C-N-CA 123.999 0.92 . . . . 0.0 110.088 -176.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -63.5 141.68 81.51 Favored 'Trans proline' 0 C--N 1.369 1.637 0 C-N-CA 123.614 2.876 . . . . 0.0 113.705 -163.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 124.89 -24.9 5.94 Favored Glycine 0 C--N 1.35 1.324 0 CA-C-N 116.035 -0.53 . . . . 0.0 112.85 178.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 75.1 mt -92.14 -71.99 0.61 Allowed 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.286 0.634 . . . . 0.0 110.774 -177.048 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -153.51 126.06 8.16 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.17 0.988 . . . . 0.0 108.711 -174.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -86.57 69.69 10.38 Favored 'General case' 0 CA--C 1.549 0.91 0 N-CA-C 109.126 -0.694 . . . . 0.0 109.126 -177.451 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -80.92 144.55 31.83 Favored 'General case' 0 C--O 1.24 0.579 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.456 168.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -87.41 70.65 9.94 Favored 'General case' 0 C--O 1.244 0.768 0 CA-C-O 121.462 0.648 . . . . 0.0 109.799 -173.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.8 pp -106.86 142.15 20.38 Favored 'Isoleucine or valine' 0 C--O 1.243 0.717 0 CA-C-N 114.855 -1.066 . . . . 0.0 110.363 179.25 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.692 HD21 ' HG2' ' A' ' 48' ' ' GLU . 8.1 p30 -151.78 128.71 11.0 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 169.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.52 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 67.3 mt -127.99 129.23 69.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.429 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -171.708 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.421 ' O ' ' HA ' ' A' ' 45' ' ' MET . 1.5 m170 -102.05 109.02 20.63 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 105.565 -2.013 . . . . 0.0 105.565 177.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.461 HD12 HD23 ' A' ' 10' ' ' LEU . 53.8 mt -101.75 105.52 18.09 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 176.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.551 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 27.0 mtp-105 -101.59 108.8 20.46 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 113.998 -1.456 . . . . 0.0 107.335 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 10.9 p90 -111.83 116.97 31.54 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 37.4 mt-10 -121.21 111.21 17.11 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 -175.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 41' ' ' VAL . 44.3 t -83.94 116.52 27.96 Favored 'Isoleucine or valine' 0 C--O 1.239 0.512 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 178.167 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 40.2 ttt-85 -127.61 155.15 44.33 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 124.116 0.966 . . . . 0.0 108.51 -178.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.6 mm-40 -105.87 111.84 24.66 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 175.358 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.539 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -97.64 146.94 24.83 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.828 0.851 . . . . 0.0 110.087 173.238 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.45 -18.05 62.33 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 122.922 0.489 . . . . 0.0 111.694 -179.881 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -69.04 -53.32 21.1 Favored 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 124.01 0.924 . . . . 0.0 111.555 179.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.434 ' HB3' HD21 ' A' ' 34' ' ' ASN . 26.3 t -124.96 5.71 7.99 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 123.05 0.54 . . . . 0.0 112.294 -169.556 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 78.92 -114.77 3.98 Favored Glycine 0 C--N 1.344 0.977 0 N-CA-C 111.126 -0.79 . . . . 0.0 111.126 -178.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -80.82 137.98 36.22 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 123.021 0.529 . . . . 0.0 110.129 174.172 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.404 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 4.3 p90 -152.84 166.96 30.65 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 109.211 -0.663 . . . . 0.0 109.211 170.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.469 HG22 HG22 ' A' ' 31' ' ' VAL . 10.8 t -124.02 122.15 63.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 174.218 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 38.3 t60 -81.09 116.6 21.1 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 170.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 90.8 m-85 -100.26 135.53 41.56 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 175.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.551 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 25.5 t70 -137.9 141.52 40.65 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 123.757 0.823 . . . . 0.0 108.831 -175.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 86.6 mtp -138.46 131.91 30.49 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 123.45 0.7 . . . . 0.0 110.0 -174.613 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.8 p-10 -150.48 176.42 10.96 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 123.017 0.527 . . . . 0.0 109.92 174.022 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 138.08 -135.34 7.43 Favored Glycine 0 N--CA 1.465 0.599 0 N-CA-C 110.937 -0.865 . . . . 0.0 110.937 175.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.692 ' HG2' HD21 ' A' ' 24' ' ' ASN . 8.0 pt-20 -151.63 168.06 26.17 Favored 'General case' 0 N--CA 1.475 0.801 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 174.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 mt -157.66 109.29 0.12 Allowed 'Isoleucine or valine' 0 C--O 1.242 0.681 0 N-CA-C 105.207 -2.146 . . . . 0.0 105.207 -166.562 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 13.9 t70 61.65 32.98 18.36 Favored 'General case' 0 N--CA 1.488 1.471 0 CA-C-O 121.798 0.808 . . . . 0.0 109.431 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 88.35 -25.41 9.25 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.934 0.733 . . . . 0.0 114.934 -173.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -82.15 118.94 73.83 Favored Pre-proline 0 N--CA 1.484 1.252 0 CA-C-N 117.831 0.816 . . . . 0.0 111.708 -175.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 64.4 Cg_endo -69.89 148.21 63.73 Favored 'Trans proline' 0 C--N 1.377 2.039 0 C-N-CA 122.639 2.226 . . . . 0.0 112.887 176.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 7.5 p90 -142.8 150.52 40.08 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.313 0.645 . . . . 0.0 109.959 179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 61.2 m -146.75 122.49 10.55 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.442 0.697 . . . . 0.0 110.348 173.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -148.89 152.62 36.75 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 124.127 0.971 . . . . 0.0 109.175 175.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 15.0 p -147.98 137.2 22.18 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 123.217 0.607 . . . . 0.0 110.699 -177.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -137.47 140.18 41.06 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 124.192 0.997 . . . . 0.0 109.71 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.9 mp0 -112.86 129.58 56.4 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -177.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 90.7 mt -123.19 129.01 25.1 Favored Pre-proline 0 N--CA 1.474 0.75 0 C-N-CA 123.581 0.753 . . . . 0.0 109.332 -179.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.404 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 40.2 Cg_endo -63.73 164.75 20.33 Favored 'Trans proline' 0 C--N 1.378 2.087 0 C-N-CA 123.042 2.495 . . . . 0.0 112.126 173.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.13 -32.61 7.12 Favored 'General case' 0 N--CA 1.486 1.347 0 C-N-CA 124.223 1.009 . . . . 0.0 113.467 -179.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -71.74 -31.51 66.76 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.344 1.058 . . . . 0.0 112.191 -177.006 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 81.5 p -125.73 12.48 7.94 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 123.338 0.655 . . . . 0.0 110.517 -171.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -59.65 -41.18 89.97 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 123.826 0.85 . . . . 0.0 112.116 -176.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 39.9 m-85 -70.23 -8.05 46.95 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 124.476 1.11 . . . . 0.0 113.096 -176.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 75.3 m-20 -80.55 1.2 30.55 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.258 0.623 . . . . 0.0 111.785 177.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.2 p90 -66.1 -18.97 65.69 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.722 1.209 . . . . 0.0 113.058 -179.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.34 -50.78 14.89 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.437 0.637 . . . . 0.0 109.734 -162.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 34.9 p -73.28 -31.41 64.04 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 114.299 -1.319 . . . . 0.0 110.309 176.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.413 ' O ' HG23 ' A' ' 75' ' ' VAL . 14.2 t70 -70.78 -58.22 3.85 Favored 'General case' 0 C--N 1.354 0.799 0 C-N-CA 123.282 0.633 . . . . 0.0 111.35 -175.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -53.27 -47.58 69.02 Favored 'General case' 0 N--CA 1.483 1.223 0 C-N-CA 124.251 1.02 . . . . 0.0 112.547 177.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.3 m -57.59 -47.08 83.11 Favored 'General case' 0 CA--C 1.547 0.862 0 C-N-CA 122.866 0.467 . . . . 0.0 110.758 176.14 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' HA ' ' HG2' ' A' ' 77' ' ' GLN . 39.4 ttp180 -57.96 -38.77 76.61 Favored 'General case' 0 N--CA 1.477 0.919 0 O-C-N 123.949 0.781 . . . . 0.0 112.508 175.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -59.63 -47.78 89.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.19 0 C-N-CA 123.116 0.566 . . . . 0.0 109.758 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.439 ' HB3' HD22 ' A' ' 81' ' ' LEU . . . -72.22 -40.09 68.06 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.583 -0.735 . . . . 0.0 111.896 -174.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.506 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 20.8 pt20 -73.56 -22.69 60.0 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 112.521 0.563 . . . . 0.0 112.521 -179.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.0 mtpp -66.13 -21.25 66.34 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 121.951 0.101 . . . . 0.0 110.732 166.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 46.1 m80 -99.56 6.16 45.86 Favored 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 123.857 0.863 . . . . 0.0 110.537 177.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 127.44 -95.85 0.43 Allowed Glycine 0 C--N 1.354 1.573 0 N-CA-C 111.201 -0.76 . . . . 0.0 111.201 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD13 HD11 ' A' ' 25' ' ' ILE . 32.5 tp 52.32 -80.22 0.01 OUTLIER 'General case' 0 CA--C 1.549 0.904 0 C-N-CA 126.466 1.906 . . . . 0.0 112.952 178.468 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -148.82 157.87 40.17 Favored Pre-proline 0 CA--C 1.549 0.905 0 C-N-CA 124.256 1.022 . . . . 0.0 109.983 -175.9 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -80.8 -167.67 0.53 Allowed 'Trans proline' 0 C--N 1.37 1.685 0 C-N-CA 122.481 2.12 . . . . 0.0 111.986 171.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 8.5 tmtm? -63.1 -36.08 82.42 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.636 0.774 . . . . 0.0 110.485 178.362 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 76.1 m-85 -59.48 -29.41 67.81 Favored 'General case' 0 N--CA 1.482 1.139 0 C-N-CA 123.515 0.726 . . . . 0.0 111.67 176.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -81.14 66.44 3.79 Favored Glycine 0 C--N 1.352 1.466 0 O-C-N 123.345 0.403 . . . . 0.0 112.437 176.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -86.23 85.75 7.34 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 123.043 0.537 . . . . 0.0 109.794 178.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 14.1 tt -76.24 -28.0 18.12 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.092 178.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.5 p -78.42 -13.19 59.95 Favored 'General case' 0 CA--C 1.549 0.909 0 C-N-CA 123.993 0.917 . . . . 0.0 111.789 178.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -63.28 -42.86 99.14 Favored 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.437 0.695 . . . . 0.0 109.445 170.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -93.39 150.82 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.117 0.967 . . . . 0.0 108.913 175.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 16.6 m-70 -84.46 86.63 7.26 Favored 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 108.906 -0.775 . . . . 0.0 108.906 172.08 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.2 tptt -79.26 71.68 5.8 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 121.8 0.81 . . . . 0.0 109.144 174.279 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 56.69 26.26 11.07 Favored 'General case' 0 N--CA 1.478 0.964 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.144 172.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -63.24 -41.97 99.15 Favored 'General case' 0 C--N 1.353 0.745 0 C-N-CA 123.962 0.905 . . . . 0.0 110.279 175.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -56.85 -32.62 65.97 Favored 'General case' 0 N--CA 1.479 1.0 0 O-C-N 124.071 0.857 . . . . 0.0 112.182 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.24 -47.95 63.25 Favored 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 123.486 0.714 . . . . 0.0 110.891 178.17 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 45.3 tpp -65.51 -40.79 93.41 Favored 'General case' 0 CA--C 1.549 0.93 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.485 177.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 51.2 t80 -55.04 -51.82 65.12 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 124.982 1.313 . . . . 0.0 111.311 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.404 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 10.1 pt-20 -69.7 -30.37 68.01 Favored 'General case' 0 N--CA 1.473 0.675 0 CA-C-N 115.729 -0.669 . . . . 0.0 111.67 -177.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 32.9 t70 -72.11 -45.62 59.88 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 122.311 0.244 . . . . 0.0 110.889 -179.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 63.4 mt -60.87 -45.35 98.3 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 C-N-CA 123.396 0.678 . . . . 0.0 110.683 175.992 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.404 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -64.56 -29.84 70.86 Favored 'General case' 0 N--CA 1.489 1.483 0 CA-C-O 120.614 0.245 . . . . 0.0 110.568 179.285 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.59 -45.72 51.46 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.439 0.696 . . . . 0.0 110.619 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.507 ' HA ' ' HE2' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -69.88 -29.88 67.19 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 122.941 0.496 . . . . 0.0 112.243 178.073 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.2 mp -70.2 -31.37 68.78 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 124.065 0.946 . . . . 0.0 110.486 171.821 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 66.8 t60 -72.76 -18.0 61.54 Favored 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 123.905 0.882 . . . . 0.0 110.493 169.232 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 80.56 -6.32 1.68 Allowed 'General case' 0 N--CA 1.485 1.312 0 C-N-CA 126.268 1.827 . . . . 0.0 112.619 176.642 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -138.98 142.75 34.5 Favored Pre-proline 0 N--CA 1.479 1.025 0 C-N-CA 124.368 1.067 . . . . 0.0 108.465 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 76.2 Cg_exo -50.18 128.31 22.21 Favored 'Trans proline' 0 C--N 1.386 2.502 0 C-N-CA 123.57 2.847 . . . . 0.0 112.866 -178.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -144.08 83.9 0.2 Allowed Glycine 0 C--N 1.334 0.443 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -174.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.425 ' HB2' ' HD2' ' A' ' 113' ' ' PRO . 11.6 pt-20 -77.68 172.02 10.91 Favored Pre-proline 0 CA--C 1.56 1.339 0 C-N-CA 123.915 0.886 . . . . 0.0 109.742 175.213 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.425 ' HD2' ' HB2' ' A' ' 112' ' ' GLU . 95.8 Cg_endo -76.95 48.75 2.58 Favored 'Trans proline' 0 C--N 1.379 2.137 0 C-N-CA 122.654 2.236 . . . . 0.0 112.882 172.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.8 p -71.19 130.0 35.02 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 108.807 -0.812 . . . . 0.0 108.807 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -104.08 29.7 5.74 Favored 'General case' 0 N--CA 1.472 0.631 0 C-N-CA 123.2 0.6 . . . . 0.0 111.009 -174.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -55.3 -30.62 60.53 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 123.733 0.813 . . . . 0.0 112.317 -176.128 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.479 ' HG2' ' HG2' ' A' ' 121' ' ' ARG . 34.1 tt0 -80.45 -32.91 37.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.458 0.703 . . . . 0.0 110.789 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.7 tmm_? -66.03 -18.55 65.42 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.299 1.04 . . . . 0.0 112.27 -168.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.541 HG22 HG12 ' A' ' 120' ' ' ILE . 3.9 mp -67.28 -52.83 38.45 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.713 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 175.538 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.541 HG12 HG22 ' A' ' 119' ' ' ILE . 33.3 mm -133.99 96.99 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.903 0 C-N-CA 123.555 0.742 . . . . 0.0 109.567 178.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.479 ' HG2' ' HG2' ' A' ' 117' ' ' GLU . 52.2 mtp180 -102.33 -45.75 5.01 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 22.0 t-80 -160.97 145.63 13.88 Favored 'General case' 0 C--O 1.24 0.598 0 CA-C-N 113.836 -1.529 . . . . 0.0 107.686 179.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 71.46 148.19 0.08 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.926 1.29 . . . . 0.0 110.72 -174.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 97.53 -56.2 1.2 Allowed Glycine 0 C--N 1.343 0.952 0 N-CA-C 111.518 -0.633 . . . . 0.0 111.518 -176.578 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 28.9 p . . . . . 0 CA--C 1.552 1.029 0 C-N-CA 123.157 0.583 . . . . 0.0 109.563 177.946 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 11.8 mm-40 . . . . . 0 N--CA 1.484 1.231 0 N-CA-C 109.977 -0.379 . . . . 0.0 109.977 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.464 ' HA3' HD23 ' A' ' 15' ' ' LEU . . . 98.88 -60.87 0.83 Allowed Glycine 0 C--N 1.342 0.88 0 N-CA-C 110.187 -1.165 . . . . 0.0 110.187 -171.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.503 ' HB2' HD11 ' A' ' 10' ' ' LEU . 47.3 p-80 -171.32 101.59 0.2 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.126 0.971 . . . . 0.0 109.428 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -86.48 97.24 10.37 Favored 'General case' 0 N--CA 1.471 0.618 0 N-CA-C 108.284 -1.006 . . . . 0.0 108.284 172.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.5 t80 -101.25 141.46 34.1 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 123.735 0.814 . . . . 0.0 110.887 -174.759 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -144.95 156.02 55.37 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.192 1.397 . . . . 0.0 108.363 173.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -60.72 105.76 0.33 Allowed 'Trans proline' 0 C--N 1.37 1.675 0 C-N-CA 122.109 1.872 . . . . 0.0 111.397 174.616 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 117.11 -20.61 11.36 Favored Glycine 0 N--CA 1.473 1.126 0 CA-C-N 115.906 -0.588 . . . . 0.0 113.243 178.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -153.04 143.88 22.87 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-N 117.413 0.607 . . . . 0.0 111.584 -175.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 3' ' ' HIS . 40.2 tp -129.33 141.26 51.13 Favored 'General case' 0 N--CA 1.469 0.489 0 C-N-CA 125.237 1.415 . . . . 0.0 108.276 176.282 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -127.57 121.18 29.92 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.563 0.745 . . . . 0.0 109.211 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.549 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 79.3 mt -100.53 128.9 46.45 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.419 0.687 . . . . 0.0 109.865 178.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 97.4 t -137.06 151.13 26.82 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 N-CA-C 105.37 -2.085 . . . . 0.0 105.37 166.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 43.7 t -86.2 115.28 23.66 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 120.766 1.621 . . . . 0.0 108.216 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.464 HD23 ' HA3' ' A' ' 2' ' ' GLY . 4.5 pp -71.43 144.07 88.65 Favored Pre-proline 0 CA--C 1.542 0.66 0 CA-C-O 119.107 -0.473 . . . . 0.0 109.943 177.293 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_endo -67.94 122.93 10.09 Favored 'Trans proline' 0 C--N 1.366 1.49 0 C-N-CA 122.026 1.817 . . . . 0.0 111.396 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 140.35 -69.24 0.47 Allowed Glycine 0 C--N 1.346 1.128 0 N-CA-C 112.087 -0.405 . . . . 0.0 112.087 174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 90.3 mt -70.73 -46.67 62.61 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-O 121.381 0.61 . . . . 0.0 109.91 179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -140.13 -177.68 5.11 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-N 114.607 -1.179 . . . . 0.0 109.218 174.681 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 58.8 tp60 -166.22 104.79 0.65 Allowed 'General case' 0 C--O 1.239 0.54 0 C-N-CA 123.567 0.747 . . . . 0.0 109.004 168.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -158.29 165.23 35.31 Favored 'General case' 0 N--CA 1.473 0.713 0 C-N-CA 124.697 1.199 . . . . 0.0 108.643 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -89.92 53.65 2.6 Favored 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.839 0.828 . . . . 0.0 111.102 -174.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.544 HG21 HD23 ' A' ' 81' ' ' LEU . 2.2 pp -90.54 116.03 31.03 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 169.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.6 m-80 -139.14 107.85 5.92 Favored 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 106.997 -1.483 . . . . 0.0 106.997 -177.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.549 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 59.1 mt -133.18 133.43 58.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.907 0 C-N-CA 123.643 0.777 . . . . 0.0 109.966 -163.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.474 ' O ' ' HA ' ' A' ' 45' ' ' MET . 2.7 m170 -104.8 113.87 27.73 Favored 'General case' 0 N--CA 1.471 0.61 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 176.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 37.8 mt -112.5 107.74 23.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.953 0 N-CA-C 108.637 -0.875 . . . . 0.0 108.637 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.6 ttp-105 -102.54 110.12 21.96 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 177.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.0 p90 -111.57 123.62 50.6 Favored 'General case' 0 N--CA 1.471 0.607 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 29.7 mt-10 -118.73 114.46 22.73 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 123.541 0.737 . . . . 0.0 109.15 -173.169 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.484 HG11 ' HG3' ' A' ' 105' ' ' LYS . 98.0 t -77.71 117.38 22.75 Favored 'Isoleucine or valine' 0 C--O 1.238 0.487 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 175.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -140.43 159.86 41.26 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 123.899 0.879 . . . . 0.0 109.103 -173.168 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.9 mm-40 -110.68 113.48 26.12 Favored 'General case' 0 CA--C 1.543 0.685 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 174.483 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.519 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -95.57 148.77 22.16 Favored 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 123.722 0.809 . . . . 0.0 109.598 170.987 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.22 -19.36 63.16 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 122.872 0.469 . . . . 0.0 111.432 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -71.05 -44.93 64.77 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 124.284 1.034 . . . . 0.0 112.323 -176.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.3 t -133.73 1.93 3.39 Favored 'General case' 0 N--CA 1.486 1.334 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 -172.368 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 84.83 -115.5 4.12 Favored Glycine 0 C--N 1.343 0.962 0 N-CA-C 110.932 -0.867 . . . . 0.0 110.932 -176.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.01 143.52 43.52 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 117.26 0.53 . . . . 0.0 110.359 174.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.418 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.9 p90 -160.3 172.79 16.72 Favored 'General case' 0 N--CA 1.477 0.911 0 C-N-CA 123.439 0.696 . . . . 0.0 109.148 169.123 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.1 t -131.01 130.25 63.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 N-CA-C 109.354 -0.609 . . . . 0.0 109.354 174.409 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 7.0 t-160 -88.68 116.45 26.94 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.866 0.866 . . . . 0.0 108.884 174.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -103.59 110.39 22.43 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 178.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -105.11 139.69 39.4 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.799 0.84 . . . . 0.0 109.165 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 40.5 mtm -141.71 140.19 33.1 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.906 0.482 . . . . 0.0 110.833 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -164.1 158.61 19.51 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 123.424 0.69 . . . . 0.0 109.724 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 154.18 -127.56 2.16 Favored Glycine 0 C--N 1.337 0.627 0 CA-C-O 119.577 -0.568 . . . . 0.0 112.052 -179.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -156.82 160.35 39.12 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 124.414 1.085 . . . . 0.0 109.27 -176.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.433 HG23 HG22 ' A' ' 23' ' ' ILE . 47.7 mt -158.04 107.49 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 N-CA-C 104.128 -2.545 . . . . 0.0 104.128 -170.185 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 38.3 t70 60.24 42.12 15.63 Favored 'General case' 0 N--CA 1.486 1.341 0 CA-C-O 122.531 1.158 . . . . 0.0 109.348 -170.496 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.99 -28.76 3.19 Favored Glycine 0 C--N 1.351 1.367 0 CA-C-N 114.64 -1.164 . . . . 0.0 114.382 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -82.57 121.41 78.03 Favored Pre-proline 0 CA--C 1.544 0.715 0 C-N-CA 124.147 0.979 . . . . 0.0 111.19 -169.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.26 152.21 76.01 Favored 'Trans proline' 0 C--N 1.376 1.98 0 C-N-CA 122.833 2.356 . . . . 0.0 113.231 -176.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 5.1 p90 -146.98 146.39 30.07 Favored 'General case' 0 N--CA 1.475 0.808 0 C-N-CA 123.313 0.645 . . . . 0.0 109.369 174.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.7 m -142.63 118.9 10.82 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.003 0.521 . . . . 0.0 110.153 175.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -151.24 154.92 37.76 Favored 'General case' 0 N--CA 1.482 1.163 0 C-N-CA 124.073 0.949 . . . . 0.0 109.917 -179.804 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.4 p -145.74 144.91 30.63 Favored 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 122.853 0.461 . . . . 0.0 110.41 177.503 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.8 p90 -136.64 136.95 39.57 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 124.09 0.956 . . . . 0.0 109.555 176.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -112.92 124.53 52.83 Favored 'General case' 0 C--O 1.242 0.663 0 N-CA-C 108.018 -1.105 . . . . 0.0 108.018 -178.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 74.6 mt -118.25 128.98 25.65 Favored Pre-proline 0 C--O 1.243 0.734 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.418 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 30.6 Cg_endo -60.38 159.26 27.86 Favored 'Trans proline' 0 C--N 1.375 1.958 0 C-N-CA 123.075 2.517 . . . . 0.0 112.069 171.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 37.3 ptt180 -42.63 -40.02 2.57 Favored 'General case' 0 N--CA 1.49 1.567 0 C-N-CA 124.944 1.298 . . . . 0.0 114.262 178.766 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -74.79 -15.12 60.76 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 123.777 0.831 . . . . 0.0 112.552 -175.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 66.2 p -132.03 4.55 4.13 Favored 'General case' 0 N--CA 1.483 1.222 0 C-N-CA 123.698 0.799 . . . . 0.0 111.778 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.2 -31.15 71.64 Favored 'General case' 0 N--CA 1.491 1.577 0 C-N-CA 123.947 0.899 . . . . 0.0 111.789 -176.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -65.34 -24.39 67.24 Favored 'General case' 0 N--CA 1.475 0.779 0 CA-C-N 114.483 -1.235 . . . . 0.0 112.261 179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 87.6 m-20 -73.96 -2.06 22.45 Favored 'General case' 0 N--CA 1.484 1.244 0 C-N-CA 123.599 0.76 . . . . 0.0 112.294 -174.481 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 2.3 p90 -70.9 -18.01 62.68 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.743 0.817 . . . . 0.0 111.809 -176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -73.88 -43.78 57.46 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 -167.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 11.3 p -76.11 -35.77 59.17 Favored 'General case' 0 CA--C 1.551 1.01 0 CA-C-N 114.238 -1.346 . . . . 0.0 111.206 171.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.435 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.8 t70 -71.17 -57.12 4.8 Favored 'General case' 0 N--CA 1.488 1.433 0 C-N-CA 123.345 0.658 . . . . 0.0 112.071 -172.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -49.36 -43.29 43.89 Favored 'General case' 0 N--CA 1.489 1.478 0 C-N-CA 124.212 1.005 . . . . 0.0 112.454 176.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 24.4 m -64.44 -46.66 82.19 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 115.582 -0.736 . . . . 0.0 110.256 176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.46 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 68.6 ttt180 -53.76 -44.21 69.82 Favored 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 123.75 0.82 . . . . 0.0 111.729 176.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.435 HG23 ' O ' ' A' ' 71' ' ' ASP . 57.4 t -60.75 -38.82 79.81 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.212 0 C-N-CA 123.078 0.551 . . . . 0.0 110.083 -177.722 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.16 -41.69 73.49 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-N 115.714 -0.676 . . . . 0.0 110.783 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 99.5 mt-30 -60.61 -34.04 73.64 Favored 'General case' 0 N--CA 1.485 1.278 0 C-N-CA 124.214 1.006 . . . . 0.0 111.363 178.566 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.46 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.3 mtpp -61.51 -36.76 81.42 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 123.559 0.743 . . . . 0.0 111.809 175.607 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.429 ' CD2' ' HB ' ' A' ' 49' ' ' ILE . 14.5 t60 -87.53 -33.19 19.04 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 -178.34 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 152.81 41.32 0.02 OUTLIER Glycine 0 C--N 1.358 1.788 0 C-N-CA 121.591 -0.338 . . . . 0.0 113.395 156.057 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.544 HD23 HG21 ' A' ' 23' ' ' ILE . 1.6 tm? -83.03 132.48 35.13 Favored 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 108.446 -0.946 . . . . 0.0 108.446 173.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.8 t-80 -61.26 129.25 90.64 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.291 1.036 . . . . 0.0 111.034 -178.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -60.09 90.43 0.08 OUTLIER 'Trans proline' 0 C--N 1.379 2.177 0 C-N-CA 122.569 2.179 . . . . 0.0 110.683 169.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 86.8 tttt -58.07 -27.73 63.91 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.992 1.317 . . . . 0.0 112.082 -174.62 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -54.77 -52.02 63.89 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.997 0.919 . . . . 0.0 111.444 179.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 62.75 -92.22 0.08 OUTLIER Glycine 0 CA--C 1.53 0.988 0 CA-C-N 115.732 -0.667 . . . . 0.0 112.224 -175.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -159.88 96.34 1.23 Allowed 'General case' 0 N--CA 1.471 0.602 0 C-N-CA 123.906 0.882 . . . . 0.0 108.977 178.404 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.1 tt -152.45 126.01 1.27 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 122.949 0.5 . . . . 0.0 110.563 -176.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 40.6 p -90.77 -34.31 15.38 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 123.849 0.86 . . . . 0.0 110.993 176.829 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -82.99 71.08 10.1 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.518 0.727 . . . . 0.0 110.751 -178.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.0 m -95.66 141.81 14.67 Favored 'Isoleucine or valine' 0 C--O 1.242 0.663 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.71 177.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 34.0 t-80 -86.97 147.06 25.91 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 176.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.733 ' HB3' ' HB3' ' A' ' 96' ' ' ASP . 36.0 mtmm -76.41 84.87 3.15 Favored 'General case' 0 CA--C 1.548 0.877 0 CA-C-O 121.163 0.506 . . . . 0.0 112.128 -172.558 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -81.08 -52.08 7.78 Favored 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 124.051 0.94 . . . . 0.0 109.379 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.9 t80 -57.93 -48.52 79.66 Favored 'General case' 0 C--O 1.214 -0.769 0 CA-C-N 114.041 -1.436 . . . . 0.0 110.514 -179.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.733 ' HB3' ' HB3' ' A' ' 93' ' ' LYS . 23.9 t70 -59.18 -37.96 78.65 Favored 'General case' 0 N--CA 1.479 1.018 0 C-N-CA 124.163 0.985 . . . . 0.0 112.663 -177.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.85 -48.81 23.08 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 122.509 0.323 . . . . 0.0 111.317 -177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.2 ttm -65.55 -32.62 74.31 Favored 'General case' 0 N--CA 1.487 1.425 0 C-N-CA 123.174 0.59 . . . . 0.0 111.523 177.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 18.4 t80 -50.31 -45.76 54.9 Favored 'General case' 0 N--CA 1.488 1.461 0 C-N-CA 124.275 1.03 . . . . 0.0 109.683 169.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 27.0 mm-40 -74.9 -28.22 60.54 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.567 -0.742 . . . . 0.0 112.061 -178.758 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -68.51 -55.31 12.18 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-O 120.793 0.33 . . . . 0.0 110.357 177.178 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 70.9 mt -59.32 -42.0 85.93 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.02 0 C-N-CA 124.531 1.133 . . . . 0.0 112.211 177.669 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.49 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.39 -31.27 72.39 Favored 'General case' 0 N--CA 1.49 1.567 0 CA-C-O 120.863 0.363 . . . . 0.0 110.444 179.589 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.47 -52.39 10.81 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 123.566 0.746 . . . . 0.0 110.526 179.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.484 ' HG3' HG11 ' A' ' 31' ' ' VAL . 17.7 tppt? -55.46 -52.97 61.86 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.769 1.228 . . . . 0.0 113.134 177.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 8.7 mp -63.07 -26.95 69.08 Favored 'General case' 0 N--CA 1.481 1.106 0 C-N-CA 123.276 0.63 . . . . 0.0 111.872 179.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 21.8 t60 -68.6 -31.92 71.43 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 123.652 0.595 . . . . 0.0 109.457 172.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.0 -1.63 3.01 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 125.608 1.563 . . . . 0.0 113.298 169.04 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.9 m-70 -135.25 129.08 18.67 Favored Pre-proline 0 C--O 1.238 0.469 0 N-CA-C 107.421 -1.326 . . . . 0.0 107.421 178.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_exo -61.23 81.85 0.08 OUTLIER 'Trans proline' 0 C--N 1.374 1.919 0 C-N-CA 122.83 2.353 . . . . 0.0 111.709 173.587 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -124.38 53.0 0.77 Allowed Glycine 0 C--N 1.342 0.862 0 CA-C-N 115.597 -0.729 . . . . 0.0 112.237 -172.007 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -73.14 152.32 90.46 Favored Pre-proline 0 CA--C 1.548 0.9 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 174.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 16.6 Cg_endo -56.6 91.11 0.05 OUTLIER 'Trans proline' 0 C--N 1.382 2.298 0 C-N-CA 122.536 2.158 . . . . 0.0 111.52 176.644 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 5.7 p -79.81 142.77 13.5 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 CA-C-N 114.746 -1.115 . . . . 0.0 109.613 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . 0.549 ' HB3' ' HB2' ' A' ' 118' ' ' ARG . 29.0 m-20 -99.21 43.24 1.07 Allowed 'General case' 0 C--O 1.24 0.591 0 C-N-CA 123.975 0.91 . . . . 0.0 110.579 -177.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -60.63 -33.64 73.08 Favored 'General case' 0 N--CA 1.482 1.142 0 CA-C-N 115.67 -0.695 . . . . 0.0 109.466 175.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -117.2 85.72 2.38 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-N 114.807 -1.088 . . . . 0.0 108.341 169.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.549 ' HB2' ' HB3' ' A' ' 115' ' ' ASP . 1.8 tmm_? -133.2 14.8 4.19 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 107.737 -1.208 . . . . 0.0 107.737 165.491 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.1 mm -107.66 -63.6 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.35 0.592 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.772 -169.472 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.8 mt -88.5 70.91 0.76 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.891 0 CA-C-O 121.991 0.9 . . . . 0.0 108.979 -178.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.403 HH11 ' HD2' ' A' ' 121' ' ' ARG . 12.9 mmt180 -107.38 84.43 1.97 Allowed 'General case' 0 N--CA 1.469 0.488 0 CA-C-N 115.119 -0.946 . . . . 0.0 109.322 -179.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 19.9 m80 -150.32 176.21 11.1 Favored 'General case' 0 N--CA 1.482 1.128 0 C-N-CA 124.291 1.036 . . . . 0.0 110.532 -178.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -140.07 151.59 45.5 Favored 'General case' 0 N--CA 1.476 0.848 0 C-N-CA 124.09 0.956 . . . . 0.0 110.197 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 77.92 -90.14 1.08 Allowed Glycine 0 C--N 1.346 1.111 0 CA-C-N 116.33 -0.396 . . . . 0.0 113.112 177.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 69.8 m . . . . . 0 C--O 1.247 0.959 0 C-N-CA 123.979 0.912 . . . . 0.0 109.19 -179.43 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 4.6 pm0 . . . . . 0 N--CA 1.481 1.098 0 CA-C-O 120.944 0.402 . . . . 0.0 110.17 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 68.62 -133.99 27.9 Favored Glycine 0 C--N 1.348 1.246 0 CA-C-N 115.717 -0.674 . . . . 0.0 113.107 179.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 8.5 p80 -100.99 59.87 0.92 Allowed 'General case' 0 CA--C 1.545 0.779 0 CA-C-O 122.201 1.001 . . . . 0.0 108.939 176.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 34.2 ttp -73.91 143.73 45.64 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 114.251 -1.341 . . . . 0.0 111.168 -176.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -106.32 146.56 30.25 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 123.279 0.631 . . . . 0.0 110.048 172.365 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -143.44 153.45 58.97 Favored Pre-proline 0 CA--C 1.552 1.031 0 C-N-CA 125.038 1.335 . . . . 0.0 108.28 177.287 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -60.75 96.98 0.12 Allowed 'Trans proline' 0 C--N 1.372 1.813 0 C-N-CA 122.139 1.893 . . . . 0.0 111.824 175.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 131.09 -25.59 4.09 Favored Glycine 0 C--N 1.347 1.168 0 CA-C-N 115.586 -0.734 . . . . 0.0 113.384 178.175 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.3 t-80 -151.91 147.24 26.35 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.177 0.591 . . . . 0.0 111.219 -169.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.565 HD23 HD12 ' A' ' 27' ' ' ILE . 41.9 tp -126.84 134.59 50.5 Favored 'General case' 0 C--O 1.24 0.6 0 C-N-CA 125.126 1.37 . . . . 0.0 107.863 173.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.5 t-160 -97.47 138.48 34.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 174.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.497 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.58 110.58 14.61 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 123.262 0.625 . . . . 0.0 109.504 175.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 35.3 m -131.98 169.25 22.21 Favored 'Isoleucine or valine' 0 C--O 1.249 1.057 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 160.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 34.5 t -104.03 138.14 41.0 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.887 -1.153 . . . . 0.0 107.887 178.658 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 67.1 mt -69.13 126.35 92.67 Favored Pre-proline 0 CA--C 1.55 0.98 0 N-CA-C 109.38 -0.6 . . . . 0.0 109.38 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -67.08 147.56 79.75 Favored 'Trans proline' 0 C--N 1.372 1.788 0 C-N-CA 122.467 2.111 . . . . 0.0 112.032 -177.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 159.42 -76.71 0.19 Allowed Glycine 0 C--N 1.339 0.733 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -176.732 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 18.9 tp -140.55 16.53 2.36 Favored 'General case' 0 N--CA 1.482 1.144 0 CA-C-O 121.701 0.762 . . . . 0.0 109.359 176.783 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -126.52 31.52 5.34 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.962 0.905 . . . . 0.0 109.055 -174.225 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 6.1 tp60 -86.95 45.38 1.26 Allowed 'General case' 0 CA--C 1.558 1.273 0 C-N-CA 123.469 0.707 . . . . 0.0 112.278 -164.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tt0 -83.28 138.27 33.64 Favored 'General case' 0 C--O 1.245 0.822 0 N-CA-C 107.564 -1.272 . . . . 0.0 107.564 163.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.5 t0 -77.33 82.71 3.79 Favored 'General case' 0 C--O 1.243 0.729 0 O-C-N 123.804 0.69 . . . . 0.0 109.237 -175.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.601 HG22 HG23 ' A' ' 49' ' ' ILE . 1.6 pp -110.36 126.57 67.64 Favored 'Isoleucine or valine' 0 C--O 1.24 0.589 0 CA-C-N 115.213 -0.903 . . . . 0.0 108.976 175.141 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.4 p30 -147.09 117.61 7.48 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 178.118 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.497 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 43.1 mt -144.85 145.94 20.54 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.722 0 C-N-CA 124.308 1.043 . . . . 0.0 108.381 -168.271 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.401 ' O ' ' HA ' ' A' ' 45' ' ' MET . 9.2 m-70 -108.73 145.66 34.74 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 176.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.565 HD12 HD23 ' A' ' 10' ' ' LEU . 55.9 mt -131.75 109.51 15.77 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.967 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 170.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.469 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 99.5 mtt180 -98.59 140.1 33.33 Favored 'General case' 0 N--CA 1.467 0.424 0 N-CA-C 108.012 -1.107 . . . . 0.0 108.012 168.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 31.9 p90 -121.65 116.85 25.34 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 165.551 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.8 mt-10 -123.96 111.89 16.56 Favored 'General case' 0 N--CA 1.467 0.414 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -175.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 41' ' ' VAL . 90.2 t -90.15 118.75 36.03 Favored 'Isoleucine or valine' 0 C--O 1.238 0.49 0 C-N-CA 123.29 0.636 . . . . 0.0 110.337 -176.4 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.402 ' HB3' ' CE1' ' A' ' 40' ' ' TYR . 26.5 ttt180 -114.58 153.24 30.45 Favored 'General case' 0 C--O 1.239 0.509 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 174.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.8 mm-40 -111.42 111.41 22.43 Favored 'General case' 0 CA--C 1.539 0.529 0 N-CA-C 107.079 -1.452 . . . . 0.0 107.079 176.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.637 HD22 ' HB3' ' A' ' 36' ' ' GLU . 9.4 p-10 -105.24 136.81 44.07 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -66.37 -20.17 66.01 Favored 'General case' 0 N--CA 1.488 1.459 0 C-N-CA 123.04 0.536 . . . . 0.0 112.308 -175.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.637 ' HB3' HD22 ' A' ' 34' ' ' ASN . 5.7 tm-20 -68.97 -45.59 70.26 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 124.589 1.156 . . . . 0.0 111.508 -178.605 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.6 t -115.54 -40.71 3.35 Favored 'General case' 0 N--CA 1.486 1.372 0 C-N-CA 122.865 0.466 . . . . 0.0 111.205 -174.423 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 121.76 -148.17 17.22 Favored Glycine 0 C--N 1.339 0.725 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -172.592 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -72.09 129.19 37.92 Favored 'General case' 0 C--O 1.243 0.737 0 C-N-CA 123.401 0.68 . . . . 0.0 110.867 176.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.542 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 3.4 p90 -144.45 166.29 25.55 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 177.185 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 31' ' ' VAL . 2.3 t -122.11 128.81 75.67 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 C-N-CA 122.943 0.497 . . . . 0.0 110.329 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.552 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 78.1 t60 -88.92 112.32 23.16 Favored 'General case' 0 C--O 1.24 0.589 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 164.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.412 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 91.8 m-85 -95.12 121.3 36.61 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 174.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.469 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 19.7 t70 -120.43 114.67 22.14 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 123.859 0.864 . . . . 0.0 109.517 -170.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.413 ' HG2' HG12 ' A' ' 27' ' ' ILE . 85.8 mtp -119.31 144.3 46.9 Favored 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 123.546 0.739 . . . . 0.0 110.881 -177.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -156.05 164.48 38.38 Favored 'General case' 0 N--CA 1.483 1.189 0 C-N-CA 123.459 0.704 . . . . 0.0 109.461 171.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 165.62 -158.6 31.54 Favored Glycine 0 N--CA 1.47 0.948 0 CA-C-O 118.843 -0.976 . . . . 0.0 111.458 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -145.79 109.97 4.95 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 118.301 1.051 . . . . 0.0 110.589 170.819 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.601 HG23 HG22 ' A' ' 23' ' ' ILE . 49.0 mt -99.78 128.0 52.07 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.134 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.901 178.529 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 62.04 17.62 9.23 Favored 'General case' 0 N--CA 1.485 1.314 0 C-N-CA 124.821 1.248 . . . . 0.0 111.846 -176.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.22 -20.25 40.86 Favored Glycine 0 C--N 1.348 1.231 0 CA-C-O 119.629 -0.54 . . . . 0.0 113.495 -174.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 8.1 mtpm? -82.8 111.17 27.44 Favored Pre-proline 0 N--CA 1.481 1.076 0 C-N-CA 123.96 0.904 . . . . 0.0 112.513 -174.156 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -73.65 143.39 33.91 Favored 'Trans proline' 0 C--N 1.38 2.22 0 C-N-CA 122.535 2.157 . . . . 0.0 111.979 176.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 28.8 p90 -148.85 161.77 41.16 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.344 0.658 . . . . 0.0 110.099 -178.541 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 40.2 t -146.65 121.32 9.82 Favored 'General case' 0 CA--C 1.543 0.689 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 170.189 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.2 t70 -138.52 145.67 41.02 Favored 'General case' 0 N--CA 1.478 0.927 0 N-CA-C 108.439 -0.949 . . . . 0.0 108.439 -174.238 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.1 p -144.26 144.66 31.61 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 122.749 0.42 . . . . 0.0 111.154 -176.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -137.53 137.15 38.32 Favored 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 124.069 0.947 . . . . 0.0 108.701 175.54 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.552 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 6.4 mp0 -113.84 126.5 55.26 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.278 0.631 . . . . 0.0 109.386 -177.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.412 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 94.2 mt -129.32 125.85 22.73 Favored Pre-proline 0 N--CA 1.474 0.756 0 N-CA-C 108.709 -0.849 . . . . 0.0 108.709 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.542 ' HA ' ' HA ' ' A' ' 40' ' ' TYR . 57.2 Cg_endo -67.19 163.91 32.38 Favored 'Trans proline' 0 C--N 1.373 1.866 0 C-N-CA 122.635 2.223 . . . . 0.0 111.555 172.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 62.3 ttp180 -45.78 -37.43 6.02 Favored 'General case' 0 N--CA 1.494 1.754 0 C-N-CA 124.678 1.191 . . . . 0.0 113.384 178.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -62.87 -29.85 71.07 Favored 'General case' 0 CA--C 1.552 1.033 0 CA-C-N 114.731 -1.122 . . . . 0.0 112.194 -177.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.0 p -129.76 12.27 5.77 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 123.882 0.873 . . . . 0.0 111.02 -177.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -61.05 -27.95 68.71 Favored 'General case' 0 N--CA 1.483 1.194 0 C-N-CA 123.655 0.782 . . . . 0.0 111.73 179.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.469 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 27.1 m-85 -70.46 -2.49 14.07 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.361 1.064 . . . . 0.0 113.79 179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 36.8 m-80 -95.3 4.94 52.93 Favored 'General case' 0 N--CA 1.481 1.112 0 C-N-CA 123.604 0.761 . . . . 0.0 110.581 174.337 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 20.5 p90 -55.59 -49.16 73.5 Favored 'General case' 0 C--N 1.354 0.785 0 C-N-CA 124.27 1.028 . . . . 0.0 112.899 -173.379 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.05 -35.2 61.89 Favored 'General case' 0 C--N 1.349 0.572 0 C-N-CA 123.162 0.585 . . . . 0.0 111.777 -168.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 29.5 p -71.51 -40.12 70.36 Favored 'General case' 0 N--CA 1.47 0.547 0 O-C-N 123.728 0.643 . . . . 0.0 109.359 -177.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -66.59 -56.64 9.84 Favored 'General case' 0 CA--C 1.546 0.821 0 CA-C-N 115.342 -0.844 . . . . 0.0 110.307 174.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.49 -40.61 12.76 Favored 'General case' 0 N--CA 1.496 1.87 0 C-N-CA 124.878 1.271 . . . . 0.0 113.429 175.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 93.1 m -71.03 -46.36 62.25 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.182 0.593 . . . . 0.0 110.327 177.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.8 ttm180 -61.71 -51.01 70.14 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.849 0.859 . . . . 0.0 111.343 -177.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 13.5 p -67.98 -34.54 67.65 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.731 0 C-N-CA 123.789 0.836 . . . . 0.0 110.689 -176.245 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -59.98 -39.04 84.35 Favored 'General case' 0 N--CA 1.476 0.853 0 CA-C-O 121.18 0.514 . . . . 0.0 110.142 173.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . . . . . . . . . 74.0 mt-30 -75.7 -36.73 59.94 Favored 'General case' 0 C--O 1.239 0.52 0 CA-C-N 114.749 -1.114 . . . . 0.0 111.45 -178.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp -64.05 -34.74 78.7 Favored 'General case' 0 N--CA 1.475 0.825 0 C-N-CA 123.431 0.692 . . . . 0.0 111.094 175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 36.9 m-70 -80.17 3.02 21.95 Favored 'General case' 0 CA--C 1.552 1.033 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 179.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 139.04 -31.92 2.32 Favored Glycine 0 C--N 1.353 1.481 0 CA-C-N 118.927 0.785 . . . . 0.0 113.605 166.154 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.478 HD13 HG21 ' A' ' 23' ' ' ILE . 17.8 tp -56.71 122.67 12.65 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.019 0.928 . . . . 0.0 110.766 179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 84.6 t60 -130.55 85.57 55.71 Favored Pre-proline 0 N--CA 1.472 0.637 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 175.144 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.458 ' HD3' ' HG ' ' A' ' 81' ' ' LEU . 81.4 Cg_endo -82.3 143.58 12.58 Favored 'Trans proline' 0 C--N 1.362 1.257 0 C-N-CA 122.272 1.982 . . . . 0.0 112.537 -177.312 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 21.7 tptm -71.59 -12.14 61.21 Favored 'General case' 0 CA--C 1.549 0.911 0 C-N-CA 123.307 0.643 . . . . 0.0 109.666 170.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 18.0 m-85 -57.22 -49.82 74.83 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 123.898 0.879 . . . . 0.0 109.271 165.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 74.36 -72.4 1.44 Allowed Glycine 0 C--N 1.349 1.305 0 CA-C-N 115.362 -0.836 . . . . 0.0 111.968 -176.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -146.41 4.46 0.91 Allowed 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 124.019 0.928 . . . . 0.0 111.172 177.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 16.4 pt -92.57 146.62 6.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.292 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 178.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 20.3 m -76.72 -39.36 52.13 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.066 0.546 . . . . 0.0 111.215 -178.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 41.3 ttm180 71.12 -57.09 0.61 Allowed 'General case' 0 N--CA 1.493 1.724 0 C-N-CA 125.72 1.608 . . . . 0.0 111.168 -174.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 46.3 t -61.97 157.41 3.51 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.028 0 C-N-CA 124.526 1.131 . . . . 0.0 109.519 167.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 48.2 m80 -57.87 135.66 56.9 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 122.565 0.346 . . . . 0.0 110.338 174.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 57.3 pttt -64.07 119.48 10.22 Favored 'General case' 0 CA--C 1.539 0.546 0 O-C-N 123.309 0.381 . . . . 0.0 110.034 -179.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -114.78 11.53 16.79 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 123.727 0.811 . . . . 0.0 109.577 167.264 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 68.5 t80 -57.22 -41.74 80.04 Favored 'General case' 0 C--N 1.357 0.922 0 C-N-CA 124.909 1.284 . . . . 0.0 112.426 -174.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.688 ' HB2' HH12 ' A' ' 118' ' ' ARG . 4.7 m-20 -55.77 -42.83 76.1 Favored 'General case' 0 N--CA 1.482 1.136 0 C-N-CA 123.608 0.763 . . . . 0.0 111.985 -177.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -60.88 -46.79 89.22 Favored 'General case' 0 N--CA 1.474 0.736 0 O-C-N 124.081 0.863 . . . . 0.0 110.746 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 50.0 ttm -61.15 -51.63 68.25 Favored 'General case' 0 N--CA 1.481 1.125 0 C-N-CA 124.237 1.015 . . . . 0.0 111.397 177.046 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -51.19 -52.13 47.26 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 125.828 1.651 . . . . 0.0 112.21 -178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.502 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 14.6 pt-20 -82.26 -27.44 32.42 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-N 115.528 -0.76 . . . . 0.0 112.295 -174.522 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -65.91 -36.55 83.7 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 174.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 14.3 mt -58.96 -55.65 22.03 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.897 0 CA-C-O 118.701 -0.666 . . . . 0.0 111.549 171.149 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.502 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -58.11 -28.1 64.33 Favored 'General case' 0 N--CA 1.501 2.109 0 CA-C-N 118.343 0.52 . . . . 0.0 111.448 -178.551 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.427 ' HB2' HH11 ' A' ' 103' ' ' ARG . . . -71.99 -48.03 47.75 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 123.753 0.821 . . . . 0.0 110.677 176.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.3 tpmt? -58.52 -35.01 71.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 123.928 0.891 . . . . 0.0 112.246 174.826 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.437 ' HA ' HG11 ' A' ' 31' ' ' VAL . 4.3 mm? -64.29 -22.55 66.99 Favored 'General case' 0 N--CA 1.48 1.057 0 C-N-CA 123.436 0.694 . . . . 0.0 112.851 175.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 86.3 t60 -72.83 -17.88 61.51 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 110.216 -0.29 . . . . 0.0 110.216 173.064 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 84.05 11.17 0.4 Allowed 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 126.476 1.91 . . . . 0.0 111.886 177.199 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 14.2 m170 -143.83 137.72 14.53 Favored Pre-proline 0 N--CA 1.476 0.85 0 C-N-CA 124.639 1.176 . . . . 0.0 108.28 172.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.15 94.63 0.57 Allowed 'Trans proline' 0 C--N 1.378 2.108 0 C-N-CA 122.718 2.278 . . . . 0.0 113.524 -170.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -91.37 54.97 3.17 Favored Glycine 0 C--N 1.343 0.927 0 N-CA-C 110.66 -0.976 . . . . 0.0 110.66 170.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -64.21 146.03 97.84 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.354 1.062 . . . . 0.0 111.574 -170.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_endo -76.38 -179.26 5.11 Favored 'Trans proline' 0 C--N 1.369 1.616 0 C-N-CA 122.29 1.993 . . . . 0.0 112.567 173.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 7.6 p -128.57 117.25 44.41 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 170.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -126.26 45.34 2.67 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 123.919 0.888 . . . . 0.0 109.122 -179.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -66.48 -36.34 82.51 Favored 'General case' 0 CA--C 1.54 0.565 0 CA-C-N 115.17 -0.923 . . . . 0.0 110.056 177.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -74.14 -19.92 60.41 Favored 'General case' 0 C--N 1.357 0.928 0 C-N-CA 123.534 0.734 . . . . 0.0 111.229 179.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.688 HH12 ' HB2' ' A' ' 96' ' ' ASP . 7.6 ttt180 -71.52 -28.13 63.67 Favored 'General case' 0 N--CA 1.476 0.85 0 C-N-CA 123.034 0.534 . . . . 0.0 111.144 -176.292 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 31.0 mm -78.58 -31.38 15.58 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.991 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.414 173.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 49.5 mm -76.29 -18.3 15.14 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.064 0 C-N-CA 124.194 0.998 . . . . 0.0 111.82 -177.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.44 ' HG2' ' HA ' ' A' ' 118' ' ' ARG . 19.3 mmm180 -51.6 104.12 0.08 Allowed 'General case' 0 N--CA 1.491 1.605 0 C-N-CA 123.697 0.799 . . . . 0.0 111.73 -177.585 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 25.6 t60 -87.02 127.01 35.11 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 176.211 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 -149.18 118.38 6.81 Favored 'General case' 0 N--CA 1.472 0.625 0 N-CA-C 108.609 -0.886 . . . . 0.0 108.609 -172.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -155.07 62.3 0.35 Allowed Glycine 0 C--N 1.338 0.681 0 O-C-N 123.726 0.641 . . . . 0.0 111.561 -178.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 22.9 t . . . . . 0 C--O 1.248 0.98 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.289 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 53.2 tt0 . . . . . 0 N--CA 1.482 1.143 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -151.36 -112.84 0.56 Allowed Glycine 0 C--N 1.344 0.999 0 N-CA-C 111.148 -0.781 . . . . 0.0 111.148 -179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 21.3 p-80 -152.62 9.77 0.47 Allowed 'General case' 0 N--CA 1.478 0.969 0 CA-C-N 117.312 0.556 . . . . 0.0 111.722 175.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.9 mmt -118.78 175.54 5.7 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.838 0.855 . . . . 0.0 111.593 -176.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.4 ' CE1' ' SD ' ' A' ' 98' ' ' MET . 67.8 t80 -80.39 147.9 30.82 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.426 1.09 . . . . 0.0 111.447 -168.785 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -140.55 154.42 69.28 Favored Pre-proline 0 CA--C 1.561 1.369 0 C-N-CA 124.968 1.307 . . . . 0.0 109.94 -178.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.43 100.53 0.1 OUTLIER 'Trans proline' 0 C--N 1.376 1.99 0 C-N-CA 122.81 2.34 . . . . 0.0 113.202 175.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 123.55 -24.38 6.5 Favored Glycine 0 C--N 1.345 1.058 0 CA-C-N 116.291 -0.413 . . . . 0.0 112.68 177.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 39.4 t-80 -147.65 150.75 34.97 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.264 0.625 . . . . 0.0 110.411 -170.342 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.509 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 42.6 tp -124.18 129.61 51.11 Favored 'General case' 0 C--O 1.242 0.688 0 C-N-CA 124.978 1.311 . . . . 0.0 107.627 177.109 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 2.4 t-160 -97.67 134.87 40.28 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 122.642 0.377 . . . . 0.0 110.137 -177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.489 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 69.2 mt -125.46 113.09 17.03 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 123.474 0.709 . . . . 0.0 110.446 175.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 32.2 m -126.93 168.74 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 159.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 39.9 t -81.69 132.5 35.29 Favored 'General case' 0 N--CA 1.471 0.585 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 -177.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 3.7 pp -81.22 121.17 80.13 Favored Pre-proline 0 CA--C 1.55 0.95 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 177.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -66.82 95.18 0.34 Allowed 'Trans proline' 0 C--N 1.368 1.559 0 C-N-CA 122.348 2.032 . . . . 0.0 112.081 179.079 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 169.98 -56.93 0.19 Allowed Glycine 0 C--N 1.335 0.523 0 N-CA-C 111.408 -0.677 . . . . 0.0 111.408 177.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.9 tp -84.91 -65.63 0.99 Allowed 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 123.344 0.658 . . . . 0.0 109.699 -178.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -119.03 144.47 46.53 Favored 'General case' 0 N--CA 1.469 0.518 0 C-N-CA 124.361 1.065 . . . . 0.0 108.702 178.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -138.08 103.99 5.1 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 44.5 tt0 -151.13 159.95 44.16 Favored 'General case' 0 N--CA 1.474 0.745 0 C-N-CA 123.055 0.542 . . . . 0.0 109.59 176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 30.1 t70 -73.29 78.05 1.33 Allowed 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 173.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.588 HG22 HG23 ' A' ' 49' ' ' ILE . 1.5 pp -123.97 138.47 53.54 Favored 'Isoleucine or valine' 0 C--O 1.242 0.693 0 CA-C-N 115.495 -0.775 . . . . 0.0 110.052 177.592 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -152.68 126.63 9.02 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 172.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.525 HD11 HD11 ' A' ' 49' ' ' ILE . 36.2 mt -142.92 142.04 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.708 0 C-N-CA 124.293 1.037 . . . . 0.0 108.271 -173.183 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.528 ' O ' ' HA ' ' A' ' 45' ' ' MET . 8.7 m170 -103.56 141.99 35.06 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 106.802 -1.555 . . . . 0.0 106.802 173.221 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.509 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 33.1 mt -126.62 108.68 19.4 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 119.27 0.941 . . . . 0.0 109.089 169.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 18.5 mtp180 -95.39 138.56 32.91 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 124.236 1.014 . . . . 0.0 108.397 175.317 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 18.5 p90 -124.43 117.29 24.1 Favored 'General case' 0 C--O 1.24 0.556 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 166.275 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -122.66 111.23 16.5 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -175.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 41' ' ' VAL . 74.7 t -85.43 117.06 29.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.439 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.758 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 50.2 ttt180 -131.32 158.84 39.59 Favored 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 124.079 0.951 . . . . 0.0 110.012 -175.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 16.7 mm-40 -115.89 110.53 19.14 Favored 'General case' 0 CA--C 1.545 0.778 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 172.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.512 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -98.96 152.09 20.18 Favored 'General case' 0 N--CA 1.492 1.674 0 C-N-CA 122.982 0.513 . . . . 0.0 110.85 172.525 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.38 -25.96 63.49 Favored 'General case' 0 N--CA 1.479 1.009 0 C-N-CA 123.693 0.797 . . . . 0.0 110.965 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -66.51 -53.45 34.83 Favored 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 124.317 1.047 . . . . 0.0 112.275 -177.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 34.8 m -126.68 -0.44 6.76 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -168.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 89.22 -133.94 12.11 Favored Glycine 0 C--N 1.349 1.29 0 CA-C-N 117.741 0.246 . . . . 0.0 112.632 177.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.594 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -82.27 131.13 35.23 Favored 'General case' 0 N--CA 1.474 0.735 0 C-N-CA 122.906 0.482 . . . . 0.0 110.256 177.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 4.1 p90 -156.99 173.66 16.68 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 122.784 0.433 . . . . 0.0 110.773 -178.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.513 HG22 HG22 ' A' ' 31' ' ' VAL . 20.9 t -132.45 125.65 53.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 C-N-CA 123.393 0.677 . . . . 0.0 109.526 179.212 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.432 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 73.2 t60 -87.91 119.35 28.18 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 123.804 0.842 . . . . 0.0 109.581 172.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.463 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 74.0 m-85 -102.79 127.94 49.74 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 175.315 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 14.0 t70 -130.26 123.87 31.12 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.084 0.554 . . . . 0.0 110.589 -170.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.528 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 79.1 mtp -122.59 132.38 54.27 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 124.018 0.927 . . . . 0.0 111.097 -175.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -154.38 154.23 32.93 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.129 0.572 . . . . 0.0 110.965 179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 162.24 -151.94 22.09 Favored Glycine 0 N--CA 1.476 1.332 0 CA-C-O 118.588 -1.118 . . . . 0.0 110.403 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -145.65 110.5 5.16 Favored 'General case' 0 C--N 1.359 0.987 0 CA-C-N 119.096 1.448 . . . . 0.0 111.72 174.081 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.588 HG23 HG22 ' A' ' 23' ' ' ILE . 68.8 mt -98.64 124.3 51.73 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.917 0 CA-C-N 113.947 -1.479 . . . . 0.0 110.603 175.217 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.519 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 7.7 m-20 63.98 24.45 13.61 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.909 1.283 . . . . 0.0 109.822 -170.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 77.47 10.38 86.27 Favored Glycine 0 C--N 1.349 1.252 0 CA-C-N 115.167 -0.924 . . . . 0.0 113.39 -175.68 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.519 ' HE2' ' HB2' ' A' ' 50' ' ' ASP . 51.3 mtmt -94.78 108.37 37.12 Favored Pre-proline 0 C--N 1.354 0.771 0 C-N-CA 123.494 0.717 . . . . 0.0 111.483 -179.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.423 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 37.5 Cg_endo -63.86 133.54 39.4 Favored 'Trans proline' 0 C--N 1.378 2.123 0 C-N-CA 122.796 2.331 . . . . 0.0 111.732 176.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 34.9 p90 -137.76 147.39 44.65 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 109.115 -0.698 . . . . 0.0 109.115 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 68.2 p -132.71 113.1 12.59 Favored 'General case' 0 C--O 1.241 0.608 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 170.127 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -139.77 136.59 34.26 Favored 'General case' 0 N--CA 1.467 0.381 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -173.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 34.2 p -148.95 145.7 27.49 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-O 120.736 0.303 . . . . 0.0 110.593 -173.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 42.6 p90 -137.87 142.46 40.69 Favored 'General case' 0 N--CA 1.471 0.583 0 C-N-CA 124.307 1.043 . . . . 0.0 109.325 179.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 7.4 mp0 -116.13 140.44 49.29 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 -179.827 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 92.3 mt -132.87 135.93 26.81 Favored Pre-proline 0 C--O 1.237 0.435 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 48.0 Cg_endo -64.17 165.26 19.95 Favored 'Trans proline' 0 C--N 1.374 1.885 0 C-N-CA 122.495 2.13 . . . . 0.0 111.713 174.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.594 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 24.6 ptt180 -38.76 -36.91 0.3 Allowed 'General case' 0 CA--C 1.566 1.563 0 C-N-CA 125.404 1.482 . . . . 0.0 114.15 174.004 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.1 m-20 -78.78 -19.14 52.91 Favored 'General case' 0 CA--C 1.547 0.832 0 N-CA-C 113.561 0.949 . . . . 0.0 113.561 -174.175 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.7 p -130.53 3.05 4.58 Favored 'General case' 0 N--CA 1.49 1.57 0 C-N-CA 123.339 0.656 . . . . 0.0 111.307 -175.662 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.06 -40.51 70.38 Favored 'General case' 0 N--CA 1.48 1.07 0 C-N-CA 124.29 1.036 . . . . 0.0 112.178 -178.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 15.7 m-85 -71.15 -17.74 62.53 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.059 0.944 . . . . 0.0 112.366 -177.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -82.95 -3.84 57.54 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 122.869 0.467 . . . . 0.0 111.103 -179.069 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.0 p90 -51.65 -44.11 62.89 Favored 'General case' 0 C--N 1.356 0.855 0 C-N-CA 124.026 0.93 . . . . 0.0 112.963 -175.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -52.7 -30.22 30.96 Favored 'General case' 0 N--CA 1.483 1.211 0 N-CA-C 113.949 1.092 . . . . 0.0 113.949 -172.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -67.69 -47.55 69.12 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 122.975 0.51 . . . . 0.0 109.855 177.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -74.44 -47.5 33.23 Favored 'General case' 0 C--O 1.212 -0.893 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.778 -178.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.51 -39.18 10.39 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 125.008 1.323 . . . . 0.0 112.477 175.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 90.1 m -73.77 -44.03 57.27 Favored 'General case' 0 CA--C 1.552 1.028 0 CA-C-N 115.606 -0.725 . . . . 0.0 110.982 174.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 78.1 ttt180 -61.67 -46.99 87.38 Favored 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 124.041 0.936 . . . . 0.0 112.464 -176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 12.5 p -72.53 -31.92 39.63 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.54 0 C-N-CA 123.415 0.686 . . . . 0.0 110.805 -179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.91 -42.21 85.79 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 122.984 0.514 . . . . 0.0 110.594 178.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.471 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 9.6 pt20 -76.84 -25.76 53.56 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.217 179.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 32.5 ttmt -68.03 -27.87 66.91 Favored 'General case' 0 CA--C 1.553 1.072 0 C-N-CA 124.032 0.933 . . . . 0.0 110.669 169.645 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 58.6 m-70 -83.79 6.65 20.52 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 123.636 0.774 . . . . 0.0 111.448 172.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 91.4 54.13 2.02 Favored Glycine 0 C--N 1.348 1.223 0 N-CA-C 114.701 0.64 . . . . 0.0 114.701 174.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.471 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 30.6 mt -85.06 148.57 26.09 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-N 118.089 0.945 . . . . 0.0 109.575 165.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 25.2 m170 73.63 135.52 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.386 0 C-N-CA 125.49 1.516 . . . . 0.0 111.666 168.269 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -61.01 177.51 0.69 Allowed 'Trans proline' 0 C--N 1.375 1.956 0 C-N-CA 123.358 2.705 . . . . 0.0 113.859 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -67.75 -17.0 64.4 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 123.144 0.577 . . . . 0.0 111.904 178.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 93.5 t80 -64.16 -43.5 95.0 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 168.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 99.12 -174.19 27.26 Favored Glycine 0 C--N 1.34 0.775 0 CA-C-N 115.353 -0.84 . . . . 0.0 112.272 -178.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -164.44 108.08 0.92 Allowed 'General case' 0 C--O 1.242 0.691 0 C-N-CA 123.53 0.732 . . . . 0.0 109.129 178.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 75.2 mt -67.23 118.63 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 174.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 8.8 t -70.51 -48.75 54.09 Favored 'General case' 0 CA--C 1.544 0.734 0 CA-C-O 118.999 -0.524 . . . . 0.0 110.029 179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 30.9 tpt180 46.12 -78.4 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.475 0 C-N-CA 126.026 1.73 . . . . 0.0 113.401 -177.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.8 m -55.6 150.88 2.33 Favored 'Isoleucine or valine' 0 C--O 1.246 0.88 0 C-N-CA 124.307 1.043 . . . . 0.0 111.667 -175.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 9.8 m170 -66.23 124.97 24.1 Favored 'General case' 0 C--O 1.238 0.462 0 N-CA-C 108.485 -0.932 . . . . 0.0 108.485 179.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.5 mmmm -83.15 59.54 5.02 Favored 'General case' 0 N--CA 1.471 0.58 0 O-C-N 123.522 0.514 . . . . 0.0 109.967 -177.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.0 mm-40 52.02 28.46 5.3 Favored 'General case' 0 C--N 1.357 0.896 0 C-N-CA 125.451 1.5 . . . . 0.0 112.727 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 39.5 t80 -68.15 -43.28 78.61 Favored 'General case' 0 C--O 1.21 -0.979 0 CA-C-N 114.703 -1.135 . . . . 0.0 110.953 -175.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -53.27 -41.71 65.79 Favored 'General case' 0 N--CA 1.487 1.425 0 N-CA-C 113.016 0.747 . . . . 0.0 113.016 179.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -74.33 -48.28 29.19 Favored 'General case' 0 N--CA 1.482 1.135 0 C-N-CA 123.135 0.574 . . . . 0.0 110.268 178.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.4 ' SD ' ' CE1' ' A' ' 5' ' ' PHE . 8.6 tpt -51.69 -42.12 61.95 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.824 1.249 . . . . 0.0 111.686 175.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -58.99 -53.26 60.43 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 125.335 1.454 . . . . 0.0 110.839 -177.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.72 -27.6 66.09 Favored 'General case' 0 N--CA 1.47 0.563 0 O-C-N 123.827 0.704 . . . . 0.0 112.101 -176.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -70.08 -55.69 8.83 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 123.335 0.397 . . . . 0.0 110.243 176.652 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.5 mt -59.8 -37.03 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.971 0 C-N-CA 123.718 0.807 . . . . 0.0 111.765 -179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -68.4 -31.27 70.51 Favored 'General case' 0 N--CA 1.489 1.476 0 CA-C-N 117.914 0.325 . . . . 0.0 110.689 -179.336 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.25 -40.4 62.39 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 115.756 -0.657 . . . . 0.0 110.072 177.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.519 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.7 OUTLIER -61.94 -38.82 89.91 Favored 'General case' 0 CA--C 1.552 1.057 0 C-N-CA 124.321 1.048 . . . . 0.0 112.898 174.014 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -63.31 -38.66 92.0 Favored 'General case' 0 N--CA 1.49 1.528 0 C-N-CA 123.241 0.616 . . . . 0.0 110.802 172.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 6.8 t-160 -66.81 -29.32 69.22 Favored 'General case' 0 CA--C 1.553 1.064 0 CA-C-N 115.51 -0.768 . . . . 0.0 109.737 174.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.39 0.4 3.58 Favored 'General case' 0 N--CA 1.488 1.439 0 C-N-CA 125.839 1.656 . . . . 0.0 112.081 177.562 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 31.8 m80 -161.33 143.79 9.16 Favored Pre-proline 0 N--CA 1.472 0.626 0 C-N-CA 125.887 1.675 . . . . 0.0 108.072 -179.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_exo -59.01 -26.73 82.74 Favored 'Trans proline' 0 C--N 1.372 1.808 0 C-N-CA 122.449 2.099 . . . . 0.0 112.597 167.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 98.01 -36.57 3.89 Favored Glycine 0 C--N 1.352 1.43 0 CA-C-N 115.556 -0.747 . . . . 0.0 111.241 -175.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 -81.15 129.14 68.23 Favored Pre-proline 0 CA--C 1.553 1.068 0 C-N-CA 124.337 1.055 . . . . 0.0 109.561 176.147 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -67.87 105.13 1.09 Allowed 'Trans proline' 0 C--N 1.375 1.95 0 C-N-CA 122.735 2.29 . . . . 0.0 110.687 176.167 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.5 p -61.84 143.99 14.53 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.965 0 C-N-CA 123.816 0.846 . . . . 0.0 111.944 -169.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 12.2 p-10 -68.79 -30.63 69.25 Favored 'General case' 0 N--CA 1.474 0.764 0 C-N-CA 124.302 1.041 . . . . 0.0 111.891 -169.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.6 pp -68.22 -6.15 22.04 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 116.178 -0.465 . . . . 0.0 112.169 179.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -120.78 -43.66 2.46 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 123.663 0.785 . . . . 0.0 110.89 178.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -75.49 -31.56 60.25 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.667 0.787 . . . . 0.0 111.578 -168.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 47.6 mm -69.39 -28.75 39.49 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.432 ' N ' HD12 ' A' ' 120' ' ' ILE . 2.0 mp -88.28 83.82 2.25 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 C-N-CA 123.74 0.816 . . . . 0.0 109.092 -175.079 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 99.9 mtt180 -135.68 -40.12 0.71 Allowed 'General case' 0 N--CA 1.488 1.428 0 C-N-CA 123.516 0.726 . . . . 0.0 111.324 176.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 11.9 m170 -154.49 129.18 9.3 Favored 'General case' 0 N--CA 1.497 1.891 0 C-N-CA 123.942 0.897 . . . . 0.0 110.667 177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.4 150.28 25.0 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 124.022 0.929 . . . . 0.0 110.338 174.546 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 162.02 -77.42 0.17 Allowed Glycine 0 C--N 1.345 1.068 0 N-CA-C 111.727 -0.549 . . . . 0.0 111.727 179.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.6 m . . . . . 0 C--O 1.254 1.326 0 C-N-CA 123.429 0.692 . . . . 0.0 109.552 176.573 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 19.0 pm0 . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 119.144 -0.455 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -62.6 -105.84 0.01 OUTLIER Glycine 0 C--N 1.356 1.678 0 N-CA-C 115.646 1.018 . . . . 0.0 115.646 -166.637 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . 0.427 ' HA ' ' O ' ' A' ' 11' ' ' HIS . 14.7 t-80 -78.72 87.6 4.62 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-N 117.715 0.757 . . . . 0.0 109.419 -179.006 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 55.5 ttp -124.63 131.05 53.49 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.162 0.985 . . . . 0.0 109.396 -176.674 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 87.7 t80 -116.21 148.58 40.27 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.911 0.885 . . . . 0.0 109.923 -179.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -150.13 157.2 37.62 Favored Pre-proline 0 CA--C 1.549 0.916 0 C-N-CA 125.455 1.502 . . . . 0.0 107.865 177.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -61.57 105.14 0.34 Allowed 'Trans proline' 0 C--N 1.372 1.773 0 C-N-CA 121.876 1.717 . . . . 0.0 111.122 174.293 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 118.1 -16.2 12.0 Favored Glycine 0 CA--C 1.531 1.092 0 CA-C-O 119.726 -0.485 . . . . 0.0 113.866 179.595 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 29.8 t-80 -158.36 151.61 22.96 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-N 117.74 0.77 . . . . 0.0 112.307 -171.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 43.9 tp -140.22 143.15 35.87 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 126.045 1.738 . . . . 0.0 107.972 175.834 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.427 ' O ' ' HA ' ' A' ' 3' ' ' HIS . 11.4 t-160 -124.41 137.55 54.44 Favored 'General case' 0 N--CA 1.472 0.669 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 171.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.411 ' N ' HD23 ' A' ' 12' ' ' LEU . 0.6 OUTLIER -136.47 118.55 15.41 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 123.349 0.66 . . . . 0.0 110.577 179.595 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 25.8 m -104.33 173.7 1.33 Allowed 'Isoleucine or valine' 0 C--O 1.246 0.918 0 N-CA-C 106.775 -1.565 . . . . 0.0 106.775 162.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.604 ' HB2' HG13 ' A' ' 23' ' ' ILE . 42.4 t -81.69 102.91 11.02 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 pp -67.23 144.34 98.13 Favored Pre-proline 0 CA--C 1.549 0.919 0 C-N-CA 123.826 0.85 . . . . 0.0 111.031 -173.118 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 33.9 Cg_endo -63.44 88.85 0.14 Allowed 'Trans proline' 0 C--N 1.38 2.215 0 C-N-CA 122.734 2.289 . . . . 0.0 111.004 176.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 162.1 -37.23 0.37 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 114.644 -1.162 . . . . 0.0 111.725 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.4 mt -118.94 86.77 2.61 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.705 0.802 . . . . 0.0 109.464 175.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 17.7 m-20 65.94 161.35 0.14 Allowed 'General case' 0 N--CA 1.485 1.292 0 C-N-CA 125.268 1.427 . . . . 0.0 113.838 175.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 14.2 pt20 -122.4 97.56 5.52 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 123.999 0.92 . . . . 0.0 109.033 176.613 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.569 ' HG3' HG23 ' A' ' 23' ' ' ILE . 19.0 pt20 -157.1 159.11 37.55 Favored 'General case' 0 N--CA 1.476 0.867 0 C-N-CA 123.802 0.841 . . . . 0.0 109.177 176.546 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -86.2 57.82 4.7 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.152 0.581 . . . . 0.0 111.648 -173.01 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.604 HG13 ' HB2' ' A' ' 14' ' ' SER . 2.0 pp -90.54 119.91 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.766 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 171.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 21.0 m-80 -140.25 118.62 12.14 Favored 'General case' 0 N--CA 1.476 0.872 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 -176.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.406 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 19.2 mt -140.53 139.42 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.015 0 C-N-CA 123.36 0.664 . . . . 0.0 109.715 -170.321 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.3 m170 -107.3 131.93 53.67 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 169.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.467 HG12 ' SD ' ' A' ' 45' ' ' MET . 55.6 mt -128.11 110.19 21.24 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.021 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 177.536 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -99.88 139.66 35.22 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 108.672 -0.862 . . . . 0.0 108.672 172.114 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.9 p90 -122.58 116.17 23.41 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.394 -1.706 . . . . 0.0 106.394 164.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -123.86 113.17 18.17 Favored 'General case' 0 N--CA 1.465 0.309 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -169.77 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 41' ' ' VAL . 87.2 t -80.22 131.4 34.17 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.497 0 N-CA-C 109.577 -0.527 . . . . 0.0 109.577 -177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.444 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 30.3 ttt180 -146.83 161.24 41.09 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 108.615 -0.884 . . . . 0.0 108.615 -178.014 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.444 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.1 mm-40 -109.74 119.41 39.29 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 123.037 0.535 . . . . 0.0 110.419 179.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.571 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -96.61 146.76 24.54 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 123.776 0.831 . . . . 0.0 110.311 170.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.27 -18.83 62.41 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 123.403 0.681 . . . . 0.0 111.82 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -71.96 -55.34 7.63 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 123.893 0.877 . . . . 0.0 112.171 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.1 t -121.13 0.69 10.21 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.167 0.587 . . . . 0.0 111.859 -168.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 88.74 -113.78 4.15 Favored Glycine 0 C--N 1.345 1.08 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 -178.655 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.512 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -78.87 144.07 35.31 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.866 0.466 . . . . 0.0 111.279 173.582 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.443 ' OH ' ' HD3' ' A' ' 32' ' ' ARG . 9.3 p90 -154.85 177.42 11.29 Favored 'General case' 0 N--CA 1.476 0.834 0 C-N-CA 123.927 0.891 . . . . 0.0 108.666 170.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.459 HG22 HG22 ' A' ' 31' ' ' VAL . 16.3 t -128.3 124.13 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 173.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 50.1 t60 -84.02 122.52 28.89 Favored 'General case' 0 N--CA 1.468 0.443 0 C-N-CA 124.641 1.176 . . . . 0.0 108.983 172.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 54.3 m-85 -106.95 126.72 52.68 Favored 'General case' 0 N--CA 1.473 0.7 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 178.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -125.89 115.03 19.32 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 123.809 0.843 . . . . 0.0 110.02 -176.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.467 ' SD ' HG12 ' A' ' 27' ' ' ILE . 38.9 mtm -120.95 148.09 44.56 Favored 'General case' 0 N--CA 1.477 0.903 0 C-N-CA 123.566 0.746 . . . . 0.0 111.004 179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -167.79 166.36 13.68 Favored 'General case' 0 N--CA 1.486 1.357 0 C-N-CA 124.213 1.005 . . . . 0.0 109.94 172.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 162.11 -144.78 10.03 Favored Glycine 0 N--CA 1.474 1.226 0 CA-C-O 118.708 -1.051 . . . . 0.0 110.7 176.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -153.99 110.06 3.27 Favored 'General case' 0 CA--C 1.547 0.863 0 CA-C-O 122.582 1.182 . . . . 0.0 111.549 171.375 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 23' ' ' ILE . 70.3 mt -100.22 127.15 53.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.171 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.015 176.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 23.9 t70 65.09 23.53 12.43 Favored 'General case' 0 N--CA 1.478 0.943 0 C-N-CA 125.088 1.355 . . . . 0.0 109.206 -170.032 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.48 -0.63 84.67 Favored Glycine 0 C--N 1.355 1.618 0 CA-C-N 115.331 -0.85 . . . . 0.0 113.401 -173.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 25.0 mtpp -86.37 109.13 21.0 Favored Pre-proline 0 C--N 1.353 0.745 0 C-N-CA 124.092 0.957 . . . . 0.0 111.48 -175.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.24 129.84 18.89 Favored 'Trans proline' 0 C--N 1.378 2.125 0 C-N-CA 122.849 2.366 . . . . 0.0 111.902 -177.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -138.49 160.25 40.02 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 -176.455 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 16.1 t -147.77 129.06 14.76 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 169.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 27.1 t70 -130.87 142.02 50.35 Favored 'General case' 0 N--CA 1.474 0.769 0 C-N-CA 124.374 1.069 . . . . 0.0 109.102 -179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 78.5 p -143.25 133.62 24.7 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 122.538 0.335 . . . . 0.0 110.425 179.447 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 16.6 p90 -141.86 144.71 33.99 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.72 0.808 . . . . 0.0 109.231 177.849 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -126.1 127.25 45.49 Favored 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 -178.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.431 ' HB2' ' HA ' ' A' ' 65' ' ' ALA . 80.8 mt -124.7 129.87 24.46 Favored Pre-proline 0 C--O 1.243 0.731 0 N-CA-C 108.153 -1.055 . . . . 0.0 108.153 -175.73 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 35.8 Cg_endo -59.32 156.31 36.18 Favored 'Trans proline' 0 C--N 1.381 2.287 0 C-N-CA 122.951 2.434 . . . . 0.0 111.215 174.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.512 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 30.1 ptt180 -45.53 -26.88 0.64 Allowed 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 115.536 1.68 . . . . 0.0 115.536 -177.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 26.8 t70 -79.38 -21.79 45.26 Favored 'General case' 0 N--CA 1.481 1.124 0 C-N-CA 123.373 0.669 . . . . 0.0 111.809 -177.627 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 67.0 p -128.65 2.87 5.5 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 123.833 0.853 . . . . 0.0 110.977 -173.663 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.431 ' HA ' ' HB2' ' A' ' 60' ' ' LEU . . . -55.32 -37.37 67.32 Favored 'General case' 0 N--CA 1.485 1.309 0 C-N-CA 124.448 1.099 . . . . 0.0 112.545 -178.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 28.0 m-85 -71.52 0.7 7.83 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 114.668 -1.151 . . . . 0.0 113.202 -177.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 85.2 m-20 -88.16 3.82 47.83 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 123.482 0.713 . . . . 0.0 110.241 174.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -57.76 -52.03 67.14 Favored 'General case' 0 C--N 1.359 0.979 0 C-N-CA 123.998 0.919 . . . . 0.0 112.036 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -56.57 -31.1 63.89 Favored 'General case' 0 N--CA 1.473 0.716 0 N-CA-C 112.61 0.596 . . . . 0.0 112.61 -178.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.5 m -73.44 -50.83 19.65 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 122.977 0.511 . . . . 0.0 110.333 176.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -66.21 -55.6 15.45 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.745 0.818 . . . . 0.0 111.383 -176.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.36 -46.75 13.28 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 124.986 1.314 . . . . 0.0 113.059 173.268 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 98.1 m -70.6 -33.15 70.74 Favored 'General case' 0 N--CA 1.483 1.225 0 C-N-CA 122.913 0.485 . . . . 0.0 111.028 178.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 32.5 tpt180 -67.33 -40.77 85.95 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 123.396 0.679 . . . . 0.0 111.003 179.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 61.8 t -72.93 -33.21 42.68 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.694 0 C-N-CA 123.629 0.772 . . . . 0.0 110.727 175.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.96 -47.92 73.02 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-O 121.323 0.582 . . . . 0.0 109.548 -179.046 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.418 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 3.6 pt20 -69.63 -31.89 70.26 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.825 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 20.4 tptp -53.69 -41.66 67.16 Favored 'General case' 0 N--CA 1.476 0.847 0 C-N-CA 124.455 1.102 . . . . 0.0 110.876 172.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -90.79 8.66 33.57 Favored 'General case' 0 CA--C 1.545 0.786 0 CA-C-N 115.107 -0.951 . . . . 0.0 113.075 -175.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 134.47 -10.02 4.66 Favored Glycine 0 N--CA 1.48 1.611 0 N-CA-C 116.348 1.299 . . . . 0.0 116.348 173.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 8.7 mp -83.03 65.66 8.25 Favored 'General case' 0 N--CA 1.49 1.544 0 CA-C-N 118.898 1.349 . . . . 0.0 111.215 -179.685 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 37.9 t-80 -84.71 108.26 14.34 Favored Pre-proline 0 CA--C 1.541 0.618 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 171.61 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_exo -55.27 104.12 0.12 Allowed 'Trans proline' 0 C--N 1.384 2.407 0 C-N-CA 122.848 2.365 . . . . 0.0 111.492 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 61.9 tttm -69.03 -33.56 73.81 Favored 'General case' 0 N--CA 1.472 0.666 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.539 -178.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.471 ' HD1' ' H ' ' A' ' 85' ' ' PHE . 1.3 p90 -78.3 -6.17 54.27 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 123.386 0.674 . . . . 0.0 111.643 173.263 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 86.65 -51.96 4.4 Favored Glycine 0 C--N 1.353 1.479 0 C-N-CA 123.073 0.368 . . . . 0.0 113.08 174.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -78.44 -173.84 3.52 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 123.94 0.896 . . . . 0.0 111.42 179.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.455 HG13 ' HB2' ' A' ' 90' ' ' ARG . 33.4 pt -135.75 -172.31 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.057 0 C-N-CA 124.463 1.105 . . . . 0.0 108.807 173.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 22.4 p -66.01 -57.99 6.53 Favored 'General case' 0 CA--C 1.548 0.871 0 C-N-CA 123.715 0.806 . . . . 0.0 110.749 175.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . 0.455 ' HB2' HG13 ' A' ' 88' ' ' ILE . 28.1 ttm-85 60.63 -77.21 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.175 0 C-N-CA 126.04 1.736 . . . . 0.0 114.246 171.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 19.0 m -60.04 79.42 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.558 1.278 0 C-N-CA 124.964 1.306 . . . . 0.0 113.272 -169.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . 0.586 ' HB3' ' HG2' ' A' ' 94' ' ' GLU . 23.1 m-70 -157.77 153.63 26.82 Favored 'General case' 0 N--CA 1.472 0.635 0 C-N-CA 125.395 1.478 . . . . 0.0 108.63 -178.009 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -110.33 18.26 20.05 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 123.551 0.74 . . . . 0.0 110.067 178.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.586 ' HG2' ' HB3' ' A' ' 92' ' ' HIS . 6.0 mm-40 -71.24 -30.4 66.28 Favored 'General case' 0 N--CA 1.48 1.058 0 C-N-CA 123.169 0.588 . . . . 0.0 110.677 -174.312 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.7 t80 -65.8 -46.63 77.95 Favored 'General case' 0 C--O 1.221 -0.442 0 CA-C-N 115.18 -0.918 . . . . 0.0 109.94 174.723 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -59.0 -34.73 72.19 Favored 'General case' 0 N--CA 1.488 1.436 0 C-N-CA 123.78 0.832 . . . . 0.0 110.962 176.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -66.14 -50.34 64.31 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 115.167 -0.924 . . . . 0.0 111.564 -179.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.7 mmt -72.27 -30.74 65.13 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.623 178.226 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 32.6 t80 -51.92 -52.4 50.28 Favored 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 124.087 0.955 . . . . 0.0 110.625 178.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -73.78 -28.76 61.82 Favored 'General case' 0 N--CA 1.471 0.616 0 O-C-N 123.798 0.686 . . . . 0.0 112.241 -173.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -73.24 -44.81 58.82 Favored 'General case' 0 CA--C 1.548 0.901 0 C-N-CA 122.382 0.273 . . . . 0.0 110.811 177.126 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.442 ' O ' HD13 ' A' ' 106' ' ' LEU . 97.6 mt -63.47 -46.52 94.98 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.22 0 C-N-CA 123.688 0.795 . . . . 0.0 111.648 177.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 4.2 ppt_? -59.69 -31.5 69.64 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 121.349 0.595 . . . . 0.0 110.496 179.207 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -75.7 -39.93 56.63 Favored 'General case' 0 CA--C 1.546 0.796 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.573 178.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.458 ' HG2' HG21 ' A' ' 31' ' ' VAL . 1.9 tpmt? -64.63 -32.67 74.43 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 123.475 0.71 . . . . 0.0 111.873 174.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.442 HD13 ' O ' ' A' ' 102' ' ' ILE . 1.0 OUTLIER -67.83 -20.96 65.22 Favored 'General case' 0 N--CA 1.485 1.308 0 C-N-CA 124.679 1.192 . . . . 0.0 111.149 171.377 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 24.3 t60 -88.24 -17.18 31.35 Favored 'General case' 0 CA--C 1.561 1.382 0 C-N-CA 124.126 0.97 . . . . 0.0 110.202 170.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 89.96 14.64 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 126.916 2.086 . . . . 0.0 112.638 173.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 73.8 m-70 -138.66 127.74 14.32 Favored Pre-proline 0 N--CA 1.49 1.561 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 173.063 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_exo -61.34 153.51 65.14 Favored 'Trans proline' 0 C--N 1.379 2.175 0 C-N-CA 123.113 2.542 . . . . 0.0 113.74 -172.772 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -141.24 62.15 0.54 Allowed Glycine 0 C--N 1.343 0.932 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -177.185 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -56.29 139.4 73.39 Favored Pre-proline 0 CA--C 1.559 1.298 0 C-N-CA 124.033 0.933 . . . . 0.0 112.436 -175.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 64.3 Cg_endo -80.22 66.02 8.85 Favored 'Trans proline' 0 C--N 1.371 1.752 0 C-N-CA 123.382 2.722 . . . . 0.0 112.531 -179.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 8.4 p -83.54 72.44 0.8 Allowed 'Isoleucine or valine' 0 CA--C 1.555 1.148 0 CA-C-O 122.845 1.307 . . . . 0.0 109.532 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -89.68 41.24 1.03 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 114.961 -1.018 . . . . 0.0 110.779 -176.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.413 HD12 ' N ' ' A' ' 117' ' ' GLU . 3.9 pp -63.23 -29.69 70.98 Favored 'General case' 0 CA--C 1.549 0.916 0 CA-C-N 115.593 -0.73 . . . . 0.0 112.325 -176.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.413 ' N ' HD12 ' A' ' 116' ' ' LEU . 31.7 tt0 -73.65 -19.17 60.92 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.496 0.718 . . . . 0.0 111.43 -177.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 17.7 tpp180 -68.53 -16.46 63.88 Favored 'General case' 0 N--CA 1.484 1.23 0 C-N-CA 122.958 0.503 . . . . 0.0 111.407 -178.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 38.3 mm -71.64 -35.3 55.4 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.783 0 C-N-CA 123.112 0.565 . . . . 0.0 109.805 171.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.413 HD12 ' N ' ' A' ' 120' ' ' ILE . 3.4 mp -84.36 78.13 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.825 0 CA-C-O 122.261 1.029 . . . . 0.0 108.246 -179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.02 -13.73 0.63 Allowed 'General case' 0 N--CA 1.475 0.792 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.861 175.058 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.4 t-80 -68.89 126.75 30.77 Favored 'General case' 0 C--N 1.355 0.813 0 C-N-CA 123.66 0.784 . . . . 0.0 109.308 177.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 16.3 mm-40 -90.57 159.18 16.59 Favored 'General case' 0 N--CA 1.477 0.921 0 C-N-CA 123.326 0.65 . . . . 0.0 109.678 178.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -77.67 66.74 2.99 Favored Glycine 0 C--N 1.345 1.059 0 O-C-N 123.192 0.307 . . . . 0.0 112.476 178.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 35.2 t . . . . . 0 C--O 1.25 1.085 0 C-N-CA 124.047 0.939 . . . . 0.0 109.306 -178.473 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 . . . . . 0 N--CA 1.48 1.049 0 N-CA-C 110.205 -0.294 . . . . 0.0 110.205 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 65.68 -165.76 36.46 Favored Glycine 0 C--N 1.349 1.299 0 O-C-N 123.618 0.574 . . . . 0.0 114.164 177.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -74.14 118.75 17.46 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 174.796 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 28.2 ttt -120.84 130.9 54.14 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.559 0.744 . . . . 0.0 109.691 -175.83 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -141.7 136.23 30.63 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 123.235 0.614 . . . . 0.0 109.801 177.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -142.82 156.91 62.35 Favored Pre-proline 0 CA--C 1.553 1.074 0 C-N-CA 124.824 1.25 . . . . 0.0 108.504 176.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -56.61 105.03 0.16 Allowed 'Trans proline' 0 C--N 1.375 1.962 0 C-N-CA 122.538 2.159 . . . . 0.0 112.242 173.849 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 115.63 -19.89 13.95 Favored Glycine 0 C--N 1.343 0.966 0 CA-C-N 116.254 -0.43 . . . . 0.0 113.691 177.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 31.8 t-80 -150.97 135.33 16.96 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-O 121.524 0.678 . . . . 0.0 112.363 -171.706 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.403 HD22 ' HE1' ' A' ' 98' ' ' MET . 46.2 tp -114.8 141.02 48.44 Favored 'General case' 0 CA--C 1.546 0.814 0 C-N-CA 125.583 1.553 . . . . 0.0 108.957 170.557 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 29.5 t-80 -133.38 126.39 31.18 Favored 'General case' 0 N--CA 1.477 0.912 0 C-N-CA 123.532 0.733 . . . . 0.0 109.349 168.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.574 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.7 OUTLIER -123.29 110.21 14.91 Favored 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.644 0.735 . . . . 0.0 110.529 179.594 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -104.6 158.29 5.53 Favored 'Isoleucine or valine' 0 C--O 1.248 1.015 0 N-CA-C 106.402 -1.703 . . . . 0.0 106.402 164.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.552 ' HB3' HG13 ' A' ' 23' ' ' ILE . 94.8 p -71.6 136.96 47.62 Favored 'General case' 0 N--CA 1.477 0.923 0 CA-C-N 118.877 0.762 . . . . 0.0 110.555 -171.324 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 91.9 mt -80.93 113.98 44.89 Favored Pre-proline 0 CA--C 1.553 1.08 0 N-CA-C 109.343 -0.614 . . . . 0.0 109.343 177.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.89 126.74 13.57 Favored 'Trans proline' 0 C--N 1.375 1.955 0 C-N-CA 123.177 2.584 . . . . 0.0 113.059 -172.293 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 166.2 -66.88 0.2 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 110.179 -1.168 . . . . 0.0 110.179 178.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 55.5 tp -91.93 -34.45 14.48 Favored 'General case' 0 N--CA 1.479 1.001 0 C-N-CA 123.367 0.667 . . . . 0.0 109.749 178.099 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -144.46 131.98 20.98 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.589 0.756 . . . . 0.0 110.583 -178.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -123.52 41.54 3.45 Favored 'General case' 0 CA--C 1.549 0.935 0 C-N-CA 124.179 0.991 . . . . 0.0 109.515 173.659 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.432 HE21 ' HB2' ' A' ' 50' ' ' ASP . 35.2 tt0 -69.34 158.3 35.32 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 109.388 -0.597 . . . . 0.0 109.388 175.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.7 t70 -85.95 53.17 2.69 Favored 'General case' 0 CA--C 1.548 0.875 0 CA-C-O 121.625 0.726 . . . . 0.0 110.255 -176.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.552 HG13 ' HB3' ' A' ' 14' ' ' SER . 2.0 pp -89.67 115.57 29.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 172.504 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 15.0 m-80 -138.2 106.39 5.75 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 -177.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.574 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 48.6 mt -127.6 132.98 68.65 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.694 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 -166.069 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 38.3 m-70 -107.35 119.17 38.65 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 175.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.502 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -120.55 114.1 42.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 174.239 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.453 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 18.4 mtp180 -104.11 135.34 45.78 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 124.447 1.099 . . . . 0.0 108.234 175.931 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 39.1 p90 -121.88 116.06 23.73 Favored 'General case' 0 C--N 1.326 -0.456 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 167.357 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.7 mt-10 -121.6 111.8 17.67 Favored 'General case' 0 N--CA 1.467 0.39 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 -172.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 41' ' ' VAL . 52.1 t -82.37 118.33 29.91 Favored 'Isoleucine or valine' 0 C--O 1.237 0.418 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 12.6 ttt180 -124.03 159.0 30.83 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 108.03 -1.1 . . . . 0.0 108.03 173.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.2 mm-40 -109.27 119.39 39.35 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 122.722 0.409 . . . . 0.0 110.35 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -95.04 154.9 16.96 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 123.877 0.871 . . . . 0.0 109.232 167.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.75 -27.65 64.1 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 122.714 0.406 . . . . 0.0 111.454 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -75.21 -54.38 7.2 Favored 'General case' 0 CA--C 1.544 0.735 0 C-N-CA 123.862 0.865 . . . . 0.0 112.348 -173.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.0 t -108.57 -1.92 19.25 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 123.11 0.564 . . . . 0.0 111.532 -173.609 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 79.84 -110.31 3.06 Favored Glycine 0 C--N 1.344 1.014 0 N-CA-C 110.658 -0.977 . . . . 0.0 110.658 -178.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -79.78 138.34 37.24 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 122.9 0.48 . . . . 0.0 110.567 173.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -147.5 166.79 26.2 Favored 'General case' 0 N--CA 1.474 0.754 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 169.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.453 HG22 HG22 ' A' ' 31' ' ' VAL . 7.6 t -127.81 127.12 67.89 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 N-CA-C 109.867 -0.42 . . . . 0.0 109.867 -178.235 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.578 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 55.4 t60 -86.18 114.41 23.0 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.462 1.105 . . . . 0.0 108.859 171.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.448 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 76.0 m-85 -99.73 111.38 23.72 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 178.33 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.453 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 27.1 t70 -107.13 124.58 49.9 Favored 'General case' 0 N--CA 1.47 0.547 0 C-N-CA 123.982 0.913 . . . . 0.0 109.408 -179.297 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.502 ' HG2' HG12 ' A' ' 27' ' ' ILE . 79.4 mtp -124.58 140.34 53.03 Favored 'General case' 0 N--CA 1.476 0.844 0 C-N-CA 123.259 0.624 . . . . 0.0 110.286 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -161.04 170.0 21.38 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 123.739 0.815 . . . . 0.0 109.663 173.913 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.16 -137.78 6.23 Favored Glycine 0 C--O 1.222 -0.625 0 CA-C-O 119.429 -0.651 . . . . 0.0 112.002 171.876 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.476 ' HA ' ' HA ' ' A' ' 53' ' ' PRO . 9.7 pt-20 -152.55 157.73 41.49 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.756 1.222 . . . . 0.0 108.546 -179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.543 HG23 HG22 ' A' ' 23' ' ' ILE . 51.2 mt -156.46 105.85 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.086 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -168.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.432 ' HB2' HE21 ' A' ' 21' ' ' GLN . 26.9 t70 59.14 47.96 11.14 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.216 1.007 . . . . 0.0 108.994 -170.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.97 -35.05 3.13 Favored Glycine 0 C--N 1.351 1.372 0 CA-C-N 114.836 -1.075 . . . . 0.0 114.384 179.072 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 34.2 mtmm -86.94 128.88 54.31 Favored Pre-proline 0 N--CA 1.477 0.881 0 C-N-CA 124.218 1.007 . . . . 0.0 112.053 -168.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 48' ' ' GLU . 89.6 Cg_endo -74.17 161.07 41.47 Favored 'Trans proline' 0 C--N 1.377 2.029 0 C-N-CA 123.064 2.509 . . . . 0.0 113.821 -177.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.415 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 8.9 p90 -152.86 148.9 27.71 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.903 0.881 . . . . 0.0 109.021 176.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 50.2 m -142.54 113.83 7.76 Favored 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.154 0.582 . . . . 0.0 110.278 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -127.21 143.09 51.33 Favored 'General case' 0 N--CA 1.483 1.195 0 C-N-CA 124.295 1.038 . . . . 0.0 109.186 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 28.3 t -143.53 134.43 25.39 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-O 121.013 0.435 . . . . 0.0 110.093 177.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -146.97 148.81 32.1 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.853 0.861 . . . . 0.0 109.703 -179.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.578 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 4.7 mp0 -118.94 138.72 52.59 Favored 'General case' 0 N--CA 1.474 0.742 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 -179.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.448 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 73.4 mt -128.89 134.36 26.23 Favored Pre-proline 0 N--CA 1.473 0.688 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 173.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -63.71 160.85 34.66 Favored 'Trans proline' 0 C--N 1.376 1.981 0 C-N-CA 122.641 2.227 . . . . 0.0 111.373 172.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.51 -36.2 9.96 Favored 'General case' 0 N--CA 1.491 1.583 0 N-CA-C 114.137 1.162 . . . . 0.0 114.137 -175.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -71.57 -23.73 61.79 Favored 'General case' 0 N--CA 1.481 1.102 0 C-N-CA 124.056 0.942 . . . . 0.0 112.258 -175.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 72.5 p -125.3 7.2 7.77 Favored 'General case' 0 N--CA 1.481 1.085 0 C-N-CA 123.952 0.901 . . . . 0.0 110.779 -175.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.13 -40.04 80.28 Favored 'General case' 0 N--CA 1.478 0.926 0 C-N-CA 124.029 0.931 . . . . 0.0 112.282 -176.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 -70.83 -6.51 38.5 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 124.086 0.954 . . . . 0.0 113.186 -175.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -78.57 -6.3 55.17 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 123.414 0.685 . . . . 0.0 111.131 175.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 4.6 p90 -64.14 -24.13 67.57 Favored 'General case' 0 C--O 1.207 -1.149 0 C-N-CA 124.542 1.137 . . . . 0.0 113.06 -174.577 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.7 -49.06 16.98 Favored 'General case' 0 N--CA 1.473 0.718 0 CA-C-O 121.252 0.549 . . . . 0.0 109.693 -162.48 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 14.9 m -72.41 -31.01 65.17 Favored 'General case' 0 CA--C 1.546 0.806 0 CA-C-N 114.362 -1.29 . . . . 0.0 110.283 178.329 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -70.07 -54.24 13.96 Favored 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 124.182 0.993 . . . . 0.0 110.793 179.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.97 -41.02 74.13 Favored 'General case' 0 N--CA 1.481 1.077 0 C-N-CA 124.631 1.172 . . . . 0.0 111.92 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 89.5 m -63.86 -50.24 69.63 Favored 'General case' 0 CA--C 1.545 0.768 0 C-N-CA 122.657 0.383 . . . . 0.0 110.34 175.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 40.7 ttp180 -54.92 -45.37 74.78 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.216 1.006 . . . . 0.0 112.058 179.858 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 11.1 p -73.34 -32.06 36.01 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 C-N-CA 122.543 0.337 . . . . 0.0 110.671 -176.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.99 -47.48 58.63 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 123.023 0.529 . . . . 0.0 110.096 -177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.611 ' HA ' HD23 ' A' ' 81' ' ' LEU . 13.2 pt20 -65.4 -22.16 66.75 Favored 'General case' 0 N--CA 1.479 1.008 0 C-N-CA 123.757 0.823 . . . . 0.0 112.641 -175.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -64.65 -19.24 65.6 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.741 0.816 . . . . 0.0 111.918 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 -90.2 25.23 2.25 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.373 0.669 . . . . 0.0 112.33 -176.787 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 98.22 49.85 1.67 Allowed Glycine 0 C--N 1.35 1.312 0 CA-C-O 120.218 -0.212 . . . . 0.0 113.493 170.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.611 HD23 ' HA ' ' A' ' 77' ' ' GLN . 0.6 OUTLIER -78.2 153.47 31.95 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 122.953 0.501 . . . . 0.0 109.701 173.428 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -71.08 164.78 53.9 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 123.949 0.9 . . . . 0.0 110.782 174.686 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -44.81 96.3 0.03 OUTLIER 'Trans proline' 0 C--N 1.382 2.341 0 C-N-CA 123.315 2.677 . . . . 0.0 112.615 165.243 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -83.37 -20.36 34.39 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 123.751 0.82 . . . . 0.0 111.748 -173.318 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 80.9 m-85 -69.5 -8.47 47.22 Favored 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 123.422 0.689 . . . . 0.0 112.118 -175.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -79.42 -4.71 89.22 Favored Glycine 0 C--N 1.349 1.287 0 CA-C-O 119.8 -0.445 . . . . 0.0 113.389 175.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -67.13 131.87 46.68 Favored 'General case' 0 N--CA 1.476 0.868 0 C-N-CA 123.292 0.637 . . . . 0.0 110.075 176.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.417 HD13 ' H ' ' A' ' 88' ' ' ILE . 0.2 OUTLIER -77.27 167.94 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 C-N-CA 123.37 0.668 . . . . 0.0 111.386 -177.836 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 13.9 t -68.54 -26.66 65.53 Favored 'General case' 0 CA--C 1.548 0.896 0 C-N-CA 123.376 0.67 . . . . 0.0 111.909 -177.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.8 ttm180 -87.53 81.12 7.86 Favored 'General case' 0 N--CA 1.473 0.704 0 CA-C-O 121.176 0.512 . . . . 0.0 110.104 -178.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 11.7 m -142.96 138.44 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 124.237 1.015 . . . . 0.0 108.852 176.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 38.0 m80 -103.79 98.81 8.61 Favored 'General case' 0 N--CA 1.473 0.709 0 C-N-CA 123.117 0.567 . . . . 0.0 110.205 -179.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 3.4 mmmp? -103.75 101.11 10.94 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.038 -1.468 . . . . 0.0 107.038 168.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -72.78 79.47 1.13 Allowed 'General case' 0 N--CA 1.477 0.907 0 CA-C-O 121.934 0.874 . . . . 0.0 110.696 -177.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 19.2 t80 -71.8 -42.26 67.28 Favored 'General case' 0 C--O 1.223 -0.298 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.818 177.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -69.27 -34.08 74.22 Favored 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 124.473 1.109 . . . . 0.0 111.815 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.1 -48.37 68.38 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 123.711 0.632 . . . . 0.0 110.696 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.403 ' HE1' HD22 ' A' ' 10' ' ' LEU . 30.4 ttm -65.45 -41.53 93.35 Favored 'General case' 0 CA--C 1.55 0.977 0 CA-C-N 115.608 -0.724 . . . . 0.0 112.012 173.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 84.6 t80 -53.24 -48.29 68.33 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.388 1.075 . . . . 0.0 110.91 176.182 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -76.0 -26.85 57.09 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.063 -0.517 . . . . 0.0 111.268 -177.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 15.7 t70 -65.72 -57.35 8.26 Favored 'General case' 0 N--CA 1.472 0.639 0 O-C-N 123.487 0.492 . . . . 0.0 110.212 176.543 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 31.6 mt -59.9 -42.41 89.16 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 C-N-CA 123.431 0.693 . . . . 0.0 111.551 178.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.53 -28.38 69.13 Favored 'General case' 0 N--CA 1.485 1.29 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -69.44 -50.22 47.74 Favored 'General case' 0 C--N 1.356 0.851 0 C-N-CA 123.312 0.645 . . . . 0.0 110.326 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.43 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 30.7 mmmt -58.34 -40.46 82.22 Favored 'General case' 0 N--CA 1.48 1.031 0 C-N-CA 123.948 0.899 . . . . 0.0 111.889 177.498 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 2.5 mp -66.62 -34.47 77.95 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.537 1.135 . . . . 0.0 111.046 178.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.442 ' HD2' ' HB2' ' A' ' 109' ' ' HIS . 13.1 t60 -81.28 -17.86 47.91 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.444 0.697 . . . . 0.0 110.562 174.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 69.96 13.45 7.91 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 125.569 1.547 . . . . 0.0 111.667 -179.362 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.442 ' HB2' ' HD2' ' A' ' 107' ' ' HIS . 73.6 m80 -148.49 152.27 38.06 Favored Pre-proline 0 N--CA 1.48 1.055 0 C-N-CA 124.993 1.317 . . . . 0.0 108.777 -176.189 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_exo -42.68 119.12 1.35 Allowed 'Trans proline' 0 C--N 1.391 2.771 0 C-N-CA 123.991 3.127 . . . . 0.0 114.206 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -92.74 -4.3 65.58 Favored Glycine 0 C--N 1.345 1.075 0 CA-C-N 115.456 -0.793 . . . . 0.0 113.371 -172.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -64.99 114.91 16.75 Favored Pre-proline 0 CA--C 1.561 1.375 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 174.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -88.64 123.18 1.48 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 122.845 2.363 . . . . 0.0 112.83 -172.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . 0.416 HG21 HD23 ' A' ' 116' ' ' LEU . 11.6 p -79.05 152.91 4.84 Favored 'Isoleucine or valine' 0 C--O 1.244 0.778 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 171.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -113.42 17.48 18.41 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 123.038 0.535 . . . . 0.0 111.774 -174.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.416 HD23 HG21 ' A' ' 114' ' ' VAL . 4.4 pp -65.65 -24.26 66.98 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 112.539 0.57 . . . . 0.0 112.539 -174.051 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -114.59 -3.14 12.96 Favored 'General case' 0 N--CA 1.483 1.205 0 C-N-CA 124.11 0.964 . . . . 0.0 110.865 -178.431 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 61.0 ttt180 -72.29 -5.27 34.92 Favored 'General case' 0 N--CA 1.489 1.487 0 C-N-CA 123.558 0.743 . . . . 0.0 112.707 -172.05 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.476 ' H ' HD12 ' A' ' 119' ' ' ILE . 4.0 mp -74.3 -7.42 9.94 Favored 'Isoleucine or valine' 0 CA--C 1.564 1.486 0 C-N-CA 123.998 0.919 . . . . 0.0 109.648 175.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 21.2 mm 60.77 54.91 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.366 1.286 0 C-N-CA 125.12 1.368 . . . . 0.0 107.501 -176.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 42.5 mtp180 -70.01 88.99 0.59 Allowed 'General case' 0 C--O 1.24 0.553 0 CA-C-N 113.423 -1.717 . . . . 0.0 110.666 -164.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 53.4 p-80 -82.7 132.77 35.17 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.834 -0.802 . . . . 0.0 108.834 178.843 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -73.69 -38.07 65.01 Favored 'General case' 0 CA--C 1.545 0.766 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 178.27 -158.24 22.82 Favored Glycine 0 C--N 1.343 0.96 0 CA-C-N 115.598 -0.728 . . . . 0.0 111.958 178.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 42.8 m . . . . . 0 C--O 1.252 1.193 0 C-N-CA 123.495 0.718 . . . . 0.0 109.352 179.493 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . 0.433 HE21 HD13 ' A' ' 12' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.48 1.047 0 N-CA-C 110.102 -0.333 . . . . 0.0 110.102 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 86.3 132.22 3.09 Favored Glycine 0 C--N 1.344 0.979 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 -174.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 52.5 t-80 -139.39 -30.55 0.72 Allowed 'General case' 0 N--CA 1.476 0.865 0 C-N-CA 123.174 0.59 . . . . 0.0 110.094 -177.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . 0.474 ' HB2' ' HB3' ' A' ' 11' ' ' HIS . 76.6 mmm -128.18 102.69 6.81 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.543 1.137 . . . . 0.0 108.607 177.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.5 t80 -108.6 147.03 32.42 Favored 'General case' 0 N--CA 1.477 0.885 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 171.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -152.47 155.6 32.94 Favored Pre-proline 0 CA--C 1.546 0.811 0 C-N-CA 124.575 1.15 . . . . 0.0 108.304 177.011 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 34.4 Cg_endo -62.72 90.83 0.13 Allowed 'Trans proline' 0 C--N 1.372 1.798 0 C-N-CA 122.285 1.99 . . . . 0.0 111.995 176.674 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.91 -26.3 3.01 Favored Glycine 0 C--N 1.343 0.962 0 CA-C-N 115.622 -0.717 . . . . 0.0 112.721 177.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 55.5 t-80 -150.53 151.63 32.94 Favored 'General case' 0 N--CA 1.479 1.02 0 CA-C-N 117.196 0.498 . . . . 0.0 111.692 -170.287 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.416 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 53.8 tp -135.02 111.63 9.93 Favored 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 124.817 1.247 . . . . 0.0 108.557 176.549 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.474 ' HB3' ' HB2' ' A' ' 4' ' ' MET . 11.6 t-160 -98.42 127.9 44.56 Favored 'General case' 0 N--CA 1.469 0.491 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 172.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.433 HD13 HE21 ' A' ' 1' ' ' GLN . 0.3 OUTLIER -121.05 132.38 54.85 Favored 'General case' 0 N--CA 1.466 0.345 0 C-N-CA 123.215 0.606 . . . . 0.0 109.931 177.991 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 22.1 m -129.09 165.13 29.7 Favored 'Isoleucine or valine' 0 C--O 1.248 1.009 0 N-CA-C 107.135 -1.431 . . . . 0.0 107.135 166.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 31.4 t -113.45 115.15 27.59 Favored 'General case' 0 C--O 1.241 0.618 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -175.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.3 mt -62.92 139.94 97.44 Favored Pre-proline 0 N--CA 1.471 0.606 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.018 173.329 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_endo -44.95 -69.67 0.08 OUTLIER 'Trans proline' 0 C--N 1.382 2.315 0 C-N-CA 123.824 3.016 . . . . 0.0 113.73 -168.836 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 62.21 -84.86 0.04 OUTLIER Glycine 0 C--N 1.343 0.929 0 O-C-N 123.355 0.409 . . . . 0.0 113.082 179.624 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.401 HD23 ' H ' ' A' ' 19' ' ' ASP . 2.3 pt? -88.8 -40.05 13.45 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.86 0.864 . . . . 0.0 110.141 176.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . 0.401 ' H ' HD23 ' A' ' 18' ' ' LEU . 1.0 OUTLIER -166.82 141.52 4.09 Favored 'General case' 0 N--CA 1.484 1.253 0 C-N-CA 125.502 1.521 . . . . 0.0 108.701 -176.058 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 59.4 tt0 -81.43 84.08 6.78 Favored 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 122.989 0.516 . . . . 0.0 109.734 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.0 tt0 -83.94 141.29 31.36 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 37.0 t70 -88.05 65.83 8.35 Favored 'General case' 0 N--CA 1.473 0.725 0 CA-C-O 121.852 0.834 . . . . 0.0 110.509 -174.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.625 HD13 HD21 ' A' ' 81' ' ' LEU . 0.6 OUTLIER -92.69 126.85 45.12 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 N-CA-C 106.323 -1.732 . . . . 0.0 106.323 172.869 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.484 HD21 ' HG3' ' A' ' 48' ' ' GLU . 6.0 p30 -151.81 110.02 3.73 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.837 -1.172 . . . . 0.0 107.837 177.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.411 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 27.8 mt -132.32 137.78 53.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.503 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.227 -168.195 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.535 ' O ' ' HA ' ' A' ' 45' ' ' MET . 4.7 m170 -99.53 128.52 45.65 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.565 HG12 ' HG2' ' A' ' 45' ' ' MET . 56.2 mt -121.9 109.62 25.06 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.7 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 173.057 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 74.9 mtp85 -96.18 124.84 40.33 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . 0.462 ' HB2' HG11 ' A' ' 41' ' ' VAL . 45.7 p90 -111.69 116.98 31.65 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.049 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 28.1 mt-10 -124.63 112.32 16.65 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 123.676 0.79 . . . . 0.0 109.29 -172.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 41' ' ' VAL . 56.3 t -75.9 126.64 36.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.639 0 C-N-CA 122.771 0.428 . . . . 0.0 110.663 -178.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 4.7 tmt_? -143.97 154.79 43.66 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 106.903 -1.518 . . . . 0.0 106.903 176.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 30.0 mm-40 -97.05 125.56 41.58 Favored 'General case' 0 N--CA 1.475 0.804 0 C-N-CA 122.713 0.405 . . . . 0.0 111.132 -176.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.533 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 1.5 p30 -100.1 147.08 26.04 Favored 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 124.635 1.174 . . . . 0.0 109.155 173.544 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.81 -10.94 60.51 Favored 'General case' 0 CA--C 1.554 1.111 0 C-N-CA 122.954 0.501 . . . . 0.0 112.233 -179.295 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.533 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 16.4 tt0 -75.81 -55.27 5.79 Favored 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 124.196 0.999 . . . . 0.0 112.012 -177.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 53.1 p -130.32 1.98 4.64 Favored 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 123.338 0.655 . . . . 0.0 112.263 -167.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.88 -106.27 3.4 Favored Glycine 0 C--O 1.213 -1.171 0 N-CA-C 110.985 -0.846 . . . . 0.0 110.985 -178.066 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 146.76 41.22 Favored 'General case' 0 N--CA 1.474 0.772 0 CA-C-N 117.794 0.797 . . . . 0.0 111.887 175.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.442 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.5 p90 -152.85 173.53 15.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 165.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.511 HG22 HG22 ' A' ' 31' ' ' VAL . 23.5 t -128.7 130.85 68.89 Favored 'Isoleucine or valine' 0 C--O 1.24 0.595 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 176.368 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 11.8 t60 -89.03 110.95 21.59 Favored 'General case' 0 CA--C 1.538 0.519 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 174.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.425 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 63.3 m-85 -96.56 139.32 32.83 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.467 0.707 . . . . 0.0 109.181 178.514 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -135.04 127.95 31.37 Favored 'General case' 0 N--CA 1.471 0.613 0 C-N-CA 123.358 0.663 . . . . 0.0 109.722 -177.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.565 ' HG2' HG12 ' A' ' 27' ' ' ILE . 83.4 mtp -123.91 131.17 53.53 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 123.919 0.888 . . . . 0.0 110.114 -177.393 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 4.4 p-10 -161.03 162.18 31.65 Favored 'General case' 0 N--CA 1.479 0.998 0 N-CA-C 109.993 -0.373 . . . . 0.0 109.993 178.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 149.71 -128.03 2.6 Favored Glycine 0 CA--C 1.505 -0.547 0 N-CA-C 110.554 -1.019 . . . . 0.0 110.554 178.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.484 ' HG3' HD21 ' A' ' 24' ' ' ASN . 10.3 pt-20 -156.59 165.43 36.31 Favored 'General case' 0 C--O 1.242 0.685 0 C-N-CA 123.198 0.599 . . . . 0.0 109.864 175.84 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 90.6 mt -155.98 103.98 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.943 0 N-CA-C 103.462 -2.792 . . . . 0.0 103.462 -161.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 60.16 37.43 20.78 Favored 'General case' 0 N--CA 1.485 1.276 0 C-N-CA 123.687 0.795 . . . . 0.0 110.1 -167.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 82.12 -21.03 7.32 Favored Glycine 0 C--N 1.35 1.353 0 CA-C-N 115.312 -0.858 . . . . 0.0 115.239 -177.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -79.65 120.23 79.46 Favored Pre-proline 0 N--CA 1.475 0.821 0 CA-C-N 117.621 0.711 . . . . 0.0 110.825 -174.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -72.61 157.05 53.09 Favored 'Trans proline' 0 C--N 1.375 1.943 0 C-N-CA 123.017 2.478 . . . . 0.0 113.266 -176.885 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -154.7 161.51 41.52 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 122.679 0.392 . . . . 0.0 111.279 175.019 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 37.5 p -141.89 116.26 9.54 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.117 0.967 . . . . 0.0 109.431 170.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -144.35 144.31 31.38 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 124.244 1.018 . . . . 0.0 108.861 179.574 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 63.3 p -148.12 149.59 32.3 Favored 'General case' 0 N--CA 1.482 1.13 0 CA-C-N 118.452 0.569 . . . . 0.0 110.753 -177.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 40.1 p90 -141.46 151.32 43.27 Favored 'General case' 0 N--CA 1.476 0.841 0 C-N-CA 123.558 0.743 . . . . 0.0 110.571 179.88 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -122.76 132.56 54.29 Favored 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 123.55 0.74 . . . . 0.0 109.863 179.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.425 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 95.7 mt -127.53 139.05 34.15 Favored Pre-proline 0 N--CA 1.476 0.875 0 C-N-CA 123.374 0.67 . . . . 0.0 109.791 178.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.3 Cg_endo -62.44 158.54 40.36 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 123.053 2.502 . . . . 0.0 112.02 172.958 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 39.5 ptt180 -41.36 -34.83 0.56 Allowed 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 125.126 1.37 . . . . 0.0 114.65 175.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -70.86 -19.88 62.59 Favored 'General case' 0 N--CA 1.485 1.299 0 C-N-CA 123.625 0.77 . . . . 0.0 112.416 -177.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 38.3 p -131.7 10.1 4.68 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.829 0.852 . . . . 0.0 110.231 -175.237 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -63.52 -43.57 96.79 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 123.493 0.717 . . . . 0.0 111.36 -177.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.7 m-85 -70.05 -22.19 63.1 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 115.148 -0.933 . . . . 0.0 111.549 176.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -80.6 -8.76 59.72 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.809 0.844 . . . . 0.0 109.545 -174.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 3.2 p90 -53.04 -30.61 36.76 Favored 'General case' 0 C--O 1.205 -1.276 0 C-N-CA 123.949 0.899 . . . . 0.0 112.918 -178.234 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -50.07 -34.16 20.77 Favored 'General case' 0 N--CA 1.48 1.053 0 N-CA-C 112.476 0.547 . . . . 0.0 112.476 176.707 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 12.6 m -69.52 -48.3 60.94 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 123.282 0.633 . . . . 0.0 110.109 176.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -64.37 -57.04 10.45 Favored 'General case' 0 C--O 1.197 -1.677 0 C-N-CA 123.806 0.842 . . . . 0.0 111.479 -179.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -43.55 -45.27 6.53 Favored 'General case' 0 N--CA 1.484 1.247 0 C-N-CA 125.778 1.631 . . . . 0.0 113.461 175.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 86.4 m -68.75 -40.55 79.73 Favored 'General case' 0 N--CA 1.479 0.998 0 C-N-CA 122.668 0.387 . . . . 0.0 110.892 176.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.411 ' HA ' ' HG2' ' A' ' 77' ' ' GLN . 31.4 ttp180 -68.59 -39.09 81.09 Favored 'General case' 0 CA--C 1.553 1.073 0 C-N-CA 123.534 0.734 . . . . 0.0 111.828 -177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 72.0 t -60.98 -50.21 81.54 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.553 0 C-N-CA 124.397 1.079 . . . . 0.0 109.451 173.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.463 ' HB1' HD22 ' A' ' 81' ' ' LEU . . . -60.74 -43.06 98.4 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.667 0.787 . . . . 0.0 111.622 -176.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.411 ' HG2' ' HA ' ' A' ' 74' ' ' ARG . 3.3 pt20 -71.11 -35.52 71.82 Favored 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 122.638 0.375 . . . . 0.0 111.284 -176.273 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 46.4 mtmt -65.1 -31.65 72.95 Favored 'General case' 0 N--CA 1.481 1.088 0 C-N-CA 122.619 0.368 . . . . 0.0 110.697 172.453 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 44.9 m-70 -89.38 5.38 45.45 Favored 'General case' 0 N--CA 1.477 0.914 0 C-N-CA 123.234 0.613 . . . . 0.0 112.143 -178.499 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 141.02 -27.09 2.45 Favored Glycine 0 C--N 1.357 1.747 0 N-CA-C 115.478 0.951 . . . . 0.0 115.478 171.642 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.625 HD21 HD13 ' A' ' 23' ' ' ILE . 9.8 mp -70.9 158.07 37.07 Favored 'General case' 0 N--CA 1.485 1.311 0 CA-C-O 121.767 0.794 . . . . 0.0 111.955 -176.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 -142.04 74.46 21.55 Favored Pre-proline 0 CA--C 1.546 0.82 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 162.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.405 ' HD3' ' HB3' ' A' ' 81' ' ' LEU . 42.4 Cg_endo -91.25 29.16 0.37 Allowed 'Trans proline' 0 C--N 1.379 2.176 0 C-N-CA 123.154 2.569 . . . . 0.0 111.494 -176.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 30.7 mmmt -67.05 -38.88 86.61 Favored 'General case' 0 N--CA 1.472 0.629 0 C-N-CA 124.585 1.154 . . . . 0.0 112.313 -170.579 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 36.5 m-85 -81.05 -42.64 20.75 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 130.56 -63.53 0.63 Allowed Glycine 0 C--N 1.347 1.155 0 CA-C-N 115.354 -0.839 . . . . 0.0 112.218 174.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 75.7 -43.95 0.5 Allowed 'General case' 0 N--CA 1.498 1.932 0 C-N-CA 125.938 1.695 . . . . 0.0 112.965 -178.452 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 61.6 mt -67.61 111.79 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.891 0 C-N-CA 124.379 1.072 . . . . 0.0 110.248 177.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.0 m -67.95 -45.43 74.26 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.252 0.621 . . . . 0.0 111.283 -178.26 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 16.9 mmm180 -79.66 76.26 6.31 Favored 'General case' 0 N--CA 1.471 0.598 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 173.063 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 48.5 t -64.46 114.87 2.5 Favored 'Isoleucine or valine' 0 C--N 1.347 0.46 0 CA-C-N 114.733 -1.121 . . . . 0.0 109.634 -176.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -77.15 94.44 4.08 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 109.689 -0.486 . . . . 0.0 109.689 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.3 mmmm -94.47 21.94 6.66 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.888 0.875 . . . . 0.0 110.535 177.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -85.12 32.88 0.54 Allowed 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 124.299 1.04 . . . . 0.0 110.536 178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 74.2 t80 -64.34 -32.44 74.05 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 124.388 1.075 . . . . 0.0 110.2 172.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 31.8 t70 -69.47 -31.29 69.49 Favored 'General case' 0 CA--C 1.552 1.037 0 C-N-CA 123.441 0.696 . . . . 0.0 111.403 174.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.59 -48.88 53.04 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 122.991 0.516 . . . . 0.0 110.976 179.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 19.6 ptm -65.97 -31.44 72.35 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 116.623 -0.262 . . . . 0.0 111.505 172.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.3 t80 -56.48 -45.97 80.67 Favored 'General case' 0 N--CA 1.488 1.45 0 C-N-CA 123.175 0.59 . . . . 0.0 110.828 176.554 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.564 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 12.3 pt-20 -76.75 -27.67 55.44 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 122.705 0.402 . . . . 0.0 111.934 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -67.51 -58.97 3.78 Favored 'General case' 0 CA--C 1.547 0.851 0 CA-C-O 120.864 0.364 . . . . 0.0 110.028 175.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.412 ' O ' HD13 ' A' ' 106' ' ' LEU . 74.7 mt -57.16 -38.05 59.07 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.068 0 C-N-CA 124.879 1.271 . . . . 0.0 112.361 179.761 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.564 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -63.69 -29.61 70.82 Favored 'General case' 0 N--CA 1.5 2.033 0 CA-C-N 118.234 0.47 . . . . 0.0 111.611 177.849 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.82 -41.19 60.39 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.074 -0.512 . . . . 0.0 109.741 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -57.35 -45.09 84.71 Favored 'General case' 0 CA--C 1.553 1.081 0 C-N-CA 123.789 0.836 . . . . 0.0 112.514 170.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.412 HD13 ' O ' ' A' ' 102' ' ' ILE . 9.7 mp -64.21 -24.95 67.86 Favored 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 123.871 0.869 . . . . 0.0 111.766 175.546 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . 0.405 ' HD2' ' HB2' ' A' ' 109' ' ' HIS . 66.8 t60 -85.68 -16.91 37.55 Favored 'General case' 0 CA--C 1.552 1.04 0 C-N-CA 123.319 0.648 . . . . 0.0 110.657 174.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.38 13.26 3.83 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 125.134 1.374 . . . . 0.0 111.608 175.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . 0.405 ' HB2' ' HD2' ' A' ' 107' ' ' HIS . 78.9 m80 -147.88 137.25 12.0 Favored Pre-proline 0 N--CA 1.473 0.686 0 C-N-CA 124.243 1.017 . . . . 0.0 108.819 -176.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -69.06 106.49 1.54 Allowed 'Trans proline' 0 C--N 1.376 1.998 0 C-N-CA 122.501 2.134 . . . . 0.0 111.678 179.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -131.45 46.7 1.06 Allowed Glycine 0 C--N 1.342 0.862 0 N-CA-C 111.755 -0.538 . . . . 0.0 111.755 -178.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -72.49 144.11 86.06 Favored Pre-proline 0 CA--C 1.549 0.937 0 C-N-CA 123.98 0.912 . . . . 0.0 110.167 -179.791 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 13.0 Cg_exo -69.21 148.81 69.45 Favored 'Trans proline' 0 C--N 1.38 2.234 0 C-N-CA 122.994 2.462 . . . . 0.0 112.128 -175.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.4 p -78.97 149.98 5.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.989 0.423 . . . . 0.0 110.275 -179.686 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -140.83 32.68 1.79 Allowed 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 123.668 0.787 . . . . 0.0 110.105 -176.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . 0.48 HD12 ' N ' ' A' ' 117' ' ' GLU . 4.5 pp -61.97 -43.03 99.68 Favored 'General case' 0 N--CA 1.48 1.065 0 C-N-CA 122.813 0.445 . . . . 0.0 110.821 -178.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 121' ' ' ARG . 0.2 OUTLIER -76.18 -22.48 55.27 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 124.757 1.223 . . . . 0.0 111.853 -178.296 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 4.3 tpp85 -50.36 -49.14 55.03 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 124.997 1.319 . . . . 0.0 112.246 -170.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 41.4 mm -77.91 -29.19 15.73 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.975 0 CA-C-N 114.614 -1.175 . . . . 0.0 110.754 -179.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.3 -24.36 18.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 C-N-CA 123.752 0.821 . . . . 0.0 111.628 -176.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 117' ' ' GLU . 31.0 mmm180 -63.71 82.66 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 C-N-CA 123.396 0.679 . . . . 0.0 111.364 -176.384 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 46.8 m80 -157.52 140.91 15.51 Favored 'General case' 0 N--CA 1.473 0.707 0 C-N-CA 125.137 1.375 . . . . 0.0 109.439 -176.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -156.07 81.16 1.0 Allowed 'General case' 0 CA--C 1.544 0.746 0 C-N-CA 123.772 0.829 . . . . 0.0 109.149 173.622 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -92.65 -72.2 1.2 Allowed Glycine 0 C--N 1.346 1.119 0 N-CA-C 111.254 -0.739 . . . . 0.0 111.254 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 70.3 m . . . . . 0 C--O 1.253 1.24 0 C-N-CA 123.884 0.874 . . . . 0.0 108.78 178.303 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 14.7 mm100 . . . . . 0 N--CA 1.477 0.918 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 69.69 -76.2 0.41 Allowed Glycine 0 C--N 1.352 1.45 0 O-C-N 123.488 0.493 . . . . 0.0 114.121 175.349 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -79.58 60.03 3.17 Favored 'General case' 0 N--CA 1.482 1.158 0 C-N-CA 124.072 0.949 . . . . 0.0 110.919 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 50.3 ttp -81.08 105.7 12.5 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-N 115.395 -0.821 . . . . 0.0 110.394 -175.296 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 86.1 t80 -96.11 139.14 32.71 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.521 -0.548 . . . . 0.0 109.521 170.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -141.13 161.3 54.13 Favored Pre-proline 0 CA--C 1.55 0.969 0 C-N-CA 124.923 1.289 . . . . 0.0 108.451 174.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.512 ' HG3' ' HB3' ' A' ' 112' ' ' GLU . 29.8 Cg_exo -62.44 109.66 0.91 Allowed 'Trans proline' 0 C--N 1.366 1.48 0 C-N-CA 121.859 1.706 . . . . 0.0 111.491 172.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.29 -13.83 33.45 Favored Glycine 0 N--CA 1.472 1.089 0 CA-C-O 119.673 -0.515 . . . . 0.0 113.896 178.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 33.1 t-80 -155.12 146.79 23.23 Favored 'General case' 0 N--CA 1.483 1.218 0 CA-C-N 117.542 0.671 . . . . 0.0 112.062 -175.552 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 33.9 tp -136.35 128.93 30.55 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 124.641 1.176 . . . . 0.0 109.039 174.076 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -100.3 125.63 46.53 Favored 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 172.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.552 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 85.8 mt -107.17 134.82 49.71 Favored 'General case' 0 C--N 1.344 0.334 0 C-N-CA 123.269 0.628 . . . . 0.0 109.928 173.256 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.408 HG23 ' O ' ' A' ' 23' ' ' ILE . 13.8 p -148.58 165.99 4.36 Favored 'Isoleucine or valine' 0 C--O 1.249 1.038 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 169.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 11.8 t -73.52 104.38 4.47 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 119.744 1.156 . . . . 0.0 108.208 176.044 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.5 pp -78.4 157.38 77.77 Favored Pre-proline 0 CA--C 1.55 0.957 0 C-N-CA 123.894 0.878 . . . . 0.0 110.983 -174.417 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -58.53 110.86 0.72 Allowed 'Trans proline' 0 C--N 1.381 2.237 0 C-N-CA 122.599 2.199 . . . . 0.0 110.908 175.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 148.02 -42.13 0.88 Allowed Glycine 0 C--N 1.338 0.644 0 N-CA-C 110.394 -1.082 . . . . 0.0 110.394 -172.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 7.8 mp -102.18 165.6 11.06 Favored 'General case' 0 N--CA 1.483 1.199 0 C-N-CA 124.48 1.112 . . . . 0.0 110.044 179.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 26.0 t70 -65.49 138.76 58.3 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 123.288 0.635 . . . . 0.0 109.917 176.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 54.2 tt0 -64.25 136.33 57.08 Favored 'General case' 0 CA--C 1.543 0.676 0 O-C-N 124.017 0.823 . . . . 0.0 111.26 -175.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.541 HE21 ' HB2' ' A' ' 50' ' ' ASP . 31.2 tt0 -150.49 154.9 38.49 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 170.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . 0.565 ' HB3' ' HA ' ' A' ' 50' ' ' ASP . 27.8 t70 -85.74 42.48 0.97 Allowed 'General case' 0 CA--C 1.557 1.215 0 CA-C-O 122.488 1.137 . . . . 0.0 110.727 -173.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.69 HG22 HG23 ' A' ' 49' ' ' ILE . 44.3 pt -89.7 139.93 16.69 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.399 0 CA-C-N 115.318 -0.855 . . . . 0.0 110.445 -178.161 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.618 HD21 ' HG2' ' A' ' 48' ' ' GLU . 5.5 p30 -152.85 125.01 8.03 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 172.087 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.552 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 31.4 mt -132.43 132.79 60.31 Favored 'Isoleucine or valine' 0 C--O 1.237 0.413 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.174 -172.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.52 ' O ' ' HA ' ' A' ' 45' ' ' MET . 5.5 m170 -108.09 109.82 21.35 Favored 'General case' 0 C--O 1.224 -0.278 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 176.772 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 60.6 mt -105.27 108.37 24.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 77.5 mtp180 -102.91 109.93 21.66 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.7 p90 -115.93 117.96 31.6 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 107.757 -1.201 . . . . 0.0 107.757 175.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -126.69 114.52 18.12 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 -175.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.567 HG11 ' HB3' ' A' ' 105' ' ' LYS . 7.1 p -82.25 126.63 39.98 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.704 0 C-N-CA 123.051 0.54 . . . . 0.0 109.726 179.128 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 30.4 ttt-85 -141.16 166.49 24.63 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 178.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 20.7 mm-40 -109.49 117.13 33.18 Favored 'General case' 0 CA--C 1.545 0.754 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 176.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 p30 -91.65 156.96 17.23 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 123.681 0.793 . . . . 0.0 109.665 172.807 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.42 -20.76 62.08 Favored 'General case' 0 N--CA 1.482 1.126 0 N-CA-C 113.056 0.761 . . . . 0.0 113.056 -175.198 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 9.6 mp0 -84.72 -53.62 5.25 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 123.28 0.632 . . . . 0.0 111.438 -171.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 32.0 t -117.86 3.92 12.21 Favored 'General case' 0 N--CA 1.477 0.891 0 C-N-CA 123.958 0.903 . . . . 0.0 111.537 -168.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 80.44 -122.41 5.72 Favored Glycine 0 C--N 1.346 1.086 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 179.824 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.95 147.55 51.47 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-N 117.618 0.709 . . . . 0.0 111.994 178.334 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -157.75 170.65 21.89 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.002 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 22.6 t -128.07 130.35 69.71 Favored 'Isoleucine or valine' 0 C--O 1.243 0.713 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 171.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.505 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 20.0 t60 -88.27 129.8 35.27 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 173.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -115.07 135.12 54.55 Favored 'General case' 0 N--CA 1.478 0.961 0 N-CA-C 109.032 -0.729 . . . . 0.0 109.032 176.323 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -137.99 141.36 40.46 Favored 'General case' 0 N--CA 1.468 0.467 0 N-CA-C 108.624 -0.88 . . . . 0.0 108.624 -179.582 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.52 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 91.3 mtp -135.19 131.59 36.92 Favored 'General case' 0 N--CA 1.471 0.597 0 C-N-CA 123.564 0.746 . . . . 0.0 109.281 -177.062 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 5.5 p-10 -150.54 162.79 39.95 Favored 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 122.782 0.433 . . . . 0.0 110.842 177.889 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 144.72 -144.08 12.8 Favored Glycine 0 C--N 1.337 0.593 0 N-CA-C 111.347 -0.701 . . . . 0.0 111.347 175.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.618 ' HG2' HD21 ' A' ' 24' ' ' ASN . 1.9 pm0 -147.23 163.16 37.24 Favored 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 124.295 1.038 . . . . 0.0 108.547 175.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.69 HG23 HG22 ' A' ' 23' ' ' ILE . 38.0 mt -157.81 104.74 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.474 0.769 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 -160.855 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.565 ' HA ' ' HB3' ' A' ' 22' ' ' ASP . 37.3 t70 55.38 26.64 8.97 Favored 'General case' 0 CA--C 1.575 1.917 0 CA-C-O 121.614 0.721 . . . . 0.0 111.394 -178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 83.22 50.97 4.33 Favored Glycine 0 C--N 1.352 1.456 0 CA-C-N 115.969 -0.56 . . . . 0.0 113.212 -173.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.418 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 52.4 mtpt -146.11 108.41 4.26 Favored Pre-proline 0 N--CA 1.497 1.92 0 C-N-CA 123.564 0.746 . . . . 0.0 110.798 -176.382 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -79.91 121.44 4.52 Favored 'Trans proline' 0 C--N 1.376 2.003 0 C-N-CA 122.863 2.375 . . . . 0.0 111.794 -178.002 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 11.1 p90 -125.54 143.68 50.9 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 122.861 0.465 . . . . 0.0 110.687 -178.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.2 p -139.92 110.55 6.74 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.312 0.645 . . . . 0.0 109.477 171.887 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -121.22 151.85 39.51 Favored 'General case' 0 N--CA 1.47 0.568 0 C-N-CA 124.697 1.199 . . . . 0.0 109.299 -179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 61.8 p -151.43 123.16 8.0 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 122.909 0.483 . . . . 0.0 109.85 174.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 36.6 p90 -138.16 146.44 42.75 Favored 'General case' 0 N--CA 1.474 0.75 0 C-N-CA 124.317 1.047 . . . . 0.0 108.98 178.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.505 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 49.6 mt-10 -123.89 141.29 52.17 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.077 0.551 . . . . 0.0 109.672 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 79.8 mt -124.79 130.28 24.3 Favored Pre-proline 0 CA--C 1.542 0.647 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 175.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -65.65 169.65 12.55 Favored 'Trans proline' 0 C--N 1.377 2.076 0 C-N-CA 122.936 2.424 . . . . 0.0 112.193 176.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 10.3 ptt180 -41.5 -39.67 1.61 Allowed 'General case' 0 N--CA 1.488 1.468 0 C-N-CA 124.473 1.109 . . . . 0.0 113.617 176.917 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 34.2 t70 -70.04 -29.5 66.55 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.243 1.017 . . . . 0.0 112.526 -174.089 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 44.8 p -130.99 8.39 4.78 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 122.966 0.507 . . . . 0.0 111.376 -169.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.58 -31.83 70.95 Favored 'General case' 0 N--CA 1.489 1.49 0 C-N-CA 123.531 0.732 . . . . 0.0 111.917 -178.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -65.16 -21.55 66.79 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 114.26 -1.337 . . . . 0.0 112.898 178.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 92.6 m-20 -72.76 3.26 5.33 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 123.406 0.683 . . . . 0.0 112.593 -177.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 1.7 p90 -72.56 -20.61 61.29 Favored 'General case' 0 C--N 1.351 0.636 0 C-N-CA 124.402 1.081 . . . . 0.0 112.209 -173.012 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -76.16 -42.9 45.11 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-O 121.938 0.875 . . . . 0.0 108.844 -169.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.6 m -74.46 -39.62 62.4 Favored 'General case' 0 CA--C 1.546 0.795 0 CA-C-N 113.711 -1.586 . . . . 0.0 110.155 173.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.43 ' O ' HG23 ' A' ' 75' ' ' VAL . 19.9 t70 -73.71 -59.1 2.87 Favored 'General case' 0 N--CA 1.479 1.022 0 C-N-CA 123.016 0.526 . . . . 0.0 112.14 -171.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -55.8 -35.45 66.33 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 123.88 0.872 . . . . 0.0 112.559 -179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.54 ' O ' ' HG2' ' A' ' 77' ' ' GLN . 95.4 m -65.81 -48.23 72.41 Favored 'General case' 0 CA--C 1.544 0.736 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 173.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 62.3 ttt180 -57.74 -34.33 69.4 Favored 'General case' 0 N--CA 1.493 1.685 0 C-N-CA 123.545 0.738 . . . . 0.0 111.951 175.78 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 71' ' ' ASP . 94.0 t -68.8 -36.81 75.99 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.884 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 177.12 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.487 ' O ' HD13 ' A' ' 81' ' ' LEU . . . -68.44 -49.72 57.9 Favored 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 123.54 0.736 . . . . 0.0 109.768 -178.782 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.54 ' HG2' ' O ' ' A' ' 73' ' ' THR . 65.7 mm-40 -66.21 -25.08 66.75 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.495 1.118 . . . . 0.0 111.101 -175.112 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 40.4 ttmt -60.13 -28.73 68.12 Favored 'General case' 0 CA--C 1.553 1.058 0 C-N-CA 124.439 1.096 . . . . 0.0 111.363 175.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 65.3 m80 -91.66 12.13 22.14 Favored 'General case' 0 N--CA 1.478 0.953 0 C-N-CA 123.648 0.779 . . . . 0.0 112.232 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 80.1 74.32 1.11 Allowed Glycine 0 C--N 1.349 1.27 0 O-C-N 122.948 0.155 . . . . 0.0 113.292 178.88 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.778 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 11.2 mp -116.25 151.18 36.3 Favored 'General case' 0 N--CA 1.485 1.306 0 C-N-CA 124.163 0.985 . . . . 0.0 109.681 170.427 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.428 ' CD2' ' HB2' ' A' ' 21' ' ' GLN . 44.9 m-70 -58.51 -47.52 98.61 Favored Pre-proline 0 CA--C 1.563 1.443 0 CA-C-O 117.848 -1.073 . . . . 0.0 112.46 173.077 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.778 ' HD2' ' HB3' ' A' ' 81' ' ' LEU . 51.2 Cg_exo -55.36 1.34 0.1 OUTLIER 'Trans proline' 0 C--N 1.404 3.475 0 C-N-CA 123.227 2.618 . . . . 0.0 116.59 -179.889 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.6 -44.76 90.01 Favored 'General case' 0 N--CA 1.478 0.975 0 C-N-CA 124.258 1.023 . . . . 0.0 110.873 176.495 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 30.0 p90 -70.48 -27.55 64.3 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-O 120.988 0.423 . . . . 0.0 110.243 175.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -78.84 70.84 2.66 Favored Glycine 0 C--N 1.348 1.216 0 CA-C-N 115.303 -0.862 . . . . 0.0 112.926 -176.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -79.79 153.22 29.31 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 108.969 -0.752 . . . . 0.0 108.969 168.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 66.2 mt 76.26 -38.42 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 C-N-CA 125.02 1.328 . . . . 0.0 111.852 -179.75 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 10.5 t -74.03 -20.47 60.3 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 121.499 -0.751 . . . . 0.0 111.166 175.42 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 12.0 ptp180 -73.77 -28.82 61.86 Favored 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 123.725 0.81 . . . . 0.0 110.442 174.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.1 m -127.81 82.73 0.75 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.828 0 C-N-CA 124.292 1.037 . . . . 0.0 109.435 178.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 49.4 t-80 -84.31 42.27 0.88 Allowed 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 123.915 0.886 . . . . 0.0 110.128 -178.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 26.6 mtmm 65.29 8.34 4.84 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.709 1.603 . . . . 0.0 112.908 177.113 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.38 -12.39 60.25 Favored 'General case' 0 N--CA 1.488 1.455 0 C-N-CA 123.535 0.734 . . . . 0.0 110.043 173.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 58.3 t80 -52.0 -41.13 61.96 Favored 'General case' 0 C--N 1.352 0.688 0 C-N-CA 125.356 1.463 . . . . 0.0 111.946 176.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -66.67 -30.45 70.7 Favored 'General case' 0 CA--C 1.546 0.812 0 O-C-N 124.199 0.937 . . . . 0.0 111.847 -177.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.12 17.82 Favored 'General case' 0 N--CA 1.476 0.839 0 C-N-CA 122.942 0.497 . . . . 0.0 110.893 -179.495 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 16.8 ptt? -70.96 -25.9 62.93 Favored 'General case' 0 N--CA 1.492 1.661 0 C-N-CA 122.565 0.346 . . . . 0.0 111.869 178.213 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 43.7 t80 -50.97 -42.73 60.3 Favored 'General case' 0 N--CA 1.488 1.437 0 C-N-CA 124.127 0.971 . . . . 0.0 110.303 164.066 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.471 ' O ' ' HG3' ' A' ' 103' ' ' ARG . 35.0 mt-10 -79.33 -27.57 42.09 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.998 -0.546 . . . . 0.0 111.488 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 36.2 m-20 -71.83 -50.31 30.68 Favored 'General case' 0 N--CA 1.472 0.642 0 N-CA-C 111.783 0.29 . . . . 0.0 111.783 179.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 38.5 mt -59.8 -38.81 77.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 C-N-CA 122.567 0.347 . . . . 0.0 111.648 173.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.471 ' HG3' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -65.42 -28.55 69.33 Favored 'General case' 0 N--CA 1.489 1.523 0 N-CA-C 110.039 -0.356 . . . . 0.0 110.039 177.739 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -74.21 -40.6 62.35 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 123.053 0.541 . . . . 0.0 110.174 177.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.567 ' HB3' HG11 ' A' ' 31' ' ' VAL . 9.5 mmpt? -58.44 -40.18 81.88 Favored 'General case' 0 N--CA 1.481 1.087 0 C-N-CA 123.61 0.764 . . . . 0.0 112.059 169.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 3.1 mp -65.25 -25.58 67.73 Favored 'General case' 0 CA--C 1.55 0.965 0 C-N-CA 124.179 0.992 . . . . 0.0 111.162 174.203 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 82.1 t60 -80.68 -17.91 49.63 Favored 'General case' 0 N--CA 1.485 1.28 0 C-N-CA 123.967 0.907 . . . . 0.0 110.891 172.488 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 81.5 36.59 0.08 Allowed 'General case' 0 N--CA 1.489 1.515 0 C-N-CA 125.899 1.679 . . . . 0.0 111.628 174.856 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 11.1 m80 -145.89 163.5 30.61 Favored Pre-proline 0 CA--C 1.557 1.226 0 C-N-CA 124.238 1.015 . . . . 0.0 109.457 176.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_exo -34.5 116.53 0.1 Allowed 'Trans proline' 0 C--N 1.402 3.392 0 C-N-CA 124.838 3.692 . . . . 0.0 115.894 -177.013 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -147.37 57.61 0.49 Allowed Glycine 0 C--O 1.238 0.38 0 N-CA-C 109.296 -1.521 . . . . 0.0 109.296 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . 0.512 ' HB3' ' HG3' ' A' ' 7' ' ' PRO . 1.1 mm-40 -96.9 114.2 64.2 Favored Pre-proline 0 CA--C 1.547 0.846 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 -175.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_exo -66.35 94.28 0.3 Allowed 'Trans proline' 0 C--N 1.373 1.832 0 C-N-CA 122.437 2.091 . . . . 0.0 112.822 -177.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 3.4 p -85.47 93.06 3.57 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.651 0 CA-C-O 122.21 1.005 . . . . 0.0 109.009 174.753 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -92.99 43.45 1.12 Allowed 'General case' 0 CA--C 1.546 0.807 0 CA-C-N 114.653 -1.158 . . . . 0.0 111.3 -173.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.3 pp -63.03 -27.82 69.67 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 122.814 0.445 . . . . 0.0 111.959 -178.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . 0.455 ' HA ' ' HD3' ' A' ' 121' ' ' ARG . 42.5 tt0 -78.28 -22.07 48.82 Favored 'General case' 0 CA--C 1.551 0.986 0 C-N-CA 122.964 0.506 . . . . 0.0 110.799 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 44.5 ttt180 -79.96 -17.09 53.86 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 122.985 0.514 . . . . 0.0 110.561 175.659 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.3 mm -78.97 91.52 1.43 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.457 0 C-N-CA 124.063 0.945 . . . . 0.0 108.696 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.1 mt 82.41 -21.93 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.455 0 CA-C-N 113.499 -1.682 . . . . 0.0 112.846 163.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . 0.455 ' HD3' ' HA ' ' A' ' 117' ' ' GLU . 15.8 mtp180 -65.86 109.61 2.55 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 122.744 0.418 . . . . 0.0 111.14 -176.378 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 60.5 t-80 -75.93 145.35 40.48 Favored 'General case' 0 C--O 1.239 0.546 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 172.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 43.9 tt0 -98.4 122.03 41.07 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 123.557 0.743 . . . . 0.0 110.264 -175.998 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -137.88 17.84 3.41 Favored Glycine 0 N--CA 1.469 0.848 0 N-CA-C 111.541 -0.623 . . . . 0.0 111.541 175.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 CA--C 1.556 1.185 0 C-N-CA 124.566 1.147 . . . . 0.0 108.177 178.358 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 18.9 mp0 . . . . . 0 N--CA 1.479 1.024 0 CA-C-O 120.731 0.301 . . . . 0.0 110.29 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . -162.04 -35.64 0.02 OUTLIER Glycine 0 C--N 1.346 1.089 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.57 -177.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 17.5 p80 -163.67 145.86 9.54 Favored 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 123.359 0.664 . . . . 0.0 110.118 -176.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 56.7 ttp -154.21 96.71 1.97 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.6 -0.519 . . . . 0.0 109.6 176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -98.54 141.32 31.54 Favored 'General case' 0 N--CA 1.474 0.741 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 176.424 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.5 pt-20 -153.79 157.02 32.61 Favored Pre-proline 0 CA--C 1.549 0.921 0 C-N-CA 124.82 1.248 . . . . 0.0 108.02 -179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -68.19 89.84 0.39 Allowed 'Trans proline' 0 C--N 1.373 1.836 0 C-N-CA 121.943 1.762 . . . . 0.0 110.554 177.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 137.12 -14.43 3.78 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 115.427 -0.806 . . . . 0.0 113.928 -179.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 46.8 t-80 -164.59 153.08 12.58 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 117.955 0.877 . . . . 0.0 111.978 -172.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.419 ' HB3' ' HB ' ' A' ' 27' ' ' ILE . 4.8 tt -143.26 132.83 23.63 Favored 'General case' 0 CA--C 1.552 1.035 0 N-CA-C 107.551 -1.277 . . . . 0.0 107.551 175.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.6 t-160 -114.55 134.09 55.3 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 123.279 0.632 . . . . 0.0 109.667 176.304 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.426 ' O ' ' HA ' ' A' ' 24' ' ' ASN . 95.1 mt -111.1 128.83 56.01 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 176.034 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 63.6 t -135.36 90.1 0.89 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.317 0.58 . . . . 0.0 110.364 176.979 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 8.7 t -92.17 102.35 14.87 Favored 'General case' 0 N--CA 1.472 0.665 0 N-CA-C 107.869 -1.16 . . . . 0.0 107.869 159.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.626 HD23 ' H ' ' A' ' 15' ' ' LEU . 1.8 pt? -79.56 155.25 76.26 Favored Pre-proline 0 CA--C 1.547 0.831 0 C-N-CA 124.285 1.034 . . . . 0.0 110.082 -179.622 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.639 ' HA ' ' HB2' ' A' ' 20' ' ' GLN . 36.6 Cg_endo -62.9 -45.73 12.42 Favored 'Trans proline' 0 C--N 1.375 1.926 0 C-N-CA 122.194 1.929 . . . . 0.0 112.769 179.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 59.66 -84.48 0.02 OUTLIER Glycine 0 N--CA 1.475 1.286 0 O-C-N 123.283 0.364 . . . . 0.0 113.135 178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 87.7 mt -98.17 39.39 1.24 Allowed 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.556 1.142 . . . . 0.0 110.407 173.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 28.7 m-20 64.54 54.61 1.44 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 124.611 1.164 . . . . 0.0 112.079 177.224 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.639 ' HB2' ' HA ' ' A' ' 16' ' ' PRO . 76.6 mt-30 -78.15 -156.44 0.09 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 115.118 -0.946 . . . . 0.0 108.969 165.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.9 tt0 -101.94 140.19 36.56 Favored 'General case' 0 C--O 1.242 0.671 0 N-CA-C 106.81 -1.552 . . . . 0.0 106.81 168.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -88.92 112.38 23.24 Favored 'General case' 0 N--CA 1.469 0.518 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 -176.19 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . . . . . . . . . 1.1 pp -110.95 138.65 38.25 Favored 'Isoleucine or valine' 0 C--O 1.243 0.752 0 N-CA-C 108.108 -1.071 . . . . 0.0 108.108 171.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.426 ' HA ' ' O ' ' A' ' 12' ' ' LEU . 0.0 OUTLIER -151.95 127.7 10.21 Favored 'General case' 0 C--O 1.243 0.742 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 165.171 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . . . . . . . . . 65.0 mt -137.81 128.87 38.49 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.618 0 C-N-CA 123.717 0.807 . . . . 0.0 109.355 -163.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 2.7 m170 -93.82 131.65 39.0 Favored 'General case' 0 N--CA 1.467 0.417 0 N-CA-C 107.164 -1.421 . . . . 0.0 107.164 171.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.419 ' HB ' ' HB3' ' A' ' 10' ' ' LEU . 56.7 mt -120.36 103.99 14.81 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.35 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 171.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 67.2 mtt180 -91.96 140.17 29.93 Favored 'General case' 0 C--N 1.32 -0.707 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 178.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 35.8 p90 -150.31 137.8 19.74 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-O 121.115 0.483 . . . . 0.0 111.197 172.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -134.25 130.77 37.62 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.848 0.859 . . . . 0.0 109.271 178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 51.2 t -80.74 117.27 26.42 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 N-CA-C 108.873 -0.788 . . . . 0.0 108.873 176.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.416 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 42.7 ttt180 -132.95 166.56 22.07 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.689 1.196 . . . . 0.0 108.144 -178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.416 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 25.7 mm-40 -106.34 127.67 53.43 Favored 'General case' 0 CA--C 1.548 0.897 0 CA-C-N 118.349 0.522 . . . . 0.0 111.19 178.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.428 ' ND2' ' HB3' ' A' ' 40' ' ' TYR . 3.2 p30 -102.95 146.54 28.17 Favored 'General case' 0 N--CA 1.477 0.904 0 C-N-CA 124.825 1.25 . . . . 0.0 108.63 170.498 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.28 -13.13 61.79 Favored 'General case' 0 N--CA 1.486 1.326 0 N-CA-C 112.807 0.669 . . . . 0.0 112.807 -177.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.414 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 9.5 tp10 -77.37 -54.32 6.6 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.354 0.662 . . . . 0.0 112.008 -175.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 46.1 t -113.55 -23.09 9.97 Favored 'General case' 0 N--CA 1.48 1.052 0 C-N-CA 123.956 0.902 . . . . 0.0 111.218 -171.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 108.16 -116.33 4.75 Favored Glycine 0 C--O 1.218 -0.898 0 N-CA-C 110.556 -1.018 . . . . 0.0 110.556 -169.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -64.12 149.65 47.23 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-N 117.501 0.651 . . . . 0.0 111.724 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.428 ' HB3' ' ND2' ' A' ' 34' ' ' ASN . 6.1 p90 -159.05 173.74 16.0 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.992 0.917 . . . . 0.0 109.278 167.467 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 12.9 t -125.45 124.47 67.03 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 174.244 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 8.7 t60 -87.63 122.75 31.72 Favored 'General case' 0 N--CA 1.469 0.495 0 N-CA-C 108.428 -0.953 . . . . 0.0 108.428 173.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 47.8 m-85 -108.14 138.62 44.1 Favored 'General case' 0 N--CA 1.477 0.897 0 C-N-CA 123.504 0.722 . . . . 0.0 110.18 179.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 43.3 m-20 -130.48 120.46 24.18 Favored 'General case' 0 N--CA 1.481 1.091 0 C-N-CA 124.329 1.052 . . . . 0.0 108.221 172.101 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 80.8 mtp -116.04 130.58 56.87 Favored 'General case' 0 N--CA 1.48 1.035 0 CA-C-N 118.444 0.565 . . . . 0.0 109.702 178.924 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -155.8 161.73 40.6 Favored 'General case' 0 N--CA 1.475 0.786 0 C-N-CA 123.494 0.717 . . . . 0.0 109.325 -176.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 159.48 -151.09 21.84 Favored Glycine 0 N--CA 1.473 1.131 0 N-CA-C 109.966 -1.254 . . . . 0.0 109.966 177.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -148.3 109.4 4.31 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 122.171 0.986 . . . . 0.0 110.426 175.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.476 HG21 ' O ' ' A' ' 80' ' ' GLY . 72.7 mt -99.47 123.9 52.48 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.204 0 CA-C-N 114.591 -1.186 . . . . 0.0 111.135 174.82 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 27.6 t70 63.52 22.93 13.42 Favored 'General case' 0 CA--C 1.555 1.151 0 C-N-CA 124.82 1.248 . . . . 0.0 110.079 -174.095 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 86.05 3.88 84.83 Favored Glycine 0 C--N 1.349 1.278 0 CA-C-N 115.294 -0.866 . . . . 0.0 113.228 -177.422 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 60.7 mttm -93.03 108.4 32.18 Favored Pre-proline 0 C--N 1.355 0.823 0 C-N-CA 123.453 0.701 . . . . 0.0 110.722 -178.349 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.448 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 66.8 Cg_endo -72.26 128.36 13.69 Favored 'Trans proline' 0 C--N 1.376 2.007 0 C-N-CA 122.476 2.117 . . . . 0.0 111.389 179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.9 p90 -131.45 150.17 52.25 Favored 'General case' 0 N--CA 1.477 0.909 0 C-N-CA 123.235 0.614 . . . . 0.0 109.88 -172.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 70.8 p -139.39 125.83 20.36 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 123.033 0.533 . . . . 0.0 110.292 174.57 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -141.71 147.59 37.69 Favored 'General case' 0 N--CA 1.472 0.643 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 174.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 57.4 p -148.51 140.08 23.57 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 -179.502 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 25.1 p90 -146.03 151.08 37.17 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.659 0.783 . . . . 0.0 109.931 -177.113 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -126.54 131.6 51.53 Favored 'General case' 0 N--CA 1.477 0.922 0 C-N-CA 123.861 0.865 . . . . 0.0 109.281 -177.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 96.5 mt -127.63 125.75 23.84 Favored Pre-proline 0 C--O 1.241 0.628 0 N-CA-C 108.631 -0.878 . . . . 0.0 108.631 -179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.422 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 30.6 Cg_endo -59.69 157.15 33.79 Favored 'Trans proline' 0 C--N 1.381 2.274 0 C-N-CA 122.912 2.408 . . . . 0.0 111.382 172.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 19.9 ptt180 -44.8 -26.73 0.43 Allowed 'General case' 0 N--CA 1.493 1.718 0 N-CA-C 114.187 1.18 . . . . 0.0 114.187 176.692 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -73.0 -28.64 62.49 Favored 'General case' 0 CA--C 1.552 1.019 0 C-N-CA 123.649 0.779 . . . . 0.0 111.442 -178.039 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 62.8 p -131.54 7.19 4.48 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.316 1.046 . . . . 0.0 111.11 -173.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -60.65 -32.47 71.64 Favored 'General case' 0 N--CA 1.486 1.351 0 C-N-CA 123.992 0.917 . . . . 0.0 111.401 178.867 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -70.91 -8.12 50.61 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.633 -1.167 . . . . 0.0 113.084 178.156 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -90.45 0.5 57.28 Favored 'General case' 0 N--CA 1.477 0.919 0 C-N-CA 123.662 0.785 . . . . 0.0 110.05 178.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.48 ' HZ ' ' HB3' ' A' ' 98' ' ' MET . 6.4 p90 -52.94 -43.62 66.45 Favored 'General case' 0 C--N 1.359 0.992 0 C-N-CA 124.394 1.078 . . . . 0.0 112.503 -177.399 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -30.28 65.87 Favored 'General case' 0 C--N 1.351 0.661 0 C-N-CA 123.651 0.78 . . . . 0.0 112.604 -176.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 t -73.03 -50.45 22.97 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 122.897 0.479 . . . . 0.0 109.864 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 13.9 t70 -71.15 -45.5 63.41 Favored 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 122.87 0.468 . . . . 0.0 112.025 -176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -46.87 -38.93 11.15 Favored 'General case' 0 N--CA 1.488 1.451 0 C-N-CA 123.717 0.807 . . . . 0.0 112.835 169.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 65.5 m -71.9 -38.28 69.97 Favored 'General case' 0 CA--C 1.552 1.047 0 C-N-CA 122.62 0.368 . . . . 0.0 110.816 174.801 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 24.6 ttt-85 -57.62 -48.53 79.18 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 123.912 0.885 . . . . 0.0 110.947 176.006 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 89.1 t -58.23 -48.55 84.44 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.597 0 C-N-CA 123.87 0.868 . . . . 0.0 110.358 178.1 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.413 ' HB1' HD22 ' A' ' 81' ' ' LEU . . . -66.72 -41.81 87.36 Favored 'General case' 0 CA--C 1.544 0.726 0 CA-C-N 114.835 -1.075 . . . . 0.0 112.104 -172.505 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.442 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 13.8 pt20 -72.39 -36.11 68.61 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.243 0.617 . . . . 0.0 110.973 -175.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -64.63 -27.93 69.27 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.23 0.612 . . . . 0.0 111.336 176.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 88.9 m-70 -98.09 7.36 46.41 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 122.824 0.45 . . . . 0.0 111.672 179.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.476 ' O ' HG21 ' A' ' 49' ' ' ILE . . . 102.12 93.0 2.21 Favored Glycine 0 C--N 1.354 1.533 0 O-C-N 123.062 0.226 . . . . 0.0 112.648 174.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.442 ' HB3' ' HA ' ' A' ' 77' ' ' GLN . 57.5 tp -143.02 146.08 33.52 Favored 'General case' 0 N--CA 1.475 0.784 0 CA-C-N 117.371 0.585 . . . . 0.0 110.691 177.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.462 ' HB2' ' HB3' ' A' ' 85' ' ' PHE . 22.0 p-80 -122.49 82.7 47.11 Favored Pre-proline 0 CA--C 1.556 1.19 0 C-N-CA 124.378 1.071 . . . . 0.0 109.213 173.387 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.76 -27.47 14.84 Favored 'Trans proline' 0 C--N 1.381 2.257 0 C-N-CA 123.233 2.622 . . . . 0.0 112.611 -177.121 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 19.8 ttmm -83.59 -49.98 8.67 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 123.424 0.69 . . . . 0.0 109.853 -178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.463 ' HE2' ' HG2' ' A' ' 20' ' ' GLN . 43.9 t80 -69.36 -17.93 63.74 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 115.247 -0.888 . . . . 0.0 112.116 -175.687 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -59.71 -31.37 71.18 Favored Glycine 0 CA--C 1.534 1.231 0 CA-C-O 120.156 -0.247 . . . . 0.0 113.283 176.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 64.08 16.52 10.03 Favored 'General case' 0 N--CA 1.484 1.232 0 C-N-CA 124.516 1.127 . . . . 0.0 112.776 174.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 13.2 mm -75.59 110.28 10.31 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.69 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 -179.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 36.8 p -71.48 -24.59 62.02 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.753 0.821 . . . . 0.0 111.248 177.451 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 87.3 mtm180 -82.38 155.92 24.46 Favored 'General case' 0 N--CA 1.474 0.737 0 C-N-CA 123.931 0.892 . . . . 0.0 109.516 171.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 32.0 m 43.34 28.79 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.383 0 C-N-CA 125.406 1.483 . . . . 0.0 113.666 -175.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 20.5 t60 -88.23 -41.35 13.0 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 115.323 -0.853 . . . . 0.0 109.758 -174.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 53.8 pttt -136.12 27.44 3.2 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 123.303 0.641 . . . . 0.0 110.381 -179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -83.85 30.38 0.51 Allowed 'General case' 0 N--CA 1.486 1.327 0 C-N-CA 123.365 0.666 . . . . 0.0 111.931 -176.773 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 48.8 t80 -53.62 -43.42 68.67 Favored 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 124.53 1.132 . . . . 0.0 110.138 176.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 15.3 m-20 -62.37 -33.54 74.93 Favored 'General case' 0 N--CA 1.472 0.658 0 O-C-N 124.592 1.183 . . . . 0.0 112.959 -177.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -71.09 -52.33 20.01 Favored 'General case' 0 N--CA 1.474 0.727 0 CA-C-O 121.004 0.431 . . . . 0.0 110.839 -175.385 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.48 ' HB3' ' HZ ' ' A' ' 68' ' ' PHE . 1.1 mpt? -61.93 -34.18 75.62 Favored 'General case' 0 CA--C 1.547 0.862 0 CA-C-N 114.899 -1.046 . . . . 0.0 111.787 173.819 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 27.2 t80 -61.4 -54.73 39.86 Favored 'General case' 0 N--CA 1.482 1.127 0 O-C-N 124.049 0.843 . . . . 0.0 110.203 178.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -69.95 -27.45 64.75 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 115.404 -0.816 . . . . 0.0 112.191 -178.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -64.29 -58.55 6.22 Favored 'General case' 0 C--O 1.244 0.777 0 CA-C-O 121.394 0.616 . . . . 0.0 110.168 175.899 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 50.7 mt -59.97 -38.22 75.65 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.145 0 CA-C-N 114.526 -1.216 . . . . 0.0 113.179 177.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -64.06 -34.57 78.34 Favored 'General case' 0 N--CA 1.502 2.158 0 CA-C-N 119.291 0.95 . . . . 0.0 111.157 -178.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -73.22 -46.8 48.19 Favored 'General case' 0 C--N 1.346 0.432 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.212 -177.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.68 -41.68 82.07 Favored 'General case' 0 N--CA 1.481 1.078 0 C-N-CA 124.085 0.954 . . . . 0.0 111.926 174.618 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 6.4 mp -64.71 -38.24 90.32 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.823 179.401 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 51.7 t60 -72.64 -31.21 64.95 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 122.439 0.296 . . . . 0.0 111.067 176.035 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 67.22 8.2 6.04 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 125.273 1.429 . . . . 0.0 114.036 172.273 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 76.1 m80 -142.24 151.44 58.43 Favored Pre-proline 0 N--CA 1.482 1.128 0 C-N-CA 123.657 0.783 . . . . 0.0 109.373 -175.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_exo -52.97 92.91 0.03 OUTLIER 'Trans proline' 0 C--N 1.387 2.586 0 C-N-CA 123.489 2.793 . . . . 0.0 113.197 175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -156.56 29.28 0.56 Allowed Glycine 0 C--N 1.342 0.884 0 CA-C-N 115.103 -0.953 . . . . 0.0 111.151 179.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -82.32 146.77 55.08 Favored Pre-proline 0 CA--C 1.552 1.032 0 C-N-CA 124.163 0.985 . . . . 0.0 110.812 -175.365 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -88.36 -167.67 0.32 Allowed 'Trans proline' 0 C--N 1.371 1.754 0 C-N-CA 123.352 2.701 . . . . 0.0 111.87 175.418 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 11.1 p -120.37 144.77 28.13 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.779 0 C-N-CA 123.322 0.649 . . . . 0.0 109.694 174.83 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -84.55 -4.95 59.24 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 124.321 1.048 . . . . 0.0 113.345 -170.937 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.4 pp -65.24 -32.89 74.79 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 118.529 0.604 . . . . 0.0 111.35 179.481 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -85.43 -2.28 57.94 Favored 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 123.493 0.717 . . . . 0.0 110.982 -178.668 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 5.4 tpp180 -86.16 -20.54 28.45 Favored 'General case' 0 N--CA 1.474 0.749 0 C-N-CA 123.253 0.621 . . . . 0.0 110.709 -176.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 3.3 mp -81.19 -59.95 2.55 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 172.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 32.6 mm -99.25 94.73 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.701 0 N-CA-C 108.526 -0.916 . . . . 0.0 108.526 -179.864 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -82.26 -69.2 0.64 Allowed 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -177.685 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 50.2 t-80 -168.3 127.65 1.21 Allowed 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 123.596 0.758 . . . . 0.0 110.111 174.622 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 20.52 -78.14 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 127.849 2.459 . . . . 0.0 115.967 173.183 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 135.64 29.55 0.36 Allowed Glycine 0 C--N 1.345 1.074 0 N-CA-C 111.046 -0.821 . . . . 0.0 111.046 -171.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 18.2 p . . . . . 0 C--O 1.252 1.197 0 C-N-CA 124.578 1.151 . . . . 0.0 109.461 179.728 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 24.5 mp0 . . . . . 0 N--CA 1.481 1.082 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . 0.449 ' HA3' HG21 ' A' ' 13' ' ' VAL . . . 77.59 -81.79 1.22 Allowed Glycine 0 C--N 1.343 0.969 0 CA-C-N 116.11 -0.495 . . . . 0.0 112.247 178.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 14.4 p80 -60.86 125.25 23.01 Favored 'General case' 0 N--CA 1.479 0.992 0 C-N-CA 122.947 0.499 . . . . 0.0 110.793 -176.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 89.2 mtp -139.53 160.57 39.55 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 123.458 0.703 . . . . 0.0 110.122 -176.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -149.08 131.1 15.31 Favored 'General case' 0 N--CA 1.469 0.48 0 C-N-CA 124.334 1.054 . . . . 0.0 108.315 170.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -152.99 161.61 28.62 Favored Pre-proline 0 CA--C 1.549 0.941 0 C-N-CA 124.404 1.082 . . . . 0.0 109.236 -176.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_exo -55.77 100.66 0.08 OUTLIER 'Trans proline' 0 C--N 1.372 1.784 0 C-N-CA 122.747 2.298 . . . . 0.0 112.599 171.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 109.36 -6.87 32.13 Favored Glycine 0 C--N 1.345 1.074 0 CA-C-O 119.173 -0.793 . . . . 0.0 114.775 174.506 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 26.5 t-80 -158.86 151.92 22.37 Favored 'General case' 0 N--CA 1.484 1.226 0 CA-C-N 118.207 1.004 . . . . 0.0 111.957 -173.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.1 tt -146.75 149.27 33.07 Favored 'General case' 0 CA--C 1.553 1.066 0 C-N-CA 125.607 1.563 . . . . 0.0 107.33 178.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 21.4 t-160 -127.26 139.73 52.71 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.183 0.593 . . . . 0.0 110.452 -178.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.575 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 96.9 mt -125.56 135.24 52.03 Favored 'General case' 0 N--CA 1.48 1.059 0 C-N-CA 125.383 1.473 . . . . 0.0 108.14 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . 0.449 HG21 ' HA3' ' A' ' 2' ' ' GLY . 8.0 m -138.26 124.9 26.6 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 C-N-CA 123.931 0.892 . . . . 0.0 110.691 178.198 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.453 ' HB3' HG13 ' A' ' 23' ' ' ILE . 17.5 p -37.22 115.28 0.38 Allowed 'General case' 0 N--CA 1.495 1.812 0 CA-C-N 114.344 -1.298 . . . . 0.0 111.618 165.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 2.1 pp -129.68 161.59 58.34 Favored Pre-proline 0 CA--C 1.551 0.996 0 C-N-CA 124.222 1.009 . . . . 0.0 110.737 -168.3 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -50.83 106.82 0.14 Allowed 'Trans proline' 0 C--N 1.386 2.536 0 C-N-CA 123.917 3.078 . . . . 0.0 112.788 177.894 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 154.85 -37.01 0.67 Allowed Glycine 0 C--N 1.339 0.706 0 N-CA-C 110.03 -1.228 . . . . 0.0 110.03 -175.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . 0.714 HD11 ' HA ' ' A' ' 83' ' ' PRO . 3.3 mm? -84.56 -83.99 0.15 Allowed 'General case' 0 CA--C 1.557 1.231 0 C-N-CA 124.049 0.94 . . . . 0.0 109.456 177.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 13.8 t70 176.76 177.78 0.26 Allowed 'General case' 0 CA--C 1.549 0.93 0 C-N-CA 126.261 1.824 . . . . 0.0 106.839 -179.231 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 12.9 pt20 -78.95 61.06 3.05 Favored 'General case' 0 CA--C 1.555 1.157 0 CA-C-O 121.84 0.828 . . . . 0.0 111.099 175.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 53.1 tt0 -112.56 145.57 40.09 Favored 'General case' 0 N--CA 1.475 0.805 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 177.041 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -94.87 87.8 5.1 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 122.615 0.366 . . . . 0.0 110.529 -174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.498 HG22 HG23 ' A' ' 49' ' ' ILE . 0.5 OUTLIER -106.76 128.89 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.169 0 N-CA-C 106.721 -1.585 . . . . 0.0 106.721 171.448 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -137.12 131.4 32.59 Favored 'General case' 0 N--CA 1.472 0.627 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.575 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 71.1 mt -144.93 135.82 19.96 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.843 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 -173.186 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 8.1 m170 -112.4 139.97 47.52 Favored 'General case' 0 N--CA 1.466 0.336 0 N-CA-C 106.138 -1.801 . . . . 0.0 106.138 171.803 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 65.2 mt -127.21 106.19 14.97 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.476 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 173.918 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 63.7 mtt180 -97.99 141.9 30.38 Favored 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 176.836 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 55.1 p90 -126.33 118.55 25.31 Favored 'General case' 0 N--CA 1.466 0.343 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 166.749 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -125.65 113.56 17.53 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 -176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 41' ' ' VAL . 58.0 t -79.35 118.11 26.22 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 N-CA-C 108.974 -0.75 . . . . 0.0 108.974 178.363 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -122.45 158.2 30.26 Favored 'General case' 0 N--CA 1.473 0.68 0 N-CA-C 106.776 -1.564 . . . . 0.0 106.776 175.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.7 mm-40 -107.06 121.55 44.71 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 121.61 -0.681 . . . . 0.0 110.344 -176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.445 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 5.1 p30 -102.04 145.41 29.35 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.765 0.826 . . . . 0.0 108.858 172.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.29 -18.05 65.03 Favored 'General case' 0 N--CA 1.486 1.35 0 C-N-CA 123.335 0.654 . . . . 0.0 112.57 179.68 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.445 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 28.5 tt0 -73.63 -47.09 42.7 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 123.743 0.817 . . . . 0.0 112.685 -173.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 25.7 t -134.91 -7.87 2.37 Favored 'General case' 0 N--CA 1.486 1.373 0 C-N-CA 123.508 0.723 . . . . 0.0 111.594 -172.485 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 96.96 -123.39 7.76 Favored Glycine 0 C--N 1.347 1.155 0 N-CA-C 111.359 -0.696 . . . . 0.0 111.359 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -65.25 128.81 37.38 Favored 'General case' 0 CA--C 1.551 1.015 0 CA-C-N 117.062 0.431 . . . . 0.0 111.747 178.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.469 ' HA ' ' HA ' ' A' ' 61' ' ' PRO . 10.8 p90 -140.62 162.26 35.79 Favored 'General case' 0 N--CA 1.479 1.001 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 171.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 31' ' ' VAL . 15.8 t -119.15 127.29 75.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 N-CA-C 110.122 -0.325 . . . . 0.0 110.122 179.749 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.544 ' HA ' ' HG3' ' A' ' 59' ' ' GLU . 5.4 t-160 -84.76 108.34 17.4 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 107.358 -1.349 . . . . 0.0 107.358 166.467 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.441 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 89.6 m-85 -94.9 116.45 28.72 Favored 'General case' 0 N--CA 1.467 0.393 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 173.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -110.44 134.45 52.32 Favored 'General case' 0 N--CA 1.469 0.514 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.511 ' SD ' ' HA ' ' A' ' 72' ' ' ALA . 87.1 mtp -129.55 129.11 44.04 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 118.908 0.776 . . . . 0.0 110.531 175.488 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 3.8 p-10 -149.99 153.53 36.71 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.113 0.565 . . . . 0.0 109.763 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.48 ' O ' ' HA ' ' A' ' 53' ' ' PRO . . . 171.37 -145.88 9.14 Favored Glycine 0 N--CA 1.472 1.062 0 CA-C-O 118.506 -1.163 . . . . 0.0 110.952 178.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 8.9 pt-20 -152.61 109.75 3.52 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.736 1.268 . . . . 0.0 112.088 173.42 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.554 HD12 ' HB3' ' A' ' 79' ' ' HIS . 50.3 mt -102.15 128.42 54.77 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.459 0 CA-C-N 114.3 -1.318 . . . . 0.0 111.589 176.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . 0.596 ' HB3' ' HE2' ' A' ' 52' ' ' LYS . 38.7 t70 66.56 23.76 10.34 Favored 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 125.39 1.476 . . . . 0.0 108.618 -169.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 79.31 3.36 88.52 Favored Glycine 0 C--N 1.355 1.606 0 CA-C-N 115.017 -0.992 . . . . 0.0 113.101 -173.813 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.596 ' HE2' ' HB3' ' A' ' 50' ' ' ASP . 51.4 mtmt -97.77 110.18 54.22 Favored Pre-proline 0 C--O 1.245 0.826 0 C-N-CA 124.302 1.041 . . . . 0.0 110.843 -173.064 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . 0.48 ' HA ' ' O ' ' A' ' 47' ' ' GLY . 41.6 Cg_endo -63.67 143.56 87.26 Favored 'Trans proline' 0 C--N 1.378 2.107 0 C-N-CA 122.889 2.393 . . . . 0.0 112.52 -177.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 31.2 p90 -144.73 155.27 43.46 Favored 'General case' 0 N--CA 1.476 0.87 0 C-N-CA 123.441 0.696 . . . . 0.0 109.724 -178.304 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 69.8 m -148.83 131.21 15.65 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 123.324 0.65 . . . . 0.0 109.866 175.767 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -142.41 160.63 39.9 Favored 'General case' 0 N--CA 1.476 0.826 0 C-N-CA 125.587 1.555 . . . . 0.0 109.168 -178.346 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.8 m -148.91 138.51 21.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 123.541 0.736 . . . . 0.0 109.811 173.313 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 38.6 p90 -136.77 132.86 35.32 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 172.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.544 ' HG3' ' HA ' ' A' ' 42' ' ' HIS . 5.6 mp0 -113.96 125.2 53.75 Favored 'General case' 0 N--CA 1.47 0.559 0 N-CA-C 108.799 -0.815 . . . . 0.0 108.799 -174.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.441 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 75.3 mt -127.08 125.64 24.17 Favored Pre-proline 0 CA--C 1.542 0.671 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 -178.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.469 ' HA ' ' HA ' ' A' ' 40' ' ' TYR . 55.6 Cg_endo -64.28 166.66 16.43 Favored 'Trans proline' 0 C--N 1.376 2.021 0 C-N-CA 122.884 2.389 . . . . 0.0 112.164 176.376 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.508 ' HG3' HD13 ' A' ' 106' ' ' LEU . 74.2 ttt180 -47.62 -25.98 1.34 Allowed 'General case' 0 N--CA 1.497 1.881 0 C-N-CA 123.868 0.867 . . . . 0.0 112.923 174.107 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -67.83 -37.24 81.67 Favored 'General case' 0 CA--C 1.555 1.139 0 C-N-CA 124.171 0.988 . . . . 0.0 112.678 177.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 69.2 p -129.39 4.97 5.18 Favored 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 123.422 0.689 . . . . 0.0 112.142 -170.243 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -55.89 -38.76 70.61 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 124.186 0.994 . . . . 0.0 112.189 -177.399 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 35.1 m-85 -71.37 0.44 8.17 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 124.892 1.277 . . . . 0.0 113.975 -176.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -93.3 -0.46 56.68 Favored 'General case' 0 N--CA 1.488 1.448 0 C-N-CA 123.646 0.779 . . . . 0.0 110.999 174.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 26.4 p90 -54.35 -34.02 60.26 Favored 'General case' 0 N--CA 1.475 0.811 0 N-CA-C 113.966 1.099 . . . . 0.0 113.966 -172.352 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.96 -33.56 68.99 Favored 'General case' 0 N--CA 1.486 1.363 0 CA-C-N 118.562 0.619 . . . . 0.0 112.582 -175.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 27.8 m -73.54 -39.25 64.89 Favored 'General case' 0 CA--C 1.545 0.763 0 O-C-N 123.571 0.544 . . . . 0.0 109.99 -177.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 27.2 m-20 -72.15 -52.97 14.17 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.452 0.701 . . . . 0.0 111.271 176.735 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.511 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -48.98 -30.24 5.79 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 125.056 1.342 . . . . 0.0 113.106 172.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 87.7 m -81.66 -41.43 21.41 Favored 'General case' 0 N--CA 1.479 1.007 0 C-N-CA 122.327 0.251 . . . . 0.0 110.665 172.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -63.73 -42.09 97.95 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.336 0.655 . . . . 0.0 111.612 -176.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 90.9 t -68.21 -39.26 80.9 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.096 0 C-N-CA 124.51 1.124 . . . . 0.0 110.401 176.328 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -63.49 -46.92 83.92 Favored 'General case' 0 N--CA 1.472 0.643 0 C-N-CA 124.003 0.921 . . . . 0.0 110.982 -177.39 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.4 ' HA ' ' HB3' ' A' ' 81' ' ' LEU . 12.9 pt20 -78.85 -32.7 46.19 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.707 -1.133 . . . . 0.0 110.627 -174.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 29.5 ttpt -51.92 -48.11 64.34 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 124.77 1.228 . . . . 0.0 112.505 178.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.554 ' HB3' HD12 ' A' ' 49' ' ' ILE . 22.5 t60 -80.72 14.06 2.3 Favored 'General case' 0 CA--C 1.556 1.178 0 N-CA-C 112.526 0.565 . . . . 0.0 112.526 -172.356 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 110.87 50.8 0.62 Allowed Glycine 0 C--N 1.349 1.265 0 O-C-N 122.051 -0.406 . . . . 0.0 112.865 170.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.462 ' HG ' ' HD3' ' A' ' 83' ' ' PRO . 65.5 tp -143.13 155.11 44.5 Favored 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 123.436 0.694 . . . . 0.0 109.716 -178.031 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 18.3 p-80 -158.13 82.13 2.87 Favored Pre-proline 0 CA--C 1.549 0.919 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 173.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.714 ' HA ' HD11 ' A' ' 18' ' ' LEU . 94.8 Cg_endo -82.67 83.38 2.0 Favored 'Trans proline' 0 C--N 1.377 2.054 0 C-N-CA 122.583 2.188 . . . . 0.0 111.883 -170.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 10.5 mtmp? -75.61 -32.68 60.38 Favored 'General case' 0 N--CA 1.48 1.074 0 CA-C-N 116.454 -0.339 . . . . 0.0 111.117 -179.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 74.9 t80 -84.02 -34.36 24.32 Favored 'General case' 0 N--CA 1.483 1.21 0 C-N-CA 122.679 0.391 . . . . 0.0 110.271 173.25 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -70.11 -43.21 65.2 Favored Glycine 0 C--N 1.345 1.067 0 CA-C-N 116.08 -0.509 . . . . 0.0 113.064 -178.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -155.6 84.15 1.04 Allowed 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 123.966 0.907 . . . . 0.0 110.071 -176.167 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -74.48 -35.78 39.79 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 122.861 0.464 . . . . 0.0 110.182 -179.446 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 7.4 m -92.32 -9.12 43.09 Favored 'General case' 0 CA--C 1.558 1.284 0 C-N-CA 123.434 0.694 . . . . 0.0 111.05 -179.944 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 7.6 tmm_? 74.08 -62.74 0.45 Allowed 'General case' 0 N--CA 1.493 1.707 0 C-N-CA 125.286 1.434 . . . . 0.0 110.416 -175.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 3.8 p -74.76 104.38 3.17 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.947 0 CA-C-O 121.503 0.668 . . . . 0.0 109.66 172.183 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 81.8 t60 -69.85 161.7 29.39 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 124.343 1.057 . . . . 0.0 110.512 178.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 94' ' ' GLU . 22.7 pttp -66.7 177.59 1.56 Allowed 'General case' 0 N--CA 1.483 1.184 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 169.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 93' ' ' LYS . 6.6 pt-20 50.19 18.57 0.41 Allowed 'General case' 0 N--CA 1.507 2.418 0 C-N-CA 124.795 1.238 . . . . 0.0 113.003 -176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 82.9 t80 -74.54 -31.86 62.27 Favored 'General case' 0 C--N 1.349 0.57 0 C-N-CA 124.532 1.133 . . . . 0.0 109.518 178.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -65.04 -30.33 71.29 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.766 0.827 . . . . 0.0 110.82 175.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -70.22 -47.52 61.07 Favored 'General case' 0 N--CA 1.477 0.917 0 C-N-CA 122.905 0.482 . . . . 0.0 110.532 176.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 25.2 ttt -62.17 -39.25 92.04 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 123.467 0.707 . . . . 0.0 111.353 174.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -53.51 -50.83 64.57 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 125.334 1.454 . . . . 0.0 110.106 174.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 19.4 mm-40 -65.61 -34.02 77.25 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 115.058 -0.974 . . . . 0.0 111.99 179.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -66.32 -50.2 64.41 Favored 'General case' 0 CA--C 1.548 0.869 0 C-N-CA 123.11 0.564 . . . . 0.0 109.948 179.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 51.3 mt -65.47 -39.94 86.73 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.076 0 C-N-CA 123.727 0.811 . . . . 0.0 112.054 178.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.9 ppt_? -68.63 -30.7 69.48 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 120.96 0.41 . . . . 0.0 110.613 -178.521 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.29 -44.33 62.91 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 115.476 -0.784 . . . . 0.0 109.822 176.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 24.3 tptp -61.71 -36.86 82.14 Favored 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 124.03 0.932 . . . . 0.0 112.43 177.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.508 HD13 ' HG3' ' A' ' 62' ' ' ARG . 26.6 mt -65.7 -27.17 68.14 Favored 'General case' 0 N--CA 1.483 1.186 0 C-N-CA 123.977 0.911 . . . . 0.0 112.56 177.424 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 13.9 t-160 -71.5 -16.85 62.36 Favored 'General case' 0 CA--C 1.564 1.501 0 C-N-CA 123.913 0.885 . . . . 0.0 110.115 173.632 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 66.67 28.39 9.13 Favored 'General case' 0 N--CA 1.488 1.445 0 C-N-CA 124.843 1.257 . . . . 0.0 110.656 -179.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 30.4 m80 -147.76 141.21 15.42 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.753 1.221 . . . . 0.0 108.647 -175.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_endo -67.14 93.06 0.34 Allowed 'Trans proline' 0 C--N 1.379 2.159 0 C-N-CA 122.774 2.316 . . . . 0.0 112.008 -176.795 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -84.8 67.67 3.64 Favored Glycine 0 C--N 1.35 1.318 0 CA-C-N 115.535 -0.757 . . . . 0.0 112.343 -177.57 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -90.76 124.74 61.42 Favored Pre-proline 0 CA--C 1.551 0.99 0 C-N-CA 123.903 0.881 . . . . 0.0 110.342 -177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.97 168.33 23.61 Favored 'Trans proline' 0 C--N 1.379 2.156 0 C-N-CA 122.952 2.435 . . . . 0.0 111.322 172.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 14.7 p -146.34 151.86 14.08 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.923 0 C-N-CA 123.369 0.668 . . . . 0.0 109.578 -179.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 21.7 t70 -117.54 69.19 0.77 Allowed 'General case' 0 N--CA 1.473 0.719 0 N-CA-C 108.476 -0.935 . . . . 0.0 108.476 177.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -98.72 -28.58 13.45 Favored 'General case' 0 N--CA 1.486 1.33 0 C-N-CA 123.337 0.655 . . . . 0.0 110.825 171.903 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -73.69 -37.07 65.33 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.892 0.877 . . . . 0.0 112.289 -172.204 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 21.1 ttp180 -71.26 -14.18 62.15 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.077 0.551 . . . . 0.0 111.782 -171.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.1 mp -75.25 -53.28 16.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.767 0 C-N-CA 123.591 0.756 . . . . 0.0 109.219 177.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 64.9 mt -114.97 92.57 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 177.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -121.87 -49.63 2.09 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 123.22 0.608 . . . . 0.0 109.937 -175.154 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 44.9 p-80 -156.65 135.2 11.53 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 123.315 0.646 . . . . 0.0 110.516 177.251 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -101.3 -61.13 1.41 Allowed 'General case' 0 N--CA 1.473 0.678 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 171.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -154.15 -160.04 9.56 Favored Glycine 0 C--N 1.345 1.043 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.737 -179.128 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 19.6 m . . . . . 0 C--O 1.254 1.319 0 C-N-CA 124.618 1.167 . . . . 0.0 110.682 -178.863 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 33.9 tt0 . . . . . 0 N--CA 1.483 1.202 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 113.9 -65.87 0.27 Allowed Glycine 0 C--N 1.348 1.233 0 N-CA-C 111.027 -0.829 . . . . 0.0 111.027 -178.298 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 58.0 m80 -135.81 105.26 6.05 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 -179.63 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 64.0 ttp -119.61 108.88 15.01 Favored 'General case' 0 N--CA 1.475 0.79 0 C-N-CA 123.313 0.645 . . . . 0.0 110.191 -178.435 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 61.9 t80 -106.43 134.68 49.19 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 170.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.7 pt-20 -145.87 155.0 51.97 Favored Pre-proline 0 CA--C 1.551 1.014 0 C-N-CA 124.553 1.141 . . . . 0.0 108.601 176.085 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_exo -55.69 108.97 0.36 Allowed 'Trans proline' 0 C--N 1.37 1.696 0 C-N-CA 122.643 2.229 . . . . 0.0 112.532 171.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.18 -25.23 11.57 Favored Glycine 0 CA--C 1.531 1.08 0 C-N-CA 123.496 0.569 . . . . 0.0 113.354 177.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 20.1 t-80 -148.28 141.95 25.55 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-O 121.632 0.73 . . . . 0.0 112.191 -171.253 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.5 tp -124.89 139.86 53.45 Favored 'General case' 0 N--CA 1.471 0.581 0 C-N-CA 124.646 1.179 . . . . 0.0 108.347 171.174 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 13.7 t-160 -128.56 117.5 21.37 Favored 'General case' 0 N--CA 1.474 0.763 0 N-CA-C 108.817 -0.809 . . . . 0.0 108.817 174.504 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.547 ' HG ' ' HB ' ' A' ' 25' ' ' ILE . 0.6 OUTLIER -120.6 110.05 15.97 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 123.837 0.855 . . . . 0.0 110.039 -179.11 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 15.3 m -117.25 171.1 6.03 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.125 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 168.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 46.8 t -93.55 128.87 39.88 Favored 'General case' 0 C--O 1.242 0.692 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 171.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 4.0 pp -59.96 143.45 87.82 Favored Pre-proline 0 CA--C 1.559 1.31 0 O-C-N 123.375 0.422 . . . . 0.0 111.305 -172.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -74.22 -169.92 0.65 Allowed 'Trans proline' 0 C--N 1.376 2.008 0 C-N-CA 122.99 2.46 . . . . 0.0 113.159 -175.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 105.06 -63.29 0.33 Allowed Glycine 0 C--N 1.346 1.133 0 N-CA-C 110.886 -0.885 . . . . 0.0 110.886 -175.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -106.3 126.75 52.62 Favored 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 108.278 -1.008 . . . . 0.0 108.278 171.776 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 38.4 t70 -76.65 83.97 3.3 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -78.5 -76.4 0.19 Allowed 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.147 178.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.7 tt0 -154.45 148.25 25.48 Favored 'General case' 0 C--O 1.241 0.634 0 N-CA-C 108.759 -0.83 . . . . 0.0 108.759 -176.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -88.97 59.08 4.86 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 123.503 0.721 . . . . 0.0 110.424 -173.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.508 HG22 HG23 ' A' ' 49' ' ' ILE . 2.3 pp -89.9 121.43 40.11 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.523 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 173.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 p30 -150.65 116.58 5.57 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -179.122 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.547 ' HB ' ' HG ' ' A' ' 12' ' ' LEU . 25.8 mt -138.61 145.08 28.63 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.406 0 C-N-CA 124.323 1.049 . . . . 0.0 108.181 -168.456 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -132.44 127.14 34.68 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 170.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.55 HG12 ' HG2' ' A' ' 45' ' ' MET . 52.3 mt -109.74 123.44 65.64 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 124.437 1.095 . . . . 0.0 108.675 -176.85 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.443 ' HB2' ' HB2' ' A' ' 44' ' ' ASP . 14.0 mmm180 -109.54 117.89 35.17 Favored 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 123.863 0.865 . . . . 0.0 109.088 175.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 27.5 p90 -111.43 119.61 39.39 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 176.381 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -122.06 113.92 20.21 Favored 'General case' 0 C--O 1.238 0.46 0 C-N-CA 123.945 0.898 . . . . 0.0 109.346 -174.457 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . . . . . . . . . 55.7 t -79.69 121.72 33.53 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 122.701 0.4 . . . . 0.0 110.434 177.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . . . . . . . . . 28.7 ttt180 -140.53 162.86 34.34 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 124.559 1.144 . . . . 0.0 108.102 -177.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . . . . . . . . . 24.0 mm-40 -111.19 117.56 33.56 Favored 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 122.832 0.453 . . . . 0.0 109.825 178.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.579 HD22 ' H ' ' A' ' 34' ' ' ASN . 0.1 OUTLIER -102.46 147.32 26.89 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 123.983 0.913 . . . . 0.0 109.93 172.046 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.24 -20.55 63.07 Favored 'General case' 0 N--CA 1.478 0.964 0 C-N-CA 123.326 0.65 . . . . 0.0 111.692 -178.952 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.9 tp10 -70.15 -53.62 16.47 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 123.883 0.873 . . . . 0.0 111.626 -178.797 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.472 ' HB2' HD21 ' A' ' 34' ' ' ASN . 13.9 m -119.21 0.88 11.28 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 112.546 0.573 . . . . 0.0 112.546 -170.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 83.3 -119.27 4.84 Favored Glycine 0 C--N 1.345 1.037 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 -175.259 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -74.44 144.72 44.14 Favored 'General case' 0 N--CA 1.471 0.623 0 CA-C-N 117.224 0.512 . . . . 0.0 110.473 172.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.453 ' HB2' ' HA ' ' A' ' 61' ' ' PRO . 3.6 p90 -158.36 169.88 23.49 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 123.5 0.5 . . . . 0.0 110.501 171.824 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 19.4 t -123.18 133.24 69.68 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.557 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.149 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 49.0 t60 -96.91 133.18 41.88 Favored 'General case' 0 CA--C 1.536 0.412 0 N-CA-C 108.315 -0.994 . . . . 0.0 108.315 173.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.4 ' HE2' ' HB2' ' A' ' 60' ' ' LEU . 83.8 m-85 -119.01 135.08 54.8 Favored 'General case' 0 N--CA 1.479 0.989 0 C-N-CA 122.758 0.423 . . . . 0.0 110.036 -177.671 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.443 ' HB2' ' HB2' ' A' ' 28' ' ' ARG . 22.9 m-20 -115.85 139.47 50.17 Favored 'General case' 0 N--CA 1.478 0.938 0 C-N-CA 124.45 1.1 . . . . 0.0 108.948 173.54 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.55 ' HG2' HG12 ' A' ' 27' ' ' ILE . 84.4 mtp -135.18 128.47 32.09 Favored 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 169.577 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 1.7 t70 -158.8 158.09 32.87 Favored 'General case' 0 N--CA 1.484 1.236 0 C-N-CA 123.742 0.817 . . . . 0.0 109.046 -176.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 151.92 -126.28 2.02 Favored Glycine 0 C--N 1.334 0.436 0 N-CA-C 109.855 -1.298 . . . . 0.0 109.855 176.323 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -159.31 163.29 35.82 Favored 'General case' 0 N--CA 1.47 0.573 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 173.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 23' ' ' ILE . 44.1 mt -157.32 107.55 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.749 0 N-CA-C 103.501 -2.777 . . . . 0.0 103.501 -166.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 30.9 t70 65.34 39.01 5.49 Favored 'General case' 0 N--CA 1.486 1.356 0 CA-C-O 122.325 1.059 . . . . 0.0 108.493 -166.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.76 -17.96 2.54 Favored Glycine 0 C--N 1.348 1.211 0 N-CA-C 115.826 1.09 . . . . 0.0 115.826 -179.052 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -88.27 123.03 69.3 Favored Pre-proline 0 N--CA 1.472 0.666 0 CA-C-N 118.011 0.905 . . . . 0.0 110.273 -173.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -72.27 152.8 56.09 Favored 'Trans proline' 0 C--N 1.375 1.968 0 C-N-CA 122.815 2.343 . . . . 0.0 113.437 -173.148 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 16.7 p90 -144.67 146.68 32.36 Favored 'General case' 0 N--CA 1.477 0.893 0 C-N-CA 123.75 0.82 . . . . 0.0 108.875 176.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 45.2 m -145.45 114.52 6.99 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 123.262 0.625 . . . . 0.0 109.421 175.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -133.53 160.23 38.08 Favored 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 125.079 1.352 . . . . 0.0 108.957 -177.33 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 62.7 p -152.21 136.39 16.58 Favored 'General case' 0 N--CA 1.469 0.482 0 C-N-CA 123.08 0.552 . . . . 0.0 110.01 172.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 35.5 p90 -136.56 141.48 43.34 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 124.162 0.985 . . . . 0.0 109.607 177.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.1 mp0 -115.31 125.04 52.78 Favored 'General case' 0 N--CA 1.474 0.731 0 N-CA-C 108.941 -0.763 . . . . 0.0 108.941 -178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . 0.4 ' HB2' ' HE2' ' A' ' 43' ' ' PHE . 96.9 mt -115.06 125.56 28.81 Favored Pre-proline 0 N--CA 1.471 0.593 0 C-N-CA 123.389 0.676 . . . . 0.0 109.184 176.521 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.453 ' HA ' ' HB2' ' A' ' 40' ' ' TYR . 33.4 Cg_endo -60.79 156.52 42.8 Favored 'Trans proline' 0 C--N 1.378 2.112 0 C-N-CA 122.888 2.392 . . . . 0.0 111.703 172.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 45.2 ttt180 -41.53 -44.85 3.1 Favored 'General case' 0 N--CA 1.495 1.823 0 C-N-CA 124.919 1.288 . . . . 0.0 112.818 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.0 t70 -60.69 -25.4 66.36 Favored 'General case' 0 CA--C 1.551 0.994 0 C-N-CA 124.749 1.22 . . . . 0.0 112.503 -177.185 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.7 p -132.04 17.91 4.58 Favored 'General case' 0 N--CA 1.479 0.995 0 C-N-CA 123.873 0.869 . . . . 0.0 110.728 -177.786 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -68.34 -44.06 76.14 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 122.884 0.474 . . . . 0.0 111.453 -175.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 -70.26 -4.79 23.56 Favored 'General case' 0 N--CA 1.482 1.146 0 C-N-CA 124.135 0.974 . . . . 0.0 112.674 179.402 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -79.51 4.6 15.22 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 123.88 0.872 . . . . 0.0 111.407 171.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 30.2 p90 -63.37 -19.47 64.68 Favored 'General case' 0 N--CA 1.477 0.896 0 C-N-CA 124.432 1.093 . . . . 0.0 113.115 -174.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.17 -42.17 56.5 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.231 0.539 . . . . 0.0 109.926 -167.87 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 49.0 m -71.53 -39.07 70.97 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 114.869 -1.06 . . . . 0.0 110.366 179.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.466 ' O ' HG23 ' A' ' 75' ' ' VAL . 21.6 t70 -74.6 -49.22 22.5 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 123.478 0.486 . . . . 0.0 111.375 -174.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -57.77 -41.94 83.05 Favored 'General case' 0 N--CA 1.488 1.473 0 C-N-CA 123.513 0.725 . . . . 0.0 112.412 179.604 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 44.3 m -66.67 -43.39 84.65 Favored 'General case' 0 CA--C 1.549 0.912 0 C-N-CA 122.649 0.38 . . . . 0.0 110.264 175.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.405 ' HB3' ' O ' ' A' ' 71' ' ' ASP . 37.0 ttm180 -52.8 -38.63 61.45 Favored 'General case' 0 N--CA 1.487 1.418 0 C-N-CA 124.133 0.973 . . . . 0.0 111.751 171.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 71' ' ' ASP . 69.6 t -71.11 -38.88 73.11 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.856 0 C-N-CA 123.346 0.658 . . . . 0.0 109.552 179.13 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.73 -49.64 51.21 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 121.369 0.604 . . . . 0.0 110.274 -173.76 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.437 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 21.1 pt20 -70.1 -24.36 63.2 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.863 -179.822 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 25.0 ttmm -60.8 -30.0 69.79 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 123.353 0.661 . . . . 0.0 110.929 172.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.492 ' HB2' HD12 ' A' ' 49' ' ' ILE . 54.7 m80 -99.78 10.59 41.07 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 123.214 0.606 . . . . 0.0 110.85 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 88.59 43.9 5.37 Favored Glycine 0 C--N 1.355 1.591 0 CA-C-O 119.651 -0.527 . . . . 0.0 113.935 174.247 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.437 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 38.7 tp -55.95 -54.33 46.01 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-O 121.292 0.568 . . . . 0.0 109.634 171.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.587 ' HB2' ' HA ' ' A' ' 87' ' ' ALA . 17.6 m80 -156.43 153.75 25.63 Favored Pre-proline 0 CA--C 1.552 1.052 0 C-N-CA 125.717 1.607 . . . . 0.0 107.739 169.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.406 ' HB2' ' HD2' ' A' ' 85' ' ' PHE . 13.5 Cg_exo -70.51 -167.35 0.25 Allowed 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.991 2.461 . . . . 0.0 113.587 -177.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -65.96 -7.6 17.79 Favored 'General case' 0 N--CA 1.489 1.506 0 C-N-CA 124.326 1.051 . . . . 0.0 112.785 -177.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . 0.406 ' HD2' ' HB2' ' A' ' 83' ' ' PRO . 92.7 m-85 -67.01 -25.57 66.35 Favored 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 123.743 0.817 . . . . 0.0 111.268 174.53 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 144.33 122.29 1.59 Allowed Glycine 0 C--N 1.351 1.362 0 CA-C-O 119.2 -0.778 . . . . 0.0 111.737 177.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.587 ' HA ' ' HB2' ' A' ' 82' ' ' HIS . . . -64.53 -61.02 2.47 Favored 'General case' 0 N--CA 1.48 1.051 0 C-N-CA 123.774 0.83 . . . . 0.0 110.302 176.487 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 3.5 pt -149.04 84.32 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.476 0.849 0 C-N-CA 125.054 1.342 . . . . 0.0 107.967 177.621 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 41.8 m -74.71 -47.75 29.67 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 115.817 -0.629 . . . . 0.0 109.984 -176.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 17.6 mmm180 -88.5 52.25 2.39 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-O 121.585 0.707 . . . . 0.0 109.571 172.232 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 4.4 p -70.01 132.49 33.13 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 CA-C-N 114.809 -1.087 . . . . 0.0 110.368 177.757 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 10.9 m170 -77.0 139.57 40.12 Favored 'General case' 0 C--O 1.238 0.499 0 N-CA-C 108.469 -0.938 . . . . 0.0 108.469 174.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.48 51.41 1.84 Allowed 'General case' 0 N--CA 1.487 1.42 0 CA-C-O 121.627 0.727 . . . . 0.0 111.744 -176.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 20.5 mm-40 -74.89 -8.89 57.81 Favored 'General case' 0 N--CA 1.473 0.715 0 C-N-CA 123.842 0.857 . . . . 0.0 110.786 177.338 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 36.4 t80 -53.43 -41.22 65.83 Favored 'General case' 0 C--O 1.21 -1.017 0 C-N-CA 124.221 1.009 . . . . 0.0 111.004 173.321 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -57.91 -40.04 79.42 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 112.79 0.663 . . . . 0.0 112.79 -178.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -73.37 -45.58 54.08 Favored 'General case' 0 N--CA 1.486 1.344 0 C-N-CA 122.419 0.288 . . . . 0.0 111.18 -179.771 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 23.7 ttt -63.41 -34.05 76.88 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.537 0.735 . . . . 0.0 111.466 176.219 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 79.7 t80 -58.49 -51.09 71.35 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.525 1.13 . . . . 0.0 109.824 172.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.482 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 34.1 mt-10 -69.52 -26.79 64.69 Favored 'General case' 0 C--N 1.356 0.852 0 O-C-N 123.943 0.777 . . . . 0.0 111.429 -178.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.44 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 14.3 t70 -70.98 -55.37 8.47 Favored 'General case' 0 C--O 1.219 -0.511 0 O-C-N 123.45 0.469 . . . . 0.0 109.803 176.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 59.9 mt -60.19 -40.73 84.42 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.155 0 C-N-CA 123.724 0.809 . . . . 0.0 112.056 179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.482 ' HG3' ' HA ' ' A' ' 100' ' ' GLU . 0.1 OUTLIER -63.01 -30.34 71.53 Favored 'General case' 0 N--CA 1.497 1.898 0 CA-C-O 121.121 0.486 . . . . 0.0 110.521 177.106 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.469 ' HB1' ' HA ' ' A' ' 110' ' ' PRO . . . -75.44 -45.39 39.0 Favored 'General case' 0 CA--C 1.545 0.758 0 CA-C-N 115.1 -0.955 . . . . 0.0 111.045 179.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.44 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.3 mmmt -59.24 -40.07 84.79 Favored 'General case' 0 N--CA 1.479 0.988 0 C-N-CA 123.857 0.863 . . . . 0.0 112.009 173.928 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 7.9 mp -61.71 -28.22 69.26 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.586 0.755 . . . . 0.0 111.917 174.348 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 54.2 t60 -77.64 -16.79 58.31 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 123.133 0.573 . . . . 0.0 111.146 177.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 84.96 -47.74 0.08 Allowed 'General case' 0 N--CA 1.488 1.454 0 C-N-CA 126.094 1.758 . . . . 0.0 110.413 179.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 11.8 m170 -95.88 107.53 34.85 Favored Pre-proline 0 CA--C 1.544 0.738 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 171.197 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.469 ' HA ' ' HB1' ' A' ' 104' ' ' ALA . 94.4 Cg_endo -74.87 127.22 10.6 Favored 'Trans proline' 0 C--N 1.37 1.669 0 C-N-CA 123.089 2.526 . . . . 0.0 113.943 -170.083 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -96.61 85.03 0.83 Allowed Glycine 0 C--N 1.339 0.729 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 169.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -62.31 128.11 90.71 Favored Pre-proline 0 CA--C 1.558 1.279 0 C-N-CA 123.562 0.745 . . . . 0.0 111.283 -178.242 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 38.4 Cg_endo -66.45 106.43 1.05 Allowed 'Trans proline' 0 C--N 1.378 2.095 0 C-N-CA 122.246 1.964 . . . . 0.0 112.206 177.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 12.4 p -78.26 148.77 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 175.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 7.8 p-10 -124.67 18.09 8.74 Favored 'General case' 0 N--CA 1.485 1.3 0 N-CA-C 112.446 0.536 . . . . 0.0 112.446 -171.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.7 pp -61.47 -36.02 79.25 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 122.563 0.345 . . . . 0.0 111.565 -178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -82.61 -30.23 29.64 Favored 'General case' 0 N--CA 1.478 0.93 0 C-N-CA 123.231 0.612 . . . . 0.0 110.666 176.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 43.0 ttt180 -66.16 -28.29 68.67 Favored 'General case' 0 N--CA 1.482 1.15 0 C-N-CA 123.423 0.689 . . . . 0.0 111.336 -178.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 49.7 mm -71.76 -30.35 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 123.241 0.616 . . . . 0.0 109.998 173.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 44.7 mt -76.67 80.28 0.68 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.872 0 CA-C-O 121.608 0.718 . . . . 0.0 109.609 177.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 68.6 mtp180 -119.99 94.66 4.46 Favored 'General case' 0 C--O 1.243 0.738 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 171.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 41.5 t-80 -66.02 126.85 29.9 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 122.585 0.354 . . . . 0.0 110.277 -176.488 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -88.43 143.05 27.23 Favored 'General case' 0 C--O 1.241 0.613 0 C-N-CA 123.444 0.697 . . . . 0.0 109.454 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -164.51 -50.87 0.02 OUTLIER Glycine 0 C--N 1.339 0.749 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 40.4 p . . . . . 0 C--O 1.253 1.256 0 C-N-CA 123.646 0.779 . . . . 0.0 109.914 -175.9 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.481 1.099 0 CA-C-O 121.012 0.434 . . . . 0.0 110.01 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 77.39 163.71 20.13 Favored Glycine 0 C--N 1.349 1.256 0 CA-C-N 116.069 -0.514 . . . . 0.0 113.242 -179.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 28.0 p80 -98.27 22.91 8.96 Favored 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 122.819 0.447 . . . . 0.0 110.626 177.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 5.1 tpt -98.62 174.64 6.33 Favored 'General case' 0 CA--C 1.552 1.028 0 C-N-CA 123.984 0.914 . . . . 0.0 109.674 179.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 25.3 t80 -77.18 137.57 38.94 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 124.16 0.984 . . . . 0.0 109.391 179.045 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -124.78 153.48 70.44 Favored Pre-proline 0 CA--C 1.559 1.299 0 C-N-CA 124.309 1.044 . . . . 0.0 108.935 176.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -61.15 109.92 0.79 Allowed 'Trans proline' 0 C--N 1.371 1.748 0 C-N-CA 122.558 2.172 . . . . 0.0 112.473 177.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 110.41 -8.4 30.57 Favored Glycine 0 N--CA 1.473 1.137 0 CA-C-O 120.25 -0.195 . . . . 0.0 112.666 178.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.547 ' NE2' ' HB3' ' A' ' 26' ' ' HIS . 11.3 t-160 -160.02 126.01 4.19 Favored 'General case' 0 CA--C 1.548 0.873 0 CA-C-O 121.321 0.581 . . . . 0.0 110.437 -173.04 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 45.2 tp -100.95 145.63 28.41 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 124.49 1.116 . . . . 0.0 109.03 -175.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . 0.469 ' HA ' ' O ' ' A' ' 25' ' ' ILE . 2.6 t-160 -124.85 117.34 23.91 Favored 'General case' 0 CA--C 1.544 0.713 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 170.832 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.567 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 89.5 mt -89.91 110.04 21.02 Favored 'General case' 0 N--CA 1.474 0.725 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 174.667 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 73.7 t -126.37 149.82 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.121 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 168.513 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . . . . . . . . . 37.9 t -77.73 160.46 28.41 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -178.52 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -46.55 139.72 6.07 Favored Pre-proline 0 CA--C 1.568 1.662 0 C-N-CA 124.641 1.176 . . . . 0.0 113.527 -176.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -72.61 -160.18 0.09 OUTLIER 'Trans proline' 0 C--N 1.377 2.055 0 C-N-CA 122.81 2.34 . . . . 0.0 112.104 175.57 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 83.45 -64.49 4.29 Favored Glycine 0 C--N 1.35 1.318 0 N-CA-C 110.854 -0.898 . . . . 0.0 110.854 -177.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 56.6 tp -122.78 122.52 38.89 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 124.289 1.036 . . . . 0.0 108.969 172.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -73.7 87.03 1.68 Allowed 'General case' 0 CA--C 1.547 0.85 0 CA-C-O 121.955 0.883 . . . . 0.0 109.13 173.519 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 22.4 tp60 -78.02 -53.86 6.93 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 115.099 -0.955 . . . . 0.0 111.375 -170.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -147.41 147.67 30.5 Favored 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -179.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -88.82 55.12 3.24 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-O 122.014 0.912 . . . . 0.0 110.529 -168.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.542 HG22 HG23 ' A' ' 49' ' ' ILE . 2.2 pp -87.95 115.32 28.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 N-CA-C 106.944 -1.502 . . . . 0.0 106.944 176.11 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.464 HD21 ' HG3' ' A' ' 48' ' ' GLU . 5.9 p30 -146.01 110.21 4.99 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -176.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.567 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.0 mt -130.01 141.21 46.98 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.5 0 CA-C-N 115.186 -0.915 . . . . 0.0 109.613 -166.169 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.595 ' O ' ' HA ' ' A' ' 45' ' ' MET . 19.1 m170 -107.4 122.21 46.15 Favored 'General case' 0 C--O 1.219 -0.512 0 N-CA-C 106.87 -1.529 . . . . 0.0 106.87 172.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.449 HG12 ' HG2' ' A' ' 45' ' ' MET . 60.0 mt -123.07 109.6 24.08 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 172.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.532 ' O ' ' HA ' ' A' ' 43' ' ' PHE . 17.7 ttt180 -91.41 133.29 35.59 Favored 'General case' 0 N--CA 1.467 0.399 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 26.7 p90 -123.9 118.62 27.5 Favored 'General case' 0 C--O 1.239 0.552 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 176.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 36.4 mt-10 -131.19 113.12 13.47 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 41' ' ' VAL . 91.1 t -82.01 116.95 27.14 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 175.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.41 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 15.6 ttt180 -127.9 161.07 29.93 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 -179.092 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.41 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.6 mm-40 -111.27 114.34 27.46 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 -179.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 32.8 p30 -96.04 154.76 17.07 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 123.915 0.886 . . . . 0.0 110.503 172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -72.32 -16.19 61.89 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 123.02 0.528 . . . . 0.0 111.952 174.0 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 13.0 tp10 -73.08 -53.1 11.93 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 123.702 0.801 . . . . 0.0 111.981 -176.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.8 t -126.55 -1.11 6.83 Favored 'General case' 0 N--CA 1.483 1.175 0 C-N-CA 123.4 0.68 . . . . 0.0 112.461 -169.559 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 87.57 -114.47 4.16 Favored Glycine 0 C--N 1.345 1.029 0 N-CA-C 110.19 -1.164 . . . . 0.0 110.19 -174.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -75.07 145.19 42.53 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-N 117.176 0.488 . . . . 0.0 110.817 172.339 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 7.0 p90 -153.27 171.91 17.82 Favored 'General case' 0 N--CA 1.48 1.071 0 N-CA-C 108.916 -0.772 . . . . 0.0 108.916 167.437 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.559 HG22 HG22 ' A' ' 31' ' ' VAL . 7.1 t -124.32 128.02 73.54 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.802 0 N-CA-C 109.416 -0.587 . . . . 0.0 109.416 174.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.498 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 8.5 t60 -84.48 123.4 30.22 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 107.91 -1.144 . . . . 0.0 107.91 172.522 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . 0.532 ' HA ' ' O ' ' A' ' 28' ' ' ARG . 94.0 m-85 -115.88 140.11 49.56 Favored 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 123.279 0.632 . . . . 0.0 109.47 172.755 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -143.41 137.9 28.98 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-O 121.038 0.447 . . . . 0.0 110.346 172.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.595 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 83.7 mtp -123.17 136.91 54.97 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 124.379 1.072 . . . . 0.0 111.114 -173.576 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -163.47 162.77 24.85 Favored 'General case' 0 N--CA 1.484 1.245 0 C-N-CA 123.125 0.57 . . . . 0.0 110.958 173.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 146.11 -130.47 3.73 Favored Glycine 0 N--CA 1.469 0.864 0 N-CA-C 110.35 -1.1 . . . . 0.0 110.35 176.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.464 ' HG3' HD21 ' A' ' 24' ' ' ASN . 10.4 pt-20 -157.89 166.32 32.96 Favored 'General case' 0 N--CA 1.48 1.026 0 C-N-CA 123.686 0.794 . . . . 0.0 110.08 173.173 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 23' ' ' ILE . 97.3 mt -155.77 105.36 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 -161.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 19.0 t70 60.67 35.34 19.83 Favored 'General case' 0 CA--C 1.556 1.183 0 CA-C-O 122.098 0.951 . . . . 0.0 108.739 -170.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 84.17 -22.26 8.73 Favored Glycine 0 C--N 1.351 1.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 114.563 -174.439 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 56.7 mttp -77.84 113.75 35.43 Favored Pre-proline 0 N--CA 1.481 1.11 0 C-N-CA 123.891 0.877 . . . . 0.0 111.148 -173.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -75.41 154.13 40.38 Favored 'Trans proline' 0 C--N 1.376 2.024 0 C-N-CA 123.143 2.562 . . . . 0.0 113.122 -174.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . 0.423 ' HZ ' HG23 ' A' ' 25' ' ' ILE . 11.8 p90 -152.69 156.42 39.15 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 122.712 0.405 . . . . 0.0 111.282 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 31.2 p -153.11 124.52 7.63 Favored 'General case' 0 CA--C 1.548 0.883 0 C-N-CA 123.858 0.863 . . . . 0.0 110.264 168.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -144.72 165.25 28.61 Favored 'General case' 0 N--CA 1.482 1.14 0 C-N-CA 125.397 1.479 . . . . 0.0 108.524 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 54.2 p -153.2 142.06 21.13 Favored 'General case' 0 N--CA 1.475 0.815 0 C-N-CA 122.723 0.409 . . . . 0.0 110.7 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 10.5 p90 -144.03 141.06 29.89 Favored 'General case' 0 N--CA 1.476 0.828 0 C-N-CA 123.834 0.853 . . . . 0.0 110.154 179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.498 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 44.6 mt-10 -125.55 125.38 43.13 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -178.808 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 91.4 mt -121.23 132.54 24.19 Favored Pre-proline 0 C--O 1.235 0.311 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 -171.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_endo -63.78 160.86 34.86 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.646 2.231 . . . . 0.0 111.175 174.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . . . . . . . . . 33.5 ptt180 -51.75 -28.4 15.09 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 113.297 0.851 . . . . 0.0 113.297 178.041 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 37.1 t70 -64.03 -37.96 89.35 Favored 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 123.927 0.891 . . . . 0.0 112.161 177.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 48.7 p -126.72 12.84 7.41 Favored 'General case' 0 N--CA 1.485 1.318 0 C-N-CA 123.098 0.559 . . . . 0.0 112.061 -171.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -62.19 -34.46 76.48 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 123.201 0.6 . . . . 0.0 111.831 -178.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -69.89 -11.49 60.91 Favored 'General case' 0 N--CA 1.478 0.972 0 C-N-CA 124.384 1.074 . . . . 0.0 113.667 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -83.61 1.59 41.5 Favored 'General case' 0 N--CA 1.488 1.472 0 C-N-CA 123.145 0.578 . . . . 0.0 111.73 176.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 6.7 p90 -54.89 -25.61 30.17 Favored 'General case' 0 N--CA 1.483 1.182 0 C-N-CA 125.227 1.411 . . . . 0.0 113.937 -173.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.22 -33.27 61.35 Favored 'General case' 0 C--N 1.351 0.633 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 -167.194 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 48.2 m -69.69 -38.24 76.94 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.473 178.899 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 15.0 m-20 -72.09 -46.62 56.07 Favored 'General case' 0 N--CA 1.478 0.947 0 O-C-N 123.507 0.505 . . . . 0.0 110.027 -179.069 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . 0.509 ' HA ' ' SD ' ' A' ' 45' ' ' MET . . . -58.06 -50.81 72.15 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 114.68 -1.145 . . . . 0.0 111.56 178.82 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 33.3 m -69.15 -23.24 63.93 Favored 'General case' 0 CA--C 1.554 1.11 0 C-N-CA 123.057 0.543 . . . . 0.0 111.533 179.494 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 39.5 ttp-105 -74.46 -34.03 63.06 Favored 'General case' 0 N--CA 1.487 1.396 0 CA-C-O 121.107 0.479 . . . . 0.0 110.465 179.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . . . . . . . . . 76.4 t -74.77 -32.56 28.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.109 0 C-N-CA 124.0 0.92 . . . . 0.0 109.908 175.157 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -75.66 -54.35 7.11 Favored 'General case' 0 CA--C 1.544 0.746 0 CA-C-N 115.18 -0.918 . . . . 0.0 110.043 -174.407 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.435 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 21.2 mm-40 -62.49 -22.86 66.58 Favored 'General case' 0 N--CA 1.477 0.922 0 CA-C-N 114.253 -1.339 . . . . 0.0 112.935 175.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -48.6 -36.45 15.7 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 123.209 0.604 . . . . 0.0 112.08 174.316 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -108.11 -31.27 8.0 Favored 'General case' 0 N--CA 1.484 1.268 0 CA-C-N 117.738 0.245 . . . . 0.0 110.527 170.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 133.59 94.35 0.53 Allowed Glycine 0 C--N 1.351 1.404 0 N-CA-C 111.324 -0.71 . . . . 0.0 111.324 160.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.435 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 52.7 tp -77.15 72.59 3.71 Favored 'General case' 0 CA--C 1.548 0.879 0 C-N-CA 124.32 1.048 . . . . 0.0 110.109 179.246 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 14.7 t-160 49.61 49.94 8.28 Favored Pre-proline 0 CA--C 1.57 1.719 0 C-N-CA 125.051 1.34 . . . . 0.0 111.535 177.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 85.6 Cg_endo -75.03 -14.08 21.17 Favored 'Trans proline' 0 C--N 1.382 2.304 0 C-N-CA 123.291 2.661 . . . . 0.0 114.954 -160.008 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 13.4 tmtt? -73.08 -44.54 60.33 Favored 'General case' 0 N--CA 1.477 0.888 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 79.3 t80 -76.07 -36.48 58.97 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 123.741 0.816 . . . . 0.0 109.943 172.692 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 68.92 -117.53 8.13 Favored Glycine 0 C--N 1.343 0.961 0 CA-C-N 115.076 -0.965 . . . . 0.0 112.346 -176.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -136.77 32.11 2.73 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.019 0.928 . . . . 0.0 109.896 -179.735 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.3 mm -77.15 84.83 0.83 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.813 0 CA-C-O 121.548 0.689 . . . . 0.0 110.047 -178.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 81.1 p -129.56 -24.03 2.81 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 124.224 1.01 . . . . 0.0 110.079 178.634 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 5.7 mpt_? 64.8 -72.48 0.07 Allowed 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 125.828 1.651 . . . . 0.0 111.205 -176.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 10.8 p -81.01 165.52 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.076 0 C-N-CA 123.403 0.681 . . . . 0.0 109.677 175.185 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 12.0 m170 74.14 14.44 3.84 Favored 'General case' 0 N--CA 1.494 1.733 0 C-N-CA 125.022 1.329 . . . . 0.0 111.433 -177.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.2 mmtp -80.42 79.56 7.0 Favored 'General case' 0 C--O 1.24 0.588 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 172.477 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -91.45 33.43 1.0 Allowed 'General case' 0 C--O 1.24 0.577 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.319 -177.644 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 46.6 t80 -61.56 -42.04 98.26 Favored 'General case' 0 C--N 1.348 0.542 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.44 167.816 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -63.39 -33.7 76.11 Favored 'General case' 0 N--CA 1.48 1.058 0 O-C-N 124.008 0.817 . . . . 0.0 110.728 177.663 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.93 -49.55 61.17 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 122.937 0.495 . . . . 0.0 110.961 -179.641 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.6 ttm -68.04 -34.39 76.37 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 123.372 0.669 . . . . 0.0 111.459 178.068 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 42.5 t80 -55.26 -47.27 75.7 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 124.311 1.045 . . . . 0.0 110.044 170.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.6 mt-10 -73.3 -25.57 60.71 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 115.289 -0.869 . . . . 0.0 112.0 179.414 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.5 t70 -64.4 -60.85 2.67 Favored 'General case' 0 N--CA 1.469 0.507 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 172.302 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.432 HG22 HD22 ' A' ' 106' ' ' LEU . 72.6 mt -54.75 -40.99 54.13 Favored 'Isoleucine or valine' 0 CA--C 1.556 1.209 0 C-N-CA 124.084 0.954 . . . . 0.0 111.729 -177.193 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.53 -31.39 72.16 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 123.207 0.317 . . . . 0.0 111.61 -179.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.08 -51.65 56.19 Favored 'General case' 0 N--CA 1.475 0.795 0 C-N-CA 123.394 0.677 . . . . 0.0 111.535 -176.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.82 -28.19 62.41 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.973 0.509 . . . . 0.0 110.542 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.432 HD22 HG22 ' A' ' 102' ' ' ILE . 6.0 mp -71.77 -28.76 63.85 Favored 'General case' 0 CA--C 1.549 0.926 0 C-N-CA 122.572 0.349 . . . . 0.0 110.447 175.126 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 11.1 t60 -81.51 -17.06 49.88 Favored 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 124.252 1.021 . . . . 0.0 109.643 174.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 69.42 18.99 7.77 Favored 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 125.782 1.633 . . . . 0.0 112.823 -177.681 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 80.4 m-70 -137.42 145.41 49.36 Favored Pre-proline 0 N--CA 1.484 1.263 0 C-N-CA 123.597 0.759 . . . . 0.0 109.839 -178.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 25.5 Cg_endo -58.96 139.1 89.37 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.261 2.641 . . . . 0.0 112.876 -177.254 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 168.12 50.2 0.03 OUTLIER Glycine 0 C--N 1.34 0.779 0 N-CA-C 111.084 -0.806 . . . . 0.0 111.084 179.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -131.58 159.99 69.37 Favored Pre-proline 0 N--CA 1.477 0.877 0 C-N-CA 124.257 1.023 . . . . 0.0 110.319 -172.079 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_exo -62.62 124.99 15.15 Favored 'Trans proline' 0 C--N 1.377 2.048 0 C-N-CA 122.674 2.249 . . . . 0.0 111.414 169.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 15.0 p -78.89 131.16 35.01 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.838 0 C-N-CA 122.961 0.504 . . . . 0.0 109.902 179.629 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -94.88 3.05 55.42 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-O 118.439 -0.791 . . . . 0.0 113.009 -170.964 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.0 pp -53.11 -34.88 58.67 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 123.762 0.664 . . . . 0.0 111.416 -170.74 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -134.54 87.34 2.34 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 106.954 -1.498 . . . . 0.0 106.954 166.223 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 56.1 ttt85 -133.39 29.62 3.94 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 107.893 -1.151 . . . . 0.0 107.893 169.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 21.9 mm -106.74 -53.39 6.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 114.864 -1.062 . . . . 0.0 109.296 -174.15 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 28.9 mm -87.97 74.56 1.1 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 108.553 -0.906 . . . . 0.0 108.553 179.187 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 4.1 mmp_? -110.8 179.61 4.01 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 124.342 1.057 . . . . 0.0 109.699 177.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 43.6 m80 -144.95 129.83 18.28 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.666 0.786 . . . . 0.0 109.209 179.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -112.49 -52.8 2.76 Favored 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.025 0.53 . . . . 0.0 110.274 -179.497 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -101.22 53.15 0.86 Allowed Glycine 0 C--N 1.343 0.972 0 CA-C-N 116.055 -0.521 . . . . 0.0 112.801 -178.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 45.3 m . . . . . 0 CA--C 1.556 1.188 0 C-N-CA 123.352 0.661 . . . . 0.0 109.742 179.674 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 . . . . . 0 N--CA 1.481 1.105 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 89.86 -56.31 3.72 Favored Glycine 0 C--N 1.349 1.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 112.719 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.7 t60 -76.2 76.85 3.01 Favored 'General case' 0 N--CA 1.479 0.979 0 C-N-CA 123.634 0.774 . . . . 0.0 110.015 -178.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 77.4 mtp -90.65 104.89 17.43 Favored 'General case' 0 N--CA 1.481 1.108 0 C-N-CA 123.911 0.884 . . . . 0.0 110.517 -175.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -96.75 138.65 33.99 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 123.461 0.704 . . . . 0.0 110.063 175.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -151.85 157.14 34.5 Favored Pre-proline 0 CA--C 1.548 0.881 0 C-N-CA 124.486 1.114 . . . . 0.0 108.356 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -59.71 102.78 0.17 Allowed 'Trans proline' 0 C--N 1.374 1.877 0 C-N-CA 121.919 1.746 . . . . 0.0 111.651 174.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 113.34 -8.62 24.61 Favored Glycine 0 C--N 1.348 1.221 0 CA-C-O 119.595 -0.558 . . . . 0.0 114.338 176.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 36.0 t-80 -157.8 151.66 24.09 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 117.529 0.664 . . . . 0.0 111.898 -175.842 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 59.7 tp -140.51 142.27 35.25 Favored 'General case' 0 CA--C 1.545 0.76 0 C-N-CA 125.596 1.558 . . . . 0.0 108.382 176.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 20.1 t-160 -111.7 138.25 48.52 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 123.587 0.755 . . . . 0.0 109.265 173.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.566 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 75.3 mt -118.53 126.65 52.45 Favored 'General case' 0 N--CA 1.47 0.553 0 C-N-CA 124.076 0.95 . . . . 0.0 109.145 176.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 84.8 t -120.27 167.34 13.78 Favored 'Isoleucine or valine' 0 C--O 1.248 1.012 0 N-CA-C 105.78 -1.933 . . . . 0.0 105.78 164.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.564 ' HB2' ' HB3' ' A' ' 20' ' ' GLN . 31.8 p -79.89 161.19 25.71 Favored 'General case' 0 C--O 1.243 0.751 0 CA-C-N 119.547 1.067 . . . . 0.0 109.501 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.8 mt -49.47 135.45 17.75 Favored Pre-proline 0 CA--C 1.563 1.476 0 O-C-N 124.15 0.907 . . . . 0.0 112.655 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 22.6 Cg_endo -55.73 126.01 21.01 Favored 'Trans proline' 0 C--N 1.388 2.625 0 C-N-CA 123.981 3.121 . . . . 0.0 113.287 -164.941 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 117.24 -19.97 11.54 Favored Glycine 0 C--N 1.339 0.707 0 CA-C-N 115.62 -0.718 . . . . 0.0 111.466 -173.429 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 85.2 mt 62.53 46.28 5.71 Favored 'General case' 0 C--N 1.356 0.875 0 C-N-CA 124.963 1.305 . . . . 0.0 111.528 177.297 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -65.52 -37.95 88.24 Favored 'General case' 0 N--CA 1.483 1.18 0 CA-C-N 115.154 -0.93 . . . . 0.0 109.721 170.336 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . 0.564 ' HB3' ' HB2' ' A' ' 14' ' ' SER . 36.0 tp60 -74.75 170.59 15.56 Favored 'General case' 0 CA--C 1.552 1.031 0 C-N-CA 124.489 1.116 . . . . 0.0 108.344 170.853 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 pt20 -73.18 -176.83 2.28 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 118.201 0.455 . . . . 0.0 111.234 -178.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -81.73 84.68 6.76 Favored 'General case' 0 CA--C 1.547 0.845 0 CA-C-O 121.218 0.532 . . . . 0.0 110.597 -171.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.488 HG22 HG23 ' A' ' 49' ' ' ILE . 0.7 OUTLIER -106.97 145.71 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 CA-C-N 115.793 -0.64 . . . . 0.0 110.432 -175.379 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 6.9 p30 -151.74 138.13 18.53 Favored 'General case' 0 C--O 1.246 0.893 0 CA-C-N 114.849 -1.069 . . . . 0.0 108.17 166.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.566 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 53.5 mt -142.64 136.49 27.43 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 N-CA-C 107.773 -1.195 . . . . 0.0 107.773 -174.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.448 ' O ' ' HA ' ' A' ' 45' ' ' MET . 7.4 m170 -107.34 136.19 47.56 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.46 -1.682 . . . . 0.0 106.46 174.768 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . . . . . . . . . 51.7 mt -130.44 108.47 15.74 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.416 ' HB2' ' HB3' ' A' ' 44' ' ' ASP . 26.2 mtp180 -92.97 134.63 34.92 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 107.857 -1.164 . . . . 0.0 107.857 169.401 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -129.38 117.11 20.06 Favored 'General case' 0 C--O 1.238 0.467 0 N-CA-C 106.854 -1.536 . . . . 0.0 106.854 170.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 39.8 mt-10 -132.74 117.14 17.45 Favored 'General case' 0 N--CA 1.47 0.525 0 C-N-CA 123.55 0.74 . . . . 0.0 109.438 -171.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 41' ' ' VAL . 48.0 t -80.03 115.67 22.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.54 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 -177.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.436 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 24.5 ttt180 -120.98 162.4 19.97 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 176.044 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.436 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.3 mm-40 -106.55 124.85 50.22 Favored 'General case' 0 CA--C 1.541 0.62 0 O-C-N 122.054 -0.404 . . . . 0.0 110.277 179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.2 p30 -94.98 144.25 25.83 Favored 'General case' 0 N--CA 1.476 0.843 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 167.901 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -70.26 -12.84 61.87 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.467 0.707 . . . . 0.0 112.089 -177.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 32.4 tt0 -79.62 -49.91 11.45 Favored 'General case' 0 CA--C 1.552 1.054 0 C-N-CA 124.006 0.922 . . . . 0.0 112.488 -175.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.3 t -128.8 -4.8 5.16 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.759 0.823 . . . . 0.0 111.543 -169.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 92.57 -118.34 5.55 Favored Glycine 0 C--N 1.342 0.881 0 N-CA-C 111.302 -0.719 . . . . 0.0 111.302 -178.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -71.96 138.01 47.72 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 123.049 0.54 . . . . 0.0 112.335 -176.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 6.0 p90 -152.92 171.13 18.79 Favored 'General case' 0 N--CA 1.48 1.03 0 C-N-CA 124.176 0.99 . . . . 0.0 109.083 170.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.527 HG22 HG22 ' A' ' 31' ' ' VAL . 30.5 t -120.77 127.68 75.96 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.818 0 C-N-CA 122.892 0.477 . . . . 0.0 110.169 175.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.432 ' HA ' ' HG2' ' A' ' 59' ' ' GLU . 6.6 t60 -88.93 108.67 19.69 Favored 'General case' 0 C--O 1.241 0.617 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 167.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -94.53 135.39 36.03 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 175.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.416 ' HB3' ' HB2' ' A' ' 28' ' ' ARG . 24.7 t70 -125.82 136.05 52.68 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 124.384 1.073 . . . . 0.0 108.545 178.26 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.448 ' HA ' ' O ' ' A' ' 26' ' ' HIS . 87.0 mtp -136.32 131.19 34.01 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 118.463 0.574 . . . . 0.0 110.496 -178.533 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -155.62 162.2 40.67 Favored 'General case' 0 N--CA 1.49 1.574 0 C-N-CA 122.772 0.429 . . . . 0.0 111.523 -179.385 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 159.09 -151.07 21.94 Favored Glycine 0 N--CA 1.477 1.394 0 N-CA-C 110.118 -1.193 . . . . 0.0 110.118 175.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -148.66 111.07 4.7 Favored 'General case' 0 CA--C 1.547 0.829 0 CA-C-N 118.122 0.961 . . . . 0.0 111.172 171.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.488 HG23 HG22 ' A' ' 23' ' ' ILE . 74.2 mt -97.61 125.47 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 CA-C-N 115.239 -0.891 . . . . 0.0 110.605 177.474 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 25.4 t0 63.24 25.57 14.82 Favored 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.11 1.364 . . . . 0.0 109.687 -170.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 81.2 4.35 90.5 Favored Glycine 0 C--N 1.356 1.656 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.294 -176.235 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -94.59 110.44 49.11 Favored Pre-proline 0 N--CA 1.474 0.766 0 C-N-CA 123.899 0.88 . . . . 0.0 111.724 -176.526 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -69.37 140.82 45.13 Favored 'Trans proline' 0 C--N 1.374 1.906 0 C-N-CA 122.829 2.353 . . . . 0.0 112.209 -175.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 39.2 p90 -141.4 145.63 35.57 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 123.143 0.577 . . . . 0.0 109.958 178.226 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 49.0 p -140.56 115.15 9.47 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 173.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -145.93 152.45 39.44 Favored 'General case' 0 N--CA 1.479 0.996 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -174.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 52.2 m -147.57 155.9 42.29 Favored 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 123.136 0.575 . . . . 0.0 111.189 -176.184 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 26.6 p90 -145.92 147.35 31.65 Favored 'General case' 0 N--CA 1.477 0.878 0 C-N-CA 123.914 0.886 . . . . 0.0 109.88 173.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . 0.432 ' HG2' ' HA ' ' A' ' 42' ' ' HIS . 41.2 mt-10 -124.89 128.09 48.12 Favored 'General case' 0 N--CA 1.479 0.997 0 C-N-CA 123.924 0.889 . . . . 0.0 109.273 -178.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 94.7 mt -129.58 123.87 21.54 Favored Pre-proline 0 N--CA 1.47 0.573 0 C-N-CA 123.913 0.885 . . . . 0.0 109.326 -174.374 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -63.52 164.57 20.37 Favored 'Trans proline' 0 C--N 1.375 1.949 0 C-N-CA 122.782 2.321 . . . . 0.0 112.199 172.606 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.682 ' HG3' ' HB3' ' A' ' 106' ' ' LEU . 37.6 ttt180 -44.66 -33.72 1.94 Allowed 'General case' 0 N--CA 1.489 1.521 0 C-N-CA 124.776 1.23 . . . . 0.0 113.773 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 32.0 t70 -71.31 -36.68 71.69 Favored 'General case' 0 CA--C 1.547 0.839 0 C-N-CA 123.418 0.687 . . . . 0.0 111.569 -178.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 73.2 p -118.53 9.65 12.35 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 123.465 0.706 . . . . 0.0 110.853 -170.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -58.48 -29.06 65.93 Favored 'General case' 0 N--CA 1.483 1.202 0 C-N-CA 123.675 0.79 . . . . 0.0 111.235 176.832 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -71.11 -8.69 55.17 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 125.283 1.433 . . . . 0.0 113.294 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -90.69 8.03 36.51 Favored 'General case' 0 N--CA 1.481 1.103 0 C-N-CA 124.113 0.965 . . . . 0.0 110.764 175.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . . . . . . . . . 32.5 p90 -51.34 -45.4 62.29 Favored 'General case' 0 C--N 1.36 1.028 0 C-N-CA 124.276 1.03 . . . . 0.0 111.644 -178.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.04 -30.34 71.53 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 113.144 0.794 . . . . 0.0 113.144 -177.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.6 m -65.98 -50.32 64.72 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 118.377 0.535 . . . . 0.0 110.336 -178.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 75' ' ' VAL . 12.5 m-20 -70.94 -48.93 50.75 Favored 'General case' 0 N--CA 1.473 0.68 0 CA-C-N 115.519 -0.764 . . . . 0.0 111.425 -179.705 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.9 -51.01 56.1 Favored 'General case' 0 N--CA 1.489 1.505 0 C-N-CA 124.171 0.988 . . . . 0.0 112.066 178.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 83.0 m -59.86 -43.56 94.62 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 123.456 0.703 . . . . 0.0 111.34 174.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 33.6 ttm180 -58.87 -48.48 81.23 Favored 'General case' 0 N--CA 1.476 0.842 0 C-N-CA 123.892 0.877 . . . . 0.0 110.49 -176.357 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 71' ' ' ASP . 63.6 t -62.66 -35.0 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.956 0 C-N-CA 123.664 0.786 . . . . 0.0 110.429 -179.58 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -71.01 -53.41 14.89 Favored 'General case' 0 N--CA 1.473 0.675 0 C-N-CA 123.335 0.654 . . . . 0.0 110.704 -175.772 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.502 ' HA ' ' HB2' ' A' ' 81' ' ' LEU . 14.0 pt20 -71.2 -34.29 70.74 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.687 -1.142 . . . . 0.0 112.778 -171.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 50.6 mtmt -60.86 -32.58 72.0 Favored 'General case' 0 N--CA 1.482 1.144 0 O-C-N 123.553 0.533 . . . . 0.0 110.759 173.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 32.4 m80 -92.58 15.47 14.2 Favored 'General case' 0 N--CA 1.471 0.575 0 C-N-CA 123.15 0.58 . . . . 0.0 111.676 -178.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 99.15 62.95 0.84 Allowed Glycine 0 C--N 1.344 0.999 0 N-CA-C 114.614 0.606 . . . . 0.0 114.614 174.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.502 ' HB2' ' HA ' ' A' ' 77' ' ' GLN . 3.5 mm? -123.79 -21.17 5.23 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 162.656 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . . . . . . . . . 33.3 m-70 67.59 165.2 0.12 Allowed Pre-proline 0 N--CA 1.493 1.71 0 C-N-CA 124.607 1.163 . . . . 0.0 109.27 -164.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 99.7 Cg_exo -47.41 102.86 0.05 OUTLIER 'Trans proline' 0 C--N 1.384 2.433 0 C-N-CA 122.354 2.036 . . . . 0.0 112.473 172.595 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.87 -16.21 63.21 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-N 115.818 -0.628 . . . . 0.0 110.978 -175.637 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -81.45 -30.84 33.3 Favored 'General case' 0 CA--C 1.545 0.763 0 C-N-CA 123.092 0.557 . . . . 0.0 109.6 173.407 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -69.86 -29.05 71.21 Favored Glycine 0 CA--C 1.533 1.195 0 CA-C-N 115.778 -0.646 . . . . 0.0 112.248 173.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -130.56 84.05 2.17 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 124.017 0.927 . . . . 0.0 108.613 172.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 29.7 pt -63.36 162.71 1.85 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.2 0 C-N-CA 124.014 0.926 . . . . 0.0 113.175 -171.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 61.7 p -62.52 -44.13 97.12 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 114.84 -1.073 . . . . 0.0 110.199 173.121 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER 74.82 -38.6 0.39 Allowed 'General case' 0 N--CA 1.491 1.624 0 C-N-CA 126.101 1.76 . . . . 0.0 111.311 178.325 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 35.9 m -63.23 -170.21 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.555 1.157 0 C-N-CA 124.848 1.259 . . . . 0.0 111.768 167.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 56.0 t-80 -54.88 140.64 36.19 Favored 'General case' 0 N--CA 1.479 0.99 0 C-N-CA 123.246 0.618 . . . . 0.0 111.069 179.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 89.1 tttt -122.8 126.25 47.06 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.973 0.909 . . . . 0.0 108.869 -178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 11.8 mp0 -107.74 21.5 17.34 Favored 'General case' 0 N--CA 1.481 1.086 0 C-N-CA 123.443 0.697 . . . . 0.0 111.334 -171.531 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -62.03 -54.29 43.55 Favored 'General case' 0 C--N 1.358 0.956 0 CA-C-N 117.802 0.274 . . . . 0.0 110.625 -177.437 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -64.86 -30.81 71.83 Favored 'General case' 0 N--CA 1.479 1.015 0 O-C-N 123.934 0.771 . . . . 0.0 111.932 -178.713 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -67.86 -49.77 60.26 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-O 121.097 0.475 . . . . 0.0 110.738 178.402 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 48.3 ttm -64.2 -35.15 79.86 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 124.291 1.036 . . . . 0.0 111.243 174.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 37.5 t80 -61.32 -51.41 68.98 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 124.498 1.119 . . . . 0.0 110.422 179.228 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -67.94 -28.67 67.67 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 112.747 0.647 . . . . 0.0 112.747 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . 0.51 ' O ' ' HG2' ' A' ' 105' ' ' LYS . 37.6 t70 -71.67 -47.7 52.49 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 174.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . 0.464 ' O ' HD23 ' A' ' 106' ' ' LEU . 42.0 mt -58.74 -44.2 89.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 C-N-CA 123.809 0.843 . . . . 0.0 111.563 178.341 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 5.6 ppt_? -62.89 -28.78 70.27 Favored 'General case' 0 N--CA 1.487 1.407 0 CA-C-O 120.883 0.373 . . . . 0.0 110.292 179.619 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -72.93 -52.36 14.92 Favored 'General case' 0 CA--C 1.545 0.786 0 C-N-CA 123.814 0.846 . . . . 0.0 111.911 175.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.51 ' HG2' ' O ' ' A' ' 101' ' ' ASP . 31.0 mmmt -58.86 -42.59 89.76 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 124.21 1.004 . . . . 0.0 112.43 -179.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.682 ' HB3' ' HG3' ' A' ' 62' ' ' ARG . 4.4 mm? -71.52 -22.22 61.8 Favored 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 123.604 0.761 . . . . 0.0 112.067 179.051 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -75.23 -24.61 57.72 Favored 'General case' 0 N--CA 1.483 1.193 0 C-N-CA 122.689 0.396 . . . . 0.0 110.474 168.782 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 74.61 91.26 0.08 Allowed 'General case' 0 N--CA 1.476 0.832 0 C-N-CA 125.701 1.6 . . . . 0.0 110.624 -174.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 28.3 m170 -112.53 163.47 17.75 Favored Pre-proline 0 N--CA 1.482 1.155 0 C-N-CA 124.958 1.303 . . . . 0.0 109.593 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 16.3 Cg_exo -69.16 76.16 0.92 Allowed 'Trans proline' 0 C--N 1.377 2.031 0 C-N-CA 122.406 2.071 . . . . 0.0 111.986 169.889 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . 77.81 -80.07 1.37 Allowed Glycine 0 C--N 1.345 1.067 0 CA-C-N 116.081 -0.509 . . . . 0.0 113.494 -179.871 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -79.57 148.93 70.72 Favored Pre-proline 0 CA--C 1.553 1.06 0 C-N-CA 123.895 0.878 . . . . 0.0 112.408 -171.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_exo -56.35 164.41 5.39 Favored 'Trans proline' 0 C--N 1.381 2.271 0 C-N-CA 123.843 3.029 . . . . 0.0 114.123 170.671 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.0 p -70.53 122.48 22.45 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.058 0 CA-C-O 121.459 0.647 . . . . 0.0 109.956 -179.891 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 40.6 m-20 -87.53 27.83 1.06 Allowed 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.832 0.853 . . . . 0.0 112.406 -169.63 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.1 pp -65.03 -30.22 71.18 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 122.471 0.308 . . . . 0.0 110.657 173.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 13.4 pt-20 -95.63 9.23 40.99 Favored 'General case' 0 CA--C 1.551 0.993 0 C-N-CA 123.897 0.879 . . . . 0.0 111.929 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 52.1 ttt180 -76.43 -9.3 58.55 Favored 'General case' 0 N--CA 1.49 1.569 0 CA-C-O 121.313 0.578 . . . . 0.0 111.412 -177.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 2.0 mp -69.76 -39.71 78.27 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.905 0 C-N-CA 124.26 1.024 . . . . 0.0 109.681 175.762 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 48.1 mt -112.12 89.08 1.22 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.938 0 N-CA-C 109.176 -0.676 . . . . 0.0 109.176 177.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 29.1 mmm180 -121.08 -172.15 2.34 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 173.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 8.9 t-80 -124.53 128.13 48.48 Favored 'General case' 0 CA--C 1.542 0.641 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 174.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.57 -34.27 41.05 Favored 'General case' 0 N--CA 1.485 1.277 0 C-N-CA 124.202 1.001 . . . . 0.0 112.409 -172.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -96.59 122.59 7.44 Favored Glycine 0 C--N 1.34 0.76 0 N-CA-C 111.506 -0.638 . . . . 0.0 111.506 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 66.1 m . . . . . 0 CA--C 1.547 0.837 0 N-CA-C 108.819 -0.808 . . . . 0.0 108.819 178.493 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 23.9 tt0 . . . . . 0 N--CA 1.484 1.245 0 CA-C-O 119.911 -0.09 . . . . 0.0 110.963 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 74.32 -87.28 0.7 Allowed Glycine 0 C--N 1.352 1.46 0 C-N-CA 123.133 0.397 . . . . 0.0 113.997 172.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 32.7 p80 -153.62 165.94 34.33 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 123.975 0.91 . . . . 0.0 110.289 -176.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 58.0 ttp -162.17 108.72 1.3 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 123.207 0.603 . . . . 0.0 109.523 178.285 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 88.7 t80 -105.46 141.51 36.82 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 123.087 0.555 . . . . 0.0 111.747 -176.9 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -138.38 154.69 73.86 Favored Pre-proline 0 CA--C 1.553 1.077 0 C-N-CA 125.335 1.454 . . . . 0.0 107.894 171.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 28.1 Cg_exo -62.82 99.45 0.22 Allowed 'Trans proline' 0 C--N 1.37 1.676 0 C-N-CA 122.284 1.99 . . . . 0.0 111.917 177.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 125.43 -18.49 6.84 Favored Glycine 0 C--N 1.35 1.325 0 CA-C-O 119.85 -0.417 . . . . 0.0 113.542 -179.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . 0.543 ' NE2' ' HB3' ' A' ' 26' ' ' HIS . 20.8 t-80 -158.27 151.25 22.67 Favored 'General case' 0 N--CA 1.485 1.3 0 CA-C-N 117.246 0.523 . . . . 0.0 111.793 -172.173 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.551 HD23 HD12 ' A' ' 27' ' ' ILE . 54.4 tp -134.61 150.04 50.65 Favored 'General case' 0 N--CA 1.476 0.837 0 C-N-CA 125.001 1.32 . . . . 0.0 108.509 179.384 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 3.3 t-160 -124.15 139.67 53.71 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 123.534 0.734 . . . . 0.0 109.24 174.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.502 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 83.8 mt -124.48 128.01 48.33 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 106.457 -1.683 . . . . 0.0 106.457 176.417 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 2.6 p -149.74 92.49 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.554 1.131 0 CA-C-O 122.728 1.251 . . . . 0.0 112.526 -175.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.519 ' H ' HG13 ' A' ' 23' ' ' ILE . 38.8 t -73.63 106.46 5.4 Favored 'General case' 0 C--O 1.244 0.782 0 CA-C-N 113.715 -1.584 . . . . 0.0 109.166 163.234 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -75.61 138.3 70.51 Favored Pre-proline 0 CA--C 1.558 1.256 0 CA-C-N 115.788 -0.642 . . . . 0.0 111.165 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -86.62 -94.67 0.0 OUTLIER 'Trans proline' 0 CA--C 1.562 1.883 0 C-N-CA 122.578 2.185 . . . . 0.0 112.156 170.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 70.94 -105.38 1.61 Allowed Glycine 0 C--N 1.36 1.882 0 CA-C-N 118.57 0.623 . . . . 0.0 112.359 -176.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 88.4 mt -78.19 -26.23 47.47 Favored 'General case' 0 N--CA 1.483 1.178 0 C-N-CA 123.448 0.699 . . . . 0.0 109.912 173.165 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -84.51 163.66 19.27 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.912 0.885 . . . . 0.0 108.985 174.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 85.4 mm-40 -99.11 -36.86 9.55 Favored 'General case' 0 C--O 1.241 0.637 0 C-N-CA 122.904 0.481 . . . . 0.0 111.713 -178.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.496 HE21 HG22 ' A' ' 23' ' ' ILE . 55.9 tp60 -77.0 107.69 9.52 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 122.748 1.261 . . . . 0.0 112.833 -170.16 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -100.49 113.33 26.02 Favored 'General case' 0 CA--C 1.551 0.996 0 CA-C-N 112.209 -2.269 . . . . 0.0 110.886 173.932 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.519 HG13 ' H ' ' A' ' 14' ' ' SER . 0.6 OUTLIER -120.38 132.3 70.34 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 163.778 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -139.82 119.63 13.38 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 174.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.502 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 52.2 mt -143.66 151.52 16.62 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 107.729 -1.211 . . . . 0.0 107.729 -170.335 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.543 ' HB3' ' NE2' ' A' ' 9' ' ' HIS . 15.1 m170 -126.61 146.53 50.13 Favored 'General case' 0 N--CA 1.469 0.48 0 N-CA-C 107.133 -1.432 . . . . 0.0 107.133 171.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.551 HD12 HD23 ' A' ' 10' ' ' LEU . 60.2 mt -125.77 106.44 16.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.633 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 172.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 31.2 ttt180 -97.33 132.61 42.9 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 175.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 37.9 p90 -135.02 125.24 26.15 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -127.32 115.55 19.17 Favored 'General case' 0 C--O 1.238 0.497 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 178.029 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 41' ' ' VAL . 47.0 t -86.93 115.21 27.36 Favored 'Isoleucine or valine' 0 C--O 1.235 0.33 0 N-CA-C 107.362 -1.347 . . . . 0.0 107.362 -179.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.422 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 51.1 ttt85 -125.17 163.64 22.0 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 -179.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.422 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 27.7 mm-40 -112.87 112.55 24.1 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 108.328 -0.99 . . . . 0.0 108.328 177.793 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.483 HD21 ' HB3' ' A' ' 37' ' ' SER . 0.1 OUTLIER -95.42 144.34 26.02 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.343 0.657 . . . . 0.0 109.511 171.442 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -67.64 -19.09 65.17 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 123.121 0.569 . . . . 0.0 111.432 178.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -67.81 -52.15 40.36 Favored 'General case' 0 CA--C 1.553 1.069 0 C-N-CA 124.749 1.22 . . . . 0.0 112.091 -179.196 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.483 ' HB3' HD21 ' A' ' 34' ' ' ASN . 32.6 t -123.4 -14.52 7.38 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 112.336 0.495 . . . . 0.0 112.336 -172.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.48 -125.97 8.69 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 111.083 -0.807 . . . . 0.0 111.083 -175.204 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . . . . . . . . . . . -68.67 134.53 50.02 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 122.817 0.447 . . . . 0.0 110.773 174.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -152.1 170.82 19.0 Favored 'General case' 0 N--CA 1.48 1.044 0 C-N-CA 123.553 0.741 . . . . 0.0 109.21 170.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.448 HG22 HG22 ' A' ' 31' ' ' VAL . 4.8 t -127.69 121.9 57.78 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 175.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 22.8 t60 -89.52 121.34 31.64 Favored 'General case' 0 C--O 1.239 0.536 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 173.198 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 61.1 m-85 -107.39 137.93 44.53 Favored 'General case' 0 N--CA 1.471 0.592 0 C-N-CA 123.402 0.681 . . . . 0.0 110.574 179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . . . . . . . . . 42.5 m-20 -126.9 123.3 36.92 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 170.233 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 72.2 mtp -118.88 130.03 55.52 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 118.279 0.491 . . . . 0.0 110.391 177.167 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 7.7 p-10 -152.92 159.84 43.0 Favored 'General case' 0 N--CA 1.483 1.18 0 C-N-CA 123.292 0.637 . . . . 0.0 110.713 -175.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 163.4 -147.11 12.49 Favored Glycine 0 N--CA 1.474 1.223 0 N-CA-C 110.001 -1.24 . . . . 0.0 110.001 175.299 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 52' ' ' LYS . 0.8 OUTLIER -148.45 108.29 4.03 Favored 'General case' 0 CA--C 1.551 1.014 0 CA-C-N 118.303 1.051 . . . . 0.0 111.653 172.666 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 69.1 mt -98.51 124.98 51.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 CA-C-N 114.588 -1.187 . . . . 0.0 110.59 176.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 21.1 t70 68.22 16.67 9.37 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 124.545 1.153 . . . . 0.0 110.5 177.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 100.36 -15.22 59.08 Favored Glycine 0 C--N 1.348 1.224 0 CA-C-N 115.704 -0.68 . . . . 0.0 113.088 -173.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.425 ' O ' ' HA ' ' A' ' 48' ' ' GLU . 95.6 mttt -83.28 109.93 20.76 Favored Pre-proline 0 N--CA 1.475 0.814 0 C-N-CA 123.816 0.847 . . . . 0.0 112.748 -173.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 68.7 Cg_endo -71.2 138.67 33.77 Favored 'Trans proline' 0 C--N 1.379 2.141 0 C-N-CA 122.324 2.016 . . . . 0.0 110.601 175.371 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 43.0 p90 -145.47 155.7 43.27 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 122.524 0.33 . . . . 0.0 110.824 -173.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 23.6 p -150.56 130.06 13.01 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 123.978 0.911 . . . . 0.0 108.969 173.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 6.9 t0 -144.91 157.29 44.2 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 -176.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 43.3 m -143.62 142.14 30.92 Favored 'General case' 0 N--CA 1.475 0.811 0 C-N-CA 122.917 0.487 . . . . 0.0 110.969 -179.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 22.2 p90 -141.11 146.58 37.26 Favored 'General case' 0 N--CA 1.473 0.708 0 C-N-CA 123.882 0.873 . . . . 0.0 109.077 171.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -126.22 129.81 49.7 Favored 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -179.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 97.0 mt -125.87 122.0 24.41 Favored Pre-proline 0 C--O 1.237 0.407 0 N-CA-C 108.515 -0.921 . . . . 0.0 108.515 -177.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -64.48 163.95 25.17 Favored 'Trans proline' 0 C--N 1.375 1.928 0 C-N-CA 122.767 2.312 . . . . 0.0 111.089 172.124 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.487 ' HG3' HD13 ' A' ' 106' ' ' LEU . 61.7 ttt180 -48.6 -30.62 5.56 Favored 'General case' 0 N--CA 1.492 1.647 0 C-N-CA 123.761 0.825 . . . . 0.0 111.568 175.102 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -57.77 -40.52 80.0 Favored 'General case' 0 CA--C 1.554 1.123 0 C-N-CA 124.766 1.226 . . . . 0.0 112.726 175.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 40.8 p -128.36 14.23 6.62 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 123.594 0.758 . . . . 0.0 111.87 -174.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' PHE . . . -63.74 -29.38 70.6 Favored 'General case' 0 N--CA 1.483 1.213 0 C-N-CA 123.541 0.737 . . . . 0.0 111.66 -178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . 0.653 ' HE1' ' HB3' ' A' ' 103' ' ' ARG . 71.6 m-85 -70.77 -1.13 10.53 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 178.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 73.3 m-20 -96.53 5.42 50.82 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 123.958 0.903 . . . . 0.0 110.269 173.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.405 ' HB3' ' O ' ' A' ' 65' ' ' ALA . 25.7 p90 -53.72 -49.66 67.64 Favored 'General case' 0 C--N 1.359 1.021 0 C-N-CA 124.632 1.173 . . . . 0.0 112.474 -170.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -75.04 -29.8 60.87 Favored 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 123.591 0.756 . . . . 0.0 111.087 -172.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.4 m -71.35 -45.34 63.17 Favored 'General case' 0 CA--C 1.537 0.451 0 O-C-N 124.003 0.814 . . . . 0.0 109.209 -176.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -73.26 -41.01 64.16 Favored 'General case' 0 CA--C 1.546 0.827 0 CA-C-N 115.448 -0.796 . . . . 0.0 110.878 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -50.85 -40.55 56.33 Favored 'General case' 0 N--CA 1.492 1.66 0 C-N-CA 123.504 0.722 . . . . 0.0 112.42 169.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . 0.422 ' O ' ' HG3' ' A' ' 77' ' ' GLN . 95.2 m -71.18 -43.24 67.85 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.708 175.722 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . 0.44 ' O ' ' HG3' ' A' ' 78' ' ' LYS . 44.7 ttt180 -55.66 -53.21 59.33 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.515 1.126 . . . . 0.0 111.734 -178.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.4 ' HA ' ' HD3' ' A' ' 78' ' ' LYS . 8.5 p -69.78 -32.17 51.1 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.785 0 C-N-CA 123.489 0.716 . . . . 0.0 111.381 -178.223 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -61.63 -37.04 82.52 Favored 'General case' 0 N--CA 1.478 0.928 0 CA-C-O 121.415 0.626 . . . . 0.0 110.429 175.341 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.789 ' HA ' HD22 ' A' ' 81' ' ' LEU . 96.3 mt-30 -76.32 -40.09 52.33 Favored 'General case' 0 C--O 1.241 0.628 0 CA-C-N 114.387 -1.278 . . . . 0.0 112.361 179.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . 0.44 ' HG3' ' O ' ' A' ' 74' ' ' ARG . 29.7 mtpp -53.18 -35.63 60.04 Favored 'General case' 0 N--CA 1.489 1.486 0 C-N-CA 124.024 0.93 . . . . 0.0 112.45 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . . . . . . . . . 71.7 m-70 -79.6 25.07 0.35 Allowed 'General case' 0 CA--C 1.551 1.019 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.48 59.45 10.82 Favored Glycine 0 C--N 1.363 2.079 0 C-N-CA 123.275 0.464 . . . . 0.0 114.141 174.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.789 HD22 ' HA ' ' A' ' 77' ' ' GLN . 1.2 pt? -76.72 -29.14 56.1 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 119.1 -0.476 . . . . 0.0 111.658 -174.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.439 ' N ' HD23 ' A' ' 81' ' ' LEU . 19.3 t-160 55.88 93.63 0.05 OUTLIER Pre-proline 0 N--CA 1.487 1.398 0 C-N-CA 123.876 0.87 . . . . 0.0 109.587 -172.195 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . . . . . . . . . 31.8 Cg_endo -60.12 89.53 0.08 OUTLIER 'Trans proline' 0 C--N 1.384 2.424 0 C-N-CA 123.195 2.597 . . . . 0.0 113.079 -171.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . 0.495 ' HD3' ' OG ' ' A' ' 14' ' ' SER . 83.0 tttt -73.77 -37.82 64.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 114.591 -1.186 . . . . 0.0 109.777 175.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -64.8 -18.34 65.01 Favored 'General case' 0 N--CA 1.481 1.083 0 C-N-CA 124.018 0.927 . . . . 0.0 111.322 177.44 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 71.24 -113.5 4.71 Favored Glycine 0 C--N 1.354 1.534 0 N-CA-C 111.198 -0.761 . . . . 0.0 111.198 -177.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -163.32 79.47 0.45 Allowed 'General case' 0 N--CA 1.473 0.687 0 C-N-CA 123.866 0.867 . . . . 0.0 108.928 175.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 mm -90.89 95.15 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.107 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 81.7 p -83.95 -3.06 57.69 Favored 'General case' 0 CA--C 1.549 0.906 0 CA-C-N 115.007 -0.997 . . . . 0.0 111.357 178.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 6.8 mpt_? -78.28 -39.71 39.14 Favored 'General case' 0 N--CA 1.474 0.742 0 C-N-CA 124.479 1.112 . . . . 0.0 110.676 -172.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 27.1 m -69.47 171.84 0.93 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.963 0 C-N-CA 123.665 0.786 . . . . 0.0 111.659 179.413 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 17.7 m-70 -77.4 85.4 3.8 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 121.202 0.525 . . . . 0.0 110.144 173.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.748 ' H ' ' HD3' ' A' ' 93' ' ' LYS . 0.0 OUTLIER -59.46 127.76 33.65 Favored 'General case' 0 CA--C 1.543 0.698 0 CA-C-N 115.178 -0.919 . . . . 0.0 109.152 168.486 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -87.01 28.41 0.91 Allowed 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 123.892 0.877 . . . . 0.0 112.296 -170.852 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 84.9 t80 -66.43 -56.09 12.63 Favored 'General case' 0 C--N 1.356 0.877 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -56.97 -39.1 73.99 Favored 'General case' 0 N--CA 1.48 1.053 0 C-N-CA 124.21 1.004 . . . . 0.0 112.085 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -64.29 -50.53 67.51 Favored 'General case' 0 N--CA 1.472 0.646 0 C-N-CA 122.737 0.415 . . . . 0.0 110.813 -177.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . . . . . . . . . 37.1 ttm -70.76 -31.28 68.03 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 115.699 -0.682 . . . . 0.0 111.617 178.641 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 49.8 t80 -63.73 -56.11 18.14 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 124.759 1.223 . . . . 0.0 110.707 -179.189 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.451 ' HA ' ' HG3' ' A' ' 103' ' ' ARG . 6.0 mm-40 -69.82 -28.28 65.58 Favored 'General case' 0 C--O 1.24 0.6 0 CA-C-N 114.793 -1.094 . . . . 0.0 112.658 -177.491 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -68.23 -49.35 61.3 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 175.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 49.2 mt -60.93 -42.77 94.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-O 118.76 -0.638 . . . . 0.0 111.441 179.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . 0.653 ' HB3' ' HE1' ' A' ' 66' ' ' PHE . 0.6 OUTLIER -65.94 -31.18 71.95 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 118.464 0.575 . . . . 0.0 111.563 -179.716 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . . . . . . . . . . . -66.85 -42.91 84.92 Favored 'General case' 0 CA--C 1.543 0.692 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.174 175.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.539 ' HE3' ' HA ' ' A' ' 105' ' ' LYS . 0.5 OUTLIER -72.66 -28.77 62.93 Favored 'General case' 0 CA--C 1.553 1.09 0 C-N-CA 123.845 0.858 . . . . 0.0 112.805 177.441 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . 0.487 HD13 ' HG3' ' A' ' 62' ' ' ARG . 89.3 mt -63.98 -34.11 77.25 Favored 'General case' 0 N--CA 1.485 1.323 0 C-N-CA 123.392 0.677 . . . . 0.0 110.572 174.429 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.4 t60 -68.69 -17.95 64.17 Favored 'General case' 0 CA--C 1.555 1.15 0 C-N-CA 123.861 0.864 . . . . 0.0 111.607 173.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 81.35 -60.08 0.23 Allowed 'General case' 0 N--CA 1.488 1.449 0 C-N-CA 126.379 1.871 . . . . 0.0 109.583 -175.712 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -76.74 130.76 75.36 Favored Pre-proline 0 CA--C 1.544 0.724 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 166.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -53.55 91.51 0.03 OUTLIER 'Trans proline' 0 C--N 1.376 1.983 0 C-N-CA 123.248 2.632 . . . . 0.0 114.118 -177.147 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -87.27 70.07 2.9 Favored Glycine 0 C--N 1.346 1.123 0 N-CA-C 110.405 -1.078 . . . . 0.0 110.405 173.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -74.72 159.38 83.32 Favored Pre-proline 0 CA--C 1.554 1.104 0 C-N-CA 124.241 1.016 . . . . 0.0 112.604 -170.45 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.432 ' HD3' ' HB3' ' A' ' 100' ' ' GLU . 26.5 Cg_endo -59.13 96.27 0.09 OUTLIER 'Trans proline' 0 C--N 1.383 2.367 0 C-N-CA 123.237 2.625 . . . . 0.0 113.706 178.488 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 13.5 p -167.74 136.58 0.58 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 123.708 0.803 . . . . 0.0 109.75 174.162 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -127.5 41.83 3.44 Favored 'General case' 0 N--CA 1.484 1.257 0 C-N-CA 124.075 0.95 . . . . 0.0 110.157 -175.353 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.2 pp -61.38 -35.61 77.96 Favored 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 123.726 0.81 . . . . 0.0 112.042 -178.393 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 43.7 tt0 -91.45 -6.43 52.73 Favored 'General case' 0 N--CA 1.479 1.004 0 C-N-CA 123.862 0.865 . . . . 0.0 111.504 -176.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 45.4 ttp180 -77.4 5.01 9.56 Favored 'General case' 0 CA--C 1.558 1.277 0 O-C-N 122.156 -0.34 . . . . 0.0 111.817 -174.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . . . . . . . . . 46.6 mm -77.19 -64.86 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 123.396 0.679 . . . . 0.0 110.062 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 67.3 mt -108.74 105.82 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.722 0 C-N-CA 123.906 0.882 . . . . 0.0 108.83 179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 43.9 mtp-105 -128.4 74.46 1.56 Allowed 'General case' 0 N--CA 1.472 0.665 0 C-N-CA 123.66 0.784 . . . . 0.0 109.6 177.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 73.0 t60 -78.47 127.83 32.72 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-N 115.578 -0.737 . . . . 0.0 109.305 173.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -77.31 130.8 37.64 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 123.115 0.566 . . . . 0.0 109.524 177.847 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -67.72 -49.68 47.75 Favored Glycine 0 C--N 1.349 1.258 0 O-C-N 123.754 0.659 . . . . 0.0 112.888 -176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 48.2 m . . . . . 0 C--O 1.249 1.043 0 C-N-CA 123.436 0.694 . . . . 0.0 110.112 -179.812 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLN . . . . . . . . . . . . . 86.6 mt-30 . . . . . 0 N--CA 1.483 1.193 0 N-CA-C 109.915 -0.402 . . . . 0.0 109.915 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLY . . . . . . . . . . . . . . . 75.9 -134.81 16.73 Favored Glycine 0 C--N 1.344 0.98 0 CA-C-N 116.367 -0.379 . . . . 0.0 112.762 -178.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' HIS . . . . . . . . . . . . . 43.4 p-80 -81.02 115.32 20.43 Favored 'General case' 0 CA--C 1.547 0.864 0 N-CA-C 109.221 -0.659 . . . . 0.0 109.221 179.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' MET . . . . . . . . . . . . . 57.4 mtm -142.62 145.63 33.69 Favored 'General case' 0 N--CA 1.486 1.337 0 C-N-CA 123.351 0.66 . . . . 0.0 110.427 -171.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 65.2 t80 -107.75 146.18 32.5 Favored 'General case' 0 N--CA 1.478 0.956 0 C-N-CA 123.278 0.631 . . . . 0.0 109.979 171.399 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -156.04 152.33 23.41 Favored Pre-proline 0 CA--C 1.553 1.069 0 C-N-CA 124.342 1.057 . . . . 0.0 109.376 174.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -57.07 96.85 0.07 OUTLIER 'Trans proline' 0 C--N 1.376 1.996 0 C-N-CA 122.862 2.375 . . . . 0.0 112.749 176.086 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 128.57 -22.11 5.28 Favored Glycine 0 C--N 1.345 1.041 0 CA-C-N 115.667 -0.697 . . . . 0.0 112.961 177.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' HIS . . . . . . . . . . . . . 54.5 t-80 -155.26 151.6 28.27 Favored 'General case' 0 N--CA 1.483 1.182 0 N-CA-C 112.592 0.589 . . . . 0.0 112.592 -172.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.473 HD22 ' SD ' ' A' ' 98' ' ' MET . 55.4 tp -135.88 131.47 35.32 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 125.747 1.619 . . . . 0.0 107.411 176.204 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' HIS . . . . . . . . . . . . . 19.9 t-160 -113.82 139.96 48.72 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 123.554 0.741 . . . . 0.0 110.452 -175.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' LEU . . . . . 0.527 ' HB2' ' HB ' ' A' ' 25' ' ' ILE . 30.3 mt -134.15 124.72 26.54 Favored 'General case' 0 N--CA 1.483 1.195 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.8 p -151.02 155.77 6.91 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.389 0 CA-C-N 120.192 1.36 . . . . 0.0 114.325 -174.345 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' SER . . . . . 0.485 ' HB2' ' H ' ' A' ' 23' ' ' ILE . 22.8 t -61.63 102.85 0.28 Allowed 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 112.235 -2.257 . . . . 0.0 106.947 164.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.415 ' HB2' ' HD2' ' A' ' 16' ' ' PRO . 3.7 pp -115.73 168.82 7.76 Favored Pre-proline 0 N--CA 1.48 1.065 0 C-N-CA 124.329 1.052 . . . . 0.0 110.254 -165.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PRO . . . . . 0.415 ' HD2' ' HB2' ' A' ' 15' ' ' LEU . 35.2 Cg_endo -60.19 91.2 0.08 OUTLIER 'Trans proline' 0 C--N 1.378 2.124 0 C-N-CA 122.635 2.223 . . . . 0.0 111.726 174.852 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLY . . . . . . . . . . . . . . . 142.6 -40.24 1.28 Allowed Glycine 0 CA--C 1.524 0.649 0 CA-C-N 114.653 -1.158 . . . . 0.0 110.516 -175.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' LEU . . . . . . . . . . . . . 57.0 tp -106.1 95.0 5.47 Favored 'General case' 0 N--CA 1.475 0.781 0 C-N-CA 124.164 0.985 . . . . 0.0 109.276 177.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASP . . . . . . . . . . . . . 8.6 p-10 -127.9 6.85 6.08 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 124.184 0.993 . . . . 0.0 110.766 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' GLN . . . . . . . . . . . . . 24.4 tm0? -56.0 -46.65 78.68 Favored 'General case' 0 N--CA 1.483 1.179 0 C-N-CA 123.184 0.593 . . . . 0.0 110.127 -179.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.438 ' HG3' HG23 ' A' ' 23' ' ' ILE . 20.1 pt20 -135.56 155.75 49.97 Favored 'General case' 0 C--O 1.244 0.793 0 C-N-CA 122.914 0.486 . . . . 0.0 110.257 173.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -78.52 100.94 7.11 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 123.792 0.837 . . . . 0.0 110.351 175.844 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ILE . . . . . 0.485 ' H ' ' HB2' ' A' ' 14' ' ' SER . 19.2 pt -117.0 145.33 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.977 0 CA-C-O 121.22 0.534 . . . . 0.0 109.954 169.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . 0.52 HD21 ' HG2' ' A' ' 48' ' ' GLU . 4.4 p30 -152.92 125.94 8.49 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 163.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ILE . . . . . 0.527 ' HB ' ' HB2' ' A' ' 12' ' ' LEU . 44.7 mt -139.32 116.3 10.53 Favored 'Isoleucine or valine' 0 C--O 1.243 0.714 0 N-CA-C 107.351 -1.351 . . . . 0.0 107.351 -171.426 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' HIS . . . . . 0.447 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.5 m170 -104.25 122.69 45.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 -178.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ILE . . . . . 0.516 ' HA ' ' HG2' ' A' ' 45' ' ' MET . 57.3 mt -114.88 105.34 18.46 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 N-CA-C 107.783 -1.191 . . . . 0.0 107.783 -178.249 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 44' ' ' ASP . 67.2 ttt180 -97.89 140.4 32.3 Favored 'General case' 0 C--N 1.319 -0.76 0 C-N-CA 124.729 1.212 . . . . 0.0 108.478 177.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -138.41 136.38 36.21 Favored 'General case' 0 N--CA 1.469 0.476 0 N-CA-C 108.862 -0.792 . . . . 0.0 108.862 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -131.52 116.04 16.92 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.375 1.07 . . . . 0.0 108.419 -172.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 105' ' ' LYS . 72.8 t -87.01 123.66 40.02 Favored 'Isoleucine or valine' 0 C--O 1.239 0.55 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -178.336 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ARG . . . . . 0.473 ' HG2' ' N ' ' A' ' 33' ' ' GLN . 19.2 ttt180 -153.14 169.25 23.44 Favored 'General case' 0 N--CA 1.476 0.851 0 C-N-CA 124.476 1.111 . . . . 0.0 108.759 -170.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLN . . . . . 0.473 ' N ' ' HG2' ' A' ' 32' ' ' ARG . 23.2 mm-40 -106.68 127.0 53.0 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 123.32 0.648 . . . . 0.0 110.225 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . 0.452 ' OD1' ' HB3' ' A' ' 36' ' ' GLU . 3.1 p30 -102.96 147.69 26.61 Favored 'General case' 0 N--CA 1.478 0.951 0 C-N-CA 124.35 1.06 . . . . 0.0 108.896 170.991 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -71.16 -20.23 62.32 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 112.349 0.5 . . . . 0.0 112.349 -178.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' GLU . . . . . 0.452 ' HB3' ' OD1' ' A' ' 34' ' ' ASN . 10.6 tp10 -71.09 -48.18 53.91 Favored 'General case' 0 CA--C 1.55 0.952 0 C-N-CA 123.9 0.88 . . . . 0.0 111.677 -174.111 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.5 m -131.47 -6.91 3.73 Favored 'General case' 0 N--CA 1.485 1.275 0 C-N-CA 123.492 0.717 . . . . 0.0 112.905 -169.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 97.94 -124.17 8.08 Favored Glycine 0 N--CA 1.473 1.117 0 N-CA-C 111.73 -0.548 . . . . 0.0 111.73 -178.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ALA . . . . . 0.427 ' HB3' ' HD3' ' A' ' 62' ' ' ARG . . . -68.5 137.14 54.16 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 117.403 0.602 . . . . 0.0 111.286 177.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 2.1 p90 -155.91 178.37 10.35 Favored 'General case' 0 N--CA 1.484 1.226 0 C-N-CA 122.882 0.473 . . . . 0.0 110.492 177.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.41 HG22 HG22 ' A' ' 31' ' ' VAL . 20.2 t -133.44 127.85 54.19 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.08 0 C-N-CA 123.778 0.831 . . . . 0.0 109.397 173.089 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . . . . . . . . . 15.5 t60 -89.31 121.43 31.58 Favored 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 123.831 0.852 . . . . 0.0 108.912 171.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 58.5 m-85 -102.8 133.22 48.21 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 123.787 0.835 . . . . 0.0 108.913 177.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 28' ' ' ARG . 27.1 t70 -133.48 114.15 13.3 Favored 'General case' 0 N--CA 1.478 0.931 0 C-N-CA 124.023 0.929 . . . . 0.0 109.883 -177.026 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.516 ' HG2' ' HA ' ' A' ' 27' ' ' ILE . 43.4 mtm -119.86 145.43 46.68 Favored 'General case' 0 N--CA 1.479 0.982 0 O-C-N 121.736 -0.603 . . . . 0.0 111.451 -178.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ASP . . . . . . . . . . . . . 8.8 p-10 -156.93 157.9 35.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 123.146 0.578 . . . . 0.0 111.24 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 161.85 -156.05 27.48 Favored Glycine 0 C--N 1.339 0.734 0 N-CA-C 110.531 -1.028 . . . . 0.0 110.531 174.274 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.52 ' HG2' HD21 ' A' ' 24' ' ' ASN . 12.5 pt-20 -148.28 115.19 6.08 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 118.845 1.322 . . . . 0.0 111.411 173.289 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.533 HD12 ' HB2' ' A' ' 79' ' ' HIS . 50.5 mt -97.74 130.69 46.08 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 CA-C-N 114.636 -1.165 . . . . 0.0 111.212 176.809 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ASP . . . . . . . . . . . . . 16.0 t70 65.33 -69.88 0.1 Allowed 'General case' 0 C--N 1.361 1.086 0 C-N-CA 126.159 1.783 . . . . 0.0 110.617 -168.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -176.27 47.21 0.11 Allowed Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.597 -2.201 . . . . 0.0 107.597 179.507 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 30.4 mtmm -137.07 104.29 8.82 Favored Pre-proline 0 C--N 1.35 0.592 0 CA-C-N 114.261 -0.97 . . . . 0.0 108.91 -172.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -69.74 136.75 33.83 Favored 'Trans proline' 0 C--N 1.375 1.947 0 C-N-CA 122.381 2.054 . . . . 0.0 110.834 176.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PHE . . . . . . . . . . . . . 46.3 p90 -135.35 138.02 42.96 Favored 'General case' 0 N--CA 1.469 0.517 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 178.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' SER . . . . . . . . . . . . . 26.2 p -134.14 118.22 17.44 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 174.299 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -132.74 139.73 47.73 Favored 'General case' 0 N--CA 1.467 0.404 0 C-N-CA 124.276 1.03 . . . . 0.0 109.385 -174.327 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 65.7 p -140.54 124.0 16.92 Favored 'General case' 0 N--CA 1.469 0.497 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 176.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 45.3 p90 -136.55 142.1 43.4 Favored 'General case' 0 N--CA 1.47 0.573 0 C-N-CA 123.814 0.846 . . . . 0.0 108.782 -178.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 50.5 mt-10 -121.33 130.58 53.71 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 123.423 0.689 . . . . 0.0 109.772 -174.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' LEU . . . . . . . . . . . . . 88.3 mt -128.29 130.32 23.57 Favored Pre-proline 0 C--O 1.241 0.616 0 N-CA-C 108.383 -0.969 . . . . 0.0 108.383 -178.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -58.79 155.64 36.83 Favored 'Trans proline' 0 C--N 1.378 2.11 0 C-N-CA 122.716 2.277 . . . . 0.0 111.187 171.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.427 ' HD3' ' HB3' ' A' ' 39' ' ' ALA . 32.3 ptt180 -41.85 -26.08 0.08 Allowed 'General case' 0 N--CA 1.496 1.86 0 N-CA-C 114.971 1.471 . . . . 0.0 114.971 176.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -85.53 -13.61 48.44 Favored 'General case' 0 CA--C 1.545 0.754 0 C-N-CA 123.753 0.821 . . . . 0.0 111.621 -173.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' THR . . . . . . . . . . . . . 45.0 p -132.49 -2.4 3.43 Favored 'General case' 0 N--CA 1.485 1.316 0 C-N-CA 124.404 1.082 . . . . 0.0 111.222 -179.115 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -57.94 -36.71 72.92 Favored 'General case' 0 N--CA 1.49 1.53 0 C-N-CA 124.552 1.141 . . . . 0.0 111.988 179.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -69.88 -9.43 54.86 Favored 'General case' 0 CA--C 1.551 0.992 0 C-N-CA 124.374 1.07 . . . . 0.0 112.761 178.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ASN . . . . . . . . . . . . . 83.0 m-20 -91.73 -7.57 49.36 Favored 'General case' 0 N--CA 1.48 1.036 0 C-N-CA 123.315 0.646 . . . . 0.0 110.514 -178.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PHE . . . . . 0.514 ' HZ ' ' SD ' ' A' ' 98' ' ' MET . 4.0 p90 -54.12 -35.78 62.55 Favored 'General case' 0 N--CA 1.478 0.955 0 C-N-CA 123.602 0.761 . . . . 0.0 112.769 -177.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -53.43 -26.56 20.49 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 112.827 0.677 . . . . 0.0 112.827 178.943 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 31.5 m -72.49 -52.66 14.81 Favored 'General case' 0 CA--C 1.547 0.863 0 N-CA-C 110.14 -0.319 . . . . 0.0 110.14 171.898 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.412 ' O ' HG23 ' A' ' 75' ' ' VAL . 38.9 t0 -73.14 -54.28 8.88 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.472 0.709 . . . . 0.0 112.799 -174.259 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ALA . . . . . . . . . . . . . . . -45.03 -38.43 4.83 Favored 'General case' 0 N--CA 1.497 1.91 0 C-N-CA 124.3 1.04 . . . . 0.0 113.041 172.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' THR . . . . . . . . . . . . . 97.9 m -77.27 -37.69 52.46 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.462 175.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ARG . . . . . . . . . . . . . 48.3 ttp180 -62.7 -47.98 81.27 Favored 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 123.946 0.898 . . . . 0.0 111.402 -177.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 71' ' ' ASP . 41.5 t -61.25 -39.5 82.81 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.852 0 C-N-CA 124.079 0.952 . . . . 0.0 110.264 177.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . 0.488 ' HB1' HD13 ' A' ' 25' ' ' ILE . . . -66.67 -44.7 81.14 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.857 0.863 . . . . 0.0 110.953 -178.655 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLN . . . . . 0.415 ' HA ' ' H ' ' A' ' 81' ' ' LEU . 5.3 pp0? -76.59 -26.85 55.48 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-N 116.147 -0.479 . . . . 0.0 111.045 -175.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -59.77 -45.9 90.84 Favored 'General case' 0 N--CA 1.474 0.731 0 C-N-CA 123.342 0.657 . . . . 0.0 111.968 171.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' HIS . . . . . 0.533 ' HB2' HD12 ' A' ' 49' ' ' ILE . 56.3 m80 -74.34 -30.35 61.98 Favored 'General case' 0 N--CA 1.482 1.134 0 N-CA-C 110.212 -0.292 . . . . 0.0 110.212 -179.052 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 144.42 80.34 0.04 OUTLIER Glycine 0 C--N 1.343 0.959 0 N-CA-C 110.443 -1.063 . . . . 0.0 110.443 158.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.415 ' H ' ' HA ' ' A' ' 77' ' ' GLN . 38.9 tp -139.26 153.31 47.78 Favored 'General case' 0 N--CA 1.477 0.906 0 CA-C-O 121.293 0.568 . . . . 0.0 110.237 178.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.624 ' H ' ' HD2' ' A' ' 83' ' ' PRO . 44.4 t-80 -167.64 -57.54 0.01 OUTLIER Pre-proline 0 CA--C 1.563 1.465 0 CA-C-O 117.504 -1.236 . . . . 0.0 110.261 175.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.624 ' HD2' ' H ' ' A' ' 82' ' ' HIS . 30.8 Cg_exo -3.8 -122.65 0.0 OUTLIER 'Trans proline' 0 C--N 1.412 3.88 1 C-N-CA 127.229 5.286 . . . . 0.0 118.101 -166.367 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -83.0 -7.13 59.7 Favored 'General case' 0 N--CA 1.478 0.973 0 C-N-CA 123.383 0.673 . . . . 0.0 111.962 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' PHE . . . . . . . . . . . . . 63.6 m-85 -76.68 -54.32 6.81 Favored 'General case' 0 N--CA 1.472 0.673 0 C-N-CA 122.852 0.461 . . . . 0.0 110.212 -175.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . 44.16 -121.96 4.15 Favored Glycine 0 C--N 1.354 1.554 0 O-C-N 124.422 1.076 . . . . 0.0 114.284 177.593 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -119.83 160.36 22.78 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.036 0.934 . . . . 0.0 109.847 176.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.2 pt -67.45 -23.74 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.233 0 C-N-CA 123.734 0.814 . . . . 0.0 111.438 177.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' THR . . . . . . . . . . . . . 34.0 p -78.51 -33.98 47.65 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 123.866 0.866 . . . . 0.0 110.994 174.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ARG . . . . . . . . . . . . . 19.4 tpp180 -70.27 -59.68 2.73 Favored 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 122.953 0.501 . . . . 0.0 109.903 -178.879 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' VAL . . . . . . . . . . . . . 30.9 m -124.09 146.82 28.96 Favored 'Isoleucine or valine' 0 C--O 1.242 0.7 0 C-N-CA 124.373 1.069 . . . . 0.0 108.615 177.3 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' HIS . . . . . . . . . . . . . 56.4 m170 -72.68 87.01 1.23 Allowed 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 121.435 0.636 . . . . 0.0 109.574 174.061 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 33.7 ttpt -90.03 43.43 1.15 Allowed 'General case' 0 CA--C 1.554 1.132 0 C-N-CA 124.871 1.268 . . . . 0.0 110.37 -174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 58.12 23.8 10.56 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 124.775 1.23 . . . . 0.0 113.014 174.03 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 71.3 t80 -65.46 -48.04 74.03 Favored 'General case' 0 C--O 1.214 -0.804 0 C-N-CA 123.837 0.855 . . . . 0.0 111.435 179.261 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -56.0 -35.9 67.3 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 123.042 0.537 . . . . 0.0 111.942 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ALA . . . . . . . . . . . . . . . -69.85 -44.69 69.35 Favored 'General case' 0 N--CA 1.481 1.089 0 CA-C-O 121.541 0.686 . . . . 0.0 110.854 174.166 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' MET . . . . . 0.514 ' SD ' ' HZ ' ' A' ' 68' ' ' PHE . 39.7 ttp -60.46 -34.45 74.04 Favored 'General case' 0 N--CA 1.481 1.118 0 C-N-CA 124.182 0.993 . . . . 0.0 112.759 174.099 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . . . . . . . . . 44.5 t80 -69.53 -53.87 16.93 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.153 0.981 . . . . 0.0 109.859 -175.577 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -61.7 -28.68 69.58 Favored 'General case' 0 N--CA 1.478 0.939 0 O-C-N 123.941 0.776 . . . . 0.0 112.785 179.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -67.58 -54.78 16.98 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 122.936 0.495 . . . . 0.0 109.982 175.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 74.4 mt -62.43 -42.02 94.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.922 0 CA-C-N 115.084 -0.962 . . . . 0.0 112.545 -177.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ARG . . . . . . . . . . . . . 1.6 ppt_? -63.14 -31.38 72.51 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-N 118.7 0.682 . . . . 0.0 110.907 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ALA . . . . . 0.59 ' HB1' ' HA ' ' A' ' 110' ' ' PRO . . . -72.88 -41.61 64.51 Favored 'General case' 0 CA--C 1.541 0.626 0 CA-C-N 115.548 -0.751 . . . . 0.0 110.593 177.654 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.478 ' HB3' HG21 ' A' ' 31' ' ' VAL . 0.1 OUTLIER -57.69 -47.94 80.93 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 123.646 0.779 . . . . 0.0 112.133 174.883 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -66.44 -39.04 88.67 Favored 'General case' 0 N--CA 1.476 0.835 0 O-C-N 123.683 0.615 . . . . 0.0 110.468 -178.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 23.8 t-160 -59.1 -31.9 69.33 Favored 'General case' 0 N--CA 1.48 1.043 0 C-N-CA 124.244 1.017 . . . . 0.0 111.196 170.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' ALA . . . . . . . . . . . . . . . 73.27 12.9 4.77 Favored 'General case' 0 N--CA 1.487 1.403 0 C-N-CA 125.397 1.479 . . . . 0.0 110.679 -176.236 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' HIS . . . . . . . . . . . . . 76.3 m-70 -143.63 122.66 7.31 Favored Pre-proline 0 CA--C 1.545 0.753 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 -176.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PRO . . . . . 0.59 ' HA ' ' HB1' ' A' ' 104' ' ' ALA . 3.2 Cg_exo -74.4 130.57 14.08 Favored 'Trans proline' 0 C--N 1.371 1.729 0 C-N-CA 123.171 2.58 . . . . 0.0 112.366 -173.154 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' GLY . . . . . . . . . . . . . . . -81.04 69.39 3.26 Favored Glycine 0 C--N 1.35 1.315 0 N-CA-C 111.94 -0.464 . . . . 0.0 111.94 179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -70.17 154.73 94.35 Favored Pre-proline 0 CA--C 1.557 1.247 0 C-N-CA 124.627 1.171 . . . . 0.0 111.969 -174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -70.66 148.08 58.5 Favored 'Trans proline' 0 C--N 1.376 2.0 0 C-N-CA 122.582 2.188 . . . . 0.0 111.945 174.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' VAL . . . . . . . . . . . . . 9.6 p -137.73 152.27 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.8 0 C-N-CA 123.728 0.811 . . . . 0.0 109.4 179.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' ASP . . . . . . . . . . . . . 18.1 m-20 -111.51 26.8 10.28 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 123.741 0.816 . . . . 0.0 111.651 -173.541 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LEU . . . . . . . . . . . . . 4.5 pp -69.5 -29.55 67.21 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 112.219 0.451 . . . . 0.0 112.219 -174.709 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -93.84 -2.23 53.78 Favored 'General case' 0 N--CA 1.477 0.902 0 C-N-CA 123.302 0.641 . . . . 0.0 111.846 -179.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . . . . . . . . . 72.7 ttt180 -75.98 -9.48 58.65 Favored 'General case' 0 N--CA 1.485 1.285 0 C-N-CA 123.588 0.755 . . . . 0.0 112.425 -170.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ILE . . . . . 0.41 HD12 ' N ' ' A' ' 119' ' ' ILE . 3.3 mp -88.51 67.42 0.55 Allowed 'Isoleucine or valine' 0 CA--C 1.556 1.206 0 CA-C-O 121.524 0.678 . . . . 0.0 109.628 -174.59 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 9.7 mt 52.95 35.56 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 C-N-CA 125.396 1.478 . . . . 0.0 112.528 166.311 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ARG . . . . . . . . . . . . . 11.7 ptt180 -74.12 134.03 42.85 Favored 'General case' 0 N--CA 1.483 1.202 0 O-C-N 121.397 -0.814 . . . . 0.0 110.439 -178.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' HIS . . . . . . . . . . . . . 55.7 m80 -142.95 127.1 17.49 Favored 'General case' 0 N--CA 1.477 0.921 0 N-CA-C 108.44 -0.948 . . . . 0.0 108.44 174.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 5.3 mp0 -77.2 -25.37 51.71 Favored 'General case' 0 N--CA 1.479 0.986 0 C-N-CA 123.155 0.582 . . . . 0.0 110.844 -173.672 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . -148.11 72.09 0.31 Allowed Glycine 0 C--N 1.345 1.055 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 176.776 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' SER . . . . . . . . . . . . . 37.7 p . . . . . 0 C--O 1.255 1.372 0 C-N-CA 123.754 0.822 . . . . 0.0 111.136 -176.874 . . . . . . . . 0 0 . 1 stop_ save_